data_2a0t_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2a0t _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.808 0.337 . . . . 0.0 110.753 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.409 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER -179.73 37.74 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.658 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.1 mm -76.75 137.52 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 CA-C-N 113.812 -1.54 . . . . 0.0 112.574 -177.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.486 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.1 t -92.98 -59.85 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.826 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 21.4 p -148.19 162.52 39.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.218 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -119.98 138.31 53.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.896 0.379 . . . . 0.0 111.221 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.439 HG22 ' CE2' ' A' ' 76' ' ' TYR . 2.1 m -106.62 122.7 60.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.728 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.43 HD11 ' CE1' ' A' ' 146' ' ' PHE . 20.5 mt -127.03 130.13 71.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.525 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 41.9 t -86.99 119.37 27.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.559 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.06 -26.48 25.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.578 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.432 HG21 ' HB3' ' A' ' 142' ' ' SER . 68.9 p -79.83 -2.36 43.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.717 0.294 . . . . 0.0 111.464 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.19 77.22 0.22 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.903 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -146.92 -43.32 0.18 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.871 0.367 . . . . 0.0 110.955 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.56 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.0 mt -116.32 141.7 28.28 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.038 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.56 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 45.2 Cg_endo -70.88 145.76 51.53 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.182 1.921 . . . . 0.0 112.148 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.9 mt -56.56 139.85 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.852 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -132.57 157.13 45.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.966 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -120.68 121.93 39.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.069 0.461 . . . . 0.0 111.959 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.527 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 8.7 mp -87.8 133.63 33.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.469 178.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.658 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -138.71 156.46 47.37 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 122.219 1.009 . . . . 0.0 113.411 -179.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.486 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.31 149.51 34.96 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 113.553 -1.658 . . . . 0.0 110.977 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 121.05 0.453 . . . . 0.0 110.993 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.5 ttpt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.751 0.31 . . . . 0.0 111.492 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 16.3 t -130.88 138.91 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 121.227 0.537 . . . . 0.0 111.736 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.537 ' O ' ' HA ' ' A' ' 90' ' ' GLN . 19.2 m-90 -102.03 139.39 37.72 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.428 -0.806 . . . . 0.0 112.086 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.481 ' CG2' ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -110.98 126.68 55.03 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.421 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.525 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 0.6 OUTLIER -110.9 145.43 38.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.12 -178.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.64 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 165.93 -179.85 39.89 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.646 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.9 mtm180 -77.58 -1.71 32.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.529 0.204 . . . . 0.0 111.505 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.426 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.5 t-20 -84.87 136.42 38.86 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 120.745 0.307 . . . . 0.0 110.996 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.5 Cg_exo -69.13 -6.45 18.32 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.704 2.269 . . . . 0.0 111.868 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.89 -45.35 14.32 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.96 0.886 . . . . 0.0 108.756 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -44.43 137.87 3.46 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 113.642 -1.617 . . . . 0.0 110.632 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -56.27 -19.33 13.66 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.927 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.525 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 46.6 t80 -130.13 130.25 44.55 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.586 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -111.04 122.3 47.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.785 0.326 . . . . 0.0 111.277 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.427 HD12 ' CA ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -120.44 179.66 4.24 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.877 179.251 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.26 133.54 52.67 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.665 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -64.78 92.3 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.849 0.357 . . . . 0.0 110.792 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.411 ' HB ' HD11 ' A' ' 84' ' ' LEU . 4.3 mt -111.99 141.07 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.235 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.9 p -65.12 -40.27 94.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.167 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -21.31 64.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.519 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.453 ' CD1' ' N ' ' A' ' 84' ' ' LEU . 3.9 mp -99.95 153.4 19.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.057 0.456 . . . . 0.0 111.365 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.2 p -99.76 169.31 9.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.808 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.64 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 1.1 m-20 -44.87 -53.89 7.03 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.367 0.603 . . . . 0.0 109.562 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -118.13 85.47 2.35 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 177.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.557 ' CD2' ' HB2' ' A' ' 105' ' ' SER . 13.8 t60 -60.03 -45.86 91.4 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.691 -176.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.516 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 30.3 p90 -150.39 164.3 36.19 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.126 -0.629 . . . . 0.0 112.034 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.537 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -135.58 134.17 39.08 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.367 -178.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 47.5 mt -110.92 131.79 61.15 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.649 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.452 ' HB3' HG13 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -123.29 140.75 52.7 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.981 0.419 . . . . 0.0 111.759 -179.29 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.435 ' HG ' ' CG1' ' A' ' 33' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.441 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.413 ' HB3' ' CD1' ' A' ' 124' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.708 0.29 . . . . 0.0 110.779 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.442 ' CB ' ' HG ' ' A' ' 92' ' ' LEU . 5.2 mp -124.23 141.0 52.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.936 0.398 . . . . 0.0 110.36 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.8 mp -112.68 126.37 55.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.087 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.434 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 67.2 t30 -119.18 136.29 54.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.11 0.481 . . . . 0.0 111.8 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.688 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 11.7 p30 -98.42 142.54 29.91 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.996 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.429 HD12 ' HG3' ' A' ' 90' ' ' GLN . 8.7 pt -145.58 24.5 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.621 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.557 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 11.2 t -92.09 154.14 18.93 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 121.594 0.711 . . . . 0.0 112.51 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.9 m -70.11 -51.94 27.63 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.607 178.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -75.33 -2.59 29.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.301 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.58 154.68 30.79 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.749 -0.739 . . . . 0.0 113.671 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 4.2 m -117.47 137.81 52.28 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.816 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -114.72 148.48 38.23 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -178.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.16 113.52 18.44 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.457 177.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 44.59 43.25 6.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.373 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.89 -7.9 75.33 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.44 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -104.81 118.61 36.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.996 0.427 . . . . 0.0 110.593 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.816 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.4 tptm -72.91 114.48 11.1 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.266 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.2 m -88.81 161.61 2.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.984 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 120' ' ' SER . 23.5 tt0 -69.75 130.79 43.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.347 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.688 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 24.2 tttt -54.49 161.61 1.38 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.899 0.381 . . . . 0.0 110.408 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.495 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.0 m-80 35.1 33.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.135 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.51 145.11 40.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.145 179.524 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -90.33 133.82 34.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.895 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.437 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 49.8 mm-40 -129.57 152.11 49.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.56 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 25.4 tp -72.64 120.16 17.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.777 0.322 . . . . 0.0 110.507 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.413 ' CD1' ' HB3' ' A' ' 99' ' ' LEU . 6.4 tt -56.64 155.71 7.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.454 0.645 . . . . 0.0 111.441 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.404 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.52 153.15 42.51 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.342 179.686 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.8 114.94 10.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.92 0.391 . . . . 0.0 110.132 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.54 23.17 73.64 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.044 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.404 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 23.1 t70 -53.81 171.27 0.1 Allowed 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 120.933 0.397 . . . . 0.0 111.162 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 21.2 tt0 -145.13 135.53 24.16 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.089 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.46 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 5.8 mt -111.39 127.73 68.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.422 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.467 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.7 m -104.41 140.74 37.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.852 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.544 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 33.9 m -140.24 158.49 25.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.14 28.38 31.07 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.192 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.409 ' HA ' HG12 ' A' ' 140' ' ' ILE . 70.6 t -72.63 140.42 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-O 121.598 0.713 . . . . 0.0 111.982 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 142.39 -39.82 1.33 Allowed Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.422 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 2.8 t -120.67 124.31 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -50.31 -35.0 25.6 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.6 p -93.77 6.7 47.51 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -178.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.422 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.6 OUTLIER -121.09 28.72 7.71 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -178.632 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.467 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.5 mt -107.27 138.11 34.92 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-O 121.544 0.688 . . . . 0.0 111.261 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.43 134.66 52.03 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.265 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.432 ' HB3' HG21 ' A' ' 40' ' ' THR . 38.5 t -111.3 148.44 32.91 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.739 0.781 . . . . 0.0 112.431 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 2.6 mm? -136.45 136.7 39.71 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.704 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.1 t -110.88 137.44 43.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.82 0.343 . . . . 0.0 111.073 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 4.9 mt -106.52 121.62 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.29 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.43 ' CE1' HD11 ' A' ' 37' ' ' ILE . 5.8 m-85 -105.37 115.3 30.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.485 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 3.1 mp -96.94 122.62 48.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.481 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -78.59 137.95 38.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.939 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.07 -18.69 60.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.366 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.52 -46.04 89.98 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.972 0.415 . . . . 0.0 110.814 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 36.5 t80 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.02 -179.934 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.568 0.223 . . . . 0.0 111.327 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.407 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER 176.77 38.99 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.708 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -73.78 134.26 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.55 0 CA-C-N 113.735 -1.575 . . . . 0.0 112.509 -177.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.489 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.8 t -93.55 -61.68 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.286 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.7 p -145.44 141.49 28.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.599 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 24.1 ttm180 -114.01 129.73 56.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.146 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.9 t -91.69 122.74 43.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.005 0.431 . . . . 0.0 111.099 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.8 mt -126.6 111.95 27.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.18 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 43.4 t -79.82 137.58 36.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.757 0.313 . . . . 0.0 110.499 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.2 t -116.36 -10.68 11.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.762 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.529 HG22 ' CB ' ' A' ' 142' ' ' SER . 5.0 p -96.38 -3.07 44.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.686 0.279 . . . . 0.0 111.262 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.48 93.11 0.25 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.042 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.56 ' HG3' ' N ' ' A' ' 43' ' ' ILE . 2.5 pt20 -171.51 -40.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.093 0.473 . . . . 0.0 111.464 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.56 ' N ' ' HG3' ' A' ' 42' ' ' GLN . 65.0 mt -124.4 140.32 34.92 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.649 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.481 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 94.8 Cg_endo -80.31 144.37 16.24 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.576 2.184 . . . . 0.0 111.643 179.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 32.2 mt -58.59 123.87 11.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.944 0.402 . . . . 0.0 111.831 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 76' ' ' TYR . 2.3 ttt-85 -122.42 164.13 18.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.985 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.93 119.84 35.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.095 0.474 . . . . 0.0 111.949 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.527 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 3.1 mt -96.55 137.46 35.6 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.708 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -146.25 158.5 43.89 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -178.612 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.489 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -139.62 141.83 37.09 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.448 -1.705 . . . . 0.0 110.671 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 121.127 0.489 . . . . 0.0 111.606 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.433 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.0 ttpt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.753 0.311 . . . . 0.0 111.273 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 14.8 t -129.49 139.22 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-O 121.343 0.592 . . . . 0.0 112.082 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.527 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.3 m-90 -100.93 139.64 36.33 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.125 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.496 ' CG2' ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -113.38 126.84 55.81 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 176.934 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.51 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.5 OUTLIER -114.52 145.55 41.78 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.294 -178.517 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.694 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 165.88 -177.56 40.96 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.792 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.425 ' HD3' ' HB2' ' A' ' 84' ' ' LEU . 5.3 mtm105 -76.26 -2.0 29.29 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -84.72 133.67 43.45 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.58 0.229 . . . . 0.0 110.91 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -68.89 -7.52 20.95 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.607 2.205 . . . . 0.0 111.786 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.68 -43.16 17.22 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 121.916 0.865 . . . . 0.0 108.806 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.44 138.26 1.84 Allowed 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 113.764 -1.562 . . . . 0.0 110.652 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -56.16 -19.34 13.11 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.695 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.493 ' CD2' ' CE2' ' A' ' 68' ' ' PHE . 1.5 t80 -130.12 130.38 44.73 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.745 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -104.42 117.48 34.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.937 0.398 . . . . 0.0 110.933 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.42 ' CB ' ' CD1' ' A' ' 43' ' ' ILE . 2.7 pp -114.87 -178.03 3.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.887 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.75 144.02 48.49 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.528 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -76.8 91.67 3.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.791 0.329 . . . . 0.0 111.245 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.408 ' O ' ' HD3' ' A' ' 70' ' ' ARG . 30.1 mt -112.09 139.99 33.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.084 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.05 -36.41 84.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.12 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.03 -15.69 63.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.799 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.464 ' CD2' ' CE1' ' A' ' 88' ' ' HIS . 51.1 mt -103.38 152.42 21.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.701 0.286 . . . . 0.0 111.174 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.8 m -99.13 167.48 10.67 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.268 -0.423 . . . . 0.0 112.007 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.694 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.1 m-20 -43.72 -53.28 5.96 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.301 0.572 . . . . 0.0 109.658 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -118.3 83.76 2.06 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.551 ' CD2' ' HB2' ' A' ' 105' ' ' SER . 14.5 t60 -60.17 -46.03 91.08 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.698 -176.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.51 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 27.5 p90 -147.82 164.01 34.97 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.019 -0.672 . . . . 0.0 112.202 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.525 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -135.56 137.12 41.7 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.276 -178.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 63.8 mt -116.04 127.17 73.72 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.55 178.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.431 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.8 OUTLIER -111.42 140.64 45.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.089 0.471 . . . . 0.0 111.469 -179.649 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.5 tm? . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.539 179.708 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.458 -0.075 0 CA-C-O 120.813 0.339 . . . . 0.0 110.831 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.435 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 2.2 mp -133.05 147.17 52.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.4 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.408 ' N ' ' CD2' ' A' ' 101' ' ' LEU . 3.0 mm? -112.77 123.95 51.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.273 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.431 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 58.1 t30 -118.5 115.79 25.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.895 0.379 . . . . 0.0 111.777 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.683 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 10.9 p30 -79.67 141.93 36.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.956 178.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.441 HG12 ' HA ' ' A' ' 89' ' ' PHE . 12.9 pt -144.69 24.22 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.767 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.551 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 10.3 t -91.4 154.44 19.18 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.54 0.686 . . . . 0.0 112.528 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.5 m -70.13 -52.02 26.86 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.553 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -75.64 -0.56 21.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.395 -0.821 . . . . 0.0 112.258 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.04 155.15 31.78 Favored Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.702 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.516 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 3.7 m -117.36 137.63 52.33 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.812 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -115.31 148.59 39.05 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -177.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.13 113.45 18.37 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.646 -1.161 . . . . 0.0 108.466 177.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 44.77 43.28 6.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.315 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.02 -6.3 79.65 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.525 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -104.16 118.59 37.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.995 0.426 . . . . 0.0 110.562 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.812 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.7 tptm -72.83 111.25 7.79 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.279 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.7 m -86.09 161.82 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.847 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 120' ' ' SER . 64.0 mt-10 -69.84 129.64 40.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.504 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.683 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 22.0 tttt -54.9 161.16 1.69 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.902 0.382 . . . . 0.0 110.343 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.8 p30 34.93 34.6 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.322 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.42 145.2 40.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.277 179.452 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -87.94 131.92 34.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.848 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.435 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 37.7 mm-40 -129.57 148.99 51.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.63 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.0 tp -72.61 126.37 29.71 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.43 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -56.71 157.76 5.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.846 0.832 . . . . 0.0 112.185 -178.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.27 152.91 44.01 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.094 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -71.81 117.13 13.01 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.83 26.87 67.61 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.858 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -50.83 170.7 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.953 0.406 . . . . 0.0 111.325 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.428 ' CG ' ' O ' ' A' ' 143' ' ' LEU . 18.1 tt0 -145.09 135.39 24.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.71 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 14.5 mt -113.07 126.35 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.474 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.443 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 4.0 m -104.23 140.11 38.3 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.51 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 33.9 m -140.05 158.52 26.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -178.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.26 25.08 32.14 Favored Glycine 0 N--CA 1.439 -1.106 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.276 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.446 ' HA ' HG12 ' A' ' 140' ' ' ILE . 77.6 t -71.21 140.38 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-O 121.522 0.677 . . . . 0.0 111.893 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 139.83 -40.98 1.35 Allowed Glycine 0 N--CA 1.435 -1.384 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -178.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.441 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 2.5 t -116.28 123.55 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.32 -36.09 30.49 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.8 p -93.55 6.69 47.4 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.441 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.7 OUTLIER -121.77 30.5 6.65 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -178.409 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.446 HG12 ' HA ' ' A' ' 134' ' ' VAL . 6.1 mt -107.3 138.27 34.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.913 177.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.461 HD13 ' HB3' ' A' ' 42' ' ' GLN . 0.8 OUTLIER -125.25 134.95 52.12 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.101 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.529 ' CB ' HG22 ' A' ' 40' ' ' THR . 0.4 OUTLIER -106.09 133.14 51.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.066 0.46 . . . . 0.0 111.727 -179.675 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.428 ' O ' ' CG ' ' A' ' 129' ' ' GLU . 42.7 mt -127.53 140.85 51.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.665 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 23.0 t -116.06 132.58 65.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.878 0.37 . . . . 0.0 111.451 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.478 HG21 HD12 ' A' ' 145' ' ' ILE . 30.4 mt -106.26 139.02 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.949 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.48 132.69 56.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.847 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 3.1 mt -93.41 134.1 32.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.462 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -81.56 110.8 17.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.693 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -59.27 -29.5 67.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.268 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.9 tttm -59.58 -45.41 91.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.919 0.39 . . . . 0.0 110.743 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.0 t80 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.949 -179.911 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.788 0.328 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.409 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER 176.0 39.41 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.713 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.3 mm -72.78 134.09 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-N 113.577 -1.647 . . . . 0.0 112.554 -177.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.483 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.9 t -92.62 -60.84 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.954 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.8 p -145.6 149.5 34.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.22 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.96 138.2 50.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.857 0.36 . . . . 0.0 111.406 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.403 ' CG2' HD13 ' A' ' 48' ' ' LEU . 24.1 t -101.54 122.77 54.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.872 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.4 mt -129.33 121.37 53.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.41 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 34.3 t -85.1 118.07 24.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.376 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.93 -29.26 27.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.74 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.455 HG23 ' HB3' ' A' ' 142' ' ' SER . 30.2 p -79.93 -2.22 42.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.652 0.263 . . . . 0.0 111.447 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.83 77.74 0.26 Allowed Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.965 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -144.09 -45.44 0.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.851 0.358 . . . . 0.0 110.834 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.543 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.0 mp -114.38 140.91 25.71 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.065 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.543 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.3 Cg_endo -73.41 136.55 24.15 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.239 1.96 . . . . 0.0 112.075 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.9 mt -54.41 129.76 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.736 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -122.99 164.28 18.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.284 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.89 119.76 37.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.985 0.421 . . . . 0.0 111.958 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.508 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 1.3 mt -96.65 134.48 39.84 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.713 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -147.82 158.93 44.28 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -178.426 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.483 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -139.66 141.65 37.01 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 113.337 -1.756 . . . . 0.0 110.185 178.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 121.35 0.595 . . . . 0.0 111.428 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.406 ' CE ' ' O ' ' A' ' 49' ' ' SER . 6.7 ttpt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.605 0.241 . . . . 0.0 110.999 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 6.6 t -122.7 138.4 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 121.292 0.568 . . . . 0.0 112.102 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.59 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 15.7 m-90 -100.8 140.12 35.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.548 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.504 ' HA ' ' CG ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -110.12 128.67 55.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.839 177.526 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.677 ' CD1' ' HB2' ' A' ' 76' ' ' TYR . 9.8 m-85 -120.59 145.46 47.34 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.501 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.626 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.24 -166.58 36.49 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.064 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.446 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 12.0 mtp-105 -84.42 5.36 27.54 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 19.4 t-20 -84.99 133.74 42.59 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.622 0.249 . . . . 0.0 110.74 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 18.0 Cg_exo -65.33 -14.96 47.73 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.493 2.129 . . . . 0.0 111.559 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.68 -45.84 13.98 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.971 0.891 . . . . 0.0 108.846 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.3 139.89 1.32 Allowed 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.794 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.9 OUTLIER -56.45 -19.19 14.01 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.087 179.049 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.677 ' HB2' ' CD1' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -130.1 127.97 40.92 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.554 179.421 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -100.99 107.91 19.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.871 0.367 . . . . 0.0 110.828 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.424 ' HA ' HG12 ' A' ' 43' ' ' ILE . 39.8 mt -71.5 -176.33 1.53 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.921 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -92.72 42.18 2.69 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.613 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.8 p30 42.83 61.0 2.25 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.891 0.377 . . . . 0.0 111.66 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.446 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 5.4 mp -96.61 126.23 49.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.788 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 m -54.77 -38.15 66.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.338 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -65.86 -22.37 66.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.159 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.0 mt -102.56 152.28 21.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.082 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.5 p -98.11 166.17 11.55 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.626 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.3 m-20 -43.41 -53.4 5.41 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.438 0.637 . . . . 0.0 109.853 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.424 ' HB2' HD13 ' A' ' 104' ' ' ILE . 16.1 mttt -118.16 82.65 1.87 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 177.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.569 ' CD2' ' HB2' ' A' ' 105' ' ' SER . 14.8 t60 -62.93 -43.83 97.72 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.157 -0.929 . . . . 0.0 113.158 -176.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.47 ' CD1' ' HB2' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -151.24 161.63 42.37 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.05 -0.66 . . . . 0.0 112.37 -179.57 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.504 ' CG ' ' HA ' ' A' ' 67' ' ' THR . 7.8 mt-30 -135.2 151.81 50.98 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.415 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 12.1 mt -124.12 127.49 73.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.206 178.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.425 ' CA ' HG13 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -111.31 149.33 31.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.013 0.435 . . . . 0.0 111.671 -179.307 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.4 tp . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.164 179.324 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.527 0.073 0 CA-C-O 120.875 0.369 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.402 HD11 ' N ' ' A' ' 122' ' ' GLN . 2.6 mm? -123.88 147.07 47.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.546 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.3 mt -113.39 122.39 47.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.013 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -116.98 124.71 50.04 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.681 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 10.9 p30 -88.16 140.24 29.69 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.424 HD13 ' HB2' ' A' ' 87' ' ' LYS . 9.5 pt -143.62 24.03 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 -179.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.569 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 10.5 t -91.13 154.45 19.34 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.709 0.766 . . . . 0.0 113.011 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.5 m -70.18 -52.08 26.14 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.469 -1.242 . . . . 0.0 110.495 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -77.92 0.67 23.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.322 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.32 155.69 31.83 Favored Glycine 0 N--CA 1.438 -1.207 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.724 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 4.0 m -117.46 137.78 52.29 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.792 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -116.58 148.54 40.81 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -177.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.32 113.54 18.37 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.812 177.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 47.31 36.21 4.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.071 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.07 -3.82 80.8 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.482 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.73 118.59 37.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.046 0.423 . . . . 0.0 110.805 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.792 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.4 tptm -72.74 120.98 19.12 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.069 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.1 m -98.24 163.81 2.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.394 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 120' ' ' SER . 44.1 tt0 -69.93 128.96 38.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.555 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.681 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 14.4 tttm -54.28 163.36 0.85 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.83 0.348 . . . . 0.0 110.183 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.6 OUTLIER 35.94 33.89 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.854 -179.251 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.5 OUTLIER -112.23 145.14 40.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.057 179.491 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.412 ' ND2' HD12 ' A' ' 92' ' ' LEU . 1.4 m-80 -87.93 132.62 34.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.877 0.37 . . . . 0.0 111.111 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.402 ' N ' HD11 ' A' ' 100' ' ' LEU . 30.1 mm-40 -129.12 145.32 51.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.45 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 26.4 tp -72.71 126.07 29.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.325 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.419 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -58.52 158.96 6.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.852 0.834 . . . . 0.0 112.316 -179.011 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.467 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -125.04 153.41 42.9 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.759 179.214 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -70.93 115.49 10.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.96 0.41 . . . . 0.0 109.921 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.25 28.18 68.77 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.552 -178.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.467 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 12.1 t70 -54.5 172.0 0.11 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.128 0.489 . . . . 0.0 111.421 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -145.2 135.33 23.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.675 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.1 mt -112.75 129.22 68.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.378 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.447 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 5.5 m -102.98 139.81 38.07 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.565 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.8 m -140.28 158.73 25.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -177.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.04 30.01 29.79 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.209 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.424 ' HB ' ' CH2' ' A' ' 110' ' ' TRP . 77.6 t -74.19 140.34 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-O 121.551 0.691 . . . . 0.0 112.013 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.9 -38.09 1.29 Allowed Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.473 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 2.7 t -121.33 128.39 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -50.56 -40.83 53.24 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.5 p -93.49 6.5 47.99 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.473 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 22.0 m-20 -117.7 30.13 7.45 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.447 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.3 mt -107.05 138.79 31.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.905 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.404 ' CD2' HD22 ' A' ' 143' ' ' LEU . 3.7 tt -124.67 134.62 52.82 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.448 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.455 ' HB3' HG23 ' A' ' 40' ' ' THR . 47.2 t -108.68 150.23 27.85 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.71 0.766 . . . . 0.0 112.576 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.404 HD22 ' CD2' ' A' ' 141' ' ' LEU . 2.1 mm? -136.1 151.03 49.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.472 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 40.5 t -125.18 133.45 69.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.803 0.335 . . . . 0.0 110.908 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -105.62 124.59 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.438 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -105.97 114.91 29.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.755 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.408 ' CD1' ' O ' ' A' ' 125' ' ' SER . 3.4 mp -85.05 133.31 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.571 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -82.34 118.78 23.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.916 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -69.94 -32.9 71.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.021 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.42 -45.55 91.23 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.959 0.409 . . . . 0.0 110.704 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 24.7 t80 . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.931 -179.934 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.88 0.371 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.407 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER 179.09 38.19 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.666 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.6 mm -74.93 136.05 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.558 0 CA-C-N 113.697 -1.592 . . . . 0.0 112.525 -177.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.49 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.0 t -91.92 -60.31 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 114.75 -1.113 . . . . 0.0 109.969 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.1 p -145.28 157.88 43.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.368 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.66 138.35 53.99 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.843 0.354 . . . . 0.0 111.474 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.45 HG23 ' CD2' ' A' ' 76' ' ' TYR . 1.1 m -108.06 122.66 62.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.724 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.2 mt -128.33 121.66 56.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.694 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 42.4 t -79.85 111.52 16.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.747 0.308 . . . . 0.0 110.257 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.5 t -78.81 -24.33 44.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.423 . . . . 0.0 112.088 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.48 HG23 ' HB3' ' A' ' 142' ' ' SER . 66.1 p -79.94 -2.14 42.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.73 0.3 . . . . 0.0 111.489 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.51 76.54 0.25 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.812 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -146.08 -43.96 0.2 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.887 0.375 . . . . 0.0 110.715 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.566 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.4 mp -117.54 142.1 29.93 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.062 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.566 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 48.2 Cg_endo -71.24 145.93 49.98 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.167 1.911 . . . . 0.0 112.27 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 42.5 mt -57.91 149.71 4.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.746 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.97 164.04 28.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.993 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.65 119.82 30.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.086 0.47 . . . . 0.0 111.948 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.505 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 7.3 mp -94.54 124.23 38.44 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.666 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -134.58 157.79 45.66 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -178.809 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.49 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -147.99 142.63 26.59 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.653 -1.612 . . . . 0.0 110.737 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 121.199 0.524 . . . . 0.0 111.003 -179.716 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.416 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.5 ttpt . . . . . 0 CA--C 1.523 -0.075 0 CA-C-O 120.706 0.289 . . . . 0.0 111.125 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 11.5 t -123.92 139.12 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 121.273 0.559 . . . . 0.0 111.951 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.535 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 16.4 m-90 -102.01 139.6 37.42 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.067 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.459 HG22 ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -108.8 132.27 54.16 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.425 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.55 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 2.7 m-85 -115.22 145.85 42.02 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.566 -178.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.704 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.91 -177.67 38.05 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.709 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.6 mtm180 -80.46 1.09 30.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.609 0.242 . . . . 0.0 111.373 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.431 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.9 t-20 -84.86 135.79 39.62 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.677 0.275 . . . . 0.0 110.872 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.1 Cg_exo -68.74 -6.96 19.22 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.672 2.248 . . . . 0.0 111.91 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.03 -45.09 14.47 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-O 122.093 0.949 . . . . 0.0 108.859 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -45.8 136.51 6.16 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 113.674 -1.603 . . . . 0.0 110.75 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.62 -19.02 14.04 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.0 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.55 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 33.3 t80 -129.76 118.7 22.25 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.678 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -93.87 107.9 19.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.865 0.364 . . . . 0.0 110.911 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.427 ' CD1' ' HA2' ' A' ' 69' ' ' GLY . 22.4 mt -73.19 -70.19 0.38 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.712 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 174.36 -86.72 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.235 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.7 p30 179.81 55.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.947 0.403 . . . . 0.0 110.866 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.1 mp -87.4 120.42 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.136 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 18.0 m -55.08 -41.49 71.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.919 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.404 ' HD3' ' CB ' ' A' ' 139' ' ' ASP . 0.0 OUTLIER -64.34 -22.43 66.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.228 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.5 mt -98.73 152.29 19.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.847 0.356 . . . . 0.0 111.118 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.7 p -95.76 165.84 12.1 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.649 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.704 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -42.76 -52.81 4.84 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.384 0.611 . . . . 0.0 109.686 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.42 ' HB2' HD11 ' A' ' 104' ' ' ILE . 19.1 mttt -119.3 84.92 2.28 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 177.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.539 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 14.7 t60 -64.19 -45.83 86.62 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.995 -1.002 . . . . 0.0 113.244 -176.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.474 ' CZ ' ' CD2' ' A' ' 68' ' ' PHE . 36.7 p90 -153.72 162.39 41.28 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.068 -0.653 . . . . 0.0 112.27 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 9.8 mt-30 -135.64 154.88 51.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.779 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 59.5 mt -123.54 132.35 71.53 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.269 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.43 ' HG ' ' CB ' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -117.3 149.91 39.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.032 0.444 . . . . 0.0 111.866 -179.243 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 18.9 tp . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.355 179.297 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.837 0.351 . . . . 0.0 110.796 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.43 ' CB ' ' HG ' ' A' ' 92' ' ' LEU . 6.5 mt -133.12 141.0 47.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.533 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.82 128.21 56.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.13 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.401 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 50.2 t30 -116.6 115.63 26.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.887 0.375 . . . . 0.0 111.972 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.701 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 13.5 p30 -78.29 143.19 37.22 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.855 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.462 HG12 ' HG3' ' A' ' 90' ' ' GLN . 9.7 pt -149.67 35.86 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.539 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -99.05 150.98 21.45 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.651 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.2 m -68.71 -31.66 70.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.457 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -93.11 -19.57 21.37 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.172 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.515 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 110.73 158.12 15.7 Favored Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.738 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.513 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.7 m -117.18 137.65 52.2 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.833 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -115.83 148.35 40.01 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -178.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.22 113.4 18.24 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.535 177.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 43.61 43.62 4.83 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.16 -11.39 67.56 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.789 -0.719 . . . . 0.0 113.449 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -103.85 118.58 37.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.997 0.427 . . . . 0.0 110.625 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.833 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 2.8 tptp -74.04 121.39 21.0 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.41 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.8 m -91.54 163.44 2.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.958 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.5 OUTLIER -69.84 128.07 35.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.448 179.694 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.701 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 18.2 tttt -54.87 161.78 1.48 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.976 0.417 . . . . 0.0 110.631 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.6 OUTLIER 35.65 33.42 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.045 -179.263 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.47 145.16 40.69 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.234 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -89.32 128.78 35.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.763 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -129.25 148.67 51.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.513 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.5 tp -72.71 111.91 8.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.885 0.374 . . . . 0.0 110.364 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.412 ' HG ' ' N ' ' A' ' 125' ' ' SER . 66.3 tp -53.68 158.88 1.75 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.247 0.546 . . . . 0.0 111.509 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.45 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.8 OUTLIER -124.01 153.25 41.58 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.331 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 12.2 tp60 -71.68 122.53 20.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.03 0.443 . . . . 0.0 110.79 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.18 21.9 48.2 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.429 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.45 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 5.3 t70 -59.87 -177.96 0.07 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 120.571 0.224 . . . . 0.0 110.449 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.44 ' HG2' ' CG2' ' A' ' 144' ' ' VAL . 6.1 mt-10 -145.07 135.55 24.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.743 0.306 . . . . 0.0 111.444 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 3.3 mt -114.52 126.66 72.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.218 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.447 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.4 m -104.28 140.04 38.43 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.041 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.538 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 26.4 m -140.33 158.37 25.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.131 0.491 . . . . 0.0 112.23 -178.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.67 24.32 33.44 Favored Glycine 0 N--CA 1.439 -1.139 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.081 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.439 ' HB ' ' CZ3' ' A' ' 110' ' ' TRP . 77.9 t -70.93 140.32 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-O 121.544 0.688 . . . . 0.0 111.994 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.71 -38.13 1.08 Allowed Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 3.3 t -121.27 129.26 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.45 -40.65 51.18 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.55 6.69 47.39 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -178.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.455 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.7 OUTLIER -119.62 32.4 6.09 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -178.514 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.447 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 6.0 mt -107.25 138.65 32.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.411 0.624 . . . . 0.0 111.064 178.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.4 tt -124.88 134.61 52.63 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.718 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.48 ' HB3' HG23 ' A' ' 40' ' ' THR . 47.0 t -109.67 150.17 28.66 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.571 0.7 . . . . 0.0 112.25 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 69.7 mt -135.95 152.78 51.33 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.976 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.44 ' CG2' ' HG2' ' A' ' 129' ' ' GLU . 21.6 t -121.31 132.78 69.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.115 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -105.74 121.73 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-O 120.881 0.372 . . . . 0.0 111.205 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.99 115.01 29.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.95 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.5 mt -85.02 134.06 27.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.445 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -78.83 105.09 9.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.669 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.29 -35.24 73.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.08 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.97 -44.66 91.56 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.986 0.422 . . . . 0.0 110.669 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 29.6 t80 . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.898 179.997 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.749 0.309 . . . . 0.0 111.029 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 177.42 38.91 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.671 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.7 mm -72.56 137.08 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 113.652 -1.613 . . . . 0.0 112.492 -177.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.478 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.3 t -91.6 -58.78 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.777 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 3.0 p -147.76 165.33 30.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.404 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -127.12 138.27 53.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.913 0.387 . . . . 0.0 111.43 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.1 p -106.94 122.62 61.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.783 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.8 mt -127.53 127.92 69.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.618 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.405 ' HA ' ' CD1' ' A' ' 143' ' ' LEU . 35.2 t -88.5 114.23 24.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.76 0.314 . . . . 0.0 110.487 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.97 -23.68 33.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.701 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.471 HG21 ' HB3' ' A' ' 142' ' ' SER . 58.3 p -79.96 -2.43 43.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.69 0.281 . . . . 0.0 111.465 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.6 69.86 1.21 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.185 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -141.01 -42.28 0.39 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.9 0.381 . . . . 0.0 110.974 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.533 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.7 mt -118.89 140.85 29.16 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.752 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.533 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.2 Cg_endo -73.39 146.02 39.15 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.139 1.893 . . . . 0.0 112.28 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.3 mt -57.31 148.38 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.08 0.467 . . . . 0.0 111.686 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.423 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -134.25 164.09 28.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.167 179.464 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -120.69 119.56 33.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.047 0.451 . . . . 0.0 111.63 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.521 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 6.8 mp -95.72 123.33 39.24 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.671 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -135.15 156.96 48.11 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 122.163 0.983 . . . . 0.0 113.407 -179.541 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.478 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -153.62 141.92 20.56 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 113.662 -1.608 . . . . 0.0 111.132 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 121.124 0.487 . . . . 0.0 111.104 -179.78 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.436 ' HE2' ' O ' ' A' ' 49' ' ' SER . 3.6 ttpt . . . . . 0 CA--C 1.523 -0.088 0 CA-C-O 120.77 0.319 . . . . 0.0 111.412 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.442 HG13 ' NE2' ' A' ' 90' ' ' GLN . 19.3 t -132.13 139.2 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.274 0.559 . . . . 0.0 111.741 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.53 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 19.7 m-90 -102.42 139.37 38.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.309 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -114.18 131.1 56.57 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.504 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.4 OUTLIER -117.13 145.49 43.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.963 -179.125 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.614 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.99 -166.41 36.9 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.759 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -90.99 36.87 0.92 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.684 0.278 . . . . 0.0 111.41 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.443 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 3.9 t-20 -119.94 135.44 24.29 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.093 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 20.2 Cg_exo -64.63 -15.54 50.56 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.491 2.127 . . . . 0.0 111.5 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.72 -45.45 14.42 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 121.95 0.881 . . . . 0.0 109.089 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.36 139.54 2.65 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 113.885 -1.507 . . . . 0.0 110.845 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 67' ' ' THR . 9.3 m-20 -56.22 -18.57 10.71 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.844 178.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.496 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 2.8 t80 -129.18 116.71 19.6 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.737 0.303 . . . . 0.0 111.007 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -88.58 107.94 19.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.779 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.9 mp -77.91 -176.33 4.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.059 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.63 11.85 68.88 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.633 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 64.76 75.63 0.36 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.956 0.408 . . . . 0.0 111.473 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.7 mp -111.51 141.42 26.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.654 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.95 -41.73 71.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.047 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.9 mmp_? -61.02 -49.07 78.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.261 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.475 ' HA ' ' HD1' ' A' ' 88' ' ' HIS . 1.4 mt -76.39 151.79 36.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.099 0.476 . . . . 0.0 111.664 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.3 p -100.89 167.55 10.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.401 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.614 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -44.56 -53.0 7.53 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.436 0.636 . . . . 0.0 109.816 179.123 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.83 82.8 2.0 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 177.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.575 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 9.2 t60 -62.73 -46.12 89.58 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.094 -0.957 . . . . 0.0 113.036 -176.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.504 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 20.4 p90 -147.98 160.1 43.18 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.592 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.459 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.2 tt0 -136.19 141.28 44.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.485 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.417 ' O ' ' CG1' ' A' ' 65' ' ' VAL . 44.1 mt -116.12 127.43 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.892 179.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.418 ' CA ' HG11 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -110.99 144.64 39.77 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.069 0.461 . . . . 0.0 111.888 -179.383 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 16.1 tp . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.485 179.369 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.408 ' HB2' ' CD1' ' A' ' 124' ' ' LEU . 1.7 mt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.844 0.354 . . . . 0.0 111.004 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.2 mp -131.49 145.22 51.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.872 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.71 124.27 52.19 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.36 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 90' ' ' GLN . 51.5 t30 -115.74 115.58 26.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.905 0.383 . . . . 0.0 111.386 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.683 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 12.1 p30 -79.11 138.76 38.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.167 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 12.3 pt -146.96 39.35 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.728 -0.214 . . . . 0.0 111.574 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.575 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -96.13 158.51 15.41 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 121.055 0.455 . . . . 0.0 111.709 -179.06 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 86.4 m -69.07 -37.83 78.72 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.862 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.61 -19.91 17.3 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.47 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 123.8 158.35 10.1 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.074 -1.06 . . . . 0.0 113.799 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.533 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.8 m -117.78 137.99 52.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.924 -0.638 . . . . 0.0 109.731 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.863 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -114.58 148.42 38.05 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -178.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.2 113.54 18.44 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.384 177.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 44.0 43.99 5.77 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.39 -11.05 66.87 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.711 -0.756 . . . . 0.0 113.486 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -103.4 118.58 37.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.01 0.433 . . . . 0.0 110.544 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.863 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 3.8 tptm -74.37 113.86 12.08 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.473 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.5 m -84.5 162.64 2.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.876 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.469 ' O ' ' OG ' ' A' ' 120' ' ' SER . 13.2 tp10 -69.85 131.14 44.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.464 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.683 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 32.3 tttm -53.1 162.97 0.58 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.7 p30 34.07 39.1 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.099 0.476 . . . . 0.0 111.83 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.469 ' OG ' ' O ' ' A' ' 117' ' ' GLU . 25.0 p -111.54 145.07 39.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.734 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -94.64 123.82 38.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.71 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -127.96 148.45 50.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.558 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.8 tp -72.68 136.25 45.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.486 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.408 ' CD1' ' HB2' ' A' ' 99' ' ' LEU . 1.5 pt? -61.81 160.48 11.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.847 0.832 . . . . 0.0 112.088 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.41 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.0 OUTLIER -125.66 153.17 44.22 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.912 178.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.56 117.55 13.26 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.36 27.27 65.3 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.917 -0.659 . . . . 0.0 111.789 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.41 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 25.0 t0 -51.24 169.38 0.05 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.05 0.452 . . . . 0.0 111.404 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 12.8 tt0 -143.77 135.34 26.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.457 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 11.6 mt -114.44 128.1 71.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.863 0.363 . . . . 0.0 111.019 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.428 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 26.9 m -104.46 142.24 34.95 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.572 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 19.9 m -140.42 158.41 24.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -178.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.34 46.53 26.12 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.419 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.453 ' HA ' HG12 ' A' ' 140' ' ' ILE . 58.5 t -85.27 140.72 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-O 121.997 0.903 . . . . 0.0 112.983 -178.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.27 -46.64 0.78 Allowed Glycine 0 N--CA 1.434 -1.494 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.504 HG12 ' CB ' ' A' ' 139' ' ' ASP . 4.6 p -104.03 118.0 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 CA-C-N 113.902 -1.149 . . . . 0.0 109.388 177.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -57.53 -24.24 54.9 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.787 0.327 . . . . 0.0 111.3 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.92 -25.91 17.83 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -177.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.504 ' CB ' HG12 ' A' ' 136' ' ' VAL . 0.5 OUTLIER -105.53 25.43 10.75 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -177.642 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.453 HG12 ' HA ' ' A' ' 134' ' ' VAL . 5.8 mt -88.8 139.81 16.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.064 177.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.0 tt -120.02 134.8 55.14 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.993 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.471 ' HB3' HG21 ' A' ' 40' ' ' THR . 43.4 t -115.65 150.26 37.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.521 0.677 . . . . 0.0 112.277 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 2.0 mm? -135.79 153.35 51.55 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.39 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 39.6 t -123.26 138.5 53.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.798 0.332 . . . . 0.0 110.695 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.3 mm -106.24 125.89 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-O 120.965 0.412 . . . . 0.0 111.064 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.33 111.72 23.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.68 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.421 HD13 ' N ' ' A' ' 147' ' ' ILE . 3.6 mp -90.6 128.23 42.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.353 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -75.95 126.13 30.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.825 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -70.31 -30.86 67.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.994 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -60.05 -46.0 90.98 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.693 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 29.1 t80 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.954 179.963 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.741 0.305 . . . . 0.0 111.091 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.2 m-20 176.65 39.41 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.704 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.1 mm -71.99 135.28 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 113.538 -1.664 . . . . 0.0 112.634 -177.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.485 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.3 t -91.38 -59.55 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.633 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.4 p -148.94 150.48 32.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.992 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.67 138.02 51.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.826 0.346 . . . . 0.0 111.639 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.6 m -102.83 122.63 55.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.572 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.9 mt -127.54 124.9 64.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.605 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 51.9 t -83.17 121.16 26.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.531 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.66 -24.55 21.59 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.515 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.459 HG21 ' HB3' ' A' ' 142' ' ' SER . 43.8 p -79.95 -2.06 42.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.461 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.6 75.97 0.31 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.787 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -147.2 -43.83 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.795 0.331 . . . . 0.0 110.886 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.532 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.0 mt -116.35 140.98 27.21 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.756 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.532 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.4 Cg_endo -72.93 145.49 40.31 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.138 1.892 . . . . 0.0 112.202 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.8 mt -56.03 141.51 12.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.669 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.449 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -127.25 164.05 22.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.17 179.551 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.7 119.66 32.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.069 0.461 . . . . 0.0 111.68 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.511 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 3.1 mt -98.66 133.0 43.62 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.704 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.98 157.97 43.87 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -178.584 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.485 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -142.12 147.79 37.28 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 113.577 -1.647 . . . . 0.0 110.748 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--N 1.33 -0.273 0 CA-C-O 121.167 0.508 . . . . 0.0 111.33 -179.376 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.433 ' CE ' ' O ' ' A' ' 49' ' ' SER . 1.9 ttpt . . . . . 0 C--O 1.232 0.149 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.407 HG11 ' HG2' ' A' ' 90' ' ' GLN . 21.3 t -136.05 139.33 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.581 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.511 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 18.2 m-90 -102.56 139.3 38.33 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.453 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.452 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -114.17 130.25 56.61 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 177.282 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.506 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 1.1 m-85 -117.97 145.25 44.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.926 0.394 . . . . 0.0 111.642 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.9 -170.22 39.87 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.751 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.413 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 20.6 mtm180 -82.01 1.42 35.75 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -84.87 135.0 40.52 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.685 0.278 . . . . 0.0 111.319 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -66.43 -12.53 36.09 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.635 2.223 . . . . 0.0 111.742 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.64 -43.94 16.35 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-O 121.965 0.888 . . . . 0.0 108.738 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.82 140.44 1.35 Allowed 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 113.707 -1.588 . . . . 0.0 110.635 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' A' ' 67' ' ' THR . 23.3 m-20 -56.14 -18.93 11.35 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.172 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.472 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 7.0 t80 -129.66 130.28 45.36 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-O 120.882 0.373 . . . . 0.0 111.017 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -105.99 113.97 27.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.784 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.4 mt -93.71 -67.02 0.88 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.875 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 179.15 -90.84 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.164 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.404 ' HA ' ' HD2' ' A' ' 70' ' ' ARG . 3.9 p30 175.97 54.25 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.839 0.352 . . . . 0.0 111.01 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.414 ' HB ' ' CD1' ' A' ' 84' ' ' LEU . 29.5 mm -83.32 134.76 26.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.872 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.53 -32.66 74.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.411 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.425 ' HD3' ' HB3' ' A' ' 139' ' ' ASP . 2.2 mpt_? -68.38 -23.77 64.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.502 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.414 ' CD1' ' HB ' ' A' ' 81' ' ' ILE . 5.7 mp -103.38 153.38 20.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.932 0.396 . . . . 0.0 111.114 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.4 m -95.94 168.58 10.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.034 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.571 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -43.45 -54.46 4.78 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.38 0.61 . . . . 0.0 109.698 179.176 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.7 84.22 2.17 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 177.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.599 ' CE1' ' OG ' ' A' ' 105' ' ' SER . 12.7 t60 -57.95 -45.39 86.7 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.705 -176.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.457 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 32.1 p90 -148.24 159.4 44.01 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.079 -0.648 . . . . 0.0 111.922 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.1 tt0 -135.79 139.95 43.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.376 -178.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.434 HD11 ' CZ ' ' A' ' 68' ' ' PHE . 44.0 mt -114.94 128.15 72.2 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.772 179.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.422 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 1.1 pt? -114.11 143.08 45.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.059 0.457 . . . . 0.0 111.61 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 28.5 tp . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.295 179.392 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.78 0.324 . . . . 0.0 110.839 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.407 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 1.8 mp -131.35 147.33 52.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.447 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 mp -112.86 124.92 53.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.304 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.422 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 61.4 t30 -120.57 115.76 24.04 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.68 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 14.3 p30 -78.13 138.93 38.97 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.4 ' CG1' ' HA ' ' A' ' 89' ' ' PHE . 7.2 pt -140.02 22.09 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.599 ' OG ' ' CE1' ' A' ' 88' ' ' HIS . 11.0 t -91.79 153.46 19.57 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 121.487 0.66 . . . . 0.0 112.641 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.1 m -69.99 -52.12 26.88 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.399 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -72.83 -5.07 35.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.139 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.53 156.04 30.88 Favored Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.73 -0.747 . . . . 0.0 113.459 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.524 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 5.6 m -117.33 137.74 52.23 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.82 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -113.39 148.44 35.8 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -177.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.25 113.42 18.25 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.252 177.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 44.51 43.22 6.2 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.98 -6.85 80.0 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.528 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -103.98 118.5 36.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.982 0.42 . . . . 0.0 110.578 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.82 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 20.9 tptt -74.54 118.32 17.36 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.343 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.0 m -95.88 159.45 2.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.864 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.646 ' O ' ' HB3' ' A' ' 120' ' ' SER . 5.5 mm-40 -69.97 133.97 47.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.109 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.68 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 27.1 tttt -55.48 165.78 0.75 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.131 0.491 . . . . 0.0 110.83 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.46 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.6 OUTLIER 36.46 34.43 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.687 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.646 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 1.4 t -112.21 145.12 40.45 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.76 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -86.7 136.1 33.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.93 0.395 . . . . 0.0 111.086 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.407 ' NE2' ' OG ' ' A' ' 120' ' ' SER . 19.0 mm-40 -128.68 144.2 51.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.204 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.2 tt -72.67 131.41 42.37 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.221 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.401 ' CD2' HG12 ' A' ' 147' ' ' ILE . 54.0 tp -58.5 151.8 19.5 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.73 0.776 . . . . 0.0 111.751 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.432 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -125.37 152.83 44.26 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.587 179.57 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.11 117.93 14.35 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.73 25.78 66.04 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.839 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.432 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 30.9 t70 -51.1 167.85 0.07 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.946 0.403 . . . . 0.0 111.505 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.8 tt0 -145.21 135.4 23.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.902 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 15.3 mt -117.68 128.33 74.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.626 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.42 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.9 m -104.11 140.07 38.3 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.54 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 33.7 m -140.13 158.39 25.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.403 ' HA2' ' HB3' ' A' ' 83' ' ' ARG . . . 86.84 29.61 23.02 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.994 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.446 ' HB ' ' CZ3' ' A' ' 110' ' ' TRP . 72.2 t -75.8 140.44 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-O 121.602 0.715 . . . . 0.0 111.942 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.25 -38.93 1.21 Allowed Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.403 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 3.3 t -120.2 118.72 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -50.6 -30.9 14.44 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.0 m -93.59 6.82 46.97 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.425 ' HB3' ' HD3' ' A' ' 83' ' ' ARG . 16.3 m-20 -130.33 35.17 4.1 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -178.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.42 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.5 mt -106.79 138.29 33.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-O 121.357 0.599 . . . . 0.0 110.562 177.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.1 134.47 52.47 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.902 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.459 ' HB3' HG21 ' A' ' 40' ' ' THR . 46.6 t -109.37 150.24 28.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.578 0.704 . . . . 0.0 112.051 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 3.2 mm? -136.12 147.53 47.81 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.615 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 23.6 t -118.1 140.21 42.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.809 0.337 . . . . 0.0 111.187 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 17.1 mt -106.26 125.84 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.099 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -111.8 117.64 33.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.563 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.401 HG12 ' CD2' ' A' ' 124' ' ' LEU . 4.6 mt -84.83 134.05 27.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.34 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -81.36 109.63 16.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.812 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -61.17 -33.09 72.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.083 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.27 -46.01 91.31 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.987 0.422 . . . . 0.0 110.773 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 18.8 t80 . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.98 -179.826 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.721 0.296 . . . . 0.0 111.302 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -176.54 37.97 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.721 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -78.41 134.34 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.57 0 CA-C-N 113.88 -1.509 . . . . 0.0 112.523 -177.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.482 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.7 t -89.15 -62.01 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.301 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.8 p -149.24 153.44 37.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.458 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 24.1 ttm180 -118.11 138.15 52.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.804 0.335 . . . . 0.0 111.592 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.471 ' CG2' ' CE1' ' A' ' 76' ' ' TYR . 34.4 m -103.48 122.91 56.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.983 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.0 mt -126.8 116.37 44.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.563 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -81.02 112.52 18.49 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.115 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.52 -20.18 40.6 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.484 HG23 ' HB3' ' A' ' 142' ' ' SER . 66.5 p -79.71 -2.5 43.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.703 0.287 . . . . 0.0 111.538 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.68 72.18 0.75 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.764 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -142.25 -41.48 0.34 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.902 0.382 . . . . 0.0 110.705 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.547 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.5 mt -119.49 142.15 32.14 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.06 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.547 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.7 Cg_endo -73.65 139.92 28.77 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.208 1.938 . . . . 0.0 112.026 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.3 mt -55.62 149.2 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.759 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -144.41 164.0 32.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.033 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -121.75 119.99 33.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.114 0.483 . . . . 0.0 112.049 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.504 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 7.3 mt -92.62 137.5 32.31 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.721 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -144.6 158.31 43.83 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -178.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.482 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -144.73 145.8 31.87 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.661 -1.609 . . . . 0.0 110.947 178.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 121.061 0.458 . . . . 0.0 111.027 -179.725 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.403 ' HE2' ' O ' ' A' ' 49' ' ' SER . 2.7 ttpt . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.72 0.295 . . . . 0.0 111.025 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.526 HG12 ' HB3' ' A' ' 92' ' ' LEU . 22.0 t -134.02 139.62 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 121.384 0.611 . . . . 0.0 112.388 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.584 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 15.6 m-90 -105.09 138.95 40.51 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.948 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.94 125.89 53.16 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.554 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 2.1 m-85 -107.05 145.84 31.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.832 -178.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.658 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.63 179.84 38.94 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.578 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 18.4 mtm180 -78.66 -1.65 35.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.605 0.241 . . . . 0.0 111.382 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.402 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 7.8 t-20 -84.83 136.88 38.45 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 120.756 0.312 . . . . 0.0 111.037 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.1 Cg_exo -69.3 -5.88 16.99 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.879 2.386 . . . . 0.0 111.948 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.89 -45.66 13.94 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-O 122.04 0.924 . . . . 0.0 108.681 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -45.41 137.74 4.67 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 113.639 -1.619 . . . . 0.0 110.533 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.17 -18.89 11.4 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.061 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.554 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 50.7 t80 -129.59 125.0 35.19 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.652 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -98.48 112.67 24.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.034 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.5 mt -82.14 -69.27 0.63 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 174.93 -91.15 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.28 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.2 p30 -178.85 54.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.828 0.347 . . . . 0.0 111.098 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 30.1 mm -88.91 124.76 41.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.154 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.69 -42.32 75.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.062 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.96 -18.73 58.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.43 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 26.5 mt -104.0 152.14 22.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.763 0.316 . . . . 0.0 111.228 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 p -96.66 170.21 9.35 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.562 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.658 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 6.1 m-20 -43.81 -56.74 3.65 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.276 0.56 . . . . 0.0 109.693 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.446 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -117.85 84.84 2.23 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 177.177 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.569 ' CD2' ' HB2' ' A' ' 105' ' ' SER . 14.9 t60 -59.34 -46.26 89.12 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.907 -1.042 . . . . 0.0 113.11 -176.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.507 ' CZ ' ' CD2' ' A' ' 68' ' ' PHE . 22.4 p90 -149.3 158.53 44.25 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.919 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.512 ' HG2' HG13 ' A' ' 65' ' ' VAL . 4.5 tt0 -136.18 138.55 42.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.834 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.4 mt -114.15 129.29 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 C-N-CA 121.122 -0.231 . . . . 0.0 110.649 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.526 ' HB3' HG12 ' A' ' 65' ' ' VAL . 2.2 pp -123.23 144.93 49.07 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 121.058 0.456 . . . . 0.0 111.864 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.253 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.441 ' CD1' ' N ' ' A' ' 99' ' ' LEU . 1.4 mp . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.733 0.301 . . . . 0.0 110.751 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.1 mp -124.14 142.57 51.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.436 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.88 123.98 51.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.135 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -118.99 115.67 24.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.963 0.411 . . . . 0.0 111.69 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.688 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 12.3 p30 -78.95 139.57 38.22 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.446 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 11.5 pt -143.16 26.49 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.909 -0.317 . . . . 0.0 111.824 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.569 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 10.6 t -92.11 155.62 17.93 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 121.534 0.683 . . . . 0.0 112.63 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 42.3 m -69.95 -52.1 27.3 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.583 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -77.59 -1.7 32.04 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.292 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.92 156.31 31.99 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.615 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.488 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 4.3 m -117.41 137.73 52.29 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.84 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -113.89 148.58 36.51 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -177.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.06 113.45 18.4 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.594 -1.185 . . . . 0.0 108.442 177.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 57.1 m-20 44.47 43.37 6.23 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.1 -11.14 65.96 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.508 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -103.15 118.57 37.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.03 0.443 . . . . 0.0 110.508 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.84 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 2.5 tptm -72.6 112.72 8.9 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.373 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.0 m -84.44 162.69 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.775 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.3 OUTLIER -69.78 128.8 37.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.497 179.745 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.688 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 26.6 tttm -54.83 161.51 1.55 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.934 0.397 . . . . 0.0 110.316 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.503 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.1 p30 36.24 32.97 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.334 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.5 144.94 41.12 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.771 179.188 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -92.49 132.23 36.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.006 0.431 . . . . 0.0 111.147 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 42.9 mm-40 -129.38 150.71 50.63 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.581 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 tt -72.67 135.99 45.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.269 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.439 HD23 ' HB2' ' A' ' 99' ' ' LEU . 64.6 tp -63.54 154.5 32.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.613 0.72 . . . . 0.0 111.698 -179.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.97 153.06 43.35 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.373 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.81 122.8 21.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.909 0.385 . . . . 0.0 110.236 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.87 23.41 50.93 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.961 -0.637 . . . . 0.0 112.236 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -51.64 170.38 0.05 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.836 0.351 . . . . 0.0 110.983 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 4.7 mt-10 -145.14 135.61 24.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.184 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 14.8 mt -113.09 126.32 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.578 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.444 ' O ' ' HB2' ' A' ' 110' ' ' TRP . 4.3 m -104.59 140.26 38.26 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.536 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.4 m -140.36 158.58 25.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.28 28.82 29.44 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.073 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.45 ' HA ' HG12 ' A' ' 140' ' ' ILE . 70.2 t -74.07 140.33 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-O 121.583 0.706 . . . . 0.0 111.945 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 140.92 -42.05 1.22 Allowed Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -178.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 2.2 t -117.32 123.41 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.3 -35.04 25.67 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 84.0 p -93.59 6.62 47.64 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.4 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 37.6 m-20 -121.65 28.61 7.58 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -178.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.45 HG12 ' HA ' ' A' ' 134' ' ' VAL . 5.1 mt -107.36 137.88 36.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.49 0.662 . . . . 0.0 111.348 178.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.5 tt -125.37 134.61 52.11 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.079 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.484 ' HB3' HG23 ' A' ' 40' ' ' THR . 46.3 t -108.47 150.06 27.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.702 0.763 . . . . 0.0 112.181 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 4.0 mp -135.15 150.48 50.17 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.74 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.3 t -121.79 134.83 63.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.741 0.305 . . . . 0.0 111.025 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.449 HG22 HD13 ' A' ' 145' ' ' ILE . 16.9 mt -106.35 123.07 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-O 120.89 0.376 . . . . 0.0 111.039 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.73 119.26 38.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.777 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.426 HG12 ' CD2' ' A' ' 124' ' ' LEU . 2.5 mt -84.98 134.11 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.352 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -79.77 116.34 19.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.765 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -58.39 -31.95 68.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.075 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 17.0 mmmt -60.32 -46.07 91.18 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.773 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 5.1 t80 . . . . . 0 C--N 1.327 -0.406 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.018 -179.92 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.958 0.409 . . . . 0.0 110.553 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.446 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER -179.27 37.17 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 179.83 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.701 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.7 mm -75.57 135.55 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 CA-C-N 113.686 -1.597 . . . . 0.0 112.655 -177.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.501 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.9 t -93.19 -60.75 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.062 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.9 p -145.44 145.42 31.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.301 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.406 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.92 138.07 50.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.797 0.332 . . . . 0.0 111.485 -179.237 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -107.17 122.75 61.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.95 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.8 mt -124.07 120.27 59.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.591 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 46.8 t -79.88 119.61 22.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.357 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.59 -23.2 22.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.648 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.469 HG22 ' HB3' ' A' ' 142' ' ' SER . 63.5 p -79.8 -2.33 42.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.782 0.325 . . . . 0.0 111.459 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.35 73.58 0.52 Allowed Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.814 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -145.92 -37.76 0.25 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.777 0.322 . . . . 0.0 111.117 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.537 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.6 mt -121.54 140.96 32.52 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.928 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.537 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.2 Cg_endo -73.22 140.36 30.68 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.191 1.927 . . . . 0.0 112.087 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.6 mt -56.62 134.16 20.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.706 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.441 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -122.57 163.03 20.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.256 179.367 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.406 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.7 OUTLIER -118.89 120.63 37.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.083 0.468 . . . . 0.0 112.162 -179.326 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.541 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 1.6 mt -96.86 133.71 41.12 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.701 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -146.24 158.91 43.91 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -178.526 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.501 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -144.38 141.89 29.98 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 113.586 -1.643 . . . . 0.0 110.731 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 121.068 0.461 . . . . 0.0 111.093 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.415 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.1 ttpt . . . . . 0 CA--C 1.523 -0.079 0 CA-C-O 120.698 0.285 . . . . 0.0 111.319 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 5.8 t -123.24 138.08 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-O 121.234 0.54 . . . . 0.0 111.768 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.541 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.3 m-90 -102.31 139.71 37.56 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.302 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.487 ' HA ' ' HG2' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -111.83 128.42 56.11 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 176.971 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.533 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.4 OUTLIER -118.66 145.28 45.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.264 -178.153 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.624 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.06 -172.4 38.19 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.748 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 27.2 mtm180 -78.69 3.2 17.12 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.436 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.9 t30 -84.69 132.46 46.47 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.687 0.279 . . . . 0.0 111.005 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.2 Cg_exo -65.98 -13.67 40.95 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.585 2.19 . . . . 0.0 111.68 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.74 -43.05 17.26 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.967 0.889 . . . . 0.0 108.953 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.23 138.7 1.6 Allowed 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 113.792 -1.549 . . . . 0.0 110.828 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.1 m-20 -56.42 -18.93 12.73 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.968 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.494 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 25.6 t80 -129.83 123.27 30.49 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.141 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -100.14 118.69 37.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.555 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.411 ' CB ' HG12 ' A' ' 43' ' ' ILE . 0.8 OUTLIER -125.39 72.36 1.25 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.247 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 48.97 -135.49 21.34 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.959 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -158.96 81.09 0.78 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.797 0.332 . . . . 0.0 110.92 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.9 mp -95.52 140.43 16.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.033 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 m -55.61 -45.0 77.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.132 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.447 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -60.74 -49.07 78.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.753 -179.357 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.444 ' CD1' ' N ' ' A' ' 84' ' ' LEU . 4.3 mp -72.56 152.88 41.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.209 0.528 . . . . 0.0 111.215 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.6 p -102.48 168.27 9.41 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.758 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.624 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 9.0 m-20 -42.47 -60.02 1.66 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.389 0.614 . . . . 0.0 109.527 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -115.63 84.58 2.12 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 176.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.61 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 10.2 t60 -61.45 -44.58 96.87 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.242 -0.89 . . . . 0.0 113.02 -176.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.533 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 12.1 p90 -146.16 162.87 37.04 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.07 -0.652 . . . . 0.0 112.254 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.526 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -135.54 138.03 42.63 Favored 'General case' 0 C--O 1.227 -0.111 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.006 -179.099 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 62.2 mt -114.86 129.23 71.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.656 178.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.425 ' CD1' ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -108.0 148.07 30.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.994 0.426 . . . . 0.0 111.294 -179.623 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 49.7 tp . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.543 179.662 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.786 0.327 . . . . 0.0 110.81 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.418 ' CB ' HD13 ' A' ' 92' ' ' LEU . 11.1 mp -131.2 143.96 50.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.671 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -112.61 125.26 54.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.128 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 90' ' ' GLN . 49.0 t30 -115.72 115.71 26.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.901 0.382 . . . . 0.0 111.584 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.692 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 14.0 p30 -78.87 136.23 37.24 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.034 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.407 HG12 ' C ' ' A' ' 89' ' ' PHE . 12.9 pt -144.28 39.7 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.576 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.42 157.01 16.21 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.191 0.52 . . . . 0.0 111.92 -178.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 92.4 m -69.11 -36.27 77.33 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.433 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 19.8 p30 -98.51 -19.86 17.4 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.504 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 122.66 156.07 9.52 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.277 -0.963 . . . . 0.0 113.515 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.534 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 4.8 m -117.68 137.78 52.43 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 122.818 0.447 . . . . 0.0 109.832 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.837 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -119.32 148.1 43.55 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -178.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.421 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.7 OUTLIER -124.75 113.56 18.12 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.544 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 45.1 m-20 49.45 42.02 21.85 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 83.98 -6.05 76.68 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.924 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.411 ' CB ' HD21 ' A' ' 111' ' ' LEU . 4.4 mt-30 -103.97 118.92 37.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.189 0.495 . . . . 0.0 110.589 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.837 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 7.3 tptt -74.92 127.14 32.5 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.339 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.2 m -103.0 164.09 3.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.883 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 120' ' ' SER . 9.9 tp10 -69.76 128.04 35.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.422 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.692 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 56.4 tttt -53.8 161.78 1.06 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.719 0.295 . . . . 0.0 110.414 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.496 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.9 p30 35.23 34.77 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.141 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.22 145.11 40.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.363 179.61 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -89.14 125.48 35.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.589 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -129.5 148.73 51.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.201 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.3 tt -72.83 114.53 11.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.015 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.2 mt -55.11 166.26 0.57 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.654 0.74 . . . . 0.0 112.063 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.426 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.6 OUTLIER -125.4 152.71 44.46 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.488 179.334 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.2 tp60 -71.95 124.48 24.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.87 0.366 . . . . 0.0 110.352 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 145' ' ' ILE . . . 58.35 20.92 46.44 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.227 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.426 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 8.3 t70 -56.85 178.67 0.05 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.656 0.265 . . . . 0.0 110.809 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 3.2 mt-10 -145.19 135.73 24.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.124 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.597 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 8.1 mt -108.9 124.62 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 121.005 0.431 . . . . 0.0 110.831 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.431 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 4.7 m -104.37 143.19 33.32 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.61 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 27.0 m -140.22 158.37 25.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.446 ' HA2' ' HG3' ' A' ' 83' ' ' ARG . . . 74.29 45.17 25.76 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.312 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.516 ' HA ' HG12 ' A' ' 140' ' ' ILE . 95.3 t -85.41 140.62 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 121.675 0.75 . . . . 0.0 112.379 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 140.29 -38.08 1.63 Allowed Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -178.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.465 HG12 ' N ' ' A' ' 139' ' ' ASP . 1.1 t -126.49 118.68 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -50.36 -24.75 3.21 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 17.0 m -93.18 4.49 53.9 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.465 ' N ' HG12 ' A' ' 136' ' ' VAL . 1.5 m-20 -128.96 26.73 5.49 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.516 HG12 ' HA ' ' A' ' 134' ' ' VAL . 6.3 mt -107.15 138.24 34.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-O 121.464 0.649 . . . . 0.0 111.487 178.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.4 tt -125.47 134.68 51.98 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.207 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.469 ' HB3' HG22 ' A' ' 40' ' ' THR . 42.2 t -113.03 147.53 37.02 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.797 0.808 . . . . 0.0 112.355 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 77.8 mt -136.55 157.27 47.16 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.855 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 26.2 t -120.64 139.14 48.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.824 0.345 . . . . 0.0 110.995 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.433 ' O ' ' HA2' ' A' ' 127' ' ' GLY . 70.0 mt -106.33 120.93 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.16 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.74 109.49 19.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.536 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.2 mt -84.64 132.11 32.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.476 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -78.5 113.39 16.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.815 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -64.57 -30.53 71.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.064 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.82 -46.13 91.73 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.763 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 30.8 t80 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.095 -179.886 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.831 0.348 . . . . 0.0 110.964 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.403 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER -179.27 37.82 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.664 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.0 mm -75.23 137.13 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 CA-C-N 113.632 -1.622 . . . . 0.0 112.778 -177.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.466 ' CG2' ' HA ' ' A' ' 49' ' ' SER . 3.1 t -91.86 -58.89 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.497 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 4.6 p -147.88 165.41 30.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.444 179.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -133.28 138.31 46.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.854 0.359 . . . . 0.0 111.323 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.8 t -107.23 122.82 61.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.955 0.407 . . . . 0.0 110.916 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 13.2 mt -122.23 121.9 65.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.508 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 42.4 t -79.86 117.02 20.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.684 0.278 . . . . 0.0 110.663 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.08 -23.36 26.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.37 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.453 HG22 ' HB3' ' A' ' 142' ' ' SER . 72.4 p -79.81 -2.33 42.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.838 0.351 . . . . 0.0 111.342 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.3 73.58 0.48 Allowed Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.203 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.4 ' CG ' HD22 ' A' ' 141' ' ' LEU . 1.8 mt-30 -146.79 -39.17 0.21 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.683 0.278 . . . . 0.0 111.181 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.546 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.8 mt -118.9 141.02 29.4 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.783 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.546 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 54.2 Cg_endo -72.28 144.54 41.65 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.157 1.905 . . . . 0.0 112.209 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.9 mt -56.45 144.6 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.66 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.488 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.2 OUTLIER -128.24 161.98 28.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.02 179.338 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -123.31 119.56 30.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.971 0.415 . . . . 0.0 111.465 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.509 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 6.9 mp -92.29 130.41 37.99 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.664 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -142.03 155.37 45.41 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 122.257 1.027 . . . . 0.0 113.524 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.46 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -141.38 141.74 33.77 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 113.387 -1.733 . . . . 0.0 110.712 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 121.168 0.509 . . . . 0.0 111.089 -179.71 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.438 ' CE ' ' O ' ' A' ' 49' ' ' SER . 4.7 ttpt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.69 0.281 . . . . 0.0 111.131 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 10.8 t -126.48 139.07 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-O 121.31 0.576 . . . . 0.0 112.016 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.509 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 17.7 m-90 -104.36 139.31 39.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.373 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -112.69 132.28 55.27 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 177.531 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.513 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 1.0 OUTLIER -118.67 145.55 45.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.899 0.38 . . . . 0.0 111.665 -178.728 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.643 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.49 -170.14 37.98 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.902 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.419 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 4.5 mtm105 -80.21 1.63 27.57 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -84.81 132.96 44.6 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.624 0.25 . . . . 0.0 111.16 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.408 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 17.0 Cg_exo -66.28 -13.07 38.26 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.661 2.241 . . . . 0.0 111.796 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.62 -43.47 16.95 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-O 121.801 0.81 . . . . 0.0 108.856 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.22 140.4 1.16 Allowed 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 113.887 -1.506 . . . . 0.0 110.633 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.9 m-20 -56.29 -18.96 12.19 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.972 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.488 ' CE1' ' HB2' ' A' ' 46' ' ' ARG . 10.9 t80 -129.62 124.3 33.4 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 120.784 0.326 . . . . 0.0 110.98 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.408 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.1 t-160 -95.56 107.85 20.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.522 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.42 HD11 ' CD2' ' A' ' 76' ' ' TYR . 11.1 mp -82.75 -78.58 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.914 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -173.38 -88.53 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.02 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.0 p30 174.7 49.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.886 0.374 . . . . 0.0 111.117 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.1 mp -78.59 126.79 38.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.865 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.87 -40.65 69.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.909 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.441 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 2.0 mmp_? -62.81 -49.13 76.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.267 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 23.2 mt -72.69 150.44 42.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.223 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.8 p -94.55 167.05 11.73 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.668 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.643 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.5 m-20 -43.73 -53.75 5.62 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.292 0.568 . . . . 0.0 109.744 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.25 83.2 2.02 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 177.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.555 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.7 t60 -58.97 -45.88 89.47 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.221 -0.899 . . . . 0.0 112.634 -176.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.513 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 20.3 p90 -144.5 159.91 41.98 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.972 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.473 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 3.6 tt0 -136.31 140.68 43.53 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.246 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 72.8 mt -115.78 130.19 70.86 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.706 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.428 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.6 OUTLIER -114.96 148.84 38.23 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.115 0.483 . . . . 0.0 111.776 -179.587 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.418 HD21 ' CE2' ' A' ' 151' ' ' PHE . 17.8 tp . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.308 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.817 0.341 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.402 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 3.3 mp -121.52 147.1 46.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.224 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 tt -112.84 123.6 50.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.467 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.428 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 49.1 t30 -116.0 115.49 26.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.983 0.42 . . . . 0.0 111.256 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.695 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 14.1 p30 -79.97 134.0 36.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.951 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 10.6 pt -141.61 40.88 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.555 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -100.87 152.32 20.68 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 120.914 0.388 . . . . 0.0 111.254 -179.245 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.5 m -68.94 -32.1 71.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.316 178.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.441 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 27.9 p30 -98.62 -19.72 17.4 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.502 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.92 155.45 9.55 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.314 -0.946 . . . . 0.0 113.731 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.557 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.9 m -117.43 137.95 52.16 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.821 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -115.34 148.41 39.3 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -177.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.18 113.37 18.23 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.238 177.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 48.4 m-20 45.61 42.94 8.79 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.2 -6.27 80.14 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.549 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.55 118.61 37.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 117.018 0.409 . . . . 0.0 110.787 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.821 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 17.7 tptt -73.72 126.97 31.55 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.181 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.7 m -102.56 165.34 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.285 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.42 ' O ' ' HB3' ' A' ' 120' ' ' SER . 2.5 tt0 -69.89 128.86 37.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.423 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.695 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 76.7 tttt -54.1 164.23 0.67 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.3 m-80 33.6 37.0 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.803 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.9 p -111.77 145.11 39.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.005 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -92.41 127.07 37.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.806 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.402 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 57.6 mm-40 -129.31 149.13 51.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.743 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.1 tp -72.86 128.83 36.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.386 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.41 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -59.75 160.92 6.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.649 0.738 . . . . 0.0 112.173 -179.23 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.495 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.99 153.3 42.99 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.636 -1.166 . . . . 0.0 110.034 179.308 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.44 119.2 15.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.882 0.373 . . . . 0.0 110.375 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.52 26.42 56.91 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.036 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.495 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 7.6 t70 -57.24 175.24 0.15 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 120.914 0.388 . . . . 0.0 111.052 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 4.6 mt-10 -145.36 135.63 24.0 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.059 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 3.3 mt -110.07 127.93 66.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.832 0.348 . . . . 0.0 110.497 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.444 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.36 138.89 40.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.851 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.505 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 30.8 m -140.17 158.41 25.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.12 27.65 30.39 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.955 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.428 ' HA ' HG12 ' A' ' 140' ' ' ILE . 72.9 t -72.01 140.44 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-O 121.724 0.773 . . . . 0.0 112.197 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.7 -49.75 0.6 Allowed Glycine 0 N--CA 1.434 -1.452 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.408 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 2.5 t -109.97 125.55 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -50.18 -35.7 27.38 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.2 t -93.57 6.67 47.47 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.413 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . 0.9 OUTLIER -122.3 31.61 6.09 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -178.473 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.444 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 6.4 mt -106.49 138.94 29.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-O 121.399 0.619 . . . . 0.0 110.898 178.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.4 HD22 ' CG ' ' A' ' 42' ' ' GLN . 0.4 OUTLIER -124.51 134.64 52.95 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.557 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.453 ' HB3' HG22 ' A' ' 40' ' ' THR . 39.4 t -111.15 150.16 29.87 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.653 0.74 . . . . 0.0 112.429 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 3.5 mm? -136.35 153.43 51.13 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.503 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 15.4 t -118.16 140.33 41.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.817 0.341 . . . . 0.0 111.067 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 41.6 mt -106.05 120.96 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.032 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.19 111.31 22.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.834 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.2 mp -85.55 129.45 37.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.342 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -81.08 128.64 33.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.01 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -74.06 -29.62 61.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.189 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.3 tttt -59.0 -43.69 91.54 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.851 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.418 ' CE2' HD21 ' A' ' 93' ' ' LEU . 30.1 t80 . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.039 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.819 0.343 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.42 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER -170.99 34.77 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.698 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 2.9 mm -77.1 131.55 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-N 113.887 -1.506 . . . . 0.0 112.388 -177.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.482 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.8 t -90.42 -62.0 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 114.623 -1.172 . . . . 0.0 110.442 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.0 p -147.89 142.53 26.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.441 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -113.83 134.1 55.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.976 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.5 t -97.45 122.88 49.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.97 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.5 mt -119.8 110.93 30.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.653 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.47 ' SG ' ' HG ' ' A' ' 143' ' ' LEU . 1.1 m -84.53 111.48 19.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.003 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.2 p -100.27 -9.68 22.12 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.581 HG23 ' CB ' ' A' ' 142' ' ' SER . 10.0 p -88.04 -2.86 58.86 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.183 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.55 90.32 0.45 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.488 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.404 ' HG3' HG13 ' A' ' 43' ' ' ILE . 10.7 pt20 -165.64 -47.28 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.791 0.329 . . . . 0.0 111.435 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.53 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 6.8 mt -130.32 142.4 45.33 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.85 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.53 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 67.4 Cg_endo -76.04 141.33 23.63 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.151 1.901 . . . . 0.0 111.509 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 47.6 mt -50.14 139.65 4.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.116 0.484 . . . . 0.0 112.054 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.86 163.0 31.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.014 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -120.22 119.86 34.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.142 0.496 . . . . 0.0 112.334 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.513 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 4.7 mt -94.04 137.55 33.12 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 178.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.698 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -146.2 158.09 43.86 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -178.272 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.482 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.33 141.89 28.92 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 113.094 -1.866 . . . . 0.0 110.166 178.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 121.209 0.528 . . . . 0.0 111.529 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.423 ' NZ ' ' HA ' ' A' ' 50' ' ' ALA . 4.5 ttpt . . . . . 0 CA--C 1.522 -0.116 0 CA-C-O 120.644 0.259 . . . . 0.0 110.779 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.458 HG11 ' HG2' ' A' ' 90' ' ' GLN . 16.4 t -128.93 139.18 52.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.409 0.623 . . . . 0.0 112.399 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.513 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.3 m-90 -101.27 138.66 38.0 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.846 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.91 126.28 54.99 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 176.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.56 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 0.6 OUTLIER -108.8 145.36 35.33 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.407 -178.225 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.699 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.79 172.61 31.48 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.981 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 1.8 mtm105 -67.13 -4.77 10.99 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.429 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.8 t30 -84.48 135.32 41.17 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.744 0.307 . . . . 0.0 111.175 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.2 Cg_exo -69.63 -6.14 17.83 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.868 2.379 . . . . 0.0 112.058 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.92 -43.59 16.32 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 122.029 0.919 . . . . 0.0 108.846 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.18 138.31 2.25 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.986 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -56.53 -18.36 11.42 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.236 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.56 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 19.7 t80 -129.0 114.36 16.32 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.785 0.326 . . . . 0.0 110.646 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.422 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.7 t-160 -88.26 130.61 35.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.271 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.418 ' CB ' HG12 ' A' ' 43' ' ' ILE . 1.4 pp -133.16 -177.67 4.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.593 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.3 -168.34 0.11 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.266 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -123.92 82.93 2.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.858 0.361 . . . . 0.0 110.734 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.42 ' HB ' ' CD1' ' A' ' 84' ' ' LEU . 3.5 mp -109.64 130.3 62.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.205 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.8 -31.23 64.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.168 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -60.75 -36.03 77.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.459 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.42 ' CD1' ' HB ' ' A' ' 81' ' ' ILE . 5.5 mp -93.28 152.98 18.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.201 0.524 . . . . 0.0 111.666 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.91 168.88 10.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.703 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.699 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.4 m-20 -44.03 -53.22 6.48 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.336 0.589 . . . . 0.0 109.722 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.45 83.56 2.06 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.523 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 15.9 t60 -60.98 -47.42 86.55 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.685 -176.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.526 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 20.0 p90 -147.17 160.44 42.45 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.254 -0.578 . . . . 0.0 111.612 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.7 tt0 -136.1 141.49 44.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.639 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 63.2 mt -116.9 127.66 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 121.219 -0.193 . . . . 0.0 110.531 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.441 ' HB3' HG13 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -112.33 150.17 31.4 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.158 0.504 . . . . 0.0 112.255 -179.14 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.403 ' CD1' ' CG1' ' A' ' 33' ' ' VAL . 6.9 tt . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.125 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 N--CA 1.458 -0.057 0 CA-C-O 120.891 0.377 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.405 ' HB2' ' HG ' ' A' ' 92' ' ' LEU . 9.1 mt -126.04 147.38 49.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.19 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.11 122.17 47.02 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 90' ' ' GLN . 59.2 t30 -112.93 115.37 28.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.614 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.701 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 11.7 p-10 -77.49 143.15 38.7 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.796 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 10.7 pt -151.41 36.79 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -178.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.523 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -99.34 148.43 24.19 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 120.924 0.392 . . . . 0.0 111.604 -179.183 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.6 m -68.7 -31.39 70.44 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 177.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -92.0 -19.82 21.99 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.484 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.488 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 113.29 152.46 11.06 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.293 -0.956 . . . . 0.0 113.937 179.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.503 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 4.9 m -117.35 137.72 52.26 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.813 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -117.56 148.18 42.13 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -178.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.27 113.56 18.42 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.468 177.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 45.31 42.69 7.55 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.25 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 84.99 -4.05 86.13 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.53 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -104.78 118.74 37.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.034 0.445 . . . . 0.0 110.655 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.813 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 6.7 tptt -74.98 117.76 17.19 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.141 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.2 m -96.6 159.77 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.201 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.453 ' O ' ' HB3' ' A' ' 120' ' ' SER . 0.0 OUTLIER -69.81 130.11 41.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.536 179.861 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.701 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 9.2 ptmt -55.13 167.73 0.4 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.08 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.5 m-80 36.93 33.44 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.983 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.453 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 22.8 t -112.44 141.38 46.25 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.849 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -92.08 129.55 38.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.85 0.357 . . . . 0.0 111.092 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.401 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 54.3 mm-40 -129.48 150.4 50.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.689 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.5 tp -72.5 133.3 44.73 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.273 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -63.48 160.85 15.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.81 0.814 . . . . 0.0 112.148 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.426 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -125.63 153.31 43.97 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.07 179.275 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -71.41 115.7 10.89 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.81 28.49 68.39 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.585 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.426 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 24.9 t0 -53.44 173.84 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.945 0.402 . . . . 0.0 111.19 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.412 ' CG ' ' O ' ' A' ' 143' ' ' LEU . 15.1 tt0 -145.15 135.24 23.86 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.898 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.512 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 15.2 mt -115.49 126.58 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.342 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.443 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.37 141.51 36.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.275 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.511 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.2 m -140.06 158.42 26.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.021 0.439 . . . . 0.0 111.996 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.18 30.25 23.13 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.932 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.439 ' HA ' HG12 ' A' ' 140' ' ' ILE . 73.9 t -77.01 140.48 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 CA-C-O 121.647 0.737 . . . . 0.0 112.101 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.17 -39.85 1.22 Allowed Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.465 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 2.8 t -118.01 119.12 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -50.42 -32.1 16.82 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 76.7 p -93.69 6.79 47.15 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.465 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.5 OUTLIER -129.49 34.44 4.35 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -178.463 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.443 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 6.1 mt -107.17 139.32 29.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.766 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.1 mp -124.15 134.78 53.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.879 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.581 ' CB ' HG23 ' A' ' 40' ' ' THR . 0.3 OUTLIER -106.59 135.49 48.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.172 0.51 . . . . 0.0 111.804 -179.327 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.47 ' HG ' ' SG ' ' A' ' 38' ' ' CYS . 5.3 mp -123.69 141.4 52.05 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.4 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 20.8 t -110.9 132.99 57.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.906 0.384 . . . . 0.0 111.196 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.2 mm -106.3 121.64 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.935 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.21 138.58 44.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.662 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.2 mp -106.63 133.03 52.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.386 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -83.91 122.74 29.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.89 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -73.74 -27.46 61.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.978 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.05 -42.54 80.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.006 0.432 . . . . 0.0 110.455 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 27.4 t80 . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.814 179.788 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.759 0.314 . . . . 0.0 110.85 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 177.01 39.66 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.656 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.6 mm -75.74 135.43 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-N 113.529 -1.669 . . . . 0.0 112.574 -177.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.488 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.7 t -92.83 -61.43 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.845 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.7 p -138.58 158.3 44.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.029 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.43 119.11 26.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.829 0.347 . . . . 0.0 111.392 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.2 t -89.18 122.67 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.912 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.9 mt -131.74 117.47 34.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.488 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 6.4 t -83.8 116.11 22.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.771 0.32 . . . . 0.0 110.149 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.3 t -92.49 -24.71 18.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.974 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.554 ' CG2' ' HB2' ' A' ' 142' ' ' SER . 49.4 p -79.78 -2.86 45.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.876 0.37 . . . . 0.0 111.484 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.15 76.58 0.6 Allowed Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 121.098 -0.572 . . . . 0.0 113.284 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -143.45 -40.41 0.3 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.815 0.34 . . . . 0.0 110.94 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.577 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 16.9 mt -132.48 143.24 47.96 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.212 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.577 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 51.5 Cg_endo -71.05 146.12 51.44 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.298 1.999 . . . . 0.0 111.967 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.4 mt -51.74 152.77 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.087 0.47 . . . . 0.0 111.998 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -147.2 164.21 33.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.041 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.53 120.01 27.31 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.531 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 7.7 mp -92.7 127.31 38.15 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.656 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -137.95 157.06 47.17 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -179.111 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.488 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -141.84 142.16 33.14 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 113.608 -1.633 . . . . 0.0 110.899 179.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 121.054 0.454 . . . . 0.0 111.117 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.41 ' CE ' ' O ' ' A' ' 49' ' ' SER . 6.4 ttpt . . . . . 0 CA--C 1.523 -0.085 0 CA-C-O 120.68 0.276 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 3.5 t -124.31 138.83 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 121.259 0.552 . . . . 0.0 112.192 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.565 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 17.3 m-90 -102.25 139.54 37.73 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.241 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.519 ' HA ' ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.45 126.97 55.92 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.612 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.618 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 1.1 m-85 -108.55 145.48 34.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.318 -178.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.683 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.97 178.43 37.52 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.26 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.405 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 11.8 mtp180 -70.49 -4.85 24.83 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.434 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.0 OUTLIER -84.55 134.06 43.15 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.711 0.291 . . . . 0.0 111.27 -179.329 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.0 Cg_exo -69.49 -6.52 18.65 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.727 2.284 . . . . 0.0 111.719 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.85 -43.79 16.21 Favored 'General case' 0 CA--C 1.497 -1.077 0 CA-C-O 121.993 0.902 . . . . 0.0 108.706 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -41.95 138.38 1.55 Allowed 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 113.698 -1.592 . . . . 0.0 110.445 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.49 -18.87 12.86 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.097 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.618 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 58.9 t80 -129.5 125.62 36.77 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 120.73 0.3 . . . . 0.0 110.667 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -98.55 131.83 44.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.907 0.384 . . . . 0.0 110.925 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -131.18 179.9 5.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.729 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.77 177.58 4.97 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.258 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -97.42 70.73 2.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.954 0.407 . . . . 0.0 110.84 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.405 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 40.0 mt -94.24 116.22 34.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.042 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.8 -34.38 62.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.313 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.468 ' HG3' ' HB3' ' A' ' 139' ' ' ASP . 1.5 mmt180 -60.84 -25.39 66.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.989 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.434 ' HA ' ' HD1' ' A' ' 88' ' ' HIS . 28.2 mt -96.03 149.92 21.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.302 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 57.9 p -93.6 169.69 10.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.604 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.683 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -43.21 -53.62 4.99 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.449 0.642 . . . . 0.0 109.912 179.251 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.405 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 6.4 ptmt -121.3 84.08 2.18 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 177.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.53 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 15.4 t60 -60.81 -47.26 87.15 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.978 -176.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.552 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 12.8 p90 -147.43 162.12 39.67 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 119.872 -0.731 . . . . 0.0 112.065 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.557 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 3.4 tt0 -135.67 146.26 47.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.532 -178.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.525 ' CD1' ' CE1' ' A' ' 68' ' ' PHE . 4.3 mp -124.03 132.08 71.92 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.337 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.452 178.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.52 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.2 OUTLIER -120.66 148.57 43.75 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.262 0.553 . . . . 0.0 112.214 -179.145 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.5 tp . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.822 178.54 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.866 0.365 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.4 mp -129.14 136.61 50.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.661 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.96 120.23 40.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.338 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.52 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 60.9 t30 -112.12 119.1 37.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.879 0.371 . . . . 0.0 111.806 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.69 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 13.8 p30 -79.99 139.36 37.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.668 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.439 HG12 ' HA ' ' A' ' 89' ' ' PHE . 17.3 pt -146.48 36.16 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -178.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.542 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -97.68 150.72 20.87 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-O 121.014 0.435 . . . . 0.0 112.14 -178.936 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.6 m -68.67 -31.61 70.85 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.683 177.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -96.13 -19.82 19.09 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -178.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.542 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.14 155.25 10.5 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.998 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.521 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.1 m -117.37 137.84 52.19 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.794 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -116.12 148.37 40.36 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 -177.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.1 113.6 18.58 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.487 177.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 44.85 42.95 6.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.399 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.62 -12.2 64.0 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.585 178.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -104.64 118.57 36.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.08 0.44 . . . . 0.0 110.627 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.794 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -71.91 125.41 27.12 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.37 -179.718 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.7 m -94.7 165.46 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.852 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.44 ' O ' ' HB2' ' A' ' 120' ' ' SER . 8.5 tp10 -69.88 126.33 29.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.586 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.69 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 64.8 tttt -53.41 161.55 0.95 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.887 0.375 . . . . 0.0 110.386 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.46 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.2 p30 36.25 33.8 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.239 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.43 145.08 40.8 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.034 179.296 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -91.62 127.63 37.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.688 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -129.21 147.13 51.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.941 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.9 tt -72.88 111.94 8.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.018 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.41 167.8 0.64 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.654 0.74 . . . . 0.0 112.0 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.404 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -125.18 153.36 43.19 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.489 179.609 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.74 116.56 12.25 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.17 24.47 73.36 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.923 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.404 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 14.8 t70 -60.09 179.74 0.13 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 120.799 0.333 . . . . 0.0 110.837 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.441 ' HG2' ' HA ' ' A' ' 144' ' ' VAL . 0.0 OUTLIER -145.05 135.38 24.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.254 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 8.5 mt -116.82 127.72 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.098 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.449 ' HB ' ' HB2' ' A' ' 110' ' ' TRP . 3.0 m -104.43 140.1 38.41 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.485 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.6 m -140.16 158.35 25.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.139 0.495 . . . . 0.0 112.198 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.23 28.69 29.91 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.649 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.439 ' HA ' HG12 ' A' ' 140' ' ' ILE . 68.8 t -74.52 140.55 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-O 121.64 0.733 . . . . 0.0 112.186 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.78 -43.5 0.83 Allowed Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -178.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.421 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 1.9 t -111.97 128.9 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -50.58 -43.43 56.54 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.7 p -93.56 6.74 47.23 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -178.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.468 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . 5.7 m-20 -119.61 34.42 5.22 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -178.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.448 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 6.2 mt -107.29 139.79 27.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.822 178.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.405 ' CD2' ' HG ' ' A' ' 143' ' ' LEU . 8.6 tt -120.97 134.69 55.3 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.949 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.554 ' HB2' ' CG2' ' A' ' 40' ' ' THR . 1.0 OUTLIER -109.99 139.48 45.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.058 0.456 . . . . 0.0 111.904 -179.375 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 40.7 mt -131.7 143.6 50.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.917 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.441 ' HA ' ' HG2' ' A' ' 129' ' ' GLU . 22.3 t -114.25 131.77 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 120.704 0.288 . . . . 0.0 111.132 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.5 mm -106.21 130.92 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-O 120.864 0.364 . . . . 0.0 110.755 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.75 112.01 21.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.954 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 7.0 mt -84.86 129.57 37.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.292 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -75.95 126.68 31.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.972 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -73.92 -35.95 64.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.97 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.1 -45.08 91.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.616 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 37.4 t80 . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.881 179.968 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.754 0.311 . . . . 0.0 111.052 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.406 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.1 t-20 175.05 39.86 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.672 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.2 mm -72.81 134.95 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 CA-C-N 113.621 -1.627 . . . . 0.0 112.407 -177.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.499 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.2 t -92.56 -60.55 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.099 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 21.8 p -142.97 164.66 29.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.381 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.6 138.22 51.14 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.849 0.357 . . . . 0.0 111.326 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.43 HG22 ' CE1' ' A' ' 76' ' ' TYR . 3.2 m -107.45 122.64 61.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.841 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.4 mt -126.66 119.53 53.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.478 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 23.1 t -79.78 111.38 16.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.808 0.337 . . . . 0.0 110.467 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.15 -23.73 35.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.825 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.498 HG22 ' HB3' ' A' ' 142' ' ' SER . 74.5 p -79.91 -2.25 42.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.788 0.327 . . . . 0.0 111.48 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.8 75.77 0.36 Allowed Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.821 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -146.6 -40.95 0.2 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.878 0.37 . . . . 0.0 111.053 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.547 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.7 mt -123.28 141.54 36.31 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.053 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.547 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.4 Cg_endo -72.63 146.01 42.82 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.33 2.02 . . . . 0.0 112.239 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.8 mt -55.51 148.98 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.677 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.43 164.15 28.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.152 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.33 119.74 31.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.993 0.425 . . . . 0.0 111.982 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.487 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 7.7 mp -95.81 125.48 40.41 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.672 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -135.51 157.39 47.0 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -178.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.499 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -148.82 148.91 30.47 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.638 -1.619 . . . . 0.0 110.81 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 121.062 0.458 . . . . 0.0 111.185 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.408 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.7 ttpt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.974 0.416 . . . . 0.0 111.962 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.403 HG13 ' HB3' ' A' ' 92' ' ' LEU . 13.0 t -129.99 139.43 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.218 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.608 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 17.8 m-90 -100.92 139.63 36.35 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.983 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.519 HG21 ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -109.58 133.04 53.57 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 177.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.531 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 1.1 m-85 -120.19 145.52 46.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.055 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.56 -172.38 36.16 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.874 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.435 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 9.5 mtp-105 -80.31 3.7 20.16 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.447 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 5.1 t-20 -84.88 133.46 43.41 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 120.659 0.266 . . . . 0.0 110.988 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 13.2 Cg_exo -68.28 -10.28 28.47 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.646 2.231 . . . . 0.0 111.88 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.29 -43.44 16.02 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-O 122.001 0.905 . . . . 0.0 108.952 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.19 136.41 2.24 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 113.658 -1.61 . . . . 0.0 111.278 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -56.71 -18.38 12.22 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.153 179.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.531 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 66.7 t80 -129.32 112.1 13.52 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-O 120.812 0.339 . . . . 0.0 111.071 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -94.99 114.39 26.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.835 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.412 HD21 ' CA ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -97.2 -80.25 0.44 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.988 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.95 -131.17 1.19 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.576 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -141.6 60.77 1.48 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.887 0.375 . . . . 0.0 110.821 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.435 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 3.9 mp -88.61 120.21 37.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.012 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 m -54.77 -42.94 72.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.878 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.466 ' HD3' ' HB3' ' A' ' 139' ' ' ASP . 0.7 OUTLIER -60.88 -18.68 57.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.113 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.7 mt -107.0 152.17 24.34 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.661 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 95.3 p -96.83 163.98 12.75 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.768 0.318 . . . . 0.0 111.709 -179.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.625 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.6 m-20 -41.27 -52.48 3.41 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.532 0.682 . . . . 0.0 109.845 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.418 ' O ' HG13 ' A' ' 104' ' ' ILE . 5.2 mttt -120.57 84.75 2.27 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 177.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.553 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.5 t60 -64.12 -45.76 87.13 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.023 -0.989 . . . . 0.0 113.252 -176.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.403 ' O ' ' N ' ' A' ' 68' ' ' PHE . 37.2 p90 -151.93 162.23 41.39 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.887 -0.725 . . . . 0.0 112.414 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.519 ' HG2' HG21 ' A' ' 67' ' ' THR . 11.0 mt-30 -135.55 154.3 51.42 Favored 'General case' 0 CA--C 1.522 -0.1 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.743 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.48 HG21 HD13 ' A' ' 91' ' ' ILE . 25.7 mt -119.91 132.19 70.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 177.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.432 ' HG ' ' CB ' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -118.71 140.18 50.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.111 0.481 . . . . 0.0 112.254 -178.547 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.408 ' CD1' ' CG1' ' A' ' 33' ' ' VAL . 11.0 tp . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.088 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.802 0.334 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.432 ' CB ' ' HG ' ' A' ' 92' ' ' LEU . 6.5 mt -133.08 140.95 47.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.096 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.6 126.05 54.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.473 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -114.07 115.51 27.67 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.491 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.679 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 9.5 p30 -79.21 143.24 35.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.942 178.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.465 HG12 ' HG3' ' A' ' 90' ' ' GLN . 9.7 pt -150.02 35.27 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -178.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.559 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -95.78 150.97 19.81 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 121.118 0.485 . . . . 0.0 112.09 -178.78 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.9 m -68.72 -31.39 70.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.791 177.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -97.76 -19.72 18.02 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.559 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 118.14 155.88 10.13 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.334 -0.936 . . . . 0.0 114.062 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 11.5 m -117.26 137.83 52.13 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.815 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -116.24 148.29 40.61 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.761 1.022 . . . . 0.0 113.761 -178.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.2 113.52 18.41 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.612 -1.177 . . . . 0.0 108.444 177.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 43.62 43.72 4.89 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.375 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.32 -12.3 65.15 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.382 178.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 9.4 mp0 -103.74 118.59 37.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.053 0.454 . . . . 0.0 110.601 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.815 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.0 tptt -73.16 124.7 26.11 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.215 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.0 m -94.92 162.37 2.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.154 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 120' ' ' SER . 4.3 pm0 -69.94 126.37 29.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.47 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.679 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 18.6 tttm -51.42 160.52 0.57 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.015 0.435 . . . . 0.0 111.046 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.8 p30 34.96 33.67 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.432 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.55 145.14 40.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.164 179.262 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -87.42 127.51 35.22 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.048 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.405 ' N ' HD23 ' A' ' 100' ' ' LEU . 34.6 mm-40 -129.35 146.3 51.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.743 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.4 tp -72.9 112.43 8.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.173 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.2 mt -59.97 167.32 2.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.676 0.75 . . . . 0.0 111.886 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.408 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.0 OUTLIER -125.36 153.42 43.39 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.319 179.425 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.41 120.92 17.68 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.58 19.2 66.72 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.055 -178.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.408 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 14.3 t70 -58.06 177.44 0.12 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 120.794 0.33 . . . . 0.0 110.791 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 10.7 mt-10 -145.11 135.54 24.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.247 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 6.0 mt -114.0 128.47 70.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.075 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.457 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.7 m -103.89 140.11 38.14 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.523 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 31.0 m -140.18 158.32 25.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.135 0.493 . . . . 0.0 112.279 -178.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.75 27.61 28.8 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.01 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.438 ' HB ' ' CZ3' ' A' ' 110' ' ' TRP . 77.3 t -73.4 140.46 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-O 121.616 0.722 . . . . 0.0 112.063 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.43 -40.33 0.99 Allowed Glycine 0 N--CA 1.434 -1.455 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.485 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 2.1 t -117.38 126.82 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -50.47 -40.1 49.96 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.2 m -93.44 6.66 47.41 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -178.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.485 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.7 OUTLIER -120.17 33.34 5.64 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -178.444 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.457 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.6 mt -107.09 138.83 31.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.384 0.611 . . . . 0.0 110.824 178.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.46 134.64 52.99 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.533 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.498 ' HB3' HG22 ' A' ' 40' ' ' THR . 42.2 t -110.29 150.44 28.73 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.615 0.721 . . . . 0.0 112.422 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 3.0 mm? -135.84 148.5 48.69 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.319 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 20.1 t -114.2 134.86 55.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.892 0.377 . . . . 0.0 111.281 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.3 mm -106.37 122.89 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.624 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.06 114.33 26.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.894 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 7.9 mm -84.95 129.35 37.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.06 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -75.88 107.92 8.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.845 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.3 -31.86 69.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.87 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -45.52 91.66 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.592 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 36.1 t80 . . . . . 0 N--CA 1.452 -0.344 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.88 179.918 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.739 0.304 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.411 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER -177.41 36.86 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.72 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.5 mm -75.77 135.65 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 CA-C-N 113.754 -1.566 . . . . 0.0 112.639 -177.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.485 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.0 t -90.81 -60.24 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.953 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.0 p -148.19 150.12 33.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.137 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.98 138.14 50.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.889 0.376 . . . . 0.0 111.622 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.9 p -104.64 122.75 58.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.642 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.3 mt -127.73 125.56 65.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.706 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.5 t -89.75 104.64 17.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.195 179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.9 p -81.55 -22.56 37.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.962 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.575 ' CG2' ' HB2' ' A' ' 142' ' ' SER . 67.8 p -79.81 -2.64 44.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.809 0.337 . . . . 0.0 111.496 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.29 74.93 0.48 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.833 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -146.26 -36.19 0.26 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.808 0.337 . . . . 0.0 111.13 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.568 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 15.8 mt -131.72 141.9 43.29 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.947 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.568 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 48.7 Cg_endo -71.01 146.0 51.35 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.19 1.927 . . . . 0.0 112.357 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.4 mt -61.35 148.61 9.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.769 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.94 164.3 30.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.162 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -120.98 119.86 33.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.1 0.476 . . . . 0.0 111.847 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.537 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 10.4 mt -96.05 136.09 36.97 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.72 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -146.97 158.7 44.0 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 -178.669 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.485 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -139.79 141.81 36.73 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 113.542 -1.663 . . . . 0.0 110.559 178.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 121.222 0.534 . . . . 0.0 111.281 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.413 ' CE ' ' O ' ' A' ' 49' ' ' SER . 4.0 ttpt . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.726 0.298 . . . . 0.0 110.985 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.497 HG11 ' HG2' ' A' ' 90' ' ' GLN . 14.2 t -132.16 139.4 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 121.255 0.55 . . . . 0.0 112.374 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.537 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.6 m-90 -104.58 139.51 39.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.943 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.563 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -114.57 125.82 54.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.123 0.487 . . . . 0.0 110.078 177.694 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.533 ' CD2' ' CD2' ' A' ' 76' ' ' TYR . 2.2 m-85 -109.73 145.48 36.53 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.061 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 157.73 -172.1 34.94 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.41 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.496 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 9.3 mtp-105 -76.92 2.45 14.69 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.417 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 0.2 OUTLIER -84.54 130.93 51.57 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.517 0.199 . . . . 0.0 110.976 -179.628 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 18.9 Cg_exo -65.54 -13.99 42.6 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.387 2.058 . . . . 0.0 111.501 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.02 -42.37 17.58 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-O 121.849 0.833 . . . . 0.0 108.839 178.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -42.05 138.32 1.62 Allowed 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.8 179.685 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.9 OUTLIER -56.33 -18.6 11.3 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.164 179.1 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.533 ' CD2' ' CD2' ' A' ' 68' ' ' PHE . 13.2 t80 -129.28 119.46 24.0 Favored 'General case' 0 CA--C 1.527 0.09 0 CA-C-O 120.758 0.313 . . . . 0.0 111.196 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -99.98 117.68 34.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.677 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.4 mt -88.85 -69.09 0.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.017 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 171.92 -85.67 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.519 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -174.46 49.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.901 0.382 . . . . 0.0 111.084 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.496 ' N ' ' HD2' ' A' ' 70' ' ' ARG . 30.1 mm -79.99 123.86 37.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.198 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 90.2 p -54.72 -41.16 69.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.254 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.461 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 8.5 tpt85 -63.71 -49.16 74.19 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.7 mt -73.88 148.26 42.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.06 0.457 . . . . 0.0 111.856 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.7 p -95.11 165.27 12.5 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.855 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.571 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.0 m-20 -41.5 -53.16 3.51 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.434 0.635 . . . . 0.0 110.21 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.446 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 8.5 ptpp? -123.8 81.96 1.97 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 177.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.554 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.9 t60 -59.73 -46.69 88.36 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.981 -1.009 . . . . 0.0 112.988 -176.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.514 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 23.6 p90 -147.65 160.55 42.55 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.116 -0.634 . . . . 0.0 111.621 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.497 ' HG2' HG11 ' A' ' 65' ' ' VAL . 5.4 tt0 -135.94 139.75 43.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.555 -178.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.454 ' O ' ' CG1' ' A' ' 65' ' ' VAL . 17.5 mt -112.37 131.51 63.65 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.233 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.673 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.419 ' HB3' HG13 ' A' ' 65' ' ' VAL . 1.8 pt? -118.93 146.83 44.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.044 0.45 . . . . 0.0 111.605 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 14.3 tp . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.396 179.597 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.707 0.289 . . . . 0.0 110.713 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.401 ' HB3' ' CD2' ' A' ' 92' ' ' LEU . 1.2 mp -127.33 144.58 51.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.327 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.77 124.72 53.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.283 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.419 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 53.7 t30 -118.19 115.53 24.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.978 0.418 . . . . 0.0 111.45 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.682 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 8.8 p30 -79.07 142.44 36.48 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.095 178.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.446 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 16.7 pt -151.09 37.59 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.554 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -95.18 155.38 16.76 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 121.0 0.429 . . . . 0.0 111.55 -179.304 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 82.8 m -68.82 -34.37 75.39 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.331 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 19.9 p30 -98.65 -19.87 17.29 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.51 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 122.6 156.67 9.7 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.279 -0.963 . . . . 0.0 113.749 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.531 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.4 m -117.35 137.9 52.14 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.827 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -116.26 148.34 40.59 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -178.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.15 113.39 18.27 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.284 177.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 44.41 42.92 5.8 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.385 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.27 -7.97 78.64 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.841 -0.695 . . . . 0.0 113.484 178.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.19 118.67 37.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.035 0.445 . . . . 0.0 110.688 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.827 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 9.6 tptp -74.16 118.28 16.93 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.236 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.4 m -90.73 164.23 2.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.14 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 120' ' ' SER . 33.8 tt0 -69.83 127.71 33.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.436 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.682 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 25.3 tttt -53.58 160.92 1.15 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.975 0.417 . . . . 0.0 110.599 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.5 p30 34.18 35.32 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.351 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.24 145.06 40.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.222 179.435 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -83.73 128.75 34.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.748 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -129.31 145.76 51.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.594 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -72.99 118.09 15.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.254 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 65.0 tp -56.41 157.25 5.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.359 0.6 . . . . 0.0 111.549 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.449 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.8 OUTLIER -124.53 153.14 42.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.592 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.6 tp60 -71.71 124.32 24.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.015 0.436 . . . . 0.0 110.61 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.37 20.65 45.43 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.344 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.449 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 9.8 t70 -58.71 173.22 0.43 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.942 0.401 . . . . 0.0 110.835 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 18.8 tt0 -145.17 135.6 24.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.106 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.5 mt -108.8 128.64 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.313 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.451 ' O ' ' HB2' ' A' ' 110' ' ' TRP . 4.1 m -103.75 136.64 43.06 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.528 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 29.8 m -138.08 158.38 32.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.183 0.516 . . . . 0.0 112.381 -178.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.453 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 82.96 38.62 11.13 Favored Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.954 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.417 ' HA ' HG12 ' A' ' 140' ' ' ILE . 56.5 t -79.84 140.47 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-O 121.676 0.75 . . . . 0.0 112.203 -179.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.48 -46.16 0.64 Allowed Glycine 0 N--CA 1.435 -1.371 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.421 HG11 ' N ' ' A' ' 139' ' ' ASP . 0.9 OUTLIER -127.19 125.49 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 CA-C-N 114.259 -0.97 . . . . 0.0 108.827 177.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.92 -24.79 2.72 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -177.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.0 t -93.05 -0.36 57.13 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.421 ' N ' HG11 ' A' ' 136' ' ' VAL . 79.1 m-20 -120.05 25.61 9.8 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -178.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.424 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 4.4 mt -106.88 138.72 31.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-O 121.405 0.621 . . . . 0.0 111.559 178.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.6 tt -124.5 134.49 53.0 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.392 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.575 ' HB2' ' CG2' ' A' ' 40' ' ' THR . 2.1 m -107.02 142.17 37.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.158 0.504 . . . . 0.0 111.976 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 2.1 mm? -135.34 137.74 42.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.448 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.1 t -110.79 137.79 41.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.88 0.371 . . . . 0.0 111.236 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.413 HG22 HD13 ' A' ' 145' ' ' ILE . 52.6 mt -106.22 128.32 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.399 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.94 114.96 27.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.364 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.5 mt -84.73 130.93 35.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.951 0.405 . . . . 0.0 111.618 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -78.97 111.95 15.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.752 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -61.38 -33.13 73.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.139 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -45.99 91.2 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.034 0.445 . . . . 0.0 110.843 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 26.8 t80 . . . . . 0 N--CA 1.451 -0.382 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.05 -179.893 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.732 0.301 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 176.42 39.6 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.651 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -74.79 135.62 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 CA-C-N 113.63 -1.623 . . . . 0.0 112.404 -177.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.477 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.3 t -91.93 -59.46 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.923 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.8 p -148.31 165.17 31.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.482 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.99 138.29 51.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.831 0.348 . . . . 0.0 111.399 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.6 t -111.18 122.81 66.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.563 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.0 mt -122.25 120.06 60.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.857 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -83.96 104.07 13.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.039 179.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.96 -20.88 48.09 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.452 HG23 ' HB3' ' A' ' 142' ' ' SER . 72.8 p -79.85 -2.41 43.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.803 0.335 . . . . 0.0 111.547 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.72 75.12 0.44 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.819 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -145.84 -40.01 0.23 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.893 0.378 . . . . 0.0 110.88 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.589 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.4 mp -125.4 142.69 42.38 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.038 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.589 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 50.7 Cg_endo -70.75 145.86 52.58 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.207 1.938 . . . . 0.0 112.131 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.2 mt -62.93 138.95 22.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.77 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.43 163.98 25.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.951 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -124.38 119.88 30.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.082 0.468 . . . . 0.0 111.854 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.535 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 7.6 mp -85.88 132.08 34.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.558 178.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.651 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -140.31 155.81 46.68 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 122.281 1.038 . . . . 0.0 113.423 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.477 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.08 141.84 29.18 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 113.533 -1.667 . . . . 0.0 110.798 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 121.256 0.551 . . . . 0.0 111.198 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.416 ' CE ' ' O ' ' A' ' 49' ' ' SER . 4.1 ttpt . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.782 0.325 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.494 HG12 ' HB3' ' A' ' 92' ' ' LEU . 17.4 t -130.67 139.21 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 121.34 0.59 . . . . 0.0 112.084 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.535 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 16.2 m-90 -105.44 138.71 41.19 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.952 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.429 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -112.01 131.95 55.1 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.493 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.517 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.4 OUTLIER -117.11 145.61 43.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.679 -178.316 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.664 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.92 -171.97 37.96 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.596 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.422 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 4.6 mtm105 -83.14 3.36 31.08 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.46 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.0 t30 -85.07 135.06 39.94 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.627 0.251 . . . . 0.0 110.95 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.8 Cg_exo -65.95 -11.83 32.67 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.613 2.209 . . . . 0.0 111.728 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.86 -45.31 14.4 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 121.952 0.882 . . . . 0.0 108.827 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.59 137.55 5.07 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 113.892 -1.504 . . . . 0.0 110.692 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.6 OUTLIER -56.66 -18.14 11.22 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.232 179.028 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.492 ' CE2' HG22 ' A' ' 43' ' ' ILE . 9.9 t80 -125.23 118.51 26.19 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-O 120.782 0.325 . . . . 0.0 110.928 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -99.77 115.73 30.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.472 ' HA ' HG12 ' A' ' 43' ' ' ILE . 2.6 mt -90.2 -168.28 2.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.093 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -91.68 19.36 48.6 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.828 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 63.88 84.31 0.15 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.865 0.365 . . . . 0.0 111.538 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.4 mp -108.3 131.4 58.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.714 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.4 m -54.88 -39.55 68.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.03 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -66.37 -45.49 79.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.907 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.6 mt -72.81 151.54 42.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.892 0.377 . . . . 0.0 111.641 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.0 p -95.83 166.98 11.54 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.733 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.664 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.7 m-20 -43.85 -54.18 5.45 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.282 0.563 . . . . 0.0 109.842 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.419 ' O ' HG13 ' A' ' 104' ' ' ILE . 0.6 OUTLIER -120.04 83.06 1.99 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.163 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.558 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 9.4 t60 -62.12 -46.32 89.54 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.791 -176.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.517 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 18.4 p90 -146.5 157.93 43.82 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.672 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.493 ' HG2' HG13 ' A' ' 65' ' ' VAL . 5.5 tt0 -135.94 140.66 44.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.332 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.431 HG13 ' CE1' ' A' ' 68' ' ' PHE . 39.3 mt -114.76 132.11 64.92 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.912 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.494 ' HB3' HG12 ' A' ' 65' ' ' VAL . 0.4 OUTLIER -123.59 146.28 48.28 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.141 0.496 . . . . 0.0 111.704 -179.805 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 14.5 tp . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.219 179.309 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.404 ' HB2' ' CD1' ' A' ' 124' ' ' LEU . 7.6 mp . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.729 0.299 . . . . 0.0 110.722 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.1 mt -133.1 146.58 51.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.879 0.371 . . . . 0.0 110.808 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.401 ' CD2' ' HB3' ' A' ' 124' ' ' LEU . 2.3 mm? -112.72 123.57 50.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.854 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 90' ' ' GLN . 41.1 t30 -112.95 115.51 28.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.04 0.448 . . . . 0.0 111.229 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.688 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 15.1 p30 -81.34 133.19 35.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.874 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 87' ' ' LYS . 19.2 pt -140.9 38.66 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.545 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -100.76 154.03 18.96 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 120.918 0.39 . . . . 0.0 111.577 -179.387 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 86.6 m -68.89 -31.77 70.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.43 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -97.74 -19.88 17.93 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.456 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.84 158.0 10.83 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.889 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.529 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.1 m -117.71 137.87 52.39 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.84 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -117.95 148.32 42.3 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.43 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.4 OUTLIER -124.58 113.67 18.37 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 176.611 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 37.3 m-20 48.19 42.05 16.78 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.63 -8.38 75.51 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.77 -0.729 . . . . 0.0 113.925 178.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -105.69 118.83 37.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.13 0.465 . . . . 0.0 110.786 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.84 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -73.14 135.08 44.66 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.404 -179.719 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.7 m -107.44 163.98 5.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.763 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 120' ' ' SER . 44.2 tt0 -69.87 127.32 32.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.384 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.688 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 76.7 tttt -52.16 161.57 0.6 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.896 0.379 . . . . 0.0 110.525 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.7 p30 34.37 34.73 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.305 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.34 145.11 40.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.453 179.618 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -87.43 123.99 32.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.615 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -129.24 146.69 51.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.858 0.361 . . . . 0.0 111.102 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 32.6 tp -75.07 118.04 17.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.101 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.404 ' CD1' ' HB2' ' A' ' 99' ' ' LEU . 2.0 pt? -58.12 168.66 0.96 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.586 0.708 . . . . 0.0 112.039 -178.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.468 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.38 154.13 40.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.81 -1.087 . . . . 0.0 109.905 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . 0.425 ' HA ' HD13 ' A' ' 147' ' ' ILE . 17.1 tp60 -70.14 119.38 14.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.085 0.469 . . . . 0.0 110.27 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.06 23.38 59.41 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.905 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.468 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 25.6 t0 -57.81 179.2 0.07 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 120.716 0.293 . . . . 0.0 110.676 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 7.2 mt-10 -145.05 135.64 24.37 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.091 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.599 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 10.2 mt -107.3 123.67 62.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.924 0.392 . . . . 0.0 110.622 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.425 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 96.9 m -104.59 140.69 37.64 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.558 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 17.7 m -140.25 158.51 25.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.32 29.8 35.8 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.114 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.477 ' HB ' ' CH2' ' A' ' 110' ' ' TRP . 86.8 t -76.36 140.51 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-O 121.604 0.716 . . . . 0.0 111.986 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 139.04 -37.75 1.74 Allowed Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -178.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.5 t -123.01 118.35 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.85 -26.43 5.77 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -178.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 20.7 t -93.74 6.75 47.31 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -132.62 33.82 3.74 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -178.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.425 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 7.2 mt -107.21 138.02 35.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-O 121.619 0.723 . . . . 0.0 111.338 178.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.4 tt -125.65 135.02 51.7 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.374 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.452 ' HB3' HG23 ' A' ' 40' ' ' THR . 46.8 t -112.38 147.42 36.44 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.87 0.843 . . . . 0.0 112.44 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 3.7 mp -135.85 153.08 51.6 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.153 -1.385 . . . . 0.0 110.854 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 21.9 t -118.17 140.03 43.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.631 0.253 . . . . 0.0 110.544 179.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.5 mm -106.2 120.85 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-O 120.957 0.408 . . . . 0.0 110.989 -179.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.69 111.06 22.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.677 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.435 HD13 ' O ' ' A' ' 125' ' ' SER . 4.1 mp -89.93 134.23 29.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.853 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -85.52 108.2 17.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.5 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.79 -31.68 68.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.202 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -60.32 -45.95 91.6 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.967 0.413 . . . . 0.0 110.779 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 36.5 t80 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.049 -179.869 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 . . . . . 0 C--O 1.23 0.032 0 CA-C-O 120.759 0.314 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.405 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.9 OUTLIER 175.2 39.66 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.852 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.666 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -72.29 135.45 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 CA-C-N 113.613 -1.63 . . . . 0.0 112.558 -177.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.483 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.5 t -91.56 -58.85 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.912 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 24.8 p -152.56 154.78 36.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.644 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.428 ' NE ' ' CG2' ' A' ' 45' ' ' ILE . 0.1 OUTLIER -119.09 138.22 53.03 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.799 0.333 . . . . 0.0 110.971 -179.85 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.3 t -107.7 122.67 62.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.895 0.379 . . . . 0.0 110.906 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.4 mt -118.69 127.97 75.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.502 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 52.6 t -81.36 100.68 9.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.518 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.98 -24.19 65.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.816 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.488 HG23 ' HB3' ' A' ' 142' ' ' SER . 72.9 p -79.82 -2.36 43.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.831 0.348 . . . . 0.0 111.376 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 59.99 76.28 0.23 Allowed Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 121.018 -0.611 . . . . 0.0 113.09 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -146.57 -43.14 0.19 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.92 0.39 . . . . 0.0 110.78 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.567 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.4 mp -119.55 142.55 32.95 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.035 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.567 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 50.7 Cg_endo -71.2 146.18 50.8 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.216 1.944 . . . . 0.0 112.203 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.428 ' CG2' ' NE ' ' A' ' 35' ' ' ARG . 51.7 mt -55.04 144.68 5.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.944 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.46 ' HB2' ' CE2' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -128.28 134.24 48.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.837 178.828 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -98.72 119.71 37.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.046 0.451 . . . . 0.0 112.199 -178.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.538 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 7.1 mp -93.68 128.12 39.71 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.666 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -133.71 156.84 47.23 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 122.067 0.937 . . . . 0.0 113.526 -179.602 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.483 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -153.02 142.02 21.28 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 113.817 -1.538 . . . . 0.0 111.136 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.104 -179.701 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.44 ' HE2' ' O ' ' A' ' 49' ' ' SER . 4.0 ttpt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.757 0.313 . . . . 0.0 111.327 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.442 HG13 ' HG2' ' A' ' 90' ' ' GLN . 16.0 t -131.27 139.27 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-O 121.155 0.503 . . . . 0.0 111.733 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.572 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 20.2 m-90 -101.02 139.24 36.98 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.002 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.4 ' HA ' ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.76 126.93 55.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.038 0.447 . . . . 0.0 109.904 177.911 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.523 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 0.5 OUTLIER -111.43 145.83 38.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.453 -178.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.657 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.42 -171.86 37.51 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.602 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.431 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 8.3 mtp-105 -82.15 1.48 36.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -84.92 134.37 41.56 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.716 0.293 . . . . 0.0 111.035 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -68.48 -8.97 24.64 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.625 2.217 . . . . 0.0 111.787 179.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.16 -43.9 15.67 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 122.031 0.92 . . . . 0.0 108.79 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.45 136.64 2.33 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 113.656 -1.611 . . . . 0.0 110.832 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -56.6 -19.08 14.26 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.831 179.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.523 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 9.8 t80 -129.95 119.3 23.0 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.723 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -93.94 111.03 22.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.907 0.384 . . . . 0.0 110.95 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 44.9 mt -76.07 -78.55 0.11 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.997 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.62 -87.16 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.506 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -177.5 47.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.853 0.359 . . . . 0.0 111.003 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.431 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 30.7 mm -83.35 117.39 29.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.108 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.7 -31.99 58.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.042 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.96 -17.39 62.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.274 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.2 mt -106.95 152.16 24.32 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.762 0.315 . . . . 0.0 111.436 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 87.2 p -96.39 166.0 11.92 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.663 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.657 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.1 m-20 -43.11 -52.35 5.48 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.425 0.631 . . . . 0.0 109.774 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.437 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 14.5 ptmt -119.77 82.86 1.95 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 177.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.589 ' CE1' ' OG ' ' A' ' 105' ' ' SER . 14.2 t60 -61.17 -46.66 89.61 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.875 -176.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.491 ' HA ' HG12 ' A' ' 104' ' ' ILE . 32.0 p90 -148.99 161.42 41.94 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.767 -179.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.486 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.4 tt0 -135.92 142.28 44.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.42 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 46.2 mt -117.55 127.64 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.004 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.412 ' HB3' HG12 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -110.72 143.49 41.14 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.058 0.456 . . . . 0.0 111.752 -179.606 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 tm? . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.394 179.307 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.728 0.299 . . . . 0.0 110.689 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 2.3 mp -125.33 145.81 49.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.455 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.9 mt -112.99 123.29 49.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.33 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.411 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 59.5 t30 -118.2 115.77 25.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.829 0.347 . . . . 0.0 111.86 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.682 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 9.2 p30 -79.14 143.14 35.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.943 178.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.491 HG12 ' HA ' ' A' ' 89' ' ' PHE . 14.3 pt -146.88 26.73 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.589 ' OG ' ' CE1' ' A' ' 88' ' ' HIS . 11.0 t -93.98 154.97 17.39 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.7 m -70.12 -52.16 25.79 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.453 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -74.64 -4.06 34.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.247 -179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.92 155.97 31.22 Favored Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.439 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.49 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 5.4 m -117.36 137.78 52.23 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.812 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -114.02 148.49 36.9 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -177.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.0 113.6 18.65 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.467 177.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 45.09 42.88 7.06 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.04 -13.44 61.38 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.726 -0.749 . . . . 0.0 113.486 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -104.49 118.49 36.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 117.104 0.452 . . . . 0.0 110.498 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.812 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -70.11 123.61 22.02 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.403 -179.793 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.7 m -95.08 164.64 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.01 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -69.94 127.88 34.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.587 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.682 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 17.6 tttm -53.66 162.47 0.85 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.754 0.312 . . . . 0.0 110.23 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.6 p30 34.52 36.32 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.004 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.7 p -111.92 145.09 40.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.706 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.4 ' HB3' ' CD2' ' A' ' 100' ' ' LEU . 18.6 m120 -92.71 130.67 38.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.872 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.45 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 58.3 mm-40 -129.28 150.93 50.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.558 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.7 tp -72.81 130.03 39.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.815 0.341 . . . . 0.0 110.226 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.437 ' HG ' ' N ' ' A' ' 125' ' ' SER . 30.0 tp -58.1 153.71 14.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.594 0.711 . . . . 0.0 111.737 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.437 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.6 OUTLIER -125.12 152.92 43.76 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.691 -1.14 . . . . 0.0 110.451 179.647 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -72.1 124.86 25.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.828 0.346 . . . . 0.0 110.09 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.84 22.82 48.92 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.758 -0.735 . . . . 0.0 111.981 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -50.4 165.71 0.09 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.896 0.379 . . . . 0.0 111.345 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -145.05 135.48 24.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.99 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 14.7 mt -114.73 128.24 71.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.798 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.443 ' O ' ' HB2' ' A' ' 110' ' ' TRP . 3.2 m -104.08 139.84 38.61 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.562 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.8 m -140.42 158.67 25.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -178.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.85 29.27 29.43 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.236 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.4 ' HA ' HG12 ' A' ' 140' ' ' ILE . 74.6 t -73.38 140.51 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-O 121.622 0.725 . . . . 0.0 112.077 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.23 -37.09 1.43 Allowed Glycine 0 N--CA 1.436 -1.36 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 -178.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.459 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 3.7 t -124.84 125.29 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.4 -35.92 30.51 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -178.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.0 p -93.59 6.57 47.8 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.459 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 30.4 m-20 -121.02 28.91 7.62 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -178.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.436 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.2 mt -107.04 138.52 32.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-O 121.5 0.667 . . . . 0.0 111.143 178.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.0 tt -124.85 134.42 52.73 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.149 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.488 ' HB3' HG23 ' A' ' 40' ' ' THR . 38.3 t -112.81 150.24 31.95 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.761 0.791 . . . . 0.0 112.642 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -136.02 143.67 44.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.525 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 24.0 t -115.86 140.27 38.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.792 0.329 . . . . 0.0 111.008 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.435 HD13 HG23 ' A' ' 145' ' ' ILE . 33.2 mt -106.0 123.39 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-O 120.951 0.405 . . . . 0.0 111.278 -179.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.2 118.35 36.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.532 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.436 HG12 HD21 ' A' ' 124' ' ' LEU . 3.6 mt -88.07 133.96 29.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.649 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -82.72 113.53 20.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.738 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.57 -29.45 66.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.074 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.65 -45.77 91.02 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 120.976 0.417 . . . . 0.0 110.672 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.1 t80 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.951 -179.933 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.828 0.346 . . . . 0.0 110.816 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.41 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.7 OUTLIER 179.0 38.08 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.707 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -75.99 135.07 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-N 113.785 -1.552 . . . . 0.0 112.506 -177.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.487 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.8 t -91.88 -61.68 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.24 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.5 p -149.34 149.02 30.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.302 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -116.7 138.3 51.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.874 0.368 . . . . 0.0 111.417 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.89 122.89 57.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.998 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.4 mt -123.09 117.72 52.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.609 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.1 t -80.74 112.75 18.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.185 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.05 -21.62 29.32 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.484 HG23 ' HB3' ' A' ' 142' ' ' SER . 75.1 p -79.79 -2.47 43.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.788 0.328 . . . . 0.0 111.592 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.46 72.37 0.74 Allowed Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.977 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -142.45 -42.13 0.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.876 0.369 . . . . 0.0 110.919 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.554 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.3 mt -121.02 141.66 33.18 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.035 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.554 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.9 Cg_endo -72.83 140.36 31.92 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.167 1.912 . . . . 0.0 112.167 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.1 mt -55.95 145.63 6.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.766 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.09 163.72 31.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.153 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -120.5 119.88 34.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.08 0.467 . . . . 0.0 112.013 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.49 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 5.1 mt -93.93 137.55 33.02 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.707 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.73 159.01 43.79 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -178.662 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.487 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -138.53 141.87 39.31 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 113.744 -1.571 . . . . 0.0 110.618 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 121.221 0.534 . . . . 0.0 111.578 -179.291 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.429 ' CE ' ' O ' ' A' ' 49' ' ' SER . 31.1 ttpt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.793 0.33 . . . . 0.0 110.667 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.508 HG13 ' HB3' ' A' ' 92' ' ' LEU . 12.4 t -121.53 139.12 49.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.272 0.558 . . . . 0.0 111.906 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.579 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 18.2 m-90 -104.07 138.61 40.33 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.069 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -113.94 128.28 56.33 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 177.049 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.522 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -115.19 145.46 42.38 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.497 -177.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.577 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.35 -172.23 38.4 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.702 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.435 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 9.4 mtm105 -80.46 2.29 25.79 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 3.0 t-20 -84.87 134.2 42.02 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.575 0.226 . . . . 0.0 111.125 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 15.8 Cg_exo -67.06 -11.9 34.01 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.531 2.154 . . . . 0.0 111.75 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.9 -43.33 16.65 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 122.017 0.913 . . . . 0.0 108.93 178.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.51 137.82 2.01 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.086 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.8 m-20 -56.58 -18.44 11.89 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.985 178.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.471 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 19.5 t80 -129.27 119.65 24.33 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.869 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -98.77 110.06 22.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.927 0.394 . . . . 0.0 111.031 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 pp -113.04 172.98 6.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.666 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.23 136.91 50.55 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.506 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -68.27 89.75 0.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.789 0.328 . . . . 0.0 110.777 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.433 ' O ' ' HD3' ' A' ' 70' ' ' ARG . 44.6 mt -107.86 135.55 46.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.024 0.44 . . . . 0.0 111.478 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 89.9 p -54.88 -43.94 73.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.274 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.45 ' HG3' ' HB3' ' A' ' 139' ' ' ASP . 1.6 mmt180 -60.85 -27.81 68.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.568 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.4 ' HA ' ' HD1' ' A' ' 88' ' ' HIS . 29.7 mt -96.23 150.95 19.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.9 0.381 . . . . 0.0 111.633 -179.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 75.4 p -98.62 169.05 9.78 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.416 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.577 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.0 m-20 -44.11 -55.3 4.85 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.318 0.58 . . . . 0.0 109.761 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.455 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 3.1 ptpp? -118.8 84.73 2.24 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 177.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.548 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 12.7 t60 -60.55 -47.02 88.0 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.874 -176.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.511 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 23.9 p90 -146.69 160.53 42.09 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.991 -179.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.473 ' HG2' HG11 ' A' ' 65' ' ' VAL . 4.3 tt0 -135.95 139.15 43.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.395 -179.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.433 ' O ' ' CG1' ' A' ' 65' ' ' VAL . 61.6 mt -114.61 132.14 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 121.104 -0.238 . . . . 0.0 110.965 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.508 ' HB3' HG13 ' A' ' 65' ' ' VAL . 0.2 OUTLIER -123.97 136.41 54.29 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.047 0.451 . . . . 0.0 111.966 -179.604 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.434 HD21 ' CE2' ' A' ' 151' ' ' PHE . 2.4 tp . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.43 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.406 ' HB3' HD11 ' A' ' 124' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.826 0.346 . . . . 0.0 110.764 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.7 mt -133.34 140.7 47.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.704 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 pp -112.66 124.61 52.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.929 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 90' ' ' GLN . 47.3 t30 -114.62 115.92 27.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.9 0.381 . . . . 0.0 111.705 -179.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.66 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 12.2 p30 -78.57 136.67 37.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.885 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.455 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 18.8 pt -147.41 38.92 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.584 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.0 151.77 20.56 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 121.098 0.475 . . . . 0.0 112.207 -178.717 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 16.7 m -68.92 -31.63 70.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.705 177.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -97.07 -19.79 18.47 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.482 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.584 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.08 156.79 10.95 Favored Glycine 0 N--CA 1.439 -1.115 0 C-N-CA 120.4 -0.905 . . . . 0.0 114.014 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.49 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.3 m -117.32 137.71 52.25 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.732 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -118.94 148.66 42.72 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -177.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.91 113.57 18.66 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.559 177.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 44.36 43.23 5.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.547 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.07 -14.21 59.53 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.435 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -104.24 118.51 36.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.09 0.445 . . . . 0.0 110.626 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.732 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -71.68 129.75 39.46 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.473 -179.65 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.0 m -96.41 166.11 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.956 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 120' ' ' SER . 23.1 mm-40 -69.92 127.2 32.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.591 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.66 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -53.98 158.51 2.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.172 0.51 . . . . 0.0 110.702 -179.962 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.503 ' H ' ' HG3' ' A' ' 118' ' ' LYS . 0.5 OUTLIER 35.73 35.45 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.798 -179.74 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.452 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -111.96 145.03 40.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.134 179.606 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -89.76 123.15 33.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.622 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -126.62 145.76 50.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.969 0.414 . . . . 0.0 110.858 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.0 tp -72.97 118.41 15.89 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.951 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.406 HD11 ' HB3' ' A' ' 99' ' ' LEU . 2.4 pt? -57.44 167.66 0.95 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.589 0.709 . . . . 0.0 111.865 -178.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.423 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.2 OUTLIER -124.89 153.75 42.14 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.228 179.769 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.04 118.92 14.42 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.8 22.03 67.94 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.458 -178.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.423 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 24.3 t70 -54.33 174.11 0.06 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.895 0.379 . . . . 0.0 111.046 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 9.6 tt0 -145.35 135.27 23.66 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.041 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 18.9 mt -114.71 126.49 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.214 178.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.428 ' O ' ' HB2' ' A' ' 110' ' ' TRP . 3.6 m -104.14 139.86 38.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.264 -0.425 . . . . 0.0 109.928 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.548 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 33.9 m -140.18 158.26 25.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.114 0.483 . . . . 0.0 112.194 -178.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.97 27.2 29.33 Favored Glycine 0 N--CA 1.44 -1.085 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.926 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.437 ' HB ' ' CZ3' ' A' ' 110' ' ' TRP . 68.9 t -74.04 140.49 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-O 121.611 0.72 . . . . 0.0 112.069 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.92 -39.76 0.93 Allowed Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.432 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 2.5 t -118.16 129.17 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -50.58 -42.35 55.58 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -178.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.6 m -93.47 6.76 47.1 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -178.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.45 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . 0.5 OUTLIER -120.14 34.54 5.18 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -178.539 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.425 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 6.1 mt -107.23 139.46 28.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.942 178.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 8.9 tt -124.03 134.64 53.39 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.647 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.484 ' HB3' HG23 ' A' ' 40' ' ' THR . 44.3 t -111.82 150.54 30.2 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.748 0.785 . . . . 0.0 112.715 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 71.5 mt -135.71 149.34 49.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.779 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 24.2 t -117.01 139.07 45.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.829 0.347 . . . . 0.0 111.075 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.418 HG21 HD12 ' A' ' 145' ' ' ILE . 17.6 mt -106.36 124.54 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.045 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.38 114.01 26.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.607 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.402 HG12 ' CD1' ' A' ' 124' ' ' LEU . 5.0 mt -84.95 134.12 27.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.546 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -86.09 105.0 16.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.737 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -57.66 -28.19 63.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.115 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -43.7 88.89 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.607 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.434 ' CE2' HD21 ' A' ' 93' ' ' LEU . 33.7 t80 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.889 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.686 0.279 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.494 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.9 m-20 176.41 41.19 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.641 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.3 mm -71.03 142.76 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-N 113.711 -1.586 . . . . 0.0 112.377 -176.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.405 ' CG2' ' CB ' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -106.01 -48.99 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-N 114.275 -1.329 . . . . 0.0 109.91 -178.575 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 32.1 p -161.13 147.96 14.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.534 179.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -114.13 138.24 50.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.893 0.378 . . . . 0.0 111.317 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.405 HG11 ' CZ ' ' A' ' 76' ' ' TYR . 21.3 t -101.81 122.73 54.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.062 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.1 mt -128.62 116.41 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.234 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 47.1 t -80.03 123.42 27.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.496 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.4 t -91.53 -27.33 18.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.546 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.498 ' CG2' ' CB ' ' A' ' 142' ' ' SER . 7.0 p -79.81 -2.6 44.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.748 0.309 . . . . 0.0 111.408 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.7 77.99 0.24 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.752 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -146.4 -45.44 0.19 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.942 0.401 . . . . 0.0 110.788 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.553 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.0 mt -116.33 141.25 27.58 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.847 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.553 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.4 Cg_endo -72.73 146.01 42.31 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.271 1.981 . . . . 0.0 112.161 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.5 mt -55.9 151.83 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.683 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -149.8 162.3 40.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.19 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -122.65 119.81 31.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.049 0.452 . . . . 0.0 111.945 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.572 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 23.3 mt -93.28 138.04 32.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.231 178.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.641 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -141.18 156.95 45.86 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 122.14 0.971 . . . . 0.0 113.5 -178.932 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.405 ' CB ' ' CG2' ' A' ' 33' ' ' VAL . . . -141.19 146.68 37.26 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 113.565 -1.652 . . . . 0.0 110.822 178.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 121.131 0.491 . . . . 0.0 111.187 -179.509 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.46 ' CE ' ' O ' ' A' ' 49' ' ' SER . 15.5 ttpt . . . . . 0 N--CA 1.462 0.147 0 CA-C-O 120.89 0.376 . . . . 0.0 111.864 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 9.5 p -108.64 139.63 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.604 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 14.8 m-90 -100.71 139.9 35.74 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.151 -1.386 . . . . 0.0 112.064 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.449 HG21 ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -107.93 131.53 54.44 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 177.408 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.569 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 3.0 m-85 -117.0 145.91 43.37 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.036 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.692 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.82 -171.34 37.74 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.293 -0.956 . . . . 0.0 113.011 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -82.67 2.97 30.91 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -84.81 142.84 39.65 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.695 0.283 . . . . 0.0 110.836 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.44 -11.79 22.65 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.341 2.027 . . . . 0.0 111.441 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.77 -43.73 16.39 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 121.931 0.872 . . . . 0.0 108.928 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.91 138.3 5.05 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 113.87 -1.514 . . . . 0.0 110.751 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.8 OUTLIER -56.37 -18.55 11.29 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.971 178.903 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.569 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 3.9 t80 -129.1 117.59 21.08 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-O 120.775 0.321 . . . . 0.0 110.96 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -92.78 107.87 19.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.655 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.9 mp -73.49 -175.04 1.84 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.107 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.16 17.71 49.76 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.804 -0.713 . . . . 0.0 113.037 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 65.43 74.71 0.37 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.022 0.439 . . . . 0.0 111.493 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 25.5 mm -112.0 126.87 69.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.643 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.02 -41.35 71.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.312 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.81 -24.02 65.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.997 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 17.9 mt -98.16 152.11 19.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.879 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.5 p -96.29 164.53 12.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.759 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.692 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 4.8 m-20 -40.06 -57.0 1.75 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.416 0.627 . . . . 0.0 109.584 178.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.427 ' HB2' HD13 ' A' ' 104' ' ' ILE . 6.4 mttp -116.59 85.69 2.36 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.581 ' CE1' ' OG ' ' A' ' 105' ' ' SER . 15.5 t60 -64.59 -44.94 89.02 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.074 -0.967 . . . . 0.0 113.428 -176.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.498 ' CZ ' ' CD2' ' A' ' 68' ' ' PHE . 34.5 p90 -154.1 162.58 41.1 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.139 -0.625 . . . . 0.0 112.053 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 14.3 mt-30 -135.7 155.46 50.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.419 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 65.0 mt -122.97 128.81 75.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.431 HD12 HD21 ' A' ' 100' ' ' LEU . 1.8 pp -118.97 130.97 55.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.008 0.432 . . . . 0.0 111.831 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.402 ' CD1' ' HG ' ' A' ' 99' ' ' LEU . 3.2 tp . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.21 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.402 ' HG ' ' CD1' ' A' ' 93' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.832 0.349 . . . . 0.0 110.842 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.431 HD21 HD12 ' A' ' 92' ' ' LEU . 10.8 mp -129.3 146.54 51.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.414 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.89 126.88 55.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.38 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -116.8 115.85 26.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.863 0.363 . . . . 0.0 111.857 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.67 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 7.5 p30 -79.76 143.28 34.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.049 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.461 HG12 ' HA ' ' A' ' 89' ' ' PHE . 12.5 pt -146.19 22.89 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.581 ' OG ' ' CE1' ' A' ' 88' ' ' HIS . 9.2 t -91.43 154.86 18.87 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.6 m -70.22 -52.11 25.7 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.447 178.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -74.42 -2.75 26.81 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.375 -179.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.87 156.08 31.88 Favored Glycine 0 N--CA 1.438 -1.203 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.468 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.45 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 5.0 m -117.44 137.68 52.35 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.796 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -115.52 148.59 39.33 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -177.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.09 113.5 18.45 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.44 177.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 44.79 43.09 6.58 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.93 -11.87 65.63 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.455 178.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -104.99 118.49 36.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.037 0.446 . . . . 0.0 110.682 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.796 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -70.99 124.54 24.61 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.484 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.2 m -96.39 162.87 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.818 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 120' ' ' SER . 2.1 tt0 -69.82 129.59 39.96 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.439 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.67 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 15.4 tttt -53.94 160.62 1.41 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.876 0.37 . . . . 0.0 110.572 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.7 p30 34.58 34.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.303 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.35 145.31 40.29 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.117 179.477 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.428 ' HB3' HD21 ' A' ' 100' ' ' LEU . 5.1 m120 -86.04 130.42 34.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.086 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.407 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 30.4 mm-40 -129.37 146.3 51.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.377 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -72.72 115.01 11.49 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.793 0.33 . . . . 0.0 110.314 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.402 ' CD2' HG12 ' A' ' 147' ' ' ILE . 65.6 tp -54.75 157.71 2.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.382 0.611 . . . . 0.0 111.7 -179.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.43 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.0 OUTLIER -124.28 153.53 41.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.374 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . 0.414 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.06 119.63 15.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.969 0.414 . . . . 0.0 110.291 -179.65 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.55 21.49 64.84 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.235 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.43 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 26.0 t70 -56.94 172.01 0.3 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.997 0.427 . . . . 0.0 111.069 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 4.5 tt0 -145.22 135.58 24.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.165 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.3 mp -110.5 128.73 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.443 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' A' ' 110' ' ' TRP . 3.1 m -103.64 140.02 38.13 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.536 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 28.2 m -140.41 158.45 25.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -178.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 87.32 24.68 35.95 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.332 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.424 ' HB ' ' CZ3' ' A' ' 110' ' ' TRP . 70.2 t -69.56 140.38 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-O 121.632 0.729 . . . . 0.0 111.907 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 143.04 -41.84 1.14 Allowed Glycine 0 N--CA 1.435 -1.385 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.441 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 6.2 t -119.15 126.05 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.28 -35.84 28.91 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 47.3 m -93.49 6.63 47.54 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.441 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 30.6 m-20 -120.81 29.65 7.29 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -178.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.445 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 7.3 mt -106.89 138.91 30.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 121.478 0.656 . . . . 0.0 110.904 178.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.3 tt -124.65 134.64 52.82 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.729 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.498 ' CB ' ' CG2' ' A' ' 40' ' ' THR . 0.9 OUTLIER -109.57 133.39 53.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.001 0.429 . . . . 0.0 111.717 -179.819 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -128.84 135.73 49.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.554 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 24.0 t -110.93 134.45 53.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.829 0.347 . . . . 0.0 111.271 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 5.2 mm -106.11 139.0 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.975 -179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.34 122.35 41.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.798 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.414 ' CD1' ' HA ' ' A' ' 126' ' ' GLN . 6.7 mt -85.01 134.11 27.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.324 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -83.35 103.57 12.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.853 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -64.14 -28.08 69.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.063 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.15 -43.67 87.47 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.062 0.458 . . . . 0.0 110.618 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 33.5 t80 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.901 179.847 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.853 0.359 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.424 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER -170.38 33.31 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -179.767 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.702 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -73.2 133.84 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-N 113.839 -1.528 . . . . 0.0 112.407 -177.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.488 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.8 t -92.54 -61.37 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.09 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.6 p -143.38 163.44 33.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.272 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 146' ' ' PHE . 0.0 OUTLIER -127.05 138.3 53.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.962 0.411 . . . . 0.0 111.782 -179.131 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.426 HG22 ' CD2' ' A' ' 76' ' ' TYR . 2.0 m -108.63 122.9 63.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.579 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.413 ' CG2' HG12 ' A' ' 45' ' ' ILE . 21.5 mt -128.42 122.11 56.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.991 -178.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 42.0 t -81.81 102.63 10.93 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 178.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -23.82 59.12 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.466 HG23 ' HB3' ' A' ' 142' ' ' SER . 72.2 p -79.78 -2.29 42.55 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.683 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.23 77.19 0.37 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.87 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -146.62 -41.0 0.2 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.935 0.398 . . . . 0.0 110.696 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.545 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.3 mp -125.77 141.34 38.98 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.8 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.545 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 46.8 Cg_endo -71.68 146.1 48.07 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.102 1.868 . . . . 0.0 112.137 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.413 HG12 ' CG2' ' A' ' 37' ' ' ILE . 39.2 mt -51.44 148.33 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.898 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.84 150.3 49.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.083 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -112.87 119.63 38.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.049 0.452 . . . . 0.0 111.368 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.521 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 3.1 mt -95.98 135.26 37.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.227 178.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.702 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -146.04 158.01 43.87 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -178.834 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.488 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -140.91 143.26 34.53 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 113.528 -1.669 . . . . 0.0 110.861 178.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 121.223 0.535 . . . . 0.0 111.093 -179.621 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.433 ' CE ' ' O ' ' A' ' 49' ' ' SER . 6.0 ttpt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.71 0.29 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.44 HG11 ' HG2' ' A' ' 90' ' ' GLN . 13.9 t -128.79 139.09 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-O 121.375 0.607 . . . . 0.0 112.299 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.526 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 15.9 m-90 -103.03 139.24 38.84 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.887 179.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -114.21 129.05 56.63 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.338 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.515 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -118.3 145.45 45.07 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.6 -178.305 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.592 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.43 -166.6 35.38 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.393 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 -86.73 6.98 28.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.504 0.192 . . . . 0.0 111.512 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.401 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 9.7 t-20 -84.95 134.01 42.19 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.547 0.213 . . . . 0.0 111.036 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.9 Cg_exo -65.43 -15.07 48.13 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.53 2.153 . . . . 0.0 111.598 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.15 -43.26 16.38 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 121.962 0.887 . . . . 0.0 108.887 178.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.47 136.03 3.38 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 113.862 -1.517 . . . . 0.0 111.045 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.9 OUTLIER -56.87 -18.62 13.79 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.952 178.611 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.534 ' CE1' HG22 ' A' ' 43' ' ' ILE . 30.5 t80 -129.57 112.1 13.38 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.783 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -89.75 111.63 22.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.22 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 88.4 mt -78.52 -172.81 3.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.839 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -90.66 21.12 34.51 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.891 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.04 74.68 0.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.944 0.402 . . . . 0.0 111.601 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.3 mp -106.62 129.18 60.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.723 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.7 m -54.91 -37.21 66.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.293 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.32 -15.94 63.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.452 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 28.4 mt -107.06 152.01 24.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.719 0.295 . . . . 0.0 110.833 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.4 m -95.79 166.63 11.72 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.496 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.592 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 1.4 m-80 -42.46 -57.55 2.59 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.439 0.638 . . . . 0.0 109.545 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.413 ' O ' HG13 ' A' ' 104' ' ' ILE . 10.3 mtpt -116.79 84.39 2.13 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 176.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.536 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 12.4 t60 -60.89 -46.73 89.46 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.596 -176.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.492 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 25.6 p90 -145.08 158.07 43.93 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.116 -0.634 . . . . 0.0 112.157 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.44 ' HG2' HG11 ' A' ' 65' ' ' VAL . 4.9 tt0 -135.9 139.91 43.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.164 -179.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.428 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 72.6 mt -115.97 130.23 71.02 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 C-N-CA 121.134 -0.227 . . . . 0.0 111.002 179.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.423 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.2 OUTLIER -115.53 150.83 35.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.12 0.486 . . . . 0.0 111.851 -179.888 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 14.6 tp . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.223 179.46 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.2 mp . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.884 0.373 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.8 mt -133.2 144.38 49.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.893 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 mt -112.73 123.21 49.78 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.745 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 90' ' ' GLN . 52.0 t30 -114.68 115.55 27.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.062 0.458 . . . . 0.0 111.664 -179.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.702 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 14.1 p30 -77.71 134.61 38.07 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.733 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 87' ' ' LYS . 13.7 pt -141.71 39.48 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.532 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -101.93 151.63 21.88 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.005 0.431 . . . . 0.0 112.021 -178.892 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.6 m -68.89 -31.59 70.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.688 177.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -95.11 -19.55 20.02 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.328 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.526 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 112.78 158.96 13.82 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.781 179.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.533 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 11.4 m -117.1 137.69 52.12 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.838 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -115.89 148.32 40.12 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -177.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.31 113.52 18.35 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.66 -1.155 . . . . 0.0 108.419 177.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 43.74 43.77 5.15 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.51 -11.14 66.87 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.58 178.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -103.57 118.59 37.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.027 0.441 . . . . 0.0 110.583 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.838 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 12.2 tptm -74.53 122.3 22.88 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.382 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.9 m -91.59 164.17 2.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.971 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 120' ' ' SER . 15.9 tt0 -69.89 126.26 29.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.468 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.702 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 28.2 tttt -53.2 162.69 0.66 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.944 0.402 . . . . 0.0 110.441 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.1 m-80 34.67 35.0 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.03 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.4 OUTLIER -112.27 145.01 40.72 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.293 179.578 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -89.11 125.56 35.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.727 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -129.31 147.65 51.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.089 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 tt -76.34 115.3 15.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.104 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -56.99 165.84 1.17 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.604 0.716 . . . . 0.0 112.043 -178.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.445 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.64 153.65 41.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.073 179.657 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -71.17 123.22 21.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.013 0.435 . . . . 0.0 110.287 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.06 20.19 53.16 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.107 -179.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.445 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 7.7 t70 -58.58 178.8 0.09 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.745 0.307 . . . . 0.0 110.673 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 5.4 mt-10 -145.11 135.61 24.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.415 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 15.3 mt -112.04 126.91 69.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.215 178.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.425 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 4.2 m -104.33 138.66 40.44 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.536 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.8 m -140.01 158.12 26.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.138 0.494 . . . . 0.0 112.268 -178.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 89.47 24.02 32.23 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.951 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.452 ' HB ' ' CZ3' ' A' ' 110' ' ' TRP . 73.5 t -71.12 140.52 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-O 121.654 0.74 . . . . 0.0 112.021 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.05 -45.74 0.66 Allowed Glycine 0 N--CA 1.433 -1.525 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.463 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 1.7 t -110.51 131.41 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -50.56 -44.22 56.53 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.8 m -93.37 6.92 46.48 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -178.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.463 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 16.5 m-20 -117.01 34.4 5.13 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -178.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.425 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 6.4 mt -107.01 139.09 29.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.973 178.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.2 tt -124.33 134.71 53.1 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.862 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.466 ' HB3' HG23 ' A' ' 40' ' ' THR . 47.1 t -110.33 150.34 28.9 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.658 0.742 . . . . 0.0 112.195 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 75.0 mt -135.87 158.1 45.21 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.881 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 22.4 t -122.54 139.92 47.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.852 0.358 . . . . 0.0 111.026 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 30.7 mt -106.3 120.96 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.833 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.406 ' O ' ' N ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -109.99 108.62 18.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.841 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.1 mt -84.6 128.98 38.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.245 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -77.82 114.16 16.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -69.02 -31.59 70.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -57.39 -43.38 83.61 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.066 0.46 . . . . 0.0 110.411 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 15.5 t80 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.624 179.771 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.912 0.387 . . . . 0.0 110.792 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.439 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.0 OUTLIER -179.88 37.22 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.92 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.704 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.4 mm -73.48 135.67 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 CA-C-N 113.664 -1.607 . . . . 0.0 112.45 -177.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.491 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.4 t -91.81 -59.77 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.916 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.0 p -150.59 152.03 33.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.26 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.99 138.21 50.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.817 0.341 . . . . 0.0 111.352 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.3 t -100.73 122.77 53.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.829 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.0 mt -132.93 122.08 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.581 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 51.4 t -80.68 136.55 36.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.405 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.405 ' HB ' HG21 ' A' ' 144' ' ' VAL . 1.3 t -97.38 -29.23 13.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.625 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.499 HG21 ' HB3' ' A' ' 142' ' ' SER . 70.4 p -79.79 -2.32 42.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.771 0.319 . . . . 0.0 111.472 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.51 78.27 0.25 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.909 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -146.58 -41.19 0.2 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.736 0.303 . . . . 0.0 111.122 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.526 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.5 mt -114.8 140.6 25.63 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.065 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.526 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.1 Cg_endo -74.35 145.93 34.86 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.24 1.96 . . . . 0.0 112.042 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.0 mt -61.92 136.69 24.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.805 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.06 164.17 26.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.08 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -117.77 123.21 45.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.128 0.49 . . . . 0.0 112.115 -179.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.529 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 0.8 OUTLIER -101.21 135.65 42.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.507 -0.77 . . . . 0.0 108.923 178.472 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.704 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.21 159.1 43.53 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -178.764 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.491 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -146.71 149.89 34.31 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 113.766 -1.561 . . . . 0.0 111.146 178.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.088 -179.742 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.403 ' CE ' ' O ' ' A' ' 49' ' ' SER . 6.4 ttpt . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.693 0.282 . . . . 0.0 111.003 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 4.4 t -118.69 136.33 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 121.36 0.6 . . . . 0.0 111.94 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.604 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 15.4 m-90 -100.68 140.37 35.05 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.516 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.538 ' HA ' ' HG2' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -111.35 129.22 56.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.201 177.978 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.642 ' CD1' ' HB2' ' A' ' 76' ' ' TYR . 5.8 m-85 -120.39 145.42 47.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.472 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.645 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.49 -168.64 36.76 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.025 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.44 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 6.4 mtm105 -79.03 3.09 18.31 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.431 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 23.7 t-20 -84.7 131.74 48.62 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.612 0.244 . . . . 0.0 111.101 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.0 Cg_exo -66.14 -14.01 42.45 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.584 2.189 . . . . 0.0 111.59 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.87 -44.05 15.87 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 121.841 0.829 . . . . 0.0 108.803 178.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -40.19 138.91 0.79 Allowed 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 113.78 -1.554 . . . . 0.0 110.951 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 67' ' ' THR . 10.9 m-20 -56.73 -19.22 15.6 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.355 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.642 ' HB2' ' CD1' ' A' ' 68' ' ' PHE . 12.6 t80 -130.36 113.66 14.63 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.672 0.273 . . . . 0.0 111.027 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.418 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.6 t-160 -85.87 107.83 17.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.672 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.494 ' HA ' HG12 ' A' ' 43' ' ' ILE . 8.0 mp -81.77 -78.76 0.18 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.007 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -173.25 -94.24 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.084 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.402 ' HA ' ' HD2' ' A' ' 70' ' ' ARG . 8.5 p30 -179.81 50.29 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.825 0.345 . . . . 0.0 111.143 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.433 HG22 HD13 ' A' ' 81' ' ' ILE . 26.0 mm -79.05 125.49 38.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.848 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.93 -37.21 66.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.913 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.416 ' CD ' ' CB ' ' A' ' 139' ' ' ASP . 6.2 mtp180 -69.53 -37.14 76.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.108 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.4 ' CD2' ' CE1' ' A' ' 88' ' ' HIS . 44.6 mt -83.74 151.58 25.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.837 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 95.3 p -97.79 164.8 12.24 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.656 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.645 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.5 m-20 -42.55 -52.4 4.77 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.497 0.665 . . . . 0.0 109.61 179.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.409 ' HB3' HD13 ' A' ' 104' ' ' ILE . 3.8 mttt -118.9 84.14 2.14 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 177.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.552 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.4 t60 -62.88 -44.7 95.4 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.103 -0.953 . . . . 0.0 113.137 -176.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.468 ' CD1' ' HB2' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -148.7 161.8 41.02 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.985 -0.686 . . . . 0.0 112.234 -179.564 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.538 ' HG2' ' HA ' ' A' ' 67' ' ' THR . 28.3 mt-30 -135.08 155.53 50.58 Favored 'General case' 0 C--N 1.334 -0.065 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.389 -178.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 32.5 mt -130.48 132.49 64.61 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.343 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 177.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.419 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.9 OUTLIER -122.73 145.78 48.09 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.069 0.461 . . . . 0.0 111.877 -179.392 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.2 tp . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.185 179.394 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.847 0.356 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -124.06 138.83 54.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.469 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.2 mp -112.6 125.06 53.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.048 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.419 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 50.4 t30 -115.8 115.75 26.82 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.689 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 8.8 p30 -78.08 142.9 37.83 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.409 HD13 ' HB3' ' A' ' 87' ' ' LYS . 8.1 pt -150.35 37.56 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -178.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.552 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -99.43 148.52 24.13 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 120.948 0.404 . . . . 0.0 111.712 -179.045 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.2 m -68.63 -31.37 70.47 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.64 177.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -94.56 -19.54 20.41 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.51 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.8 152.0 9.6 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.227 -0.987 . . . . 0.0 113.888 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.499 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.7 m -117.57 137.86 52.31 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.841 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -118.39 148.3 42.67 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.16 113.65 18.61 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.484 177.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 45.3 43.01 7.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.273 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.5 -7.65 75.35 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.512 178.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -104.42 118.63 37.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.018 0.437 . . . . 0.0 110.671 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.841 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.0 tptm -74.12 121.5 21.25 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.187 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.2 m -96.22 163.57 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.133 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -69.77 128.83 37.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.493 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.689 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 12.4 tttt -53.72 162.77 0.8 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.764 0.316 . . . . 0.0 110.29 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.8 m-80 33.5 37.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.846 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.9 p -111.78 145.16 39.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.893 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -88.83 124.44 34.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.864 0.364 . . . . 0.0 110.713 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 -128.98 149.45 50.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.598 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.5 tp -72.63 132.85 44.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.889 0.376 . . . . 0.0 110.441 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.404 ' HG ' ' N ' ' A' ' 125' ' ' SER . 64.0 tp -69.47 157.85 36.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.428 0.633 . . . . 0.0 111.519 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.446 ' O ' HD13 ' A' ' 147' ' ' ILE . 0.6 OUTLIER -124.33 153.17 42.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.926 179.59 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . 0.414 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.25 122.9 21.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.979 0.419 . . . . 0.0 110.659 -179.314 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 56.98 22.93 44.05 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.267 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.428 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 15.5 t70 -56.17 175.06 0.11 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.852 0.358 . . . . 0.0 110.828 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.0 mt-10 -143.8 135.63 26.36 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.081 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 2.2 mp -112.5 128.14 69.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.574 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.44 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.0 m -104.32 145.12 30.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.443 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.503 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 29.9 m -140.37 158.46 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.052 0.453 . . . . 0.0 112.156 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.51 42.01 12.32 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.268 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.454 ' HB ' ' CH2' ' A' ' 110' ' ' TRP . 74.8 t -86.67 140.4 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-O 121.544 0.688 . . . . 0.0 112.124 -179.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 139.22 -34.1 2.1 Favored Glycine 0 N--CA 1.435 -1.371 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.0 t -124.56 118.34 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -50.77 -29.6 11.94 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -178.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 31.9 m -93.61 6.7 47.38 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -178.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.416 ' CB ' ' CD ' ' A' ' 83' ' ' ARG . 0.8 OUTLIER -130.07 31.28 4.69 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -178.583 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.44 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 6.1 mt -107.11 138.46 32.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-O 121.351 0.595 . . . . 0.0 110.866 178.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.3 tt -125.09 134.72 52.38 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.692 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.499 ' HB3' HG21 ' A' ' 40' ' ' THR . 44.4 t -106.84 149.62 27.22 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.544 0.688 . . . . 0.0 112.066 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 75.6 mt -136.39 158.04 45.36 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.695 -1.138 . . . . 0.0 111.219 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.405 HG21 ' HB ' ' A' ' 39' ' ' THR . 21.7 t -129.18 140.16 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.851 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.1 mm -106.36 129.55 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 CA-C-O 120.944 0.402 . . . . 0.0 110.911 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.02 110.67 21.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.858 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.446 HD13 ' O ' ' A' ' 125' ' ' SER . 4.3 mp -85.83 134.14 27.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.483 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -84.94 123.69 30.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.819 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -72.01 -27.78 62.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.069 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -58.74 -44.43 90.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.035 0.445 . . . . 0.0 110.756 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.4 t80 . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.898 179.963 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.873 0.368 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.419 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER -169.99 34.68 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 -179.9 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.662 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 2.9 mm -77.77 134.02 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 CA-C-N 113.878 -1.51 . . . . 0.0 112.58 -177.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.465 ' CG2' ' HA ' ' A' ' 49' ' ' SER . 2.8 t -90.25 -60.89 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.677 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.6 p -146.14 150.8 36.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.169 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.97 138.12 50.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.743 0.306 . . . . 0.0 111.214 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.6 t -101.7 122.66 54.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.874 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.9 mt -129.43 125.78 62.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.405 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.4 t -95.36 107.37 19.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.904 0.383 . . . . 0.0 110.485 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 79.3 p -82.02 -20.6 38.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.516 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.533 HG23 ' CB ' ' A' ' 142' ' ' SER . 12.3 p -80.04 -3.1 47.11 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.736 0.303 . . . . 0.0 111.333 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.39 70.93 0.97 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 121.087 -0.578 . . . . 0.0 113.775 178.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -145.08 -37.36 0.28 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.623 0.249 . . . . 0.0 111.469 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.57 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 52.2 mt -123.55 142.83 39.99 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.097 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.57 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 53.0 Cg_endo -71.97 146.04 46.37 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.206 1.937 . . . . 0.0 112.25 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.2 mt -59.58 144.22 12.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.773 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.34 164.02 31.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.013 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -131.64 119.85 21.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.993 0.425 . . . . 0.0 112.114 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.517 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 8.2 mp -87.25 133.83 33.62 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 178.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.662 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -138.69 156.18 47.62 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 -179.444 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.462 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -143.87 141.75 30.47 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 113.455 -1.702 . . . . 0.0 110.706 178.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 121.077 0.465 . . . . 0.0 111.232 -179.473 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.408 ' NZ ' ' HA ' ' A' ' 50' ' ' ALA . 2.6 ttpt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.933 0.397 . . . . 0.0 111.648 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.464 HG11 ' HB3' ' A' ' 92' ' ' LEU . 21.8 t -135.34 139.43 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.776 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.517 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 19.7 m-90 -102.21 138.7 38.81 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.086 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.52 125.15 52.66 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.548 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 0.8 OUTLIER -108.09 145.58 33.85 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.305 -178.668 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.657 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 166.64 178.52 39.27 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.831 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.445 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 9.3 mtp-105 -73.46 -5.29 39.01 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.422 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.0 t-20 -84.89 134.96 40.53 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.699 0.285 . . . . 0.0 111.038 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 10.0 Cg_exo -69.76 -5.22 15.68 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.815 2.343 . . . . 0.0 111.831 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.54 -43.38 17.19 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 122.022 0.915 . . . . 0.0 108.558 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -44.04 139.34 2.51 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 113.641 -1.618 . . . . 0.0 110.469 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -56.12 -18.93 11.26 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.066 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.548 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 7.0 t80 -129.73 133.25 46.92 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.866 0.365 . . . . 0.0 110.94 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -109.77 120.42 42.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.643 179.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.417 ' HB3' ' CD1' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -101.36 -81.63 0.48 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.124 -179.879 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.09 -133.07 1.41 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.512 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -138.73 66.7 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.879 0.371 . . . . 0.0 111.439 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.445 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 31.6 mm -97.11 117.8 42.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.253 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 92.5 p -54.77 -30.98 58.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.19 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.507 ' HG3' ' HB3' ' A' ' 139' ' ' ASP . 1.6 mmp_? -71.51 -23.65 61.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.386 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.421 HD21 ' CE1' ' A' ' 88' ' ' HIS . 29.5 mt -94.23 152.08 18.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.503 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 85.7 p -96.57 166.6 11.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.851 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.657 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 1.5 m-80 -42.81 -52.88 4.86 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.437 0.637 . . . . 0.0 109.675 179.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.452 ' HB2' HD12 ' A' ' 104' ' ' ILE . 3.7 ptmm? -120.51 84.78 2.28 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 177.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.571 ' CD2' ' HB2' ' A' ' 105' ' ' SER . 14.1 t60 -60.3 -46.99 87.94 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.952 -1.022 . . . . 0.0 113.042 -176.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.47 ' HA ' HG12 ' A' ' 104' ' ' ILE . 29.3 p90 -151.61 159.54 44.02 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.874 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.453 ' HG2' HG12 ' A' ' 65' ' ' VAL . 5.2 tt0 -136.11 139.56 43.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.55 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.427 ' O ' ' CG1' ' A' ' 65' ' ' VAL . 29.4 mt -116.17 129.58 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.915 179.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.464 ' HB3' HG11 ' A' ' 65' ' ' VAL . 0.4 OUTLIER -114.58 149.33 36.7 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.234 0.54 . . . . 0.0 112.029 -179.541 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.9 tp . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.033 179.071 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.7 mt . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.78 0.324 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.429 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 6.3 mp -125.51 139.15 53.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.55 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.87 123.4 50.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.084 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.43 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 61.1 t30 -117.74 115.85 25.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.889 0.376 . . . . 0.0 111.967 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.678 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 11.3 p30 -78.49 142.99 37.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.924 178.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.47 HG12 ' HA ' ' A' ' 89' ' ' PHE . 11.5 pt -147.76 28.0 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.651 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.571 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 11.3 t -93.56 155.09 17.5 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 121.584 0.707 . . . . 0.0 112.598 -178.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 65.9 m -70.1 -52.17 25.83 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.731 178.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -78.54 0.57 25.63 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.44 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.07 154.28 30.77 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 120.75 -0.738 . . . . 0.0 114.041 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 3.7 m -117.5 137.86 52.26 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.789 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -116.1 148.54 40.16 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -177.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -124.44 113.64 18.41 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.956 177.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 48.3 35.53 5.73 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.072 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.17 -4.8 83.05 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.853 -0.689 . . . . 0.0 113.515 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.37 118.57 36.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.934 0.397 . . . . 0.0 110.498 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.789 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 9.1 tptm -71.04 111.64 6.56 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.128 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.1 m -87.89 162.95 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.106 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.8 OUTLIER -69.91 127.88 34.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.497 179.725 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.678 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 53.9 tttm -54.47 161.68 1.35 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.865 0.364 . . . . 0.0 110.517 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.506 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.9 p30 35.45 33.89 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.371 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.38 145.09 40.71 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.991 179.279 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -90.14 131.42 36.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.904 0.383 . . . . 0.0 110.976 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.429 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 43.9 mm-40 -129.28 148.77 51.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.43 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.61 123.96 24.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.374 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.8 tt -55.21 154.34 5.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.484 0.659 . . . . 0.0 111.723 -179.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.412 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.73 153.24 42.68 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.303 179.73 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.66 126.35 29.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.828 0.347 . . . . 0.0 110.182 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.44 20.3 50.69 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.224 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.412 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 11.0 t70 -53.48 164.36 0.51 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.892 0.377 . . . . 0.0 111.074 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.405 ' CG ' ' O ' ' A' ' 143' ' ' LEU . 3.7 tt0 -144.26 135.39 25.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.928 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 1.4 mp -109.1 127.02 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.598 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.464 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.7 m -104.17 140.48 37.76 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.514 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.0 m -140.18 158.42 25.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.87 23.6 41.28 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.283 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.419 ' HB ' ' CH2' ' A' ' 110' ' ' TRP . 82.2 t -68.34 140.47 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-O 121.515 0.674 . . . . 0.0 111.915 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 141.79 -41.23 1.24 Allowed Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -178.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.445 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 2.2 t -120.32 123.31 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.16 -31.05 12.63 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.68 6.75 47.29 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -178.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.507 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . 16.7 m-20 -125.34 31.0 5.67 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -178.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.464 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 10.0 mt -106.42 138.71 30.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-O 121.456 0.646 . . . . 0.0 110.985 178.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.1 tt -124.76 134.53 52.76 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.517 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.533 ' CB ' HG23 ' A' ' 40' ' ' THR . 0.7 OUTLIER -111.43 131.47 55.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.072 0.463 . . . . 0.0 111.698 -179.699 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.405 ' O ' ' CG ' ' A' ' 129' ' ' GLU . 2.8 mm? -127.56 134.41 49.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.555 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.8 t -110.68 133.96 54.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.854 0.359 . . . . 0.0 111.18 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.2 mm -106.2 121.22 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.08 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -99.88 129.39 45.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.663 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.414 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 3.3 mp -92.54 129.21 43.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.867 0.365 . . . . 0.0 111.209 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -82.81 113.26 20.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.983 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 28.4 p-10 -61.17 -26.69 67.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.976 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.65 -43.44 84.92 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.007 0.432 . . . . 0.0 110.556 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.1 t80 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.746 179.847 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 120.837 0.351 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.9 p -145.25 -70.83 0.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.881 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.0 -37.49 87.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.861 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -60.41 -37.22 80.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.882 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -58.46 -41.96 86.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.2 tp -60.47 -32.59 71.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.72 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.43 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.8 mt -73.15 -35.34 47.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.913 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -57.46 -40.03 77.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.509 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -23.86 65.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.654 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.43 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.78 -47.55 79.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.228 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.2 m -81.2 -45.87 15.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.805 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -99.45 94.28 6.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.917 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -92.09 135.44 33.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.839 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.86 101.82 11.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.963 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.5 mm -89.03 138.46 19.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 CA-C-O 121.614 0.721 . . . . 0.0 111.864 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.36 50.01 1.08 Allowed Glycine 0 C--N 1.314 -0.679 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.574 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -70.44 -43.16 70.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.808 0.337 . . . . 0.0 110.753 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.409 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER -179.73 37.74 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.658 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.1 mm -76.75 137.52 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 CA-C-N 113.812 -1.54 . . . . 0.0 112.574 -177.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.486 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.1 t -92.98 -59.85 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.826 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 21.4 p -148.19 162.52 39.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.218 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -119.98 138.31 53.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.896 0.379 . . . . 0.0 111.221 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.439 HG22 ' CE2' ' A' ' 76' ' ' TYR . 2.1 m -106.62 122.7 60.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.728 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.43 HD11 ' CE1' ' A' ' 146' ' ' PHE . 20.5 mt -127.03 130.13 71.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.525 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 41.9 t -86.99 119.37 27.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.559 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.06 -26.48 25.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.578 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.432 HG21 ' HB3' ' A' ' 142' ' ' SER . 68.9 p -79.83 -2.36 43.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.717 0.294 . . . . 0.0 111.464 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.19 77.22 0.22 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.903 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -146.92 -43.32 0.18 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.871 0.367 . . . . 0.0 110.955 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.56 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.0 mt -116.32 141.7 28.28 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.038 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.56 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 45.2 Cg_endo -70.88 145.76 51.53 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.182 1.921 . . . . 0.0 112.148 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.9 mt -56.56 139.85 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.852 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -132.57 157.13 45.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.966 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -120.68 121.93 39.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.069 0.461 . . . . 0.0 111.959 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.527 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 8.7 mp -87.8 133.63 33.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.469 178.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.658 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -138.71 156.46 47.37 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 122.219 1.009 . . . . 0.0 113.411 -179.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.486 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.31 149.51 34.96 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 113.553 -1.658 . . . . 0.0 110.977 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.488 ' HB2' ' HG3' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -76.28 128.35 34.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.05 0.453 . . . . 0.0 110.993 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 34.3 mt -64.1 -39.61 86.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.602 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.4 m -59.29 -39.64 83.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.198 0.523 . . . . 0.0 110.505 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.488 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 3.7 mm100 -68.55 -45.17 72.88 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.564 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.4 t -62.15 -39.21 83.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.354 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.04 -37.86 72.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.08 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.1 tptt -74.64 -45.55 44.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.146 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.84 120.58 14.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.02 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -106.61 -25.09 11.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.888 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -115.81 162.7 16.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.925 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 74.5 m 60.32 -175.55 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.88 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.443 HG21 HD12 ' A' ' 62' ' ' ILE . 19.4 mm -92.29 141.9 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.197 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.8 mmtm -64.1 -59.32 4.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.984 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.5 ttpt -150.39 143.07 24.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.492 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 16.3 t -130.88 138.91 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 121.227 0.537 . . . . 0.0 111.736 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.537 ' O ' ' HA ' ' A' ' 90' ' ' GLN . 19.2 m-90 -102.03 139.39 37.72 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.428 -0.806 . . . . 0.0 112.086 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.481 ' CG2' ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -110.98 126.68 55.03 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.421 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.525 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 0.6 OUTLIER -110.9 145.43 38.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.12 -178.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.64 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 165.93 -179.85 39.89 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.646 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.9 mtm180 -77.58 -1.71 32.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.529 0.204 . . . . 0.0 111.505 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.426 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.5 t-20 -84.87 136.42 38.86 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 120.745 0.307 . . . . 0.0 110.996 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.5 Cg_exo -69.13 -6.45 18.32 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.704 2.269 . . . . 0.0 111.868 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.89 -45.35 14.32 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.96 0.886 . . . . 0.0 108.756 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -44.43 137.87 3.46 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 113.642 -1.617 . . . . 0.0 110.632 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -56.27 -19.33 13.66 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.927 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.525 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 46.6 t80 -130.13 130.25 44.55 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.586 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -111.04 122.3 47.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.785 0.326 . . . . 0.0 111.277 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.427 HD12 ' CA ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -120.44 179.66 4.24 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.877 179.251 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.26 133.54 52.67 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.665 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -64.78 92.3 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.849 0.357 . . . . 0.0 110.792 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.411 ' HB ' HD11 ' A' ' 84' ' ' LEU . 4.3 mt -111.99 141.07 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.235 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.432 ' HB2' HD12 ' B' ' 170' ' ' LEU . 2.9 p -65.12 -40.27 94.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.167 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -21.31 64.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.519 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.453 ' CD1' ' N ' ' A' ' 84' ' ' LEU . 3.9 mp -99.95 153.4 19.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.057 0.456 . . . . 0.0 111.365 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.2 p -99.76 169.31 9.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.808 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.64 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 1.1 m-20 -44.87 -53.89 7.03 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.367 0.603 . . . . 0.0 109.562 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -118.13 85.47 2.35 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 177.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.557 ' CD2' ' HB2' ' A' ' 105' ' ' SER . 13.8 t60 -60.03 -45.86 91.4 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.691 -176.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.516 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 30.3 p90 -150.39 164.3 36.19 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.126 -0.629 . . . . 0.0 112.034 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.537 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -135.58 134.17 39.08 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.367 -178.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 47.5 mt -110.92 131.79 61.15 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.649 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.452 ' HB3' HG13 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -123.29 140.75 52.7 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.981 0.419 . . . . 0.0 111.759 -179.29 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.435 ' HG ' ' CG1' ' A' ' 33' ' ' VAL . 1.0 OUTLIER -125.25 122.95 38.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.441 179.166 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -178.68 -144.19 5.56 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.327 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 58.41 -166.95 0.15 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.759 0.314 . . . . 0.0 110.879 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -81.18 59.88 4.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.973 0.416 . . . . 0.0 110.867 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.29 -178.97 36.01 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.578 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 33.5 m120 61.86 174.76 0.12 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.909 0.385 . . . . 0.0 110.917 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.413 ' HB3' ' CD1' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -124.29 160.31 28.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.779 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.442 ' CB ' ' HG ' ' A' ' 92' ' ' LEU . 5.2 mp -124.23 141.0 52.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.936 0.398 . . . . 0.0 110.36 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.8 mp -112.68 126.37 55.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.087 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.434 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 67.2 t30 -119.18 136.29 54.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.11 0.481 . . . . 0.0 111.8 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.688 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 11.7 p30 -98.42 142.54 29.91 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.996 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.429 HD12 ' HG3' ' A' ' 90' ' ' GLN . 8.7 pt -145.58 24.5 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.621 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.557 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 11.2 t -92.09 154.14 18.93 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 121.594 0.711 . . . . 0.0 112.51 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.424 ' CB ' ' CG2' ' B' ' 169' ' ' TPO . 22.9 m -70.11 -51.94 27.63 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.607 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -75.33 -2.59 29.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.301 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.58 154.68 30.79 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.749 -0.739 . . . . 0.0 113.671 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 4.2 m -117.47 137.81 52.28 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.816 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -114.72 148.48 38.23 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -178.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.16 113.52 18.44 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.457 177.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 44.59 43.25 6.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.373 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.89 -7.9 75.33 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.44 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -104.81 118.61 36.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.996 0.427 . . . . 0.0 110.593 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.816 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.4 tptm -72.91 114.48 11.1 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.266 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.2 m -88.81 161.61 2.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.984 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 120' ' ' SER . 23.5 tt0 -69.75 130.79 43.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.347 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.688 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 24.2 tttt -54.49 161.61 1.38 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.899 0.381 . . . . 0.0 110.408 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.495 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.0 m-80 35.1 33.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.135 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.51 145.11 40.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.145 179.524 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -90.33 133.82 34.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.895 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.437 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 49.8 mm-40 -129.57 152.11 49.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.56 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 25.4 tp -72.64 120.16 17.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.777 0.322 . . . . 0.0 110.507 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.413 ' CD1' ' HB3' ' A' ' 99' ' ' LEU . 6.4 tt -56.64 155.71 7.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.454 0.645 . . . . 0.0 111.441 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.404 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.52 153.15 42.51 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.342 179.686 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.8 114.94 10.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.92 0.391 . . . . 0.0 110.132 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.54 23.17 73.64 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.044 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.404 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 23.1 t70 -53.81 171.27 0.1 Allowed 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 120.933 0.397 . . . . 0.0 111.162 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 21.2 tt0 -145.13 135.53 24.16 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.089 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.46 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 5.8 mt -111.39 127.73 68.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.422 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.467 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.7 m -104.41 140.74 37.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.852 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.544 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 33.9 m -140.24 158.49 25.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.14 28.38 31.07 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.192 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.409 ' HA ' HG12 ' A' ' 140' ' ' ILE . 70.6 t -72.63 140.42 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-O 121.598 0.713 . . . . 0.0 111.982 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 142.39 -39.82 1.33 Allowed Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.422 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 2.8 t -120.67 124.31 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -50.31 -35.0 25.6 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.6 p -93.77 6.7 47.51 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -178.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.422 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.6 OUTLIER -121.09 28.72 7.71 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -178.632 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.467 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.5 mt -107.27 138.11 34.92 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-O 121.544 0.688 . . . . 0.0 111.261 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.43 134.66 52.03 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.265 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.432 ' HB3' HG21 ' A' ' 40' ' ' THR . 38.5 t -111.3 148.44 32.91 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.739 0.781 . . . . 0.0 112.431 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 2.6 mm? -136.45 136.7 39.71 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.704 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.1 t -110.88 137.44 43.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.82 0.343 . . . . 0.0 111.073 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 4.9 mt -106.52 121.62 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.29 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.43 ' CE1' HD11 ' A' ' 37' ' ' ILE . 5.8 m-85 -105.37 115.3 30.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.485 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 3.1 mp -96.94 122.62 48.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.481 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -78.59 137.95 38.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.939 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.07 -18.69 60.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.366 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.52 -46.04 89.98 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.972 0.415 . . . . 0.0 110.814 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -59.97 -44.2 94.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.02 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt -65.33 -34.91 79.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.989 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.99 -47.01 86.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.056 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.8 t -67.56 -43.26 81.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.906 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.88 -35.95 71.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.86 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.14 -41.78 97.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.756 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.59 -36.17 33.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.825 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.8 p30 42.45 36.42 0.77 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.524 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.03 135.43 52.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.81 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.9 p -97.82 132.1 43.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.103 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -162.47 31.12 0.11 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.983 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.87 155.46 23.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.864 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.8 pt -100.96 117.8 46.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.105 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.222 -0.895 . . . . 0.0 110.976 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.853 0.358 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -150.3 143.02 16.12 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.755 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -74.65 -168.47 0.5 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.542 2.161 . . . . 0.0 112.303 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -169.73 105.82 0.35 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.996 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 169' ' ' TPO . . . . . 0.424 ' CG2' ' CB ' ' A' ' 106' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . 0.432 HD12 ' HB2' ' A' ' 82' ' ' SER . 0.0 OUTLIER -154.01 -178.36 7.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.333 -179.776 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . 0.517 ' O ' ' O ' ' B' ' 172' ' ' ILE . 51.6 mt-10 -140.49 73.04 1.41 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.818 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.517 ' O ' ' O ' ' B' ' 171' ' ' GLU . 13.4 tt 49.88 156.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.038 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 173' ' ' TYR . . . . . 0.432 ' N ' HG12 ' B' ' 172' ' ' ILE . 3.1 p90 -105.45 141.18 37.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.833 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.169 -0.919 . . . . 0.0 110.987 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.836 0.35 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.5 t -165.44 -44.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -60.84 -41.49 95.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.935 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -40.28 88.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.894 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -56.92 -42.29 79.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.487 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.7 tp -59.02 -31.86 69.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.186 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.448 ' O ' ' CD2' ' A' ' 23' ' ' PHE . 8.7 mt -69.84 -48.05 66.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.545 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.75 -33.81 76.48 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.22 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -58.01 -46.92 84.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.312 -0.403 . . . . 0.0 112.01 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.546 ' CD1' ' N ' ' A' ' 24' ' ' SER . 4.3 p90 -71.83 -47.42 53.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.012 0.434 . . . . 0.0 111.031 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.546 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 0.7 OUTLIER -60.76 -37.65 82.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.925 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -134.87 82.12 1.94 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.884 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.53 136.33 40.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.791 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -68.61 102.22 1.44 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.968 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.408 HG23 ' N ' ' A' ' 29' ' ' GLY . 18.1 mm -83.47 138.31 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 CA-C-O 121.675 0.75 . . . . 0.0 111.632 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.408 ' N ' HG23 ' A' ' 28' ' ' ILE . . . 90.52 41.77 5.34 Favored Glycine 0 C--N 1.313 -0.697 0 CA-C-N 114.509 -1.223 . . . . 0.0 112.309 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -89.0 -30.14 18.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.568 0.223 . . . . 0.0 111.327 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.407 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER 176.77 38.99 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.708 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -73.78 134.26 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.55 0 CA-C-N 113.735 -1.575 . . . . 0.0 112.509 -177.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.489 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.8 t -93.55 -61.68 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.286 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.7 p -145.44 141.49 28.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.599 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 24.1 ttm180 -114.01 129.73 56.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.146 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.9 t -91.69 122.74 43.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.005 0.431 . . . . 0.0 111.099 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.8 mt -126.6 111.95 27.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.18 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 43.4 t -79.82 137.58 36.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.757 0.313 . . . . 0.0 110.499 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.2 t -116.36 -10.68 11.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.762 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.529 HG22 ' CB ' ' A' ' 142' ' ' SER . 5.0 p -96.38 -3.07 44.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.686 0.279 . . . . 0.0 111.262 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.48 93.11 0.25 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.042 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.56 ' HG3' ' N ' ' A' ' 43' ' ' ILE . 2.5 pt20 -171.51 -40.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.093 0.473 . . . . 0.0 111.464 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.56 ' N ' ' HG3' ' A' ' 42' ' ' GLN . 65.0 mt -124.4 140.32 34.92 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.649 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.481 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 94.8 Cg_endo -80.31 144.37 16.24 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.576 2.184 . . . . 0.0 111.643 179.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 32.2 mt -58.59 123.87 11.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.944 0.402 . . . . 0.0 111.831 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 76' ' ' TYR . 2.3 ttt-85 -122.42 164.13 18.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.985 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.93 119.84 35.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.095 0.474 . . . . 0.0 111.949 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.527 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 3.1 mt -96.55 137.46 35.6 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.708 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -146.25 158.5 43.89 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -178.612 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.489 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -139.62 141.83 37.09 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.448 -1.705 . . . . 0.0 110.671 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.452 ' HB3' ' HG2' ' A' ' 54' ' ' GLN . 0.7 OUTLIER -79.99 125.94 30.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.127 0.489 . . . . 0.0 111.606 -179.416 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.3 mt -64.49 -45.12 96.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.547 -0.752 . . . . 0.0 112.184 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.1 -39.82 79.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.363 0.602 . . . . 0.0 110.572 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.452 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 9.2 mm-40 -68.58 -36.89 79.35 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.674 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.7 t -70.37 -41.58 78.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.983 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.04 -35.27 71.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.6 mmtt -73.65 -47.33 40.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.962 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.89 112.91 12.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.905 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.0 ptpt -103.7 28.82 6.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.866 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -101.07 -178.19 3.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.895 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.459 ' O ' ' CG2' ' A' ' 62' ' ' ILE . 9.3 t -70.84 139.47 50.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.911 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.459 ' CG2' ' O ' ' A' ' 61' ' ' SER . 7.8 tp 56.45 155.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.703 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -120.67 -64.19 1.27 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.154 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.433 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.0 ttpt -147.54 134.04 19.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.273 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 14.8 t -129.49 139.22 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-O 121.343 0.592 . . . . 0.0 112.082 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.527 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.3 m-90 -100.93 139.64 36.33 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.125 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.496 ' CG2' ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -113.38 126.84 55.81 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 176.934 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.51 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.5 OUTLIER -114.52 145.55 41.78 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.294 -178.517 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.694 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 165.88 -177.56 40.96 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.792 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.425 ' HD3' ' HB2' ' A' ' 84' ' ' LEU . 5.3 mtm105 -76.26 -2.0 29.29 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -84.72 133.67 43.45 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.58 0.229 . . . . 0.0 110.91 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -68.89 -7.52 20.95 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.607 2.205 . . . . 0.0 111.786 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.68 -43.16 17.22 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 121.916 0.865 . . . . 0.0 108.806 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.44 138.26 1.84 Allowed 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 113.764 -1.562 . . . . 0.0 110.652 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -56.16 -19.34 13.11 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.695 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.493 ' CD2' ' CE2' ' A' ' 68' ' ' PHE . 1.5 t80 -130.12 130.38 44.73 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.745 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -104.42 117.48 34.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.937 0.398 . . . . 0.0 110.933 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.42 ' CB ' ' CD1' ' A' ' 43' ' ' ILE . 2.7 pp -114.87 -178.03 3.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.887 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.75 144.02 48.49 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.528 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -76.8 91.67 3.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.791 0.329 . . . . 0.0 111.245 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.408 ' O ' ' HD3' ' A' ' 70' ' ' ARG . 30.1 mt -112.09 139.99 33.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.084 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.05 -36.41 84.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.12 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.03 -15.69 63.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.799 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.464 ' CD2' ' CE1' ' A' ' 88' ' ' HIS . 51.1 mt -103.38 152.42 21.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.701 0.286 . . . . 0.0 111.174 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.8 m -99.13 167.48 10.67 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.268 -0.423 . . . . 0.0 112.007 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.694 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.1 m-20 -43.72 -53.28 5.96 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.301 0.572 . . . . 0.0 109.658 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -118.3 83.76 2.06 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.551 ' CD2' ' HB2' ' A' ' 105' ' ' SER . 14.5 t60 -60.17 -46.03 91.08 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.698 -176.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.51 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 27.5 p90 -147.82 164.01 34.97 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.019 -0.672 . . . . 0.0 112.202 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.525 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -135.56 137.12 41.7 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.276 -178.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 63.8 mt -116.04 127.17 73.72 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.55 178.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.431 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.8 OUTLIER -111.42 140.64 45.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.089 0.471 . . . . 0.0 111.469 -179.649 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -114.05 123.48 49.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.539 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -178.37 -128.03 1.13 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.289 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 51.36 30.12 5.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.774 0.321 . . . . 0.0 111.05 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 43.5 t0 69.17 28.85 4.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.072 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 129.67 -43.48 1.3 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.744 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -57.75 158.91 5.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.801 0.334 . . . . 0.0 111.142 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.54 152.56 25.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.831 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.435 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 2.2 mp -133.05 147.17 52.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.4 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.408 ' N ' ' CD2' ' A' ' 101' ' ' LEU . 3.0 mm? -112.77 123.95 51.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.273 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.431 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 58.1 t30 -118.5 115.79 25.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.895 0.379 . . . . 0.0 111.777 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.683 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 10.9 p30 -79.67 141.93 36.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.956 178.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.441 HG12 ' HA ' ' A' ' 89' ' ' PHE . 12.9 pt -144.69 24.22 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.767 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.551 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 10.3 t -91.4 154.44 19.18 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.54 0.686 . . . . 0.0 112.528 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.5 m -70.13 -52.02 26.86 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.553 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -75.64 -0.56 21.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.395 -0.821 . . . . 0.0 112.258 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.04 155.15 31.78 Favored Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.702 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.516 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 3.7 m -117.36 137.63 52.33 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.812 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -115.31 148.59 39.05 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -177.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.13 113.45 18.37 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.646 -1.161 . . . . 0.0 108.466 177.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 44.77 43.28 6.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.315 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.02 -6.3 79.65 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.525 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -104.16 118.59 37.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.995 0.426 . . . . 0.0 110.562 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.812 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.7 tptm -72.83 111.25 7.79 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.279 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.7 m -86.09 161.82 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.847 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 120' ' ' SER . 64.0 mt-10 -69.84 129.64 40.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.504 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.683 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 22.0 tttt -54.9 161.16 1.69 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.902 0.382 . . . . 0.0 110.343 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.8 p30 34.93 34.6 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.322 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.42 145.2 40.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.277 179.452 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -87.94 131.92 34.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.848 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.435 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 37.7 mm-40 -129.57 148.99 51.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.63 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.0 tp -72.61 126.37 29.71 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.43 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -56.71 157.76 5.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.846 0.832 . . . . 0.0 112.185 -178.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.27 152.91 44.01 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.094 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -71.81 117.13 13.01 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.83 26.87 67.61 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.858 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -50.83 170.7 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.953 0.406 . . . . 0.0 111.325 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.428 ' CG ' ' O ' ' A' ' 143' ' ' LEU . 18.1 tt0 -145.09 135.39 24.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.71 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 14.5 mt -113.07 126.35 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.474 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.443 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 4.0 m -104.23 140.11 38.3 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.51 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 33.9 m -140.05 158.52 26.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -178.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.26 25.08 32.14 Favored Glycine 0 N--CA 1.439 -1.106 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.276 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.446 ' HA ' HG12 ' A' ' 140' ' ' ILE . 77.6 t -71.21 140.38 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-O 121.522 0.677 . . . . 0.0 111.893 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 139.83 -40.98 1.35 Allowed Glycine 0 N--CA 1.435 -1.384 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -178.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.441 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 2.5 t -116.28 123.55 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.32 -36.09 30.49 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.8 p -93.55 6.69 47.4 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.441 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.7 OUTLIER -121.77 30.5 6.65 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -178.409 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.446 HG12 ' HA ' ' A' ' 134' ' ' VAL . 6.1 mt -107.3 138.27 34.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.913 177.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.461 HD13 ' HB3' ' A' ' 42' ' ' GLN . 0.8 OUTLIER -125.25 134.95 52.12 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.101 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.529 ' CB ' HG22 ' A' ' 40' ' ' THR . 0.4 OUTLIER -106.09 133.14 51.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.066 0.46 . . . . 0.0 111.727 -179.675 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.428 ' O ' ' CG ' ' A' ' 129' ' ' GLU . 42.7 mt -127.53 140.85 51.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.665 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 23.0 t -116.06 132.58 65.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.878 0.37 . . . . 0.0 111.451 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.478 HG21 HD12 ' A' ' 145' ' ' ILE . 30.4 mt -106.26 139.02 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.949 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.48 132.69 56.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.847 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 3.1 mt -93.41 134.1 32.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.462 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -81.56 110.8 17.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.693 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -59.27 -29.5 67.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.268 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.9 tttm -59.58 -45.41 91.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.919 0.39 . . . . 0.0 110.743 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -59.4 -44.1 92.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.949 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 13.7 tttp -65.03 -36.61 84.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.035 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -65.29 -47.1 77.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.02 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.2 t -65.97 -45.98 79.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.031 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.94 -43.48 91.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.883 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.57 -40.84 96.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.782 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.17 -27.09 63.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.99 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -122.96 102.4 7.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.944 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 17.4 pttt -89.31 161.97 16.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.919 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.4 m -78.19 133.65 29.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.158 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 59.69 94.8 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.953 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.13 -38.4 3.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 11.0 mt -76.94 117.65 22.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.065 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.27 -0.872 . . . . 0.0 110.942 179.947 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 2.5 t30 . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.8 0.333 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.73 166.5 31.86 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.899 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.25 -175.56 0.68 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.537 2.158 . . . . 0.0 112.254 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -172.44 138.76 0.94 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.162 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 1.9 pp -161.36 -178.15 6.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.058 0.456 . . . . 0.0 111.684 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -142.89 160.45 40.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.343 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.415 ' CD1' HG22 ' A' ' 136' ' ' VAL . 3.2 tp -51.32 142.0 4.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.892 0.377 . . . . 0.0 111.094 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 173' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -98.41 133.68 42.46 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.95 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 3.9 m . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.232 -0.889 . . . . 0.0 111.011 179.954 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.723 0.297 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.45 -50.86 2.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.982 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.9 -44.15 64.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.872 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.07 -36.0 74.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.966 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -58.23 -48.13 81.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.946 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 mp -58.85 -41.73 87.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.826 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.469 ' O ' ' CD2' ' A' ' 23' ' ' PHE . 33.6 mm -66.52 -47.98 81.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.025 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -60.85 -33.67 73.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.364 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -56.4 -47.19 79.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.339 -0.391 . . . . 0.0 112.033 -178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.56 ' CD1' ' N ' ' A' ' 24' ' ' SER . 5.7 p90 -71.89 -47.29 53.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.972 0.415 . . . . 0.0 110.964 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.56 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 0.4 OUTLIER -59.63 -46.96 87.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.843 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -73.82 81.38 1.61 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.869 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -90.16 143.82 26.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -83.67 123.44 29.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.1 mm -82.1 138.27 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-O 121.684 0.754 . . . . 0.0 111.859 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -143.48 56.71 0.55 Allowed Glycine 0 C--N 1.315 -0.631 0 CA-C-N 114.467 -1.242 . . . . 0.0 112.389 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -68.85 -39.77 79.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.788 0.328 . . . . 0.0 111.088 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.409 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER 176.0 39.41 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.713 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.3 mm -72.78 134.09 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-N 113.577 -1.647 . . . . 0.0 112.554 -177.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.483 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.9 t -92.62 -60.84 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.954 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.8 p -145.6 149.5 34.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.22 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.96 138.2 50.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.857 0.36 . . . . 0.0 111.406 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.403 ' CG2' HD13 ' A' ' 48' ' ' LEU . 24.1 t -101.54 122.77 54.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.872 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.4 mt -129.33 121.37 53.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.41 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 34.3 t -85.1 118.07 24.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.376 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.93 -29.26 27.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.74 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.455 HG23 ' HB3' ' A' ' 142' ' ' SER . 30.2 p -79.93 -2.22 42.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.652 0.263 . . . . 0.0 111.447 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.83 77.74 0.26 Allowed Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.965 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -144.09 -45.44 0.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.851 0.358 . . . . 0.0 110.834 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.543 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.0 mp -114.38 140.91 25.71 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.065 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.543 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.3 Cg_endo -73.41 136.55 24.15 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.239 1.96 . . . . 0.0 112.075 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.9 mt -54.41 129.76 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.736 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -122.99 164.28 18.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.284 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.89 119.76 37.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.985 0.421 . . . . 0.0 111.958 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.508 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 1.3 mt -96.65 134.48 39.84 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.713 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -147.82 158.93 44.28 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -178.426 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.483 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -139.66 141.65 37.01 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 113.337 -1.756 . . . . 0.0 110.185 178.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.52 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -81.67 134.15 35.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.35 0.595 . . . . 0.0 111.428 -179.327 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 54.8 mt -64.22 -42.69 96.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.186 -0.916 . . . . 0.0 112.246 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.9 t -56.96 -41.96 79.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.051 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.52 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -68.64 -38.62 80.65 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.676 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.0 t -67.04 -43.19 89.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.902 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.9 mt -71.12 -31.61 67.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.5 tpmp? -81.02 -48.25 12.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.085 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -72.17 106.75 4.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.874 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -93.03 87.35 5.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.916 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -158.55 178.44 10.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.4 p -73.36 -56.48 5.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.934 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.2 tp -86.56 148.54 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.122 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.72 -62.96 1.21 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.912 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.406 ' CE ' ' O ' ' A' ' 49' ' ' SER . 6.7 ttpt -149.82 129.64 13.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.999 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 6.6 t -122.7 138.4 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 121.292 0.568 . . . . 0.0 112.102 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.59 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 15.7 m-90 -100.8 140.12 35.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.548 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.504 ' HA ' ' CG ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -110.12 128.67 55.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.839 177.526 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.677 ' CD1' ' HB2' ' A' ' 76' ' ' TYR . 9.8 m-85 -120.59 145.46 47.34 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.501 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.626 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.24 -166.58 36.49 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.064 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.446 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 12.0 mtp-105 -84.42 5.36 27.54 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 19.4 t-20 -84.99 133.74 42.59 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.622 0.249 . . . . 0.0 110.74 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 18.0 Cg_exo -65.33 -14.96 47.73 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.493 2.129 . . . . 0.0 111.559 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.68 -45.84 13.98 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.971 0.891 . . . . 0.0 108.846 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.3 139.89 1.32 Allowed 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.794 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.9 OUTLIER -56.45 -19.19 14.01 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.087 179.049 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.677 ' HB2' ' CD1' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -130.1 127.97 40.92 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.554 179.421 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -100.99 107.91 19.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.871 0.367 . . . . 0.0 110.828 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.424 ' HA ' HG12 ' A' ' 43' ' ' ILE . 39.8 mt -71.5 -176.33 1.53 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.921 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -92.72 42.18 2.69 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.613 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.8 p30 42.83 61.0 2.25 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.891 0.377 . . . . 0.0 111.66 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.446 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 5.4 mp -96.61 126.23 49.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.788 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 m -54.77 -38.15 66.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.338 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -65.86 -22.37 66.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.159 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.0 mt -102.56 152.28 21.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.082 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.414 ' HA ' ' O3P' ' B' ' 169' ' ' TPO . 23.5 p -98.11 166.17 11.55 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.626 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.3 m-20 -43.41 -53.4 5.41 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.438 0.637 . . . . 0.0 109.853 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.424 ' HB2' HD13 ' A' ' 104' ' ' ILE . 16.1 mttt -118.16 82.65 1.87 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 177.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.569 ' CD2' ' HB2' ' A' ' 105' ' ' SER . 14.8 t60 -62.93 -43.83 97.72 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.157 -0.929 . . . . 0.0 113.158 -176.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.47 ' CD1' ' HB2' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -151.24 161.63 42.37 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.05 -0.66 . . . . 0.0 112.37 -179.57 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.504 ' CG ' ' HA ' ' A' ' 67' ' ' THR . 7.8 mt-30 -135.2 151.81 50.98 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.415 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 12.1 mt -124.12 127.49 73.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.206 178.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.425 ' CA ' HG13 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -111.31 149.33 31.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.013 0.435 . . . . 0.0 111.671 -179.307 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.4 tp -125.08 122.79 38.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.164 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.53 -171.92 41.1 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.792 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.6 -36.43 82.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.799 0.333 . . . . 0.0 110.966 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.86 152.45 43.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.792 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.77 -21.11 35.2 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.646 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -65.3 176.53 1.34 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.919 0.39 . . . . 0.0 110.881 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.01 160.13 39.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.92 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.402 HD11 ' N ' ' A' ' 122' ' ' GLN . 2.6 mm? -123.88 147.07 47.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.546 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.3 mt -113.39 122.39 47.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.013 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -116.98 124.71 50.04 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.681 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 10.9 p30 -88.16 140.24 29.69 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.424 HD13 ' HB2' ' A' ' 87' ' ' LYS . 9.5 pt -143.62 24.03 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 -179.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.569 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 10.5 t -91.13 154.45 19.34 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.709 0.766 . . . . 0.0 113.011 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.5 m -70.18 -52.08 26.14 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.469 -1.242 . . . . 0.0 110.495 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -77.92 0.67 23.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.322 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.32 155.69 31.83 Favored Glycine 0 N--CA 1.438 -1.207 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.724 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 4.0 m -117.46 137.78 52.29 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.792 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -116.58 148.54 40.81 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -177.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.32 113.54 18.37 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.812 177.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 47.31 36.21 4.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.071 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.07 -3.82 80.8 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.482 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.73 118.59 37.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.046 0.423 . . . . 0.0 110.805 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.792 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.4 tptm -72.74 120.98 19.12 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.069 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.1 m -98.24 163.81 2.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.394 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 120' ' ' SER . 44.1 tt0 -69.93 128.96 38.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.555 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.681 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 14.4 tttm -54.28 163.36 0.85 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.83 0.348 . . . . 0.0 110.183 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.6 OUTLIER 35.94 33.89 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.854 -179.251 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.5 OUTLIER -112.23 145.14 40.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.057 179.491 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.412 ' ND2' HD12 ' A' ' 92' ' ' LEU . 1.4 m-80 -87.93 132.62 34.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.877 0.37 . . . . 0.0 111.111 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.402 ' N ' HD11 ' A' ' 100' ' ' LEU . 30.1 mm-40 -129.12 145.32 51.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.45 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 26.4 tp -72.71 126.07 29.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.325 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.419 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -58.52 158.96 6.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.852 0.834 . . . . 0.0 112.316 -179.011 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.467 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -125.04 153.41 42.9 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.759 179.214 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -70.93 115.49 10.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.96 0.41 . . . . 0.0 109.921 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.25 28.18 68.77 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.552 -178.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.467 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 12.1 t70 -54.5 172.0 0.11 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.128 0.489 . . . . 0.0 111.421 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -145.2 135.33 23.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.675 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.1 mt -112.75 129.22 68.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.378 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.447 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 5.5 m -102.98 139.81 38.07 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.565 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.8 m -140.28 158.73 25.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -177.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.04 30.01 29.79 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.209 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.424 ' HB ' ' CH2' ' A' ' 110' ' ' TRP . 77.6 t -74.19 140.34 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-O 121.551 0.691 . . . . 0.0 112.013 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.9 -38.09 1.29 Allowed Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.473 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 2.7 t -121.33 128.39 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -50.56 -40.83 53.24 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.5 p -93.49 6.5 47.99 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.473 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 22.0 m-20 -117.7 30.13 7.45 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.447 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.3 mt -107.05 138.79 31.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.905 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.404 ' CD2' HD22 ' A' ' 143' ' ' LEU . 3.7 tt -124.67 134.62 52.82 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.448 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.455 ' HB3' HG23 ' A' ' 40' ' ' THR . 47.2 t -108.68 150.23 27.85 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.71 0.766 . . . . 0.0 112.576 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.404 HD22 ' CD2' ' A' ' 141' ' ' LEU . 2.1 mm? -136.1 151.03 49.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.472 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 40.5 t -125.18 133.45 69.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.803 0.335 . . . . 0.0 110.908 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -105.62 124.59 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.438 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -105.97 114.91 29.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.755 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.408 ' CD1' ' O ' ' A' ' 125' ' ' SER . 3.4 mp -85.05 133.31 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.571 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -82.34 118.78 23.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.916 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -69.94 -32.9 71.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.021 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.42 -45.55 91.23 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.959 0.409 . . . . 0.0 110.704 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -58.7 -44.16 90.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.931 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -63.46 -33.93 76.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.84 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.33 -43.85 97.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.027 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 10.0 t -66.52 -46.01 77.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.055 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.77 -37.25 86.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.007 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -60.69 -36.04 77.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.79 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -92.05 -30.99 15.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.928 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.8 p30 42.61 34.45 0.56 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.532 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.38 159.56 20.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.875 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 12.3 p -83.55 136.33 23.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.105 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -86.75 134.12 33.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.933 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -89.43 156.67 18.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 16.8 tt -91.07 129.36 41.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.025 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.904 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.807 0.337 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.97 166.43 12.45 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.897 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.2 139.46 42.19 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.529 2.153 . . . . 0.0 112.208 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -92.35 58.2 3.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 169' ' ' TPO . . . . . 0.414 ' O3P' ' HA ' ' A' ' 85' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -157.45 -176.37 5.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.052 0.453 . . . . 0.0 111.412 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . 0.516 ' O ' ' O ' ' B' ' 172' ' ' ILE . 51.1 mt-10 -156.51 79.28 0.95 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.603 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.516 ' O ' ' O ' ' B' ' 171' ' ' GLU . 15.8 tt 50.15 156.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 121.228 0.537 . . . . 0.0 112.048 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 173' ' ' TYR . . . . . 0.402 ' N ' HG12 ' B' ' 172' ' ' ILE . 4.5 p90 -112.69 87.89 2.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.946 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 4.8 p . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.893 179.975 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.8 0.334 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.98 -38.64 3.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.058 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -72.06 -41.96 66.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.94 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.48 -45.52 92.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.867 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -58.94 -35.02 72.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.996 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.04 -39.96 94.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.962 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.504 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 10.1 mm -70.38 -35.25 61.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.187 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -57.29 -37.6 72.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.952 0.406 . . . . 0.0 110.43 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -67.35 -23.68 65.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.79 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.504 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.57 -47.64 79.08 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.257 -179.72 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.3 m -66.08 -34.77 78.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.823 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -132.43 69.56 1.48 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.732 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -75.66 146.72 40.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.009 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -79.19 142.11 36.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.816 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.419 HG21 ' N ' ' A' ' 29' ' ' GLY . 18.2 mm -81.83 138.12 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-O 121.7 0.762 . . . . 0.0 111.769 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.419 ' N ' HG21 ' A' ' 28' ' ' ILE . . . 173.75 106.59 0.19 Allowed Glycine 0 C--N 1.313 -0.709 0 CA-C-N 114.419 -1.264 . . . . 0.0 112.437 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -86.63 -30.0 22.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.88 0.371 . . . . 0.0 111.008 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.407 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER 179.09 38.19 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.666 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.6 mm -74.93 136.05 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.558 0 CA-C-N 113.697 -1.592 . . . . 0.0 112.525 -177.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.49 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.0 t -91.92 -60.31 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 114.75 -1.113 . . . . 0.0 109.969 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.1 p -145.28 157.88 43.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.368 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.66 138.35 53.99 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.843 0.354 . . . . 0.0 111.474 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.45 HG23 ' CD2' ' A' ' 76' ' ' TYR . 1.1 m -108.06 122.66 62.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.724 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.2 mt -128.33 121.66 56.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.694 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 42.4 t -79.85 111.52 16.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.747 0.308 . . . . 0.0 110.257 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.5 t -78.81 -24.33 44.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.423 . . . . 0.0 112.088 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.48 HG23 ' HB3' ' A' ' 142' ' ' SER . 66.1 p -79.94 -2.14 42.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.73 0.3 . . . . 0.0 111.489 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.51 76.54 0.25 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.812 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -146.08 -43.96 0.2 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.887 0.375 . . . . 0.0 110.715 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.566 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.4 mp -117.54 142.1 29.93 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.062 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.566 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 48.2 Cg_endo -71.24 145.93 49.98 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.167 1.911 . . . . 0.0 112.27 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 42.5 mt -57.91 149.71 4.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.746 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.97 164.04 28.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.993 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.65 119.82 30.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.086 0.47 . . . . 0.0 111.948 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.505 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 7.3 mp -94.54 124.23 38.44 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.666 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -134.58 157.79 45.66 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -178.809 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.49 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -147.99 142.63 26.59 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.653 -1.612 . . . . 0.0 110.737 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.478 ' HB2' ' HG3' ' A' ' 54' ' ' GLN . 1.2 m-20 -74.85 126.82 31.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.199 0.524 . . . . 0.0 111.003 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.403 HD12 ' HB3' ' A' ' 154' ' ' CYS . 63.8 mt -64.11 -38.75 83.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.98 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 m -56.62 -40.44 75.37 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.885 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.478 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -68.49 -43.82 76.08 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.574 179.822 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.3 t -63.62 -37.93 80.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.38 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.63 -42.03 74.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.348 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? -74.49 -38.2 62.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.306 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -82.94 125.15 31.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.945 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.16 84.33 1.91 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.871 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.6 mtp85 -151.27 -177.29 5.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.822 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 78.3 p -98.16 30.42 3.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.794 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.9 tp -171.25 140.12 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.999 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.61 -53.22 0.94 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.416 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.5 ttpt -151.59 131.42 13.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.125 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 11.5 t -123.92 139.12 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 121.273 0.559 . . . . 0.0 111.951 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.535 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 16.4 m-90 -102.01 139.6 37.42 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.067 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.459 HG22 ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -108.8 132.27 54.16 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.425 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.55 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 2.7 m-85 -115.22 145.85 42.02 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.566 -178.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.704 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.91 -177.67 38.05 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.709 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.6 mtm180 -80.46 1.09 30.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.609 0.242 . . . . 0.0 111.373 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.431 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.9 t-20 -84.86 135.79 39.62 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.677 0.275 . . . . 0.0 110.872 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.1 Cg_exo -68.74 -6.96 19.22 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.672 2.248 . . . . 0.0 111.91 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.03 -45.09 14.47 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-O 122.093 0.949 . . . . 0.0 108.859 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -45.8 136.51 6.16 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 113.674 -1.603 . . . . 0.0 110.75 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.62 -19.02 14.04 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.0 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.55 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 33.3 t80 -129.76 118.7 22.25 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.678 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -93.87 107.9 19.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.865 0.364 . . . . 0.0 110.911 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.427 ' CD1' ' HA2' ' A' ' 69' ' ' GLY . 22.4 mt -73.19 -70.19 0.38 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.712 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 174.36 -86.72 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.235 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.7 p30 179.81 55.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.947 0.403 . . . . 0.0 110.866 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.1 mp -87.4 120.42 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.136 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 18.0 m -55.08 -41.49 71.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.919 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.404 ' HD3' ' CB ' ' A' ' 139' ' ' ASP . 0.0 OUTLIER -64.34 -22.43 66.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.228 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.5 mt -98.73 152.29 19.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.847 0.356 . . . . 0.0 111.118 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.7 p -95.76 165.84 12.1 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.649 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.704 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -42.76 -52.81 4.84 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.384 0.611 . . . . 0.0 109.686 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.42 ' HB2' HD11 ' A' ' 104' ' ' ILE . 19.1 mttt -119.3 84.92 2.28 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 177.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.539 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 14.7 t60 -64.19 -45.83 86.62 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.995 -1.002 . . . . 0.0 113.244 -176.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.474 ' CZ ' ' CD2' ' A' ' 68' ' ' PHE . 36.7 p90 -153.72 162.39 41.28 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.068 -0.653 . . . . 0.0 112.27 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 9.8 mt-30 -135.64 154.88 51.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.779 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 59.5 mt -123.54 132.35 71.53 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.269 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.43 ' HG ' ' CB ' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -117.3 149.91 39.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.032 0.444 . . . . 0.0 111.866 -179.243 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 18.9 tp -125.21 122.93 38.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.355 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.83 -152.27 20.23 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.633 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.91 173.2 10.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.824 0.345 . . . . 0.0 110.924 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 59.8 -167.5 0.17 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.835 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -95.57 27.85 14.31 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.51 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -98.58 160.32 14.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.838 0.351 . . . . 0.0 110.967 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.47 155.2 50.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.796 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.43 ' CB ' ' HG ' ' A' ' 92' ' ' LEU . 6.5 mt -133.12 141.0 47.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.533 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.82 128.21 56.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.13 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.401 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 50.2 t30 -116.6 115.63 26.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.887 0.375 . . . . 0.0 111.972 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.701 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 13.5 p30 -78.29 143.19 37.22 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.855 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.462 HG12 ' HG3' ' A' ' 90' ' ' GLN . 9.7 pt -149.67 35.86 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.539 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -99.05 150.98 21.45 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.651 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.2 m -68.71 -31.66 70.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.457 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -93.11 -19.57 21.37 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.172 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.515 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 110.73 158.12 15.7 Favored Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.738 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.513 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.7 m -117.18 137.65 52.2 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.833 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -115.83 148.35 40.01 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -178.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.22 113.4 18.24 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.535 177.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 43.61 43.62 4.83 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.16 -11.39 67.56 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.789 -0.719 . . . . 0.0 113.449 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -103.85 118.58 37.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.997 0.427 . . . . 0.0 110.625 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.833 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 2.8 tptp -74.04 121.39 21.0 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.41 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.8 m -91.54 163.44 2.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.958 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.5 OUTLIER -69.84 128.07 35.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.448 179.694 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.701 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 18.2 tttt -54.87 161.78 1.48 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.976 0.417 . . . . 0.0 110.631 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.6 OUTLIER 35.65 33.42 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.045 -179.263 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.47 145.16 40.69 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.234 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -89.32 128.78 35.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.763 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -129.25 148.67 51.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.513 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.5 tp -72.71 111.91 8.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.885 0.374 . . . . 0.0 110.364 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.412 ' HG ' ' N ' ' A' ' 125' ' ' SER . 66.3 tp -53.68 158.88 1.75 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.247 0.546 . . . . 0.0 111.509 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.45 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.8 OUTLIER -124.01 153.25 41.58 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.331 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 12.2 tp60 -71.68 122.53 20.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.03 0.443 . . . . 0.0 110.79 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.18 21.9 48.2 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.429 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.45 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 5.3 t70 -59.87 -177.96 0.07 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 120.571 0.224 . . . . 0.0 110.449 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.44 ' HG2' ' CG2' ' A' ' 144' ' ' VAL . 6.1 mt-10 -145.07 135.55 24.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.743 0.306 . . . . 0.0 111.444 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 3.3 mt -114.52 126.66 72.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.218 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.447 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.4 m -104.28 140.04 38.43 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.041 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.538 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 26.4 m -140.33 158.37 25.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.131 0.491 . . . . 0.0 112.23 -178.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.67 24.32 33.44 Favored Glycine 0 N--CA 1.439 -1.139 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.081 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.439 ' HB ' ' CZ3' ' A' ' 110' ' ' TRP . 77.9 t -70.93 140.32 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-O 121.544 0.688 . . . . 0.0 111.994 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.71 -38.13 1.08 Allowed Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 3.3 t -121.27 129.26 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.45 -40.65 51.18 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.55 6.69 47.39 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -178.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.455 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.7 OUTLIER -119.62 32.4 6.09 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -178.514 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.447 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 6.0 mt -107.25 138.65 32.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.411 0.624 . . . . 0.0 111.064 178.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.4 tt -124.88 134.61 52.63 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.718 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.48 ' HB3' HG23 ' A' ' 40' ' ' THR . 47.0 t -109.67 150.17 28.66 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.571 0.7 . . . . 0.0 112.25 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 69.7 mt -135.95 152.78 51.33 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.976 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.44 ' CG2' ' HG2' ' A' ' 129' ' ' GLU . 21.6 t -121.31 132.78 69.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.115 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -105.74 121.73 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-O 120.881 0.372 . . . . 0.0 111.205 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.99 115.01 29.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.95 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.5 mt -85.02 134.06 27.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.445 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -78.83 105.09 9.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.669 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.29 -35.24 73.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.08 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.97 -44.66 91.56 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.986 0.422 . . . . 0.0 110.669 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -58.77 -44.03 90.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.898 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.55 -42.24 98.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.031 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -36.96 78.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.017 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . 0.403 ' HB3' HD12 ' A' ' 52' ' ' ILE . 8.7 t -68.17 -42.14 80.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.197 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -66.49 -49.58 66.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.303 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -56.28 -35.67 67.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.276 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? -88.8 -37.13 15.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.052 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.4 p30 44.81 -173.41 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.549 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -117.11 128.32 55.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.913 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 10.3 m -87.46 130.61 36.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.096 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.58 62.01 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.931 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 60.48 96.74 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.871 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.3 pt -79.37 111.61 16.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.114 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.958 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.731 0.3 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -64.94 115.7 23.22 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.891 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.63 143.85 58.11 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.395 2.063 . . . . 0.0 112.389 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -173.19 115.84 0.27 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.753 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -163.44 174.6 11.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.07 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . 0.416 ' O ' ' O ' ' B' ' 172' ' ' ILE . 5.4 mt-10 -142.66 78.13 1.6 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.858 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.416 ' O ' ' O ' ' B' ' 171' ' ' GLU . 3.2 tp 43.01 102.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.9 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 173' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -55.68 -177.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.013 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 26.9 t . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.188 -0.91 . . . . 0.0 110.901 179.982 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.847 0.356 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 81.8 p -144.87 -61.58 0.36 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.837 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -67.32 -34.71 77.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.927 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.51 -35.99 81.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.83 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -57.98 -42.77 85.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.828 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.57 -31.98 71.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.67 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.423 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.5 mt -72.98 -35.43 48.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.939 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -57.5 -41.47 80.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.939 0.399 . . . . 0.0 110.498 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.17 -23.76 65.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.667 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.423 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.65 -47.53 79.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.217 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.8 p -79.32 -36.7 39.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.831 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 64.73 -79.18 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.978 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -77.18 145.78 37.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.941 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.61 122.95 26.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.836 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.416 HG22 ' N ' ' A' ' 29' ' ' GLY . 17.9 mm -83.04 138.2 19.72 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 CA-C-O 121.678 0.751 . . . . 0.0 111.832 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.416 ' N ' HG22 ' A' ' 28' ' ' ILE . . . -79.33 62.4 4.06 Favored Glycine 0 C--N 1.314 -0.641 0 CA-C-N 114.47 -1.241 . . . . 0.0 112.446 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.37 -42.19 95.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.749 0.309 . . . . 0.0 111.029 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 177.42 38.91 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.671 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.7 mm -72.56 137.08 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 113.652 -1.613 . . . . 0.0 112.492 -177.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.478 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.3 t -91.6 -58.78 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.777 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 3.0 p -147.76 165.33 30.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.404 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -127.12 138.27 53.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.913 0.387 . . . . 0.0 111.43 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.1 p -106.94 122.62 61.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.783 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.8 mt -127.53 127.92 69.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.618 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.405 ' HA ' ' CD1' ' A' ' 143' ' ' LEU . 35.2 t -88.5 114.23 24.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.76 0.314 . . . . 0.0 110.487 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.97 -23.68 33.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.701 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.471 HG21 ' HB3' ' A' ' 142' ' ' SER . 58.3 p -79.96 -2.43 43.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.69 0.281 . . . . 0.0 111.465 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.6 69.86 1.21 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.185 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -141.01 -42.28 0.39 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.9 0.381 . . . . 0.0 110.974 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.533 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.7 mt -118.89 140.85 29.16 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.752 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.533 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.2 Cg_endo -73.39 146.02 39.15 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.139 1.893 . . . . 0.0 112.28 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.3 mt -57.31 148.38 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.08 0.467 . . . . 0.0 111.686 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.423 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -134.25 164.09 28.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.167 179.464 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -120.69 119.56 33.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.047 0.451 . . . . 0.0 111.63 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.521 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 6.8 mp -95.72 123.33 39.24 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.671 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -135.15 156.96 48.11 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 122.163 0.983 . . . . 0.0 113.407 -179.541 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.478 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -153.62 141.92 20.56 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 113.662 -1.608 . . . . 0.0 111.132 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.406 ' CB ' ' HG2' ' A' ' 54' ' ' GLN . 2.4 m-20 -76.89 127.83 33.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.124 0.487 . . . . 0.0 111.104 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 55.1 mt -64.45 -43.11 96.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.093 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 71.8 m -58.28 -40.4 81.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.315 0.578 . . . . 0.0 110.808 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.406 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 4.4 mm-40 -68.43 -37.16 80.01 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.769 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.2 t -73.22 -44.29 55.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.036 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.5 mp -70.48 -31.48 68.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.922 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -77.13 -45.78 25.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.908 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -79.08 122.37 26.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.918 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -104.1 31.31 4.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.867 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.5 mmm180 -80.04 -179.05 6.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.92 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.73 -39.35 84.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.977 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.6 tp -140.52 155.08 22.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.054 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.47 -66.55 1.04 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.111 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.436 ' HE2' ' O ' ' A' ' 49' ' ' SER . 3.6 ttpt -138.09 136.0 36.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.412 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.442 HG13 ' NE2' ' A' ' 90' ' ' GLN . 19.3 t -132.13 139.2 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.274 0.559 . . . . 0.0 111.741 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.53 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 19.7 m-90 -102.42 139.37 38.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.309 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -114.18 131.1 56.57 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.504 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.4 OUTLIER -117.13 145.49 43.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.963 -179.125 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.614 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.99 -166.41 36.9 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.759 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -90.99 36.87 0.92 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.684 0.278 . . . . 0.0 111.41 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.443 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 3.9 t-20 -119.94 135.44 24.29 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.093 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 20.2 Cg_exo -64.63 -15.54 50.56 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.491 2.127 . . . . 0.0 111.5 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.72 -45.45 14.42 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 121.95 0.881 . . . . 0.0 109.089 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.36 139.54 2.65 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 113.885 -1.507 . . . . 0.0 110.845 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 67' ' ' THR . 9.3 m-20 -56.22 -18.57 10.71 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.844 178.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.496 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 2.8 t80 -129.18 116.71 19.6 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.737 0.303 . . . . 0.0 111.007 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -88.58 107.94 19.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.779 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.9 mp -77.91 -176.33 4.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.059 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.63 11.85 68.88 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.633 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 64.76 75.63 0.36 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.956 0.408 . . . . 0.0 111.473 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.7 mp -111.51 141.42 26.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.654 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.95 -41.73 71.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.047 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.411 ' CD ' HD13 ' B' ' 172' ' ' ILE . 9.9 mmp_? -61.02 -49.07 78.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.261 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.475 ' HA ' ' HD1' ' A' ' 88' ' ' HIS . 1.4 mt -76.39 151.79 36.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.099 0.476 . . . . 0.0 111.664 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.3 p -100.89 167.55 10.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.401 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.614 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -44.56 -53.0 7.53 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.436 0.636 . . . . 0.0 109.816 179.123 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.83 82.8 2.0 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 177.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.575 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 9.2 t60 -62.73 -46.12 89.58 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.094 -0.957 . . . . 0.0 113.036 -176.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.504 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 20.4 p90 -147.98 160.1 43.18 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.592 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.459 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.2 tt0 -136.19 141.28 44.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.485 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.417 ' O ' ' CG1' ' A' ' 65' ' ' VAL . 44.1 mt -116.12 127.43 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.892 179.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.418 ' CA ' HG11 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -110.99 144.64 39.77 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.069 0.461 . . . . 0.0 111.888 -179.383 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 16.1 tp -125.28 129.3 49.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.485 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.83 -153.31 24.71 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.755 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 63.12 -80.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.735 0.303 . . . . 0.0 111.077 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -117.31 -164.74 1.01 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.757 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -86.48 51.68 4.39 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.522 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -153.49 -170.48 3.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.901 0.381 . . . . 0.0 110.693 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.408 ' HB2' ' CD1' ' A' ' 124' ' ' LEU . 1.7 mt -119.65 160.16 23.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.004 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.2 mp -131.49 145.22 51.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.872 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.71 124.27 52.19 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.36 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 90' ' ' GLN . 51.5 t30 -115.74 115.58 26.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.905 0.383 . . . . 0.0 111.386 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.683 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 12.1 p30 -79.11 138.76 38.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.167 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 12.3 pt -146.96 39.35 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.728 -0.214 . . . . 0.0 111.574 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.575 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -96.13 158.51 15.41 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 121.055 0.455 . . . . 0.0 111.709 -179.06 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 86.4 m -69.07 -37.83 78.72 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.862 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.61 -19.91 17.3 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.47 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 123.8 158.35 10.1 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.074 -1.06 . . . . 0.0 113.799 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.533 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.8 m -117.78 137.99 52.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.924 -0.638 . . . . 0.0 109.731 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.863 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -114.58 148.42 38.05 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -178.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.2 113.54 18.44 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.384 177.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 44.0 43.99 5.77 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.39 -11.05 66.87 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.711 -0.756 . . . . 0.0 113.486 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -103.4 118.58 37.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.01 0.433 . . . . 0.0 110.544 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.863 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 3.8 tptm -74.37 113.86 12.08 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.473 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.5 m -84.5 162.64 2.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.876 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.469 ' O ' ' OG ' ' A' ' 120' ' ' SER . 13.2 tp10 -69.85 131.14 44.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.464 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.683 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 32.3 tttm -53.1 162.97 0.58 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.7 p30 34.07 39.1 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.099 0.476 . . . . 0.0 111.83 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.469 ' OG ' ' O ' ' A' ' 117' ' ' GLU . 25.0 p -111.54 145.07 39.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.734 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -94.64 123.82 38.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.71 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -127.96 148.45 50.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.558 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.8 tp -72.68 136.25 45.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.486 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.408 ' CD1' ' HB2' ' A' ' 99' ' ' LEU . 1.5 pt? -61.81 160.48 11.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.847 0.832 . . . . 0.0 112.088 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.41 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.0 OUTLIER -125.66 153.17 44.22 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.912 178.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.56 117.55 13.26 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.36 27.27 65.3 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.917 -0.659 . . . . 0.0 111.789 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.41 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 25.0 t0 -51.24 169.38 0.05 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.05 0.452 . . . . 0.0 111.404 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 12.8 tt0 -143.77 135.34 26.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.457 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 11.6 mt -114.44 128.1 71.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.863 0.363 . . . . 0.0 111.019 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.428 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 26.9 m -104.46 142.24 34.95 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.572 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 19.9 m -140.42 158.41 24.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -178.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.34 46.53 26.12 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.419 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.453 ' HA ' HG12 ' A' ' 140' ' ' ILE . 58.5 t -85.27 140.72 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-O 121.997 0.903 . . . . 0.0 112.983 -178.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.27 -46.64 0.78 Allowed Glycine 0 N--CA 1.434 -1.494 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.504 HG12 ' CB ' ' A' ' 139' ' ' ASP . 4.6 p -104.03 118.0 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 CA-C-N 113.902 -1.149 . . . . 0.0 109.388 177.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -57.53 -24.24 54.9 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.787 0.327 . . . . 0.0 111.3 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.92 -25.91 17.83 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -177.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.504 ' CB ' HG12 ' A' ' 136' ' ' VAL . 0.5 OUTLIER -105.53 25.43 10.75 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -177.642 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.453 HG12 ' HA ' ' A' ' 134' ' ' VAL . 5.8 mt -88.8 139.81 16.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.064 177.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.0 tt -120.02 134.8 55.14 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.993 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.471 ' HB3' HG21 ' A' ' 40' ' ' THR . 43.4 t -115.65 150.26 37.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.521 0.677 . . . . 0.0 112.277 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 2.0 mm? -135.79 153.35 51.55 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.39 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 39.6 t -123.26 138.5 53.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.798 0.332 . . . . 0.0 110.695 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.3 mm -106.24 125.89 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-O 120.965 0.412 . . . . 0.0 111.064 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.33 111.72 23.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.68 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.421 HD13 ' N ' ' A' ' 147' ' ' ILE . 3.6 mp -90.6 128.23 42.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.353 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -75.95 126.13 30.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.825 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -70.31 -30.86 67.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.994 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -60.05 -46.0 90.98 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.693 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -58.56 -44.12 89.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.954 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -65.08 -34.49 78.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.893 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -58.95 -47.0 86.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.047 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 10.9 t -65.86 -46.05 79.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.976 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.26 -35.97 80.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.835 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.97 -40.62 89.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.818 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.417 ' O ' ' N ' ' A' ' 159' ' ' LYS . 0.9 OUTLIER -86.78 -31.04 21.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.9 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 43.4 -91.01 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.638 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 157' ' ' GLN . 0.1 OUTLIER -107.65 152.44 24.3 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.827 0.346 . . . . 0.0 110.879 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 13.3 p -100.65 117.26 45.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.126 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -61.59 -45.51 93.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.769 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.51 168.33 22.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.894 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.415 HG23 HD11 ' A' ' 163' ' ' ILE . 0.2 OUTLIER -105.19 140.01 24.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.157 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.302 -0.856 . . . . 0.0 111.068 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.875 0.369 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -133.01 88.54 36.61 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.015 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -51.52 144.56 32.09 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.551 2.167 . . . . 0.0 112.25 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -177.75 79.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.873 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -164.74 -179.44 5.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.814 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . 0.495 ' O ' ' O ' ' B' ' 172' ' ' ILE . 0.0 OUTLIER -132.56 43.77 2.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.88 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.495 ' O ' ' O ' ' B' ' 171' ' ' GLU . 8.5 tp 50.06 161.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.999 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 173' ' ' TYR . . . . . 0.409 ' N ' HG13 ' B' ' 172' ' ' ILE . 12.5 m-85 -47.76 96.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.144 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.922 -179.892 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.885 0.374 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.6 p -121.51 34.47 5.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.759 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -60.05 -47.21 86.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.828 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -71.24 -35.85 71.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.962 0.41 . . . . 0.0 110.541 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -58.05 -44.19 87.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.859 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 mp -60.99 -43.02 99.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.725 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.433 ' O ' ' CD2' ' A' ' 23' ' ' PHE . 47.7 mm -64.57 -48.14 86.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.812 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -33.74 71.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.433 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.15 -47.14 87.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.985 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' A' ' 24' ' ' SER . 3.5 p90 -71.76 -47.59 52.6 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.132 0.491 . . . . 0.0 111.031 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.533 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 0.9 OUTLIER -59.68 -44.79 93.48 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.987 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -104.03 102.46 12.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.855 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.35 141.11 41.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.819 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.12 115.66 27.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.4 mm -81.98 138.29 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 CA-C-O 121.683 0.754 . . . . 0.0 111.67 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.32 109.15 0.46 Allowed Glycine 0 C--N 1.314 -0.672 0 CA-C-N 114.475 -1.239 . . . . 0.0 112.55 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.02 -28.54 20.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.741 0.305 . . . . 0.0 111.091 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.2 m-20 176.65 39.41 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.704 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.1 mm -71.99 135.28 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 113.538 -1.664 . . . . 0.0 112.634 -177.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.485 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.3 t -91.38 -59.55 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.633 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.4 p -148.94 150.48 32.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.992 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.67 138.02 51.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.826 0.346 . . . . 0.0 111.639 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.6 m -102.83 122.63 55.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.572 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.9 mt -127.54 124.9 64.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.605 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 51.9 t -83.17 121.16 26.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.531 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.66 -24.55 21.59 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.515 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.459 HG21 ' HB3' ' A' ' 142' ' ' SER . 43.8 p -79.95 -2.06 42.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.461 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.6 75.97 0.31 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.787 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -147.2 -43.83 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.795 0.331 . . . . 0.0 110.886 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.532 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.0 mt -116.35 140.98 27.21 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.756 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.532 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.4 Cg_endo -72.93 145.49 40.31 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.138 1.892 . . . . 0.0 112.202 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.8 mt -56.03 141.51 12.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.669 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.449 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -127.25 164.05 22.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.17 179.551 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.7 119.66 32.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.069 0.461 . . . . 0.0 111.68 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.511 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 3.1 mt -98.66 133.0 43.62 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.704 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.98 157.97 43.87 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -178.584 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.485 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -142.12 147.79 37.28 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 113.577 -1.647 . . . . 0.0 110.748 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.429 ' CB ' ' HG2' ' A' ' 54' ' ' GLN . 1.6 m-20 -74.96 136.26 41.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.167 0.508 . . . . 0.0 111.33 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 93.1 mt -64.32 -44.41 97.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.086 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.4 p -56.72 -38.15 71.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.191 0.519 . . . . 0.0 110.506 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.429 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 4.4 mm-40 -68.55 -36.86 79.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.421 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.9 t -69.62 -45.22 78.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.097 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.0 mt -66.08 -42.09 89.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -67.28 -31.91 72.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.31 116.37 5.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.863 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.83 83.13 3.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.886 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 58.04 70.56 0.64 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.995 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.93 176.32 5.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.897 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.8 tp -79.79 148.57 5.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.052 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.71 -38.79 1.48 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.723 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.433 ' CE ' ' O ' ' A' ' 49' ' ' SER . 1.9 ttpt -155.23 139.89 17.02 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.407 HG11 ' HG2' ' A' ' 90' ' ' GLN . 21.3 t -136.05 139.33 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.581 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.511 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 18.2 m-90 -102.56 139.3 38.33 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.453 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.452 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -114.17 130.25 56.61 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 177.282 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.506 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 1.1 m-85 -117.97 145.25 44.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.926 0.394 . . . . 0.0 111.642 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.9 -170.22 39.87 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.751 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.413 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 20.6 mtm180 -82.01 1.42 35.75 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -84.87 135.0 40.52 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.685 0.278 . . . . 0.0 111.319 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -66.43 -12.53 36.09 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.635 2.223 . . . . 0.0 111.742 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.64 -43.94 16.35 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-O 121.965 0.888 . . . . 0.0 108.738 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.82 140.44 1.35 Allowed 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 113.707 -1.588 . . . . 0.0 110.635 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' A' ' 67' ' ' THR . 23.3 m-20 -56.14 -18.93 11.35 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.172 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.472 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 7.0 t80 -129.66 130.28 45.36 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-O 120.882 0.373 . . . . 0.0 111.017 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -105.99 113.97 27.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.784 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.4 mt -93.71 -67.02 0.88 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.875 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 179.15 -90.84 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.164 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.404 ' HA ' ' HD2' ' A' ' 70' ' ' ARG . 3.9 p30 175.97 54.25 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.839 0.352 . . . . 0.0 111.01 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.414 ' HB ' ' CD1' ' A' ' 84' ' ' LEU . 29.5 mm -83.32 134.76 26.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.872 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.53 -32.66 74.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.411 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.425 ' HD3' ' HB3' ' A' ' 139' ' ' ASP . 2.2 mpt_? -68.38 -23.77 64.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.502 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.414 ' CD1' ' HB ' ' A' ' 81' ' ' ILE . 5.7 mp -103.38 153.38 20.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.932 0.396 . . . . 0.0 111.114 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.4 m -95.94 168.58 10.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.034 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.571 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -43.45 -54.46 4.78 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.38 0.61 . . . . 0.0 109.698 179.176 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.7 84.22 2.17 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 177.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.599 ' CE1' ' OG ' ' A' ' 105' ' ' SER . 12.7 t60 -57.95 -45.39 86.7 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.705 -176.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.457 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 32.1 p90 -148.24 159.4 44.01 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.079 -0.648 . . . . 0.0 111.922 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.1 tt0 -135.79 139.95 43.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.376 -178.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.434 HD11 ' CZ ' ' A' ' 68' ' ' PHE . 44.0 mt -114.94 128.15 72.2 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.772 179.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.422 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 1.1 pt? -114.11 143.08 45.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.059 0.457 . . . . 0.0 111.61 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 28.5 tp -125.04 122.9 38.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.295 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 133.95 102.14 0.75 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.439 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -159.33 -45.74 0.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.819 0.342 . . . . 0.0 111.007 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -165.18 -43.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.978 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 174.2 43.03 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.475 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 39.3 p30 -165.92 -176.76 3.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.825 0.345 . . . . 0.0 110.983 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.99 159.79 16.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.839 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.407 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 1.8 mp -131.35 147.33 52.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.447 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 mp -112.86 124.92 53.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.304 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.422 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 61.4 t30 -120.57 115.76 24.04 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.68 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 14.3 p30 -78.13 138.93 38.97 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.4 ' CG1' ' HA ' ' A' ' 89' ' ' PHE . 7.2 pt -140.02 22.09 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.599 ' OG ' ' CE1' ' A' ' 88' ' ' HIS . 11.0 t -91.79 153.46 19.57 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 121.487 0.66 . . . . 0.0 112.641 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.1 m -69.99 -52.12 26.88 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.399 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -72.83 -5.07 35.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.139 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.53 156.04 30.88 Favored Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.73 -0.747 . . . . 0.0 113.459 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.524 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 5.6 m -117.33 137.74 52.23 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.82 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -113.39 148.44 35.8 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -177.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.25 113.42 18.25 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.252 177.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 44.51 43.22 6.2 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.98 -6.85 80.0 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.528 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -103.98 118.5 36.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.982 0.42 . . . . 0.0 110.578 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.82 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 20.9 tptt -74.54 118.32 17.36 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.343 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.0 m -95.88 159.45 2.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.864 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.646 ' O ' ' HB3' ' A' ' 120' ' ' SER . 5.5 mm-40 -69.97 133.97 47.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.109 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.68 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 27.1 tttt -55.48 165.78 0.75 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.131 0.491 . . . . 0.0 110.83 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.46 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.6 OUTLIER 36.46 34.43 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.687 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.646 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 1.4 t -112.21 145.12 40.45 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.76 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -86.7 136.1 33.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.93 0.395 . . . . 0.0 111.086 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.407 ' NE2' ' OG ' ' A' ' 120' ' ' SER . 19.0 mm-40 -128.68 144.2 51.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.204 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.2 tt -72.67 131.41 42.37 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.221 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.401 ' CD2' HG12 ' A' ' 147' ' ' ILE . 54.0 tp -58.5 151.8 19.5 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.73 0.776 . . . . 0.0 111.751 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.432 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -125.37 152.83 44.26 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.587 179.57 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.11 117.93 14.35 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.73 25.78 66.04 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.839 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.432 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 30.9 t70 -51.1 167.85 0.07 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.946 0.403 . . . . 0.0 111.505 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.8 tt0 -145.21 135.4 23.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.902 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 15.3 mt -117.68 128.33 74.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.626 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.42 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.9 m -104.11 140.07 38.3 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.54 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 33.7 m -140.13 158.39 25.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.403 ' HA2' ' HB3' ' A' ' 83' ' ' ARG . . . 86.84 29.61 23.02 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.994 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.446 ' HB ' ' CZ3' ' A' ' 110' ' ' TRP . 72.2 t -75.8 140.44 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-O 121.602 0.715 . . . . 0.0 111.942 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.25 -38.93 1.21 Allowed Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.403 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 3.3 t -120.2 118.72 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -50.6 -30.9 14.44 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.0 m -93.59 6.82 46.97 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.425 ' HB3' ' HD3' ' A' ' 83' ' ' ARG . 16.3 m-20 -130.33 35.17 4.1 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -178.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.42 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.5 mt -106.79 138.29 33.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-O 121.357 0.599 . . . . 0.0 110.562 177.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.1 134.47 52.47 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.902 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.459 ' HB3' HG21 ' A' ' 40' ' ' THR . 46.6 t -109.37 150.24 28.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.578 0.704 . . . . 0.0 112.051 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 3.2 mm? -136.12 147.53 47.81 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.615 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 23.6 t -118.1 140.21 42.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.809 0.337 . . . . 0.0 111.187 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 17.1 mt -106.26 125.84 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.099 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -111.8 117.64 33.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.563 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.401 HG12 ' CD2' ' A' ' 124' ' ' LEU . 4.6 mt -84.83 134.05 27.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.34 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -81.36 109.63 16.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.812 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -61.17 -33.09 72.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.083 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.27 -46.01 91.31 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.987 0.422 . . . . 0.0 110.773 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -60.06 -44.15 94.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.98 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 15.9 tttm -65.01 -39.41 93.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.94 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -61.45 -40.69 95.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.1 t -60.94 -46.11 92.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.965 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -62.76 -46.38 88.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.83 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.98 -37.28 75.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.769 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -69.38 -15.0 63.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.157 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -128.57 178.78 6.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.845 0.355 . . . . 0.0 111.028 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -124.38 141.65 51.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.865 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.4 m -77.29 138.87 19.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.116 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.1 t0 60.78 160.18 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.34 139.33 22.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.834 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.5 pt -98.46 112.09 29.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.12 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.943 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.879 0.371 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -122.97 76.43 49.85 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.949 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.25 176.33 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.618 2.212 . . . . 0.0 112.24 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -124.72 137.58 54.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.796 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -179.52 -179.23 0.52 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.023 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . 0.499 ' O ' ' CG2' ' B' ' 172' ' ' ILE . 10.3 mt-10 -140.96 72.76 1.4 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.735 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.499 ' CG2' ' O ' ' B' ' 171' ' ' GLU . 18.2 tt 49.88 158.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.151 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 173' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -56.21 90.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.91 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.894 -179.979 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.827 0.346 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.7 m -135.52 -45.97 0.68 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.948 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -59.95 -44.89 94.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.941 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.8 mtm-85 -59.57 -42.46 92.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.905 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -60.19 -38.52 83.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.968 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.71 -42.12 96.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.93 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.501 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 9.6 mm -71.19 -35.07 56.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.22 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -57.17 -35.49 69.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.956 0.408 . . . . 0.0 110.45 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.2 -23.92 65.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.839 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.501 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.59 -47.68 79.04 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.059 0.457 . . . . 0.0 111.227 -179.808 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 m -67.28 -37.47 83.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.844 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 65.01 -78.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.033 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -64.92 139.22 58.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.026 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -69.35 142.19 54.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.884 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.2 mm -81.88 138.36 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 CA-C-O 121.706 0.765 . . . . 0.0 111.688 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.31 65.81 0.01 OUTLIER Glycine 0 C--N 1.314 -0.644 0 CA-C-N 114.403 -1.271 . . . . 0.0 112.311 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -89.0 -36.34 15.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.721 0.296 . . . . 0.0 111.302 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -176.54 37.97 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.721 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -78.41 134.34 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.57 0 CA-C-N 113.88 -1.509 . . . . 0.0 112.523 -177.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.482 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.7 t -89.15 -62.01 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.301 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.8 p -149.24 153.44 37.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.458 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 24.1 ttm180 -118.11 138.15 52.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.804 0.335 . . . . 0.0 111.592 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.471 ' CG2' ' CE1' ' A' ' 76' ' ' TYR . 34.4 m -103.48 122.91 56.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.983 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.0 mt -126.8 116.37 44.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.563 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -81.02 112.52 18.49 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.115 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.52 -20.18 40.6 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.484 HG23 ' HB3' ' A' ' 142' ' ' SER . 66.5 p -79.71 -2.5 43.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.703 0.287 . . . . 0.0 111.538 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.68 72.18 0.75 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.764 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -142.25 -41.48 0.34 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.902 0.382 . . . . 0.0 110.705 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.547 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.5 mt -119.49 142.15 32.14 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.06 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.547 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.7 Cg_endo -73.65 139.92 28.77 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.208 1.938 . . . . 0.0 112.026 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.3 mt -55.62 149.2 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.759 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -144.41 164.0 32.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.033 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -121.75 119.99 33.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.114 0.483 . . . . 0.0 112.049 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.504 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 7.3 mt -92.62 137.5 32.31 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.721 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -144.6 158.31 43.83 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -178.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.482 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -144.73 145.8 31.87 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.661 -1.609 . . . . 0.0 110.947 178.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.465 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 4.3 m-20 -75.19 108.22 7.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.061 0.458 . . . . 0.0 111.027 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 38.0 mt -64.53 -42.02 93.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.287 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.9 t -58.21 -41.65 84.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.313 0.577 . . . . 0.0 110.935 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.465 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 24.3 mt-30 -68.44 -36.87 79.65 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.941 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 49.6 t -68.63 -38.04 78.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.882 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.98 -42.02 85.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.94 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -69.31 -34.37 74.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -83.75 122.07 28.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.892 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.3 33.11 2.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.937 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.14 -176.92 3.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.63 179.21 4.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.428 HG23 ' O ' ' A' ' 62' ' ' ILE . 2.4 tp 35.9 95.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.221 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.26 -72.14 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.016 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.403 ' HE2' ' O ' ' A' ' 49' ' ' SER . 2.7 ttpt -131.24 138.61 49.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.025 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.526 HG12 ' HB3' ' A' ' 92' ' ' LEU . 22.0 t -134.02 139.62 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 121.384 0.611 . . . . 0.0 112.388 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.584 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 15.6 m-90 -105.09 138.95 40.51 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.948 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.94 125.89 53.16 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.554 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 2.1 m-85 -107.05 145.84 31.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.832 -178.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.658 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.63 179.84 38.94 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.578 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 18.4 mtm180 -78.66 -1.65 35.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.605 0.241 . . . . 0.0 111.382 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.402 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 7.8 t-20 -84.83 136.88 38.45 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 120.756 0.312 . . . . 0.0 111.037 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.1 Cg_exo -69.3 -5.88 16.99 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.879 2.386 . . . . 0.0 111.948 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.89 -45.66 13.94 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-O 122.04 0.924 . . . . 0.0 108.681 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -45.41 137.74 4.67 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 113.639 -1.619 . . . . 0.0 110.533 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.17 -18.89 11.4 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.061 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.554 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 50.7 t80 -129.59 125.0 35.19 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.652 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -98.48 112.67 24.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.034 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.5 mt -82.14 -69.27 0.63 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 174.93 -91.15 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.28 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.2 p30 -178.85 54.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.828 0.347 . . . . 0.0 111.098 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 30.1 mm -88.91 124.76 41.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.154 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.403 ' HB3' ' CD1' ' B' ' 170' ' ' LEU . 0.3 OUTLIER -55.69 -42.32 75.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.062 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.96 -18.73 58.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.43 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 26.5 mt -104.0 152.14 22.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.763 0.316 . . . . 0.0 111.228 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 p -96.66 170.21 9.35 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.562 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.658 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 6.1 m-20 -43.81 -56.74 3.65 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.276 0.56 . . . . 0.0 109.693 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.446 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -117.85 84.84 2.23 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 177.177 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.569 ' CD2' ' HB2' ' A' ' 105' ' ' SER . 14.9 t60 -59.34 -46.26 89.12 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.907 -1.042 . . . . 0.0 113.11 -176.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.507 ' CZ ' ' CD2' ' A' ' 68' ' ' PHE . 22.4 p90 -149.3 158.53 44.25 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.919 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.512 ' HG2' HG13 ' A' ' 65' ' ' VAL . 4.5 tt0 -136.18 138.55 42.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.834 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.4 mt -114.15 129.29 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 C-N-CA 121.122 -0.231 . . . . 0.0 110.649 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.526 ' HB3' HG12 ' A' ' 65' ' ' VAL . 2.2 pp -123.23 144.93 49.07 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 121.058 0.456 . . . . 0.0 111.864 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.22 122.95 38.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.253 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -123.93 -168.4 12.94 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.729 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -76.41 110.82 11.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.838 0.352 . . . . 0.0 110.902 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -178.5 -39.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.841 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 123.4 -24.73 6.46 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.471 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -114.02 -178.1 3.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.804 0.335 . . . . 0.0 111.01 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.441 ' CD1' ' N ' ' A' ' 99' ' ' LEU . 1.4 mp -107.95 160.26 15.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.751 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.1 mp -124.14 142.57 51.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.436 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.88 123.98 51.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.135 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -118.99 115.67 24.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.963 0.411 . . . . 0.0 111.69 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.688 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 12.3 p30 -78.95 139.57 38.22 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.446 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 11.5 pt -143.16 26.49 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.909 -0.317 . . . . 0.0 111.824 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.569 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 10.6 t -92.11 155.62 17.93 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 121.534 0.683 . . . . 0.0 112.63 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 42.3 m -69.95 -52.1 27.3 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.583 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -77.59 -1.7 32.04 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.292 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.92 156.31 31.99 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.615 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.488 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 4.3 m -117.41 137.73 52.29 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.84 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -113.89 148.58 36.51 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -177.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.06 113.45 18.4 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.594 -1.185 . . . . 0.0 108.442 177.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 57.1 m-20 44.47 43.37 6.23 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.1 -11.14 65.96 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.508 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -103.15 118.57 37.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.03 0.443 . . . . 0.0 110.508 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.84 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 2.5 tptm -72.6 112.72 8.9 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.373 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.0 m -84.44 162.69 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.775 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.3 OUTLIER -69.78 128.8 37.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.497 179.745 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.688 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 26.6 tttm -54.83 161.51 1.55 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.934 0.397 . . . . 0.0 110.316 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.503 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.1 p30 36.24 32.97 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.334 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.5 144.94 41.12 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.771 179.188 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -92.49 132.23 36.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.006 0.431 . . . . 0.0 111.147 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 42.9 mm-40 -129.38 150.71 50.63 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.581 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 tt -72.67 135.99 45.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.269 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.439 HD23 ' HB2' ' A' ' 99' ' ' LEU . 64.6 tp -63.54 154.5 32.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.613 0.72 . . . . 0.0 111.698 -179.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.97 153.06 43.35 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.373 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.81 122.8 21.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.909 0.385 . . . . 0.0 110.236 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.87 23.41 50.93 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.961 -0.637 . . . . 0.0 112.236 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -51.64 170.38 0.05 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.836 0.351 . . . . 0.0 110.983 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 4.7 mt-10 -145.14 135.61 24.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.184 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 14.8 mt -113.09 126.32 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.578 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.444 ' O ' ' HB2' ' A' ' 110' ' ' TRP . 4.3 m -104.59 140.26 38.26 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.536 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.4 m -140.36 158.58 25.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.28 28.82 29.44 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.073 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.45 ' HA ' HG12 ' A' ' 140' ' ' ILE . 70.2 t -74.07 140.33 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-O 121.583 0.706 . . . . 0.0 111.945 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 140.92 -42.05 1.22 Allowed Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -178.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.448 HG22 ' CD1' ' B' ' 172' ' ' ILE . 2.2 t -117.32 123.41 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.3 -35.04 25.67 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 84.0 p -93.59 6.62 47.64 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.4 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 37.6 m-20 -121.65 28.61 7.58 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -178.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.45 HG12 ' HA ' ' A' ' 134' ' ' VAL . 5.1 mt -107.36 137.88 36.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.49 0.662 . . . . 0.0 111.348 178.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.5 tt -125.37 134.61 52.11 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.079 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.484 ' HB3' HG23 ' A' ' 40' ' ' THR . 46.3 t -108.47 150.06 27.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.702 0.763 . . . . 0.0 112.181 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 4.0 mp -135.15 150.48 50.17 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.74 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.3 t -121.79 134.83 63.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.741 0.305 . . . . 0.0 111.025 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.449 HG22 HD13 ' A' ' 145' ' ' ILE . 16.9 mt -106.35 123.07 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-O 120.89 0.376 . . . . 0.0 111.039 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.73 119.26 38.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.777 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.426 HG12 ' CD2' ' A' ' 124' ' ' LEU . 2.5 mt -84.98 134.11 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.352 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -79.77 116.34 19.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.765 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -58.39 -31.95 68.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.075 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 17.0 mmmt -60.32 -46.07 91.18 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.773 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -60.69 -44.19 96.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.018 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -65.14 -49.52 69.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.89 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -38.85 79.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.996 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.8 t -60.04 -46.04 90.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.979 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.0 -43.94 73.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.946 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.68 -35.34 74.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.97 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -81.62 -30.75 32.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.897 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -121.89 82.09 1.91 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.948 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.7 tttt -65.78 155.0 37.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.928 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 17.6 m -75.94 124.59 34.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.123 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -129.29 -177.12 4.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.912 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 62.3 mtt85 -98.79 34.32 2.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.872 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 10.2 mt -96.7 111.04 25.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.13 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 48.3 mmm-85 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.915 179.964 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 2.9 m120 . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.766 0.317 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -173.74 134.29 0.61 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.012 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -73.17 140.19 30.57 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.514 2.142 . . . . 0.0 112.207 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -104.18 63.52 0.75 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.03 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . 0.403 ' CD1' ' HB3' ' A' ' 82' ' ' SER . 1.6 tt -90.48 151.39 21.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.013 0.435 . . . . 0.0 111.108 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -147.21 139.37 24.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.594 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.448 ' CD1' HG22 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -50.15 128.97 7.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.079 0.466 . . . . 0.0 111.363 -179.746 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 173' ' ' TYR . . . . . 0.423 ' CD1' HD13 ' B' ' 172' ' ' ILE . 2.0 p90 -66.59 -178.19 0.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.869 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 2.4 m . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.89 179.887 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.812 0.339 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.8 m -137.84 -54.11 0.65 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.848 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.27 -34.52 76.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.897 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -36.09 79.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.831 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.89 -39.67 94.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.899 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 12.3 mt -58.49 -40.34 82.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.808 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.507 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.4 mm -70.14 -34.93 61.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.133 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.26 -33.66 67.84 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.481 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -67.24 -23.92 65.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.866 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.507 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.91 -47.56 80.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.187 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -61.1 -33.61 73.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.358 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -51.5 -47.93 63.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.86 0.362 . . . . 0.0 111.11 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.02 120.96 32.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.721 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -98.82 128.02 44.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.944 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.2 mm -81.94 138.31 19.72 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 CA-C-O 121.6 0.714 . . . . 0.0 111.613 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -139.01 89.9 0.2 Allowed Glycine 0 C--N 1.314 -0.674 0 CA-C-N 114.586 -1.188 . . . . 0.0 112.745 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -83.02 -37.35 24.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.958 0.409 . . . . 0.0 110.553 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.446 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER -179.27 37.17 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 179.83 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.701 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.7 mm -75.57 135.55 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 CA-C-N 113.686 -1.597 . . . . 0.0 112.655 -177.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.501 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.9 t -93.19 -60.75 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.062 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.9 p -145.44 145.42 31.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.301 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.406 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.92 138.07 50.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.797 0.332 . . . . 0.0 111.485 -179.237 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -107.17 122.75 61.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.95 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.8 mt -124.07 120.27 59.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.591 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 46.8 t -79.88 119.61 22.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.357 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.59 -23.2 22.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.648 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.469 HG22 ' HB3' ' A' ' 142' ' ' SER . 63.5 p -79.8 -2.33 42.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.782 0.325 . . . . 0.0 111.459 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.35 73.58 0.52 Allowed Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.814 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -145.92 -37.76 0.25 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.777 0.322 . . . . 0.0 111.117 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.537 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.6 mt -121.54 140.96 32.52 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.928 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.537 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.2 Cg_endo -73.22 140.36 30.68 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.191 1.927 . . . . 0.0 112.087 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.6 mt -56.62 134.16 20.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.706 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.441 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -122.57 163.03 20.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.256 179.367 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.406 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.7 OUTLIER -118.89 120.63 37.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.083 0.468 . . . . 0.0 112.162 -179.326 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.541 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 1.6 mt -96.86 133.71 41.12 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.701 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -146.24 158.91 43.91 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -178.526 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.501 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -144.38 141.89 29.98 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 113.586 -1.643 . . . . 0.0 110.731 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.453 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -78.11 141.84 38.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.068 0.461 . . . . 0.0 111.093 -179.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 89.2 mt -64.05 -42.49 95.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.557 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.4 p -56.63 -38.22 71.81 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.588 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.453 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 1.6 mt-30 -68.32 -36.88 79.97 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.306 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.6 t -73.04 -41.48 59.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.948 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 tp -71.08 -32.26 68.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.807 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.45 -43.58 80.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.815 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -63.29 117.41 6.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.871 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -82.65 80.32 8.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.893 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.27 82.19 0.16 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.874 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.16 -170.14 0.28 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.824 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.1 tp -68.75 148.17 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.953 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -116.75 -61.0 1.78 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.013 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.415 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.1 ttpt -155.06 133.28 11.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.319 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 5.8 t -123.24 138.08 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-O 121.234 0.54 . . . . 0.0 111.768 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.541 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.3 m-90 -102.31 139.71 37.56 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.302 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.487 ' HA ' ' HG2' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -111.83 128.42 56.11 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 176.971 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.533 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.4 OUTLIER -118.66 145.28 45.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.264 -178.153 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.624 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.06 -172.4 38.19 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.748 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 27.2 mtm180 -78.69 3.2 17.12 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.436 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.9 t30 -84.69 132.46 46.47 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.687 0.279 . . . . 0.0 111.005 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.2 Cg_exo -65.98 -13.67 40.95 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.585 2.19 . . . . 0.0 111.68 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.74 -43.05 17.26 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.967 0.889 . . . . 0.0 108.953 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.23 138.7 1.6 Allowed 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 113.792 -1.549 . . . . 0.0 110.828 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.1 m-20 -56.42 -18.93 12.73 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.968 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.494 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 25.6 t80 -129.83 123.27 30.49 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.141 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -100.14 118.69 37.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.555 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.411 ' CB ' HG12 ' A' ' 43' ' ' ILE . 0.8 OUTLIER -125.39 72.36 1.25 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.247 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 48.97 -135.49 21.34 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.959 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -158.96 81.09 0.78 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.797 0.332 . . . . 0.0 110.92 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.9 mp -95.52 140.43 16.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.033 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 m -55.61 -45.0 77.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.132 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.447 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -60.74 -49.07 78.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.753 -179.357 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.444 ' CD1' ' N ' ' A' ' 84' ' ' LEU . 4.3 mp -72.56 152.88 41.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.209 0.528 . . . . 0.0 111.215 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.6 p -102.48 168.27 9.41 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.758 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.624 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 9.0 m-20 -42.47 -60.02 1.66 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.389 0.614 . . . . 0.0 109.527 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -115.63 84.58 2.12 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 176.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.61 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 10.2 t60 -61.45 -44.58 96.87 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.242 -0.89 . . . . 0.0 113.02 -176.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.533 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 12.1 p90 -146.16 162.87 37.04 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.07 -0.652 . . . . 0.0 112.254 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.526 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -135.54 138.03 42.63 Favored 'General case' 0 C--O 1.227 -0.111 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.006 -179.099 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 62.2 mt -114.86 129.23 71.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.656 178.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.425 ' CD1' ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -108.0 148.07 30.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.994 0.426 . . . . 0.0 111.294 -179.623 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 49.7 tp -125.13 123.41 39.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.543 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 155.1 -149.86 21.21 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.529 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.91 83.57 0.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.945 0.403 . . . . 0.0 110.817 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.04 29.95 18.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.981 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 72.81 33.33 60.28 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.543 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.2 m-20 -108.66 178.62 4.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.864 0.364 . . . . 0.0 110.91 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.74 138.84 51.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.81 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.418 ' CB ' HD13 ' A' ' 92' ' ' LEU . 11.1 mp -131.2 143.96 50.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.671 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -112.61 125.26 54.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.128 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 90' ' ' GLN . 49.0 t30 -115.72 115.71 26.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.901 0.382 . . . . 0.0 111.584 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.692 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 14.0 p30 -78.87 136.23 37.24 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.034 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.407 HG12 ' C ' ' A' ' 89' ' ' PHE . 12.9 pt -144.28 39.7 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.576 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.42 157.01 16.21 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.191 0.52 . . . . 0.0 111.92 -178.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 92.4 m -69.11 -36.27 77.33 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.433 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 19.8 p30 -98.51 -19.86 17.4 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.504 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 122.66 156.07 9.52 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.277 -0.963 . . . . 0.0 113.515 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.534 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 4.8 m -117.68 137.78 52.43 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 122.818 0.447 . . . . 0.0 109.832 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.837 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -119.32 148.1 43.55 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -178.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.421 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.7 OUTLIER -124.75 113.56 18.12 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.544 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 45.1 m-20 49.45 42.02 21.85 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 83.98 -6.05 76.68 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.924 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.411 ' CB ' HD21 ' A' ' 111' ' ' LEU . 4.4 mt-30 -103.97 118.92 37.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.189 0.495 . . . . 0.0 110.589 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.837 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 7.3 tptt -74.92 127.14 32.5 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.339 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.2 m -103.0 164.09 3.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.883 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 120' ' ' SER . 9.9 tp10 -69.76 128.04 35.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.422 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.692 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 56.4 tttt -53.8 161.78 1.06 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.719 0.295 . . . . 0.0 110.414 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.496 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.9 p30 35.23 34.77 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.141 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.22 145.11 40.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.363 179.61 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -89.14 125.48 35.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.589 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -129.5 148.73 51.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.201 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.3 tt -72.83 114.53 11.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.015 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.2 mt -55.11 166.26 0.57 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.654 0.74 . . . . 0.0 112.063 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.426 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.6 OUTLIER -125.4 152.71 44.46 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.488 179.334 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.2 tp60 -71.95 124.48 24.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.87 0.366 . . . . 0.0 110.352 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 145' ' ' ILE . . . 58.35 20.92 46.44 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.227 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.426 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 8.3 t70 -56.85 178.67 0.05 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.656 0.265 . . . . 0.0 110.809 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 3.2 mt-10 -145.19 135.73 24.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.124 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.597 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 8.1 mt -108.9 124.62 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 121.005 0.431 . . . . 0.0 110.831 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.431 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 4.7 m -104.37 143.19 33.32 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.61 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 27.0 m -140.22 158.37 25.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.446 ' HA2' ' HG3' ' A' ' 83' ' ' ARG . . . 74.29 45.17 25.76 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.312 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.516 ' HA ' HG12 ' A' ' 140' ' ' ILE . 95.3 t -85.41 140.62 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 121.675 0.75 . . . . 0.0 112.379 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 140.29 -38.08 1.63 Allowed Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -178.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.465 HG12 ' N ' ' A' ' 139' ' ' ASP . 1.1 t -126.49 118.68 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -50.36 -24.75 3.21 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 17.0 m -93.18 4.49 53.9 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.465 ' N ' HG12 ' A' ' 136' ' ' VAL . 1.5 m-20 -128.96 26.73 5.49 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.516 HG12 ' HA ' ' A' ' 134' ' ' VAL . 6.3 mt -107.15 138.24 34.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-O 121.464 0.649 . . . . 0.0 111.487 178.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.4 tt -125.47 134.68 51.98 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.207 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.469 ' HB3' HG22 ' A' ' 40' ' ' THR . 42.2 t -113.03 147.53 37.02 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.797 0.808 . . . . 0.0 112.355 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 77.8 mt -136.55 157.27 47.16 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.855 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 26.2 t -120.64 139.14 48.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.824 0.345 . . . . 0.0 110.995 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.433 ' O ' ' HA2' ' A' ' 127' ' ' GLY . 70.0 mt -106.33 120.93 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.16 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.74 109.49 19.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.536 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.2 mt -84.64 132.11 32.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.476 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -78.5 113.39 16.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.815 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -64.57 -30.53 71.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.064 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.82 -46.13 91.73 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.763 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -61.7 -44.16 97.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.095 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -64.19 -37.7 88.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.074 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.98 -40.04 83.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.173 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.0 t -67.95 -44.56 76.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.121 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -69.06 -41.74 77.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.009 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -42.82 93.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.003 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -84.56 -37.04 21.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.951 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.7 p30 44.13 -171.31 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.565 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.55 117.38 21.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.892 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.36 133.63 33.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.154 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -79.45 -42.1 26.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.84 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 -159.45 134.58 8.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.926 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 32.6 mt -100.56 125.99 54.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.142 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.899 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.773 0.32 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -79.03 149.55 73.57 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.999 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.16 161.83 44.53 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.583 2.189 . . . . 0.0 112.276 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -142.42 167.62 21.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.969 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.71 148.93 9.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.075 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . 0.497 ' O ' ' O ' ' B' ' 172' ' ' ILE . 13.4 mt-10 -140.03 45.85 1.87 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.171 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.527 HD11 HG21 ' B' ' 172' ' ' ILE . 10.4 tt 50.27 156.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.035 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 173' ' ' TYR . . . . . 0.471 ' N ' HG12 ' B' ' 172' ' ' ILE . 13.3 m-85 -56.52 -171.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.04 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 32.9 t . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.892 -179.991 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.81 0.338 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.1 t -140.42 -55.33 0.52 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.924 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -72.21 -32.62 66.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.878 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 -65.45 -37.55 87.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.005 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -57.07 -41.22 78.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.639 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.08 -31.78 71.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.5 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.6 mt -70.41 -43.76 77.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.864 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -57.8 -34.04 69.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.02 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -35.54 80.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.005 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -58.11 -47.32 83.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.012 0.434 . . . . 0.0 111.167 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.88 -30.85 71.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.963 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -59.1 -29.61 67.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.889 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.05 120.97 12.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.861 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -102.07 102.03 12.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.937 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.5 mm -81.92 138.36 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-O 121.629 0.728 . . . . 0.0 111.674 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.9 120.52 4.5 Favored Glycine 0 C--N 1.314 -0.659 0 CA-C-N 114.487 -1.233 . . . . 0.0 112.554 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -84.79 -27.82 26.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.831 0.348 . . . . 0.0 110.964 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.403 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER -179.27 37.82 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.664 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.0 mm -75.23 137.13 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 CA-C-N 113.632 -1.622 . . . . 0.0 112.778 -177.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.466 ' CG2' ' HA ' ' A' ' 49' ' ' SER . 3.1 t -91.86 -58.89 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.497 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 4.6 p -147.88 165.41 30.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.444 179.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -133.28 138.31 46.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.854 0.359 . . . . 0.0 111.323 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.8 t -107.23 122.82 61.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.955 0.407 . . . . 0.0 110.916 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 13.2 mt -122.23 121.9 65.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.508 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 42.4 t -79.86 117.02 20.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.684 0.278 . . . . 0.0 110.663 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.08 -23.36 26.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.37 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.453 HG22 ' HB3' ' A' ' 142' ' ' SER . 72.4 p -79.81 -2.33 42.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.838 0.351 . . . . 0.0 111.342 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.3 73.58 0.48 Allowed Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.203 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.4 ' CG ' HD22 ' A' ' 141' ' ' LEU . 1.8 mt-30 -146.79 -39.17 0.21 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.683 0.278 . . . . 0.0 111.181 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.546 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.8 mt -118.9 141.02 29.4 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.783 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.546 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 54.2 Cg_endo -72.28 144.54 41.65 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.157 1.905 . . . . 0.0 112.209 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.9 mt -56.45 144.6 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.66 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.488 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.2 OUTLIER -128.24 161.98 28.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.02 179.338 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -123.31 119.56 30.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.971 0.415 . . . . 0.0 111.465 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.509 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 6.9 mp -92.29 130.41 37.99 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.664 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -142.03 155.37 45.41 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 122.257 1.027 . . . . 0.0 113.524 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.46 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -141.38 141.74 33.77 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 113.387 -1.733 . . . . 0.0 110.712 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.485 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 2.3 m-20 -78.09 129.22 34.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.168 0.509 . . . . 0.0 111.089 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.4 mm -64.36 -41.65 93.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.383 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.3 m -57.29 -41.85 80.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.205 0.526 . . . . 0.0 110.898 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.485 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 11.5 mt-30 -68.44 -37.0 79.83 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.825 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.5 t -66.25 -39.89 85.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.947 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 tp -71.27 -42.02 69.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.319 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.69 -30.84 56.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.333 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -82.36 127.81 33.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.809 0.338 . . . . 0.0 110.871 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -130.49 15.95 5.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.247 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.5 ttt85 -142.15 149.57 39.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.694 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 m 60.04 162.7 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.679 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.7 tp -61.25 141.41 17.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.096 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.99 -69.75 0.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.991 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.438 ' CE ' ' O ' ' A' ' 49' ' ' SER . 4.7 ttpt -152.62 136.88 16.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.131 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 10.8 t -126.48 139.07 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-O 121.31 0.576 . . . . 0.0 112.016 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.509 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 17.7 m-90 -104.36 139.31 39.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.373 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -112.69 132.28 55.27 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 177.531 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.513 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 1.0 OUTLIER -118.67 145.55 45.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.899 0.38 . . . . 0.0 111.665 -178.728 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.643 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.49 -170.14 37.98 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.902 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.419 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 4.5 mtm105 -80.21 1.63 27.57 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -84.81 132.96 44.6 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.624 0.25 . . . . 0.0 111.16 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.408 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 17.0 Cg_exo -66.28 -13.07 38.26 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.661 2.241 . . . . 0.0 111.796 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.62 -43.47 16.95 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-O 121.801 0.81 . . . . 0.0 108.856 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.22 140.4 1.16 Allowed 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 113.887 -1.506 . . . . 0.0 110.633 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.9 m-20 -56.29 -18.96 12.19 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.972 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.488 ' CE1' ' HB2' ' A' ' 46' ' ' ARG . 10.9 t80 -129.62 124.3 33.4 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 120.784 0.326 . . . . 0.0 110.98 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.408 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.1 t-160 -95.56 107.85 20.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.522 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.42 HD11 ' CD2' ' A' ' 76' ' ' TYR . 11.1 mp -82.75 -78.58 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.914 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -173.38 -88.53 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.02 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.0 p30 174.7 49.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.886 0.374 . . . . 0.0 111.117 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.1 mp -78.59 126.79 38.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.865 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.87 -40.65 69.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.909 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.441 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 2.0 mmp_? -62.81 -49.13 76.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.267 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 23.2 mt -72.69 150.44 42.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.223 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.8 p -94.55 167.05 11.73 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.668 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.643 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.5 m-20 -43.73 -53.75 5.62 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.292 0.568 . . . . 0.0 109.744 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.25 83.2 2.02 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 177.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.555 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.7 t60 -58.97 -45.88 89.47 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.221 -0.899 . . . . 0.0 112.634 -176.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.513 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 20.3 p90 -144.5 159.91 41.98 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.972 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.473 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 3.6 tt0 -136.31 140.68 43.53 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.246 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 72.8 mt -115.78 130.19 70.86 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.706 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.428 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.6 OUTLIER -114.96 148.84 38.23 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.115 0.483 . . . . 0.0 111.776 -179.587 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.418 HD21 ' CE2' ' A' ' 151' ' ' PHE . 17.8 tp -125.16 122.79 38.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.308 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -84.42 178.88 51.65 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.672 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -57.57 -60.58 3.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.802 0.334 . . . . 0.0 110.86 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -68.92 175.64 3.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.659 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.99 -169.52 0.25 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.477 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 66.02 136.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.839 0.352 . . . . 0.0 111.137 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.2 mp -106.96 160.26 15.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.879 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.402 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 3.3 mp -121.52 147.1 46.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.224 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 tt -112.84 123.6 50.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.467 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.428 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 49.1 t30 -116.0 115.49 26.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.983 0.42 . . . . 0.0 111.256 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.695 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 14.1 p30 -79.97 134.0 36.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.951 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 10.6 pt -141.61 40.88 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.555 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -100.87 152.32 20.68 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 120.914 0.388 . . . . 0.0 111.254 -179.245 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.5 m -68.94 -32.1 71.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.316 178.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.441 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 27.9 p30 -98.62 -19.72 17.4 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.502 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.92 155.45 9.55 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.314 -0.946 . . . . 0.0 113.731 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.557 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.9 m -117.43 137.95 52.16 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.821 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -115.34 148.41 39.3 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -177.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.18 113.37 18.23 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.238 177.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 48.4 m-20 45.61 42.94 8.79 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.2 -6.27 80.14 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.549 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.55 118.61 37.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 117.018 0.409 . . . . 0.0 110.787 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.821 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 17.7 tptt -73.72 126.97 31.55 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.181 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.7 m -102.56 165.34 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.285 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.42 ' O ' ' HB3' ' A' ' 120' ' ' SER . 2.5 tt0 -69.89 128.86 37.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.423 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.695 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 76.7 tttt -54.1 164.23 0.67 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.3 m-80 33.6 37.0 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.803 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.9 p -111.77 145.11 39.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.005 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -92.41 127.07 37.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.806 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.402 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 57.6 mm-40 -129.31 149.13 51.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.743 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.1 tp -72.86 128.83 36.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.386 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.41 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -59.75 160.92 6.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.649 0.738 . . . . 0.0 112.173 -179.23 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.495 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.99 153.3 42.99 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.636 -1.166 . . . . 0.0 110.034 179.308 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.44 119.2 15.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.882 0.373 . . . . 0.0 110.375 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.52 26.42 56.91 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.036 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.495 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 7.6 t70 -57.24 175.24 0.15 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 120.914 0.388 . . . . 0.0 111.052 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 4.6 mt-10 -145.36 135.63 24.0 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.059 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 3.3 mt -110.07 127.93 66.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.832 0.348 . . . . 0.0 110.497 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.444 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.36 138.89 40.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.851 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.505 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 30.8 m -140.17 158.41 25.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.12 27.65 30.39 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.955 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.428 ' HA ' HG12 ' A' ' 140' ' ' ILE . 72.9 t -72.01 140.44 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-O 121.724 0.773 . . . . 0.0 112.197 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.7 -49.75 0.6 Allowed Glycine 0 N--CA 1.434 -1.452 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.408 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 2.5 t -109.97 125.55 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -50.18 -35.7 27.38 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.2 t -93.57 6.67 47.47 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.413 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . 0.9 OUTLIER -122.3 31.61 6.09 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -178.473 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.444 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 6.4 mt -106.49 138.94 29.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-O 121.399 0.619 . . . . 0.0 110.898 178.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.4 HD22 ' CG ' ' A' ' 42' ' ' GLN . 0.4 OUTLIER -124.51 134.64 52.95 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.557 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.453 ' HB3' HG22 ' A' ' 40' ' ' THR . 39.4 t -111.15 150.16 29.87 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.653 0.74 . . . . 0.0 112.429 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 3.5 mm? -136.35 153.43 51.13 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.503 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 15.4 t -118.16 140.33 41.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.817 0.341 . . . . 0.0 111.067 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 41.6 mt -106.05 120.96 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.032 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.19 111.31 22.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.834 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.2 mp -85.55 129.45 37.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.342 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -81.08 128.64 33.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.01 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -74.06 -29.62 61.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.189 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.3 tttt -59.0 -43.69 91.54 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.851 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.418 ' CE2' HD21 ' A' ' 93' ' ' LEU . 30.1 t80 -63.47 -43.01 98.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.039 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -60.71 -50.1 74.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.214 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -60.28 -36.91 78.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.168 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 10.5 t -65.21 -45.89 82.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.956 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -67.51 -36.0 80.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.821 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -64.88 -33.99 77.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.956 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.82 -36.62 13.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.892 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.4 p30 42.68 87.5 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.481 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 11.0 mmmt -123.83 138.12 54.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.909 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.7 t -77.44 126.98 38.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.057 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -162.31 146.48 12.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.912 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -93.45 149.02 21.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.919 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 19.4 pt -91.82 130.83 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.071 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.902 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.809 0.338 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -113.25 90.49 16.78 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.86 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_exo -51.66 114.88 1.78 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.554 2.169 . . . . 0.0 112.333 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -111.05 134.63 52.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -175.2 177.6 1.86 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.006 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . 0.493 ' O ' ' CG2' ' B' ' 172' ' ' ILE . 29.7 mt-10 -141.33 72.64 1.39 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.902 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.493 ' CG2' ' O ' ' B' ' 171' ' ' GLU . 19.6 tt 50.37 159.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.173 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 173' ' ' TYR . . . . . 0.432 ' N ' HG12 ' B' ' 172' ' ' ILE . 3.5 m-85 -64.97 76.82 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.816 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.866 -179.915 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.836 0.35 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.37 -31.6 29.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.87 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -69.78 -46.91 64.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.91 -37.95 79.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.891 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -63.93 -35.87 82.07 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.36 -41.81 97.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.921 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.478 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 9.4 mm -69.6 -35.07 64.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.151 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -57.19 -36.4 70.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.877 0.37 . . . . 0.0 110.368 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.7 ttpp -67.3 -23.83 65.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.755 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.478 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.7 -47.47 79.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.239 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.0 t -78.43 -44.16 25.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.828 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -99.29 104.44 16.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.19 139.28 48.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.1 102.03 6.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.917 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.424 HG21 ' N ' ' A' ' 29' ' ' GLY . 17.9 mm -84.03 138.22 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-O 121.695 0.759 . . . . 0.0 111.768 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.424 ' N ' HG21 ' A' ' 28' ' ' ILE . . . -169.32 39.25 0.2 Allowed Glycine 0 C--N 1.314 -0.681 0 CA-C-N 114.458 -1.246 . . . . 0.0 112.455 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -76.99 -42.47 38.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.819 0.343 . . . . 0.0 111.0 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.42 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER -170.99 34.77 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.698 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 2.9 mm -77.1 131.55 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-N 113.887 -1.506 . . . . 0.0 112.388 -177.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.482 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.8 t -90.42 -62.0 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 114.623 -1.172 . . . . 0.0 110.442 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.0 p -147.89 142.53 26.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.441 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -113.83 134.1 55.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.976 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.5 t -97.45 122.88 49.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.97 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.5 mt -119.8 110.93 30.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.653 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.47 ' SG ' ' HG ' ' A' ' 143' ' ' LEU . 1.1 m -84.53 111.48 19.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.003 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.2 p -100.27 -9.68 22.12 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.581 HG23 ' CB ' ' A' ' 142' ' ' SER . 10.0 p -88.04 -2.86 58.86 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.183 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.55 90.32 0.45 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.488 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.404 ' HG3' HG13 ' A' ' 43' ' ' ILE . 10.7 pt20 -165.64 -47.28 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.791 0.329 . . . . 0.0 111.435 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.53 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 6.8 mt -130.32 142.4 45.33 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.85 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.53 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 67.4 Cg_endo -76.04 141.33 23.63 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.151 1.901 . . . . 0.0 111.509 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 47.6 mt -50.14 139.65 4.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.116 0.484 . . . . 0.0 112.054 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.86 163.0 31.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.014 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -120.22 119.86 34.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.142 0.496 . . . . 0.0 112.334 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.513 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 4.7 mt -94.04 137.55 33.12 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 178.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.698 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -146.2 158.09 43.86 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -178.272 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.482 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.33 141.89 28.92 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 113.094 -1.866 . . . . 0.0 110.166 178.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.519 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -78.88 142.46 36.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.209 0.528 . . . . 0.0 111.529 -179.171 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 mp -64.1 -43.46 97.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.002 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.7 t -56.55 -38.34 71.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.433 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.519 ' CG ' ' HB2' ' A' ' 51' ' ' ASP . 0.4 OUTLIER -68.43 -36.7 79.44 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.281 179.304 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.6 t -70.44 -41.71 78.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.26 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 68.3 mt -71.06 -28.96 64.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.166 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.36 -45.98 14.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.001 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -62.94 115.97 4.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.035 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.9 ptpt -103.95 -24.67 13.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.857 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.7 mmm180 -55.95 -171.22 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.893 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.8 p -95.64 31.64 2.0 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.988 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.407 ' CD1' ' CG2' ' A' ' 65' ' ' VAL . 10.0 tp -168.69 150.28 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.083 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -138.57 -67.22 0.47 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.861 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.423 ' NZ ' ' HA ' ' A' ' 50' ' ' ALA . 4.5 ttpt -141.03 129.76 22.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.779 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.458 HG11 ' HG2' ' A' ' 90' ' ' GLN . 16.4 t -128.93 139.18 52.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.409 0.623 . . . . 0.0 112.399 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.513 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.3 m-90 -101.27 138.66 38.0 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.846 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.91 126.28 54.99 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 176.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.56 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 0.6 OUTLIER -108.8 145.36 35.33 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.407 -178.225 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.699 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.79 172.61 31.48 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.981 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 1.8 mtm105 -67.13 -4.77 10.99 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.429 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.8 t30 -84.48 135.32 41.17 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.744 0.307 . . . . 0.0 111.175 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.2 Cg_exo -69.63 -6.14 17.83 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.868 2.379 . . . . 0.0 112.058 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.92 -43.59 16.32 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 122.029 0.919 . . . . 0.0 108.846 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.18 138.31 2.25 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.986 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -56.53 -18.36 11.42 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.236 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.56 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 19.7 t80 -129.0 114.36 16.32 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.785 0.326 . . . . 0.0 110.646 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.422 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.7 t-160 -88.26 130.61 35.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.271 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.418 ' CB ' HG12 ' A' ' 43' ' ' ILE . 1.4 pp -133.16 -177.67 4.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.593 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.3 -168.34 0.11 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.266 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -123.92 82.93 2.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.858 0.361 . . . . 0.0 110.734 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.42 ' HB ' ' CD1' ' A' ' 84' ' ' LEU . 3.5 mp -109.64 130.3 62.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.205 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.406 ' CB ' HD12 ' B' ' 170' ' ' LEU . 0.0 OUTLIER -56.8 -31.23 64.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.168 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -60.75 -36.03 77.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.459 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.42 ' CD1' ' HB ' ' A' ' 81' ' ' ILE . 5.5 mp -93.28 152.98 18.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.201 0.524 . . . . 0.0 111.666 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.91 168.88 10.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.703 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.699 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.4 m-20 -44.03 -53.22 6.48 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.336 0.589 . . . . 0.0 109.722 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.45 83.56 2.06 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.523 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 15.9 t60 -60.98 -47.42 86.55 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.685 -176.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.526 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 20.0 p90 -147.17 160.44 42.45 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.254 -0.578 . . . . 0.0 111.612 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.7 tt0 -136.1 141.49 44.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.639 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 63.2 mt -116.9 127.66 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 121.219 -0.193 . . . . 0.0 110.531 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.441 ' HB3' HG13 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -112.33 150.17 31.4 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.158 0.504 . . . . 0.0 112.255 -179.14 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.403 ' CD1' ' CG1' ' A' ' 33' ' ' VAL . 6.9 tt -121.84 122.8 40.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.125 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -172.0 -158.78 16.89 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.561 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 59.44 -177.55 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.822 0.344 . . . . 0.0 110.82 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -74.53 64.43 1.18 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.789 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.82 -173.03 34.59 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.417 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.3 m120 62.14 172.01 0.13 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.866 0.365 . . . . 0.0 110.86 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -130.81 160.22 35.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.122 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.405 ' HB2' ' HG ' ' A' ' 92' ' ' LEU . 9.1 mt -126.04 147.38 49.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.19 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.11 122.17 47.02 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 90' ' ' GLN . 59.2 t30 -112.93 115.37 28.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.614 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.701 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 11.7 p-10 -77.49 143.15 38.7 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.796 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 10.7 pt -151.41 36.79 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -178.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.523 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -99.34 148.43 24.19 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 120.924 0.392 . . . . 0.0 111.604 -179.183 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.6 m -68.7 -31.39 70.44 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 177.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -92.0 -19.82 21.99 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.484 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.488 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 113.29 152.46 11.06 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.293 -0.956 . . . . 0.0 113.937 179.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.503 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 4.9 m -117.35 137.72 52.26 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.813 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -117.56 148.18 42.13 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -178.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.27 113.56 18.42 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.468 177.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 45.31 42.69 7.55 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.25 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 84.99 -4.05 86.13 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.53 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -104.78 118.74 37.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.034 0.445 . . . . 0.0 110.655 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.813 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 6.7 tptt -74.98 117.76 17.19 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.141 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.2 m -96.6 159.77 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.201 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.453 ' O ' ' HB3' ' A' ' 120' ' ' SER . 0.0 OUTLIER -69.81 130.11 41.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.536 179.861 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.701 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 9.2 ptmt -55.13 167.73 0.4 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.08 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.5 m-80 36.93 33.44 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.983 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.453 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 22.8 t -112.44 141.38 46.25 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.849 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -92.08 129.55 38.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.85 0.357 . . . . 0.0 111.092 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.401 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 54.3 mm-40 -129.48 150.4 50.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.689 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.5 tp -72.5 133.3 44.73 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.273 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -63.48 160.85 15.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.81 0.814 . . . . 0.0 112.148 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.426 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -125.63 153.31 43.97 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.07 179.275 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -71.41 115.7 10.89 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.81 28.49 68.39 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.585 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.426 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 24.9 t0 -53.44 173.84 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.945 0.402 . . . . 0.0 111.19 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.412 ' CG ' ' O ' ' A' ' 143' ' ' LEU . 15.1 tt0 -145.15 135.24 23.86 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.898 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.512 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 15.2 mt -115.49 126.58 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.342 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.443 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.37 141.51 36.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.275 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.511 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.2 m -140.06 158.42 26.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.021 0.439 . . . . 0.0 111.996 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.18 30.25 23.13 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.932 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.439 ' HA ' HG12 ' A' ' 140' ' ' ILE . 73.9 t -77.01 140.48 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 CA-C-O 121.647 0.737 . . . . 0.0 112.101 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.17 -39.85 1.22 Allowed Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.465 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 2.8 t -118.01 119.12 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -50.42 -32.1 16.82 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 76.7 p -93.69 6.79 47.15 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.465 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.5 OUTLIER -129.49 34.44 4.35 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -178.463 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.443 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 6.1 mt -107.17 139.32 29.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.766 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.1 mp -124.15 134.78 53.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.879 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.581 ' CB ' HG23 ' A' ' 40' ' ' THR . 0.3 OUTLIER -106.59 135.49 48.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.172 0.51 . . . . 0.0 111.804 -179.327 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.47 ' HG ' ' SG ' ' A' ' 38' ' ' CYS . 5.3 mp -123.69 141.4 52.05 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.4 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 20.8 t -110.9 132.99 57.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.906 0.384 . . . . 0.0 111.196 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.2 mm -106.3 121.64 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.935 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.21 138.58 44.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.662 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.2 mp -106.63 133.03 52.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.386 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -83.91 122.74 29.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.89 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -73.74 -27.46 61.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.978 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.05 -42.54 80.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.006 0.432 . . . . 0.0 110.455 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -58.95 -43.64 91.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.814 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -36.3 82.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.892 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -61.62 -47.1 86.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.043 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 7.6 t -68.01 -41.53 82.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.97 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.15 -35.93 82.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.99 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -43.62 98.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.8 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.411 ' O ' ' N ' ' A' ' 159' ' ' LYS . 2.8 mm100 -84.71 -30.97 24.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.864 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.35 -90.68 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.595 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 157' ' ' GLN . 3.2 ttpp -83.34 129.33 34.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.86 0.362 . . . . 0.0 110.936 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.4 t -95.54 131.68 41.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.145 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -98.8 142.97 29.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.827 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.78 -32.49 25.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.003 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 32.7 mt -92.82 117.42 36.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.135 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 9.6 mtm-85 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.888 179.932 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.8 0.333 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -126.96 98.77 29.97 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.993 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.64 -173.95 0.64 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.46 2.107 . . . . 0.0 112.283 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -168.71 155.87 7.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.848 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 169' ' ' TPO . . . . . 0.4 ' C ' ' CD1' ' B' ' 170' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . 0.406 HD12 ' CB ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -161.3 179.53 8.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.003 0.43 . . . . 0.0 111.231 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . 0.509 ' O ' ' CG2' ' B' ' 172' ' ' ILE . 2.0 mt-10 -141.43 69.39 1.33 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.475 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.509 ' CG2' ' O ' ' B' ' 171' ' ' GLU . 13.9 tt 50.64 156.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.005 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 173' ' ' TYR . . . . . 0.447 ' N ' HG12 ' B' ' 172' ' ' ILE . 2.2 p90 -100.02 56.0 0.94 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.893 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.852 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.847 0.356 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -162.73 -45.76 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.973 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -67.1 -39.82 86.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.4 ttm180 -59.97 -42.42 94.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.863 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -58.36 -38.69 77.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.798 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.0 mp -60.1 -31.76 70.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.746 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.413 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.2 mt -71.98 -35.59 54.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.788 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.55 -41.81 81.73 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.952 0.406 . . . . 0.0 110.371 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.11 -23.79 65.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.689 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.413 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.49 -47.35 79.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.246 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.4 m -64.09 -39.9 95.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.799 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 63.41 -80.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.973 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -70.49 159.01 35.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.891 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -64.83 142.1 58.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.813 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.4 mm -81.78 138.31 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 CA-C-O 121.673 0.749 . . . . 0.0 111.639 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -145.81 80.47 0.22 Allowed Glycine 0 C--N 1.314 -0.647 0 CA-C-N 114.457 -1.247 . . . . 0.0 112.542 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.42 -36.85 79.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.759 0.314 . . . . 0.0 110.85 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 177.01 39.66 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.656 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.6 mm -75.74 135.43 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-N 113.529 -1.669 . . . . 0.0 112.574 -177.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.488 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.7 t -92.83 -61.43 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.845 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.7 p -138.58 158.3 44.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.029 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.43 119.11 26.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.829 0.347 . . . . 0.0 111.392 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.2 t -89.18 122.67 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.912 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.9 mt -131.74 117.47 34.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.488 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 6.4 t -83.8 116.11 22.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.771 0.32 . . . . 0.0 110.149 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.3 t -92.49 -24.71 18.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.974 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.554 ' CG2' ' HB2' ' A' ' 142' ' ' SER . 49.4 p -79.78 -2.86 45.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.876 0.37 . . . . 0.0 111.484 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.15 76.58 0.6 Allowed Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 121.098 -0.572 . . . . 0.0 113.284 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -143.45 -40.41 0.3 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.815 0.34 . . . . 0.0 110.94 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.577 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 16.9 mt -132.48 143.24 47.96 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.212 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.577 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 51.5 Cg_endo -71.05 146.12 51.44 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.298 1.999 . . . . 0.0 111.967 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.4 mt -51.74 152.77 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.087 0.47 . . . . 0.0 111.998 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -147.2 164.21 33.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.041 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.53 120.01 27.31 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.531 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 7.7 mp -92.7 127.31 38.15 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.656 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -137.95 157.06 47.17 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -179.111 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.488 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -141.84 142.16 33.14 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 113.608 -1.633 . . . . 0.0 110.899 179.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.425 ' CB ' ' HG2' ' A' ' 54' ' ' GLN . 0.9 OUTLIER -74.93 136.73 41.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.054 0.454 . . . . 0.0 111.117 -179.713 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.4 mm -64.21 -43.25 97.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.955 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.5 p -56.82 -37.9 71.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.168 0.508 . . . . 0.0 110.508 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.425 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 43.8 mm-40 -68.59 -36.8 79.19 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.352 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.74 -40.7 84.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.054 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.1 mt -70.98 -37.99 72.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.024 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -73.39 -38.6 65.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.877 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -69.16 106.58 2.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.951 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.69 30.51 4.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.831 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.67 -166.82 1.11 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.785 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 m -97.89 33.23 2.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.754 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.4 ' CD1' ' HB2' ' A' ' 92' ' ' LEU . 7.7 tp -173.78 151.69 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.025 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -135.54 -58.74 0.78 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.976 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.41 ' CE ' ' O ' ' A' ' 49' ' ' SER . 6.4 ttpt -145.53 131.0 18.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.981 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 3.5 t -124.31 138.83 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 121.259 0.552 . . . . 0.0 112.192 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.565 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 17.3 m-90 -102.25 139.54 37.73 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.241 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.519 ' HA ' ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.45 126.97 55.92 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.612 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.618 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 1.1 m-85 -108.55 145.48 34.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.318 -178.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.683 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.97 178.43 37.52 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.26 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.405 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 11.8 mtp180 -70.49 -4.85 24.83 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.434 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.0 OUTLIER -84.55 134.06 43.15 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.711 0.291 . . . . 0.0 111.27 -179.329 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.0 Cg_exo -69.49 -6.52 18.65 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.727 2.284 . . . . 0.0 111.719 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.85 -43.79 16.21 Favored 'General case' 0 CA--C 1.497 -1.077 0 CA-C-O 121.993 0.902 . . . . 0.0 108.706 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -41.95 138.38 1.55 Allowed 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 113.698 -1.592 . . . . 0.0 110.445 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.49 -18.87 12.86 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.097 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.618 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 58.9 t80 -129.5 125.62 36.77 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 120.73 0.3 . . . . 0.0 110.667 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -98.55 131.83 44.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.907 0.384 . . . . 0.0 110.925 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -131.18 179.9 5.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.729 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.77 177.58 4.97 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.258 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -97.42 70.73 2.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.954 0.407 . . . . 0.0 110.84 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.405 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 40.0 mt -94.24 116.22 34.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.042 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.424 ' HB3' ' CD1' ' B' ' 170' ' ' LEU . 0.1 OUTLIER -54.8 -34.38 62.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.313 -179.806 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.468 ' HG3' ' HB3' ' A' ' 139' ' ' ASP . 1.5 mmt180 -60.84 -25.39 66.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.989 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.434 ' HA ' ' HD1' ' A' ' 88' ' ' HIS . 28.2 mt -96.03 149.92 21.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.302 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 57.9 p -93.6 169.69 10.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.604 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.683 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -43.21 -53.62 4.99 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.449 0.642 . . . . 0.0 109.912 179.251 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.405 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 6.4 ptmt -121.3 84.08 2.18 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 177.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.53 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 15.4 t60 -60.81 -47.26 87.15 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.978 -176.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.552 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 12.8 p90 -147.43 162.12 39.67 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 119.872 -0.731 . . . . 0.0 112.065 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.557 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 3.4 tt0 -135.67 146.26 47.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.532 -178.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.525 ' CD1' ' CE1' ' A' ' 68' ' ' PHE . 4.3 mp -124.03 132.08 71.92 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.337 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.452 178.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.52 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.2 OUTLIER -120.66 148.57 43.75 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.262 0.553 . . . . 0.0 112.214 -179.145 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.5 tp -125.42 122.87 37.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.822 178.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.56 -42.1 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.747 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -51.62 170.6 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.738 0.304 . . . . 0.0 111.137 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -79.82 72.89 6.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.98 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 103.62 -32.71 7.26 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.651 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -77.36 156.92 30.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.818 0.342 . . . . 0.0 110.863 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.8 160.09 19.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.955 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.4 mp -129.14 136.61 50.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.661 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.96 120.23 40.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.338 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.52 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 60.9 t30 -112.12 119.1 37.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.879 0.371 . . . . 0.0 111.806 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.69 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 13.8 p30 -79.99 139.36 37.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.668 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.439 HG12 ' HA ' ' A' ' 89' ' ' PHE . 17.3 pt -146.48 36.16 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -178.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.542 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -97.68 150.72 20.87 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-O 121.014 0.435 . . . . 0.0 112.14 -178.936 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.6 m -68.67 -31.61 70.85 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.683 177.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -96.13 -19.82 19.09 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -178.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.542 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.14 155.25 10.5 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.998 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.521 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.1 m -117.37 137.84 52.19 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.794 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -116.12 148.37 40.36 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 -177.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.1 113.6 18.58 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.487 177.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 44.85 42.95 6.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.399 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.62 -12.2 64.0 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.585 178.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -104.64 118.57 36.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.08 0.44 . . . . 0.0 110.627 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.794 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -71.91 125.41 27.12 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.37 -179.718 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.7 m -94.7 165.46 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.852 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.44 ' O ' ' HB2' ' A' ' 120' ' ' SER . 8.5 tp10 -69.88 126.33 29.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.586 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.69 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 64.8 tttt -53.41 161.55 0.95 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.887 0.375 . . . . 0.0 110.386 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.46 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.2 p30 36.25 33.8 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.239 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.43 145.08 40.8 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.034 179.296 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -91.62 127.63 37.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.688 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -129.21 147.13 51.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.941 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.9 tt -72.88 111.94 8.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.018 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.41 167.8 0.64 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.654 0.74 . . . . 0.0 112.0 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.404 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -125.18 153.36 43.19 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.489 179.609 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.74 116.56 12.25 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.17 24.47 73.36 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.923 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.404 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 14.8 t70 -60.09 179.74 0.13 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 120.799 0.333 . . . . 0.0 110.837 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.441 ' HG2' ' HA ' ' A' ' 144' ' ' VAL . 0.0 OUTLIER -145.05 135.38 24.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.254 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 8.5 mt -116.82 127.72 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.098 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.449 ' HB ' ' HB2' ' A' ' 110' ' ' TRP . 3.0 m -104.43 140.1 38.41 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.485 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.6 m -140.16 158.35 25.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.139 0.495 . . . . 0.0 112.198 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.23 28.69 29.91 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.649 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.439 ' HA ' HG12 ' A' ' 140' ' ' ILE . 68.8 t -74.52 140.55 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-O 121.64 0.733 . . . . 0.0 112.186 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.78 -43.5 0.83 Allowed Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -178.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.421 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 1.9 t -111.97 128.9 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -50.58 -43.43 56.54 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.7 p -93.56 6.74 47.23 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -178.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.468 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . 5.7 m-20 -119.61 34.42 5.22 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -178.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.448 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 6.2 mt -107.29 139.79 27.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.822 178.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.405 ' CD2' ' HG ' ' A' ' 143' ' ' LEU . 8.6 tt -120.97 134.69 55.3 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.949 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.554 ' HB2' ' CG2' ' A' ' 40' ' ' THR . 1.0 OUTLIER -109.99 139.48 45.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.058 0.456 . . . . 0.0 111.904 -179.375 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 40.7 mt -131.7 143.6 50.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.917 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.441 ' HA ' ' HG2' ' A' ' 129' ' ' GLU . 22.3 t -114.25 131.77 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 120.704 0.288 . . . . 0.0 111.132 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.5 mm -106.21 130.92 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-O 120.864 0.364 . . . . 0.0 110.755 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.75 112.01 21.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.954 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 7.0 mt -84.86 129.57 37.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.292 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -75.95 126.68 31.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.972 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -73.92 -35.95 64.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.97 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.1 -45.08 91.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.616 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.45 ' CE2' ' CD1' ' A' ' 155' ' ' LEU . 37.4 t80 -58.15 -44.12 87.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.881 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 45.7 mttt -59.67 -40.88 89.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.998 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -59.1 -40.32 84.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.006 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 10.5 t -65.4 -45.96 81.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.017 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.45 ' CD1' ' CE2' ' A' ' 151' ' ' PHE . 0.1 OUTLIER -69.28 -44.57 71.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.933 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.89 -35.41 70.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.983 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -90.84 -34.23 15.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.893 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.6 p30 42.26 32.27 0.31 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.503 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 19.7 mtmt -124.97 142.79 51.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.891 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 5.7 m -98.48 125.11 51.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.077 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.26 80.93 2.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.843 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -121.76 31.42 6.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.928 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 14.1 pt -104.91 121.58 57.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.167 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.897 179.975 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 1.5 t30 . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.788 0.328 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -92.78 156.2 41.05 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.18 107.52 1.37 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.571 2.181 . . . . 0.0 112.228 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -110.7 162.34 14.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.989 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . 0.424 ' CD1' ' HB3' ' A' ' 82' ' ' SER . 1.3 tt -75.9 150.81 37.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.229 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -147.0 131.84 18.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.465 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.415 ' CD1' HG23 ' A' ' 136' ' ' VAL . 3.0 tp -51.28 139.42 6.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.079 0.466 . . . . 0.0 111.55 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 173' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -71.78 139.48 49.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.667 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.34 -0.838 . . . . 0.0 110.878 -179.956 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.876 0.37 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.64 -68.56 0.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.838 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -71.53 -30.61 66.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -36.78 77.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -60.54 -42.41 96.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 tp -59.85 -42.78 94.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.888 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.497 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.3 mm -71.23 -35.12 56.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.16 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -57.14 -35.98 70.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.915 0.388 . . . . 0.0 110.409 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -67.24 -23.92 65.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.787 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.497 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.67 -47.54 79.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.148 -179.814 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.23 -43.04 71.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.895 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -131.62 134.02 45.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.916 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.23 130.2 40.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.914 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -77.28 137.93 39.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.923 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.3 mm -81.98 138.35 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-O 121.685 0.755 . . . . 0.0 111.704 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.65 47.48 76.57 Favored Glycine 0 C--N 1.314 -0.684 0 CA-C-N 114.546 -1.206 . . . . 0.0 112.33 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.78 -40.19 96.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.754 0.311 . . . . 0.0 111.052 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.406 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.1 t-20 175.05 39.86 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.672 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.2 mm -72.81 134.95 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 CA-C-N 113.621 -1.627 . . . . 0.0 112.407 -177.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.499 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.2 t -92.56 -60.55 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.099 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 21.8 p -142.97 164.66 29.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.381 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.6 138.22 51.14 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.849 0.357 . . . . 0.0 111.326 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.43 HG22 ' CE1' ' A' ' 76' ' ' TYR . 3.2 m -107.45 122.64 61.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.841 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.4 mt -126.66 119.53 53.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.478 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 23.1 t -79.78 111.38 16.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.808 0.337 . . . . 0.0 110.467 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.15 -23.73 35.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.825 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.498 HG22 ' HB3' ' A' ' 142' ' ' SER . 74.5 p -79.91 -2.25 42.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.788 0.327 . . . . 0.0 111.48 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.8 75.77 0.36 Allowed Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.821 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -146.6 -40.95 0.2 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.878 0.37 . . . . 0.0 111.053 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.547 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.7 mt -123.28 141.54 36.31 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.053 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.547 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.4 Cg_endo -72.63 146.01 42.82 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.33 2.02 . . . . 0.0 112.239 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.8 mt -55.51 148.98 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.677 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.43 164.15 28.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.152 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.33 119.74 31.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.993 0.425 . . . . 0.0 111.982 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.487 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 7.7 mp -95.81 125.48 40.41 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.672 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -135.51 157.39 47.0 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -178.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.499 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -148.82 148.91 30.47 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.638 -1.619 . . . . 0.0 110.81 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.424 ' CB ' ' HG2' ' A' ' 54' ' ' GLN . 0.7 OUTLIER -74.98 134.88 41.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.062 0.458 . . . . 0.0 111.185 -179.827 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 79.2 mt -64.31 -43.87 97.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.696 -0.683 . . . . 0.0 112.061 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.86 -38.56 72.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.346 0.593 . . . . 0.0 110.678 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.424 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 4.0 mm-40 -68.5 -36.92 79.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.607 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.8 t -72.36 -43.54 64.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.127 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.7 tp -70.94 -32.18 69.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.998 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.15 -42.7 36.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.965 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -82.9 120.69 26.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.972 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.22 30.38 1.78 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.908 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -119.07 -51.04 2.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.865 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.94 -168.87 2.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.915 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.3 mm -66.3 158.51 5.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.032 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -126.07 -41.05 1.96 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.296 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.408 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.7 ttpt -142.9 123.87 14.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.974 0.416 . . . . 0.0 111.962 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.403 HG13 ' HB3' ' A' ' 92' ' ' LEU . 13.0 t -129.99 139.43 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.218 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.608 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 17.8 m-90 -100.92 139.63 36.35 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.983 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.519 HG21 ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -109.58 133.04 53.57 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 177.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.531 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 1.1 m-85 -120.19 145.52 46.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.055 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.56 -172.38 36.16 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.874 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.435 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 9.5 mtp-105 -80.31 3.7 20.16 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.447 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 5.1 t-20 -84.88 133.46 43.41 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 120.659 0.266 . . . . 0.0 110.988 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 13.2 Cg_exo -68.28 -10.28 28.47 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.646 2.231 . . . . 0.0 111.88 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.29 -43.44 16.02 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-O 122.001 0.905 . . . . 0.0 108.952 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.19 136.41 2.24 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 113.658 -1.61 . . . . 0.0 111.278 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -56.71 -18.38 12.22 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.153 179.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.531 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 66.7 t80 -129.32 112.1 13.52 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-O 120.812 0.339 . . . . 0.0 111.071 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -94.99 114.39 26.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.835 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.412 HD21 ' CA ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -97.2 -80.25 0.44 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.988 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.95 -131.17 1.19 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.576 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -141.6 60.77 1.48 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.887 0.375 . . . . 0.0 110.821 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.435 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 3.9 mp -88.61 120.21 37.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.012 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 m -54.77 -42.94 72.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.878 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.466 ' HD3' ' HB3' ' A' ' 139' ' ' ASP . 0.7 OUTLIER -60.88 -18.68 57.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.113 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.7 mt -107.0 152.17 24.34 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.661 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 95.3 p -96.83 163.98 12.75 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.768 0.318 . . . . 0.0 111.709 -179.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.625 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.6 m-20 -41.27 -52.48 3.41 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.532 0.682 . . . . 0.0 109.845 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.418 ' O ' HG13 ' A' ' 104' ' ' ILE . 5.2 mttt -120.57 84.75 2.27 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 177.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.553 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.5 t60 -64.12 -45.76 87.13 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.023 -0.989 . . . . 0.0 113.252 -176.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.403 ' O ' ' N ' ' A' ' 68' ' ' PHE . 37.2 p90 -151.93 162.23 41.39 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.887 -0.725 . . . . 0.0 112.414 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.519 ' HG2' HG21 ' A' ' 67' ' ' THR . 11.0 mt-30 -135.55 154.3 51.42 Favored 'General case' 0 CA--C 1.522 -0.1 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.743 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.48 HG21 HD13 ' A' ' 91' ' ' ILE . 25.7 mt -119.91 132.19 70.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 177.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.432 ' HG ' ' CB ' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -118.71 140.18 50.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.111 0.481 . . . . 0.0 112.254 -178.547 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.408 ' CD1' ' CG1' ' A' ' 33' ' ' VAL . 11.0 tp -125.36 128.83 48.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.088 178.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 160.88 -138.49 5.51 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.595 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 64.51 -78.88 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.751 0.31 . . . . 0.0 110.793 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -130.15 -42.07 1.24 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.995 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 167.27 -28.94 0.17 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.512 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -60.46 -174.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.842 0.353 . . . . 0.0 110.859 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -113.17 145.89 40.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.848 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.432 ' CB ' ' HG ' ' A' ' 92' ' ' LEU . 6.5 mt -133.08 140.95 47.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.096 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.6 126.05 54.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.473 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -114.07 115.51 27.67 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.491 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.679 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 9.5 p30 -79.21 143.24 35.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.942 178.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.465 HG12 ' HG3' ' A' ' 90' ' ' GLN . 9.7 pt -150.02 35.27 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -178.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.559 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -95.78 150.97 19.81 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 121.118 0.485 . . . . 0.0 112.09 -178.78 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.9 m -68.72 -31.39 70.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.791 177.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -97.76 -19.72 18.02 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.559 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 118.14 155.88 10.13 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.334 -0.936 . . . . 0.0 114.062 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 11.5 m -117.26 137.83 52.13 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.815 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -116.24 148.29 40.61 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.761 1.022 . . . . 0.0 113.761 -178.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.2 113.52 18.41 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.612 -1.177 . . . . 0.0 108.444 177.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 43.62 43.72 4.89 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.375 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.32 -12.3 65.15 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.382 178.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 9.4 mp0 -103.74 118.59 37.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.053 0.454 . . . . 0.0 110.601 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.815 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.0 tptt -73.16 124.7 26.11 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.215 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.0 m -94.92 162.37 2.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.154 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 120' ' ' SER . 4.3 pm0 -69.94 126.37 29.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.47 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.679 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 18.6 tttm -51.42 160.52 0.57 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.015 0.435 . . . . 0.0 111.046 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.8 p30 34.96 33.67 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.432 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.55 145.14 40.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.164 179.262 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -87.42 127.51 35.22 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.048 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.405 ' N ' HD23 ' A' ' 100' ' ' LEU . 34.6 mm-40 -129.35 146.3 51.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.743 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.4 tp -72.9 112.43 8.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.173 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.2 mt -59.97 167.32 2.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.676 0.75 . . . . 0.0 111.886 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.408 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.0 OUTLIER -125.36 153.42 43.39 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.319 179.425 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.41 120.92 17.68 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.58 19.2 66.72 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.055 -178.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.408 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 14.3 t70 -58.06 177.44 0.12 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 120.794 0.33 . . . . 0.0 110.791 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 10.7 mt-10 -145.11 135.54 24.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.247 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 6.0 mt -114.0 128.47 70.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.075 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.457 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.7 m -103.89 140.11 38.14 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.523 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 31.0 m -140.18 158.32 25.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.135 0.493 . . . . 0.0 112.279 -178.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.75 27.61 28.8 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.01 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.438 ' HB ' ' CZ3' ' A' ' 110' ' ' TRP . 77.3 t -73.4 140.46 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-O 121.616 0.722 . . . . 0.0 112.063 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.43 -40.33 0.99 Allowed Glycine 0 N--CA 1.434 -1.455 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.485 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 2.1 t -117.38 126.82 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -50.47 -40.1 49.96 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.2 m -93.44 6.66 47.41 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -178.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.485 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.7 OUTLIER -120.17 33.34 5.64 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -178.444 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.457 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.6 mt -107.09 138.83 31.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.384 0.611 . . . . 0.0 110.824 178.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.46 134.64 52.99 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.533 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.498 ' HB3' HG22 ' A' ' 40' ' ' THR . 42.2 t -110.29 150.44 28.73 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.615 0.721 . . . . 0.0 112.422 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 3.0 mm? -135.84 148.5 48.69 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.319 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 20.1 t -114.2 134.86 55.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.892 0.377 . . . . 0.0 111.281 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.3 mm -106.37 122.89 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.624 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.06 114.33 26.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.894 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 7.9 mm -84.95 129.35 37.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.06 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -75.88 107.92 8.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.845 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.3 -31.86 69.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.87 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -45.52 91.66 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.592 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -58.73 -44.22 90.4 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.88 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -65.17 -39.63 93.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.995 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -59.05 -46.39 88.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.971 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.1 t -65.97 -44.07 86.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.948 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.47 -36.0 82.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.13 -45.72 93.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.969 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -82.1 -36.52 27.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.887 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.3 p30 42.43 76.36 0.08 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.476 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.2 ttmm -69.96 122.94 20.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.875 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 30.5 m -88.57 136.46 23.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.119 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -68.7 -74.18 0.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.856 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.7 mtm180 -149.94 -48.13 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.862 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.3 mt -100.76 136.69 31.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.111 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 8.4 ptt85 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.977 -179.959 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.905 0.383 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -97.08 100.67 7.99 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.803 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.1 176.29 4.76 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.329 2.019 . . . . 0.0 112.303 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.09 65.43 0.37 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.022 0.439 . . . . 0.0 110.843 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . 0.415 ' CD2' ' HA ' ' A' ' 83' ' ' ARG . 0.6 OUTLIER -90.12 148.41 23.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.002 -179.756 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . 0.506 ' O ' ' O ' ' B' ' 172' ' ' ILE . 3.4 mt-10 -143.84 49.72 1.37 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.876 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.506 ' O ' ' O ' ' B' ' 171' ' ' GLU . 9.5 tt 50.72 152.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.206 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 173' ' ' TYR . . . . . 0.437 ' N ' HG12 ' B' ' 172' ' ' ILE . 3.0 p90 -86.21 -178.28 6.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.76 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 10.7 t . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.264 -0.875 . . . . 0.0 110.918 179.98 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.824 0.345 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -108.38 -64.32 1.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.837 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -68.81 -40.44 79.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.883 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -37.04 86.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.816 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -57.95 -39.85 79.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.784 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.7 -31.98 73.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.679 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.41 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.4 mt -73.23 -35.41 46.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.826 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.48 -43.11 83.83 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.968 0.413 . . . . 0.0 110.385 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.02 -23.81 65.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.607 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.41 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.74 -47.51 79.87 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.25 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 m -76.7 -47.09 23.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.913 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -105.51 51.75 0.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.673 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.62 121.18 22.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.004 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -64.96 101.96 0.56 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.319 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.6 mm -81.92 138.15 19.99 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.461 0 CA-C-O 121.794 0.807 . . . . 0.0 111.855 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.419 ' HA2' ' CG1' ' A' ' 32' ' ' ILE . . . 62.76 109.94 0.01 OUTLIER Glycine 0 C--N 1.314 -0.676 0 CA-C-N 114.305 -1.316 . . . . 0.0 112.712 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -86.85 -29.28 22.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.739 0.304 . . . . 0.0 110.94 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.411 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER -177.41 36.86 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.72 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.5 mm -75.77 135.65 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 CA-C-N 113.754 -1.566 . . . . 0.0 112.639 -177.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.485 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.0 t -90.81 -60.24 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.953 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.0 p -148.19 150.12 33.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.137 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.98 138.14 50.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.889 0.376 . . . . 0.0 111.622 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.9 p -104.64 122.75 58.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.642 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.3 mt -127.73 125.56 65.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.706 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.5 t -89.75 104.64 17.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.195 179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.9 p -81.55 -22.56 37.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.962 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.575 ' CG2' ' HB2' ' A' ' 142' ' ' SER . 67.8 p -79.81 -2.64 44.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.809 0.337 . . . . 0.0 111.496 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.29 74.93 0.48 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.833 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -146.26 -36.19 0.26 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.808 0.337 . . . . 0.0 111.13 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.568 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 15.8 mt -131.72 141.9 43.29 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.947 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.568 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 48.7 Cg_endo -71.01 146.0 51.35 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.19 1.927 . . . . 0.0 112.357 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.4 mt -61.35 148.61 9.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.769 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.94 164.3 30.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.162 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -120.98 119.86 33.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.1 0.476 . . . . 0.0 111.847 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.537 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 10.4 mt -96.05 136.09 36.97 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.72 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -146.97 158.7 44.0 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 -178.669 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.485 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -139.79 141.81 36.73 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 113.542 -1.663 . . . . 0.0 110.559 178.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.518 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 0.4 OUTLIER -79.31 141.1 37.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.222 0.534 . . . . 0.0 111.281 -179.526 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 64.5 mt -65.11 -45.35 94.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.254 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.3 p -60.13 -43.05 95.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.869 -178.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.518 ' HG3' ' O ' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -68.77 -36.87 78.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.924 0.392 . . . . 0.0 110.515 179.747 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.5 t -71.05 -37.99 69.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.917 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.4 tp -70.13 -30.79 68.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.923 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.4 mttt -80.49 -47.06 14.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.941 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.95 116.94 5.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.904 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.88 29.86 3.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.769 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.71 -55.15 3.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.9 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.7 t -177.94 -39.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.954 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.43 ' CD1' ' HB2' ' A' ' 92' ' ' LEU . 8.8 tp -129.17 153.37 38.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.232 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.404 ' N ' HG13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -111.09 -67.69 0.98 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.855 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.413 ' CE ' ' O ' ' A' ' 49' ' ' SER . 4.0 ttpt -141.15 138.19 33.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.985 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.497 HG11 ' HG2' ' A' ' 90' ' ' GLN . 14.2 t -132.16 139.4 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 121.255 0.55 . . . . 0.0 112.374 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.537 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.6 m-90 -104.58 139.51 39.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.943 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.563 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -114.57 125.82 54.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.123 0.487 . . . . 0.0 110.078 177.694 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.533 ' CD2' ' CD2' ' A' ' 76' ' ' TYR . 2.2 m-85 -109.73 145.48 36.53 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.061 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 157.73 -172.1 34.94 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.41 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.496 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 9.3 mtp-105 -76.92 2.45 14.69 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.417 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 0.2 OUTLIER -84.54 130.93 51.57 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.517 0.199 . . . . 0.0 110.976 -179.628 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 18.9 Cg_exo -65.54 -13.99 42.6 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.387 2.058 . . . . 0.0 111.501 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.02 -42.37 17.58 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-O 121.849 0.833 . . . . 0.0 108.839 178.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -42.05 138.32 1.62 Allowed 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.8 179.685 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.9 OUTLIER -56.33 -18.6 11.3 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.164 179.1 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.533 ' CD2' ' CD2' ' A' ' 68' ' ' PHE . 13.2 t80 -129.28 119.46 24.0 Favored 'General case' 0 CA--C 1.527 0.09 0 CA-C-O 120.758 0.313 . . . . 0.0 111.196 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -99.98 117.68 34.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.677 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.4 mt -88.85 -69.09 0.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.017 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 171.92 -85.67 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.519 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -174.46 49.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.901 0.382 . . . . 0.0 111.084 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.496 ' N ' ' HD2' ' A' ' 70' ' ' ARG . 30.1 mm -79.99 123.86 37.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.198 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.4 ' HB2' ' CD1' ' B' ' 170' ' ' LEU . 90.2 p -54.72 -41.16 69.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.254 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.471 ' HA ' ' CD2' ' B' ' 170' ' ' LEU . 8.5 tpt85 -63.71 -49.16 74.19 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.7 mt -73.88 148.26 42.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.06 0.457 . . . . 0.0 111.856 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.7 p -95.11 165.27 12.5 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.855 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.571 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.0 m-20 -41.5 -53.16 3.51 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.434 0.635 . . . . 0.0 110.21 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.446 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 8.5 ptpp? -123.8 81.96 1.97 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 177.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.554 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.9 t60 -59.73 -46.69 88.36 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.981 -1.009 . . . . 0.0 112.988 -176.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.514 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 23.6 p90 -147.65 160.55 42.55 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.116 -0.634 . . . . 0.0 111.621 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.497 ' HG2' HG11 ' A' ' 65' ' ' VAL . 5.4 tt0 -135.94 139.75 43.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.555 -178.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.454 ' O ' ' CG1' ' A' ' 65' ' ' VAL . 17.5 mt -112.37 131.51 63.65 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.233 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.673 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.43 ' HB2' ' CD1' ' A' ' 62' ' ' ILE . 1.8 pt? -118.93 146.83 44.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.044 0.45 . . . . 0.0 111.605 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 14.3 tp -125.11 122.9 38.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.396 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -167.28 -156.46 9.86 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.628 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 60.14 -169.85 0.15 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.793 0.33 . . . . 0.0 110.869 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -82.09 59.66 4.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.824 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 101.13 -168.3 19.99 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.43 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 30.3 m120 60.92 178.57 0.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.868 0.366 . . . . 0.0 110.985 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.44 160.1 36.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.713 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.401 ' HB3' ' CD2' ' A' ' 92' ' ' LEU . 1.2 mp -127.33 144.58 51.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.327 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.77 124.72 53.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.283 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.419 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 53.7 t30 -118.19 115.53 24.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.978 0.418 . . . . 0.0 111.45 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.682 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 8.8 p30 -79.07 142.44 36.48 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.095 178.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.446 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 16.7 pt -151.09 37.59 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.554 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -95.18 155.38 16.76 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 121.0 0.429 . . . . 0.0 111.55 -179.304 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 82.8 m -68.82 -34.37 75.39 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.331 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 19.9 p30 -98.65 -19.87 17.29 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.51 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 122.6 156.67 9.7 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.279 -0.963 . . . . 0.0 113.749 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.531 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.4 m -117.35 137.9 52.14 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.827 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -116.26 148.34 40.59 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -178.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.15 113.39 18.27 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.284 177.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 44.41 42.92 5.8 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.385 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.27 -7.97 78.64 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.841 -0.695 . . . . 0.0 113.484 178.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.19 118.67 37.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.035 0.445 . . . . 0.0 110.688 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.827 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 9.6 tptp -74.16 118.28 16.93 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.236 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.4 m -90.73 164.23 2.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.14 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 120' ' ' SER . 33.8 tt0 -69.83 127.71 33.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.436 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.682 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 25.3 tttt -53.58 160.92 1.15 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.975 0.417 . . . . 0.0 110.599 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.5 p30 34.18 35.32 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.351 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.24 145.06 40.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.222 179.435 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -83.73 128.75 34.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.748 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -129.31 145.76 51.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.594 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -72.99 118.09 15.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.254 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 65.0 tp -56.41 157.25 5.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.359 0.6 . . . . 0.0 111.549 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.449 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.8 OUTLIER -124.53 153.14 42.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.592 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.6 tp60 -71.71 124.32 24.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.015 0.436 . . . . 0.0 110.61 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.37 20.65 45.43 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.344 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.449 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 9.8 t70 -58.71 173.22 0.43 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.942 0.401 . . . . 0.0 110.835 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 18.8 tt0 -145.17 135.6 24.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.106 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.5 mt -108.8 128.64 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.313 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.451 ' O ' ' HB2' ' A' ' 110' ' ' TRP . 4.1 m -103.75 136.64 43.06 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.528 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 29.8 m -138.08 158.38 32.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.183 0.516 . . . . 0.0 112.381 -178.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.453 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 82.96 38.62 11.13 Favored Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.954 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.417 ' HA ' HG12 ' A' ' 140' ' ' ILE . 56.5 t -79.84 140.47 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-O 121.676 0.75 . . . . 0.0 112.203 -179.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.48 -46.16 0.64 Allowed Glycine 0 N--CA 1.435 -1.371 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.661 ' CG2' HD11 ' B' ' 172' ' ' ILE . 0.9 OUTLIER -127.19 125.49 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 CA-C-N 114.259 -0.97 . . . . 0.0 108.827 177.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.92 -24.79 2.72 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -177.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.0 t -93.05 -0.36 57.13 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.421 ' N ' HG11 ' A' ' 136' ' ' VAL . 79.1 m-20 -120.05 25.61 9.8 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -178.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.424 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 4.4 mt -106.88 138.72 31.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-O 121.405 0.621 . . . . 0.0 111.559 178.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.6 tt -124.5 134.49 53.0 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.392 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.575 ' HB2' ' CG2' ' A' ' 40' ' ' THR . 2.1 m -107.02 142.17 37.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.158 0.504 . . . . 0.0 111.976 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 2.1 mm? -135.34 137.74 42.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.448 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.1 t -110.79 137.79 41.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.88 0.371 . . . . 0.0 111.236 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.413 HG22 HD13 ' A' ' 145' ' ' ILE . 52.6 mt -106.22 128.32 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.399 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.94 114.96 27.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.364 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.5 mt -84.73 130.93 35.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.951 0.405 . . . . 0.0 111.618 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -78.97 111.95 15.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.752 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -61.38 -33.13 73.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.139 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -45.99 91.2 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.034 0.445 . . . . 0.0 110.843 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.408 ' CE2' HD22 ' A' ' 155' ' ' LEU . 26.8 t80 -60.5 -44.13 96.3 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.05 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.51 -34.43 69.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.097 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -62.42 -46.59 87.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.862 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 10.4 t -66.28 -45.18 81.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.92 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.457 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 0.2 OUTLIER -57.5 -44.01 84.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.793 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -70.33 -33.46 71.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.039 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.455 ' O ' ' C ' ' A' ' 158' ' ' ASN . 2.1 tt0 -73.06 -15.55 61.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.114 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.457 ' ND2' ' O ' ' A' ' 155' ' ' LEU . 1.6 p30 -24.85 -46.87 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 157' ' ' GLN . 4.2 tttt -125.06 133.32 52.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.778 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.4 t -78.61 134.35 28.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.11 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -152.91 109.55 3.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.02 98.32 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.835 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 21.7 mt -84.93 138.38 19.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.154 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.898 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.782 0.325 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.47 163.92 47.34 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.951 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.39 144.87 63.27 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.588 2.192 . . . . 0.0 112.214 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -99.97 80.78 2.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.049 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . 0.471 ' CD2' ' HA ' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -117.89 144.11 45.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.993 -179.234 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' B' ' 172' ' ' ILE . 3.3 mm-40 -119.67 47.15 1.77 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.505 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.661 HD11 ' CG2' ' A' ' 136' ' ' VAL . 4.5 tp 51.77 162.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.873 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 173' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -99.78 121.94 42.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.815 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.898 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.849 0.357 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.1 p -150.82 -58.32 0.17 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -61.13 -41.25 96.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.957 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -38.34 82.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.911 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -64.69 -35.05 79.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.889 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.37 -41.59 96.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.935 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.405 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 7.2 mm -68.45 -35.27 69.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.194 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -57.19 -45.82 83.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.895 0.378 . . . . 0.0 110.341 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -67.0 -23.76 65.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.381 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.405 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.5 -47.42 79.32 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.293 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.6 m -67.34 -31.33 71.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.867 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -156.51 112.25 2.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.791 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -77.63 133.28 38.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -88.44 107.51 18.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.932 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.2 mm -82.04 138.33 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 CA-C-O 121.595 0.712 . . . . 0.0 111.81 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 137.34 65.43 0.05 OUTLIER Glycine 0 C--N 1.313 -0.699 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.428 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -82.25 -37.65 25.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.732 0.301 . . . . 0.0 110.94 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 176.42 39.6 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.651 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -74.79 135.62 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 CA-C-N 113.63 -1.623 . . . . 0.0 112.404 -177.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.477 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.3 t -91.93 -59.46 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.923 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.8 p -148.31 165.17 31.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.482 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.99 138.29 51.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.831 0.348 . . . . 0.0 111.399 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.6 t -111.18 122.81 66.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.563 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.0 mt -122.25 120.06 60.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.857 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -83.96 104.07 13.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.039 179.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.96 -20.88 48.09 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.452 HG23 ' HB3' ' A' ' 142' ' ' SER . 72.8 p -79.85 -2.41 43.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.803 0.335 . . . . 0.0 111.547 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.72 75.12 0.44 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.819 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -145.84 -40.01 0.23 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.893 0.378 . . . . 0.0 110.88 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.589 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.4 mp -125.4 142.69 42.38 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.038 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.589 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 50.7 Cg_endo -70.75 145.86 52.58 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.207 1.938 . . . . 0.0 112.131 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.2 mt -62.93 138.95 22.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.77 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.43 163.98 25.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.951 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -124.38 119.88 30.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.082 0.468 . . . . 0.0 111.854 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.535 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 7.6 mp -85.88 132.08 34.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.558 178.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.651 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -140.31 155.81 46.68 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 122.281 1.038 . . . . 0.0 113.423 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.477 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.08 141.84 29.18 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 113.533 -1.667 . . . . 0.0 110.798 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.447 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 0.5 OUTLIER -76.07 135.89 39.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.256 0.551 . . . . 0.0 111.198 -179.625 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 68.3 mt -64.83 -38.9 83.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.048 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.1 p -60.92 -42.72 98.67 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.721 -178.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.447 ' CG ' ' O ' ' A' ' 51' ' ' ASP . 5.6 pt20 -68.56 -36.94 79.46 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.465 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.08 -44.04 95.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.966 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.5 tp -71.03 -30.97 67.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.887 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.88 -48.27 18.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.968 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.84 136.86 56.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.914 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.3 30.73 1.95 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.03 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.3 -58.14 2.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.857 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.09 -63.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.91 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.3 mm -110.51 145.22 17.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.094 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -96.88 -46.95 6.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.006 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.416 ' CE ' ' O ' ' A' ' 49' ' ' SER . 4.1 ttpt -155.01 140.34 17.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.192 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.494 HG12 ' HB3' ' A' ' 92' ' ' LEU . 17.4 t -130.67 139.21 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 121.34 0.59 . . . . 0.0 112.084 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.535 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 16.2 m-90 -105.44 138.71 41.19 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.952 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.429 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -112.01 131.95 55.1 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.493 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.517 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.4 OUTLIER -117.11 145.61 43.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.679 -178.316 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.664 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.92 -171.97 37.96 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.596 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.422 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 4.6 mtm105 -83.14 3.36 31.08 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.46 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.0 t30 -85.07 135.06 39.94 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.627 0.251 . . . . 0.0 110.95 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.8 Cg_exo -65.95 -11.83 32.67 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.613 2.209 . . . . 0.0 111.728 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.86 -45.31 14.4 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 121.952 0.882 . . . . 0.0 108.827 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.59 137.55 5.07 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 113.892 -1.504 . . . . 0.0 110.692 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.6 OUTLIER -56.66 -18.14 11.22 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.232 179.028 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.492 ' CE2' HG22 ' A' ' 43' ' ' ILE . 9.9 t80 -125.23 118.51 26.19 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-O 120.782 0.325 . . . . 0.0 110.928 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -99.77 115.73 30.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.472 ' HA ' HG12 ' A' ' 43' ' ' ILE . 2.6 mt -90.2 -168.28 2.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.093 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -91.68 19.36 48.6 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.828 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 63.88 84.31 0.15 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.865 0.365 . . . . 0.0 111.538 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.4 mp -108.3 131.4 58.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.714 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.433 ' O ' ' HB2' ' B' ' 170' ' ' LEU . 2.4 m -54.88 -39.55 68.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.03 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.424 ' HA ' ' HB2' ' B' ' 170' ' ' LEU . 1.9 tpt180 -66.37 -45.49 79.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.907 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.6 mt -72.81 151.54 42.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.892 0.377 . . . . 0.0 111.641 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.0 p -95.83 166.98 11.54 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.733 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.664 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.7 m-20 -43.85 -54.18 5.45 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.282 0.563 . . . . 0.0 109.842 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.419 ' O ' HG13 ' A' ' 104' ' ' ILE . 0.6 OUTLIER -120.04 83.06 1.99 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.163 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.558 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 9.4 t60 -62.12 -46.32 89.54 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.791 -176.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.517 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 18.4 p90 -146.5 157.93 43.82 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.672 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.493 ' HG2' HG13 ' A' ' 65' ' ' VAL . 5.5 tt0 -135.94 140.66 44.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.332 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.431 HG13 ' CE1' ' A' ' 68' ' ' PHE . 39.3 mt -114.76 132.11 64.92 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.912 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.494 ' HB3' HG12 ' A' ' 65' ' ' VAL . 0.4 OUTLIER -123.59 146.28 48.28 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.141 0.496 . . . . 0.0 111.704 -179.805 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 14.5 tp -125.02 122.87 38.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.219 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.68 84.78 0.1 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.529 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 176.95 -167.81 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 0.0 110.752 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -83.98 57.77 4.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.886 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 100.02 -19.54 52.68 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.603 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -71.74 147.41 47.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.947 0.403 . . . . 0.0 110.996 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.404 ' HB2' ' CD1' ' A' ' 124' ' ' LEU . 7.6 mp -118.27 159.99 22.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.722 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.1 mt -133.1 146.58 51.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.879 0.371 . . . . 0.0 110.808 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.401 ' CD2' ' HB3' ' A' ' 124' ' ' LEU . 2.3 mm? -112.72 123.57 50.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.854 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 90' ' ' GLN . 41.1 t30 -112.95 115.51 28.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.04 0.448 . . . . 0.0 111.229 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.688 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 15.1 p30 -81.34 133.19 35.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.874 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 87' ' ' LYS . 19.2 pt -140.9 38.66 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.545 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -100.76 154.03 18.96 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 120.918 0.39 . . . . 0.0 111.577 -179.387 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 86.6 m -68.89 -31.77 70.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.43 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -97.74 -19.88 17.93 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.456 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.84 158.0 10.83 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.889 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.529 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.1 m -117.71 137.87 52.39 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.84 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -117.95 148.32 42.3 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.43 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.4 OUTLIER -124.58 113.67 18.37 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 176.611 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 37.3 m-20 48.19 42.05 16.78 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.63 -8.38 75.51 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.77 -0.729 . . . . 0.0 113.925 178.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -105.69 118.83 37.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.13 0.465 . . . . 0.0 110.786 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.84 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -73.14 135.08 44.66 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.404 -179.719 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.7 m -107.44 163.98 5.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.763 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 120' ' ' SER . 44.2 tt0 -69.87 127.32 32.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.384 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.688 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 76.7 tttt -52.16 161.57 0.6 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.896 0.379 . . . . 0.0 110.525 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.7 p30 34.37 34.73 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.305 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.34 145.11 40.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.453 179.618 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -87.43 123.99 32.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.615 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -129.24 146.69 51.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.858 0.361 . . . . 0.0 111.102 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 32.6 tp -75.07 118.04 17.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.101 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.404 ' CD1' ' HB2' ' A' ' 99' ' ' LEU . 2.0 pt? -58.12 168.66 0.96 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.586 0.708 . . . . 0.0 112.039 -178.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.468 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.38 154.13 40.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.81 -1.087 . . . . 0.0 109.905 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.425 ' HA ' HD13 ' A' ' 147' ' ' ILE . 17.1 tp60 -70.14 119.38 14.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.085 0.469 . . . . 0.0 110.27 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.06 23.38 59.41 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.905 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.468 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 25.6 t0 -57.81 179.2 0.07 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 120.716 0.293 . . . . 0.0 110.676 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 7.2 mt-10 -145.05 135.64 24.37 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.091 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.599 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 10.2 mt -107.3 123.67 62.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.924 0.392 . . . . 0.0 110.622 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.425 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 96.9 m -104.59 140.69 37.64 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.558 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 17.7 m -140.25 158.51 25.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.32 29.8 35.8 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.114 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.477 ' HB ' ' CH2' ' A' ' 110' ' ' TRP . 86.8 t -76.36 140.51 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-O 121.604 0.716 . . . . 0.0 111.986 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 139.04 -37.75 1.74 Allowed Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -178.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.446 HG21 ' HB ' ' B' ' 172' ' ' ILE . 2.5 t -123.01 118.35 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.85 -26.43 5.77 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -178.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 20.7 t -93.74 6.75 47.31 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -132.62 33.82 3.74 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -178.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.425 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 7.2 mt -107.21 138.02 35.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-O 121.619 0.723 . . . . 0.0 111.338 178.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.4 tt -125.65 135.02 51.7 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.374 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.452 ' HB3' HG23 ' A' ' 40' ' ' THR . 46.8 t -112.38 147.42 36.44 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.87 0.843 . . . . 0.0 112.44 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 3.7 mp -135.85 153.08 51.6 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.153 -1.385 . . . . 0.0 110.854 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 21.9 t -118.17 140.03 43.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.631 0.253 . . . . 0.0 110.544 179.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.5 mm -106.2 120.85 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-O 120.957 0.408 . . . . 0.0 110.989 -179.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.69 111.06 22.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.677 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.435 HD13 ' O ' ' A' ' 125' ' ' SER . 4.1 mp -89.93 134.23 29.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.853 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -85.52 108.2 17.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.5 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.79 -31.68 68.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.202 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -60.32 -45.95 91.6 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.967 0.413 . . . . 0.0 110.779 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -59.38 -44.1 92.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.049 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 34.4 mttt -64.34 -34.48 78.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.148 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -61.59 -43.32 99.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.154 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.5 t -68.05 -42.93 79.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.131 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -68.99 -45.59 70.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.095 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -62.86 -48.07 80.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.052 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -77.33 -36.94 53.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.068 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.3 p30 42.61 55.23 4.28 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.409 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -67.06 121.46 15.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.921 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 10.7 m -76.0 137.9 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.116 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -73.18 109.16 6.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.879 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.64 95.17 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.916 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 6.2 tp -104.63 130.16 55.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.095 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.266 -0.874 . . . . 0.0 110.872 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 30.3 m120 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.9 0.381 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -101.15 101.81 17.98 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.819 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.07 92.93 0.39 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.433 2.088 . . . . 0.0 112.363 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -125.38 124.97 42.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.841 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . 0.433 ' HB2' ' O ' ' A' ' 82' ' ' SER . 1.1 tp -150.49 -170.0 3.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.984 0.421 . . . . 0.0 111.454 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 179.93 112.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.256 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.446 ' HB ' HG21 ' A' ' 136' ' ' VAL . 3.9 tp -46.36 144.32 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.011 0.434 . . . . 0.0 111.576 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 173' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -90.53 120.64 31.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.891 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.95 -179.985 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.851 0.358 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.6 m -126.08 -53.33 1.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.868 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -64.36 -42.96 95.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.952 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 22.9 mtt180 -59.89 -36.04 76.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.894 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -62.88 -40.25 96.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.2 -45.63 92.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.47 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.4 mm -65.99 -35.14 74.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.155 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -57.13 -37.75 72.47 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.939 0.399 . . . . 0.0 110.437 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -67.28 -23.84 65.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.659 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.47 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.74 -47.51 79.88 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.09 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.2 m -80.13 -26.38 39.45 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.917 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 64.7 145.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.879 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -63.03 152.53 36.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -75.14 106.65 6.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.961 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.424 HG21 ' N ' ' A' ' 29' ' ' GLY . 18.4 mm -81.96 138.22 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-O 121.658 0.742 . . . . 0.0 111.75 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.424 ' N ' HG21 ' A' ' 28' ' ' ILE . . . 117.42 81.98 0.86 Allowed Glycine 0 C--N 1.314 -0.682 0 CA-C-N 114.531 -1.213 . . . . 0.0 112.385 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -58.88 -43.37 90.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.759 0.314 . . . . 0.0 110.98 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.405 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.9 OUTLIER 175.2 39.66 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.852 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.666 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -72.29 135.45 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 CA-C-N 113.613 -1.63 . . . . 0.0 112.558 -177.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.483 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.5 t -91.56 -58.85 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.912 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 24.8 p -152.56 154.78 36.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.644 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.428 ' NE ' ' CG2' ' A' ' 45' ' ' ILE . 0.1 OUTLIER -119.09 138.22 53.03 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.799 0.333 . . . . 0.0 110.971 -179.85 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.3 t -107.7 122.67 62.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.895 0.379 . . . . 0.0 110.906 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.4 mt -118.69 127.97 75.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.502 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 52.6 t -81.36 100.68 9.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.518 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.98 -24.19 65.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.816 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.488 HG23 ' HB3' ' A' ' 142' ' ' SER . 72.9 p -79.82 -2.36 43.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.831 0.348 . . . . 0.0 111.376 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 59.99 76.28 0.23 Allowed Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 121.018 -0.611 . . . . 0.0 113.09 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -146.57 -43.14 0.19 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.92 0.39 . . . . 0.0 110.78 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.567 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.4 mp -119.55 142.55 32.95 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.035 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.567 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 50.7 Cg_endo -71.2 146.18 50.8 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.216 1.944 . . . . 0.0 112.203 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.428 ' CG2' ' NE ' ' A' ' 35' ' ' ARG . 51.7 mt -55.04 144.68 5.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.944 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.46 ' HB2' ' CE2' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -128.28 134.24 48.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.837 178.828 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -98.72 119.71 37.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.046 0.451 . . . . 0.0 112.199 -178.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.538 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 7.1 mp -93.68 128.12 39.71 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.666 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -133.71 156.84 47.23 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 122.067 0.937 . . . . 0.0 113.526 -179.602 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.483 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -153.02 142.02 21.28 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 113.817 -1.538 . . . . 0.0 111.136 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.426 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 24.7 m-20 -77.59 122.82 25.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.104 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.454 HG22 HD13 ' A' ' 52' ' ' ILE . 61.4 mt -64.51 -43.78 96.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.128 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.2 t -59.02 -40.71 85.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.337 0.589 . . . . 0.0 110.719 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.426 ' CG ' ' HB2' ' A' ' 51' ' ' ASP . 4.5 mm-40 -68.55 -36.86 79.38 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.742 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 49.1 t -65.94 -39.49 84.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.936 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.1 mt -70.98 -31.36 67.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.823 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.02 -50.8 37.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.9 130.37 35.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.77 33.39 2.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.799 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.14 -66.18 0.86 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.4 m -164.05 -64.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.918 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.3 tp -113.79 152.48 15.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.165 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -112.15 -73.91 0.65 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.959 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.44 ' HE2' ' O ' ' A' ' 49' ' ' SER . 4.0 ttpt -136.62 131.51 33.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.327 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.442 HG13 ' HG2' ' A' ' 90' ' ' GLN . 16.0 t -131.27 139.27 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-O 121.155 0.503 . . . . 0.0 111.733 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.572 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 20.2 m-90 -101.02 139.24 36.98 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.002 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.4 ' HA ' ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.76 126.93 55.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.038 0.447 . . . . 0.0 109.904 177.911 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.523 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 0.5 OUTLIER -111.43 145.83 38.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.453 -178.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.657 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.42 -171.86 37.51 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.602 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.431 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 8.3 mtp-105 -82.15 1.48 36.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -84.92 134.37 41.56 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.716 0.293 . . . . 0.0 111.035 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -68.48 -8.97 24.64 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.625 2.217 . . . . 0.0 111.787 179.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.16 -43.9 15.67 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 122.031 0.92 . . . . 0.0 108.79 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.45 136.64 2.33 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 113.656 -1.611 . . . . 0.0 110.832 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -56.6 -19.08 14.26 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.831 179.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.523 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 9.8 t80 -129.95 119.3 23.0 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.723 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -93.94 111.03 22.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.907 0.384 . . . . 0.0 110.95 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 44.9 mt -76.07 -78.55 0.11 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.997 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.62 -87.16 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.506 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -177.5 47.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.853 0.359 . . . . 0.0 111.003 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.431 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 30.7 mm -83.35 117.39 29.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.108 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.7 -31.99 58.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.042 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.96 -17.39 62.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.274 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.2 mt -106.95 152.16 24.32 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.762 0.315 . . . . 0.0 111.436 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 87.2 p -96.39 166.0 11.92 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.663 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.657 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.1 m-20 -43.11 -52.35 5.48 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.425 0.631 . . . . 0.0 109.774 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.437 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 14.5 ptmt -119.77 82.86 1.95 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 177.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.589 ' CE1' ' OG ' ' A' ' 105' ' ' SER . 14.2 t60 -61.17 -46.66 89.61 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.875 -176.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.491 ' HA ' HG12 ' A' ' 104' ' ' ILE . 32.0 p90 -148.99 161.42 41.94 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.767 -179.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.486 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.4 tt0 -135.92 142.28 44.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.42 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 46.2 mt -117.55 127.64 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.004 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.412 ' HB3' HG12 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -110.72 143.49 41.14 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.058 0.456 . . . . 0.0 111.752 -179.606 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -125.15 122.89 38.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.394 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.59 -161.75 13.35 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.585 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 60.41 -173.92 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.794 0.331 . . . . 0.0 110.766 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -82.56 58.89 4.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.019 0.438 . . . . 0.0 110.807 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 108.69 -171.94 16.13 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.516 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.4 m120 61.54 170.2 0.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.901 0.382 . . . . 0.0 111.043 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.05 160.12 39.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.689 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 2.3 mp -125.33 145.81 49.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.455 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.9 mt -112.99 123.29 49.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.33 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.411 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 59.5 t30 -118.2 115.77 25.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.829 0.347 . . . . 0.0 111.86 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.682 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 9.2 p30 -79.14 143.14 35.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.943 178.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.491 HG12 ' HA ' ' A' ' 89' ' ' PHE . 14.3 pt -146.88 26.73 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.589 ' OG ' ' CE1' ' A' ' 88' ' ' HIS . 11.0 t -93.98 154.97 17.39 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.7 m -70.12 -52.16 25.79 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.453 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -74.64 -4.06 34.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.247 -179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.92 155.97 31.22 Favored Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.439 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.49 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 5.4 m -117.36 137.78 52.23 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.812 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -114.02 148.49 36.9 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -177.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.0 113.6 18.65 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.467 177.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 45.09 42.88 7.06 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.04 -13.44 61.38 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.726 -0.749 . . . . 0.0 113.486 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -104.49 118.49 36.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 117.104 0.452 . . . . 0.0 110.498 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.812 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -70.11 123.61 22.02 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.403 -179.793 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.7 m -95.08 164.64 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.01 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -69.94 127.88 34.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.587 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.682 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 17.6 tttm -53.66 162.47 0.85 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.754 0.312 . . . . 0.0 110.23 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.6 p30 34.52 36.32 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.004 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.7 p -111.92 145.09 40.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.706 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.4 ' HB3' ' CD2' ' A' ' 100' ' ' LEU . 18.6 m120 -92.71 130.67 38.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.872 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.45 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 58.3 mm-40 -129.28 150.93 50.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.558 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.7 tp -72.81 130.03 39.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.815 0.341 . . . . 0.0 110.226 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.437 ' HG ' ' N ' ' A' ' 125' ' ' SER . 30.0 tp -58.1 153.71 14.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.594 0.711 . . . . 0.0 111.737 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.437 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.6 OUTLIER -125.12 152.92 43.76 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.691 -1.14 . . . . 0.0 110.451 179.647 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -72.1 124.86 25.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.828 0.346 . . . . 0.0 110.09 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.84 22.82 48.92 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.758 -0.735 . . . . 0.0 111.981 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -50.4 165.71 0.09 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.896 0.379 . . . . 0.0 111.345 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -145.05 135.48 24.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.99 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 14.7 mt -114.73 128.24 71.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.798 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.443 ' O ' ' HB2' ' A' ' 110' ' ' TRP . 3.2 m -104.08 139.84 38.61 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.562 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.8 m -140.42 158.67 25.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -178.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.85 29.27 29.43 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.236 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.4 ' HA ' HG12 ' A' ' 140' ' ' ILE . 74.6 t -73.38 140.51 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-O 121.622 0.725 . . . . 0.0 112.077 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.23 -37.09 1.43 Allowed Glycine 0 N--CA 1.436 -1.36 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 -178.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.459 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 3.7 t -124.84 125.29 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.4 -35.92 30.51 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -178.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.0 p -93.59 6.57 47.8 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.459 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 30.4 m-20 -121.02 28.91 7.62 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -178.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.436 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.2 mt -107.04 138.52 32.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-O 121.5 0.667 . . . . 0.0 111.143 178.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.0 tt -124.85 134.42 52.73 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.149 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.488 ' HB3' HG23 ' A' ' 40' ' ' THR . 38.3 t -112.81 150.24 31.95 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.761 0.791 . . . . 0.0 112.642 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -136.02 143.67 44.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.525 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 24.0 t -115.86 140.27 38.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.792 0.329 . . . . 0.0 111.008 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.435 HD13 HG23 ' A' ' 145' ' ' ILE . 33.2 mt -106.0 123.39 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-O 120.951 0.405 . . . . 0.0 111.278 -179.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.2 118.35 36.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.532 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.436 HG12 HD21 ' A' ' 124' ' ' LEU . 3.6 mt -88.07 133.96 29.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.649 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -82.72 113.53 20.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.738 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.57 -29.45 66.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.074 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.65 -45.77 91.02 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 120.976 0.417 . . . . 0.0 110.672 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -58.64 -44.12 89.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.951 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.0 -41.08 95.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.992 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -59.18 -40.1 84.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.103 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.3 t -60.7 -46.13 91.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.016 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.04 -38.39 79.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.016 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.76 -46.42 85.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.966 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.45 -37.07 32.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.946 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.1 p30 42.22 82.98 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.532 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.79 141.23 55.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.963 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 10.6 m -96.73 136.22 28.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.099 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.54 107.49 1.72 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.821 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 59.95 171.16 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.965 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.1 tp -76.98 138.49 20.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.054 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.874 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 1.2 m120 . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.781 0.324 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.58 150.37 91.22 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.57 131.52 21.68 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.582 2.188 . . . . 0.0 112.254 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -121.78 47.32 1.9 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.008 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -160.27 -177.88 6.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.9 0.381 . . . . 0.0 111.298 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . 0.503 ' O ' ' CG2' ' B' ' 172' ' ' ILE . 21.5 mt-10 -143.66 75.08 1.46 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.654 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.503 ' CG2' ' O ' ' B' ' 171' ' ' GLU . 16.1 tt 50.28 156.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 121.395 0.617 . . . . 0.0 111.996 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 173' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -109.75 137.83 47.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.852 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 34.9 t . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.906 179.959 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.85 0.357 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -111.86 41.5 1.92 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.844 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -59.95 -46.92 87.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.768 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.74 -35.86 72.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.8 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -56.99 -43.49 81.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.535 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.72 -31.86 68.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.251 179.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.428 ' O ' ' CD2' ' A' ' 23' ' ' PHE . 11.5 mt -69.45 -47.99 69.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.57 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -63.33 -33.78 76.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.366 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.19 -47.04 86.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.936 -178.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.525 ' CD1' ' N ' ' A' ' 24' ' ' SER . 4.0 p90 -71.83 -47.43 53.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.022 0.439 . . . . 0.0 111.101 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.525 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 12.3 m -58.49 -47.04 85.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.928 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -115.37 86.23 2.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.89 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -92.44 131.19 37.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.845 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -80.61 124.47 29.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.859 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.0 mm -82.61 138.35 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-O 121.728 0.775 . . . . 0.0 111.809 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 56.2 77.47 0.16 Allowed Glycine 0 C--N 1.315 -0.59 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.603 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.38 -42.52 98.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.828 0.346 . . . . 0.0 110.816 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.41 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.7 OUTLIER 179.0 38.08 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.707 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -75.99 135.07 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-N 113.785 -1.552 . . . . 0.0 112.506 -177.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.487 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.8 t -91.88 -61.68 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.24 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.5 p -149.34 149.02 30.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.302 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -116.7 138.3 51.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.874 0.368 . . . . 0.0 111.417 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.89 122.89 57.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.998 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.4 mt -123.09 117.72 52.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.609 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.1 t -80.74 112.75 18.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.185 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.05 -21.62 29.32 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.484 HG23 ' HB3' ' A' ' 142' ' ' SER . 75.1 p -79.79 -2.47 43.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.788 0.328 . . . . 0.0 111.592 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.46 72.37 0.74 Allowed Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.977 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -142.45 -42.13 0.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.876 0.369 . . . . 0.0 110.919 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.554 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.3 mt -121.02 141.66 33.18 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.035 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.554 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.9 Cg_endo -72.83 140.36 31.92 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.167 1.912 . . . . 0.0 112.167 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.1 mt -55.95 145.63 6.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.766 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.09 163.72 31.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.153 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -120.5 119.88 34.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.08 0.467 . . . . 0.0 112.013 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.49 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 5.1 mt -93.93 137.55 33.02 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.707 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.73 159.01 43.79 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -178.662 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.487 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -138.53 141.87 39.31 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 113.744 -1.571 . . . . 0.0 110.618 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.423 ' CB ' ' HG2' ' A' ' 54' ' ' GLN . 3.6 m-20 -84.19 129.89 34.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.221 0.534 . . . . 0.0 111.578 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.2 mt -64.5 -45.39 95.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.435 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.9 t -56.67 -38.85 72.78 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.611 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.423 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 4.8 mm100 -68.55 -36.65 79.1 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.316 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.5 t -59.77 -49.23 84.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.0 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.1 tt -68.77 -30.69 69.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.102 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -77.61 -46.54 21.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.037 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -83.63 129.98 34.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.935 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.03 31.12 3.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.908 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.1 mtm-85 -69.35 -69.24 0.35 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.827 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.7 m -164.82 -42.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.032 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.6 tp -135.54 147.28 28.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.994 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -71.71 -68.89 0.42 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.859 0.362 . . . . 0.0 110.728 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.429 ' CE ' ' O ' ' A' ' 49' ' ' SER . 31.1 ttpt -150.69 140.09 21.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.667 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.508 HG13 ' HB3' ' A' ' 92' ' ' LEU . 12.4 t -121.53 139.12 49.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.272 0.558 . . . . 0.0 111.906 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.579 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 18.2 m-90 -104.07 138.61 40.33 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.069 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -113.94 128.28 56.33 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 177.049 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.522 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -115.19 145.46 42.38 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.497 -177.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.577 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.35 -172.23 38.4 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.702 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.435 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 9.4 mtm105 -80.46 2.29 25.79 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 3.0 t-20 -84.87 134.2 42.02 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.575 0.226 . . . . 0.0 111.125 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 15.8 Cg_exo -67.06 -11.9 34.01 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.531 2.154 . . . . 0.0 111.75 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.9 -43.33 16.65 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 122.017 0.913 . . . . 0.0 108.93 178.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.51 137.82 2.01 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.086 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.8 m-20 -56.58 -18.44 11.89 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.985 178.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.471 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 19.5 t80 -129.27 119.65 24.33 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.869 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -98.77 110.06 22.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.927 0.394 . . . . 0.0 111.031 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 pp -113.04 172.98 6.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.666 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.23 136.91 50.55 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.506 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -68.27 89.75 0.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.789 0.328 . . . . 0.0 110.777 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.433 ' O ' ' HD3' ' A' ' 70' ' ' ARG . 44.6 mt -107.86 135.55 46.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.024 0.44 . . . . 0.0 111.478 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.424 ' HB2' ' CD1' ' B' ' 170' ' ' LEU . 89.9 p -54.88 -43.94 73.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.274 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.45 ' HG3' ' HB3' ' A' ' 139' ' ' ASP . 1.6 mmt180 -60.85 -27.81 68.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.568 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.4 ' HA ' ' HD1' ' A' ' 88' ' ' HIS . 29.7 mt -96.23 150.95 19.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.9 0.381 . . . . 0.0 111.633 -179.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 75.4 p -98.62 169.05 9.78 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.416 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.577 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.0 m-20 -44.11 -55.3 4.85 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.318 0.58 . . . . 0.0 109.761 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.455 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 3.1 ptpp? -118.8 84.73 2.24 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 177.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.548 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 12.7 t60 -60.55 -47.02 88.0 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.874 -176.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.511 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 23.9 p90 -146.69 160.53 42.09 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.991 -179.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.473 ' HG2' HG11 ' A' ' 65' ' ' VAL . 4.3 tt0 -135.95 139.15 43.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.395 -179.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.433 ' O ' ' CG1' ' A' ' 65' ' ' VAL . 61.6 mt -114.61 132.14 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 121.104 -0.238 . . . . 0.0 110.965 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.508 ' HB3' HG13 ' A' ' 65' ' ' VAL . 0.2 OUTLIER -123.97 136.41 54.29 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.047 0.451 . . . . 0.0 111.966 -179.604 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.434 HD21 ' CE2' ' A' ' 151' ' ' PHE . 2.4 tp -125.41 122.98 38.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.43 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.25 41.65 0.06 OUTLIER Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.854 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.52 76.07 1.16 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.878 0.371 . . . . 0.0 110.733 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.68 29.88 18.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.825 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 103.09 175.68 26.53 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.351 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 62.05 -170.75 0.16 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.839 0.352 . . . . 0.0 110.83 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.406 ' HB3' HD11 ' A' ' 124' ' ' LEU . 0.3 OUTLIER -124.22 159.82 29.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.764 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.7 mt -133.34 140.7 47.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.704 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 pp -112.66 124.61 52.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.929 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 90' ' ' GLN . 47.3 t30 -114.62 115.92 27.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.9 0.381 . . . . 0.0 111.705 -179.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.66 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 12.2 p30 -78.57 136.67 37.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.885 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.455 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 18.8 pt -147.41 38.92 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.584 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.0 151.77 20.56 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 121.098 0.475 . . . . 0.0 112.207 -178.717 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 16.7 m -68.92 -31.63 70.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.705 177.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -97.07 -19.79 18.47 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.482 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.584 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.08 156.79 10.95 Favored Glycine 0 N--CA 1.439 -1.115 0 C-N-CA 120.4 -0.905 . . . . 0.0 114.014 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.49 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.3 m -117.32 137.71 52.25 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.732 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -118.94 148.66 42.72 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -177.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.91 113.57 18.66 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.559 177.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 44.36 43.23 5.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.547 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.07 -14.21 59.53 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.435 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -104.24 118.51 36.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.09 0.445 . . . . 0.0 110.626 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.732 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -71.68 129.75 39.46 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.473 -179.65 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.0 m -96.41 166.11 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.956 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 120' ' ' SER . 23.1 mm-40 -69.92 127.2 32.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.591 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.66 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -53.98 158.51 2.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.172 0.51 . . . . 0.0 110.702 -179.962 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.503 ' H ' ' HG3' ' A' ' 118' ' ' LYS . 0.5 OUTLIER 35.73 35.45 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.798 -179.74 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.452 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -111.96 145.03 40.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.134 179.606 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -89.76 123.15 33.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.622 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -126.62 145.76 50.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.969 0.414 . . . . 0.0 110.858 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.0 tp -72.97 118.41 15.89 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.951 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.406 HD11 ' HB3' ' A' ' 99' ' ' LEU . 2.4 pt? -57.44 167.66 0.95 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.589 0.709 . . . . 0.0 111.865 -178.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.423 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.2 OUTLIER -124.89 153.75 42.14 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.228 179.769 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.04 118.92 14.42 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.8 22.03 67.94 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.458 -178.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.423 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 24.3 t70 -54.33 174.11 0.06 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.895 0.379 . . . . 0.0 111.046 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 9.6 tt0 -145.35 135.27 23.66 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.041 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 18.9 mt -114.71 126.49 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.214 178.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.428 ' O ' ' HB2' ' A' ' 110' ' ' TRP . 3.6 m -104.14 139.86 38.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.264 -0.425 . . . . 0.0 109.928 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.548 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 33.9 m -140.18 158.26 25.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.114 0.483 . . . . 0.0 112.194 -178.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.97 27.2 29.33 Favored Glycine 0 N--CA 1.44 -1.085 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.926 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.437 ' HB ' ' CZ3' ' A' ' 110' ' ' TRP . 68.9 t -74.04 140.49 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-O 121.611 0.72 . . . . 0.0 112.069 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.92 -39.76 0.93 Allowed Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.432 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 2.5 t -118.16 129.17 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -50.58 -42.35 55.58 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -178.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.6 m -93.47 6.76 47.1 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -178.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.45 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . 0.5 OUTLIER -120.14 34.54 5.18 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -178.539 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.425 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 6.1 mt -107.23 139.46 28.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.942 178.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 8.9 tt -124.03 134.64 53.39 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.647 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.484 ' HB3' HG23 ' A' ' 40' ' ' THR . 44.3 t -111.82 150.54 30.2 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.748 0.785 . . . . 0.0 112.715 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 71.5 mt -135.71 149.34 49.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.779 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 24.2 t -117.01 139.07 45.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.829 0.347 . . . . 0.0 111.075 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.418 HG21 HD12 ' A' ' 145' ' ' ILE . 17.6 mt -106.36 124.54 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.045 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.38 114.01 26.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.607 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.402 HG12 ' CD1' ' A' ' 124' ' ' LEU . 5.0 mt -84.95 134.12 27.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.546 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -86.09 105.0 16.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.737 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -57.66 -28.19 63.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.115 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -43.7 88.89 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.607 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.434 ' CE2' HD21 ' A' ' 93' ' ' LEU . 33.7 t80 -59.5 -44.01 93.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.889 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -62.69 -33.94 76.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.912 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.62 -36.92 84.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.031 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 7.8 t -68.0 -40.82 82.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.108 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.15 -50.0 57.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.126 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -58.54 -42.39 87.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.001 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.11 -36.11 35.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.835 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.3 p30 42.39 79.31 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.487 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.2 pttp -120.04 136.93 54.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.86 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 6.7 m -72.6 128.62 35.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.176 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -107.3 -45.78 4.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.865 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 8.9 ttm-85 -139.04 29.9 2.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.882 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.4 mt -105.04 137.93 32.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.044 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.859 -179.997 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.886 0.374 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.91 165.77 19.23 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.75 171.4 9.77 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.553 2.168 . . . . 0.0 112.228 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 178.41 85.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.005 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . 0.424 ' CD1' ' HB2' ' A' ' 82' ' ' SER . 0.3 OUTLIER -163.53 153.0 14.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.92 -179.411 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . 0.51 ' O ' ' O ' ' B' ' 172' ' ' ILE . 9.0 mt-10 -138.87 61.34 1.57 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.139 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.51 ' O ' ' O ' ' B' ' 171' ' ' GLU . 14.0 tt 49.44 158.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.276 0.56 . . . . 0.0 112.145 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 173' ' ' TYR . . . . . 0.449 ' N ' HG12 ' B' ' 172' ' ' ILE . 4.3 m-85 -51.64 94.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.005 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.293 -0.861 . . . . 0.0 110.863 -179.94 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.859 0.361 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.9 t -160.28 -45.74 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.888 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -71.95 -44.45 63.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.922 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.94 -45.74 89.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.957 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -59.56 -35.81 74.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.851 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -65.22 -41.85 94.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.798 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.44 ' O ' ' CD2' ' A' ' 23' ' ' PHE . 43.9 mm -68.19 -48.08 75.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.002 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.02 -33.67 72.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.329 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.3 tptp -58.6 -47.25 84.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.932 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.546 ' CD1' ' N ' ' A' ' 24' ' ' SER . 4.4 p90 -71.85 -47.38 53.44 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.982 0.42 . . . . 0.0 111.023 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.546 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 0.1 OUTLIER -61.74 -37.05 82.8 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.915 -179.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.03 169.1 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -81.02 131.35 35.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.843 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -87.59 131.41 34.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.888 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.405 HG21 ' N ' ' A' ' 29' ' ' GLY . 18.5 mm -81.93 138.13 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 CA-C-O 121.65 0.738 . . . . 0.0 111.536 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.405 ' N ' HG21 ' A' ' 28' ' ' ILE . . . 80.91 106.19 0.31 Allowed Glycine 0 C--N 1.313 -0.747 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.179 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 -80.82 -29.46 35.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.686 0.279 . . . . 0.0 111.156 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.494 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.9 m-20 176.41 41.19 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.641 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.3 mm -71.03 142.76 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-N 113.711 -1.586 . . . . 0.0 112.377 -176.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.405 ' CG2' ' CB ' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -106.01 -48.99 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-N 114.275 -1.329 . . . . 0.0 109.91 -178.575 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 32.1 p -161.13 147.96 14.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.534 179.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -114.13 138.24 50.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.893 0.378 . . . . 0.0 111.317 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.405 HG11 ' CZ ' ' A' ' 76' ' ' TYR . 21.3 t -101.81 122.73 54.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.062 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.1 mt -128.62 116.41 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.234 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 47.1 t -80.03 123.42 27.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.496 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.4 t -91.53 -27.33 18.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.546 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.498 ' CG2' ' CB ' ' A' ' 142' ' ' SER . 7.0 p -79.81 -2.6 44.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.748 0.309 . . . . 0.0 111.408 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.7 77.99 0.24 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.752 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -146.4 -45.44 0.19 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.942 0.401 . . . . 0.0 110.788 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.553 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.0 mt -116.33 141.25 27.58 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.847 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.553 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.4 Cg_endo -72.73 146.01 42.31 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.271 1.981 . . . . 0.0 112.161 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.5 mt -55.9 151.83 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.683 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -149.8 162.3 40.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.19 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -122.65 119.81 31.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.049 0.452 . . . . 0.0 111.945 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.572 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 23.3 mt -93.28 138.04 32.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.231 178.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.641 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -141.18 156.95 45.86 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 122.14 0.971 . . . . 0.0 113.5 -178.932 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.405 ' CB ' ' CG2' ' A' ' 33' ' ' VAL . . . -141.19 146.68 37.26 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 113.565 -1.652 . . . . 0.0 110.822 178.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.413 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 4.3 m-20 -74.94 125.74 29.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.131 0.491 . . . . 0.0 111.187 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.407 HG12 ' CZ ' ' A' ' 151' ' ' PHE . 91.3 mt -64.37 -44.46 97.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.641 -0.708 . . . . 0.0 112.099 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.9 m -57.06 -41.16 78.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.369 0.604 . . . . 0.0 110.673 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.413 ' CG ' ' HB2' ' A' ' 51' ' ' ASP . 5.0 mm100 -68.62 -36.78 79.1 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.922 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.4 t -69.13 -50.11 55.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.245 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.3 pp -62.46 -25.36 67.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.093 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -79.65 -55.04 5.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.936 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.11 108.75 4.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.97 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.52 -31.44 18.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.8 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.05 -179.09 3.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.687 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 58.84 -173.28 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.745 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.405 HG13 ' N ' ' A' ' 63' ' ' LYS . 9.4 tp -91.39 156.53 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.104 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.405 ' N ' HG13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -94.43 -67.32 0.86 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.143 -179.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.46 ' CE ' ' O ' ' A' ' 49' ' ' SER . 15.5 ttpt -155.03 115.4 3.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.89 0.376 . . . . 0.0 111.864 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 9.5 p -108.64 139.63 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.604 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 14.8 m-90 -100.71 139.9 35.74 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.151 -1.386 . . . . 0.0 112.064 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.449 HG21 ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -107.93 131.53 54.44 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 177.408 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.569 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 3.0 m-85 -117.0 145.91 43.37 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.036 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.692 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.82 -171.34 37.74 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.293 -0.956 . . . . 0.0 113.011 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -82.67 2.97 30.91 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -84.81 142.84 39.65 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.695 0.283 . . . . 0.0 110.836 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.44 -11.79 22.65 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.341 2.027 . . . . 0.0 111.441 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.77 -43.73 16.39 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 121.931 0.872 . . . . 0.0 108.928 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.91 138.3 5.05 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 113.87 -1.514 . . . . 0.0 110.751 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.8 OUTLIER -56.37 -18.55 11.29 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.971 178.903 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.569 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 3.9 t80 -129.1 117.59 21.08 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-O 120.775 0.321 . . . . 0.0 110.96 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -92.78 107.87 19.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.655 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.9 mp -73.49 -175.04 1.84 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.107 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.16 17.71 49.76 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.804 -0.713 . . . . 0.0 113.037 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 65.43 74.71 0.37 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.022 0.439 . . . . 0.0 111.493 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 25.5 mm -112.0 126.87 69.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.643 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.02 -41.35 71.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.312 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.81 -24.02 65.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.997 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 17.9 mt -98.16 152.11 19.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.879 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.5 p -96.29 164.53 12.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.759 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.692 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 4.8 m-20 -40.06 -57.0 1.75 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.416 0.627 . . . . 0.0 109.584 178.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.427 ' HB2' HD13 ' A' ' 104' ' ' ILE . 6.4 mttp -116.59 85.69 2.36 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.581 ' CE1' ' OG ' ' A' ' 105' ' ' SER . 15.5 t60 -64.59 -44.94 89.02 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.074 -0.967 . . . . 0.0 113.428 -176.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.498 ' CZ ' ' CD2' ' A' ' 68' ' ' PHE . 34.5 p90 -154.1 162.58 41.1 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.139 -0.625 . . . . 0.0 112.053 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 14.3 mt-30 -135.7 155.46 50.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.419 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 65.0 mt -122.97 128.81 75.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.431 HD12 HD21 ' A' ' 100' ' ' LEU . 1.8 pp -118.97 130.97 55.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.008 0.432 . . . . 0.0 111.831 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.405 ' O ' ' HB2' ' A' ' 63' ' ' LYS . 3.2 tp -108.12 139.82 42.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.21 179.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -178.45 -141.36 4.27 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.412 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 58.26 -176.58 0.08 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.798 0.332 . . . . 0.0 110.885 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -63.04 -30.89 71.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.901 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 174.56 66.65 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.493 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -155.62 169.95 23.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.861 0.363 . . . . 0.0 110.935 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.402 ' HG ' ' CD1' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -117.06 149.28 40.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.842 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.431 HD21 HD12 ' A' ' 92' ' ' LEU . 10.8 mp -129.3 146.54 51.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.414 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.89 126.88 55.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.38 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -116.8 115.85 26.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.863 0.363 . . . . 0.0 111.857 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.67 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 7.5 p30 -79.76 143.28 34.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.049 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.461 HG12 ' HA ' ' A' ' 89' ' ' PHE . 12.5 pt -146.19 22.89 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.581 ' OG ' ' CE1' ' A' ' 88' ' ' HIS . 9.2 t -91.43 154.86 18.87 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.6 m -70.22 -52.11 25.7 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.447 178.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -74.42 -2.75 26.81 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.375 -179.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.87 156.08 31.88 Favored Glycine 0 N--CA 1.438 -1.203 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.468 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.45 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 5.0 m -117.44 137.68 52.35 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.796 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -115.52 148.59 39.33 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -177.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.09 113.5 18.45 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.44 177.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 44.79 43.09 6.58 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.93 -11.87 65.63 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.455 178.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -104.99 118.49 36.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.037 0.446 . . . . 0.0 110.682 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.796 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -70.99 124.54 24.61 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.484 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.2 m -96.39 162.87 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.818 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 120' ' ' SER . 2.1 tt0 -69.82 129.59 39.96 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.439 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.67 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 15.4 tttt -53.94 160.62 1.41 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.876 0.37 . . . . 0.0 110.572 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.7 p30 34.58 34.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.303 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.35 145.31 40.29 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.117 179.477 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.428 ' HB3' HD21 ' A' ' 100' ' ' LEU . 5.1 m120 -86.04 130.42 34.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.086 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.407 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 30.4 mm-40 -129.37 146.3 51.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.377 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -72.72 115.01 11.49 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.793 0.33 . . . . 0.0 110.314 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.402 ' CD2' HG12 ' A' ' 147' ' ' ILE . 65.6 tp -54.75 157.71 2.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.382 0.611 . . . . 0.0 111.7 -179.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.43 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.0 OUTLIER -124.28 153.53 41.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.374 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.414 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.06 119.63 15.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.969 0.414 . . . . 0.0 110.291 -179.65 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.55 21.49 64.84 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.235 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.43 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 26.0 t70 -56.94 172.01 0.3 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.997 0.427 . . . . 0.0 111.069 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 4.5 tt0 -145.22 135.58 24.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.165 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.3 mp -110.5 128.73 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.443 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' A' ' 110' ' ' TRP . 3.1 m -103.64 140.02 38.13 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.536 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 28.2 m -140.41 158.45 25.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -178.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 87.32 24.68 35.95 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.332 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.424 ' HB ' ' CZ3' ' A' ' 110' ' ' TRP . 70.2 t -69.56 140.38 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-O 121.632 0.729 . . . . 0.0 111.907 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 143.04 -41.84 1.14 Allowed Glycine 0 N--CA 1.435 -1.385 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.441 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 6.2 t -119.15 126.05 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.28 -35.84 28.91 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 47.3 m -93.49 6.63 47.54 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.441 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 30.6 m-20 -120.81 29.65 7.29 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -178.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.445 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 7.3 mt -106.89 138.91 30.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 121.478 0.656 . . . . 0.0 110.904 178.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.3 tt -124.65 134.64 52.82 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.729 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.498 ' CB ' ' CG2' ' A' ' 40' ' ' THR . 0.9 OUTLIER -109.57 133.39 53.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.001 0.429 . . . . 0.0 111.717 -179.819 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -128.84 135.73 49.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.554 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 24.0 t -110.93 134.45 53.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.829 0.347 . . . . 0.0 111.271 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 5.2 mm -106.11 139.0 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.975 -179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.34 122.35 41.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.798 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.414 ' CD1' ' HA ' ' A' ' 126' ' ' GLN . 6.7 mt -85.01 134.11 27.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.324 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -83.35 103.57 12.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.853 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -64.14 -28.08 69.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.063 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.15 -43.67 87.47 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.062 0.458 . . . . 0.0 110.618 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.407 ' CZ ' HG12 ' A' ' 52' ' ' ILE . 33.5 t80 -58.53 -44.01 89.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.901 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -60.94 -40.45 93.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.955 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -60.61 -37.09 80.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.073 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 10.2 t -64.71 -45.34 86.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.085 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -62.35 -36.01 80.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.919 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -62.19 -34.71 76.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.993 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -92.07 -37.0 13.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.928 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.9 p30 44.36 -171.49 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.598 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -95.92 134.47 38.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.883 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.7 t -80.55 126.62 39.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.14 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -98.85 166.84 11.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.946 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -107.0 114.54 28.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.874 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.8 mt -85.4 134.56 26.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.075 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.87 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.852 0.358 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -62.66 119.65 52.74 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.826 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.89 126.56 11.41 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.359 2.039 . . . . 0.0 112.427 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -107.69 78.51 1.2 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.709 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.6 173.06 6.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.904 0.383 . . . . 0.0 111.555 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . 0.515 ' O ' ' O ' ' B' ' 172' ' ' ILE . 31.0 mt-10 -161.47 92.71 0.9 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.723 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.515 ' O ' ' O ' ' B' ' 171' ' ' GLU . 0.9 OUTLIER 44.85 114.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 121.349 0.595 . . . . 0.0 112.047 -179.73 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 173' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -80.99 60.53 4.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.055 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 83.4 p . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.854 179.951 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.772 0.32 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.7 m 70.37 -64.17 0.37 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.903 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -41.11 88.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.921 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -62.13 -35.98 80.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.844 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -56.86 -39.26 73.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.741 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.8 mp -61.37 -31.91 71.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.422 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.42 ' O ' ' CD1' ' A' ' 23' ' ' PHE . 8.2 mt -69.21 -44.4 80.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.771 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -57.56 -32.71 67.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.418 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.5 -22.28 7.82 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.01 -179.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.42 ' CD1' ' O ' ' A' ' 20' ' ' ILE . 1.9 p90 -55.66 -44.3 77.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.925 0.393 . . . . 0.0 111.474 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.419 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 51.8 p -80.38 -25.13 39.28 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.935 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 65.11 141.24 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.866 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -63.04 140.91 58.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.826 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -82.82 109.02 16.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.923 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.4 mm -81.92 138.39 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 CA-C-O 121.615 0.721 . . . . 0.0 111.694 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.79 52.41 3.15 Favored Glycine 0 C--N 1.313 -0.705 0 CA-C-N 114.593 -1.185 . . . . 0.0 112.359 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -73.89 -44.6 54.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.853 0.359 . . . . 0.0 111.112 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.424 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER -170.38 33.31 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -179.767 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.702 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -73.2 133.84 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-N 113.839 -1.528 . . . . 0.0 112.407 -177.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.488 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.8 t -92.54 -61.37 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.09 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.6 p -143.38 163.44 33.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.272 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 146' ' ' PHE . 0.0 OUTLIER -127.05 138.3 53.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.962 0.411 . . . . 0.0 111.782 -179.131 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.426 HG22 ' CD2' ' A' ' 76' ' ' TYR . 2.0 m -108.63 122.9 63.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.579 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.413 ' CG2' HG12 ' A' ' 45' ' ' ILE . 21.5 mt -128.42 122.11 56.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.991 -178.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 42.0 t -81.81 102.63 10.93 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 178.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -23.82 59.12 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.466 HG23 ' HB3' ' A' ' 142' ' ' SER . 72.2 p -79.78 -2.29 42.55 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.683 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.23 77.19 0.37 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.87 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -146.62 -41.0 0.2 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.935 0.398 . . . . 0.0 110.696 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.545 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.3 mp -125.77 141.34 38.98 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.8 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.545 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 46.8 Cg_endo -71.68 146.1 48.07 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.102 1.868 . . . . 0.0 112.137 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.413 HG12 ' CG2' ' A' ' 37' ' ' ILE . 39.2 mt -51.44 148.33 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.898 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.84 150.3 49.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.083 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -112.87 119.63 38.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.049 0.452 . . . . 0.0 111.368 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.521 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 3.1 mt -95.98 135.26 37.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.227 178.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.702 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -146.04 158.01 43.87 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -178.834 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.488 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -140.91 143.26 34.53 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 113.528 -1.669 . . . . 0.0 110.861 178.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.481 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 23.3 m-20 -74.92 122.31 23.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.223 0.535 . . . . 0.0 111.093 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.4 mt -64.34 -40.96 90.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.4 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 p -57.05 -42.17 80.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.229 0.538 . . . . 0.0 110.825 -178.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.481 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 13.4 mt-30 -68.7 -37.13 79.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.891 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.1 t -65.59 -45.51 92.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.283 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.13 -28.9 64.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.12 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.1 tmtm? -81.0 -46.78 14.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.048 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -77.08 135.0 38.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.905 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.98 29.39 4.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.9 mtm105 -150.21 151.81 33.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.865 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 59.42 -174.64 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.822 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.5 tp -81.96 144.46 10.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.1 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 tpmp? -69.38 -72.57 0.18 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.965 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.433 ' CE ' ' O ' ' A' ' 49' ' ' SER . 6.0 ttpt -149.38 137.37 20.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.952 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.44 HG11 ' HG2' ' A' ' 90' ' ' GLN . 13.9 t -128.79 139.09 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-O 121.375 0.607 . . . . 0.0 112.299 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.526 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 15.9 m-90 -103.03 139.24 38.84 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.887 179.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -114.21 129.05 56.63 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.338 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.515 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -118.3 145.45 45.07 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.6 -178.305 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.592 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.43 -166.6 35.38 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.393 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 -86.73 6.98 28.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.504 0.192 . . . . 0.0 111.512 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.401 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 9.7 t-20 -84.95 134.01 42.19 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.547 0.213 . . . . 0.0 111.036 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.9 Cg_exo -65.43 -15.07 48.13 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.53 2.153 . . . . 0.0 111.598 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.15 -43.26 16.38 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 121.962 0.887 . . . . 0.0 108.887 178.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.47 136.03 3.38 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 113.862 -1.517 . . . . 0.0 111.045 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.9 OUTLIER -56.87 -18.62 13.79 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.952 178.611 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.534 ' CE1' HG22 ' A' ' 43' ' ' ILE . 30.5 t80 -129.57 112.1 13.38 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.783 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -89.75 111.63 22.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.22 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 88.4 mt -78.52 -172.81 3.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.839 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -90.66 21.12 34.51 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.891 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.04 74.68 0.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.944 0.402 . . . . 0.0 111.601 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.3 mp -106.62 129.18 60.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.723 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.7 m -54.91 -37.21 66.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.293 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.418 ' HA ' ' CD2' ' B' ' 170' ' ' LEU . 0.0 OUTLIER -69.32 -15.94 63.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.452 -179.814 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 28.4 mt -107.06 152.01 24.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.719 0.295 . . . . 0.0 110.833 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.4 m -95.79 166.63 11.72 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.496 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.592 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 1.4 m-80 -42.46 -57.55 2.59 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.439 0.638 . . . . 0.0 109.545 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.413 ' O ' HG13 ' A' ' 104' ' ' ILE . 10.3 mtpt -116.79 84.39 2.13 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 176.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.536 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 12.4 t60 -60.89 -46.73 89.46 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.596 -176.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.492 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 25.6 p90 -145.08 158.07 43.93 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.116 -0.634 . . . . 0.0 112.157 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.44 ' HG2' HG11 ' A' ' 65' ' ' VAL . 4.9 tt0 -135.9 139.91 43.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.164 -179.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.428 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 72.6 mt -115.97 130.23 71.02 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 C-N-CA 121.134 -0.227 . . . . 0.0 111.002 179.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.423 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.2 OUTLIER -115.53 150.83 35.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.12 0.486 . . . . 0.0 111.851 -179.888 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 14.6 tp -124.99 122.87 38.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.223 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -82.67 -178.26 52.29 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.82 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -96.38 110.17 22.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.819 0.343 . . . . 0.0 110.864 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.1 t0 57.94 98.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.948 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 162.75 -94.32 0.12 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.515 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -154.18 -171.13 3.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.843 0.354 . . . . 0.0 110.864 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.2 mp -106.95 157.16 18.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.762 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.8 mt -133.2 144.38 49.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.893 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 mt -112.73 123.21 49.78 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.745 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 90' ' ' GLN . 52.0 t30 -114.68 115.55 27.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.062 0.458 . . . . 0.0 111.664 -179.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.702 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 14.1 p30 -77.71 134.61 38.07 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.733 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 87' ' ' LYS . 13.7 pt -141.71 39.48 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.532 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -101.93 151.63 21.88 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.005 0.431 . . . . 0.0 112.021 -178.892 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.44 ' CG2' ' HB ' ' B' ' 169' ' ' TPO . 19.6 m -68.89 -31.59 70.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.688 177.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -95.11 -19.55 20.02 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.328 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.526 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 112.78 158.96 13.82 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.781 179.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.533 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 11.4 m -117.1 137.69 52.12 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.838 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -115.89 148.32 40.12 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -177.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.31 113.52 18.35 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.66 -1.155 . . . . 0.0 108.419 177.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 43.74 43.77 5.15 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.51 -11.14 66.87 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.58 178.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -103.57 118.59 37.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.027 0.441 . . . . 0.0 110.583 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.838 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 12.2 tptm -74.53 122.3 22.88 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.382 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.9 m -91.59 164.17 2.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.971 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 120' ' ' SER . 15.9 tt0 -69.89 126.26 29.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.468 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.702 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 28.2 tttt -53.2 162.69 0.66 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.944 0.402 . . . . 0.0 110.441 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.1 m-80 34.67 35.0 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.03 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.4 OUTLIER -112.27 145.01 40.72 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.293 179.578 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -89.11 125.56 35.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.727 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -129.31 147.65 51.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.089 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 tt -76.34 115.3 15.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.104 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -56.99 165.84 1.17 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.604 0.716 . . . . 0.0 112.043 -178.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.445 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.64 153.65 41.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.073 179.657 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -71.17 123.22 21.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.013 0.435 . . . . 0.0 110.287 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.06 20.19 53.16 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.107 -179.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.445 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 7.7 t70 -58.58 178.8 0.09 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.745 0.307 . . . . 0.0 110.673 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 5.4 mt-10 -145.11 135.61 24.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.415 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 15.3 mt -112.04 126.91 69.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.215 178.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.425 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 4.2 m -104.33 138.66 40.44 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.536 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.8 m -140.01 158.12 26.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.138 0.494 . . . . 0.0 112.268 -178.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 89.47 24.02 32.23 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.951 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.452 ' HB ' ' CZ3' ' A' ' 110' ' ' TRP . 73.5 t -71.12 140.52 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-O 121.654 0.74 . . . . 0.0 112.021 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.05 -45.74 0.66 Allowed Glycine 0 N--CA 1.433 -1.525 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.479 ' CG2' HG12 ' B' ' 172' ' ' ILE . 1.7 t -110.51 131.41 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -50.56 -44.22 56.53 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.8 m -93.37 6.92 46.48 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -178.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.463 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 16.5 m-20 -117.01 34.4 5.13 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -178.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.425 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 6.4 mt -107.01 139.09 29.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.973 178.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.2 tt -124.33 134.71 53.1 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.862 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.466 ' HB3' HG23 ' A' ' 40' ' ' THR . 47.1 t -110.33 150.34 28.9 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.658 0.742 . . . . 0.0 112.195 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 75.0 mt -135.87 158.1 45.21 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.881 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 22.4 t -122.54 139.92 47.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.852 0.358 . . . . 0.0 111.026 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 30.7 mt -106.3 120.96 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.833 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.406 ' O ' ' N ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -109.99 108.62 18.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.841 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.1 mt -84.6 128.98 38.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.245 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -77.82 114.16 16.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -69.02 -31.59 70.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -57.39 -43.38 83.61 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.066 0.46 . . . . 0.0 110.411 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -58.18 -44.08 87.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.624 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -65.12 -34.43 78.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.957 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -64.13 -43.45 95.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.068 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 13.2 t -58.9 -46.21 88.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.939 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.1 -35.93 76.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.83 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -37.68 80.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -88.32 -37.12 16.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.94 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.5 p30 44.24 -171.33 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.6 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.87 120.54 25.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.819 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 26.3 t -103.06 129.5 54.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.077 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -119.64 -68.38 0.92 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.958 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? 61.16 31.35 19.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.864 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 20.4 mt -102.79 117.18 47.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.178 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.176 -0.916 . . . . 0.0 110.945 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.888 0.375 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.1 146.81 33.27 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.832 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.29 155.01 56.47 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.474 2.116 . . . . 0.0 112.376 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -112.39 97.47 6.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.799 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 169' ' ' TPO . . . . . 0.44 ' HB ' ' CG2' ' A' ' 106' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . 0.418 ' CD2' ' HA ' ' A' ' 83' ' ' ARG . 2.3 tt -53.36 152.18 4.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.437 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . 0.502 ' O ' ' O ' ' B' ' 172' ' ' ILE . 53.6 mt-10 -153.83 79.76 1.14 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.869 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.502 ' O ' ' O ' ' B' ' 171' ' ' GLU . 0.1 OUTLIER 53.37 134.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 121.182 0.515 . . . . 0.0 111.587 -179.862 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 173' ' ' TYR . . . . . 0.428 ' N ' ' CD1' ' B' ' 172' ' ' ILE . 20.9 m-85 -56.17 105.67 0.21 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.939 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 1.3 p . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.899 -179.973 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.646 0.26 . . . . 0.0 111.031 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.0 m 74.99 -52.91 0.67 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.413 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -59.66 -34.27 72.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.712 0.292 . . . . 0.0 110.962 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.81 -38.27 90.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.76 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -61.42 -40.77 95.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.716 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.6 mt -58.93 -31.83 69.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.726 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.402 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.8 mt -72.55 -35.31 50.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.921 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -57.32 -42.88 82.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.478 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.21 -24.17 65.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.537 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.402 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.91 -47.57 80.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.204 179.859 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.1 t -70.89 -31.12 67.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.001 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -63.08 82.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.858 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -65.22 155.34 35.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.767 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -85.56 101.86 13.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.931 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.42 HG23 ' N ' ' A' ' 29' ' ' GLY . 18.3 mm -84.45 138.18 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 CA-C-O 121.611 0.72 . . . . 0.0 111.656 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.42 ' N ' HG23 ' A' ' 28' ' ' ILE . . . 139.07 43.61 0.08 OUTLIER Glycine 0 C--N 1.313 -0.701 0 CA-C-N 114.546 -1.206 . . . . 0.0 112.549 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -59.89 -41.39 91.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.912 0.387 . . . . 0.0 110.792 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.439 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.0 OUTLIER -179.88 37.22 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.92 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.704 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.4 mm -73.48 135.67 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 CA-C-N 113.664 -1.607 . . . . 0.0 112.45 -177.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.491 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.4 t -91.81 -59.77 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.916 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.0 p -150.59 152.03 33.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.26 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.99 138.21 50.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.817 0.341 . . . . 0.0 111.352 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.3 t -100.73 122.77 53.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.829 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.0 mt -132.93 122.08 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.581 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 51.4 t -80.68 136.55 36.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.405 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.405 ' HB ' HG21 ' A' ' 144' ' ' VAL . 1.3 t -97.38 -29.23 13.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.625 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.499 HG21 ' HB3' ' A' ' 142' ' ' SER . 70.4 p -79.79 -2.32 42.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.771 0.319 . . . . 0.0 111.472 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.51 78.27 0.25 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.909 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -146.58 -41.19 0.2 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.736 0.303 . . . . 0.0 111.122 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.526 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.5 mt -114.8 140.6 25.63 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.065 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.526 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.1 Cg_endo -74.35 145.93 34.86 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.24 1.96 . . . . 0.0 112.042 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.0 mt -61.92 136.69 24.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.805 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.06 164.17 26.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.08 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -117.77 123.21 45.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.128 0.49 . . . . 0.0 112.115 -179.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.529 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 0.8 OUTLIER -101.21 135.65 42.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.507 -0.77 . . . . 0.0 108.923 178.472 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.704 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.21 159.1 43.53 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -178.764 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.491 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -146.71 149.89 34.31 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 113.766 -1.561 . . . . 0.0 111.146 178.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.416 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 11.5 m-20 -79.18 123.95 27.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.088 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 49.3 mt -64.46 -42.58 95.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.176 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.3 p -56.97 -40.0 75.68 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.307 0.575 . . . . 0.0 110.704 -179.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.416 ' CG ' ' HB2' ' A' ' 51' ' ' ASP . 4.6 mm100 -68.58 -36.89 79.33 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.756 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.4 t -73.04 -49.1 41.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.126 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.22 -29.6 68.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.928 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.2 tptt -77.31 -59.07 2.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.785 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -76.69 133.91 39.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.886 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.77 49.56 2.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.984 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.74 -65.63 0.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.924 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 31.3 t -178.99 -38.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.754 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.447 HG22 HD13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -132.62 151.22 34.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.949 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.404 ' N ' ' CD1' ' A' ' 62' ' ' ILE . 0.1 OUTLIER -117.58 -64.62 1.28 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.133 -179.859 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.403 ' CE ' ' O ' ' A' ' 49' ' ' SER . 6.4 ttpt -137.17 130.83 31.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.003 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 4.4 t -118.69 136.33 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 121.36 0.6 . . . . 0.0 111.94 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.604 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 15.4 m-90 -100.68 140.37 35.05 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.516 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.538 ' HA ' ' HG2' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -111.35 129.22 56.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.201 177.978 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.642 ' CD1' ' HB2' ' A' ' 76' ' ' TYR . 5.8 m-85 -120.39 145.42 47.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.472 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.645 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.49 -168.64 36.76 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.025 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.44 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 6.4 mtm105 -79.03 3.09 18.31 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.431 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 23.7 t-20 -84.7 131.74 48.62 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.612 0.244 . . . . 0.0 111.101 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.0 Cg_exo -66.14 -14.01 42.45 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.584 2.189 . . . . 0.0 111.59 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.87 -44.05 15.87 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 121.841 0.829 . . . . 0.0 108.803 178.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -40.19 138.91 0.79 Allowed 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 113.78 -1.554 . . . . 0.0 110.951 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 67' ' ' THR . 10.9 m-20 -56.73 -19.22 15.6 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.355 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.642 ' HB2' ' CD1' ' A' ' 68' ' ' PHE . 12.6 t80 -130.36 113.66 14.63 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.672 0.273 . . . . 0.0 111.027 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.418 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.6 t-160 -85.87 107.83 17.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.672 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.494 ' HA ' HG12 ' A' ' 43' ' ' ILE . 8.0 mp -81.77 -78.76 0.18 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.007 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -173.25 -94.24 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.084 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.402 ' HA ' ' HD2' ' A' ' 70' ' ' ARG . 8.5 p30 -179.81 50.29 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.825 0.345 . . . . 0.0 111.143 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.433 HG22 HD13 ' A' ' 81' ' ' ILE . 26.0 mm -79.05 125.49 38.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.848 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.93 -37.21 66.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.913 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.416 ' CD ' ' CB ' ' A' ' 139' ' ' ASP . 6.2 mtp180 -69.53 -37.14 76.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.108 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.4 ' CD2' ' CE1' ' A' ' 88' ' ' HIS . 44.6 mt -83.74 151.58 25.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.837 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 95.3 p -97.79 164.8 12.24 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.656 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.645 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.5 m-20 -42.55 -52.4 4.77 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.497 0.665 . . . . 0.0 109.61 179.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.409 ' HB3' HD13 ' A' ' 104' ' ' ILE . 3.8 mttt -118.9 84.14 2.14 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 177.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.552 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.4 t60 -62.88 -44.7 95.4 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.103 -0.953 . . . . 0.0 113.137 -176.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.468 ' CD1' ' HB2' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -148.7 161.8 41.02 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.985 -0.686 . . . . 0.0 112.234 -179.564 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.538 ' HG2' ' HA ' ' A' ' 67' ' ' THR . 28.3 mt-30 -135.08 155.53 50.58 Favored 'General case' 0 C--N 1.334 -0.065 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.389 -178.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 32.5 mt -130.48 132.49 64.61 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.343 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 177.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.419 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.9 OUTLIER -122.73 145.78 48.09 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.069 0.461 . . . . 0.0 111.877 -179.392 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.2 tp -125.1 144.28 50.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.185 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.37 165.38 31.85 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.488 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -63.76 118.48 8.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.808 0.337 . . . . 0.0 110.956 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 176.96 -36.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.844 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 115.57 22.01 4.89 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.568 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -159.68 -177.59 6.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.766 0.317 . . . . 0.0 110.792 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.74 158.75 24.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.851 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -124.06 138.83 54.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.469 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.2 mp -112.6 125.06 53.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.048 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.419 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 50.4 t30 -115.8 115.75 26.82 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.689 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 8.8 p30 -78.08 142.9 37.83 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.409 HD13 ' HB3' ' A' ' 87' ' ' LYS . 8.1 pt -150.35 37.56 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -178.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.552 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -99.43 148.52 24.13 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 120.948 0.404 . . . . 0.0 111.712 -179.045 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.2 m -68.63 -31.37 70.47 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.64 177.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -94.56 -19.54 20.41 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.51 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.8 152.0 9.6 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.227 -0.987 . . . . 0.0 113.888 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.499 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.7 m -117.57 137.86 52.31 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.841 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -118.39 148.3 42.67 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.16 113.65 18.61 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.484 177.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 45.3 43.01 7.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.273 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.5 -7.65 75.35 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.512 178.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -104.42 118.63 37.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.018 0.437 . . . . 0.0 110.671 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.841 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.0 tptm -74.12 121.5 21.25 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.187 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.2 m -96.22 163.57 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.133 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -69.77 128.83 37.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.493 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.689 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 12.4 tttt -53.72 162.77 0.8 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.764 0.316 . . . . 0.0 110.29 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.8 m-80 33.5 37.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.846 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.9 p -111.78 145.16 39.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.893 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -88.83 124.44 34.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.864 0.364 . . . . 0.0 110.713 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 -128.98 149.45 50.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.598 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.5 tp -72.63 132.85 44.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.889 0.376 . . . . 0.0 110.441 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.404 ' HG ' ' N ' ' A' ' 125' ' ' SER . 64.0 tp -69.47 157.85 36.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.428 0.633 . . . . 0.0 111.519 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.446 ' O ' HD13 ' A' ' 147' ' ' ILE . 0.6 OUTLIER -124.33 153.17 42.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.926 179.59 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.414 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.25 122.9 21.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.979 0.419 . . . . 0.0 110.659 -179.314 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 56.98 22.93 44.05 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.267 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.428 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 15.5 t70 -56.17 175.06 0.11 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.852 0.358 . . . . 0.0 110.828 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.0 mt-10 -143.8 135.63 26.36 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.081 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 2.2 mp -112.5 128.14 69.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.574 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.44 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.0 m -104.32 145.12 30.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.443 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.503 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 29.9 m -140.37 158.46 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.052 0.453 . . . . 0.0 112.156 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.51 42.01 12.32 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.268 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.454 ' HB ' ' CH2' ' A' ' 110' ' ' TRP . 74.8 t -86.67 140.4 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-O 121.544 0.688 . . . . 0.0 112.124 -179.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 139.22 -34.1 2.1 Favored Glycine 0 N--CA 1.435 -1.371 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.42 ' CG2' ' CD1' ' B' ' 172' ' ' ILE . 9.0 t -124.56 118.34 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -50.77 -29.6 11.94 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -178.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 31.9 m -93.61 6.7 47.38 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -178.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.416 ' CB ' ' CD ' ' A' ' 83' ' ' ARG . 0.8 OUTLIER -130.07 31.28 4.69 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -178.583 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.44 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 6.1 mt -107.11 138.46 32.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-O 121.351 0.595 . . . . 0.0 110.866 178.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.3 tt -125.09 134.72 52.38 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.692 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.499 ' HB3' HG21 ' A' ' 40' ' ' THR . 44.4 t -106.84 149.62 27.22 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.544 0.688 . . . . 0.0 112.066 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 75.6 mt -136.39 158.04 45.36 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.695 -1.138 . . . . 0.0 111.219 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.405 HG21 ' HB ' ' A' ' 39' ' ' THR . 21.7 t -129.18 140.16 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.851 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.1 mm -106.36 129.55 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 CA-C-O 120.944 0.402 . . . . 0.0 110.911 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.02 110.67 21.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.858 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.446 HD13 ' O ' ' A' ' 125' ' ' SER . 4.3 mp -85.83 134.14 27.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.483 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -84.94 123.69 30.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.819 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -72.01 -27.78 62.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.069 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -58.74 -44.43 90.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.035 0.445 . . . . 0.0 110.756 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -59.36 -44.09 92.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.898 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.06 -40.66 95.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.905 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -59.16 -47.03 86.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.086 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 11.8 t -60.91 -45.99 92.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.968 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.65 -43.46 98.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.911 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -61.47 -39.6 91.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.814 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -68.17 -26.02 65.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.926 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -123.54 96.73 5.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.006 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 6.9 mttm -107.72 136.24 47.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.825 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.2 m -65.01 126.52 24.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.107 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -152.35 -46.05 0.1 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.952 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 63.15 -79.58 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.01 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.3 pp -89.19 135.01 26.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.178 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.955 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 5.6 p30 . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.784 0.326 . . . . 0.0 111.256 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.96 100.82 53.17 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.908 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -49.36 167.39 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.483 2.122 . . . . 0.0 112.381 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -108.52 117.47 34.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.915 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -156.4 -176.56 6.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.068 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . 0.509 ' O ' ' O ' ' B' ' 172' ' ' ILE . 31.0 mt-10 -145.24 68.6 1.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.94 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.509 ' O ' ' O ' ' B' ' 171' ' ' GLU . 15.0 tt 49.22 157.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.161 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 173' ' ' TYR . . . . . 0.416 ' N ' ' CG1' ' B' ' 172' ' ' ILE . 11.8 m-85 -53.85 92.1 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.078 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.951 -179.988 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.847 0.356 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.8 p -125.05 -44.28 1.92 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.954 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -46.98 64.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.95 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.3 ttm-85 -69.9 -43.25 72.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.9 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.66 -35.01 73.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.842 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.64 -40.81 96.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.94 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.475 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 10.2 mm -72.45 -35.29 51.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.231 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -57.41 -40.37 78.15 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.923 0.392 . . . . 0.0 110.301 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.24 -23.89 65.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.749 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.475 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.64 -47.63 79.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.364 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.62 -47.04 14.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.093 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -129.93 114.07 15.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.105 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -70.88 158.76 35.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -87.61 101.86 14.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.923 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.2 mm -86.9 138.48 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 CA-C-O 121.719 0.771 . . . . 0.0 111.903 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.7 62.79 4.29 Favored Glycine 0 C--N 1.316 -0.572 0 CA-C-N 114.443 -1.253 . . . . 0.0 112.581 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -83.81 -43.01 15.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.873 0.368 . . . . 0.0 110.986 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.419 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER -169.99 34.68 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 -179.9 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.662 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 2.9 mm -77.77 134.02 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 CA-C-N 113.878 -1.51 . . . . 0.0 112.58 -177.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.465 ' CG2' ' HA ' ' A' ' 49' ' ' SER . 2.8 t -90.25 -60.89 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.677 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.6 p -146.14 150.8 36.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.169 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.97 138.12 50.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.743 0.306 . . . . 0.0 111.214 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.6 t -101.7 122.66 54.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.874 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.9 mt -129.43 125.78 62.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.405 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.4 t -95.36 107.37 19.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.904 0.383 . . . . 0.0 110.485 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 79.3 p -82.02 -20.6 38.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.516 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.533 HG23 ' CB ' ' A' ' 142' ' ' SER . 12.3 p -80.04 -3.1 47.11 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.736 0.303 . . . . 0.0 111.333 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.39 70.93 0.97 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 121.087 -0.578 . . . . 0.0 113.775 178.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -145.08 -37.36 0.28 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.623 0.249 . . . . 0.0 111.469 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.57 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 52.2 mt -123.55 142.83 39.99 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.097 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.57 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 53.0 Cg_endo -71.97 146.04 46.37 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.206 1.937 . . . . 0.0 112.25 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.2 mt -59.58 144.22 12.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.773 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.34 164.02 31.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.013 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -131.64 119.85 21.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.993 0.425 . . . . 0.0 112.114 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.517 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 8.2 mp -87.25 133.83 33.62 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 178.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.662 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -138.69 156.18 47.62 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 -179.444 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.462 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -143.87 141.75 30.47 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 113.455 -1.702 . . . . 0.0 110.706 178.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.491 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 39.9 m-20 -89.17 128.1 35.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.077 0.465 . . . . 0.0 111.232 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.1 mp -64.26 -45.18 96.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.81 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 73.2 m -56.66 -41.22 76.87 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.343 0.592 . . . . 0.0 110.603 -178.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.491 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 19.6 mt-30 -68.49 -36.58 79.13 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.228 -0.897 . . . . 0.0 110.546 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.3 t -58.68 -49.26 83.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.066 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.6 -37.28 80.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.956 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -67.35 -36.22 80.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.918 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.78 114.83 23.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.69 88.4 4.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.805 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.68 156.42 9.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m -57.84 -26.84 62.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.031 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.433 ' CD1' ' CG2' ' A' ' 65' ' ' VAL . 8.5 tp -114.99 146.95 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.111 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -131.98 -43.95 0.97 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.252 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.408 ' NZ ' ' HA ' ' A' ' 50' ' ' ALA . 2.6 ttpt -154.77 134.03 12.5 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.933 0.397 . . . . 0.0 111.648 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.464 HG11 ' HB3' ' A' ' 92' ' ' LEU . 21.8 t -135.34 139.43 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.776 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.517 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 19.7 m-90 -102.21 138.7 38.81 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.086 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.52 125.15 52.66 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.548 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 0.8 OUTLIER -108.09 145.58 33.85 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.305 -178.668 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.657 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 166.64 178.52 39.27 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.831 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.445 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 9.3 mtp-105 -73.46 -5.29 39.01 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.422 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.0 t-20 -84.89 134.96 40.53 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.699 0.285 . . . . 0.0 111.038 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 10.0 Cg_exo -69.76 -5.22 15.68 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.815 2.343 . . . . 0.0 111.831 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.54 -43.38 17.19 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 122.022 0.915 . . . . 0.0 108.558 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -44.04 139.34 2.51 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 113.641 -1.618 . . . . 0.0 110.469 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -56.12 -18.93 11.26 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.066 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.548 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 7.0 t80 -129.73 133.25 46.92 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.866 0.365 . . . . 0.0 110.94 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -109.77 120.42 42.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.643 179.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.417 ' HB3' ' CD1' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -101.36 -81.63 0.48 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.124 -179.879 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.09 -133.07 1.41 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.512 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -138.73 66.7 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.879 0.371 . . . . 0.0 111.439 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.445 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 31.6 mm -97.11 117.8 42.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.253 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.411 ' HB2' ' CD1' ' B' ' 170' ' ' LEU . 92.5 p -54.77 -30.98 58.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.19 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.507 ' HG3' ' HB3' ' A' ' 139' ' ' ASP . 1.6 mmp_? -71.51 -23.65 61.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.386 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.421 HD21 ' CE1' ' A' ' 88' ' ' HIS . 29.5 mt -94.23 152.08 18.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.503 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 85.7 p -96.57 166.6 11.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.851 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.657 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 1.5 m-80 -42.81 -52.88 4.86 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.437 0.637 . . . . 0.0 109.675 179.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.452 ' HB2' HD12 ' A' ' 104' ' ' ILE . 3.7 ptmm? -120.51 84.78 2.28 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 177.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.571 ' CD2' ' HB2' ' A' ' 105' ' ' SER . 14.1 t60 -60.3 -46.99 87.94 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.952 -1.022 . . . . 0.0 113.042 -176.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.47 ' HA ' HG12 ' A' ' 104' ' ' ILE . 29.3 p90 -151.61 159.54 44.02 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.874 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.453 ' HG2' HG12 ' A' ' 65' ' ' VAL . 5.2 tt0 -136.11 139.56 43.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.55 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.427 ' O ' ' CG1' ' A' ' 65' ' ' VAL . 29.4 mt -116.17 129.58 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.915 179.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.464 ' HB3' HG11 ' A' ' 65' ' ' VAL . 0.4 OUTLIER -114.58 149.33 36.7 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.234 0.54 . . . . 0.0 112.029 -179.541 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.9 tp -125.19 125.88 44.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.033 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -123.01 149.37 16.82 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.584 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.45 107.41 0.66 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.791 0.329 . . . . 0.0 110.899 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -177.8 -39.62 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.896 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 130.8 -21.44 4.7 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.654 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -109.23 172.33 6.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.76 0.314 . . . . 0.0 111.076 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.7 mt -116.07 160.06 20.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.665 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.429 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 6.3 mp -125.51 139.15 53.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.55 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.87 123.4 50.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.084 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.43 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 61.1 t30 -117.74 115.85 25.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.889 0.376 . . . . 0.0 111.967 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.678 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 11.3 p30 -78.49 142.99 37.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.924 178.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.47 HG12 ' HA ' ' A' ' 89' ' ' PHE . 11.5 pt -147.76 28.0 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.651 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.571 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 11.3 t -93.56 155.09 17.5 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 121.584 0.707 . . . . 0.0 112.598 -178.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 65.9 m -70.1 -52.17 25.83 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.731 178.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -78.54 0.57 25.63 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.44 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.07 154.28 30.77 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 120.75 -0.738 . . . . 0.0 114.041 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 3.7 m -117.5 137.86 52.26 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.789 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -116.1 148.54 40.16 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -177.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -124.44 113.64 18.41 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.956 177.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 48.3 35.53 5.73 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.072 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.17 -4.8 83.05 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.853 -0.689 . . . . 0.0 113.515 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.37 118.57 36.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.934 0.397 . . . . 0.0 110.498 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.789 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 9.1 tptm -71.04 111.64 6.56 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.128 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.1 m -87.89 162.95 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.106 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.8 OUTLIER -69.91 127.88 34.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.497 179.725 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.678 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 53.9 tttm -54.47 161.68 1.35 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.865 0.364 . . . . 0.0 110.517 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.506 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.9 p30 35.45 33.89 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.371 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.38 145.09 40.71 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.991 179.279 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -90.14 131.42 36.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.904 0.383 . . . . 0.0 110.976 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.429 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 43.9 mm-40 -129.28 148.77 51.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.43 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.61 123.96 24.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.374 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.8 tt -55.21 154.34 5.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.484 0.659 . . . . 0.0 111.723 -179.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.412 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.73 153.24 42.68 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.303 179.73 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.66 126.35 29.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.828 0.347 . . . . 0.0 110.182 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.44 20.3 50.69 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.224 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.412 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 11.0 t70 -53.48 164.36 0.51 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.892 0.377 . . . . 0.0 111.074 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.405 ' CG ' ' O ' ' A' ' 143' ' ' LEU . 3.7 tt0 -144.26 135.39 25.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.928 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 1.4 mp -109.1 127.02 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.598 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.464 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.7 m -104.17 140.48 37.76 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.514 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.0 m -140.18 158.42 25.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.87 23.6 41.28 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.283 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.419 ' HB ' ' CH2' ' A' ' 110' ' ' TRP . 82.2 t -68.34 140.47 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-O 121.515 0.674 . . . . 0.0 111.915 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 141.79 -41.23 1.24 Allowed Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -178.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.445 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 2.2 t -120.32 123.31 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.16 -31.05 12.63 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.68 6.75 47.29 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -178.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.507 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . 16.7 m-20 -125.34 31.0 5.67 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -178.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.464 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 10.0 mt -106.42 138.71 30.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-O 121.456 0.646 . . . . 0.0 110.985 178.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.1 tt -124.76 134.53 52.76 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.517 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.533 ' CB ' HG23 ' A' ' 40' ' ' THR . 0.7 OUTLIER -111.43 131.47 55.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.072 0.463 . . . . 0.0 111.698 -179.699 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.405 ' O ' ' CG ' ' A' ' 129' ' ' GLU . 2.8 mm? -127.56 134.41 49.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.555 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.8 t -110.68 133.96 54.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.854 0.359 . . . . 0.0 111.18 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.2 mm -106.2 121.22 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.08 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -99.88 129.39 45.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.663 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.414 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 3.3 mp -92.54 129.21 43.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.867 0.365 . . . . 0.0 111.209 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -82.81 113.26 20.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.983 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 28.4 p-10 -61.17 -26.69 67.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.976 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.65 -43.44 84.92 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.007 0.432 . . . . 0.0 110.556 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -58.73 -43.7 90.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.746 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.0 mtmp? -63.77 -34.64 78.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.89 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.84 -36.89 78.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.065 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.0 t -66.1 -41.94 89.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.925 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.58 -37.86 82.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.942 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.28 -46.17 90.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.933 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -80.37 -34.05 36.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.1 p30 42.31 85.06 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.534 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -74.94 128.44 35.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.925 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 28.5 t -93.92 127.05 46.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.058 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 60.99 -178.34 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -106.14 172.47 6.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.0 pt -100.83 116.87 45.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.212 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.855 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.854 0.359 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -113.21 113.24 49.04 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.914 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.57 -177.39 0.9 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.313 2.009 . . . . 0.0 112.137 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -143.74 48.61 1.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.045 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . 0.433 ' CD2' ' HA ' ' A' ' 83' ' ' ARG . 1.5 tt -57.64 152.8 14.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.5 -179.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -151.73 143.97 24.0 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.62 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.44 ' CD1' ' CG2' ' A' ' 136' ' ' VAL . 1.1 tp -52.83 140.77 7.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.967 0.413 . . . . 0.0 111.236 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 173' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -42.73 162.69 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.257 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 74.4 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.911 -179.995 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.808 0.337 . . . . 0.0 110.753 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER -179.73 37.74 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.658 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.1 mm -76.75 137.52 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 CA-C-N 113.812 -1.54 . . . . 0.0 112.574 -177.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.98 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.1 t -92.98 -59.85 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.826 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.401 ' SG ' HD22 ' A' ' 48' ' ' LEU . 21.4 p -148.19 162.52 39.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.218 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.406 ' HB3' ' HB2' ' A' ' 146' ' ' PHE . 2.8 ttm180 -119.98 138.31 53.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.896 0.379 . . . . 0.0 111.221 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.657 HG11 ' CE2' ' A' ' 68' ' ' PHE . 2.1 m -106.62 122.7 60.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.728 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.867 HG23 HG12 ' A' ' 45' ' ' ILE . 20.5 mt -127.03 130.13 71.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.525 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.713 ' HA ' HD13 ' A' ' 143' ' ' LEU . 41.9 t -86.99 119.37 27.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.559 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.43 ' OG1' HG23 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -86.06 -26.48 25.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.578 -179.244 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.511 HG21 ' H ' ' A' ' 142' ' ' SER . 68.9 p -79.83 -2.36 43.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.717 0.294 . . . . 0.0 111.464 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.19 77.22 0.22 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.903 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.506 ' OE1' HD11 ' A' ' 141' ' ' LEU . 12.8 mt-30 -146.92 -43.32 0.18 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.871 0.367 . . . . 0.0 110.955 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.573 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.0 mt -116.32 141.7 28.28 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.038 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.573 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 45.2 Cg_endo -70.88 145.76 51.53 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.182 1.921 . . . . 0.0 112.148 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.867 HG12 HG23 ' A' ' 37' ' ' ILE . 38.9 mt -56.56 139.85 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.852 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -132.57 157.13 45.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.966 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -120.68 121.93 39.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.069 0.461 . . . . 0.0 111.959 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.844 HD23 ' CD2' ' A' ' 66' ' ' TRP . 8.7 mp -87.8 133.63 33.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.469 178.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.98 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -138.71 156.46 47.37 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 122.219 1.009 . . . . 0.0 113.411 -179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.486 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.31 149.51 34.96 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 113.553 -1.658 . . . . 0.0 110.977 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 121.05 0.453 . . . . 0.0 110.993 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.406 ' HE2' ' O ' ' A' ' 49' ' ' SER . 7.5 ttpt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.751 0.31 . . . . 0.0 111.492 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 91' ' ' ILE . 16.3 t -130.88 138.91 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 121.227 0.537 . . . . 0.0 111.736 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.844 ' CD2' HD23 ' A' ' 48' ' ' LEU . 19.2 m-90 -102.03 139.39 37.72 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.428 -0.806 . . . . 0.0 112.086 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.984 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -110.98 126.68 55.03 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.421 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.657 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -110.9 145.43 38.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.12 -178.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.653 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 165.93 -179.85 39.89 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.646 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.9 mtm180 -77.58 -1.71 32.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.529 0.204 . . . . 0.0 111.505 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.456 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.5 t-20 -84.87 136.42 38.86 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 120.745 0.307 . . . . 0.0 110.996 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.5 Cg_exo -69.13 -6.45 18.32 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.704 2.269 . . . . 0.0 111.868 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.89 -45.35 14.32 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.96 0.886 . . . . 0.0 108.756 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -44.43 137.87 3.46 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 113.642 -1.617 . . . . 0.0 110.632 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -56.27 -19.33 13.66 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.927 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.525 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 46.6 t80 -130.13 130.25 44.55 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.586 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -111.04 122.3 47.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.785 0.326 . . . . 0.0 111.277 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.554 HD11 ' CA ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -120.44 179.66 4.24 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.877 179.251 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.26 133.54 52.67 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.665 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -64.78 92.3 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.849 0.357 . . . . 0.0 110.792 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.659 ' HB ' HD13 ' A' ' 84' ' ' LEU . 4.3 mt -111.99 141.07 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.235 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.9 p -65.12 -40.27 94.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.167 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.491 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -62.03 -21.31 64.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.519 -179.674 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.659 HD13 ' HB ' ' A' ' 81' ' ' ILE . 3.9 mp -99.95 153.4 19.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.057 0.456 . . . . 0.0 111.365 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.2 p -99.76 169.31 9.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.808 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.653 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 1.1 m-20 -44.87 -53.89 7.03 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.367 0.603 . . . . 0.0 109.562 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.607 ' CB ' HD12 ' A' ' 104' ' ' ILE . 71.7 mttt -118.13 85.47 2.35 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 177.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.697 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 60.3 t-80 -60.03 -45.86 91.4 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.691 -176.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.516 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 30.3 p90 -150.39 164.3 36.19 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.126 -0.629 . . . . 0.0 112.034 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.984 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.58 134.17 39.08 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.367 -178.987 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.646 HG23 HD12 ' A' ' 101' ' ' LEU . 47.5 mt -110.92 131.79 61.15 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.649 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.513 ' CB ' HG22 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -123.29 140.75 52.7 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.981 0.419 . . . . 0.0 111.759 -179.29 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.554 HD13 ' C ' ' A' ' 93' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.441 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.676 HD11 HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.708 0.29 . . . . 0.0 110.779 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.502 HD23 ' HB3' ' A' ' 121' ' ' ASN . 5.2 mp -124.23 141.0 52.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.936 0.398 . . . . 0.0 110.36 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.646 HD12 HG23 ' A' ' 91' ' ' ILE . 2.8 mp -112.68 126.37 55.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.087 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.46 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 67.2 t30 -119.18 136.29 54.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.11 0.481 . . . . 0.0 111.8 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.807 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.7 p30 -98.42 142.54 29.91 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.996 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.607 HD12 ' CB ' ' A' ' 87' ' ' LYS . 8.7 pt -145.58 24.5 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.621 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.55 ' HB2' ' CG ' ' A' ' 88' ' ' HIS . 11.2 t -92.09 154.14 18.93 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 121.594 0.711 . . . . 0.0 112.51 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.9 m -70.11 -51.94 27.63 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.607 178.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -75.33 -2.59 29.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.301 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.58 154.68 30.79 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.749 -0.739 . . . . 0.0 113.671 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 4.2 m -117.47 137.81 52.28 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.845 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -114.72 148.48 38.23 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -178.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.461 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.16 113.52 18.44 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.457 177.622 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 44.59 43.25 6.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.373 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.89 -7.9 75.33 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.44 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -104.81 118.61 36.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.996 0.427 . . . . 0.0 110.593 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.845 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.4 tptm -72.91 114.48 11.1 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.266 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.807 HG23 ' OD2' ' A' ' 103' ' ' ASP . 6.2 m -88.81 161.61 2.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.984 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 120' ' ' SER . 23.5 tt0 -69.75 130.79 43.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.347 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.686 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 24.2 tttt -54.49 161.61 1.38 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.899 0.381 . . . . 0.0 110.408 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.495 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.0 m-80 35.1 33.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.135 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.481 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.51 145.11 40.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.145 179.524 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.502 ' HB3' HD23 ' A' ' 100' ' ' LEU . 33.7 m-80 -90.33 133.82 34.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.895 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.452 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 49.8 mm-40 -129.57 152.11 49.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.56 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 25.4 tp -72.64 120.16 17.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.777 0.322 . . . . 0.0 110.507 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.664 HD13 ' CB ' ' A' ' 99' ' ' LEU . 6.4 tt -56.64 155.71 7.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.454 0.645 . . . . 0.0 111.441 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.401 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.52 153.15 42.51 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.342 179.686 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.8 114.94 10.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.92 0.391 . . . . 0.0 110.132 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.54 23.17 73.64 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.044 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.401 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 23.1 t70 -53.81 171.27 0.1 Allowed 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 120.933 0.397 . . . . 0.0 111.162 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.635 ' HG3' HG22 ' A' ' 144' ' ' VAL . 21.2 tt0 -145.13 135.53 24.16 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.089 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.516 ' CG2' HG22 ' A' ' 109' ' ' THR . 5.8 mt -111.39 127.73 68.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.422 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.677 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.7 m -104.41 140.74 37.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.852 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.697 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 33.9 m -140.24 158.49 25.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.14 28.38 31.07 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.192 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.433 ' HA ' HG12 ' A' ' 140' ' ' ILE . 70.6 t -72.63 140.42 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-O 121.598 0.713 . . . . 0.0 111.982 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 142.39 -39.82 1.33 Allowed Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.421 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 2.8 t -120.67 124.31 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -50.31 -35.0 25.6 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.6 p -93.77 6.7 47.51 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -178.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.421 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.6 OUTLIER -121.09 28.72 7.71 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -178.632 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.677 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.5 mt -107.27 138.11 34.92 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-O 121.544 0.688 . . . . 0.0 111.261 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.506 HD11 ' OE1' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -125.43 134.66 52.03 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.265 179.67 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.565 ' C ' HD22 ' A' ' 143' ' ' LEU . 38.5 t -111.3 148.44 32.91 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.739 0.781 . . . . 0.0 112.431 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.713 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.6 mm? -136.45 136.7 39.71 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.704 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.635 HG22 ' HG3' ' A' ' 129' ' ' GLU . 21.1 t -110.88 137.44 43.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.82 0.343 . . . . 0.0 111.073 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.516 HD12 HD21 ' A' ' 101' ' ' LEU . 4.9 mt -106.52 121.62 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.29 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.818 ' CE1' HD12 ' A' ' 37' ' ' ILE . 5.8 m-85 -105.37 115.3 30.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.485 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.606 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.1 mp -96.94 122.62 48.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.481 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -78.59 137.95 38.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.939 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.07 -18.69 60.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.366 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.52 -46.04 89.98 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.972 0.415 . . . . 0.0 110.814 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 36.5 t80 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.02 -179.934 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.568 0.223 . . . . 0.0 111.327 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER 176.77 38.99 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.722 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -73.78 134.26 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.55 0 CA-C-N 113.735 -1.575 . . . . 0.0 112.509 -177.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.034 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -93.55 -61.68 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.286 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.669 ' SG ' HD12 ' A' ' 48' ' ' LEU . 3.7 p -145.44 141.49 28.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.599 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.407 ' HD3' ' CG2' ' A' ' 45' ' ' ILE . 24.1 ttm180 -114.01 129.73 56.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.146 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.597 HG21 ' HE2' ' A' ' 68' ' ' PHE . 20.9 t -91.69 122.74 43.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.005 0.431 . . . . 0.0 111.099 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.812 HG23 HG12 ' A' ' 45' ' ' ILE . 21.8 mt -126.6 111.95 27.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.18 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 43.4 t -79.82 137.58 36.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.757 0.313 . . . . 0.0 110.499 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.2 t -116.36 -10.68 11.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.762 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.755 HG21 ' OG ' ' A' ' 142' ' ' SER . 5.0 p -96.38 -3.07 44.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.686 0.279 . . . . 0.0 111.262 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.48 93.11 0.25 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.042 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.569 ' HG3' ' N ' ' A' ' 43' ' ' ILE . 2.5 pt20 -171.51 -40.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.093 0.473 . . . . 0.0 111.464 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.663 HD12 HD21 ' A' ' 143' ' ' LEU . 65.0 mt -124.4 140.32 34.92 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.649 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.565 ' HD2' HG23 ' A' ' 43' ' ' ILE . 94.8 Cg_endo -80.31 144.37 16.24 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.576 2.184 . . . . 0.0 111.643 179.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.812 HG12 HG23 ' A' ' 37' ' ' ILE . 32.2 mt -58.59 123.87 11.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.944 0.402 . . . . 0.0 111.831 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.48 ' HB2' ' CZ ' ' A' ' 76' ' ' TYR . 2.3 ttt-85 -122.42 164.13 18.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.985 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.93 119.84 35.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.095 0.474 . . . . 0.0 111.949 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.669 HD12 ' SG ' ' A' ' 34' ' ' CYS . 3.1 mt -96.55 137.46 35.6 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . 1.034 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.25 158.5 43.89 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -178.612 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.489 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -139.62 141.83 37.09 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.448 -1.705 . . . . 0.0 110.671 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 121.127 0.489 . . . . 0.0 111.606 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.433 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.0 ttpt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.753 0.311 . . . . 0.0 111.273 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.589 HG13 ' C ' ' A' ' 91' ' ' ILE . 14.8 t -129.49 139.22 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-O 121.343 0.592 . . . . 0.0 112.082 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.544 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.3 m-90 -100.93 139.64 36.33 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.125 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . 1.038 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -113.38 126.84 55.81 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 176.934 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.68 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.5 OUTLIER -114.52 145.55 41.78 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.294 -178.517 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.702 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 165.88 -177.56 40.96 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.792 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.47 ' HG3' HD11 ' A' ' 78' ' ' LEU . 5.3 mtm105 -76.26 -2.0 29.29 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.408 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.6 t-20 -84.72 133.67 43.45 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.58 0.229 . . . . 0.0 110.91 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.0 Cg_exo -68.89 -7.52 20.95 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.607 2.205 . . . . 0.0 111.786 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.68 -43.16 17.22 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 121.916 0.865 . . . . 0.0 108.806 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.44 138.26 1.84 Allowed 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 113.764 -1.562 . . . . 0.0 110.652 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -56.16 -19.34 13.11 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.695 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.493 ' CD2' ' CE2' ' A' ' 68' ' ' PHE . 1.5 t80 -130.12 130.38 44.73 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.745 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -104.42 117.48 34.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.937 0.398 . . . . 0.0 110.933 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.48 ' HB3' HD13 ' A' ' 43' ' ' ILE . 2.7 pp -114.87 -178.03 3.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.887 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.75 144.02 48.49 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.528 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -76.8 91.67 3.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.791 0.329 . . . . 0.0 111.245 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.518 HD12 HD11 ' A' ' 84' ' ' LEU . 30.1 mt -112.09 139.99 33.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.084 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.05 -36.41 84.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.12 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.511 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -69.03 -15.69 63.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.799 -179.609 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.684 HD22 ' CD2' ' A' ' 88' ' ' HIS . 51.1 mt -103.38 152.42 21.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.701 0.286 . . . . 0.0 111.174 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.8 m -99.13 167.48 10.67 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.268 -0.423 . . . . 0.0 112.007 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.702 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.1 m-20 -43.72 -53.28 5.96 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.301 0.572 . . . . 0.0 109.658 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.546 ' HB3' HG22 ' A' ' 67' ' ' THR . 17.7 mtmt -118.3 83.76 2.06 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.684 ' CD2' HD22 ' A' ' 84' ' ' LEU . 60.5 t-80 -60.17 -46.03 91.08 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.698 -176.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.51 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 27.5 p90 -147.82 164.01 34.97 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.019 -0.672 . . . . 0.0 112.202 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 1.038 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.56 137.12 41.7 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.276 -178.867 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.68 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 63.8 mt -116.04 127.17 73.72 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.55 178.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.515 ' CB ' HG22 ' A' ' 65' ' ' VAL . 0.8 OUTLIER -111.42 140.64 45.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.089 0.471 . . . . 0.0 111.469 -179.649 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.621 HD23 ' HG ' ' A' ' 99' ' ' LEU . 2.5 tm? . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.539 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.621 ' HG ' HD23 ' A' ' 93' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.458 -0.075 0 CA-C-O 120.813 0.339 . . . . 0.0 110.831 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.628 HD23 ' HB3' ' A' ' 121' ' ' ASN . 2.2 mp -133.05 147.17 52.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.4 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.581 HD22 ' C ' ' A' ' 100' ' ' LEU . 3.0 mm? -112.77 123.95 51.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.273 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.456 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 58.1 t30 -118.5 115.79 25.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.895 0.379 . . . . 0.0 111.777 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.801 ' OD2' HG23 ' A' ' 116' ' ' VAL . 10.9 p30 -79.67 141.93 36.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.956 178.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.494 HG12 ' HA ' ' A' ' 89' ' ' PHE . 12.9 pt -144.69 24.22 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.767 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.529 ' HB2' ' CG ' ' A' ' 88' ' ' HIS . 10.3 t -91.4 154.44 19.18 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.54 0.686 . . . . 0.0 112.528 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.5 m -70.13 -52.02 26.86 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.553 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -75.64 -0.56 21.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.395 -0.821 . . . . 0.0 112.258 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.04 155.15 31.78 Favored Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.702 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.553 HG22 ' CG2' ' A' ' 130' ' ' ILE . 3.7 m -117.36 137.63 52.33 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.835 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -115.31 148.59 39.05 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -177.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.458 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.13 113.45 18.37 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.646 -1.161 . . . . 0.0 108.466 177.589 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.7 m120 44.77 43.28 6.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.315 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.02 -6.3 79.65 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.525 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -104.16 118.59 37.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.995 0.426 . . . . 0.0 110.562 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.835 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.7 tptm -72.83 111.25 7.79 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.279 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.801 HG23 ' OD2' ' A' ' 103' ' ' ASP . 15.7 m -86.09 161.82 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.847 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 120' ' ' SER . 64.0 mt-10 -69.84 129.64 40.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.504 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.683 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 22.0 tttt -54.9 161.16 1.69 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.902 0.382 . . . . 0.0 110.343 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 34.93 34.6 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.322 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.42 145.2 40.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.277 179.452 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.628 ' HB3' HD23 ' A' ' 100' ' ' LEU . 33.0 m-80 -87.94 131.92 34.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.848 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.447 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 37.7 mm-40 -129.57 148.99 51.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.63 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.0 tp -72.61 126.37 29.71 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.569 ' C ' HD22 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -56.71 157.76 5.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.846 0.832 . . . . 0.0 112.185 -178.957 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.27 152.91 44.01 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.094 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -71.81 117.13 13.01 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.83 26.87 67.61 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.858 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -50.83 170.7 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.953 0.406 . . . . 0.0 111.325 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.428 ' CG ' ' O ' ' A' ' 143' ' ' LEU . 18.1 tt0 -145.09 135.39 24.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.71 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.553 ' CG2' HG22 ' A' ' 109' ' ' THR . 14.5 mt -113.07 126.35 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.474 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.59 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.0 m -104.23 140.11 38.3 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.684 HG23 HD21 ' A' ' 84' ' ' LEU . 33.9 m -140.05 158.52 26.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -178.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.26 25.08 32.14 Favored Glycine 0 N--CA 1.439 -1.106 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.276 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.475 ' HA ' HG12 ' A' ' 140' ' ' ILE . 77.6 t -71.21 140.38 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-O 121.522 0.677 . . . . 0.0 111.893 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 139.83 -40.98 1.35 Allowed Glycine 0 N--CA 1.435 -1.384 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -178.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.442 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 2.5 t -116.28 123.55 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.32 -36.09 30.49 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.078 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.8 p -93.55 6.69 47.4 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.442 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.7 OUTLIER -121.77 30.5 6.65 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -178.409 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.59 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.1 mt -107.3 138.27 34.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.913 177.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.497 HD13 ' HA ' ' A' ' 141' ' ' LEU . 0.8 OUTLIER -125.25 134.95 52.12 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.101 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.755 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.4 OUTLIER -106.09 133.14 51.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.066 0.46 . . . . 0.0 111.727 -179.675 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.663 HD21 HD12 ' A' ' 43' ' ' ILE . 42.7 mt -127.53 140.85 51.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.665 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 23.0 t -116.06 132.58 65.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.878 0.37 . . . . 0.0 111.451 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 30.4 mt -106.26 139.02 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.949 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.48 132.69 56.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.847 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.545 ' CD1' HD23 ' A' ' 124' ' ' LEU . 3.1 mt -93.41 134.1 32.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.462 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.56 110.8 17.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.693 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -59.27 -29.5 67.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.268 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.9 tttm -59.58 -45.41 91.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.919 0.39 . . . . 0.0 110.743 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.0 t80 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.949 -179.911 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.788 0.328 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.429 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER 176.0 39.41 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.725 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.3 mm -72.78 134.09 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-N 113.577 -1.647 . . . . 0.0 112.554 -177.334 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.056 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -92.62 -60.84 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.954 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.633 ' SG ' HD12 ' A' ' 48' ' ' LEU . 1.8 p -145.6 149.5 34.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.22 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.96 138.2 50.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.857 0.36 . . . . 0.0 111.406 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.566 ' CG2' HD11 ' A' ' 48' ' ' LEU . 24.1 t -101.54 122.77 54.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.872 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.613 HG23 HG12 ' A' ' 45' ' ' ILE . 18.4 mt -129.33 121.37 53.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.41 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.679 ' HA ' HD13 ' A' ' 143' ' ' LEU . 34.3 t -85.1 118.07 24.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.376 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.93 -29.26 27.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.74 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.558 HG21 ' H ' ' A' ' 142' ' ' SER . 30.2 p -79.93 -2.22 42.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.652 0.263 . . . . 0.0 111.447 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.83 77.74 0.26 Allowed Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.965 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -144.09 -45.44 0.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.851 0.358 . . . . 0.0 110.834 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.634 HG12 HD23 ' A' ' 78' ' ' LEU . 3.0 mp -114.38 140.91 25.71 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.065 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.552 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.3 Cg_endo -73.41 136.55 24.15 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.239 1.96 . . . . 0.0 112.075 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.613 HG12 HG23 ' A' ' 37' ' ' ILE . 33.9 mt -54.41 129.76 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.736 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -122.99 164.28 18.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.284 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.89 119.76 37.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.985 0.421 . . . . 0.0 111.958 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.633 HD12 ' SG ' ' A' ' 34' ' ' CYS . 1.3 mt -96.65 134.48 39.84 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . 1.056 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -147.82 158.93 44.28 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -178.426 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.483 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -139.66 141.65 37.01 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 113.337 -1.756 . . . . 0.0 110.185 178.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 121.35 0.595 . . . . 0.0 111.428 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.406 ' CE ' ' O ' ' A' ' 49' ' ' SER . 6.7 ttpt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.605 0.241 . . . . 0.0 110.999 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.706 HG22 ' HB3' ' A' ' 92' ' ' LEU . 6.6 t -122.7 138.4 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 121.292 0.568 . . . . 0.0 112.102 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.616 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 15.7 m-90 -100.8 140.12 35.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.548 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.727 HG23 ' CG ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -110.12 128.67 55.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.839 177.526 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.707 ' CD1' ' HB2' ' A' ' 76' ' ' TYR . 9.8 m-85 -120.59 145.46 47.34 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.501 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.629 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.24 -166.58 36.49 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.064 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.462 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 12.0 mtp-105 -84.42 5.36 27.54 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.431 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 19.4 t-20 -84.99 133.74 42.59 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.622 0.249 . . . . 0.0 110.74 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 18.0 Cg_exo -65.33 -14.96 47.73 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.493 2.129 . . . . 0.0 111.559 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.68 -45.84 13.98 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.971 0.891 . . . . 0.0 108.846 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.3 139.89 1.32 Allowed 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.794 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.9 OUTLIER -56.45 -19.19 14.01 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.087 179.049 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.707 ' HB2' ' CD1' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -130.1 127.97 40.92 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.554 179.421 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -100.99 107.91 19.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.871 0.367 . . . . 0.0 110.828 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.895 HD13 HD13 ' A' ' 84' ' ' LEU . 39.8 mt -71.5 -176.33 1.53 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.921 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -92.72 42.18 2.69 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.613 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.462 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 1.0 OUTLIER 42.83 61.0 2.25 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.891 0.377 . . . . 0.0 111.66 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.722 HD13 HD12 ' A' ' 84' ' ' LEU . 5.4 mp -96.61 126.23 49.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.788 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 m -54.77 -38.15 66.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.338 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.434 ' H ' HG22 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -65.86 -22.37 66.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.159 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.895 HD13 HD13 ' A' ' 78' ' ' LEU . 25.0 mt -102.56 152.28 21.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.082 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.5 p -98.11 166.17 11.55 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.629 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.3 m-20 -43.41 -53.4 5.41 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.438 0.637 . . . . 0.0 109.853 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.588 ' HB2' HD12 ' A' ' 104' ' ' ILE . 16.1 mttt -118.16 82.65 1.87 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 177.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.708 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 62.8 t-80 -62.93 -43.83 97.72 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.157 -0.929 . . . . 0.0 113.158 -176.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.49 ' CD1' ' HB2' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -151.24 161.63 42.37 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.05 -0.66 . . . . 0.0 112.37 -179.57 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.727 ' CG ' HG23 ' A' ' 67' ' ' THR . 7.8 mt-30 -135.2 151.81 50.98 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.415 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.525 ' C ' HG13 ' A' ' 65' ' ' VAL . 12.1 mt -124.12 127.49 73.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.206 178.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.768 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -111.31 149.33 31.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.013 0.435 . . . . 0.0 111.671 -179.307 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.537 HD13 ' HG ' ' A' ' 99' ' ' LEU . 24.4 tp . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.164 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 1.012 HD11 HG12 ' A' ' 33' ' ' VAL . 0.5 OUTLIER . . . . . 0 CA--C 1.527 0.073 0 CA-C-O 120.875 0.369 . . . . 0.0 110.92 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.638 HD13 ' O ' ' A' ' 122' ' ' GLN . 2.6 mm? -123.88 147.07 47.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.546 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.612 HD11 ' HA ' ' A' ' 124' ' ' LEU . 2.3 mt -113.39 122.39 47.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.013 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.768 ' HB2' HD11 ' A' ' 92' ' ' LEU . 58.8 t30 -116.98 124.71 50.04 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.811 ' OD2' HG23 ' A' ' 116' ' ' VAL . 10.9 p30 -88.16 140.24 29.69 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.588 HD12 ' HB2' ' A' ' 87' ' ' LYS . 9.5 pt -143.62 24.03 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 -179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.565 ' HB2' ' CG ' ' A' ' 88' ' ' HIS . 10.5 t -91.13 154.45 19.34 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.709 0.766 . . . . 0.0 113.011 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.5 m -70.18 -52.08 26.14 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.469 -1.242 . . . . 0.0 110.495 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -77.92 0.67 23.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.322 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.32 155.69 31.83 Favored Glycine 0 N--CA 1.438 -1.207 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.724 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 4.0 m -117.46 137.78 52.29 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.82 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -116.58 148.54 40.81 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -177.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.735 HD12 HG11 ' A' ' 116' ' ' VAL . 0.6 OUTLIER -124.32 113.54 18.37 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.812 177.421 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 47.31 36.21 4.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.071 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.07 -3.82 80.8 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.482 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.73 118.59 37.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.046 0.423 . . . . 0.0 110.805 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.82 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.4 tptm -72.74 120.98 19.12 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.069 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.811 HG23 ' OD2' ' A' ' 103' ' ' ASP . 9.1 m -98.24 163.81 2.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.394 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 120' ' ' SER . 44.1 tt0 -69.93 128.96 38.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.555 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.676 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 14.4 tttm -54.28 163.36 0.85 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.83 0.348 . . . . 0.0 110.183 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.6 OUTLIER 35.94 33.89 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.854 -179.251 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.5 OUTLIER -112.23 145.14 40.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.057 179.491 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.56 ' OD1' HD13 ' A' ' 92' ' ' LEU . 1.4 m-80 -87.93 132.62 34.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.877 0.37 . . . . 0.0 111.111 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.638 ' O ' HD13 ' A' ' 100' ' ' LEU . 30.1 mm-40 -129.12 145.32 51.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.45 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 26.4 tp -72.71 126.07 29.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.325 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.614 HD23 HG12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -58.52 158.96 6.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.852 0.834 . . . . 0.0 112.316 -179.011 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.769 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.3 OUTLIER -125.04 153.41 42.9 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.759 179.214 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.546 ' HA ' HD13 ' A' ' 147' ' ' ILE . 1.2 mm-40 -70.93 115.49 10.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.96 0.41 . . . . 0.0 109.921 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.25 28.18 68.77 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.552 -178.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.584 ' OD2' HD23 ' A' ' 111' ' ' LEU . 12.1 t70 -54.5 172.0 0.11 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.128 0.489 . . . . 0.0 111.421 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 2.4 tt0 -145.2 135.33 23.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.675 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.759 HG13 HD11 ' A' ' 145' ' ' ILE . 4.1 mt -112.75 129.22 68.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.378 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.583 HG22 ' CG2' ' A' ' 140' ' ' ILE . 5.5 m -102.98 139.81 38.07 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.708 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.8 m -140.28 158.73 25.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -177.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.04 30.01 29.79 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.209 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.443 ' HB ' ' CH2' ' A' ' 110' ' ' TRP . 77.6 t -74.19 140.34 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-O 121.551 0.691 . . . . 0.0 112.013 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.9 -38.09 1.29 Allowed Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.477 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 2.7 t -121.33 128.39 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -50.56 -40.83 53.24 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.5 p -93.49 6.5 47.99 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.477 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 22.0 m-20 -117.7 30.13 7.45 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.583 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.3 mt -107.05 138.79 31.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.905 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.797 HD23 ' N ' ' A' ' 142' ' ' SER . 3.7 tt -124.67 134.62 52.82 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.448 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.797 ' N ' HD23 ' A' ' 141' ' ' LEU . 47.2 t -108.68 150.23 27.85 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.71 0.766 . . . . 0.0 112.576 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.679 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.1 mm? -136.1 151.03 49.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.472 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 40.5 t -125.18 133.45 69.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.803 0.335 . . . . 0.0 110.908 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.759 HD11 HG13 ' A' ' 130' ' ' ILE . 0.9 OUTLIER -105.62 124.59 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.438 -178.85 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -105.97 114.91 29.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.755 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.769 HD11 ' O ' ' A' ' 125' ' ' SER . 3.4 mp -85.05 133.31 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.571 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -82.34 118.78 23.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.916 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -69.94 -32.9 71.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.021 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.42 -45.55 91.23 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.959 0.409 . . . . 0.0 110.704 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 24.7 t80 . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.931 -179.934 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.88 0.371 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER 179.09 38.19 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.679 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.6 mm -74.93 136.05 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.558 0 CA-C-N 113.697 -1.592 . . . . 0.0 112.525 -177.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.016 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.0 t -91.92 -60.31 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 114.75 -1.113 . . . . 0.0 109.969 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.1 p -145.28 157.88 43.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.368 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.66 138.35 53.99 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.843 0.354 . . . . 0.0 111.474 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.788 HG11 ' CE2' ' A' ' 68' ' ' PHE . 1.1 m -108.06 122.66 62.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.724 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.807 HG23 HG12 ' A' ' 45' ' ' ILE . 19.2 mt -128.33 121.66 56.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.694 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.718 ' HA ' HD23 ' A' ' 143' ' ' LEU . 42.4 t -79.85 111.52 16.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.747 0.308 . . . . 0.0 110.257 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.5 t -78.81 -24.33 44.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.423 . . . . 0.0 112.088 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.522 HG23 ' HB3' ' A' ' 142' ' ' SER . 66.1 p -79.94 -2.14 42.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.73 0.3 . . . . 0.0 111.489 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.51 76.54 0.25 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.812 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -146.08 -43.96 0.2 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.887 0.375 . . . . 0.0 110.715 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.588 HG23 ' HD2' ' A' ' 44' ' ' PRO . 2.4 mp -117.54 142.1 29.93 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.062 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.588 ' HD2' HG23 ' A' ' 43' ' ' ILE . 48.2 Cg_endo -71.24 145.93 49.98 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.167 1.911 . . . . 0.0 112.27 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.807 HG12 HG23 ' A' ' 37' ' ' ILE . 42.5 mt -57.91 149.71 4.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.746 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.97 164.04 28.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.993 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.65 119.82 30.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.086 0.47 . . . . 0.0 111.948 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.731 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.3 mp -94.54 124.23 38.44 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . 1.016 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -134.58 157.79 45.66 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -178.809 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.49 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -147.99 142.63 26.59 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.653 -1.612 . . . . 0.0 110.737 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 121.199 0.524 . . . . 0.0 111.003 -179.716 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.416 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.5 ttpt . . . . . 0 CA--C 1.523 -0.075 0 CA-C-O 120.706 0.289 . . . . 0.0 111.125 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.526 HG22 ' CB ' ' A' ' 92' ' ' LEU . 11.5 t -123.92 139.12 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 121.273 0.559 . . . . 0.0 111.951 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.731 ' CD2' HD23 ' A' ' 48' ' ' LEU . 16.4 m-90 -102.01 139.6 37.42 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.067 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.611 HG23 ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -108.8 132.27 54.16 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.425 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.788 ' CE2' HG11 ' A' ' 36' ' ' VAL . 2.7 m-85 -115.22 145.85 42.02 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.566 -178.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.786 ' HA2' HD12 ' A' ' 78' ' ' LEU . . . 161.91 -177.67 38.05 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.709 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.6 mtm180 -80.46 1.09 30.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.609 0.242 . . . . 0.0 111.373 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.46 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.9 t-20 -84.86 135.79 39.62 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.677 0.275 . . . . 0.0 110.872 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.1 Cg_exo -68.74 -6.96 19.22 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.672 2.248 . . . . 0.0 111.91 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.03 -45.09 14.47 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-O 122.093 0.949 . . . . 0.0 108.859 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -45.8 136.51 6.16 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 113.674 -1.603 . . . . 0.0 110.75 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.62 -19.02 14.04 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.0 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.61 ' HE1' HD23 ' A' ' 78' ' ' LEU . 33.3 t80 -129.76 118.7 22.25 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.678 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -93.87 107.9 19.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.865 0.364 . . . . 0.0 110.911 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.786 HD12 ' HA2' ' A' ' 69' ' ' GLY . 22.4 mt -73.19 -70.19 0.38 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.712 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 174.36 -86.72 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.235 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.7 p30 179.81 55.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.947 0.403 . . . . 0.0 110.866 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 1.109 HD13 HD12 ' A' ' 84' ' ' LEU . 4.1 mp -87.4 120.42 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.136 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 18.0 m -55.08 -41.49 71.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.919 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.404 ' HD3' ' CB ' ' A' ' 139' ' ' ASP . 0.0 OUTLIER -64.34 -22.43 66.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.228 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.109 HD12 HD13 ' A' ' 81' ' ' ILE . 49.5 mt -98.73 152.29 19.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.847 0.356 . . . . 0.0 111.118 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.7 p -95.76 165.84 12.1 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.649 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.717 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -42.76 -52.81 4.84 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.384 0.611 . . . . 0.0 109.686 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.484 ' HB3' HD11 ' A' ' 104' ' ' ILE . 19.1 mttt -119.3 84.92 2.28 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 177.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.548 ' NE2' ' HB ' ' A' ' 132' ' ' VAL . 14.7 t60 -64.19 -45.83 86.62 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.995 -1.002 . . . . 0.0 113.244 -176.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.499 ' HA ' HG12 ' A' ' 104' ' ' ILE . 36.7 p90 -153.72 162.39 41.28 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.068 -0.653 . . . . 0.0 112.27 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.611 ' HG2' HG23 ' A' ' 67' ' ' THR . 9.8 mt-30 -135.64 154.88 51.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.779 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.521 ' O ' HG13 ' A' ' 65' ' ' VAL . 59.5 mt -123.54 132.35 71.53 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.269 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.536 HD11 HD13 ' A' ' 100' ' ' LEU . 0.6 OUTLIER -117.3 149.91 39.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.032 0.444 . . . . 0.0 111.866 -179.243 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.68 HD22 ' CG1' ' A' ' 33' ' ' VAL . 18.9 tp . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.355 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.501 HD23 ' O ' ' A' ' 92' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.837 0.351 . . . . 0.0 110.796 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.859 HD22 ' HB3' ' A' ' 121' ' ' ASN . 6.5 mt -133.12 141.0 47.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.533 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.82 128.21 56.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.13 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.416 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 50.2 t30 -116.6 115.63 26.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.887 0.375 . . . . 0.0 111.972 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.808 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.5 p30 -78.29 143.19 37.22 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.855 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.565 HG21 ' OE1' ' A' ' 90' ' ' GLN . 9.7 pt -149.67 35.86 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.591 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.05 150.98 21.45 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.651 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.2 m -68.71 -31.66 70.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.457 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -93.11 -19.57 21.37 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.172 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.591 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 110.73 158.12 15.7 Favored Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.738 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.501 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.7 m -117.18 137.65 52.2 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.865 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -115.83 148.35 40.01 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -178.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.555 HD13 ' OD2' ' A' ' 128' ' ' ASP . 0.2 OUTLIER -124.22 113.4 18.24 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.535 177.603 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.404 ' N ' HD12 ' A' ' 111' ' ' LEU . 71.6 m-20 43.61 43.62 4.83 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.16 -11.39 67.56 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.789 -0.719 . . . . 0.0 113.449 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -103.85 118.58 37.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.997 0.427 . . . . 0.0 110.625 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.865 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 2.8 tptp -74.04 121.39 21.0 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.41 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.808 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.8 m -91.54 163.44 2.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.958 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.5 OUTLIER -69.84 128.07 35.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.448 179.694 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.703 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 18.2 tttt -54.87 161.78 1.48 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.976 0.417 . . . . 0.0 110.631 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.6 OUTLIER 35.65 33.42 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.045 -179.263 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.47 145.16 40.69 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.234 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.859 ' HB3' HD22 ' A' ' 100' ' ' LEU . 2.1 m-80 -89.32 128.78 35.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.763 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.708 ' O ' HD23 ' A' ' 100' ' ' LEU . 40.1 mm-40 -129.25 148.67 51.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.513 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.5 tp -72.71 111.91 8.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.885 0.374 . . . . 0.0 110.364 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.423 ' HG ' ' N ' ' A' ' 125' ' ' SER . 66.3 tp -53.68 158.88 1.75 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.247 0.546 . . . . 0.0 111.509 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.45 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.8 OUTLIER -124.01 153.25 41.58 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.331 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.434 ' HA ' HD12 ' A' ' 147' ' ' ILE . 12.2 tp60 -71.68 122.53 20.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.03 0.443 . . . . 0.0 110.79 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.18 21.9 48.2 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.429 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.555 ' OD2' HD13 ' A' ' 111' ' ' LEU . 5.3 t70 -59.87 -177.96 0.07 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 120.571 0.224 . . . . 0.0 110.449 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.888 ' CG ' HG22 ' A' ' 144' ' ' VAL . 6.1 mt-10 -145.07 135.55 24.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.743 0.306 . . . . 0.0 111.444 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.822 HG13 HD11 ' A' ' 145' ' ' ILE . 3.3 mt -114.52 126.66 72.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.218 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.574 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.4 m -104.28 140.04 38.43 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.041 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.548 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 26.4 m -140.33 158.37 25.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.131 0.491 . . . . 0.0 112.23 -178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.67 24.32 33.44 Favored Glycine 0 N--CA 1.439 -1.139 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.081 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.445 ' HB ' ' CZ3' ' A' ' 110' ' ' TRP . 77.9 t -70.93 140.32 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-O 121.544 0.688 . . . . 0.0 111.994 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.71 -38.13 1.08 Allowed Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.458 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 3.3 t -121.27 129.26 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.45 -40.65 51.18 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.55 6.69 47.39 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -178.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.458 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.7 OUTLIER -119.62 32.4 6.09 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -178.514 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.574 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.0 mt -107.25 138.65 32.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.411 0.624 . . . . 0.0 111.064 178.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.4 tt -124.88 134.61 52.63 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.718 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.522 ' HB3' HG23 ' A' ' 40' ' ' THR . 47.0 t -109.67 150.17 28.66 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.571 0.7 . . . . 0.0 112.25 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.718 HD23 ' HA ' ' A' ' 38' ' ' CYS . 69.7 mt -135.95 152.78 51.33 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.976 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.888 HG22 ' CG ' ' A' ' 129' ' ' GLU . 21.6 t -121.31 132.78 69.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.115 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.822 HD11 HG13 ' A' ' 130' ' ' ILE . 1.0 OUTLIER -105.74 121.73 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-O 120.881 0.372 . . . . 0.0 111.205 -179.345 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.99 115.01 29.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.95 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.434 HD12 ' HA ' ' A' ' 126' ' ' GLN . 6.5 mt -85.02 134.06 27.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.445 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -78.83 105.09 9.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.669 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.29 -35.24 73.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.08 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.97 -44.66 91.56 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.986 0.422 . . . . 0.0 110.669 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 29.6 t80 . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.898 179.997 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.749 0.309 . . . . 0.0 111.029 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.408 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.8 OUTLIER 177.42 38.91 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.682 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.7 mm -72.56 137.08 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 113.652 -1.613 . . . . 0.0 112.492 -177.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.002 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.3 t -91.6 -58.78 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.777 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.414 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 3.0 p -147.76 165.33 30.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.404 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -127.12 138.27 53.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.913 0.387 . . . . 0.0 111.43 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.455 HG13 ' O ' ' A' ' 36' ' ' VAL . 12.1 p -106.94 122.62 61.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.783 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.769 HG23 HG12 ' A' ' 45' ' ' ILE . 20.8 mt -127.53 127.92 69.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.618 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.47 ' HA ' HD13 ' A' ' 143' ' ' LEU . 35.2 t -88.5 114.23 24.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.76 0.314 . . . . 0.0 110.487 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.97 -23.68 33.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.701 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.502 HG21 ' H ' ' A' ' 142' ' ' SER . 58.3 p -79.96 -2.43 43.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.69 0.281 . . . . 0.0 111.465 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.6 69.86 1.21 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.185 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -141.01 -42.28 0.39 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.9 0.381 . . . . 0.0 110.974 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.543 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.7 mt -118.89 140.85 29.16 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.752 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.543 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.2 Cg_endo -73.39 146.02 39.15 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.139 1.893 . . . . 0.0 112.28 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.769 HG12 HG23 ' A' ' 37' ' ' ILE . 41.3 mt -57.31 148.38 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.08 0.467 . . . . 0.0 111.686 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -134.25 164.09 28.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.167 179.464 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -120.69 119.56 33.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.047 0.451 . . . . 0.0 111.63 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.797 HD23 ' CD2' ' A' ' 66' ' ' TRP . 6.8 mp -95.72 123.33 39.24 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . 1.002 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -135.15 156.96 48.11 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 122.163 0.983 . . . . 0.0 113.407 -179.541 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.478 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -153.62 141.92 20.56 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 113.662 -1.608 . . . . 0.0 111.132 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 121.124 0.487 . . . . 0.0 111.104 -179.78 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.457 ' HE2' ' O ' ' A' ' 49' ' ' SER . 3.6 ttpt . . . . . 0 CA--C 1.523 -0.088 0 CA-C-O 120.77 0.319 . . . . 0.0 111.412 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.655 HG12 ' HG2' ' A' ' 90' ' ' GLN . 19.3 t -132.13 139.2 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.274 0.559 . . . . 0.0 111.741 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.797 ' CD2' HD23 ' A' ' 48' ' ' LEU . 19.7 m-90 -102.42 139.37 38.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.309 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.644 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -114.18 131.1 56.57 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.779 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.686 ' HZ ' HD21 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -117.13 145.49 43.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.963 -179.125 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.616 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.99 -166.41 36.9 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.759 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -90.99 36.87 0.92 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.684 0.278 . . . . 0.0 111.41 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.464 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 3.9 t-20 -119.94 135.44 24.29 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.093 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 20.2 Cg_exo -64.63 -15.54 50.56 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.491 2.127 . . . . 0.0 111.5 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.72 -45.45 14.42 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 121.95 0.881 . . . . 0.0 109.089 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.36 139.54 2.65 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 113.885 -1.507 . . . . 0.0 110.845 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 67' ' ' THR . 9.3 m-20 -56.22 -18.57 10.71 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.844 178.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.537 ' CE2' HG21 ' A' ' 43' ' ' ILE . 2.8 t80 -129.18 116.71 19.6 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.737 0.303 . . . . 0.0 111.007 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -88.58 107.94 19.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.779 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.639 HD23 HD13 ' A' ' 84' ' ' LEU . 6.9 mp -77.91 -176.33 4.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.059 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.63 11.85 68.88 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.633 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 64.76 75.63 0.36 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.956 0.408 . . . . 0.0 111.473 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.933 ' HB ' HD12 ' A' ' 84' ' ' LEU . 3.7 mp -111.51 141.42 26.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.654 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.95 -41.73 71.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.047 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.526 ' H ' HG22 ' A' ' 81' ' ' ILE . 9.9 mmp_? -61.02 -49.07 78.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.261 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.933 HD12 ' HB ' ' A' ' 81' ' ' ILE . 1.4 mt -76.39 151.79 36.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.099 0.476 . . . . 0.0 111.664 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.3 p -100.89 167.55 10.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.401 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.616 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -44.56 -53.0 7.53 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.436 0.636 . . . . 0.0 109.816 179.123 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.654 ' HB2' HD12 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -121.83 82.8 2.0 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 177.456 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.586 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 9.2 t60 -62.73 -46.12 89.58 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.094 -0.957 . . . . 0.0 113.036 -176.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.504 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 20.4 p90 -147.98 160.1 43.18 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.592 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.655 ' HG2' HG12 ' A' ' 65' ' ' VAL . 17.8 tt0 -136.19 141.28 44.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.485 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.607 ' O ' HG13 ' A' ' 65' ' ' VAL . 44.1 mt -116.12 127.43 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.892 179.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.431 ' CA ' HG13 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -110.99 144.64 39.77 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.069 0.461 . . . . 0.0 111.888 -179.383 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.768 HD22 HG11 ' A' ' 33' ' ' VAL . 16.1 tp . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.485 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.92 ' HB2' HD13 ' A' ' 124' ' ' LEU . 1.7 mt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.844 0.354 . . . . 0.0 111.004 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.601 HD12 ' O ' ' A' ' 99' ' ' LEU . 3.2 mp -131.49 145.22 51.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.872 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.448 HD21 ' HB2' ' A' ' 122' ' ' GLN . 0.6 OUTLIER -112.71 124.27 52.19 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.36 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.414 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 51.5 t30 -115.74 115.58 26.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.905 0.383 . . . . 0.0 111.386 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.76 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.1 p30 -79.11 138.76 38.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.167 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.654 HD12 ' HB2' ' A' ' 87' ' ' LYS . 12.3 pt -146.96 39.35 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.728 -0.214 . . . . 0.0 111.574 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.574 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -96.13 158.51 15.41 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 121.055 0.455 . . . . 0.0 111.709 -179.06 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 86.4 m -69.07 -37.83 78.72 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.862 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.61 -19.91 17.3 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.553 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 123.8 158.35 10.1 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.074 -1.06 . . . . 0.0 113.799 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.8 m -117.78 137.99 52.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.924 -0.638 . . . . 0.0 109.731 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.891 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -114.58 148.42 38.05 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -178.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.472 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.2 113.54 18.44 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.384 177.393 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.417 ' N ' HD12 ' A' ' 111' ' ' LEU . 87.3 m-20 44.0 43.99 5.77 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.39 -11.05 66.87 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.711 -0.756 . . . . 0.0 113.486 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -103.4 118.58 37.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.01 0.433 . . . . 0.0 110.544 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.891 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 3.8 tptm -74.37 113.86 12.08 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.473 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.76 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.5 m -84.5 162.64 2.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.876 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.416 ' O ' ' CB ' ' A' ' 120' ' ' SER . 13.2 tp10 -69.85 131.14 44.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.464 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.674 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 32.3 tttm -53.1 162.97 0.58 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 34.07 39.1 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.099 0.476 . . . . 0.0 111.83 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 25.0 p -111.54 145.07 39.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.734 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.574 ' HB3' HD23 ' A' ' 100' ' ' LEU . 71.9 m-20 -94.64 123.82 38.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.71 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.448 ' HB2' HD21 ' A' ' 101' ' ' LEU . 24.7 mm-40 -127.96 148.45 50.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.558 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.8 tp -72.68 136.25 45.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.486 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.92 HD13 ' HB2' ' A' ' 99' ' ' LEU . 1.5 pt? -61.81 160.48 11.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.847 0.832 . . . . 0.0 112.088 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.406 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.0 OUTLIER -125.66 153.17 44.22 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.912 178.929 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.56 117.55 13.26 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.36 27.27 65.3 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.917 -0.659 . . . . 0.0 111.789 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.406 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 25.0 t0 -51.24 169.38 0.05 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.05 0.452 . . . . 0.0 111.404 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 12.8 tt0 -143.77 135.34 26.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.457 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.513 ' CG2' HG22 ' A' ' 109' ' ' THR . 11.6 mt -114.44 128.1 71.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.863 0.363 . . . . 0.0 111.019 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.56 HG23 ' CG2' ' A' ' 140' ' ' ILE . 26.9 m -104.46 142.24 34.95 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.715 HG21 HD21 ' A' ' 84' ' ' LEU . 19.9 m -140.42 158.41 24.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -178.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.34 46.53 26.12 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.419 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.482 ' HA ' HG12 ' A' ' 140' ' ' ILE . 58.5 t -85.27 140.72 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-O 121.997 0.903 . . . . 0.0 112.983 -178.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.27 -46.64 0.78 Allowed Glycine 0 N--CA 1.434 -1.494 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.652 HG11 ' CB ' ' A' ' 139' ' ' ASP . 4.6 p -104.03 118.0 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 CA-C-N 113.902 -1.149 . . . . 0.0 109.388 177.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.478 ' HA ' HD12 ' A' ' 140' ' ' ILE . 1.2 pt-20 -57.53 -24.24 54.9 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.787 0.327 . . . . 0.0 111.3 -179.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.536 ' H ' HG22 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -92.92 -25.91 17.83 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -177.925 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.652 ' CB ' HG11 ' A' ' 136' ' ' VAL . 0.5 OUTLIER -105.53 25.43 10.75 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -177.642 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.56 ' CG2' HG23 ' A' ' 131' ' ' THR . 5.8 mt -88.8 139.81 16.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.064 177.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.777 HD23 ' N ' ' A' ' 142' ' ' SER . 3.0 tt -120.02 134.8 55.14 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.993 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.777 ' N ' HD23 ' A' ' 141' ' ' LEU . 43.4 t -115.65 150.26 37.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.521 0.677 . . . . 0.0 112.277 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.502 ' CD2' HD22 ' A' ' 141' ' ' LEU . 2.0 mm? -135.79 153.35 51.55 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.39 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 39.6 t -123.26 138.5 53.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.798 0.332 . . . . 0.0 110.695 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.5 HD11 HD11 ' A' ' 91' ' ' ILE . 1.3 mm -106.24 125.89 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-O 120.965 0.412 . . . . 0.0 111.064 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.33 111.72 23.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.68 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.759 HG12 HD12 ' A' ' 124' ' ' LEU . 3.6 mp -90.6 128.23 42.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.353 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -75.95 126.13 30.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.825 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -70.31 -30.86 67.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.994 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -60.05 -46.0 90.98 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.693 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 29.1 t80 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.954 179.963 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.741 0.305 . . . . 0.0 111.091 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.441 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.2 m-20 176.65 39.41 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.717 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.1 mm -71.99 135.28 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 113.538 -1.664 . . . . 0.0 112.634 -177.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.01 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.3 t -91.38 -59.55 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.633 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.692 ' SG ' HD12 ' A' ' 48' ' ' LEU . 3.4 p -148.94 150.48 32.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.992 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.429 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -114.67 138.02 51.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.826 0.346 . . . . 0.0 111.639 -179.129 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.584 HG11 ' CE2' ' A' ' 68' ' ' PHE . 3.6 m -102.83 122.63 55.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.572 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.827 HG23 HG12 ' A' ' 45' ' ' ILE . 20.9 mt -127.54 124.9 64.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.605 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.696 ' HA ' HD13 ' A' ' 143' ' ' LEU . 51.9 t -83.17 121.16 26.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.531 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.66 -24.55 21.59 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.515 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.514 HG21 ' H ' ' A' ' 142' ' ' SER . 43.8 p -79.95 -2.06 42.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.461 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.6 75.97 0.31 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.787 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -147.2 -43.83 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.795 0.331 . . . . 0.0 110.886 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.812 HD13 HD22 ' A' ' 78' ' ' LEU . 3.0 mt -116.35 140.98 27.21 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.756 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.544 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.4 Cg_endo -72.93 145.49 40.31 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.138 1.892 . . . . 0.0 112.202 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.827 HG12 HG23 ' A' ' 37' ' ' ILE . 35.8 mt -56.03 141.51 12.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.669 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.461 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -127.25 164.05 22.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.17 179.551 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.429 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.7 OUTLIER -121.7 119.66 32.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.069 0.461 . . . . 0.0 111.68 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.692 HD12 ' SG ' ' A' ' 34' ' ' CYS . 3.1 mt -98.66 133.0 43.62 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . 1.01 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.98 157.97 43.87 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -178.584 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.485 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -142.12 147.79 37.28 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 113.577 -1.647 . . . . 0.0 110.748 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--N 1.33 -0.273 0 CA-C-O 121.167 0.508 . . . . 0.0 111.33 -179.376 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.433 ' CE ' ' O ' ' A' ' 49' ' ' SER . 1.9 ttpt . . . . . 0 C--O 1.232 0.149 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.605 HG13 ' O ' ' A' ' 91' ' ' ILE . 21.3 t -136.05 139.33 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.581 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.521 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 18.2 m-90 -102.56 139.3 38.33 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.453 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.687 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.17 130.25 56.61 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 177.282 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.584 ' CE2' HG11 ' A' ' 36' ' ' VAL . 1.1 m-85 -117.97 145.25 44.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.926 0.394 . . . . 0.0 111.642 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.579 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.9 -170.22 39.87 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.751 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.435 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 20.6 mtm180 -82.01 1.42 35.75 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.448 HD22 ' HB3' ' A' ' 73' ' ' ALA . 2.0 t30 -84.87 135.0 40.52 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.685 0.278 . . . . 0.0 111.319 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -66.43 -12.53 36.09 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.635 2.223 . . . . 0.0 111.742 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.448 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.64 -43.94 16.35 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-O 121.965 0.888 . . . . 0.0 108.738 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.82 140.44 1.35 Allowed 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 113.707 -1.588 . . . . 0.0 110.635 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' A' ' 67' ' ' THR . 23.3 m-20 -56.14 -18.93 11.35 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.172 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.487 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 7.0 t80 -129.66 130.28 45.36 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-O 120.882 0.373 . . . . 0.0 111.017 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -105.99 113.97 27.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.784 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.812 HD22 HD13 ' A' ' 43' ' ' ILE . 1.4 mt -93.71 -67.02 0.88 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.875 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 179.15 -90.84 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.164 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.401 ' HA ' ' HD2' ' A' ' 70' ' ' ARG . 1.6 p-10 175.97 54.25 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.839 0.352 . . . . 0.0 111.01 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.745 ' HB ' HD13 ' A' ' 84' ' ' LEU . 29.5 mm -83.32 134.76 26.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.872 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.53 -32.66 74.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.411 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.549 ' H ' HG22 ' A' ' 81' ' ' ILE . 2.2 mpt_? -68.38 -23.77 64.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.502 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.745 HD13 ' HB ' ' A' ' 81' ' ' ILE . 5.7 mp -103.38 153.38 20.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.932 0.396 . . . . 0.0 111.114 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.4 m -95.94 168.58 10.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.034 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.579 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -43.45 -54.46 4.78 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.38 0.61 . . . . 0.0 109.698 179.176 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.573 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.1 OUTLIER -119.7 84.22 2.17 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 177.247 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.671 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 60.1 t-80 -57.95 -45.39 86.7 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.705 -176.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.457 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 32.1 p90 -148.24 159.4 44.01 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.079 -0.648 . . . . 0.0 111.922 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.687 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.1 tt0 -135.79 139.95 43.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.376 -178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.605 ' O ' HG13 ' A' ' 65' ' ' VAL . 44.0 mt -114.94 128.15 72.2 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.772 179.077 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.768 HD21 ' OD1' ' A' ' 121' ' ' ASN . 1.1 pt? -114.11 143.08 45.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.059 0.457 . . . . 0.0 111.61 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.87 HD22 HG11 ' A' ' 33' ' ' VAL . 28.5 tp . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.295 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.787 ' HG ' HD13 ' A' ' 93' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.78 0.324 . . . . 0.0 110.839 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.724 HD23 ' OD1' ' A' ' 121' ' ' ASN . 1.8 mp -131.35 147.33 52.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.447 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.801 HD11 ' HA ' ' A' ' 124' ' ' LEU . 2.7 mp -112.86 124.92 53.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.304 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.446 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 61.4 t30 -120.57 115.76 24.04 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.794 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.3 p30 -78.13 138.93 38.97 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.523 HD12 ' CB ' ' A' ' 87' ' ' LYS . 7.2 pt -140.02 22.09 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.621 ' HB2' ' CG ' ' A' ' 88' ' ' HIS . 11.0 t -91.79 153.46 19.57 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 121.487 0.66 . . . . 0.0 112.641 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.1 m -69.99 -52.12 26.88 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.399 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -72.83 -5.07 35.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.139 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.53 156.04 30.88 Favored Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.73 -0.747 . . . . 0.0 113.459 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.501 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 5.6 m -117.33 137.74 52.23 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.846 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -113.39 148.44 35.8 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -177.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.428 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.25 113.42 18.25 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.252 177.382 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 44.51 43.22 6.2 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.98 -6.85 80.0 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.528 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -103.98 118.5 36.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.982 0.42 . . . . 0.0 110.578 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.846 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 20.9 tptt -74.54 118.32 17.36 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.343 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.794 HG23 ' OD2' ' A' ' 103' ' ' ASP . 7.0 m -95.88 159.45 2.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.864 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.677 ' O ' ' HB3' ' A' ' 120' ' ' SER . 5.5 mm-40 -69.97 133.97 47.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.109 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.686 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 27.1 tttt -55.48 165.78 0.75 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.131 0.491 . . . . 0.0 110.83 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.46 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.6 OUTLIER 36.46 34.43 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.687 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.677 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 1.4 t -112.21 145.12 40.45 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.76 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.768 ' OD1' HD21 ' A' ' 92' ' ' LEU . 11.4 m-80 -86.7 136.1 33.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.93 0.395 . . . . 0.0 111.086 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.501 ' O ' HD12 ' A' ' 101' ' ' LEU . 3.8 mm100 -128.68 144.2 51.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.204 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.621 HD23 ' O ' ' A' ' 124' ' ' LEU . 3.2 tt -72.67 131.41 42.37 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.221 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.913 HD21 HG12 ' A' ' 147' ' ' ILE . 54.0 tp -58.5 151.8 19.5 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.73 0.776 . . . . 0.0 111.751 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.429 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -125.37 152.83 44.26 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.587 179.57 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -72.11 117.93 14.35 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.73 25.78 66.04 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.839 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.429 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 30.9 t70 -51.1 167.85 0.07 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.946 0.403 . . . . 0.0 111.505 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.8 tt0 -145.21 135.4 23.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.902 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.545 HD11 HD23 ' A' ' 101' ' ' LEU . 15.3 mt -117.68 128.33 74.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.626 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.567 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.9 m -104.11 140.07 38.3 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.671 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 33.7 m -140.13 158.39 25.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.43 ' HA2' ' HB3' ' A' ' 83' ' ' ARG . . . 86.84 29.61 23.02 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.994 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.453 ' HB ' ' CZ3' ' A' ' 110' ' ' TRP . 72.2 t -75.8 140.44 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-O 121.602 0.715 . . . . 0.0 111.942 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.25 -38.93 1.21 Allowed Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.425 HG11 ' OD2' ' A' ' 139' ' ' ASP . 3.3 t -120.2 118.72 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -50.6 -30.9 14.44 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.0 m -93.59 6.82 46.97 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.44 ' HB3' ' HD3' ' A' ' 83' ' ' ARG . 16.3 m-20 -130.33 35.17 4.1 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -178.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.567 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.5 mt -106.79 138.29 33.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-O 121.357 0.599 . . . . 0.0 110.562 177.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.1 134.47 52.47 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.902 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.626 ' C ' HD22 ' A' ' 143' ' ' LEU . 46.6 t -109.37 150.24 28.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.578 0.704 . . . . 0.0 112.051 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.696 HD13 ' HA ' ' A' ' 38' ' ' CYS . 3.2 mm? -136.12 147.53 47.81 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.615 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 23.6 t -118.1 140.21 42.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.809 0.337 . . . . 0.0 111.187 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.401 HG21 HD11 ' A' ' 124' ' ' LEU . 17.1 mt -106.26 125.84 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.099 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -111.8 117.64 33.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.563 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.913 HG12 HD21 ' A' ' 124' ' ' LEU . 4.6 mt -84.83 134.05 27.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.34 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.4 ' ND2' ' HB ' ' A' ' 32' ' ' ILE . 10.4 t30 -81.36 109.63 16.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.812 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -61.17 -33.09 72.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.083 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.27 -46.01 91.31 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.987 0.422 . . . . 0.0 110.773 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 18.8 t80 . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.98 -179.826 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.721 0.296 . . . . 0.0 111.302 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -176.54 37.97 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.746 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -78.41 134.34 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.57 0 CA-C-N 113.88 -1.509 . . . . 0.0 112.523 -177.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.023 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.7 t -89.15 -62.01 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.301 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.8 p -149.24 153.44 37.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.458 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 24.1 ttm180 -118.11 138.15 52.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.804 0.335 . . . . 0.0 111.592 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.758 HG11 ' CE2' ' A' ' 68' ' ' PHE . 34.4 m -103.48 122.91 56.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.983 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.85 HG23 HG12 ' A' ' 45' ' ' ILE . 21.0 mt -126.8 116.37 44.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.563 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.668 ' SG ' HD12 ' A' ' 43' ' ' ILE . 0.9 OUTLIER -81.02 112.52 18.49 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.115 179.374 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.52 -20.18 40.6 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.527 HG21 ' H ' ' A' ' 142' ' ' SER . 66.5 p -79.71 -2.5 43.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.703 0.287 . . . . 0.0 111.538 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.68 72.18 0.75 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.764 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -142.25 -41.48 0.34 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.902 0.382 . . . . 0.0 110.705 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.668 HD12 ' SG ' ' A' ' 38' ' ' CYS . 3.5 mt -119.49 142.15 32.14 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.06 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.602 ' HD2' HG23 ' A' ' 43' ' ' ILE . 57.7 Cg_endo -73.65 139.92 28.77 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.208 1.938 . . . . 0.0 112.026 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.85 HG12 HG23 ' A' ' 37' ' ' ILE . 34.3 mt -55.62 149.2 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.759 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -144.41 164.0 32.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.033 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -121.75 119.99 33.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.114 0.483 . . . . 0.0 112.049 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.557 HD22 ' CD1' ' A' ' 66' ' ' TRP . 7.3 mt -92.62 137.5 32.31 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . 1.023 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -144.6 158.31 43.83 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -178.961 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.482 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -144.73 145.8 31.87 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.661 -1.609 . . . . 0.0 110.947 178.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 121.061 0.458 . . . . 0.0 111.027 -179.725 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.426 ' HE2' ' O ' ' A' ' 49' ' ' SER . 2.7 ttpt . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.72 0.295 . . . . 0.0 111.025 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.663 HG22 ' CB ' ' A' ' 92' ' ' LEU . 22.0 t -134.02 139.62 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 121.384 0.611 . . . . 0.0 112.388 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.591 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 15.6 m-90 -105.09 138.95 40.51 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.948 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.689 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -115.94 125.89 53.16 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.298 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.79 ' CE1' HD12 ' A' ' 91' ' ' ILE . 2.1 m-85 -107.05 145.84 31.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.832 -178.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.669 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.63 179.84 38.94 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.578 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 18.4 mtm180 -78.66 -1.65 35.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.605 0.241 . . . . 0.0 111.382 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.481 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 7.8 t-20 -84.83 136.88 38.45 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 120.756 0.312 . . . . 0.0 111.037 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.1 Cg_exo -69.3 -5.88 16.99 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.879 2.386 . . . . 0.0 111.948 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.89 -45.66 13.94 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-O 122.04 0.924 . . . . 0.0 108.681 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -45.41 137.74 4.67 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 113.639 -1.619 . . . . 0.0 110.533 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.17 -18.89 11.4 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.061 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.662 ' CE1' HG21 ' A' ' 36' ' ' VAL . 50.7 t80 -129.59 125.0 35.19 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.652 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -98.48 112.67 24.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.034 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.642 HD23 ' HE2' ' A' ' 76' ' ' TYR . 19.5 mt -82.14 -69.27 0.63 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 174.93 -91.15 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.28 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.2 p30 -178.85 54.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.828 0.347 . . . . 0.0 111.098 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 30.1 mm -88.91 124.76 41.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.154 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.69 -42.32 75.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.062 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.96 -18.73 58.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.43 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.661 HD21 HG23 ' A' ' 132' ' ' VAL . 26.5 mt -104.0 152.14 22.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.763 0.316 . . . . 0.0 111.228 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 p -96.66 170.21 9.35 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.562 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.669 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 6.1 m-20 -43.81 -56.74 3.65 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.276 0.56 . . . . 0.0 109.693 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.446 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -117.85 84.84 2.23 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 177.177 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.658 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 61.7 t-80 -59.34 -46.26 89.12 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.907 -1.042 . . . . 0.0 113.11 -176.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.507 ' CZ ' ' CD2' ' A' ' 68' ' ' PHE . 22.4 p90 -149.3 158.53 44.25 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.919 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.689 ' HG3' HG23 ' A' ' 67' ' ' THR . 25.5 tt0 -136.18 138.55 42.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.834 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.79 HD12 ' CE1' ' A' ' 68' ' ' PHE . 4.4 mt -114.15 129.29 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 C-N-CA 121.122 -0.231 . . . . 0.0 110.649 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.663 ' CB ' HG22 ' A' ' 65' ' ' VAL . 2.2 pp -123.23 144.93 49.07 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 121.058 0.456 . . . . 0.0 111.864 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.644 HD13 ' CG1' ' A' ' 33' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.253 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.813 HD21 HG12 ' A' ' 33' ' ' VAL . 1.4 mp . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.733 0.301 . . . . 0.0 110.751 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.451 HD12 ' O ' ' A' ' 99' ' ' LEU . 4.1 mp -124.14 142.57 51.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.436 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.738 HD11 ' HA ' ' A' ' 124' ' ' LEU . 0.5 OUTLIER -112.88 123.98 51.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.135 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -118.99 115.67 24.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.963 0.411 . . . . 0.0 111.69 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.788 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.3 p30 -78.95 139.57 38.22 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.488 HG12 ' HA ' ' A' ' 89' ' ' PHE . 11.5 pt -143.16 26.49 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.909 -0.317 . . . . 0.0 111.824 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.554 ' HB2' ' CG ' ' A' ' 88' ' ' HIS . 10.6 t -92.11 155.62 17.93 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 121.534 0.683 . . . . 0.0 112.63 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 42.3 m -69.95 -52.1 27.3 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.583 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -77.59 -1.7 32.04 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.292 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.92 156.31 31.99 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.615 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.513 HG22 ' CG2' ' A' ' 130' ' ' ILE . 4.3 m -117.41 137.73 52.29 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.87 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -113.89 148.58 36.51 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -177.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.465 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.06 113.45 18.4 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.594 -1.185 . . . . 0.0 108.442 177.546 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.401 ' N ' HD12 ' A' ' 111' ' ' LEU . 57.1 m-20 44.47 43.37 6.23 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.1 -11.14 65.96 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.508 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -103.15 118.57 37.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.03 0.443 . . . . 0.0 110.508 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.87 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 2.5 tptm -72.6 112.72 8.9 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.373 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.788 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.0 m -84.44 162.69 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.775 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.3 OUTLIER -69.78 128.8 37.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.497 179.745 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.687 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 26.6 tttm -54.83 161.51 1.55 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.934 0.397 . . . . 0.0 110.316 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.503 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 36.24 32.97 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.334 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.5 144.94 41.12 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.771 179.188 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.645 ' OD1' HD21 ' A' ' 92' ' ' LEU . 13.5 m-80 -92.49 132.23 36.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.006 0.431 . . . . 0.0 111.147 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.735 ' O ' HD12 ' A' ' 101' ' ' LEU . 42.9 mm-40 -129.38 150.71 50.63 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.581 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.648 HD23 ' O ' ' A' ' 124' ' ' LEU . 3.1 tt -72.67 135.99 45.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.269 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.811 HD21 HG12 ' A' ' 147' ' ' ILE . 64.6 tp -63.54 154.5 32.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.613 0.72 . . . . 0.0 111.698 -179.15 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.413 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -124.97 153.06 43.35 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.373 179.606 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.81 122.8 21.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.909 0.385 . . . . 0.0 110.236 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.87 23.41 50.93 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.961 -0.637 . . . . 0.0 112.236 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -51.64 170.38 0.05 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.836 0.351 . . . . 0.0 110.983 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.902 ' CG ' HG22 ' A' ' 144' ' ' VAL . 4.7 mt-10 -145.14 135.61 24.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.184 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.756 HD11 HD11 ' A' ' 145' ' ' ILE . 14.8 mt -113.09 126.32 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.578 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.587 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.3 m -104.59 140.26 38.26 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.661 HG23 HD21 ' A' ' 84' ' ' LEU . 35.4 m -140.36 158.58 25.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.28 28.82 29.44 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.073 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.475 ' HA ' HG12 ' A' ' 140' ' ' ILE . 70.2 t -74.07 140.33 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-O 121.583 0.706 . . . . 0.0 111.945 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 140.92 -42.05 1.22 Allowed Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -178.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.2 t -117.32 123.41 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.3 -35.04 25.67 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 84.0 p -93.59 6.62 47.64 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -121.65 28.61 7.58 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.587 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.1 mt -107.36 137.88 36.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.49 0.662 . . . . 0.0 111.348 178.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.474 HD21 ' SG ' ' A' ' 38' ' ' CYS . 9.5 tt -125.37 134.61 52.11 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.079 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.527 ' H ' HG21 ' A' ' 40' ' ' THR . 46.3 t -108.47 150.06 27.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.702 0.763 . . . . 0.0 112.181 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.477 HD12 ' O ' ' A' ' 130' ' ' ILE . 4.0 mp -135.15 150.48 50.17 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.74 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.902 HG22 ' CG ' ' A' ' 129' ' ' GLU . 21.3 t -121.79 134.83 63.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.741 0.305 . . . . 0.0 111.025 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.756 HD11 HD11 ' A' ' 130' ' ' ILE . 16.9 mt -106.35 123.07 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-O 120.89 0.376 . . . . 0.0 111.039 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.73 119.26 38.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.777 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.811 HG12 HD21 ' A' ' 124' ' ' LEU . 2.5 mt -84.98 134.11 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.352 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -79.77 116.34 19.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.765 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -58.39 -31.95 68.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.075 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 17.0 mmmt -60.32 -46.07 91.18 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.773 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 5.1 t80 . . . . . 0 C--N 1.327 -0.406 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.018 -179.92 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.958 0.409 . . . . 0.0 110.553 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.468 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER -179.27 37.17 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 179.83 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.709 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.7 mm -75.57 135.55 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 CA-C-N 113.686 -1.597 . . . . 0.0 112.655 -177.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.037 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -93.19 -60.75 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.062 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.63 ' SG ' HD12 ' A' ' 48' ' ' LEU . 1.9 p -145.44 145.42 31.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.301 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.426 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.92 138.07 50.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.797 0.332 . . . . 0.0 111.485 -179.237 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.662 HG21 ' CE2' ' A' ' 68' ' ' PHE . 44.6 t -107.17 122.75 61.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.95 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.817 HG23 HG12 ' A' ' 45' ' ' ILE . 17.8 mt -124.07 120.27 59.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.591 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.737 ' HA ' HD23 ' A' ' 143' ' ' LEU . 46.8 t -79.88 119.61 22.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.357 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.59 -23.2 22.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.648 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.534 HG21 ' H ' ' A' ' 142' ' ' SER . 63.5 p -79.8 -2.33 42.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.782 0.325 . . . . 0.0 111.459 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.35 73.58 0.52 Allowed Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.814 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -145.92 -37.76 0.25 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.777 0.322 . . . . 0.0 111.117 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.589 HD13 ' HB3' ' A' ' 78' ' ' LEU . 2.6 mt -121.54 140.96 32.52 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.928 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.547 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.2 Cg_endo -73.22 140.36 30.68 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.191 1.927 . . . . 0.0 112.087 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.817 HG12 HG23 ' A' ' 37' ' ' ILE . 34.6 mt -56.62 134.16 20.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.706 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.463 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -122.57 163.03 20.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.256 179.367 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.426 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.7 OUTLIER -118.89 120.63 37.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.083 0.468 . . . . 0.0 112.162 -179.326 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.63 HD12 ' SG ' ' A' ' 34' ' ' CYS . 1.6 mt -96.86 133.71 41.12 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . 1.037 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.24 158.91 43.91 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -178.526 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.501 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -144.38 141.89 29.98 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 113.586 -1.643 . . . . 0.0 110.731 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 121.068 0.461 . . . . 0.0 111.093 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.415 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.1 ttpt . . . . . 0 CA--C 1.523 -0.079 0 CA-C-O 120.698 0.285 . . . . 0.0 111.319 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.517 HG13 ' O ' ' A' ' 91' ' ' ILE . 5.8 t -123.24 138.08 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-O 121.234 0.54 . . . . 0.0 111.768 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.554 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.3 m-90 -102.31 139.71 37.56 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.302 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.979 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -111.83 128.42 56.11 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 176.971 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.677 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.4 OUTLIER -118.66 145.28 45.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.264 -178.153 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.629 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.06 -172.4 38.19 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.748 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 27.2 mtm180 -78.69 3.2 17.12 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.516 HD22 ' HB3' ' A' ' 73' ' ' ALA . 1.9 t30 -84.69 132.46 46.47 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.687 0.279 . . . . 0.0 111.005 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.2 Cg_exo -65.98 -13.67 40.95 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.585 2.19 . . . . 0.0 111.68 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.516 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.74 -43.05 17.26 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.967 0.889 . . . . 0.0 108.953 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.23 138.7 1.6 Allowed 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 113.792 -1.549 . . . . 0.0 110.828 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.1 m-20 -56.42 -18.93 12.73 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.968 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.506 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 25.6 t80 -129.83 123.27 30.49 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.141 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -100.14 118.69 37.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.555 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.626 HD13 HD23 ' A' ' 84' ' ' LEU . 0.8 OUTLIER -125.39 72.36 1.25 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.247 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 48.97 -135.49 21.34 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.959 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -158.96 81.09 0.78 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.797 0.332 . . . . 0.0 110.92 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.639 HD13 HD22 ' A' ' 84' ' ' LEU . 4.9 mp -95.52 140.43 16.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.033 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 m -55.61 -45.0 77.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.132 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.498 ' HG3' ' HA2' ' A' ' 133' ' ' GLY . 0.0 OUTLIER -60.74 -49.07 78.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.753 -179.357 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.639 HD22 HD13 ' A' ' 81' ' ' ILE . 4.3 mp -72.56 152.88 41.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.209 0.528 . . . . 0.0 111.215 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.6 p -102.48 168.27 9.41 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.758 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.629 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 9.0 m-20 -42.47 -60.02 1.66 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.389 0.614 . . . . 0.0 109.527 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.598 ' HB3' HG22 ' A' ' 67' ' ' THR . 3.0 mtmp? -115.63 84.58 2.12 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 176.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.627 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 10.2 t60 -61.45 -44.58 96.87 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.242 -0.89 . . . . 0.0 113.02 -176.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.533 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 12.1 p90 -146.16 162.87 37.04 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.07 -0.652 . . . . 0.0 112.254 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.979 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.54 138.03 42.63 Favored 'General case' 0 C--O 1.227 -0.111 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.006 -179.099 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.677 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 62.2 mt -114.86 129.23 71.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.656 178.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.859 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -108.0 148.07 30.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.994 0.426 . . . . 0.0 111.294 -179.623 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.828 HD22 HG11 ' A' ' 33' ' ' VAL . 49.7 tp . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.543 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.699 ' C ' HD12 ' A' ' 100' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.786 0.327 . . . . 0.0 110.81 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.877 HD23 ' HB3' ' A' ' 121' ' ' ASN . 11.1 mp -131.2 143.96 50.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.671 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.524 HD11 ' CD1' ' A' ' 130' ' ' ILE . 0.9 OUTLIER -112.61 125.26 54.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.128 179.715 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.859 ' HB2' HD11 ' A' ' 92' ' ' LEU . 49.0 t30 -115.72 115.71 26.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.901 0.382 . . . . 0.0 111.584 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.778 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.0 p30 -78.87 136.23 37.24 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.034 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.476 HD12 ' HB2' ' A' ' 87' ' ' LYS . 12.9 pt -144.28 39.7 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.58 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -97.42 157.01 16.21 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.191 0.52 . . . . 0.0 111.92 -178.872 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 92.4 m -69.11 -36.27 77.33 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.433 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 19.8 p30 -98.51 -19.86 17.4 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.58 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 122.66 156.07 9.52 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.277 -0.963 . . . . 0.0 113.515 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.523 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 4.8 m -117.68 137.78 52.43 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 122.818 0.447 . . . . 0.0 109.832 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.858 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -119.32 148.1 43.55 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -178.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.74 HD23 ' O ' ' A' ' 114' ' ' GLN . 0.7 OUTLIER -124.75 113.56 18.12 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.544 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 45.1 m-20 49.45 42.02 21.85 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 83.98 -6.05 76.68 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.924 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.74 ' O ' HD23 ' A' ' 111' ' ' LEU . 4.4 mt-30 -103.97 118.92 37.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.189 0.495 . . . . 0.0 110.589 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.858 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 7.3 tptt -74.92 127.14 32.5 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.339 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.778 HG23 ' OD2' ' A' ' 103' ' ' ASP . 13.2 m -103.0 164.09 3.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.883 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 120' ' ' SER . 9.9 tp10 -69.76 128.04 35.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.422 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.693 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 56.4 tttt -53.8 161.78 1.06 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.719 0.295 . . . . 0.0 110.414 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.9 p-10 35.23 34.77 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.141 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.22 145.11 40.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.363 179.61 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.877 ' HB3' HD23 ' A' ' 100' ' ' LEU . 6.5 m120 -89.14 125.48 35.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.589 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -129.5 148.73 51.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.201 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.617 HD23 ' O ' ' A' ' 124' ' ' LEU . 5.3 tt -72.83 114.53 11.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.015 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.733 HD21 HD13 ' A' ' 145' ' ' ILE . 5.2 mt -55.11 166.26 0.57 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.654 0.74 . . . . 0.0 112.063 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.428 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.6 OUTLIER -125.4 152.71 44.46 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.488 179.334 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.44 ' HA ' HD12 ' A' ' 147' ' ' ILE . 15.2 tp60 -71.95 124.48 24.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.87 0.366 . . . . 0.0 110.352 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 145' ' ' ILE . . . 58.35 20.92 46.44 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.227 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.428 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 8.3 t70 -56.85 178.67 0.05 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.656 0.265 . . . . 0.0 110.809 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.899 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.2 mt-10 -145.19 135.73 24.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.124 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.751 HD11 HD11 ' A' ' 145' ' ' ILE . 8.1 mt -108.9 124.62 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 121.005 0.431 . . . . 0.0 110.831 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.534 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.7 m -104.37 143.19 33.32 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.627 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 27.0 m -140.22 158.37 25.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.498 ' HA2' ' HG3' ' A' ' 83' ' ' ARG . . . 74.29 45.17 25.76 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.312 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.548 ' HA ' HG12 ' A' ' 140' ' ' ILE . 95.3 t -85.41 140.62 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 121.675 0.75 . . . . 0.0 112.379 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 140.29 -38.08 1.63 Allowed Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -178.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 139' ' ' ASP . 1.1 t -126.49 118.68 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.463 ' HA ' HD12 ' A' ' 140' ' ' ILE . 3.2 mp0 -50.36 -24.75 3.21 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 17.0 m -93.18 4.49 53.9 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.475 ' N ' HG12 ' A' ' 136' ' ' VAL . 1.5 m-20 -128.96 26.73 5.49 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.548 HG12 ' HA ' ' A' ' 134' ' ' VAL . 6.3 mt -107.15 138.24 34.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-O 121.464 0.649 . . . . 0.0 111.487 178.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.4 tt -125.47 134.68 51.98 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.207 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.534 ' H ' HG21 ' A' ' 40' ' ' THR . 42.2 t -113.03 147.53 37.02 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.797 0.808 . . . . 0.0 112.355 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.737 HD23 ' HA ' ' A' ' 38' ' ' CYS . 77.8 mt -136.55 157.27 47.16 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.855 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.899 HG22 ' CG ' ' A' ' 129' ' ' GLU . 26.2 t -120.64 139.14 48.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.824 0.345 . . . . 0.0 110.995 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.751 HD11 HD11 ' A' ' 130' ' ' ILE . 70.0 mt -106.33 120.93 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.16 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.74 109.49 19.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.536 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' A' ' 126' ' ' GLN . 6.2 mt -84.64 132.11 32.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.476 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -78.5 113.39 16.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.815 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -64.57 -30.53 71.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.064 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.82 -46.13 91.73 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.763 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 30.8 t80 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.095 -179.886 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.831 0.348 . . . . 0.0 110.964 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER -179.27 37.82 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.675 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.0 mm -75.23 137.13 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 CA-C-N 113.632 -1.622 . . . . 0.0 112.778 -177.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.02 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.1 t -91.86 -58.89 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.497 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.72 ' SG ' HD22 ' A' ' 48' ' ' LEU . 4.6 p -147.88 165.41 30.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.444 179.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -133.28 138.31 46.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.854 0.359 . . . . 0.0 111.323 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.708 HG21 ' CE2' ' A' ' 68' ' ' PHE . 42.8 t -107.23 122.82 61.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.955 0.407 . . . . 0.0 110.916 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.816 HG23 HG12 ' A' ' 45' ' ' ILE . 13.2 mt -122.23 121.9 65.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.508 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.74 ' HA ' HD13 ' A' ' 143' ' ' LEU . 42.4 t -79.86 117.02 20.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.684 0.278 . . . . 0.0 110.663 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.555 HG23 HG21 ' A' ' 144' ' ' VAL . 0.6 OUTLIER -86.08 -23.36 26.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.37 -179.706 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.513 HG21 ' H ' ' A' ' 142' ' ' SER . 72.4 p -79.81 -2.33 42.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.838 0.351 . . . . 0.0 111.342 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.3 73.58 0.48 Allowed Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.203 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.436 ' HG3' HD21 ' A' ' 141' ' ' LEU . 6.0 mt-30 -146.79 -39.17 0.21 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.683 0.278 . . . . 0.0 111.181 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.557 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.8 mt -118.9 141.02 29.4 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.783 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.557 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 54.2 Cg_endo -72.28 144.54 41.65 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.157 1.905 . . . . 0.0 112.209 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.816 HG12 HG23 ' A' ' 37' ' ' ILE . 43.9 mt -56.45 144.6 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.66 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.497 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.2 OUTLIER -128.24 161.98 28.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.02 179.338 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -123.31 119.56 30.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.971 0.415 . . . . 0.0 111.465 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.85 HD23 ' CD2' ' A' ' 66' ' ' TRP . 6.9 mp -92.29 130.41 37.99 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . 1.02 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -142.03 155.37 45.41 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 122.257 1.027 . . . . 0.0 113.524 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.46 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -141.38 141.74 33.77 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 113.387 -1.733 . . . . 0.0 110.712 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 121.168 0.509 . . . . 0.0 111.089 -179.71 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.438 ' CE ' ' O ' ' A' ' 49' ' ' SER . 4.7 ttpt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.69 0.281 . . . . 0.0 111.131 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.583 HG12 ' HG2' ' A' ' 90' ' ' GLN . 10.8 t -126.48 139.07 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-O 121.31 0.576 . . . . 0.0 112.016 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.85 ' CD2' HD23 ' A' ' 48' ' ' LEU . 17.7 m-90 -104.36 139.31 39.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.373 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.706 HG22 ' HB3' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -112.69 132.28 55.27 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 177.531 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.757 ' HZ ' HD21 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -118.67 145.55 45.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.899 0.38 . . . . 0.0 111.665 -178.728 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.65 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.49 -170.14 37.98 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.902 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.43 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 4.5 mtm105 -80.21 1.63 27.57 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.502 HD22 ' HB3' ' A' ' 73' ' ' ALA . 2.1 t30 -84.81 132.96 44.6 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.624 0.25 . . . . 0.0 111.16 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.28 -13.07 38.26 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.661 2.241 . . . . 0.0 111.796 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.502 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.62 -43.47 16.95 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-O 121.801 0.81 . . . . 0.0 108.856 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.22 140.4 1.16 Allowed 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 113.887 -1.506 . . . . 0.0 110.633 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.9 m-20 -56.29 -18.96 12.19 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.972 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.497 ' CE1' ' HB2' ' A' ' 46' ' ' ARG . 10.9 t80 -129.62 124.3 33.4 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 120.784 0.326 . . . . 0.0 110.98 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -95.56 107.85 20.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.522 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.438 HD13 ' N ' ' A' ' 69' ' ' GLY . 11.1 mp -82.75 -78.58 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.914 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -173.38 -88.53 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.02 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.0 p30 174.7 49.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.886 0.374 . . . . 0.0 111.117 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 1.11 HD13 HD12 ' A' ' 84' ' ' LEU . 4.1 mp -78.59 126.79 38.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.865 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.87 -40.65 69.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.909 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.441 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 2.0 mmp_? -62.81 -49.13 76.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.267 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.11 HD12 HD13 ' A' ' 81' ' ' ILE . 23.2 mt -72.69 150.44 42.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.223 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.8 p -94.55 167.05 11.73 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.668 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.65 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.5 m-20 -43.73 -53.75 5.62 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.292 0.568 . . . . 0.0 109.744 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.706 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.1 OUTLIER -120.25 83.2 2.02 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 177.184 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.557 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.7 t60 -58.97 -45.88 89.47 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.221 -0.899 . . . . 0.0 112.634 -176.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.513 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 20.3 p90 -144.5 159.91 41.98 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.972 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.697 ' HG3' HG23 ' A' ' 67' ' ' THR . 3.6 tt0 -136.31 140.68 43.53 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.246 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.63 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 72.8 mt -115.78 130.19 70.86 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.706 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.441 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.6 OUTLIER -114.96 148.84 38.23 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.115 0.483 . . . . 0.0 111.776 -179.587 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.712 HD22 HG11 ' A' ' 33' ' ' VAL . 17.8 tp . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.308 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 1.005 HD21 HG12 ' A' ' 33' ' ' VAL . 5.2 mp . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.817 0.341 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.585 HD23 ' HB3' ' A' ' 121' ' ' ASN . 3.3 mp -121.52 147.1 46.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.224 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.635 HD11 HG12 ' A' ' 130' ' ' ILE . 1.1 tt -112.84 123.6 50.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.467 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.441 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 49.1 t30 -116.0 115.49 26.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.983 0.42 . . . . 0.0 111.256 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.776 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.1 p30 -79.97 134.0 36.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.951 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.494 HD12 ' HB2' ' A' ' 87' ' ' LYS . 10.6 pt -141.61 40.88 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -178.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.59 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -100.87 152.32 20.68 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 120.914 0.388 . . . . 0.0 111.254 -179.245 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.5 m -68.94 -32.1 71.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.316 178.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.441 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 27.9 p30 -98.62 -19.72 17.4 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.59 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.92 155.45 9.55 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.314 -0.946 . . . . 0.0 113.731 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.547 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.9 m -117.43 137.95 52.16 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.848 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -115.34 148.41 39.3 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -177.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.479 HD13 ' OD2' ' A' ' 128' ' ' ASP . 0.2 OUTLIER -124.18 113.37 18.23 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.238 177.371 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.406 ' N ' HD12 ' A' ' 111' ' ' LEU . 48.4 m-20 45.61 42.94 8.79 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.2 -6.27 80.14 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.549 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.55 118.61 37.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 117.018 0.409 . . . . 0.0 110.787 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.848 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 17.7 tptt -73.72 126.97 31.55 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.181 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.776 HG23 ' OD2' ' A' ' 103' ' ' ASP . 9.7 m -102.56 165.34 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.285 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.401 ' O ' ' HB3' ' A' ' 120' ' ' SER . 2.5 tt0 -69.89 128.86 37.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.423 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.691 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 76.7 tttt -54.1 164.23 0.67 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.3 m-80 33.6 37.0 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.803 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.9 p -111.77 145.11 39.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.005 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.585 ' HB3' HD23 ' A' ' 100' ' ' LEU . 75.9 m-20 -92.41 127.07 37.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.806 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.415 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 57.6 mm-40 -129.31 149.13 51.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.743 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.1 tp -72.86 128.83 36.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.386 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.584 HD23 HG12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -59.75 160.92 6.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.649 0.738 . . . . 0.0 112.173 -179.23 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.713 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.4 OUTLIER -124.99 153.3 42.99 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.636 -1.166 . . . . 0.0 110.034 179.308 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.605 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.44 119.2 15.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.882 0.373 . . . . 0.0 110.375 -179.71 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.52 26.42 56.91 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.036 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.496 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 7.6 t70 -57.24 175.24 0.15 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 120.914 0.388 . . . . 0.0 111.052 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.859 ' CG ' HG22 ' A' ' 144' ' ' VAL . 4.6 mt-10 -145.36 135.63 24.0 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.059 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 1.058 HD11 HD11 ' A' ' 145' ' ' ILE . 3.3 mt -110.07 127.93 66.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.832 0.348 . . . . 0.0 110.497 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.594 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.36 138.89 40.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.851 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.515 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 30.8 m -140.17 158.41 25.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.12 27.65 30.39 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.955 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.466 ' HA ' HG12 ' A' ' 140' ' ' ILE . 72.9 t -72.01 140.44 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-O 121.724 0.773 . . . . 0.0 112.197 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.7 -49.75 0.6 Allowed Glycine 0 N--CA 1.434 -1.452 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.406 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 2.5 t -109.97 125.55 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -50.18 -35.7 27.38 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.2 t -93.57 6.67 47.47 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.422 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . 0.9 OUTLIER -122.3 31.61 6.09 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -178.473 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.594 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.4 mt -106.49 138.94 29.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-O 121.399 0.619 . . . . 0.0 110.898 178.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.459 ' HA ' HD22 ' A' ' 141' ' ' LEU . 0.4 OUTLIER -124.51 134.64 52.95 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.557 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.659 ' C ' HD22 ' A' ' 143' ' ' LEU . 39.4 t -111.15 150.16 29.87 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.653 0.74 . . . . 0.0 112.429 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.74 HD13 ' HA ' ' A' ' 38' ' ' CYS . 3.5 mm? -136.35 153.43 51.13 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.503 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.859 HG22 ' CG ' ' A' ' 129' ' ' GLU . 15.4 t -118.16 140.33 41.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.817 0.341 . . . . 0.0 111.067 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 1.058 HD11 HD11 ' A' ' 130' ' ' ILE . 41.6 mt -106.05 120.96 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.032 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.19 111.31 22.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.834 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.713 HD11 ' O ' ' A' ' 125' ' ' SER . 4.2 mp -85.55 129.45 37.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.342 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -81.08 128.64 33.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.01 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -74.06 -29.62 61.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.189 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.3 tttt -59.0 -43.69 91.54 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.851 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 30.1 t80 . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.039 -179.855 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.819 0.343 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.438 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER -170.99 34.77 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.71 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 2.9 mm -77.1 131.55 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-N 113.887 -1.506 . . . . 0.0 112.388 -177.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.034 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -90.42 -62.0 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 114.623 -1.172 . . . . 0.0 110.442 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.506 ' SG ' HD12 ' A' ' 48' ' ' LEU . 4.0 p -147.89 142.53 26.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.441 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -113.83 134.1 55.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.976 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.69 HG21 ' HE2' ' A' ' 68' ' ' PHE . 38.5 t -97.45 122.88 49.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.97 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.795 HG23 HG12 ' A' ' 45' ' ' ILE . 15.5 mt -119.8 110.93 30.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.653 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 1.1 m -84.53 111.48 19.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.003 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.2 p -100.27 -9.68 22.12 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.784 HG21 ' OG ' ' A' ' 142' ' ' SER . 10.0 p -88.04 -2.86 58.86 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.183 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.55 90.32 0.45 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.488 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.76 ' OE1' HD23 ' A' ' 141' ' ' LEU . 10.7 pt20 -165.64 -47.28 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.791 0.329 . . . . 0.0 111.435 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.61 HG23 ' HD2' ' A' ' 44' ' ' PRO . 6.8 mt -130.32 142.4 45.33 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.85 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.61 ' HD2' HG23 ' A' ' 43' ' ' ILE . 67.4 Cg_endo -76.04 141.33 23.63 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.151 1.901 . . . . 0.0 111.509 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.795 HG12 HG23 ' A' ' 37' ' ' ILE . 47.6 mt -50.14 139.65 4.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.116 0.484 . . . . 0.0 112.054 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.41 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -135.86 163.0 31.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.014 179.105 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -120.22 119.86 34.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.142 0.496 . . . . 0.0 112.334 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.527 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 4.7 mt -94.04 137.55 33.12 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 178.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . 1.034 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.2 158.09 43.86 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -178.272 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.482 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.33 141.89 28.92 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 113.094 -1.866 . . . . 0.0 110.166 178.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 121.209 0.528 . . . . 0.0 111.529 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.43 ' NZ ' ' HA ' ' A' ' 50' ' ' ALA . 4.5 ttpt . . . . . 0 CA--C 1.522 -0.116 0 CA-C-O 120.644 0.259 . . . . 0.0 110.779 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.685 HG12 ' HG2' ' A' ' 90' ' ' GLN . 16.4 t -128.93 139.18 52.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.409 0.623 . . . . 0.0 112.399 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.527 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.3 m-90 -101.27 138.66 38.0 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.846 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.694 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.91 126.28 54.99 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 176.857 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.69 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -108.8 145.36 35.33 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.407 -178.225 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.71 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.79 172.61 31.48 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.981 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.541 ' HG3' HD11 ' A' ' 78' ' ' LEU . 1.8 mtm105 -67.13 -4.77 10.99 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.456 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.8 t30 -84.48 135.32 41.17 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.744 0.307 . . . . 0.0 111.175 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.2 Cg_exo -69.63 -6.14 17.83 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.868 2.379 . . . . 0.0 112.058 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.92 -43.59 16.32 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 122.029 0.919 . . . . 0.0 108.846 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.18 138.31 2.25 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.986 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -56.53 -18.36 11.42 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.236 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.56 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 19.7 t80 -129.0 114.36 16.32 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.785 0.326 . . . . 0.0 110.646 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -88.26 130.61 35.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.271 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.576 HD21 ' CA ' ' A' ' 69' ' ' GLY . 1.4 pp -133.16 -177.67 4.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.593 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.556 ' O ' HD12 ' A' ' 78' ' ' LEU . . . -57.3 -168.34 0.11 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.266 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -123.92 82.93 2.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.858 0.361 . . . . 0.0 110.734 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.575 HG22 ' H ' ' A' ' 83' ' ' ARG . 3.5 mp -109.64 130.3 62.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.205 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.8 -31.23 64.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.168 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.575 ' H ' HG22 ' A' ' 81' ' ' ILE . 1.4 mmp_? -60.75 -36.03 77.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.459 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.911 HD21 HG21 ' A' ' 132' ' ' VAL . 5.5 mp -93.28 152.98 18.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.201 0.524 . . . . 0.0 111.666 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.91 168.88 10.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.703 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.71 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.4 m-20 -44.03 -53.22 6.48 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.336 0.589 . . . . 0.0 109.722 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.53 ' NZ ' HG21 ' A' ' 67' ' ' THR . 0.1 OUTLIER -119.45 83.56 2.06 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.375 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.523 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 15.9 t60 -60.98 -47.42 86.55 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.685 -176.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.526 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 20.0 p90 -147.17 160.44 42.45 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.254 -0.578 . . . . 0.0 111.612 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.694 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.7 tt0 -136.1 141.49 44.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.639 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.613 ' O ' HG13 ' A' ' 65' ' ' VAL . 63.2 mt -116.9 127.66 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 121.219 -0.193 . . . . 0.0 110.531 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.504 ' CB ' HG22 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -112.33 150.17 31.4 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.158 0.504 . . . . 0.0 112.255 -179.14 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 1.036 HD12 HD11 ' A' ' 99' ' ' LEU . 6.9 tt . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.125 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 1.036 HD11 HD12 ' A' ' 93' ' ' LEU . 3.9 mm? . . . . . 0 N--CA 1.458 -0.057 0 CA-C-O 120.891 0.377 . . . . 0.0 111.122 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.725 HD23 ' O ' ' A' ' 122' ' ' GLN . 9.1 mt -126.04 147.38 49.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.19 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.11 122.17 47.02 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -112.93 115.37 28.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.614 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.862 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.7 p-10 -77.49 143.15 38.7 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.796 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.438 HG12 ' HA ' ' A' ' 89' ' ' PHE . 10.7 pt -151.41 36.79 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -178.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.562 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.34 148.43 24.19 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 120.924 0.392 . . . . 0.0 111.604 -179.183 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.6 m -68.7 -31.39 70.44 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 177.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -92.0 -19.82 21.99 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.484 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.562 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 113.29 152.46 11.06 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.293 -0.956 . . . . 0.0 113.937 179.009 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.537 HG22 ' CG2' ' A' ' 130' ' ' ILE . 4.9 m -117.35 137.72 52.26 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.837 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -117.56 148.18 42.13 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -178.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.474 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.27 113.56 18.42 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.468 177.597 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.417 ' N ' HD12 ' A' ' 111' ' ' LEU . 92.8 m-20 45.31 42.69 7.55 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.25 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 84.99 -4.05 86.13 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.53 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -104.78 118.74 37.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.034 0.445 . . . . 0.0 110.655 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.837 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 6.7 tptt -74.98 117.76 17.19 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.141 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.862 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.2 m -96.6 159.77 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.201 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.493 ' O ' ' HB3' ' A' ' 120' ' ' SER . 0.0 OUTLIER -69.81 130.11 41.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.536 179.861 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.698 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 9.2 ptmt -55.13 167.73 0.4 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.08 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.5 m-80 36.93 33.44 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.983 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.493 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 22.8 t -112.44 141.38 46.25 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.849 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.583 ' HB3' HD22 ' A' ' 100' ' ' LEU . 4.8 m-80 -92.08 129.55 38.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.85 0.357 . . . . 0.0 111.092 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.725 ' O ' HD23 ' A' ' 100' ' ' LEU . 13.3 mm100 -129.48 150.4 50.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.689 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.5 tp -72.5 133.3 44.73 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.273 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.901 HD13 ' HB2' ' A' ' 99' ' ' LEU . 1.3 pt? -63.48 160.85 15.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.81 0.814 . . . . 0.0 112.148 -179.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.719 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.3 OUTLIER -125.63 153.31 43.97 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.07 179.275 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.591 ' HA ' HD13 ' A' ' 147' ' ' ILE . 8.1 mm100 -71.41 115.7 10.89 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.81 28.49 68.39 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.585 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.419 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 24.9 t0 -53.44 173.84 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.945 0.402 . . . . 0.0 111.19 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 15.1 tt0 -145.15 135.24 23.86 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.898 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.537 ' CG2' HG22 ' A' ' 109' ' ' THR . 15.2 mt -115.49 126.58 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.342 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.539 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.37 141.51 36.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.275 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.911 HG21 HD21 ' A' ' 84' ' ' LEU . 34.2 m -140.06 158.42 26.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.021 0.439 . . . . 0.0 111.996 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.18 30.25 23.13 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.932 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.476 ' HA ' HG12 ' A' ' 140' ' ' ILE . 73.9 t -77.01 140.48 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 CA-C-O 121.647 0.737 . . . . 0.0 112.101 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.17 -39.85 1.22 Allowed Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.509 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 2.8 t -118.01 119.12 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -50.42 -32.1 16.82 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 76.7 p -93.69 6.79 47.15 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.509 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.5 OUTLIER -129.49 34.44 4.35 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -178.463 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.539 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.1 mt -107.17 139.32 29.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.766 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.76 HD23 ' OE1' ' A' ' 42' ' ' GLN . 2.1 mp -124.15 134.78 53.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.879 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.784 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.3 OUTLIER -106.59 135.49 48.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.172 0.51 . . . . 0.0 111.804 -179.327 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.754 HD12 ' C ' ' A' ' 142' ' ' SER . 5.3 mp -123.69 141.4 52.05 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.4 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 20.8 t -110.9 132.99 57.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.906 0.384 . . . . 0.0 111.196 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.547 HD13 HG22 ' A' ' 36' ' ' VAL . 2.2 mm -106.3 121.64 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.935 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.21 138.58 44.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.662 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.719 HD11 ' O ' ' A' ' 125' ' ' SER . 4.2 mp -106.63 133.03 52.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.386 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -83.91 122.74 29.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.89 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -73.74 -27.46 61.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.978 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.05 -42.54 80.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.006 0.432 . . . . 0.0 110.455 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 27.4 t80 . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.814 179.788 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.759 0.314 . . . . 0.0 110.85 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.408 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER 177.01 39.66 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.682 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.6 mm -75.74 135.43 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-N 113.529 -1.669 . . . . 0.0 112.574 -177.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.023 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.7 t -92.83 -61.43 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.845 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.501 ' SG ' HD22 ' A' ' 48' ' ' LEU . 1.7 p -138.58 158.3 44.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.029 178.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.43 119.11 26.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.829 0.347 . . . . 0.0 111.392 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.784 HG21 ' CE2' ' A' ' 68' ' ' PHE . 23.2 t -89.18 122.67 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.912 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.876 HG23 HG12 ' A' ' 45' ' ' ILE . 18.9 mt -131.74 117.47 34.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.488 -179.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 6.4 t -83.8 116.11 22.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.771 0.32 . . . . 0.0 110.149 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.3 t -92.49 -24.71 18.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.974 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.575 ' CG2' ' HB2' ' A' ' 142' ' ' SER . 49.4 p -79.78 -2.86 45.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.876 0.37 . . . . 0.0 111.484 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.405 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 72.15 76.58 0.6 Allowed Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 121.098 -0.572 . . . . 0.0 113.284 178.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.437 ' CB ' HD11 ' A' ' 141' ' ' LEU . 4.5 mt-30 -143.45 -40.41 0.3 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.815 0.34 . . . . 0.0 110.94 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.681 HG23 ' HD2' ' A' ' 44' ' ' PRO . 16.9 mt -132.48 143.24 47.96 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.212 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.681 ' HD2' HG23 ' A' ' 43' ' ' ILE . 51.5 Cg_endo -71.05 146.12 51.44 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.298 1.999 . . . . 0.0 111.967 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.876 HG12 HG23 ' A' ' 37' ' ' ILE . 37.4 mt -51.74 152.77 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.087 0.47 . . . . 0.0 111.998 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -147.2 164.21 33.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.041 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.53 120.01 27.31 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.766 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.7 mp -92.7 127.31 38.15 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.045 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . 1.023 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -137.95 157.06 47.17 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -179.111 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.488 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -141.84 142.16 33.14 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 113.608 -1.633 . . . . 0.0 110.899 179.03 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 121.054 0.454 . . . . 0.0 111.117 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.41 ' CE ' ' O ' ' A' ' 49' ' ' SER . 6.4 ttpt . . . . . 0 CA--C 1.523 -0.085 0 CA-C-O 120.68 0.276 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.562 HG22 ' HB3' ' A' ' 92' ' ' LEU . 3.5 t -124.31 138.83 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 121.259 0.552 . . . . 0.0 112.192 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.766 ' CD2' HD23 ' A' ' 48' ' ' LEU . 17.3 m-90 -102.25 139.54 37.73 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.241 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.726 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.45 126.97 55.92 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.612 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.836 ' CE1' HD13 ' A' ' 91' ' ' ILE . 1.1 m-85 -108.55 145.48 34.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.318 -178.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.694 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.97 178.43 37.52 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.26 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.476 ' HG3' HD11 ' A' ' 78' ' ' LEU . 11.8 mtp180 -70.49 -4.85 24.83 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.447 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 4.8 t30 -84.55 134.06 43.15 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.711 0.291 . . . . 0.0 111.27 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.0 Cg_exo -69.49 -6.52 18.65 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.727 2.284 . . . . 0.0 111.719 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.85 -43.79 16.21 Favored 'General case' 0 CA--C 1.497 -1.077 0 CA-C-O 121.993 0.902 . . . . 0.0 108.706 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -41.95 138.38 1.55 Allowed 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 113.698 -1.592 . . . . 0.0 110.445 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.49 -18.87 12.86 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.097 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.618 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 58.9 t80 -129.5 125.62 36.77 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 120.73 0.3 . . . . 0.0 110.667 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -98.55 131.83 44.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.907 0.384 . . . . 0.0 110.925 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.656 HD12 ' O ' ' A' ' 79' ' ' GLY . 0.9 OUTLIER -131.18 179.9 5.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.729 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.656 ' O ' HD12 ' A' ' 78' ' ' LEU . . . -61.77 177.58 4.97 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.258 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -97.42 70.73 2.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.954 0.407 . . . . 0.0 110.84 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.606 HD11 HD12 ' A' ' 141' ' ' LEU . 40.0 mt -94.24 116.22 34.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.042 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.8 -34.38 62.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.313 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.518 ' HG3' ' HB3' ' A' ' 139' ' ' ASP . 1.5 mmt180 -60.84 -25.39 66.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.989 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.696 HD21 HG23 ' A' ' 132' ' ' VAL . 28.2 mt -96.03 149.92 21.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.302 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 57.9 p -93.6 169.69 10.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.604 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.694 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.3 m-20 -43.21 -53.62 4.99 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.449 0.642 . . . . 0.0 109.912 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.47 ' HB2' HD12 ' A' ' 104' ' ' ILE . 6.4 ptmt -121.3 84.08 2.18 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 177.327 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.532 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 15.4 t60 -60.81 -47.26 87.15 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.978 -176.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.552 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 12.8 p90 -147.43 162.12 39.67 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 119.872 -0.731 . . . . 0.0 112.065 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.726 ' HG3' HG23 ' A' ' 67' ' ' THR . 3.4 tt0 -135.67 146.26 47.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.532 -178.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.836 HD13 ' CE1' ' A' ' 68' ' ' PHE . 4.3 mp -124.03 132.08 71.92 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.337 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.452 178.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.841 HD21 ' HB2' ' A' ' 102' ' ' ASN . 0.2 OUTLIER -120.66 148.57 43.75 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.262 0.553 . . . . 0.0 112.214 -179.145 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.709 HD13 ' CG1' ' A' ' 33' ' ' VAL . 5.5 tp . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.822 178.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.587 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.866 0.365 . . . . 0.0 110.955 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.587 HD12 ' O ' ' A' ' 99' ' ' LEU . 4.4 mp -129.14 136.61 50.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.661 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.891 HD11 HD11 ' A' ' 130' ' ' ILE . 0.3 OUTLIER -112.96 120.23 40.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.338 179.913 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.841 ' HB2' HD21 ' A' ' 92' ' ' LEU . 60.9 t30 -112.12 119.1 37.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.879 0.371 . . . . 0.0 111.806 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.785 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.8 p30 -79.99 139.36 37.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.668 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.488 HG12 ' HA ' ' A' ' 89' ' ' PHE . 17.3 pt -146.48 36.16 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -178.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.628 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -97.68 150.72 20.87 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-O 121.014 0.435 . . . . 0.0 112.14 -178.936 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.6 m -68.67 -31.61 70.85 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.683 177.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -96.13 -19.82 19.09 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -178.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.628 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.14 155.25 10.5 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.998 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.1 m -117.37 137.84 52.19 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.827 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -116.12 148.37 40.36 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 -177.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.472 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.1 113.6 18.58 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.487 177.536 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.416 ' N ' HD12 ' A' ' 111' ' ' LEU . 2.6 m120 44.85 42.95 6.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.399 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.62 -12.2 64.0 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.585 178.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -104.64 118.57 36.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.08 0.44 . . . . 0.0 110.627 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.827 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -71.91 125.41 27.12 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.37 -179.718 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.785 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.7 m -94.7 165.46 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.852 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 120' ' ' SER . 8.5 tp10 -69.88 126.33 29.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.586 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.691 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 64.8 tttt -53.41 161.55 0.95 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.887 0.375 . . . . 0.0 110.386 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.46 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.7 p-10 36.25 33.8 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.239 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.43 145.08 40.8 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.034 179.296 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.621 ' OD1' HD11 ' A' ' 92' ' ' LEU . 34.7 m-80 -91.62 127.63 37.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.688 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -129.21 147.13 51.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.941 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.699 HD23 ' O ' ' A' ' 124' ' ' LEU . 7.9 tt -72.88 111.94 8.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.018 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.699 ' O ' HD23 ' A' ' 123' ' ' LEU . 0.3 OUTLIER -56.41 167.8 0.64 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.654 0.74 . . . . 0.0 112.0 -178.979 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.18 153.36 43.19 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.489 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.74 116.56 12.25 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.17 24.47 73.36 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.923 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -60.09 179.74 0.13 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 120.799 0.333 . . . . 0.0 110.837 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.759 ' CG ' HG22 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -145.05 135.38 24.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.254 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.891 HD11 HD11 ' A' ' 101' ' ' LEU . 8.5 mt -116.82 127.72 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.098 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.582 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.0 m -104.43 140.1 38.41 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.696 HG23 HD21 ' A' ' 84' ' ' LEU . 35.6 m -140.16 158.35 25.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.139 0.495 . . . . 0.0 112.198 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.23 28.69 29.91 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.649 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.471 ' HA ' HG12 ' A' ' 140' ' ' ILE . 68.8 t -74.52 140.55 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-O 121.64 0.733 . . . . 0.0 112.186 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.78 -43.5 0.83 Allowed Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -178.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.438 HG11 ' OD2' ' A' ' 139' ' ' ASP . 1.9 t -111.97 128.9 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -50.58 -43.43 56.54 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.7 p -93.56 6.74 47.23 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -178.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.518 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . 5.7 m-20 -119.61 34.42 5.22 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -178.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.582 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.2 mt -107.29 139.79 27.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.822 178.194 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.606 HD12 HD11 ' A' ' 81' ' ' ILE . 8.6 tt -120.97 134.69 55.3 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.949 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.575 ' HB2' ' CG2' ' A' ' 40' ' ' THR . 1.0 OUTLIER -109.99 139.48 45.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.058 0.456 . . . . 0.0 111.904 -179.375 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 40.7 mt -131.7 143.6 50.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.917 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.759 HG22 ' CG ' ' A' ' 129' ' ' GLU . 22.3 t -114.25 131.77 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 120.704 0.288 . . . . 0.0 111.132 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.558 HG21 ' CD2' ' A' ' 124' ' ' LEU . 1.5 mm -106.21 130.92 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-O 120.864 0.364 . . . . 0.0 110.755 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.75 112.01 21.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.954 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.428 HG23 HD13 ' A' ' 99' ' ' LEU . 7.0 mt -84.86 129.57 37.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.292 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -75.95 126.68 31.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.972 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -73.92 -35.95 64.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.97 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.1 -45.08 91.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.616 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.421 ' HE2' HD21 ' A' ' 93' ' ' LEU . 37.4 t80 . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.881 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.754 0.311 . . . . 0.0 111.052 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.1 t-20 175.05 39.86 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.2 mm -72.81 134.95 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 CA-C-N 113.621 -1.627 . . . . 0.0 112.407 -177.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.0 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.2 t -92.56 -60.55 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.099 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.474 ' SG ' HD22 ' A' ' 48' ' ' LEU . 21.8 p -142.97 164.66 29.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.381 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.6 138.22 51.14 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.849 0.357 . . . . 0.0 111.326 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.741 HG11 ' CE2' ' A' ' 68' ' ' PHE . 3.2 m -107.45 122.64 61.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.841 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.804 HG23 HG12 ' A' ' 45' ' ' ILE . 18.4 mt -126.66 119.53 53.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.478 -179.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.759 ' HA ' HD13 ' A' ' 143' ' ' LEU . 23.1 t -79.78 111.38 16.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.808 0.337 . . . . 0.0 110.467 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.437 HG23 HG21 ' A' ' 144' ' ' VAL . 0.1 OUTLIER -82.15 -23.73 35.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.825 -179.163 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.518 HG23 ' HB3' ' A' ' 142' ' ' SER . 74.5 p -79.91 -2.25 42.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.788 0.327 . . . . 0.0 111.48 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.8 75.77 0.36 Allowed Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.821 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.554 ' CD ' HD11 ' A' ' 141' ' ' LEU . 9.7 mt-30 -146.6 -40.95 0.2 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.878 0.37 . . . . 0.0 111.053 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.559 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.7 mt -123.28 141.54 36.31 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.053 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.559 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.4 Cg_endo -72.63 146.01 42.82 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.33 2.02 . . . . 0.0 112.239 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.804 HG12 HG23 ' A' ' 37' ' ' ILE . 35.8 mt -55.51 148.98 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.677 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.43 164.15 28.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.152 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.33 119.74 31.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.993 0.425 . . . . 0.0 111.982 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.734 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.7 mp -95.81 125.48 40.41 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.247 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . 1.0 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -135.51 157.39 47.0 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -178.8 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.502 ' HB3' ' CD2' ' A' ' 93' ' ' LEU . . . -148.82 148.91 30.47 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.638 -1.619 . . . . 0.0 110.81 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 121.062 0.458 . . . . 0.0 111.185 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.432 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.7 ttpt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.974 0.416 . . . . 0.0 111.962 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 91' ' ' ILE . 13.0 t -129.99 139.43 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.218 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.734 ' CD2' HD23 ' A' ' 48' ' ' LEU . 17.8 m-90 -100.92 139.63 36.35 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.983 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.656 HG23 ' CD ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -109.58 133.04 53.57 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 177.968 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.741 ' CE2' HG11 ' A' ' 36' ' ' VAL . 1.1 m-85 -120.19 145.52 46.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.055 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.763 ' CA ' HD21 ' A' ' 78' ' ' LEU . . . 159.56 -172.38 36.16 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.874 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.453 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 9.5 mtp-105 -80.31 3.7 20.16 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.469 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 5.1 t-20 -84.88 133.46 43.41 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 120.659 0.266 . . . . 0.0 110.988 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 13.2 Cg_exo -68.28 -10.28 28.47 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.646 2.231 . . . . 0.0 111.88 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.408 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -83.29 -43.44 16.02 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-O 122.001 0.905 . . . . 0.0 108.952 179.042 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.19 136.41 2.24 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 113.658 -1.61 . . . . 0.0 111.278 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -56.71 -18.38 12.22 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.153 179.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.531 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 66.7 t80 -129.32 112.1 13.52 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-O 120.812 0.339 . . . . 0.0 111.071 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -94.99 114.39 26.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.835 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.763 HD21 ' CA ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -97.2 -80.25 0.44 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.988 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.95 -131.17 1.19 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.576 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -141.6 60.77 1.48 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.887 0.375 . . . . 0.0 110.821 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.866 HD13 HD12 ' A' ' 84' ' ' LEU . 3.9 mp -88.61 120.21 37.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.012 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 m -54.77 -42.94 72.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.878 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.565 ' CZ ' HG21 ' A' ' 136' ' ' VAL . 0.7 OUTLIER -60.88 -18.68 57.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.113 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.866 HD12 HD13 ' A' ' 81' ' ' ILE . 38.7 mt -107.0 152.17 24.34 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.661 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 95.3 p -96.83 163.98 12.75 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.768 0.318 . . . . 0.0 111.709 -179.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.631 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.6 m-20 -41.27 -52.48 3.41 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.532 0.682 . . . . 0.0 109.845 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.468 ' HB3' HD11 ' A' ' 104' ' ' ILE . 5.2 mttt -120.57 84.75 2.27 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 177.321 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.557 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.5 t60 -64.12 -45.76 87.13 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.023 -0.989 . . . . 0.0 113.252 -176.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.454 ' HA ' HG12 ' A' ' 104' ' ' ILE . 37.2 p90 -151.93 162.23 41.39 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.887 -0.725 . . . . 0.0 112.414 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.656 ' CD ' HG23 ' A' ' 67' ' ' THR . 11.0 mt-30 -135.55 154.3 51.42 Favored 'General case' 0 CA--C 1.522 -0.1 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.743 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.66 HG23 HD22 ' A' ' 101' ' ' LEU . 25.7 mt -119.91 132.19 70.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 177.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.565 HD11 HD13 ' A' ' 100' ' ' LEU . 0.6 OUTLIER -118.71 140.18 50.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.111 0.481 . . . . 0.0 112.254 -178.547 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.801 HD13 ' CG1' ' A' ' 33' ' ' VAL . 11.0 tp . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.088 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.499 ' HB3' HD12 ' A' ' 124' ' ' LEU . 3.2 mm? . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.802 0.334 . . . . 0.0 110.848 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.844 HD22 ' HB3' ' A' ' 121' ' ' ASN . 6.5 mt -133.08 140.95 47.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.096 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.66 HD22 HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -112.6 126.05 54.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.473 -179.782 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.403 ' HB2' HD23 ' A' ' 92' ' ' LEU . 48.8 t30 -114.07 115.51 27.67 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.491 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.851 ' OD2' HG23 ' A' ' 116' ' ' VAL . 9.5 p30 -79.21 143.24 35.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.942 178.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.516 HG21 ' OE1' ' A' ' 90' ' ' GLN . 9.7 pt -150.02 35.27 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -178.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.654 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -95.78 150.97 19.81 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 121.118 0.485 . . . . 0.0 112.09 -178.78 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.9 m -68.72 -31.39 70.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.791 177.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -97.76 -19.72 18.02 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.654 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 118.14 155.88 10.13 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.334 -0.936 . . . . 0.0 114.062 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 11.5 m -117.26 137.83 52.13 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.851 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -116.24 148.29 40.61 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.761 1.022 . . . . 0.0 113.761 -178.04 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.2 113.52 18.41 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.612 -1.177 . . . . 0.0 108.444 177.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.7 m120 43.62 43.72 4.89 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.375 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.32 -12.3 65.15 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.382 178.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 9.4 mp0 -103.74 118.59 37.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.053 0.454 . . . . 0.0 110.601 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.851 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.0 tptt -73.16 124.7 26.11 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.215 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.851 HG23 ' OD2' ' A' ' 103' ' ' ASP . 13.0 m -94.92 162.37 2.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.154 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 120' ' ' SER . 4.3 pm0 -69.94 126.37 29.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.47 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.687 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 18.6 tttm -51.42 160.52 0.57 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.015 0.435 . . . . 0.0 111.046 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.7 p-10 34.96 33.67 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.432 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.55 145.14 40.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.164 179.262 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.844 ' HB3' HD22 ' A' ' 100' ' ' LEU . 1.3 m-80 -87.42 127.51 35.22 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.048 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.697 ' O ' HD23 ' A' ' 100' ' ' LEU . 34.6 mm-40 -129.35 146.3 51.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.743 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.4 tp -72.9 112.43 8.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.173 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.566 HD22 HG21 ' A' ' 145' ' ' ILE . 3.2 mt -59.97 167.32 2.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.676 0.75 . . . . 0.0 111.886 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.408 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.0 OUTLIER -125.36 153.42 43.39 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.319 179.425 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -71.41 120.92 17.68 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.58 19.2 66.72 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.055 -178.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.408 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 14.3 t70 -58.06 177.44 0.12 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 120.794 0.33 . . . . 0.0 110.791 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.887 ' CG ' HG22 ' A' ' 144' ' ' VAL . 10.7 mt-10 -145.11 135.54 24.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.247 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.443 HG23 ' O ' ' A' ' 110' ' ' TRP . 6.0 mt -114.0 128.47 70.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.075 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.63 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.7 m -103.89 140.11 38.14 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.535 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 31.0 m -140.18 158.32 25.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.135 0.493 . . . . 0.0 112.279 -178.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.75 27.61 28.8 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.01 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.445 ' HB ' ' CZ3' ' A' ' 110' ' ' TRP . 77.3 t -73.4 140.46 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-O 121.616 0.722 . . . . 0.0 112.063 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.43 -40.33 0.99 Allowed Glycine 0 N--CA 1.434 -1.455 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.565 HG21 ' CZ ' ' A' ' 83' ' ' ARG . 2.1 t -117.38 126.82 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -50.47 -40.1 49.96 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.2 m -93.44 6.66 47.41 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -178.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.482 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.7 OUTLIER -120.17 33.34 5.64 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -178.444 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.63 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.6 mt -107.09 138.83 31.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.384 0.611 . . . . 0.0 110.824 178.105 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.554 HD11 ' CD ' ' A' ' 42' ' ' GLN . 0.3 OUTLIER -124.46 134.64 52.99 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.533 -179.871 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.587 ' C ' HD22 ' A' ' 143' ' ' LEU . 42.2 t -110.29 150.44 28.73 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.615 0.721 . . . . 0.0 112.422 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.759 HD13 ' HA ' ' A' ' 38' ' ' CYS . 3.0 mm? -135.84 148.5 48.69 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.319 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.887 HG22 ' CG ' ' A' ' 129' ' ' GLU . 20.1 t -114.2 134.86 55.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.892 0.377 . . . . 0.0 111.281 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.566 HG21 HD22 ' A' ' 124' ' ' LEU . 2.3 mm -106.37 122.89 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.624 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.06 114.33 26.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.894 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 7.9 mm -84.95 129.35 37.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.06 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -75.88 107.92 8.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.845 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.3 -31.86 69.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.87 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -45.52 91.66 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.592 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 36.1 t80 . . . . . 0 N--CA 1.452 -0.344 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.88 179.918 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.739 0.304 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.435 ' O ' ' HB3' ' A' ' 49' ' ' SER . 2.0 m-20 -177.41 36.86 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.734 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.5 mm -75.77 135.65 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 CA-C-N 113.754 -1.566 . . . . 0.0 112.639 -177.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.038 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.0 t -90.81 -60.24 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.953 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.0 p -148.19 150.12 33.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.137 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.98 138.14 50.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.889 0.376 . . . . 0.0 111.622 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.521 HG21 ' HE2' ' A' ' 68' ' ' PHE . 12.9 p -104.64 122.75 58.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.642 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.808 HG23 HG12 ' A' ' 45' ' ' ILE . 20.3 mt -127.73 125.56 65.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.706 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.602 ' SG ' HD21 ' A' ' 141' ' ' LEU . 3.5 t -89.75 104.64 17.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.195 179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.9 p -81.55 -22.56 37.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.962 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.736 HG23 ' HB2' ' A' ' 142' ' ' SER . 67.8 p -79.81 -2.64 44.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.809 0.337 . . . . 0.0 111.496 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.29 74.93 0.48 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.833 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.506 ' HB2' HD21 ' A' ' 141' ' ' LEU . 0.5 OUTLIER -146.26 -36.19 0.26 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.808 0.337 . . . . 0.0 111.13 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.821 HD13 HD22 ' A' ' 78' ' ' LEU . 15.8 mt -131.72 141.9 43.29 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.947 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.578 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 48.7 Cg_endo -71.01 146.0 51.35 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.19 1.927 . . . . 0.0 112.357 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.808 HG12 HG23 ' A' ' 37' ' ' ILE . 36.4 mt -61.35 148.61 9.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.769 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.94 164.3 30.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.162 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -120.98 119.86 33.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.1 0.476 . . . . 0.0 111.847 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.611 HD22 ' CD1' ' A' ' 66' ' ' TRP . 10.4 mt -96.05 136.09 36.97 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . 1.038 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.97 158.7 44.0 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 -178.669 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.485 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -139.79 141.81 36.73 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 113.542 -1.663 . . . . 0.0 110.559 178.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 121.222 0.534 . . . . 0.0 111.281 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.422 ' HE2' ' O ' ' A' ' 49' ' ' SER . 4.0 ttpt . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.726 0.298 . . . . 0.0 110.985 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 91' ' ' ILE . 14.2 t -132.16 139.4 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 121.255 0.55 . . . . 0.0 112.374 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.611 ' CD1' HD22 ' A' ' 48' ' ' LEU . 16.6 m-90 -104.58 139.51 39.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.943 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.625 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.57 125.82 54.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.123 0.487 . . . . 0.0 110.078 177.694 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.533 ' CD2' ' CD2' ' A' ' 76' ' ' TYR . 2.2 m-85 -109.73 145.48 36.53 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.061 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 157.73 -172.1 34.94 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.41 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.501 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 9.3 mtp-105 -76.92 2.45 14.69 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 0.2 OUTLIER -84.54 130.93 51.57 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.517 0.199 . . . . 0.0 110.976 -179.628 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 18.9 Cg_exo -65.54 -13.99 42.6 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.387 2.058 . . . . 0.0 111.501 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.02 -42.37 17.58 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-O 121.849 0.833 . . . . 0.0 108.839 178.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -42.05 138.32 1.62 Allowed 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.8 179.685 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.9 OUTLIER -56.33 -18.6 11.3 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.164 179.1 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.533 ' CD2' ' CD2' ' A' ' 68' ' ' PHE . 13.2 t80 -129.28 119.46 24.0 Favored 'General case' 0 CA--C 1.527 0.09 0 CA-C-O 120.758 0.313 . . . . 0.0 111.196 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -99.98 117.68 34.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.677 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.821 HD22 HD13 ' A' ' 43' ' ' ILE . 1.4 mt -88.85 -69.09 0.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.017 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 171.92 -85.67 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.519 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -174.46 49.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.901 0.382 . . . . 0.0 111.084 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.501 ' N ' ' HD2' ' A' ' 70' ' ' ARG . 30.1 mm -79.99 123.86 37.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.198 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 90.2 p -54.72 -41.16 69.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.254 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.483 ' HG2' ' CA ' ' A' ' 133' ' ' GLY . 8.5 tpt85 -63.71 -49.16 74.19 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.437 ' CD1' HD13 ' A' ' 78' ' ' LEU . 16.7 mt -73.88 148.26 42.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.06 0.457 . . . . 0.0 111.856 -179.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.7 p -95.11 165.27 12.5 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.855 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.575 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.0 m-20 -41.5 -53.16 3.51 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.434 0.635 . . . . 0.0 110.21 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.443 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 8.5 ptpp? -123.8 81.96 1.97 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 177.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.558 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.9 t60 -59.73 -46.69 88.36 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.981 -1.009 . . . . 0.0 112.988 -176.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.514 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 23.6 p90 -147.65 160.55 42.55 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.116 -0.634 . . . . 0.0 111.621 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.625 ' HG3' HG23 ' A' ' 67' ' ' THR . 29.6 tt0 -135.94 139.75 43.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.555 -178.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.629 ' O ' HG13 ' A' ' 65' ' ' VAL . 17.5 mt -112.37 131.51 63.65 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.233 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.673 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.677 HD23 ' H ' ' A' ' 92' ' ' LEU . 1.8 pt? -118.93 146.83 44.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.044 0.45 . . . . 0.0 111.605 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.524 HD13 ' HG ' ' A' ' 99' ' ' LEU . 14.3 tp . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.396 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.955 HD11 HG12 ' A' ' 33' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.707 0.289 . . . . 0.0 110.713 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.49 ' HB3' HD21 ' A' ' 92' ' ' LEU . 1.2 mp -127.33 144.58 51.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.327 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.761 HD11 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -112.77 124.72 53.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.283 -179.921 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.646 ' HB2' HD22 ' A' ' 92' ' ' LEU . 53.7 t30 -118.19 115.53 24.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.978 0.418 . . . . 0.0 111.45 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.825 ' OD2' HG23 ' A' ' 116' ' ' VAL . 8.8 p30 -79.07 142.44 36.48 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.095 178.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.499 HD11 HG22 ' A' ' 67' ' ' THR . 16.7 pt -151.09 37.59 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.602 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -95.18 155.38 16.76 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 121.0 0.429 . . . . 0.0 111.55 -179.304 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 82.8 m -68.82 -34.37 75.39 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.331 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 19.9 p30 -98.65 -19.87 17.29 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.602 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 122.6 156.67 9.7 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.279 -0.963 . . . . 0.0 113.749 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.507 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.4 m -117.35 137.9 52.14 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.855 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -116.26 148.34 40.59 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -178.172 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.468 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.15 113.39 18.27 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.284 177.441 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.41 ' N ' HD12 ' A' ' 111' ' ' LEU . 3.2 m120 44.41 42.92 5.8 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.385 -179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.27 -7.97 78.64 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.841 -0.695 . . . . 0.0 113.484 178.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.19 118.67 37.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.035 0.445 . . . . 0.0 110.688 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.855 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 9.6 tptp -74.16 118.28 16.93 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.236 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.825 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.4 m -90.73 164.23 2.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.14 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 120' ' ' SER . 33.8 tt0 -69.83 127.71 33.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.436 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.687 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 25.3 tttt -53.58 160.92 1.15 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.975 0.417 . . . . 0.0 110.599 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 34.18 35.32 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.351 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.24 145.06 40.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.222 179.435 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.457 ' HB3' HD23 ' A' ' 100' ' ' LEU . 14.2 m120 -83.73 128.75 34.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.748 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.409 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 4.2 mm100 -129.31 145.76 51.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.594 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.449 HD22 ' HA ' ' A' ' 123' ' ' LEU . 1.5 tm? -72.99 118.09 15.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.254 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.599 HD21 HG12 ' A' ' 147' ' ' ILE . 65.0 tp -56.41 157.25 5.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.359 0.6 . . . . 0.0 111.549 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.451 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.8 OUTLIER -124.53 153.14 42.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.592 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.436 ' HA ' HD12 ' A' ' 147' ' ' ILE . 8.6 tp60 -71.71 124.32 24.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.015 0.436 . . . . 0.0 110.61 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.37 20.65 45.43 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.344 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.451 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 9.8 t70 -58.71 173.22 0.43 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.942 0.401 . . . . 0.0 110.835 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 18.8 tt0 -145.17 135.6 24.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.106 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.897 HD11 HD11 ' A' ' 145' ' ' ILE . 5.5 mt -108.8 128.64 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.313 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.641 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.1 m -103.75 136.64 43.06 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.54 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 29.8 m -138.08 158.38 32.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.183 0.516 . . . . 0.0 112.381 -178.204 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.483 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 82.96 38.62 11.13 Favored Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.954 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.441 ' HA ' HG12 ' A' ' 140' ' ' ILE . 56.5 t -79.84 140.47 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-O 121.676 0.75 . . . . 0.0 112.203 -179.076 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.48 -46.16 0.64 Allowed Glycine 0 N--CA 1.435 -1.371 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.434 HG12 ' N ' ' A' ' 139' ' ' ASP . 0.9 OUTLIER -127.19 125.49 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 CA-C-N 114.259 -0.97 . . . . 0.0 108.827 177.975 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.417 ' HA ' HD12 ' A' ' 140' ' ' ILE . 0.1 OUTLIER -49.92 -24.79 2.72 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -177.87 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.0 t -93.05 -0.36 57.13 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.434 ' N ' HG12 ' A' ' 136' ' ' VAL . 79.1 m-20 -120.05 25.61 9.8 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -178.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.641 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.4 mt -106.88 138.72 31.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-O 121.405 0.621 . . . . 0.0 111.559 178.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.602 HD21 ' SG ' ' A' ' 38' ' ' CYS . 1.6 tt -124.5 134.49 53.0 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.392 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.736 ' HB2' HG23 ' A' ' 40' ' ' THR . 2.1 m -107.02 142.17 37.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.158 0.504 . . . . 0.0 111.976 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.595 ' CD2' HD22 ' A' ' 141' ' ' LEU . 2.1 mm? -135.34 137.74 42.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.448 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 21.1 t -110.79 137.79 41.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.88 0.371 . . . . 0.0 111.236 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.897 HD11 HD11 ' A' ' 130' ' ' ILE . 52.6 mt -106.22 128.32 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.399 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.94 114.96 27.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.364 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.599 HG12 HD21 ' A' ' 124' ' ' LEU . 6.5 mt -84.73 130.93 35.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.951 0.405 . . . . 0.0 111.618 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -78.97 111.95 15.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.752 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -61.38 -33.13 73.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.139 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -45.99 91.2 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.034 0.445 . . . . 0.0 110.843 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 26.8 t80 . . . . . 0 N--CA 1.451 -0.382 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.05 -179.893 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.732 0.301 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.41 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER 176.42 39.6 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.668 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -74.79 135.62 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 CA-C-N 113.63 -1.623 . . . . 0.0 112.404 -177.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.978 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.3 t -91.93 -59.46 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.923 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.47 ' SG ' HD22 ' A' ' 48' ' ' LEU . 4.8 p -148.31 165.17 31.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.482 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.99 138.29 51.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.831 0.348 . . . . 0.0 111.399 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.696 HG21 ' CE2' ' A' ' 68' ' ' PHE . 47.6 t -111.18 122.81 66.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.563 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.828 HG23 HG12 ' A' ' 45' ' ' ILE . 19.0 mt -122.25 120.06 60.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.857 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.548 ' SG ' HD13 ' A' ' 43' ' ' ILE . 0.9 OUTLIER -83.96 104.07 13.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.039 179.14 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.96 -20.88 48.09 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.585 HG21 ' H ' ' A' ' 142' ' ' SER . 72.8 p -79.85 -2.41 43.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.803 0.335 . . . . 0.0 111.547 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.72 75.12 0.44 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.819 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.642 ' HB2' HD12 ' A' ' 43' ' ' ILE . 9.5 mt-30 -145.84 -40.01 0.23 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.893 0.378 . . . . 0.0 110.88 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.642 HD12 ' HB2' ' A' ' 42' ' ' GLN . 4.4 mp -125.4 142.69 42.38 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.038 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.622 ' HD2' HG23 ' A' ' 43' ' ' ILE . 50.7 Cg_endo -70.75 145.86 52.58 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.207 1.938 . . . . 0.0 112.131 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.828 HG12 HG23 ' A' ' 37' ' ' ILE . 35.2 mt -62.93 138.95 22.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.77 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.43 163.98 25.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.951 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -124.38 119.88 30.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.082 0.468 . . . . 0.0 111.854 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.823 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.6 mp -85.88 132.08 34.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.558 178.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.978 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -140.31 155.81 46.68 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 122.281 1.038 . . . . 0.0 113.423 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.477 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.08 141.84 29.18 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 113.533 -1.667 . . . . 0.0 110.798 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 121.256 0.551 . . . . 0.0 111.198 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.416 ' CE ' ' O ' ' A' ' 49' ' ' SER . 4.1 ttpt . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.782 0.325 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.598 HG13 ' O ' ' A' ' 91' ' ' ILE . 17.4 t -130.67 139.21 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 121.34 0.59 . . . . 0.0 112.084 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.823 ' CD2' HD23 ' A' ' 48' ' ' LEU . 16.2 m-90 -105.44 138.71 41.19 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.952 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.456 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -112.01 131.95 55.1 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.493 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.696 ' HZ ' HD21 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -117.11 145.61 43.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.679 -178.316 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.673 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.92 -171.97 37.96 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.596 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 4.6 mtm105 -83.14 3.36 31.08 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.48 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.0 t30 -85.07 135.06 39.94 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.627 0.251 . . . . 0.0 110.95 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.8 Cg_exo -65.95 -11.83 32.67 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.613 2.209 . . . . 0.0 111.728 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.429 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.86 -45.31 14.4 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 121.952 0.882 . . . . 0.0 108.827 178.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.59 137.55 5.07 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 113.892 -1.504 . . . . 0.0 110.692 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.6 OUTLIER -56.66 -18.14 11.22 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.232 179.028 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.456 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 9.9 t80 -125.23 118.51 26.19 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-O 120.782 0.325 . . . . 0.0 110.928 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -99.77 115.73 30.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.543 HD11 ' HA2' ' A' ' 69' ' ' GLY . 2.6 mt -90.2 -168.28 2.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.093 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -91.68 19.36 48.6 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.828 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 63.88 84.31 0.15 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.865 0.365 . . . . 0.0 111.538 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.92 HD13 HD12 ' A' ' 84' ' ' LEU . 3.4 mp -108.3 131.4 58.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.714 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.4 m -54.88 -39.55 68.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.03 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.511 ' NH1' HG23 ' A' ' 136' ' ' VAL . 1.9 tpt180 -66.37 -45.49 79.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.907 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.92 HD12 HD13 ' A' ' 81' ' ' ILE . 42.6 mt -72.81 151.54 42.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.892 0.377 . . . . 0.0 111.641 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.0 p -95.83 166.98 11.54 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.733 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.673 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.7 m-20 -43.85 -54.18 5.45 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.282 0.563 . . . . 0.0 109.842 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.455 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.6 OUTLIER -120.04 83.06 1.99 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.163 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.576 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 9.4 t60 -62.12 -46.32 89.54 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.791 -176.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.517 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 18.4 p90 -146.5 157.93 43.82 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.672 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.568 ' HG2' HG12 ' A' ' 65' ' ' VAL . 29.4 tt0 -135.94 140.66 44.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.332 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.755 HG12 HD13 ' A' ' 101' ' ' LEU . 39.3 mt -114.76 132.11 64.92 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.912 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.675 HD12 ' HB2' ' A' ' 100' ' ' LEU . 0.4 OUTLIER -123.59 146.28 48.28 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.141 0.496 . . . . 0.0 111.704 -179.805 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.761 HD13 ' HG ' ' A' ' 99' ' ' LEU . 14.5 tp . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.219 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.761 ' HG ' HD13 ' A' ' 93' ' ' LEU . 7.6 mp . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.729 0.299 . . . . 0.0 110.722 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.675 ' HB2' HD12 ' A' ' 92' ' ' LEU . 16.1 mt -133.1 146.58 51.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.879 0.371 . . . . 0.0 110.808 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.755 HD13 HG12 ' A' ' 91' ' ' ILE . 2.3 mm? -112.72 123.57 50.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.854 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -112.95 115.51 28.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.04 0.448 . . . . 0.0 111.229 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.823 ' OD2' HG23 ' A' ' 116' ' ' VAL . 15.1 p30 -81.34 133.19 35.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.874 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.461 HG12 ' HA ' ' A' ' 89' ' ' PHE . 19.2 pt -140.9 38.66 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.543 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -100.76 154.03 18.96 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 120.918 0.39 . . . . 0.0 111.577 -179.387 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 86.6 m -68.89 -31.77 70.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.43 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -97.74 -19.88 17.93 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.523 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.84 158.0 10.83 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.889 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.1 m -117.71 137.87 52.39 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.87 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -117.95 148.32 42.3 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.768 HD23 ' O ' ' A' ' 114' ' ' GLN . 0.4 OUTLIER -124.58 113.67 18.37 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 176.611 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 37.3 m-20 48.19 42.05 16.78 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.63 -8.38 75.51 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.77 -0.729 . . . . 0.0 113.925 178.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.768 ' O ' HD23 ' A' ' 111' ' ' LEU . 6.9 mt-30 -105.69 118.83 37.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.13 0.465 . . . . 0.0 110.786 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.87 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -73.14 135.08 44.66 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.404 -179.719 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.823 HG23 ' OD2' ' A' ' 103' ' ' ASP . 16.7 m -107.44 163.98 5.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.763 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 120' ' ' SER . 44.2 tt0 -69.87 127.32 32.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.384 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.69 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 76.7 tttt -52.16 161.57 0.6 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.896 0.379 . . . . 0.0 110.525 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.9 p-10 34.37 34.73 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.305 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.492 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.34 145.11 40.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.453 179.618 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.665 ' HB3' HD22 ' A' ' 100' ' ' LEU . 48.4 m-80 -87.43 123.99 32.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.615 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.472 ' O ' HD23 ' A' ' 100' ' ' LEU . 30.0 mm-40 -129.24 146.69 51.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.858 0.361 . . . . 0.0 111.102 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 32.6 tp -75.07 118.04 17.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.101 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.509 HD13 ' HB2' ' A' ' 99' ' ' LEU . 2.0 pt? -58.12 168.66 0.96 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.586 0.708 . . . . 0.0 112.039 -178.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.524 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.4 OUTLIER -124.38 154.13 40.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.81 -1.087 . . . . 0.0 109.905 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.751 ' HA ' HD13 ' A' ' 147' ' ' ILE . 17.1 tp60 -70.14 119.38 14.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.085 0.469 . . . . 0.0 110.27 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.06 23.38 59.41 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.905 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.468 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 25.6 t0 -57.81 179.2 0.07 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 120.716 0.293 . . . . 0.0 110.676 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.841 ' CG ' HG22 ' A' ' 144' ' ' VAL . 7.2 mt-10 -145.05 135.64 24.37 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.091 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.595 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 10.2 mt -107.3 123.67 62.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.924 0.392 . . . . 0.0 110.622 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.48 ' HB ' ' HB2' ' A' ' 110' ' ' TRP . 96.9 m -104.59 140.69 37.64 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.576 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 17.7 m -140.25 158.51 25.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.32 29.8 35.8 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.114 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.493 ' HB ' ' CH2' ' A' ' 110' ' ' TRP . 86.8 t -76.36 140.51 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-O 121.604 0.716 . . . . 0.0 111.986 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 139.04 -37.75 1.74 Allowed Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -178.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.511 HG23 ' NH1' ' A' ' 83' ' ' ARG . 2.5 t -123.01 118.35 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.241 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.85 -26.43 5.77 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -178.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 20.7 t -93.74 6.75 47.31 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -132.62 33.82 3.74 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -178.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.449 HG12 ' HA ' ' A' ' 134' ' ' VAL . 7.2 mt -107.21 138.02 35.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-O 121.619 0.723 . . . . 0.0 111.338 178.111 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.443 HD23 ' N ' ' A' ' 142' ' ' SER . 1.4 tt -125.65 135.02 51.7 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.374 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.585 ' H ' HG21 ' A' ' 40' ' ' THR . 46.8 t -112.38 147.42 36.44 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.87 0.843 . . . . 0.0 112.44 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.486 HD12 ' O ' ' A' ' 130' ' ' ILE . 3.7 mp -135.85 153.08 51.6 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.153 -1.385 . . . . 0.0 110.854 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.841 HG22 ' CG ' ' A' ' 129' ' ' GLU . 21.9 t -118.17 140.03 43.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.631 0.253 . . . . 0.0 110.544 179.174 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.5 mm -106.2 120.85 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-O 120.957 0.408 . . . . 0.0 110.989 -179.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.69 111.06 22.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.677 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.751 HD13 ' HA ' ' A' ' 126' ' ' GLN . 4.1 mp -89.93 134.23 29.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.853 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -85.52 108.2 17.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.5 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.79 -31.68 68.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.202 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -60.32 -45.95 91.6 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.967 0.413 . . . . 0.0 110.779 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 36.5 t80 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.049 -179.869 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 . . . . . 0 C--O 1.23 0.032 0 CA-C-O 120.759 0.314 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.9 OUTLIER 175.2 39.66 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.852 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.683 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -72.29 135.45 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 CA-C-N 113.613 -1.63 . . . . 0.0 112.558 -177.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.985 HG12 HD11 ' A' ' 99' ' ' LEU . 3.5 t -91.56 -58.85 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.912 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 24.8 p -152.56 154.78 36.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.644 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.87 ' NE ' HG21 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -119.09 138.22 53.03 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.799 0.333 . . . . 0.0 110.971 -179.85 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.515 HG21 ' CE2' ' A' ' 68' ' ' PHE . 57.3 t -107.7 122.67 62.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.895 0.379 . . . . 0.0 110.906 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.691 HG23 HG12 ' A' ' 45' ' ' ILE . 14.4 mt -118.69 127.97 75.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.502 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.83 ' HA ' HD13 ' A' ' 143' ' ' LEU . 52.6 t -81.36 100.68 9.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.518 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.583 ' OG1' HG23 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -67.98 -24.19 65.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.816 -179.249 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.525 HG23 ' HB3' ' A' ' 142' ' ' SER . 72.9 p -79.82 -2.36 43.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.831 0.348 . . . . 0.0 111.376 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 59.99 76.28 0.23 Allowed Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 121.018 -0.611 . . . . 0.0 113.09 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -146.57 -43.14 0.19 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.92 0.39 . . . . 0.0 110.78 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.647 HG23 ' HD2' ' A' ' 44' ' ' PRO . 3.4 mp -119.55 142.55 32.95 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.035 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.647 ' HD2' HG23 ' A' ' 43' ' ' ILE . 50.7 Cg_endo -71.2 146.18 50.8 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.216 1.944 . . . . 0.0 112.203 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.87 HG21 ' NE ' ' A' ' 35' ' ' ARG . 51.7 mt -55.04 144.68 5.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.944 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.481 ' HB2' ' CE2' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -128.28 134.24 48.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.837 178.828 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -98.72 119.71 37.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.046 0.451 . . . . 0.0 112.199 -178.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.762 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.1 mp -93.68 128.12 39.71 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.984 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -133.71 156.84 47.23 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 122.067 0.937 . . . . 0.0 113.526 -179.602 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.483 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -153.02 142.02 21.28 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 113.817 -1.538 . . . . 0.0 111.136 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.104 -179.701 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.462 ' HE2' ' O ' ' A' ' 49' ' ' SER . 4.0 ttpt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.757 0.313 . . . . 0.0 111.327 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.71 HG12 ' HG2' ' A' ' 90' ' ' GLN . 16.0 t -131.27 139.27 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-O 121.155 0.503 . . . . 0.0 111.733 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.762 ' CD2' HD23 ' A' ' 48' ' ' LEU . 20.2 m-90 -101.02 139.24 36.98 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.002 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.683 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.76 126.93 55.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.038 0.447 . . . . 0.0 109.904 177.911 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.635 ' HZ ' HD21 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -111.43 145.83 38.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.453 -178.965 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.682 ' HA2' HD12 ' A' ' 78' ' ' LEU . . . 161.42 -171.86 37.51 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.602 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.454 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 8.3 mtp-105 -82.15 1.48 36.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.624 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 8.9 t-20 -84.92 134.37 41.56 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.716 0.293 . . . . 0.0 111.035 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.5 Cg_exo -68.48 -8.97 24.64 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.625 2.217 . . . . 0.0 111.787 179.288 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.624 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -83.16 -43.9 15.67 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 122.031 0.92 . . . . 0.0 108.79 178.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.45 136.64 2.33 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 113.656 -1.611 . . . . 0.0 110.832 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -56.6 -19.08 14.26 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.831 179.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.644 ' HE1' HD23 ' A' ' 78' ' ' LEU . 9.8 t80 -129.95 119.3 23.0 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.723 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -93.94 111.03 22.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.907 0.384 . . . . 0.0 110.95 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.682 HD12 ' HA2' ' A' ' 69' ' ' GLY . 44.9 mt -76.07 -78.55 0.11 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.997 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.62 -87.16 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.506 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -177.5 47.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.853 0.359 . . . . 0.0 111.003 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.454 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 30.7 mm -83.35 117.39 29.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.108 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.7 -31.99 58.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.042 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.415 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.4 OUTLIER -70.96 -17.39 62.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.274 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.709 HD21 HG23 ' A' ' 132' ' ' VAL . 41.2 mt -106.95 152.16 24.32 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.762 0.315 . . . . 0.0 111.436 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 87.2 p -96.39 166.0 11.92 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.663 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.664 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.1 m-20 -43.11 -52.35 5.48 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.425 0.631 . . . . 0.0 109.774 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.445 ' HB2' HD12 ' A' ' 104' ' ' ILE . 14.5 ptmt -119.77 82.86 1.95 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 177.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.671 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 61.1 t-80 -61.17 -46.66 89.61 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.875 -176.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.539 ' HA ' HG12 ' A' ' 104' ' ' ILE . 32.0 p90 -148.99 161.42 41.94 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.767 -179.363 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.71 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.4 tt0 -135.92 142.28 44.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.42 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.622 ' C ' HG13 ' A' ' 65' ' ' VAL . 46.2 mt -117.55 127.64 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.004 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.476 ' O ' HD23 ' A' ' 99' ' ' LEU . 0.7 OUTLIER -110.72 143.49 41.14 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.058 0.456 . . . . 0.0 111.752 -179.606 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.76 HD23 ' HG ' ' A' ' 99' ' ' LEU . 2.0 tm? . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.394 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.985 HD11 HG12 ' A' ' 33' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.728 0.299 . . . . 0.0 110.689 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.624 HD23 ' HB3' ' A' ' 121' ' ' ASN . 2.3 mp -125.33 145.81 49.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.455 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.521 HD23 HG23 ' A' ' 91' ' ' ILE . 55.9 mt -112.99 123.29 49.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.33 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.436 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 59.5 t30 -118.2 115.77 25.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.829 0.347 . . . . 0.0 111.86 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.797 ' OD2' HG23 ' A' ' 116' ' ' VAL . 9.2 p30 -79.14 143.14 35.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.943 178.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.539 HG12 ' HA ' ' A' ' 89' ' ' PHE . 14.3 pt -146.88 26.73 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.585 ' HB2' ' CG ' ' A' ' 88' ' ' HIS . 11.0 t -93.98 154.97 17.39 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.7 m -70.12 -52.16 25.79 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.453 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -74.64 -4.06 34.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.247 -179.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.92 155.97 31.22 Favored Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.439 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.502 HG22 ' CG2' ' A' ' 130' ' ' ILE . 5.4 m -117.36 137.78 52.23 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.843 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -114.02 148.49 36.9 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -177.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.0 113.6 18.65 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.467 177.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 45.09 42.88 7.06 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.04 -13.44 61.38 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.726 -0.749 . . . . 0.0 113.486 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -104.49 118.49 36.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 117.104 0.452 . . . . 0.0 110.498 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.843 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -70.11 123.61 22.02 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.403 -179.793 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.797 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.7 m -95.08 164.64 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.01 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -69.94 127.88 34.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.587 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.682 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 17.6 tttm -53.66 162.47 0.85 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.754 0.312 . . . . 0.0 110.23 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.7 p-10 34.52 36.32 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.004 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.7 p -111.92 145.09 40.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.706 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.624 ' HB3' HD23 ' A' ' 100' ' ' LEU . 28.2 m-80 -92.71 130.67 38.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.872 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 58.3 mm-40 -129.28 150.93 50.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.558 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.7 tp -72.81 130.03 39.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.815 0.341 . . . . 0.0 110.226 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.754 HD22 ' HB2' ' A' ' 99' ' ' LEU . 30.0 tp -58.1 153.71 14.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.594 0.711 . . . . 0.0 111.737 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.452 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.6 OUTLIER -125.12 152.92 43.76 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.691 -1.14 . . . . 0.0 110.451 179.647 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -72.1 124.86 25.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.828 0.346 . . . . 0.0 110.09 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.84 22.82 48.92 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.758 -0.735 . . . . 0.0 111.981 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -50.4 165.71 0.09 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.896 0.379 . . . . 0.0 111.345 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.46 ' HG3' HG22 ' A' ' 144' ' ' VAL . 25.8 tt0 -145.05 135.48 24.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.99 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.502 ' CG2' HG22 ' A' ' 109' ' ' THR . 14.7 mt -114.73 128.24 71.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.798 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.639 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.08 139.84 38.61 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.709 HG23 HD21 ' A' ' 84' ' ' LEU . 35.8 m -140.42 158.67 25.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -178.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.85 29.27 29.43 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.236 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.426 ' HA ' HG12 ' A' ' 140' ' ' ILE . 74.6 t -73.38 140.51 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-O 121.622 0.725 . . . . 0.0 112.077 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.23 -37.09 1.43 Allowed Glycine 0 N--CA 1.436 -1.36 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 -178.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.461 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 3.7 t -124.84 125.29 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.4 -35.92 30.51 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -178.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.0 p -93.59 6.57 47.8 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.461 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 30.4 m-20 -121.02 28.91 7.62 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -178.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.639 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.2 mt -107.04 138.52 32.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-O 121.5 0.667 . . . . 0.0 111.143 178.301 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.694 HD23 ' N ' ' A' ' 142' ' ' SER . 3.0 tt -124.85 134.42 52.73 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.149 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.694 ' N ' HD23 ' A' ' 141' ' ' LEU . 38.3 t -112.81 150.24 31.95 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.761 0.791 . . . . 0.0 112.642 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.83 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.9 mm? -136.02 143.67 44.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.525 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.583 HG23 ' OG1' ' A' ' 39' ' ' THR . 24.0 t -115.86 140.27 38.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.792 0.329 . . . . 0.0 111.008 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.55 HG21 HD11 ' A' ' 124' ' ' LEU . 33.2 mt -106.0 123.39 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-O 120.951 0.405 . . . . 0.0 111.278 -179.069 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.2 118.35 36.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.532 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.597 HG12 HD21 ' A' ' 124' ' ' LEU . 3.6 mt -88.07 133.96 29.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.649 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -82.72 113.53 20.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.738 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.57 -29.45 66.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.074 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.65 -45.77 91.02 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 120.976 0.417 . . . . 0.0 110.672 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.1 t80 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.951 -179.933 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.828 0.346 . . . . 0.0 110.816 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.7 OUTLIER 179.0 38.08 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.717 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -75.99 135.07 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-N 113.785 -1.552 . . . . 0.0 112.506 -177.374 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.037 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -91.88 -61.68 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.24 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.465 ' SG ' HD12 ' A' ' 48' ' ' LEU . 7.5 p -149.34 149.02 30.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.302 179.292 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -116.7 138.3 51.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.874 0.368 . . . . 0.0 111.417 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.635 HG21 ' HE2' ' A' ' 68' ' ' PHE . 24.0 t -103.89 122.89 57.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.998 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.823 HG23 HG12 ' A' ' 45' ' ' ILE . 21.4 mt -123.09 117.72 52.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.609 -179.415 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.582 ' HA ' HD23 ' A' ' 143' ' ' LEU . 49.1 t -80.74 112.75 18.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.185 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.05 -21.62 29.32 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.559 HG21 ' H ' ' A' ' 142' ' ' SER . 75.1 p -79.79 -2.47 43.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.788 0.328 . . . . 0.0 111.592 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.46 72.37 0.74 Allowed Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.977 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -142.45 -42.13 0.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.876 0.369 . . . . 0.0 110.919 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.561 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.3 mt -121.02 141.66 33.18 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.035 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.561 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.9 Cg_endo -72.83 140.36 31.92 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.167 1.912 . . . . 0.0 112.167 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.823 HG12 HG23 ' A' ' 37' ' ' ILE . 36.1 mt -55.95 145.63 6.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.766 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.09 163.72 31.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.153 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -120.5 119.88 34.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.08 0.467 . . . . 0.0 112.013 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.633 HD22 ' CD1' ' A' ' 66' ' ' TRP . 5.1 mt -93.93 137.55 33.02 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . 1.037 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.73 159.01 43.79 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -178.662 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.487 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -138.53 141.87 39.31 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 113.744 -1.571 . . . . 0.0 110.618 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 121.221 0.534 . . . . 0.0 111.578 -179.291 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.429 ' CE ' ' O ' ' A' ' 49' ' ' SER . 31.1 ttpt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.793 0.33 . . . . 0.0 110.667 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.597 HG13 ' O ' ' A' ' 91' ' ' ILE . 12.4 t -121.53 139.12 49.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.272 0.558 . . . . 0.0 111.906 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.633 ' CD1' HD22 ' A' ' 48' ' ' LEU . 18.2 m-90 -104.07 138.61 40.33 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.069 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.676 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.94 128.28 56.33 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 177.049 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.677 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -115.19 145.46 42.38 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.497 -177.963 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.584 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.35 -172.23 38.4 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.702 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.458 ' HD3' ' O ' ' A' ' 81' ' ' ILE . 9.4 mtm105 -80.46 2.29 25.79 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.476 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 3.0 t-20 -84.87 134.2 42.02 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.575 0.226 . . . . 0.0 111.125 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 15.8 Cg_exo -67.06 -11.9 34.01 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.531 2.154 . . . . 0.0 111.75 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.9 -43.33 16.65 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 122.017 0.913 . . . . 0.0 108.93 178.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.51 137.82 2.01 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.086 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.8 m-20 -56.58 -18.44 11.89 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.985 178.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.471 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 19.5 t80 -129.27 119.65 24.33 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.869 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -98.77 110.06 22.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.927 0.394 . . . . 0.0 111.031 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.456 HD11 ' HG3' ' A' ' 70' ' ' ARG . 1.9 pp -113.04 172.98 6.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.666 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.23 136.91 50.55 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.506 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -68.27 89.75 0.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.789 0.328 . . . . 0.0 110.777 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.458 ' O ' ' HD3' ' A' ' 70' ' ' ARG . 44.6 mt -107.86 135.55 46.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.024 0.44 . . . . 0.0 111.478 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 89.9 p -54.88 -43.94 73.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.274 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.505 ' HG3' ' HB3' ' A' ' 139' ' ' ASP . 1.6 mmt180 -60.85 -27.81 68.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.568 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.616 HD21 HG23 ' A' ' 132' ' ' VAL . 29.7 mt -96.23 150.95 19.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.9 0.381 . . . . 0.0 111.633 -179.268 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 75.4 p -98.62 169.05 9.78 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.416 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.584 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.0 m-20 -44.11 -55.3 4.85 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.318 0.58 . . . . 0.0 109.761 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.457 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 3.1 ptpp? -118.8 84.73 2.24 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 177.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.562 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 12.7 t60 -60.55 -47.02 88.0 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.874 -176.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.511 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 23.9 p90 -146.69 160.53 42.09 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.991 -179.161 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.676 ' HG3' HG23 ' A' ' 67' ' ' THR . 20.7 tt0 -135.95 139.15 43.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.395 -179.233 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.677 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 61.6 mt -114.61 132.14 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 121.104 -0.238 . . . . 0.0 110.965 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.507 HD21 ' HB2' ' A' ' 102' ' ' ASN . 0.2 OUTLIER -123.97 136.41 54.29 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.047 0.451 . . . . 0.0 111.966 -179.604 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.804 HD22 ' CG1' ' A' ' 33' ' ' VAL . 2.4 tp . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.43 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.748 ' HB3' HD22 ' A' ' 124' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.826 0.346 . . . . 0.0 110.764 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.737 HD13 ' HB3' ' A' ' 121' ' ' ASN . 12.7 mt -133.34 140.7 47.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.704 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.491 ' O ' HD12 ' A' ' 101' ' ' LEU . 3.1 pp -112.66 124.61 52.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.929 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.507 ' HB2' HD21 ' A' ' 92' ' ' LEU . 47.3 t30 -114.62 115.92 27.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.9 0.381 . . . . 0.0 111.705 -179.123 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.767 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.2 p30 -78.57 136.67 37.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.885 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.484 HD11 HG22 ' A' ' 67' ' ' THR . 18.8 pt -147.41 38.92 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.645 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.0 151.77 20.56 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 121.098 0.475 . . . . 0.0 112.207 -178.717 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 16.7 m -68.92 -31.63 70.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.705 177.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -97.07 -19.79 18.47 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.482 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.645 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.08 156.79 10.95 Favored Glycine 0 N--CA 1.439 -1.115 0 C-N-CA 120.4 -0.905 . . . . 0.0 114.014 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.477 HG22 ' CG2' ' A' ' 130' ' ' ILE . 6.3 m -117.32 137.71 52.25 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.761 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -118.94 148.66 42.72 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -177.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.472 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -123.91 113.57 18.66 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.559 177.676 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.415 ' N ' HD12 ' A' ' 111' ' ' LEU . 87.5 m-20 44.36 43.23 5.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.547 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.07 -14.21 59.53 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.435 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -104.24 118.51 36.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.09 0.445 . . . . 0.0 110.626 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.761 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -71.68 129.75 39.46 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.473 -179.65 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.767 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.0 m -96.41 166.11 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.956 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 120' ' ' SER . 23.1 mm-40 -69.92 127.2 32.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.591 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.663 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -53.98 158.51 2.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.172 0.51 . . . . 0.0 110.702 -179.962 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.49 ' H ' ' HG3' ' A' ' 118' ' ' LYS . 0.5 OUTLIER 35.73 35.45 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.798 -179.74 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -111.96 145.03 40.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.134 179.606 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.737 ' HB3' HD13 ' A' ' 100' ' ' LEU . 65.6 m-20 -89.76 123.15 33.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.622 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.559 ' O ' HD23 ' A' ' 100' ' ' LEU . 6.3 mm100 -126.62 145.76 50.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.969 0.414 . . . . 0.0 110.858 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.0 tp -72.97 118.41 15.89 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.951 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.748 HD22 ' HB3' ' A' ' 99' ' ' LEU . 2.4 pt? -57.44 167.66 0.95 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.589 0.709 . . . . 0.0 111.865 -178.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.414 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.2 OUTLIER -124.89 153.75 42.14 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.228 179.769 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.04 118.92 14.42 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.8 22.03 67.94 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.458 -178.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.414 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 24.3 t70 -54.33 174.11 0.06 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.895 0.379 . . . . 0.0 111.046 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 9.6 tt0 -145.35 135.27 23.66 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.041 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.796 HD11 HD11 ' A' ' 145' ' ' ILE . 18.9 mt -114.71 126.49 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.214 178.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.543 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.6 m -104.14 139.86 38.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.264 -0.425 . . . . 0.0 109.928 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.616 HG23 HD21 ' A' ' 84' ' ' LEU . 33.9 m -140.18 158.26 25.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.114 0.483 . . . . 0.0 112.194 -178.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.97 27.2 29.33 Favored Glycine 0 N--CA 1.44 -1.085 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.926 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.444 ' HB ' ' CZ3' ' A' ' 110' ' ' TRP . 68.9 t -74.04 140.49 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-O 121.611 0.72 . . . . 0.0 112.069 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.92 -39.76 0.93 Allowed Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.496 HG21 ' NH1' ' A' ' 83' ' ' ARG . 2.5 t -118.16 129.17 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -50.58 -42.35 55.58 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -178.062 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.6 m -93.47 6.76 47.1 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -178.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.505 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . 0.5 OUTLIER -120.14 34.54 5.18 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -178.539 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.543 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.1 mt -107.23 139.46 28.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.942 178.197 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 8.9 tt -124.03 134.64 53.39 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.647 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.559 ' H ' HG21 ' A' ' 40' ' ' THR . 44.3 t -111.82 150.54 30.2 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.748 0.785 . . . . 0.0 112.715 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.582 HD23 ' HA ' ' A' ' 38' ' ' CYS . 71.5 mt -135.71 149.34 49.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.779 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 24.2 t -117.01 139.07 45.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.829 0.347 . . . . 0.0 111.075 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.796 HD11 HD11 ' A' ' 130' ' ' ILE . 17.6 mt -106.36 124.54 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.045 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.38 114.01 26.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.607 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.491 HG12 HD12 ' A' ' 124' ' ' LEU . 5.0 mt -84.95 134.12 27.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.546 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -86.09 105.0 16.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.737 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -57.66 -28.19 63.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.115 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -43.7 88.89 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.607 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 33.7 t80 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.889 -179.97 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.686 0.279 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.516 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.9 m-20 176.41 41.19 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.654 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.3 mm -71.03 142.76 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-N 113.711 -1.586 . . . . 0.0 112.377 -176.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.722 ' CG2' HD22 ' A' ' 93' ' ' LEU . 0.9 OUTLIER -106.01 -48.99 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-N 114.275 -1.329 . . . . 0.0 109.91 -178.575 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.812 ' SG ' HD12 ' A' ' 48' ' ' LEU . 32.1 p -161.13 147.96 14.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.534 179.087 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -114.13 138.24 50.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.893 0.378 . . . . 0.0 111.317 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.748 HG21 ' CE2' ' A' ' 68' ' ' PHE . 21.3 t -101.81 122.73 54.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.062 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.559 HG23 HG12 ' A' ' 45' ' ' ILE . 20.1 mt -128.62 116.41 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.234 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.578 ' HA ' HD13 ' A' ' 143' ' ' LEU . 47.1 t -80.03 123.42 27.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.496 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.4 t -91.53 -27.33 18.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.546 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.578 HG21 ' H ' ' A' ' 142' ' ' SER . 7.0 p -79.81 -2.6 44.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.748 0.309 . . . . 0.0 111.408 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.7 77.99 0.24 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.752 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -146.4 -45.44 0.19 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.942 0.401 . . . . 0.0 110.788 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.56 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.0 mt -116.33 141.25 27.58 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.847 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.56 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.4 Cg_endo -72.73 146.01 42.31 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.271 1.981 . . . . 0.0 112.161 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.559 HG12 HG23 ' A' ' 37' ' ' ILE . 36.5 mt -55.9 151.83 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.683 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -149.8 162.3 40.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.19 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -122.65 119.81 31.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.049 0.452 . . . . 0.0 111.945 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.812 HD12 ' SG ' ' A' ' 34' ' ' CYS . 23.3 mt -93.28 138.04 32.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.231 178.577 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.654 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -141.18 156.95 45.86 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 122.14 0.971 . . . . 0.0 113.5 -178.932 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.621 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . -141.19 146.68 37.26 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 113.565 -1.652 . . . . 0.0 110.822 178.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 121.131 0.491 . . . . 0.0 111.187 -179.509 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.46 ' CE ' ' O ' ' A' ' 49' ' ' SER . 15.5 ttpt . . . . . 0 N--CA 1.462 0.147 0 CA-C-O 120.89 0.376 . . . . 0.0 111.864 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 91' ' ' ILE . 9.5 p -108.64 139.63 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.791 ' CD1' HD22 ' A' ' 48' ' ' LEU . 14.8 m-90 -100.71 139.9 35.74 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.151 -1.386 . . . . 0.0 112.064 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.597 HG23 ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -107.93 131.53 54.44 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 177.408 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.768 ' HZ ' HD11 ' A' ' 48' ' ' LEU . 3.0 m-85 -117.0 145.91 43.37 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.036 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.704 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.82 -171.34 37.74 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.293 -0.956 . . . . 0.0 113.011 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -82.67 2.97 30.91 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -84.81 142.84 39.65 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.695 0.283 . . . . 0.0 110.836 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.44 -11.79 22.65 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.341 2.027 . . . . 0.0 111.441 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.77 -43.73 16.39 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 121.931 0.872 . . . . 0.0 108.928 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.91 138.3 5.05 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 113.87 -1.514 . . . . 0.0 110.751 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.8 OUTLIER -56.37 -18.55 11.29 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.971 178.903 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.569 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 3.9 t80 -129.1 117.59 21.08 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-O 120.775 0.321 . . . . 0.0 110.96 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -92.78 107.87 19.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.655 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.957 HD23 HD13 ' A' ' 84' ' ' LEU . 8.9 mp -73.49 -175.04 1.84 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.107 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.16 17.71 49.76 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.804 -0.713 . . . . 0.0 113.037 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 65.43 74.71 0.37 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.022 0.439 . . . . 0.0 111.493 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.43 ' HB ' HD12 ' A' ' 84' ' ' LEU . 25.5 mm -112.0 126.87 69.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.643 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.02 -41.35 71.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.312 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.81 -24.02 65.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.997 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.957 HD13 HD23 ' A' ' 78' ' ' LEU . 17.9 mt -98.16 152.11 19.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.879 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.5 p -96.29 164.53 12.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.759 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.704 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -40.06 -57.0 1.75 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.416 0.627 . . . . 0.0 109.584 178.976 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.462 ' HB3' HD11 ' A' ' 104' ' ' ILE . 6.4 mttp -116.59 85.69 2.36 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.68 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 63.5 t-80 -64.59 -44.94 89.02 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.074 -0.967 . . . . 0.0 113.428 -176.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.515 ' HA ' HG12 ' A' ' 104' ' ' ILE . 34.5 p90 -154.1 162.58 41.1 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.139 -0.625 . . . . 0.0 112.053 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.631 ' OE1' HG21 ' A' ' 104' ' ' ILE . 14.3 mt-30 -135.7 155.46 50.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.419 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.567 ' O ' HG23 ' A' ' 65' ' ' VAL . 65.0 mt -122.97 128.81 75.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.716 HD23 ' HB2' ' A' ' 102' ' ' ASN . 1.8 pp -118.97 130.97 55.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.008 0.432 . . . . 0.0 111.831 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.722 HD22 ' CG2' ' A' ' 33' ' ' VAL . 3.2 tp . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.21 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.683 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.832 0.349 . . . . 0.0 110.842 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.765 HD23 ' HB3' ' A' ' 121' ' ' ASN . 10.8 mp -129.3 146.54 51.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.414 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.503 HD11 HD11 ' A' ' 130' ' ' ILE . 0.2 OUTLIER -112.89 126.88 55.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.38 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.716 ' HB2' HD23 ' A' ' 92' ' ' LEU . 53.4 t30 -116.8 115.85 26.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.863 0.363 . . . . 0.0 111.857 -179.322 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.827 ' OD2' HG23 ' A' ' 116' ' ' VAL . 7.5 p30 -79.76 143.28 34.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.049 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.631 HG21 ' OE1' ' A' ' 90' ' ' GLN . 12.5 pt -146.19 22.89 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.588 ' HB2' ' CG ' ' A' ' 88' ' ' HIS . 9.2 t -91.43 154.86 18.87 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.6 m -70.22 -52.11 25.7 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.447 178.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -74.42 -2.75 26.81 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.375 -179.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.87 156.08 31.88 Favored Glycine 0 N--CA 1.438 -1.203 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.468 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.463 HG22 ' CG2' ' A' ' 130' ' ' ILE . 5.0 m -117.44 137.68 52.35 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.829 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -115.52 148.59 39.33 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -177.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.473 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.09 113.5 18.45 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.44 177.529 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.419 ' N ' HD12 ' A' ' 111' ' ' LEU . 46.0 m-20 44.79 43.09 6.58 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.93 -11.87 65.63 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.455 178.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -104.99 118.49 36.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.037 0.446 . . . . 0.0 110.682 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.829 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -70.99 124.54 24.61 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.484 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.827 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.2 m -96.39 162.87 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.818 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.48 ' O ' ' HB2' ' A' ' 120' ' ' SER . 2.1 tt0 -69.82 129.59 39.96 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.439 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.672 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 15.4 tttt -53.94 160.62 1.41 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.876 0.37 . . . . 0.0 110.572 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.7 p-10 34.58 34.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.303 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.48 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.35 145.31 40.29 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.117 179.477 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.765 ' HB3' HD23 ' A' ' 100' ' ' LEU . 1.7 m-80 -86.04 130.42 34.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.086 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.421 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 6.7 mm100 -129.37 146.3 51.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.377 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.432 HD13 ' C ' ' A' ' 123' ' ' LEU . 1.2 tm? -72.72 115.01 11.49 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.793 0.33 . . . . 0.0 110.314 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.496 HD21 HG12 ' A' ' 147' ' ' ILE . 65.6 tp -54.75 157.71 2.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.382 0.611 . . . . 0.0 111.7 -179.236 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.43 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.0 OUTLIER -124.28 153.53 41.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.374 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.463 ' HA ' HD12 ' A' ' 147' ' ' ILE . 6.4 mm-40 -71.06 119.63 15.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.969 0.414 . . . . 0.0 110.291 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.55 21.49 64.84 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.235 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.43 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 26.0 t70 -56.94 172.01 0.3 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.997 0.427 . . . . 0.0 111.069 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 4.5 tt0 -145.22 135.58 24.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.165 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.503 HD11 HD11 ' A' ' 101' ' ' LEU . 1.3 mp -110.5 128.73 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.443 179.322 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.605 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.1 m -103.64 140.02 38.13 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.68 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 28.2 m -140.41 158.45 25.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -178.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 87.32 24.68 35.95 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.332 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.427 ' HB ' ' CZ3' ' A' ' 110' ' ' TRP . 70.2 t -69.56 140.38 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-O 121.632 0.729 . . . . 0.0 111.907 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 143.04 -41.84 1.14 Allowed Glycine 0 N--CA 1.435 -1.385 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.442 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 6.2 t -119.15 126.05 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.28 -35.84 28.91 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 47.3 m -93.49 6.63 47.54 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.442 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 30.6 m-20 -120.81 29.65 7.29 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -178.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.605 ' CG2' HG22 ' A' ' 131' ' ' THR . 7.3 mt -106.89 138.91 30.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 121.478 0.656 . . . . 0.0 110.904 178.197 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.671 HD22 ' CD2' ' A' ' 143' ' ' LEU . 1.3 tt -124.65 134.64 52.82 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.729 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.6 ' N ' HD23 ' A' ' 141' ' ' LEU . 0.9 OUTLIER -109.57 133.39 53.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.001 0.429 . . . . 0.0 111.717 -179.819 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.671 ' CD2' HD22 ' A' ' 141' ' ' LEU . 1.4 mm? -128.84 135.73 49.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.554 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.422 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 24.0 t -110.93 134.45 53.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.829 0.347 . . . . 0.0 111.271 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.435 HD13 HG22 ' A' ' 36' ' ' VAL . 5.2 mm -106.11 139.0 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.975 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.34 122.35 41.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.798 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.496 HG12 HD21 ' A' ' 124' ' ' LEU . 6.7 mt -85.01 134.11 27.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.324 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -83.35 103.57 12.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.853 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -64.14 -28.08 69.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.063 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.15 -43.67 87.47 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.062 0.458 . . . . 0.0 110.618 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 33.5 t80 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.901 179.847 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.853 0.359 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.441 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER -170.38 33.31 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -179.767 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.702 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -73.2 133.84 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-N 113.839 -1.528 . . . . 0.0 112.407 -177.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.998 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -92.54 -61.37 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.09 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.691 ' SG ' HD12 ' A' ' 48' ' ' LEU . 1.6 p -143.38 163.44 33.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.272 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 146' ' ' PHE . 0.0 OUTLIER -127.05 138.3 53.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.962 0.411 . . . . 0.0 111.782 -179.131 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.668 HG11 ' CE2' ' A' ' 68' ' ' PHE . 2.0 m -108.63 122.9 63.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.579 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.897 HG23 HG12 ' A' ' 45' ' ' ILE . 21.5 mt -128.42 122.11 56.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.991 -178.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.845 ' HA ' HD23 ' A' ' 143' ' ' LEU . 42.0 t -81.81 102.63 10.93 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 178.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.488 ' OG1' HG23 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -74.32 -23.82 59.12 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.68 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.554 HG21 ' H ' ' A' ' 142' ' ' SER . 72.2 p -79.78 -2.29 42.55 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.683 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.23 77.19 0.37 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.87 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.714 ' OE1' HD12 ' A' ' 141' ' ' LEU . 15.9 mt-30 -146.62 -41.0 0.2 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.935 0.398 . . . . 0.0 110.696 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.583 HG21 ' CE1' ' A' ' 76' ' ' TYR . 1.3 mp -125.77 141.34 38.98 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.8 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.556 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 46.8 Cg_endo -71.68 146.1 48.07 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.102 1.868 . . . . 0.0 112.137 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.897 HG12 HG23 ' A' ' 37' ' ' ILE . 39.2 mt -51.44 148.33 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.898 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.84 150.3 49.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.083 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -112.87 119.63 38.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.049 0.452 . . . . 0.0 111.368 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.691 HD12 ' SG ' ' A' ' 34' ' ' CYS . 3.1 mt -95.98 135.26 37.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.227 178.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.998 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.04 158.01 43.87 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -178.834 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.488 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -140.91 143.26 34.53 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 113.528 -1.669 . . . . 0.0 110.861 178.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 121.223 0.535 . . . . 0.0 111.093 -179.621 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.433 ' CE ' ' O ' ' A' ' 49' ' ' SER . 6.0 ttpt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.71 0.29 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.617 HG12 ' HG2' ' A' ' 90' ' ' GLN . 13.9 t -128.79 139.09 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-O 121.375 0.607 . . . . 0.0 112.299 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.532 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.9 m-90 -103.03 139.24 38.84 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.887 179.142 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.62 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -114.21 129.05 56.63 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.338 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.668 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -118.3 145.45 45.07 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.6 -178.305 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.597 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.43 -166.6 35.38 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.393 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.412 ' HD3' ' O ' ' A' ' 81' ' ' ILE . 12.9 mtm180 -86.73 6.98 28.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.504 0.192 . . . . 0.0 111.512 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.671 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 9.7 t-20 -84.95 134.01 42.19 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.547 0.213 . . . . 0.0 111.036 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.9 Cg_exo -65.43 -15.07 48.13 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.53 2.153 . . . . 0.0 111.598 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.671 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -83.15 -43.26 16.38 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 121.962 0.887 . . . . 0.0 108.887 178.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.47 136.03 3.38 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 113.862 -1.517 . . . . 0.0 111.045 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.9 OUTLIER -56.87 -18.62 13.79 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.952 178.611 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.583 ' CE1' HG21 ' A' ' 43' ' ' ILE . 30.5 t80 -129.57 112.1 13.38 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.783 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -89.75 111.63 22.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.22 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.769 HD13 HD13 ' A' ' 84' ' ' LEU . 88.4 mt -78.52 -172.81 3.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.839 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -90.66 21.12 34.51 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.891 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 61.04 74.68 0.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.944 0.402 . . . . 0.0 111.601 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 1.042 HD13 HD12 ' A' ' 84' ' ' LEU . 4.3 mp -106.62 129.18 60.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.723 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.7 m -54.91 -37.21 66.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.293 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.455 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -69.32 -15.94 63.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.452 -179.814 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.042 HD12 HD13 ' A' ' 81' ' ' ILE . 28.4 mt -107.06 152.01 24.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.719 0.295 . . . . 0.0 110.833 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.4 m -95.79 166.63 11.72 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.496 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.597 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 1.4 m-80 -42.46 -57.55 2.59 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.439 0.638 . . . . 0.0 109.545 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.486 ' HB3' HG22 ' A' ' 67' ' ' THR . 10.3 mtpt -116.79 84.39 2.13 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 176.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.549 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 12.4 t60 -60.89 -46.73 89.46 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.596 -176.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.492 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 25.6 p90 -145.08 158.07 43.93 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.116 -0.634 . . . . 0.0 112.157 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.62 ' HG3' HG23 ' A' ' 67' ' ' THR . 26.1 tt0 -135.9 139.91 43.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.164 -179.148 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.598 ' O ' HG13 ' A' ' 65' ' ' VAL . 72.6 mt -115.97 130.23 71.02 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 C-N-CA 121.134 -0.227 . . . . 0.0 111.002 179.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.51 HD21 ' HB2' ' A' ' 102' ' ' ASN . 0.2 OUTLIER -115.53 150.83 35.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.12 0.486 . . . . 0.0 111.851 -179.888 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.422 HD13 ' HG ' ' A' ' 99' ' ' LEU . 14.6 tp . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.223 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.983 HD21 HG12 ' A' ' 33' ' ' VAL . 4.2 mp . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.884 0.373 . . . . 0.0 110.762 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.735 HD22 ' HB3' ' A' ' 121' ' ' ASN . 13.8 mt -133.2 144.38 49.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.893 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.649 HD11 ' HA ' ' A' ' 124' ' ' LEU . 2.2 mt -112.73 123.21 49.78 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.745 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.51 ' HB2' HD21 ' A' ' 92' ' ' LEU . 52.0 t30 -114.68 115.55 27.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.062 0.458 . . . . 0.0 111.664 -179.069 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.82 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.1 p30 -77.71 134.61 38.07 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.733 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.459 HD12 ' HB2' ' A' ' 87' ' ' LYS . 13.7 pt -141.71 39.48 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.623 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -101.93 151.63 21.88 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.005 0.431 . . . . 0.0 112.021 -178.892 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.6 m -68.89 -31.59 70.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.688 177.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -95.11 -19.55 20.02 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.328 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.623 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 112.78 158.96 13.82 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.781 179.265 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 11.4 m -117.1 137.69 52.12 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.871 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -115.89 148.32 40.12 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -177.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.485 HD13 ' OD2' ' A' ' 128' ' ' ASP . 0.2 OUTLIER -124.31 113.52 18.35 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.66 -1.155 . . . . 0.0 108.419 177.545 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 43.74 43.77 5.15 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.51 -11.14 66.87 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.58 178.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -103.57 118.59 37.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.027 0.441 . . . . 0.0 110.583 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.871 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 12.2 tptm -74.53 122.3 22.88 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.382 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.82 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.9 m -91.59 164.17 2.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.971 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 120' ' ' SER . 15.9 tt0 -69.89 126.26 29.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.468 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.702 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 28.2 tttt -53.2 162.69 0.66 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.944 0.402 . . . . 0.0 110.441 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.1 m-80 34.67 35.0 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.03 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.4 OUTLIER -112.27 145.01 40.72 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.293 179.578 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.735 ' HB3' HD22 ' A' ' 100' ' ' LEU . 50.3 m-80 -89.11 125.56 35.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.727 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.508 ' O ' HD23 ' A' ' 100' ' ' LEU . 38.5 mm-40 -129.31 147.65 51.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.089 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 tt -76.34 115.3 15.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.104 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.649 ' HA ' HD11 ' A' ' 101' ' ' LEU . 1.6 pt? -56.99 165.84 1.17 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.604 0.716 . . . . 0.0 112.043 -178.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.449 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.64 153.65 41.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.073 179.657 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.522 ' HA ' HD12 ' A' ' 147' ' ' ILE . 1.6 tp-100 -71.17 123.22 21.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.013 0.435 . . . . 0.0 110.287 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.06 20.19 53.16 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.107 -179.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.485 ' OD2' HD13 ' A' ' 111' ' ' LEU . 7.7 t70 -58.58 178.8 0.09 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.745 0.307 . . . . 0.0 110.673 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.885 ' CG ' HG22 ' A' ' 144' ' ' VAL . 5.4 mt-10 -145.11 135.61 24.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.415 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 1.038 HD11 HD11 ' A' ' 145' ' ' ILE . 15.3 mt -112.04 126.91 69.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.215 178.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.51 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.2 m -104.33 138.66 40.44 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.563 HG23 HD21 ' A' ' 84' ' ' LEU . 35.8 m -140.01 158.12 26.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.138 0.494 . . . . 0.0 112.268 -178.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 89.47 24.02 32.23 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.951 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.461 ' HB ' ' CZ3' ' A' ' 110' ' ' TRP . 73.5 t -71.12 140.52 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-O 121.654 0.74 . . . . 0.0 112.021 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.05 -45.74 0.66 Allowed Glycine 0 N--CA 1.433 -1.525 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.47 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 1.7 t -110.51 131.41 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -50.56 -44.22 56.53 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.8 m -93.37 6.92 46.48 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -178.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.47 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 16.5 m-20 -117.01 34.4 5.13 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -178.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.51 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.4 mt -107.01 139.09 29.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.973 178.182 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.714 HD12 ' OE1' ' A' ' 42' ' ' GLN . 10.2 tt -124.33 134.71 53.1 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.862 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.554 ' H ' HG21 ' A' ' 40' ' ' THR . 47.1 t -110.33 150.34 28.9 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.658 0.742 . . . . 0.0 112.195 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.845 HD23 ' HA ' ' A' ' 38' ' ' CYS . 75.0 mt -135.87 158.1 45.21 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.881 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.885 HG22 ' CG ' ' A' ' 129' ' ' GLU . 22.4 t -122.54 139.92 47.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.852 0.358 . . . . 0.0 111.026 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 1.038 HD11 HD11 ' A' ' 130' ' ' ILE . 30.7 mt -106.3 120.96 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.833 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.406 ' O ' ' N ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -109.99 108.62 18.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.841 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.522 HD12 ' HA ' ' A' ' 126' ' ' GLN . 6.1 mt -84.6 128.98 38.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.245 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -77.82 114.16 16.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -69.02 -31.59 70.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -57.39 -43.38 83.61 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.066 0.46 . . . . 0.0 110.411 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 15.5 t80 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.624 179.771 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.473 ' HG2' HD11 ' A' ' 32' ' ' ILE . 2.5 pt-20 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.912 0.387 . . . . 0.0 110.792 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.461 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.0 OUTLIER -179.88 37.22 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.92 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.722 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.4 mm -73.48 135.67 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 CA-C-N 113.664 -1.607 . . . . 0.0 112.45 -177.399 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.014 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.4 t -91.81 -59.77 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.916 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.718 ' SG ' HD12 ' A' ' 48' ' ' LEU . 7.0 p -150.59 152.03 33.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.26 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.425 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.99 138.21 50.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.817 0.341 . . . . 0.0 111.352 -179.396 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.629 HG23 HD11 ' A' ' 48' ' ' LEU . 24.3 t -100.73 122.77 53.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.829 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.699 HG23 HG12 ' A' ' 45' ' ' ILE . 17.0 mt -132.93 122.08 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.581 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.621 ' HA ' HD23 ' A' ' 143' ' ' LEU . 51.4 t -80.68 136.55 36.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.405 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 t -97.38 -29.23 13.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.625 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.534 HG23 ' HB3' ' A' ' 142' ' ' SER . 70.4 p -79.79 -2.32 42.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.771 0.319 . . . . 0.0 111.472 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.51 78.27 0.25 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.909 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -146.58 -41.19 0.2 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.736 0.303 . . . . 0.0 111.122 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.729 HD12 HD21 ' A' ' 143' ' ' LEU . 1.5 mt -114.8 140.6 25.63 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.065 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.538 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.1 Cg_endo -74.35 145.93 34.86 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.24 1.96 . . . . 0.0 112.042 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.699 HG12 HG23 ' A' ' 37' ' ' ILE . 35.0 mt -61.92 136.69 24.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.805 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.06 164.17 26.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.08 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.425 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 1.3 p30 -117.77 123.21 45.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.128 0.49 . . . . 0.0 112.115 -179.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.718 HD12 ' SG ' ' A' ' 34' ' ' CYS . 0.8 OUTLIER -101.21 135.65 42.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.507 -0.77 . . . . 0.0 108.923 178.472 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . 1.014 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.21 159.1 43.53 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -178.764 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.491 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -146.71 149.89 34.31 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 113.766 -1.561 . . . . 0.0 111.146 178.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.088 -179.742 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.403 ' CE ' ' O ' ' A' ' 49' ' ' SER . 6.4 ttpt . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.693 0.282 . . . . 0.0 111.003 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.521 HG22 ' CB ' ' A' ' 92' ' ' LEU . 4.4 t -118.69 136.33 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 121.36 0.6 . . . . 0.0 111.94 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.633 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 15.4 m-90 -100.68 140.37 35.05 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.516 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.757 HG23 ' CG ' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -111.35 129.22 56.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.201 177.978 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.678 ' CD1' ' HB2' ' A' ' 76' ' ' TYR . 5.8 m-85 -120.39 145.42 47.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.472 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.651 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.49 -168.64 36.76 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.025 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.452 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 6.4 mtm105 -79.03 3.09 18.31 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.456 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 23.7 t-20 -84.7 131.74 48.62 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.612 0.244 . . . . 0.0 111.101 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.0 Cg_exo -66.14 -14.01 42.45 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.584 2.189 . . . . 0.0 111.59 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.87 -44.05 15.87 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 121.841 0.829 . . . . 0.0 108.803 178.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -40.19 138.91 0.79 Allowed 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 113.78 -1.554 . . . . 0.0 110.951 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 67' ' ' THR . 10.9 m-20 -56.73 -19.22 15.6 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.355 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.678 ' HB2' ' CD1' ' A' ' 68' ' ' PHE . 12.6 t80 -130.36 113.66 14.63 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.672 0.273 . . . . 0.0 111.027 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -85.87 107.83 17.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.672 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.557 HD22 ' HA2' ' A' ' 69' ' ' GLY . 8.0 mp -81.77 -78.76 0.18 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.007 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -173.25 -94.24 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.084 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.41 ' HA ' ' HD2' ' A' ' 70' ' ' ARG . 8.5 p30 -179.81 50.29 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.825 0.345 . . . . 0.0 111.143 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.407 HG22 ' H ' ' A' ' 83' ' ' ARG . 26.0 mm -79.05 125.49 38.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.848 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.93 -37.21 66.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.913 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.741 ' NH1' HG23 ' A' ' 136' ' ' VAL . 6.2 mtp180 -69.53 -37.14 76.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.108 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.558 HD21 HG23 ' A' ' 132' ' ' VAL . 44.6 mt -83.74 151.58 25.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.837 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 95.3 p -97.79 164.8 12.24 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.656 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.651 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.5 m-20 -42.55 -52.4 4.77 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.497 0.665 . . . . 0.0 109.61 179.076 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.732 ' HB3' HG22 ' A' ' 67' ' ' THR . 3.8 mttt -118.9 84.14 2.14 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 177.276 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.554 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.4 t60 -62.88 -44.7 95.4 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.103 -0.953 . . . . 0.0 113.137 -176.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.544 ' HZ ' HD13 ' A' ' 143' ' ' LEU . 0.1 OUTLIER -148.7 161.8 41.02 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.985 -0.686 . . . . 0.0 112.234 -179.564 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.757 ' CG ' HG23 ' A' ' 67' ' ' THR . 28.3 mt-30 -135.08 155.53 50.58 Favored 'General case' 0 C--N 1.334 -0.065 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.389 -178.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.709 HD11 HD11 ' A' ' 145' ' ' ILE . 32.5 mt -130.48 132.49 64.61 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.343 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 177.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.622 HD23 ' HB2' ' A' ' 102' ' ' ASN . 0.9 OUTLIER -122.73 145.78 48.09 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.069 0.461 . . . . 0.0 111.877 -179.392 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.807 HD22 ' CG1' ' A' ' 33' ' ' VAL . 8.2 tp . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.185 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.704 HD11 HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.847 0.356 . . . . 0.0 110.851 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.751 HD13 ' O ' ' A' ' 122' ' ' GLN . 3.4 mm? -124.06 138.83 54.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.469 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.808 HD11 HD13 ' A' ' 124' ' ' LEU . 9.2 mp -112.6 125.06 53.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.048 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.622 ' HB2' HD23 ' A' ' 92' ' ' LEU . 50.4 t30 -115.8 115.75 26.82 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.12 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.785 ' OD2' HG23 ' A' ' 116' ' ' VAL . 8.8 p30 -78.08 142.9 37.83 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.524 HG21 ' OE1' ' A' ' 90' ' ' GLN . 8.1 pt -150.35 37.56 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -178.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.587 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.43 148.52 24.13 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 120.948 0.404 . . . . 0.0 111.712 -179.045 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.2 m -68.63 -31.37 70.47 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.64 177.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -94.56 -19.54 20.41 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.587 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.8 152.0 9.6 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.227 -0.987 . . . . 0.0 113.888 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.472 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.7 m -117.57 137.86 52.31 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.869 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -118.39 148.3 42.67 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.514 HD13 ' OD2' ' A' ' 128' ' ' ASP . 0.2 OUTLIER -124.16 113.65 18.61 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.484 177.541 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.409 ' N ' HD12 ' A' ' 111' ' ' LEU . 2.5 m120 45.3 43.01 7.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.273 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.5 -7.65 75.35 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.512 178.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -104.42 118.63 37.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.018 0.437 . . . . 0.0 110.671 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.869 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.0 tptm -74.12 121.5 21.25 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.187 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.785 HG23 ' OD2' ' A' ' 103' ' ' ASP . 8.2 m -96.22 163.57 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.133 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -69.77 128.83 37.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.493 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.686 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 12.4 tttt -53.72 162.77 0.8 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.764 0.316 . . . . 0.0 110.29 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.8 m-80 33.5 37.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.846 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.9 p -111.78 145.16 39.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.893 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.456 ' HB3' HD12 ' A' ' 100' ' ' LEU . 8.2 m-80 -88.83 124.44 34.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.864 0.364 . . . . 0.0 110.713 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.751 ' O ' HD13 ' A' ' 100' ' ' LEU . 50.6 mm-40 -128.98 149.45 50.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.598 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.5 tp -72.63 132.85 44.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.889 0.376 . . . . 0.0 110.441 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.834 HD11 HG21 ' A' ' 145' ' ' ILE . 64.0 tp -69.47 157.85 36.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.428 0.633 . . . . 0.0 111.519 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.427 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.6 OUTLIER -124.33 153.17 42.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.926 179.59 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.705 ' HA ' HD13 ' A' ' 147' ' ' ILE . 1.2 mm-40 -71.25 122.9 21.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.979 0.419 . . . . 0.0 110.659 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 56.98 22.93 44.05 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.267 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.514 ' OD2' HD13 ' A' ' 111' ' ' LEU . 15.5 t70 -56.17 175.06 0.11 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.852 0.358 . . . . 0.0 110.828 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.923 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.0 mt-10 -143.8 135.63 26.36 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.081 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.667 HD11 HG13 ' A' ' 145' ' ' ILE . 2.2 mp -112.5 128.14 69.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.574 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.567 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.0 m -104.32 145.12 30.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.443 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.558 HG23 HD21 ' A' ' 84' ' ' LEU . 29.9 m -140.37 158.46 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.052 0.453 . . . . 0.0 112.156 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.51 42.01 12.32 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.268 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.472 ' HB ' ' CH2' ' A' ' 110' ' ' TRP . 74.8 t -86.67 140.4 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-O 121.544 0.688 . . . . 0.0 112.124 -179.175 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 139.22 -34.1 2.1 Favored Glycine 0 N--CA 1.435 -1.371 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.741 HG23 ' NH1' ' A' ' 83' ' ' ARG . 9.0 t -124.56 118.34 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.125 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -50.77 -29.6 11.94 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -178.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 31.9 m -93.61 6.7 47.38 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -178.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.418 ' CB ' ' HD3' ' A' ' 83' ' ' ARG . 0.8 OUTLIER -130.07 31.28 4.69 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -178.583 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.567 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.1 mt -107.11 138.46 32.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-O 121.351 0.595 . . . . 0.0 110.866 178.052 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.407 HD23 ' C ' ' A' ' 141' ' ' LEU . 9.3 tt -125.09 134.72 52.38 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.692 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.534 ' HB3' HG23 ' A' ' 40' ' ' THR . 44.4 t -106.84 149.62 27.22 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.544 0.688 . . . . 0.0 112.066 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.729 HD21 HD12 ' A' ' 43' ' ' ILE . 75.6 mt -136.39 158.04 45.36 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.695 -1.138 . . . . 0.0 111.219 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.923 HG22 ' CG ' ' A' ' 129' ' ' GLU . 21.7 t -129.18 140.16 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.851 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.834 HG21 HD11 ' A' ' 124' ' ' LEU . 1.1 mm -106.36 129.55 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 CA-C-O 120.944 0.402 . . . . 0.0 110.911 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.02 110.67 21.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.858 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.705 HD13 ' HA ' ' A' ' 126' ' ' GLN . 4.3 mp -85.83 134.14 27.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.483 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -84.94 123.69 30.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.819 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -72.01 -27.78 62.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.069 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -58.74 -44.43 90.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.035 0.445 . . . . 0.0 110.756 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.4 t80 . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.898 179.963 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.873 0.368 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.436 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER -169.99 34.68 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 -179.9 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.682 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 2.9 mm -77.77 134.02 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 CA-C-N 113.878 -1.51 . . . . 0.0 112.58 -177.16 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.997 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -90.25 -60.89 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.677 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.6 p -146.14 150.8 36.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.169 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.97 138.12 50.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.743 0.306 . . . . 0.0 111.214 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.605 HG21 ' HE2' ' A' ' 68' ' ' PHE . 26.6 t -101.7 122.66 54.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.874 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.577 HG23 HG12 ' A' ' 45' ' ' ILE . 18.9 mt -129.43 125.78 62.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.405 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.475 ' SG ' HD21 ' A' ' 141' ' ' LEU . 7.4 t -95.36 107.37 19.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.904 0.383 . . . . 0.0 110.485 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 79.3 p -82.02 -20.6 38.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.516 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.7 HG21 ' OG ' ' A' ' 142' ' ' SER . 12.3 p -80.04 -3.1 47.11 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.736 0.303 . . . . 0.0 111.333 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.39 70.93 0.97 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 121.087 -0.578 . . . . 0.0 113.775 178.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.524 ' HB2' HD21 ' A' ' 141' ' ' LEU . 0.8 OUTLIER -145.08 -37.36 0.28 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.623 0.249 . . . . 0.0 111.469 179.411 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.835 HD13 ' HB3' ' A' ' 78' ' ' LEU . 52.2 mt -123.55 142.83 39.99 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.097 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.66 ' HD2' HG23 ' A' ' 43' ' ' ILE . 53.0 Cg_endo -71.97 146.04 46.37 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.206 1.937 . . . . 0.0 112.25 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.577 HG12 HG23 ' A' ' 37' ' ' ILE . 35.2 mt -59.58 144.22 12.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.773 -179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.34 164.02 31.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.013 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -131.64 119.85 21.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.993 0.425 . . . . 0.0 112.114 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.816 HD23 ' CD2' ' A' ' 66' ' ' TRP . 8.2 mp -87.25 133.83 33.62 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 178.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.997 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -138.69 156.18 47.62 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 -179.444 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.462 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -143.87 141.75 30.47 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 113.455 -1.702 . . . . 0.0 110.706 178.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 121.077 0.465 . . . . 0.0 111.232 -179.473 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.417 ' HE2' ' O ' ' A' ' 49' ' ' SER . 2.6 ttpt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.933 0.397 . . . . 0.0 111.648 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.645 HG12 ' HG2' ' A' ' 90' ' ' GLN . 21.8 t -135.34 139.43 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.776 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.816 ' CD2' HD23 ' A' ' 48' ' ' LEU . 19.7 m-90 -102.21 138.7 38.81 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.086 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.655 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -115.52 125.15 52.66 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.275 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.662 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.8 OUTLIER -108.09 145.58 33.85 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.305 -178.668 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.736 ' CA ' HD21 ' A' ' 78' ' ' LEU . . . 166.64 178.52 39.27 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.831 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.463 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 9.3 mtp-105 -73.46 -5.29 39.01 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.441 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.0 t-20 -84.89 134.96 40.53 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.699 0.285 . . . . 0.0 111.038 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 10.0 Cg_exo -69.76 -5.22 15.68 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.815 2.343 . . . . 0.0 111.831 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.54 -43.38 17.19 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 122.022 0.915 . . . . 0.0 108.558 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -44.04 139.34 2.51 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 113.641 -1.618 . . . . 0.0 110.469 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -56.12 -18.93 11.26 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.066 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.548 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 7.0 t80 -129.73 133.25 46.92 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.866 0.365 . . . . 0.0 110.94 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -109.77 120.42 42.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.643 179.47 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.835 ' HB3' HD13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -101.36 -81.63 0.48 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.124 -179.879 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.09 -133.07 1.41 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.512 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -138.73 66.7 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.879 0.371 . . . . 0.0 111.439 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.465 HG22 ' H ' ' A' ' 83' ' ' ARG . 31.6 mm -97.11 117.8 42.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.253 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 92.5 p -54.77 -30.98 58.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.19 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.506 ' HG3' ' HB3' ' A' ' 139' ' ' ASP . 1.6 mmp_? -71.51 -23.65 61.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.386 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.524 HD21 HG23 ' A' ' 132' ' ' VAL . 29.5 mt -94.23 152.08 18.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.503 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 85.7 p -96.57 166.6 11.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.851 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.672 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 1.5 m-80 -42.81 -52.88 4.86 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.437 0.637 . . . . 0.0 109.675 179.078 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.554 ' HB2' HD12 ' A' ' 104' ' ' ILE . 3.7 ptmm? -120.51 84.78 2.28 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 177.306 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.665 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 61.0 t-80 -60.3 -46.99 87.94 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.952 -1.022 . . . . 0.0 113.042 -176.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.518 ' HA ' HG12 ' A' ' 104' ' ' ILE . 29.3 p90 -151.61 159.54 44.02 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.874 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.655 ' HG3' HG23 ' A' ' 67' ' ' THR . 28.5 tt0 -136.11 139.56 43.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.55 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.662 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 29.4 mt -116.17 129.58 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.915 179.096 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.588 ' CB ' HG22 ' A' ' 65' ' ' VAL . 0.4 OUTLIER -114.58 149.33 36.7 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.234 0.54 . . . . 0.0 112.029 -179.541 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.859 HD22 HG11 ' A' ' 33' ' ' VAL . 57.9 tp . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.033 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.63 ' HB2' HD13 ' A' ' 124' ' ' LEU . 1.7 mt . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.78 0.324 . . . . 0.0 110.665 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.687 HD23 ' HB3' ' A' ' 121' ' ' ASN . 6.3 mp -125.51 139.15 53.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.55 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.593 HD11 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -112.87 123.4 50.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.084 179.665 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.452 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 61.1 t30 -117.74 115.85 25.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.889 0.376 . . . . 0.0 111.967 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.843 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.3 p30 -78.49 142.99 37.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.924 178.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.554 HD12 ' HB2' ' A' ' 87' ' ' LYS . 11.5 pt -147.76 28.0 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.651 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.534 ' HB2' ' CG ' ' A' ' 88' ' ' HIS . 11.3 t -93.56 155.09 17.5 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 121.584 0.707 . . . . 0.0 112.598 -178.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 65.9 m -70.1 -52.17 25.83 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.731 178.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -78.54 0.57 25.63 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.44 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.07 154.28 30.77 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 120.75 -0.738 . . . . 0.0 114.041 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.546 HG22 ' CG2' ' A' ' 130' ' ' ILE . 3.7 m -117.5 137.86 52.26 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.811 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -116.1 148.54 40.16 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -177.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.892 HD12 HG11 ' A' ' 116' ' ' VAL . 1.0 OUTLIER -124.44 113.64 18.41 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.956 177.363 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 48.3 35.53 5.73 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.072 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.17 -4.8 83.05 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.853 -0.689 . . . . 0.0 113.515 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.37 118.57 36.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.934 0.397 . . . . 0.0 110.498 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.811 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 9.1 tptm -71.04 111.64 6.56 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.128 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.892 HG11 HD12 ' A' ' 111' ' ' LEU . 17.1 m -87.89 162.95 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.106 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.8 OUTLIER -69.91 127.88 34.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.497 179.725 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.681 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 53.9 tttm -54.47 161.68 1.35 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.865 0.364 . . . . 0.0 110.517 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.506 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 35.45 33.89 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.371 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.38 145.09 40.71 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.991 179.279 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.687 ' HB3' HD23 ' A' ' 100' ' ' LEU . 17.3 m-80 -90.14 131.42 36.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.904 0.383 . . . . 0.0 110.976 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.442 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 43.9 mm-40 -129.28 148.77 51.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.43 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.61 123.96 24.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.374 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.63 HD13 ' HB2' ' A' ' 99' ' ' LEU . 7.8 tt -55.21 154.34 5.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.484 0.659 . . . . 0.0 111.723 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.419 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.73 153.24 42.68 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.303 179.73 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.56 ' HA ' HD13 ' A' ' 147' ' ' ILE . 1.9 tp-100 -71.66 126.35 29.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.828 0.347 . . . . 0.0 110.182 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.44 20.3 50.69 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.224 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.419 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 11.0 t70 -53.48 164.36 0.51 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.892 0.377 . . . . 0.0 111.074 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.7 tt0 -144.26 135.39 25.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.928 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.593 HD11 HD11 ' A' ' 101' ' ' LEU . 1.4 mp -109.1 127.02 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.598 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.592 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.7 m -104.17 140.48 37.76 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.665 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.0 m -140.18 158.42 25.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.87 23.6 41.28 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.283 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.437 ' HB ' ' CH2' ' A' ' 110' ' ' TRP . 82.2 t -68.34 140.47 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-O 121.515 0.674 . . . . 0.0 111.915 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 141.79 -41.23 1.24 Allowed Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -178.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 2.2 t -120.32 123.31 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.304 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.16 -31.05 12.63 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.118 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.68 6.75 47.29 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -178.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.506 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . 16.7 m-20 -125.34 31.0 5.67 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -178.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.592 ' CG2' HG22 ' A' ' 131' ' ' THR . 10.0 mt -106.42 138.71 30.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-O 121.456 0.646 . . . . 0.0 110.985 178.216 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' A' ' 143' ' ' LEU . 1.1 tt -124.76 134.53 52.76 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.517 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.7 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.7 OUTLIER -111.43 131.47 55.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.072 0.463 . . . . 0.0 111.698 -179.699 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.735 ' CD2' HD22 ' A' ' 141' ' ' LEU . 2.8 mm? -127.56 134.41 49.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.555 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 18.8 t -110.68 133.96 54.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.854 0.359 . . . . 0.0 111.18 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.569 ' CD1' HG22 ' A' ' 36' ' ' VAL . 1.2 mm -106.2 121.22 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.08 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -99.88 129.39 45.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.663 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.645 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.3 mp -92.54 129.21 43.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.867 0.365 . . . . 0.0 111.209 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -82.81 113.26 20.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.983 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 28.4 p-10 -61.17 -26.69 67.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.976 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.65 -43.44 84.92 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.007 0.432 . . . . 0.0 110.556 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.1 t80 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.746 179.847 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 120.837 0.351 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.9 p -145.25 -70.83 0.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.881 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.0 -37.49 87.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.861 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -60.41 -37.22 80.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.882 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -58.46 -41.96 86.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.2 tp -60.47 -32.59 71.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.72 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.455 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.8 mt -73.15 -35.34 47.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.913 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -57.46 -40.03 77.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.509 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -23.86 65.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.654 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.78 -47.55 79.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.228 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.2 m -81.2 -45.87 15.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.805 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -99.45 94.28 6.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.917 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -92.09 135.44 33.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.839 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.86 101.82 11.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.963 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.5 mm -89.03 138.46 19.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 CA-C-O 121.614 0.721 . . . . 0.0 111.864 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.36 50.01 1.08 Allowed Glycine 0 C--N 1.314 -0.679 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.574 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -70.44 -43.16 70.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.808 0.337 . . . . 0.0 110.753 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.7 m-20 -179.73 37.74 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.658 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.1 mm -76.75 137.52 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 CA-C-N 113.812 -1.54 . . . . 0.0 112.574 -177.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.98 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.1 t -92.98 -59.85 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.826 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.401 ' SG ' HD22 ' A' ' 48' ' ' LEU . 21.4 p -148.19 162.52 39.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.218 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.406 ' HB3' ' HB2' ' A' ' 146' ' ' PHE . 2.8 ttm180 -119.98 138.31 53.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.896 0.379 . . . . 0.0 111.221 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.657 HG11 ' CE2' ' A' ' 68' ' ' PHE . 2.1 m -106.62 122.7 60.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.728 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.867 HG23 HG12 ' A' ' 45' ' ' ILE . 20.5 mt -127.03 130.13 71.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.525 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.713 ' HA ' HD13 ' A' ' 143' ' ' LEU . 41.9 t -86.99 119.37 27.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.559 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.43 ' OG1' HG23 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -86.06 -26.48 25.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.578 -179.244 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.511 HG21 ' H ' ' A' ' 142' ' ' SER . 68.9 p -79.83 -2.36 43.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.717 0.294 . . . . 0.0 111.464 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.19 77.22 0.22 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.903 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.506 ' OE1' HD11 ' A' ' 141' ' ' LEU . 12.8 mt-30 -146.92 -43.32 0.18 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.871 0.367 . . . . 0.0 110.955 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.573 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.0 mt -116.32 141.7 28.28 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.038 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.573 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 45.2 Cg_endo -70.88 145.76 51.53 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.182 1.921 . . . . 0.0 112.148 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.867 HG12 HG23 ' A' ' 37' ' ' ILE . 38.9 mt -56.56 139.85 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.852 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -132.57 157.13 45.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.966 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -120.68 121.93 39.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.069 0.461 . . . . 0.0 111.959 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.844 HD23 ' CD2' ' A' ' 66' ' ' TRP . 8.7 mp -87.8 133.63 33.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.469 178.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.98 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -138.71 156.46 47.37 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 122.219 1.009 . . . . 0.0 113.411 -179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.486 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.31 149.51 34.96 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 113.553 -1.658 . . . . 0.0 110.977 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.622 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -76.28 128.35 34.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.05 0.453 . . . . 0.0 110.993 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.808 HD13 ' SG ' ' A' ' 154' ' ' CYS . 34.3 mt -64.1 -39.61 86.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.602 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.4 m -59.29 -39.64 83.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.198 0.523 . . . . 0.0 110.505 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.546 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 3.7 mm100 -68.55 -45.17 72.88 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.564 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.769 HG13 ' HG3' ' A' ' 63' ' ' LYS . 46.4 t -62.15 -39.21 83.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.354 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.532 HD21 ' HA ' ' A' ' 158' ' ' ASN . 0.2 OUTLIER -71.04 -37.86 72.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.08 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.1 tptt -74.64 -45.55 44.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.146 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.84 120.58 14.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.02 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -106.61 -25.09 11.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.888 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -115.81 162.7 16.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.925 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 74.5 m 60.32 -175.55 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.88 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.89 HG21 ' HB2' ' A' ' 92' ' ' LEU . 19.4 mm -92.29 141.9 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.197 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.769 ' HG3' HG13 ' A' ' 55' ' ' VAL . 27.8 mmtm -64.1 -59.32 4.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.984 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.406 ' HE2' ' O ' ' A' ' 49' ' ' SER . 7.5 ttpt -150.39 143.07 24.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.492 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 91' ' ' ILE . 16.3 t -130.88 138.91 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 121.227 0.537 . . . . 0.0 111.736 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.844 ' CD2' HD23 ' A' ' 48' ' ' LEU . 19.2 m-90 -102.03 139.39 37.72 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.428 -0.806 . . . . 0.0 112.086 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.984 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -110.98 126.68 55.03 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.421 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.657 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -110.9 145.43 38.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.12 -178.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.653 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 165.93 -179.85 39.89 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.646 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.9 mtm180 -77.58 -1.71 32.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.529 0.204 . . . . 0.0 111.505 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.456 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.5 t-20 -84.87 136.42 38.86 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 120.745 0.307 . . . . 0.0 110.996 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.5 Cg_exo -69.13 -6.45 18.32 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.704 2.269 . . . . 0.0 111.868 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.89 -45.35 14.32 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.96 0.886 . . . . 0.0 108.756 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -44.43 137.87 3.46 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 113.642 -1.617 . . . . 0.0 110.632 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -56.27 -19.33 13.66 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.927 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.525 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 46.6 t80 -130.13 130.25 44.55 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.586 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -111.04 122.3 47.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.785 0.326 . . . . 0.0 111.277 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.554 HD11 ' CA ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -120.44 179.66 4.24 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.877 179.251 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.26 133.54 52.67 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.665 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -64.78 92.3 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.849 0.357 . . . . 0.0 110.792 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.659 ' HB ' HD13 ' A' ' 84' ' ' LEU . 4.3 mt -111.99 141.07 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.235 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.738 ' HB2' HD11 ' B' ' 170' ' ' LEU . 2.9 p -65.12 -40.27 94.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.167 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.491 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -62.03 -21.31 64.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.519 -179.674 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.659 HD13 ' HB ' ' A' ' 81' ' ' ILE . 3.9 mp -99.95 153.4 19.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.057 0.456 . . . . 0.0 111.365 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.2 p -99.76 169.31 9.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.808 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.653 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 1.1 m-20 -44.87 -53.89 7.03 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.367 0.603 . . . . 0.0 109.562 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.607 ' CB ' HD12 ' A' ' 104' ' ' ILE . 71.7 mttt -118.13 85.47 2.35 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 177.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.697 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 60.3 t-80 -60.03 -45.86 91.4 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.691 -176.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.516 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 30.3 p90 -150.39 164.3 36.19 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.126 -0.629 . . . . 0.0 112.034 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.984 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.58 134.17 39.08 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.367 -178.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.646 HG23 HD12 ' A' ' 101' ' ' LEU . 47.5 mt -110.92 131.79 61.15 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.649 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.89 ' HB2' HG21 ' A' ' 62' ' ' ILE . 0.6 OUTLIER -123.29 140.75 52.7 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.981 0.419 . . . . 0.0 111.759 -179.29 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.71 HD22 ' N ' ' A' ' 94' ' ' GLY . 1.0 OUTLIER -125.25 122.95 38.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.441 179.166 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.71 ' N ' HD22 ' A' ' 93' ' ' LEU . . . -178.68 -144.19 5.56 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.327 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 58.41 -166.95 0.15 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.759 0.314 . . . . 0.0 110.879 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -81.18 59.88 4.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.973 0.416 . . . . 0.0 110.867 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.29 -178.97 36.01 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.578 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 33.5 m120 61.86 174.76 0.12 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.909 0.385 . . . . 0.0 110.917 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.676 HD11 HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -124.29 160.31 28.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.779 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.502 HD23 ' HB3' ' A' ' 121' ' ' ASN . 5.2 mp -124.23 141.0 52.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.936 0.398 . . . . 0.0 110.36 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.646 HD12 HG23 ' A' ' 91' ' ' ILE . 2.8 mp -112.68 126.37 55.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.087 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.46 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 67.2 t30 -119.18 136.29 54.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.11 0.481 . . . . 0.0 111.8 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.807 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.7 p30 -98.42 142.54 29.91 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.996 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.607 HD12 ' CB ' ' A' ' 87' ' ' LYS . 8.7 pt -145.58 24.5 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.621 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.55 ' HB2' ' CG ' ' A' ' 88' ' ' HIS . 11.2 t -92.09 154.14 18.93 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 121.594 0.711 . . . . 0.0 112.51 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.707 HG21 HG23 ' B' ' 169' ' ' TPO . 22.9 m -70.11 -51.94 27.63 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.607 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -75.33 -2.59 29.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.301 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.58 154.68 30.79 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.749 -0.739 . . . . 0.0 113.671 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 4.2 m -117.47 137.81 52.28 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.845 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -114.72 148.48 38.23 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -178.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.461 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.16 113.52 18.44 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.457 177.622 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 44.59 43.25 6.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.373 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.89 -7.9 75.33 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.44 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -104.81 118.61 36.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.996 0.427 . . . . 0.0 110.593 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.845 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.4 tptm -72.91 114.48 11.1 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.266 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.807 HG23 ' OD2' ' A' ' 103' ' ' ASP . 6.2 m -88.81 161.61 2.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.984 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 120' ' ' SER . 23.5 tt0 -69.75 130.79 43.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.347 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.686 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 24.2 tttt -54.49 161.61 1.38 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.899 0.381 . . . . 0.0 110.408 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.495 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.0 m-80 35.1 33.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.135 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.481 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.51 145.11 40.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.145 179.524 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.502 ' HB3' HD23 ' A' ' 100' ' ' LEU . 33.7 m-80 -90.33 133.82 34.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.895 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.452 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 49.8 mm-40 -129.57 152.11 49.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.56 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 25.4 tp -72.64 120.16 17.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.777 0.322 . . . . 0.0 110.507 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.664 HD13 ' CB ' ' A' ' 99' ' ' LEU . 6.4 tt -56.64 155.71 7.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.454 0.645 . . . . 0.0 111.441 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.401 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.52 153.15 42.51 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.342 179.686 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.8 114.94 10.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.92 0.391 . . . . 0.0 110.132 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.54 23.17 73.64 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.044 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.401 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 23.1 t70 -53.81 171.27 0.1 Allowed 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 120.933 0.397 . . . . 0.0 111.162 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.635 ' HG3' HG22 ' A' ' 144' ' ' VAL . 21.2 tt0 -145.13 135.53 24.16 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.089 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.516 ' CG2' HG22 ' A' ' 109' ' ' THR . 5.8 mt -111.39 127.73 68.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.422 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.677 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.7 m -104.41 140.74 37.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.852 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.697 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 33.9 m -140.24 158.49 25.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.14 28.38 31.07 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.192 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.433 ' HA ' HG12 ' A' ' 140' ' ' ILE . 70.6 t -72.63 140.42 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-O 121.598 0.713 . . . . 0.0 111.982 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.649 ' O ' HD12 ' B' ' 172' ' ' ILE . . . 142.39 -39.82 1.33 Allowed Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -178.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.625 HG22 HG13 ' B' ' 172' ' ' ILE . 2.8 t -120.67 124.31 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -50.31 -35.0 25.6 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.6 p -93.77 6.7 47.51 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -178.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.421 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.6 OUTLIER -121.09 28.72 7.71 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -178.632 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.677 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.5 mt -107.27 138.11 34.92 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-O 121.544 0.688 . . . . 0.0 111.261 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.506 HD11 ' OE1' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -125.43 134.66 52.03 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.265 179.67 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.565 ' C ' HD22 ' A' ' 143' ' ' LEU . 38.5 t -111.3 148.44 32.91 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.739 0.781 . . . . 0.0 112.431 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.713 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.6 mm? -136.45 136.7 39.71 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.704 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.635 HG22 ' HG3' ' A' ' 129' ' ' GLU . 21.1 t -110.88 137.44 43.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.82 0.343 . . . . 0.0 111.073 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.516 HD12 HD21 ' A' ' 101' ' ' LEU . 4.9 mt -106.52 121.62 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.29 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.818 ' CE1' HD12 ' A' ' 37' ' ' ILE . 5.8 m-85 -105.37 115.3 30.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.485 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.606 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.1 mp -96.94 122.62 48.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.481 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -78.59 137.95 38.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.939 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.07 -18.69 60.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.366 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.52 -46.04 89.98 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.972 0.415 . . . . 0.0 110.814 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -59.97 -44.2 94.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.02 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt -65.33 -34.91 79.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.989 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.99 -47.01 86.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.056 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.808 ' SG ' HD13 ' A' ' 52' ' ' ILE . 8.8 t -67.56 -43.26 81.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.906 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.88 -35.95 71.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.86 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.14 -41.78 97.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.756 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.59 -36.17 33.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.825 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.532 ' HA ' HD21 ' A' ' 56' ' ' LEU . 2.4 p-10 42.45 36.42 0.77 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.524 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.03 135.43 52.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.81 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.9 p -97.82 132.1 43.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.103 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -162.47 31.12 0.11 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.983 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.87 155.46 23.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.864 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.8 pt -100.96 117.8 46.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.105 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.222 -0.895 . . . . 0.0 110.976 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.853 0.358 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -150.3 143.02 16.12 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.755 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -74.65 -168.47 0.5 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.542 2.161 . . . . 0.0 112.303 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -169.73 105.82 0.35 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.996 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 169' ' ' TPO . . . . . 0.707 HG23 HG21 ' A' ' 106' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.738 HD11 ' HB2' ' A' ' 82' ' ' SER . 0.0 OUTLIER -154.01 -178.36 7.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.333 -179.776 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 171' ' ' GLU . . . . . 0.517 ' O ' ' O ' ' B' ' 172' ' ' ILE . 51.6 mt-10 -140.49 73.04 1.41 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.818 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 0.649 HD12 ' O ' ' A' ' 135' ' ' GLY . 13.4 tt 49.88 156.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.038 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 173' ' ' TYR . . . . . 0.461 ' N ' HG12 ' B' ' 172' ' ' ILE . 3.1 p90 -105.45 141.18 37.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.833 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.169 -0.919 . . . . 0.0 110.987 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.836 0.35 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.405 HG23 ' N ' ' A' ' 16' ' ' GLN . 9.5 t -165.44 -44.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.405 ' N ' HG23 ' A' ' 15' ' ' THR . 58.9 tt0 -60.84 -41.49 95.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.935 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -40.28 88.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.894 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -56.92 -42.29 79.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.487 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.7 tp -59.02 -31.86 69.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.186 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.525 HG23 ' HE2' ' A' ' 23' ' ' PHE . 8.7 mt -69.84 -48.05 66.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.545 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.75 -33.81 76.48 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.22 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -58.01 -46.92 84.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.312 -0.403 . . . . 0.0 112.01 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.546 ' CD1' ' N ' ' A' ' 24' ' ' SER . 4.3 p90 -71.83 -47.42 53.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.012 0.434 . . . . 0.0 111.031 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.546 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 0.7 OUTLIER -60.76 -37.65 82.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.925 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -134.87 82.12 1.94 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.884 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.53 136.33 40.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.791 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -68.61 102.22 1.44 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.968 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.1 mm -83.47 138.31 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 CA-C-O 121.675 0.75 . . . . 0.0 111.632 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.52 41.77 5.34 Favored Glycine 0 C--N 1.313 -0.697 0 CA-C-N 114.509 -1.223 . . . . 0.0 112.309 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -89.0 -30.14 18.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.568 0.223 . . . . 0.0 111.327 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER 176.77 38.99 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.722 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -73.78 134.26 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.55 0 CA-C-N 113.735 -1.575 . . . . 0.0 112.509 -177.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.034 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -93.55 -61.68 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.286 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.669 ' SG ' HD12 ' A' ' 48' ' ' LEU . 3.7 p -145.44 141.49 28.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.599 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.407 ' HD3' ' CG2' ' A' ' 45' ' ' ILE . 24.1 ttm180 -114.01 129.73 56.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.146 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.597 HG21 ' HE2' ' A' ' 68' ' ' PHE . 20.9 t -91.69 122.74 43.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.005 0.431 . . . . 0.0 111.099 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.812 HG23 HG12 ' A' ' 45' ' ' ILE . 21.8 mt -126.6 111.95 27.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.18 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 43.4 t -79.82 137.58 36.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.757 0.313 . . . . 0.0 110.499 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.2 t -116.36 -10.68 11.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.762 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.755 HG21 ' OG ' ' A' ' 142' ' ' SER . 5.0 p -96.38 -3.07 44.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.686 0.279 . . . . 0.0 111.262 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.48 93.11 0.25 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.042 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.569 ' HG3' ' N ' ' A' ' 43' ' ' ILE . 2.5 pt20 -171.51 -40.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.093 0.473 . . . . 0.0 111.464 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.663 HD12 HD21 ' A' ' 143' ' ' LEU . 65.0 mt -124.4 140.32 34.92 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.649 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.565 ' HD2' HG23 ' A' ' 43' ' ' ILE . 94.8 Cg_endo -80.31 144.37 16.24 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.576 2.184 . . . . 0.0 111.643 179.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.812 HG12 HG23 ' A' ' 37' ' ' ILE . 32.2 mt -58.59 123.87 11.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.944 0.402 . . . . 0.0 111.831 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.48 ' HB2' ' CZ ' ' A' ' 76' ' ' TYR . 2.3 ttt-85 -122.42 164.13 18.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.985 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.93 119.84 35.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.095 0.474 . . . . 0.0 111.949 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.669 HD12 ' SG ' ' A' ' 34' ' ' CYS . 3.1 mt -96.55 137.46 35.6 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . 1.034 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.25 158.5 43.89 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -178.612 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.489 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -139.62 141.83 37.09 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.448 -1.705 . . . . 0.0 110.671 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.845 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -79.99 125.94 30.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.127 0.489 . . . . 0.0 111.606 -179.416 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.796 HD13 ' SG ' ' A' ' 154' ' ' CYS . 41.3 mt -64.49 -45.12 96.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.547 -0.752 . . . . 0.0 112.184 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.1 -39.82 79.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.363 0.602 . . . . 0.0 110.572 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.496 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 9.2 mm-40 -68.58 -36.89 79.35 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.674 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 51' ' ' ASP . 46.7 t -70.37 -41.58 78.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.983 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.04 -35.27 71.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.6 mmtt -73.65 -47.33 40.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.962 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.89 112.91 12.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.905 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.0 ptpt -103.7 28.82 6.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.866 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -101.07 -178.19 3.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.895 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.789 ' O ' HG22 ' A' ' 62' ' ' ILE . 9.3 t -70.84 139.47 50.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.911 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.945 HD11 ' HB2' ' A' ' 92' ' ' LEU . 7.8 tp 56.45 155.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.703 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.773 ' HG2' HG13 ' A' ' 55' ' ' VAL . 1.2 mptt -120.67 -64.19 1.27 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.154 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.433 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.0 ttpt -147.54 134.04 19.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.273 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.589 HG13 ' C ' ' A' ' 91' ' ' ILE . 14.8 t -129.49 139.22 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-O 121.343 0.592 . . . . 0.0 112.082 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.544 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.3 m-90 -100.93 139.64 36.33 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.125 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . 1.038 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -113.38 126.84 55.81 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 176.934 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.68 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.5 OUTLIER -114.52 145.55 41.78 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.294 -178.517 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.702 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 165.88 -177.56 40.96 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.792 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.47 ' HG3' HD11 ' A' ' 78' ' ' LEU . 5.3 mtm105 -76.26 -2.0 29.29 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.408 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.6 t-20 -84.72 133.67 43.45 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.58 0.229 . . . . 0.0 110.91 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.0 Cg_exo -68.89 -7.52 20.95 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.607 2.205 . . . . 0.0 111.786 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.68 -43.16 17.22 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 121.916 0.865 . . . . 0.0 108.806 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.44 138.26 1.84 Allowed 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 113.764 -1.562 . . . . 0.0 110.652 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -56.16 -19.34 13.11 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.695 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.493 ' CD2' ' CE2' ' A' ' 68' ' ' PHE . 1.5 t80 -130.12 130.38 44.73 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.745 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -104.42 117.48 34.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.937 0.398 . . . . 0.0 110.933 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.48 ' HB3' HD13 ' A' ' 43' ' ' ILE . 2.7 pp -114.87 -178.03 3.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.887 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.75 144.02 48.49 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.528 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -76.8 91.67 3.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.791 0.329 . . . . 0.0 111.245 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.518 HD12 HD11 ' A' ' 84' ' ' LEU . 30.1 mt -112.09 139.99 33.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.084 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.771 ' HB3' HD21 ' B' ' 170' ' ' LEU . 0.4 OUTLIER -65.05 -36.41 84.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.12 -179.87 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.511 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -69.03 -15.69 63.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.799 -179.609 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.684 HD22 ' CD2' ' A' ' 88' ' ' HIS . 51.1 mt -103.38 152.42 21.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.701 0.286 . . . . 0.0 111.174 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.8 m -99.13 167.48 10.67 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.268 -0.423 . . . . 0.0 112.007 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.702 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.1 m-20 -43.72 -53.28 5.96 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.301 0.572 . . . . 0.0 109.658 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.546 ' HB3' HG22 ' A' ' 67' ' ' THR . 17.7 mtmt -118.3 83.76 2.06 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.684 ' CD2' HD22 ' A' ' 84' ' ' LEU . 60.5 t-80 -60.17 -46.03 91.08 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.698 -176.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.51 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 27.5 p90 -147.82 164.01 34.97 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.019 -0.672 . . . . 0.0 112.202 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 1.038 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.56 137.12 41.7 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.276 -178.867 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.68 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 63.8 mt -116.04 127.17 73.72 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.55 178.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.945 ' HB2' HD11 ' A' ' 62' ' ' ILE . 0.8 OUTLIER -111.42 140.64 45.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.089 0.471 . . . . 0.0 111.469 -179.649 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.621 HD23 ' HG ' ' A' ' 99' ' ' LEU . 2.5 tm? -114.05 123.48 49.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.539 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.443 ' N ' HD22 ' A' ' 93' ' ' LEU . . . -178.37 -128.03 1.13 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.289 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 51.36 30.12 5.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.774 0.321 . . . . 0.0 111.05 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 43.5 t0 69.17 28.85 4.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.072 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 129.67 -43.48 1.3 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.744 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -57.75 158.91 5.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.801 0.334 . . . . 0.0 111.142 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.621 ' HG ' HD23 ' A' ' 93' ' ' LEU . 0.8 OUTLIER -109.54 152.56 25.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.831 179.952 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.628 HD23 ' HB3' ' A' ' 121' ' ' ASN . 2.2 mp -133.05 147.17 52.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.4 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.581 HD22 ' C ' ' A' ' 100' ' ' LEU . 3.0 mm? -112.77 123.95 51.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.273 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.456 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 58.1 t30 -118.5 115.79 25.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.895 0.379 . . . . 0.0 111.777 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.801 ' OD2' HG23 ' A' ' 116' ' ' VAL . 10.9 p30 -79.67 141.93 36.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.956 178.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.494 HG12 ' HA ' ' A' ' 89' ' ' PHE . 12.9 pt -144.69 24.22 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.767 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.529 ' HB2' ' CG ' ' A' ' 88' ' ' HIS . 10.3 t -91.4 154.44 19.18 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.54 0.686 . . . . 0.0 112.528 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.479 ' CB ' HG21 ' B' ' 169' ' ' TPO . 8.5 m -70.13 -52.02 26.86 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.553 178.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.64 -0.56 21.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.395 -0.821 . . . . 0.0 112.258 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.04 155.15 31.78 Favored Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.702 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.553 HG22 ' CG2' ' A' ' 130' ' ' ILE . 3.7 m -117.36 137.63 52.33 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.835 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -115.31 148.59 39.05 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -177.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.458 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.13 113.45 18.37 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.646 -1.161 . . . . 0.0 108.466 177.589 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.7 m120 44.77 43.28 6.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.315 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.02 -6.3 79.65 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.525 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -104.16 118.59 37.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.995 0.426 . . . . 0.0 110.562 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.835 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.7 tptm -72.83 111.25 7.79 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.279 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.801 HG23 ' OD2' ' A' ' 103' ' ' ASP . 15.7 m -86.09 161.82 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.847 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 120' ' ' SER . 64.0 mt-10 -69.84 129.64 40.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.504 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.683 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 22.0 tttt -54.9 161.16 1.69 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.902 0.382 . . . . 0.0 110.343 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 34.93 34.6 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.322 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.42 145.2 40.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.277 179.452 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.628 ' HB3' HD23 ' A' ' 100' ' ' LEU . 33.0 m-80 -87.94 131.92 34.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.848 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.447 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 37.7 mm-40 -129.57 148.99 51.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.63 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.0 tp -72.61 126.37 29.71 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.569 ' C ' HD22 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -56.71 157.76 5.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.846 0.832 . . . . 0.0 112.185 -178.957 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.27 152.91 44.01 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.094 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -71.81 117.13 13.01 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.83 26.87 67.61 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.858 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -50.83 170.7 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.953 0.406 . . . . 0.0 111.325 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.428 ' CG ' ' O ' ' A' ' 143' ' ' LEU . 18.1 tt0 -145.09 135.39 24.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.71 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.553 ' CG2' HG22 ' A' ' 109' ' ' THR . 14.5 mt -113.07 126.35 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.474 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.59 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.0 m -104.23 140.11 38.3 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.684 HG23 HD21 ' A' ' 84' ' ' LEU . 33.9 m -140.05 158.52 26.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -178.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.26 25.08 32.14 Favored Glycine 0 N--CA 1.439 -1.106 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.276 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.475 ' HA ' HG12 ' A' ' 140' ' ' ILE . 77.6 t -71.21 140.38 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-O 121.522 0.677 . . . . 0.0 111.893 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 139.83 -40.98 1.35 Allowed Glycine 0 N--CA 1.435 -1.384 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -178.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.964 HG22 HD13 ' B' ' 172' ' ' ILE . 2.5 t -116.28 123.55 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.32 -36.09 30.49 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.8 p -93.55 6.69 47.4 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.442 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.7 OUTLIER -121.77 30.5 6.65 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -178.409 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.59 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.1 mt -107.3 138.27 34.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.913 177.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.497 HD13 ' HA ' ' A' ' 141' ' ' LEU . 0.8 OUTLIER -125.25 134.95 52.12 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.101 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.755 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.4 OUTLIER -106.09 133.14 51.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.066 0.46 . . . . 0.0 111.727 -179.675 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.663 HD21 HD12 ' A' ' 43' ' ' ILE . 42.7 mt -127.53 140.85 51.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.665 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 23.0 t -116.06 132.58 65.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.878 0.37 . . . . 0.0 111.451 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 30.4 mt -106.26 139.02 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.949 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.48 132.69 56.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.847 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.545 ' CD1' HD23 ' A' ' 124' ' ' LEU . 3.1 mt -93.41 134.1 32.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.462 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.56 110.8 17.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.693 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -59.27 -29.5 67.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.268 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.9 tttm -59.58 -45.41 91.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.919 0.39 . . . . 0.0 110.743 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -59.4 -44.1 92.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.949 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 13.7 tttp -65.03 -36.61 84.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.035 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -65.29 -47.1 77.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.02 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.796 ' SG ' HD13 ' A' ' 52' ' ' ILE . 9.2 t -65.97 -45.98 79.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.031 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.94 -43.48 91.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.883 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.57 -40.84 96.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.782 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.17 -27.09 63.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.99 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -122.96 102.4 7.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.944 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 17.4 pttt -89.31 161.97 16.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.919 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.4 m -78.19 133.65 29.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.158 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 59.69 94.8 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.953 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.13 -38.4 3.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 11.0 mt -76.94 117.65 22.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.065 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.27 -0.872 . . . . 0.0 110.942 179.947 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 2.5 t30 . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.8 0.333 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.73 166.5 31.86 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.899 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.25 -175.56 0.68 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.537 2.158 . . . . 0.0 112.254 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -172.44 138.76 0.94 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.162 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 169' ' ' TPO . . . . . 0.493 HG23 ' N ' ' B' ' 170' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.771 HD21 ' HB3' ' A' ' 82' ' ' SER . 1.9 pp -161.36 -178.15 6.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.058 0.456 . . . . 0.0 111.684 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -142.89 160.45 40.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.343 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 0.964 HD13 HG22 ' A' ' 136' ' ' VAL . 3.2 tp -51.32 142.0 4.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.892 0.377 . . . . 0.0 111.094 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 173' ' ' TYR . . . . . 0.618 ' H ' HD12 ' B' ' 172' ' ' ILE . 4.8 p90 -98.41 133.68 42.46 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.95 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 3.9 m . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.232 -0.889 . . . . 0.0 111.011 179.954 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.723 0.297 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.45 -50.86 2.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.982 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.9 -44.15 64.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.872 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.07 -36.0 74.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.966 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -58.23 -48.13 81.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.946 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 mp -58.85 -41.73 87.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.826 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.587 HG23 ' HE2' ' A' ' 23' ' ' PHE . 33.6 mm -66.52 -47.98 81.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.025 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -60.85 -33.67 73.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.364 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -56.4 -47.19 79.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.339 -0.391 . . . . 0.0 112.033 -178.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.587 ' HE2' HG23 ' A' ' 20' ' ' ILE . 5.7 p90 -71.89 -47.29 53.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.972 0.415 . . . . 0.0 110.964 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.56 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 0.4 OUTLIER -59.63 -46.96 87.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.843 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -73.82 81.38 1.61 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.869 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -90.16 143.82 26.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -83.67 123.44 29.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.1 mm -82.1 138.27 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-O 121.684 0.754 . . . . 0.0 111.859 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -143.48 56.71 0.55 Allowed Glycine 0 C--N 1.315 -0.631 0 CA-C-N 114.467 -1.242 . . . . 0.0 112.389 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -68.85 -39.77 79.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.788 0.328 . . . . 0.0 111.088 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.429 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER 176.0 39.41 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.725 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.3 mm -72.78 134.09 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-N 113.577 -1.647 . . . . 0.0 112.554 -177.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.056 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -92.62 -60.84 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.954 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.633 ' SG ' HD12 ' A' ' 48' ' ' LEU . 1.8 p -145.6 149.5 34.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.22 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.96 138.2 50.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.857 0.36 . . . . 0.0 111.406 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.566 ' CG2' HD11 ' A' ' 48' ' ' LEU . 24.1 t -101.54 122.77 54.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.872 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.613 HG23 HG12 ' A' ' 45' ' ' ILE . 18.4 mt -129.33 121.37 53.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.41 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.679 ' HA ' HD13 ' A' ' 143' ' ' LEU . 34.3 t -85.1 118.07 24.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.376 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.93 -29.26 27.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.74 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.558 HG21 ' H ' ' A' ' 142' ' ' SER . 30.2 p -79.93 -2.22 42.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.652 0.263 . . . . 0.0 111.447 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.83 77.74 0.26 Allowed Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.965 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -144.09 -45.44 0.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.851 0.358 . . . . 0.0 110.834 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.634 HG12 HD23 ' A' ' 78' ' ' LEU . 3.0 mp -114.38 140.91 25.71 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.065 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.552 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.3 Cg_endo -73.41 136.55 24.15 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.239 1.96 . . . . 0.0 112.075 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.613 HG12 HG23 ' A' ' 37' ' ' ILE . 33.9 mt -54.41 129.76 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.736 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -122.99 164.28 18.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.284 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.89 119.76 37.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.985 0.421 . . . . 0.0 111.958 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.633 HD12 ' SG ' ' A' ' 34' ' ' CYS . 1.3 mt -96.65 134.48 39.84 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . 1.056 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -147.82 158.93 44.28 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -178.426 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.483 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -139.66 141.65 37.01 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 113.337 -1.756 . . . . 0.0 110.185 178.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.754 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -81.67 134.15 35.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.35 0.595 . . . . 0.0 111.428 -179.327 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.688 HD13 ' SG ' ' A' ' 154' ' ' CYS . 54.8 mt -64.22 -42.69 96.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.186 -0.916 . . . . 0.0 112.246 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.9 t -56.96 -41.96 79.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.051 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.546 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -68.64 -38.62 80.65 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.676 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 51' ' ' ASP . 41.0 t -67.04 -43.19 89.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.902 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.472 HD12 HG22 ' A' ' 52' ' ' ILE . 30.9 mt -71.12 -31.61 67.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.5 tpmp? -81.02 -48.25 12.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.085 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -72.17 106.75 4.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.874 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -93.03 87.35 5.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.916 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -158.55 178.44 10.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.4 p -73.36 -56.48 5.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.934 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.763 HD11 ' CG2' ' A' ' 65' ' ' VAL . 9.2 tp -86.56 148.54 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.122 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.733 ' HD3' HG13 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -124.72 -62.96 1.21 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.912 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.406 ' CE ' ' O ' ' A' ' 49' ' ' SER . 6.7 ttpt -149.82 129.64 13.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.999 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.763 ' CG2' HD11 ' A' ' 62' ' ' ILE . 6.6 t -122.7 138.4 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 121.292 0.568 . . . . 0.0 112.102 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.616 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 15.7 m-90 -100.8 140.12 35.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.548 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.727 HG23 ' CG ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -110.12 128.67 55.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.839 177.526 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.707 ' CD1' ' HB2' ' A' ' 76' ' ' TYR . 9.8 m-85 -120.59 145.46 47.34 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.501 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.629 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.24 -166.58 36.49 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.064 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.462 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 12.0 mtp-105 -84.42 5.36 27.54 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.431 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 19.4 t-20 -84.99 133.74 42.59 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.622 0.249 . . . . 0.0 110.74 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 18.0 Cg_exo -65.33 -14.96 47.73 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.493 2.129 . . . . 0.0 111.559 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.68 -45.84 13.98 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.971 0.891 . . . . 0.0 108.846 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.3 139.89 1.32 Allowed 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.794 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.9 OUTLIER -56.45 -19.19 14.01 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.087 179.049 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.707 ' HB2' ' CD1' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -130.1 127.97 40.92 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.554 179.421 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -100.99 107.91 19.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.871 0.367 . . . . 0.0 110.828 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.895 HD13 HD13 ' A' ' 84' ' ' LEU . 39.8 mt -71.5 -176.33 1.53 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.921 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -92.72 42.18 2.69 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.613 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.462 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 1.0 OUTLIER 42.83 61.0 2.25 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.891 0.377 . . . . 0.0 111.66 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.722 HD13 HD12 ' A' ' 84' ' ' LEU . 5.4 mp -96.61 126.23 49.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.788 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.748 ' CB ' HD21 ' B' ' 170' ' ' LEU . 1.5 m -54.77 -38.15 66.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.338 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.434 ' H ' HG22 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -65.86 -22.37 66.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.159 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.895 HD13 HD13 ' A' ' 78' ' ' LEU . 25.0 mt -102.56 152.28 21.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.082 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.414 ' HA ' ' O3P' ' B' ' 169' ' ' TPO . 23.5 p -98.11 166.17 11.55 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.629 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.3 m-20 -43.41 -53.4 5.41 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.438 0.637 . . . . 0.0 109.853 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.588 ' HB2' HD12 ' A' ' 104' ' ' ILE . 16.1 mttt -118.16 82.65 1.87 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 177.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.708 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 62.8 t-80 -62.93 -43.83 97.72 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.157 -0.929 . . . . 0.0 113.158 -176.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.49 ' CD1' ' HB2' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -151.24 161.63 42.37 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.05 -0.66 . . . . 0.0 112.37 -179.57 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.727 ' CG ' HG23 ' A' ' 67' ' ' THR . 7.8 mt-30 -135.2 151.81 50.98 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.415 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.525 ' C ' HG13 ' A' ' 65' ' ' VAL . 12.1 mt -124.12 127.49 73.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.206 178.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.768 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -111.31 149.33 31.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.013 0.435 . . . . 0.0 111.671 -179.307 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.537 HD13 ' HG ' ' A' ' 99' ' ' LEU . 24.4 tp -125.08 122.79 38.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.164 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.53 -171.92 41.1 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.792 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.6 -36.43 82.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.799 0.333 . . . . 0.0 110.966 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.86 152.45 43.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.792 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.598 ' HA2' HD22 ' A' ' 155' ' ' LEU . . . -56.77 -21.11 35.2 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.646 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -65.3 176.53 1.34 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.919 0.39 . . . . 0.0 110.881 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 1.012 HD11 HG12 ' A' ' 33' ' ' VAL . 0.5 OUTLIER -135.01 160.13 39.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.92 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.638 HD13 ' O ' ' A' ' 122' ' ' GLN . 2.6 mm? -123.88 147.07 47.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.546 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.612 HD11 ' HA ' ' A' ' 124' ' ' LEU . 2.3 mt -113.39 122.39 47.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.013 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.768 ' HB2' HD11 ' A' ' 92' ' ' LEU . 58.8 t30 -116.98 124.71 50.04 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.811 ' OD2' HG23 ' A' ' 116' ' ' VAL . 10.9 p30 -88.16 140.24 29.69 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.588 HD12 ' HB2' ' A' ' 87' ' ' LYS . 9.5 pt -143.62 24.03 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 -179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.565 ' HB2' ' CG ' ' A' ' 88' ' ' HIS . 10.5 t -91.13 154.45 19.34 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.709 0.766 . . . . 0.0 113.011 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.474 HG21 ' CG2' ' B' ' 169' ' ' TPO . 17.5 m -70.18 -52.08 26.14 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.469 -1.242 . . . . 0.0 110.495 178.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -77.92 0.67 23.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.322 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.32 155.69 31.83 Favored Glycine 0 N--CA 1.438 -1.207 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.724 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 4.0 m -117.46 137.78 52.29 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.82 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -116.58 148.54 40.81 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -177.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.735 HD12 HG11 ' A' ' 116' ' ' VAL . 0.6 OUTLIER -124.32 113.54 18.37 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.812 177.421 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 47.31 36.21 4.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.071 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.07 -3.82 80.8 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.482 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.73 118.59 37.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.046 0.423 . . . . 0.0 110.805 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.82 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.4 tptm -72.74 120.98 19.12 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.069 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.811 HG23 ' OD2' ' A' ' 103' ' ' ASP . 9.1 m -98.24 163.81 2.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.394 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 120' ' ' SER . 44.1 tt0 -69.93 128.96 38.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.555 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.676 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 14.4 tttm -54.28 163.36 0.85 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.83 0.348 . . . . 0.0 110.183 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.6 OUTLIER 35.94 33.89 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.854 -179.251 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.5 OUTLIER -112.23 145.14 40.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.057 179.491 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.56 ' OD1' HD13 ' A' ' 92' ' ' LEU . 1.4 m-80 -87.93 132.62 34.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.877 0.37 . . . . 0.0 111.111 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.638 ' O ' HD13 ' A' ' 100' ' ' LEU . 30.1 mm-40 -129.12 145.32 51.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.45 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 26.4 tp -72.71 126.07 29.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.325 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.614 HD23 HG12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -58.52 158.96 6.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.852 0.834 . . . . 0.0 112.316 -179.011 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.769 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.3 OUTLIER -125.04 153.41 42.9 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.759 179.214 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.546 ' HA ' HD13 ' A' ' 147' ' ' ILE . 1.2 mm-40 -70.93 115.49 10.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.96 0.41 . . . . 0.0 109.921 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.25 28.18 68.77 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.552 -178.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.584 ' OD2' HD23 ' A' ' 111' ' ' LEU . 12.1 t70 -54.5 172.0 0.11 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.128 0.489 . . . . 0.0 111.421 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 2.4 tt0 -145.2 135.33 23.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.675 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.759 HG13 HD11 ' A' ' 145' ' ' ILE . 4.1 mt -112.75 129.22 68.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.378 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.583 HG22 ' CG2' ' A' ' 140' ' ' ILE . 5.5 m -102.98 139.81 38.07 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.708 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.8 m -140.28 158.73 25.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -177.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.04 30.01 29.79 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.209 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.443 ' HB ' ' CH2' ' A' ' 110' ' ' TRP . 77.6 t -74.19 140.34 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-O 121.551 0.691 . . . . 0.0 112.013 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.574 ' O ' HD12 ' B' ' 172' ' ' ILE . . . 144.9 -38.09 1.29 Allowed Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -178.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.589 HG22 HG13 ' B' ' 172' ' ' ILE . 2.7 t -121.33 128.39 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -50.56 -40.83 53.24 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.5 p -93.49 6.5 47.99 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.477 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 22.0 m-20 -117.7 30.13 7.45 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.583 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.3 mt -107.05 138.79 31.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.905 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.797 HD23 ' N ' ' A' ' 142' ' ' SER . 3.7 tt -124.67 134.62 52.82 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.448 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.797 ' N ' HD23 ' A' ' 141' ' ' LEU . 47.2 t -108.68 150.23 27.85 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.71 0.766 . . . . 0.0 112.576 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.679 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.1 mm? -136.1 151.03 49.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.472 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 40.5 t -125.18 133.45 69.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.803 0.335 . . . . 0.0 110.908 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.759 HD11 HG13 ' A' ' 130' ' ' ILE . 0.9 OUTLIER -105.62 124.59 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.438 -178.85 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -105.97 114.91 29.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.755 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.769 HD11 ' O ' ' A' ' 125' ' ' SER . 3.4 mp -85.05 133.31 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.571 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -82.34 118.78 23.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.916 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -69.94 -32.9 71.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.021 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.42 -45.55 91.23 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.959 0.409 . . . . 0.0 110.704 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -58.7 -44.16 90.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.931 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -63.46 -33.93 76.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.84 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.33 -43.85 97.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.027 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.688 ' SG ' HD13 ' A' ' 52' ' ' ILE . 10.0 t -66.52 -46.01 77.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.055 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.598 HD22 ' HA2' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -63.77 -37.25 86.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.007 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -60.69 -36.04 77.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.79 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -92.05 -30.99 15.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.928 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.8 p30 42.61 34.45 0.56 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.532 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.38 159.56 20.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.875 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 12.3 p -83.55 136.33 23.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.105 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -86.75 134.12 33.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.933 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -89.43 156.67 18.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 16.8 tt -91.07 129.36 41.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.025 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.904 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.807 0.337 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.97 166.43 12.45 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.897 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.2 139.46 42.19 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.529 2.153 . . . . 0.0 112.208 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -92.35 58.2 3.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 169' ' ' TPO . . . . . 0.633 ' O3P' HG22 ' B' ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.748 HD21 ' CB ' ' A' ' 82' ' ' SER . 0.5 OUTLIER -157.45 -176.37 5.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.052 0.453 . . . . 0.0 111.412 -179.669 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 171' ' ' GLU . . . . . 0.543 ' O ' HG22 ' B' ' 172' ' ' ILE . 51.1 mt-10 -156.51 79.28 0.95 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.603 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 0.589 HG13 HG22 ' A' ' 136' ' ' VAL . 15.8 tt 50.15 156.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 121.228 0.537 . . . . 0.0 112.048 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 173' ' ' TYR . . . . . 0.428 ' N ' HG12 ' B' ' 172' ' ' ILE . 4.5 p90 -112.69 87.89 2.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.946 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 4.8 p . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.893 179.975 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.8 0.334 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.98 -38.64 3.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.058 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -72.06 -41.96 66.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.94 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.48 -45.52 92.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.867 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -58.94 -35.02 72.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.996 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.04 -39.96 94.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.962 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.532 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 10.1 mm -70.38 -35.25 61.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.187 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -57.29 -37.6 72.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.952 0.406 . . . . 0.0 110.43 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -67.35 -23.68 65.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.79 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.532 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.57 -47.64 79.08 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.257 -179.72 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.3 m -66.08 -34.77 78.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.823 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -132.43 69.56 1.48 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.732 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -75.66 146.72 40.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.009 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -79.19 142.11 36.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.816 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.2 mm -81.83 138.12 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-O 121.7 0.762 . . . . 0.0 111.769 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 173.75 106.59 0.19 Allowed Glycine 0 C--N 1.313 -0.709 0 CA-C-N 114.419 -1.264 . . . . 0.0 112.437 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -86.63 -30.0 22.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.88 0.371 . . . . 0.0 111.008 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.1 m-20 179.09 38.19 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.679 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.6 mm -74.93 136.05 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.558 0 CA-C-N 113.697 -1.592 . . . . 0.0 112.525 -177.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.016 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.0 t -91.92 -60.31 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 114.75 -1.113 . . . . 0.0 109.969 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.1 p -145.28 157.88 43.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.368 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.66 138.35 53.99 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.843 0.354 . . . . 0.0 111.474 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.788 HG11 ' CE2' ' A' ' 68' ' ' PHE . 1.1 m -108.06 122.66 62.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.724 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.807 HG23 HG12 ' A' ' 45' ' ' ILE . 19.2 mt -128.33 121.66 56.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.694 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.718 ' HA ' HD23 ' A' ' 143' ' ' LEU . 42.4 t -79.85 111.52 16.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.747 0.308 . . . . 0.0 110.257 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.5 t -78.81 -24.33 44.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.423 . . . . 0.0 112.088 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.522 HG23 ' HB3' ' A' ' 142' ' ' SER . 66.1 p -79.94 -2.14 42.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.73 0.3 . . . . 0.0 111.489 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.51 76.54 0.25 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.812 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -146.08 -43.96 0.2 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.887 0.375 . . . . 0.0 110.715 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.588 HG23 ' HD2' ' A' ' 44' ' ' PRO . 2.4 mp -117.54 142.1 29.93 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.062 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.588 ' HD2' HG23 ' A' ' 43' ' ' ILE . 48.2 Cg_endo -71.24 145.93 49.98 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.167 1.911 . . . . 0.0 112.27 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.807 HG12 HG23 ' A' ' 37' ' ' ILE . 42.5 mt -57.91 149.71 4.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.746 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.97 164.04 28.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.993 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.65 119.82 30.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.086 0.47 . . . . 0.0 111.948 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.731 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.3 mp -94.54 124.23 38.44 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . 1.016 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -134.58 157.79 45.66 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -178.809 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.49 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -147.99 142.63 26.59 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.653 -1.612 . . . . 0.0 110.737 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.516 ' HB2' ' HG3' ' A' ' 54' ' ' GLN . 1.2 m-20 -74.85 126.82 31.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.199 0.524 . . . . 0.0 111.003 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.584 HD13 ' SG ' ' A' ' 154' ' ' CYS . 63.8 mt -64.11 -38.75 83.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.98 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 m -56.62 -40.44 75.37 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.885 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.516 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -68.49 -43.82 76.08 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.574 179.822 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.827 HG13 ' HD3' ' A' ' 63' ' ' LYS . 46.3 t -63.62 -37.93 80.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.38 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.63 -42.03 74.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.348 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? -74.49 -38.2 62.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.306 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -82.94 125.15 31.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.945 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.16 84.33 1.91 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.871 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.6 mtp85 -151.27 -177.29 5.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.822 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 78.3 p -98.16 30.42 3.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.794 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.882 HD11 ' CG2' ' A' ' 65' ' ' VAL . 8.9 tp -171.25 140.12 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.999 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.827 ' HD3' HG13 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -132.61 -53.22 0.94 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.416 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.5 ttpt -151.59 131.42 13.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.125 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.882 ' CG2' HD11 ' A' ' 62' ' ' ILE . 11.5 t -123.92 139.12 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 121.273 0.559 . . . . 0.0 111.951 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.731 ' CD2' HD23 ' A' ' 48' ' ' LEU . 16.4 m-90 -102.01 139.6 37.42 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.067 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.611 HG23 ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -108.8 132.27 54.16 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.425 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.788 ' CE2' HG11 ' A' ' 36' ' ' VAL . 2.7 m-85 -115.22 145.85 42.02 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.566 -178.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.786 ' HA2' HD12 ' A' ' 78' ' ' LEU . . . 161.91 -177.67 38.05 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.709 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.6 mtm180 -80.46 1.09 30.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.609 0.242 . . . . 0.0 111.373 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.46 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.9 t-20 -84.86 135.79 39.62 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.677 0.275 . . . . 0.0 110.872 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.1 Cg_exo -68.74 -6.96 19.22 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.672 2.248 . . . . 0.0 111.91 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.03 -45.09 14.47 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-O 122.093 0.949 . . . . 0.0 108.859 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -45.8 136.51 6.16 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 113.674 -1.603 . . . . 0.0 110.75 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.62 -19.02 14.04 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.0 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.61 ' HE1' HD23 ' A' ' 78' ' ' LEU . 33.3 t80 -129.76 118.7 22.25 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.678 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -93.87 107.9 19.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.865 0.364 . . . . 0.0 110.911 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.786 HD12 ' HA2' ' A' ' 69' ' ' GLY . 22.4 mt -73.19 -70.19 0.38 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.712 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 174.36 -86.72 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.235 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.7 p30 179.81 55.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.947 0.403 . . . . 0.0 110.866 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 1.109 HD13 HD12 ' A' ' 84' ' ' LEU . 4.1 mp -87.4 120.42 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.136 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.706 ' HB3' HD11 ' B' ' 170' ' ' LEU . 18.0 m -55.08 -41.49 71.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.919 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.604 ' CZ ' HD12 ' B' ' 170' ' ' LEU . 0.0 OUTLIER -64.34 -22.43 66.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.228 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.109 HD12 HD13 ' A' ' 81' ' ' ILE . 49.5 mt -98.73 152.29 19.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.847 0.356 . . . . 0.0 111.118 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.7 p -95.76 165.84 12.1 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.649 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.717 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -42.76 -52.81 4.84 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.384 0.611 . . . . 0.0 109.686 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.484 ' HB3' HD11 ' A' ' 104' ' ' ILE . 19.1 mttt -119.3 84.92 2.28 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 177.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.548 ' NE2' ' HB ' ' A' ' 132' ' ' VAL . 14.7 t60 -64.19 -45.83 86.62 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.995 -1.002 . . . . 0.0 113.244 -176.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.499 ' HA ' HG12 ' A' ' 104' ' ' ILE . 36.7 p90 -153.72 162.39 41.28 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.068 -0.653 . . . . 0.0 112.27 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.611 ' HG2' HG23 ' A' ' 67' ' ' THR . 9.8 mt-30 -135.64 154.88 51.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.779 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.521 ' O ' HG13 ' A' ' 65' ' ' VAL . 59.5 mt -123.54 132.35 71.53 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.269 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.536 HD11 HD13 ' A' ' 100' ' ' LEU . 0.6 OUTLIER -117.3 149.91 39.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.032 0.444 . . . . 0.0 111.866 -179.243 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.68 HD22 ' CG1' ' A' ' 33' ' ' VAL . 18.9 tp -125.21 122.93 38.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.355 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.83 -152.27 20.23 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.633 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.91 173.2 10.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.824 0.345 . . . . 0.0 110.924 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 59.8 -167.5 0.17 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.835 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -95.57 27.85 14.31 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.51 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -98.58 160.32 14.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.838 0.351 . . . . 0.0 110.967 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.501 HD23 ' O ' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -134.47 155.2 50.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.796 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.859 HD22 ' HB3' ' A' ' 121' ' ' ASN . 6.5 mt -133.12 141.0 47.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.533 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.82 128.21 56.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.13 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.416 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 50.2 t30 -116.6 115.63 26.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.887 0.375 . . . . 0.0 111.972 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.808 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.5 p30 -78.29 143.19 37.22 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.855 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.565 HG21 ' OE1' ' A' ' 90' ' ' GLN . 9.7 pt -149.67 35.86 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.591 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.05 150.98 21.45 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.651 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.546 HG21 ' CG2' ' B' ' 169' ' ' TPO . 3.2 m -68.71 -31.66 70.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.457 177.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -93.11 -19.57 21.37 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.172 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.591 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 110.73 158.12 15.7 Favored Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.738 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.501 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.7 m -117.18 137.65 52.2 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.865 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -115.83 148.35 40.01 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -178.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.555 HD13 ' OD2' ' A' ' 128' ' ' ASP . 0.2 OUTLIER -124.22 113.4 18.24 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.535 177.603 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.404 ' N ' HD12 ' A' ' 111' ' ' LEU . 71.6 m-20 43.61 43.62 4.83 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.16 -11.39 67.56 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.789 -0.719 . . . . 0.0 113.449 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -103.85 118.58 37.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.997 0.427 . . . . 0.0 110.625 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.865 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 2.8 tptp -74.04 121.39 21.0 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.41 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.808 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.8 m -91.54 163.44 2.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.958 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.5 OUTLIER -69.84 128.07 35.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.448 179.694 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.703 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 18.2 tttt -54.87 161.78 1.48 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.976 0.417 . . . . 0.0 110.631 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.6 OUTLIER 35.65 33.42 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.045 -179.263 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.47 145.16 40.69 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.234 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.859 ' HB3' HD22 ' A' ' 100' ' ' LEU . 2.1 m-80 -89.32 128.78 35.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.763 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.708 ' O ' HD23 ' A' ' 100' ' ' LEU . 40.1 mm-40 -129.25 148.67 51.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.513 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.5 tp -72.71 111.91 8.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.885 0.374 . . . . 0.0 110.364 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.423 ' HG ' ' N ' ' A' ' 125' ' ' SER . 66.3 tp -53.68 158.88 1.75 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.247 0.546 . . . . 0.0 111.509 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.45 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.8 OUTLIER -124.01 153.25 41.58 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.331 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.434 ' HA ' HD12 ' A' ' 147' ' ' ILE . 12.2 tp60 -71.68 122.53 20.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.03 0.443 . . . . 0.0 110.79 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.18 21.9 48.2 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.429 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.555 ' OD2' HD13 ' A' ' 111' ' ' LEU . 5.3 t70 -59.87 -177.96 0.07 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 120.571 0.224 . . . . 0.0 110.449 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.888 ' CG ' HG22 ' A' ' 144' ' ' VAL . 6.1 mt-10 -145.07 135.55 24.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.743 0.306 . . . . 0.0 111.444 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.822 HG13 HD11 ' A' ' 145' ' ' ILE . 3.3 mt -114.52 126.66 72.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.218 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.574 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.4 m -104.28 140.04 38.43 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.041 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.548 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 26.4 m -140.33 158.37 25.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.131 0.491 . . . . 0.0 112.23 -178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.67 24.32 33.44 Favored Glycine 0 N--CA 1.439 -1.139 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.081 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.445 ' HB ' ' CZ3' ' A' ' 110' ' ' TRP . 77.9 t -70.93 140.32 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-O 121.544 0.688 . . . . 0.0 111.994 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.71 -38.13 1.08 Allowed Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 1.014 HG22 HD13 ' B' ' 172' ' ' ILE . 3.3 t -121.27 129.26 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.45 -40.65 51.18 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.55 6.69 47.39 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -178.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.458 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.7 OUTLIER -119.62 32.4 6.09 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -178.514 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.574 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.0 mt -107.25 138.65 32.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.411 0.624 . . . . 0.0 111.064 178.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.4 tt -124.88 134.61 52.63 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.718 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.522 ' HB3' HG23 ' A' ' 40' ' ' THR . 47.0 t -109.67 150.17 28.66 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.571 0.7 . . . . 0.0 112.25 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.718 HD23 ' HA ' ' A' ' 38' ' ' CYS . 69.7 mt -135.95 152.78 51.33 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.976 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.888 HG22 ' CG ' ' A' ' 129' ' ' GLU . 21.6 t -121.31 132.78 69.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.115 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.822 HD11 HG13 ' A' ' 130' ' ' ILE . 1.0 OUTLIER -105.74 121.73 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-O 120.881 0.372 . . . . 0.0 111.205 -179.345 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.99 115.01 29.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.95 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.434 HD12 ' HA ' ' A' ' 126' ' ' GLN . 6.5 mt -85.02 134.06 27.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.445 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -78.83 105.09 9.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.669 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.29 -35.24 73.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.08 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.97 -44.66 91.56 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.986 0.422 . . . . 0.0 110.669 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -58.77 -44.03 90.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.898 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.431 ' HE3' HG22 ' A' ' 147' ' ' ILE . 0.1 OUTLIER -61.55 -42.24 98.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.031 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -36.96 78.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.017 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.584 ' SG ' HD13 ' A' ' 52' ' ' ILE . 8.7 t -68.17 -42.14 80.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.197 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -66.49 -49.58 66.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.303 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -56.28 -35.67 67.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.276 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? -88.8 -37.13 15.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.052 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.4 p30 44.81 -173.41 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.549 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -117.11 128.32 55.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.913 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 10.3 m -87.46 130.61 36.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.096 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.58 62.01 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.931 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 60.48 96.74 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.871 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.3 pt -79.37 111.61 16.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.114 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.958 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.731 0.3 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -64.94 115.7 23.22 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.891 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.63 143.85 58.11 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.395 2.063 . . . . 0.0 112.389 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -173.19 115.84 0.27 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.753 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 169' ' ' TPO . . . . . 0.728 ' C ' HD23 ' B' ' 170' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.728 HD23 ' C ' ' B' ' 169' ' ' TPO . 0.1 OUTLIER -163.44 174.6 11.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.07 -179.619 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 171' ' ' GLU . . . . . 0.416 ' O ' ' O ' ' B' ' 172' ' ' ILE . 5.4 mt-10 -142.66 78.13 1.6 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.858 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 1.014 HD13 HG22 ' A' ' 136' ' ' VAL . 3.2 tp 43.01 102.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.9 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 173' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -55.68 -177.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.013 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 26.9 t . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.188 -0.91 . . . . 0.0 110.901 179.982 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.847 0.356 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 81.8 p -144.87 -61.58 0.36 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.837 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -67.32 -34.71 77.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.927 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.51 -35.99 81.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.83 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -57.98 -42.77 85.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.828 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.57 -31.98 71.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.67 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.447 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.5 mt -72.98 -35.43 48.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.939 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -57.5 -41.47 80.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.939 0.399 . . . . 0.0 110.498 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.17 -23.76 65.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.667 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.65 -47.53 79.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.217 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.8 p -79.32 -36.7 39.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.831 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 64.73 -79.18 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.978 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -77.18 145.78 37.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.941 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.61 122.95 26.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.836 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.9 mm -83.04 138.2 19.72 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 CA-C-O 121.678 0.751 . . . . 0.0 111.832 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.33 62.4 4.06 Favored Glycine 0 C--N 1.314 -0.641 0 CA-C-N 114.47 -1.241 . . . . 0.0 112.446 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.37 -42.19 95.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.749 0.309 . . . . 0.0 111.029 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.408 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.8 OUTLIER 177.42 38.91 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.682 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.7 mm -72.56 137.08 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 113.652 -1.613 . . . . 0.0 112.492 -177.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.002 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.3 t -91.6 -58.78 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.777 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.414 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 3.0 p -147.76 165.33 30.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.404 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -127.12 138.27 53.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.913 0.387 . . . . 0.0 111.43 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.455 HG13 ' O ' ' A' ' 36' ' ' VAL . 12.1 p -106.94 122.62 61.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.783 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.769 HG23 HG12 ' A' ' 45' ' ' ILE . 20.8 mt -127.53 127.92 69.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.618 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.47 ' HA ' HD13 ' A' ' 143' ' ' LEU . 35.2 t -88.5 114.23 24.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.76 0.314 . . . . 0.0 110.487 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.97 -23.68 33.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.701 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.502 HG21 ' H ' ' A' ' 142' ' ' SER . 58.3 p -79.96 -2.43 43.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.69 0.281 . . . . 0.0 111.465 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.6 69.86 1.21 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.185 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -141.01 -42.28 0.39 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.9 0.381 . . . . 0.0 110.974 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.543 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.7 mt -118.89 140.85 29.16 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.752 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.543 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.2 Cg_endo -73.39 146.02 39.15 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.139 1.893 . . . . 0.0 112.28 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.769 HG12 HG23 ' A' ' 37' ' ' ILE . 41.3 mt -57.31 148.38 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.08 0.467 . . . . 0.0 111.686 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -134.25 164.09 28.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.167 179.464 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -120.69 119.56 33.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.047 0.451 . . . . 0.0 111.63 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.797 HD23 ' CD2' ' A' ' 66' ' ' TRP . 6.8 mp -95.72 123.33 39.24 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . 1.002 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -135.15 156.96 48.11 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 122.163 0.983 . . . . 0.0 113.407 -179.541 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.478 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -153.62 141.92 20.56 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 113.662 -1.608 . . . . 0.0 111.132 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.692 ' O ' HG23 ' A' ' 55' ' ' VAL . 2.4 m-20 -76.89 127.83 33.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.124 0.487 . . . . 0.0 111.104 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.488 HD13 ' SG ' ' A' ' 154' ' ' CYS . 55.1 mt -64.45 -43.11 96.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.093 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 71.8 m -58.28 -40.4 81.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.315 0.578 . . . . 0.0 110.808 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.44 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 4.4 mm-40 -68.43 -37.16 80.01 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.769 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.873 HG13 ' HG3' ' A' ' 63' ' ' LYS . 48.2 t -73.22 -44.29 55.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.036 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.5 mp -70.48 -31.48 68.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.922 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -77.13 -45.78 25.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.908 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -79.08 122.37 26.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.918 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -104.1 31.31 4.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.867 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.5 mmm180 -80.04 -179.05 6.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.92 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.73 -39.35 84.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.977 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.427 HD13 HD12 ' A' ' 92' ' ' LEU . 9.6 tp -140.52 155.08 22.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.054 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.873 ' HG3' HG13 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -108.47 -66.55 1.04 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.111 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.457 ' HE2' ' O ' ' A' ' 49' ' ' SER . 3.6 ttpt -138.09 136.0 36.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.412 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.655 HG12 ' HG2' ' A' ' 90' ' ' GLN . 19.3 t -132.13 139.2 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.274 0.559 . . . . 0.0 111.741 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.797 ' CD2' HD23 ' A' ' 48' ' ' LEU . 19.7 m-90 -102.42 139.37 38.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.309 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.644 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -114.18 131.1 56.57 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.779 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.686 ' HZ ' HD21 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -117.13 145.49 43.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.963 -179.125 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.616 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.99 -166.41 36.9 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.759 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -90.99 36.87 0.92 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.684 0.278 . . . . 0.0 111.41 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.464 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 3.9 t-20 -119.94 135.44 24.29 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.093 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 20.2 Cg_exo -64.63 -15.54 50.56 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.491 2.127 . . . . 0.0 111.5 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.72 -45.45 14.42 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 121.95 0.881 . . . . 0.0 109.089 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.36 139.54 2.65 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 113.885 -1.507 . . . . 0.0 110.845 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 67' ' ' THR . 9.3 m-20 -56.22 -18.57 10.71 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.844 178.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.537 ' CE2' HG21 ' A' ' 43' ' ' ILE . 2.8 t80 -129.18 116.71 19.6 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.737 0.303 . . . . 0.0 111.007 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -88.58 107.94 19.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.779 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.639 HD23 HD13 ' A' ' 84' ' ' LEU . 6.9 mp -77.91 -176.33 4.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.059 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.63 11.85 68.88 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.633 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 64.76 75.63 0.36 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.956 0.408 . . . . 0.0 111.473 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.933 ' HB ' HD12 ' A' ' 84' ' ' LEU . 3.7 mp -111.51 141.42 26.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.654 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.453 ' HB3' HD11 ' B' ' 170' ' ' LEU . 0.5 OUTLIER -54.95 -41.73 71.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.047 -179.724 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.526 ' H ' HG22 ' A' ' 81' ' ' ILE . 9.9 mmp_? -61.02 -49.07 78.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.261 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.933 HD12 ' HB ' ' A' ' 81' ' ' ILE . 1.4 mt -76.39 151.79 36.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.099 0.476 . . . . 0.0 111.664 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.3 p -100.89 167.55 10.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.401 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.616 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -44.56 -53.0 7.53 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.436 0.636 . . . . 0.0 109.816 179.123 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.654 ' HB2' HD12 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -121.83 82.8 2.0 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 177.456 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.586 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 9.2 t60 -62.73 -46.12 89.58 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.094 -0.957 . . . . 0.0 113.036 -176.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.504 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 20.4 p90 -147.98 160.1 43.18 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.592 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.655 ' HG2' HG12 ' A' ' 65' ' ' VAL . 17.8 tt0 -136.19 141.28 44.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.485 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.607 ' O ' HG13 ' A' ' 65' ' ' VAL . 44.1 mt -116.12 127.43 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.892 179.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.431 ' CA ' HG13 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -110.99 144.64 39.77 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.069 0.461 . . . . 0.0 111.888 -179.383 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.768 HD22 HG11 ' A' ' 33' ' ' VAL . 16.1 tp -125.28 129.3 49.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.485 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.83 -153.31 24.71 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.755 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 63.12 -80.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.735 0.303 . . . . 0.0 111.077 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -117.31 -164.74 1.01 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.757 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -86.48 51.68 4.39 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.522 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -153.49 -170.48 3.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.901 0.381 . . . . 0.0 110.693 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.92 ' HB2' HD13 ' A' ' 124' ' ' LEU . 1.7 mt -119.65 160.16 23.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.004 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.601 HD12 ' O ' ' A' ' 99' ' ' LEU . 3.2 mp -131.49 145.22 51.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.872 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.448 HD21 ' HB2' ' A' ' 122' ' ' GLN . 0.6 OUTLIER -112.71 124.27 52.19 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.36 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.414 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 51.5 t30 -115.74 115.58 26.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.905 0.383 . . . . 0.0 111.386 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.76 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.1 p30 -79.11 138.76 38.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.167 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.654 HD12 ' HB2' ' A' ' 87' ' ' LYS . 12.3 pt -146.96 39.35 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.728 -0.214 . . . . 0.0 111.574 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.574 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -96.13 158.51 15.41 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 121.055 0.455 . . . . 0.0 111.709 -179.06 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.646 HG22 ' HG3' ' B' ' 171' ' ' GLU . 86.4 m -69.07 -37.83 78.72 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.862 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.61 -19.91 17.3 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.553 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 123.8 158.35 10.1 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.074 -1.06 . . . . 0.0 113.799 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.8 m -117.78 137.99 52.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.924 -0.638 . . . . 0.0 109.731 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.891 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -114.58 148.42 38.05 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -178.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.472 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.2 113.54 18.44 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.384 177.393 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.417 ' N ' HD12 ' A' ' 111' ' ' LEU . 87.3 m-20 44.0 43.99 5.77 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.39 -11.05 66.87 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.711 -0.756 . . . . 0.0 113.486 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -103.4 118.58 37.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.01 0.433 . . . . 0.0 110.544 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.891 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 3.8 tptm -74.37 113.86 12.08 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.473 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.76 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.5 m -84.5 162.64 2.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.876 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.416 ' O ' ' CB ' ' A' ' 120' ' ' SER . 13.2 tp10 -69.85 131.14 44.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.464 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.674 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 32.3 tttm -53.1 162.97 0.58 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 34.07 39.1 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.099 0.476 . . . . 0.0 111.83 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 25.0 p -111.54 145.07 39.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.734 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.574 ' HB3' HD23 ' A' ' 100' ' ' LEU . 71.9 m-20 -94.64 123.82 38.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.71 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.448 ' HB2' HD21 ' A' ' 101' ' ' LEU . 24.7 mm-40 -127.96 148.45 50.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.558 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.8 tp -72.68 136.25 45.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.486 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.92 HD13 ' HB2' ' A' ' 99' ' ' LEU . 1.5 pt? -61.81 160.48 11.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.847 0.832 . . . . 0.0 112.088 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.406 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.0 OUTLIER -125.66 153.17 44.22 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.912 178.929 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.56 117.55 13.26 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.36 27.27 65.3 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.917 -0.659 . . . . 0.0 111.789 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.406 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 25.0 t0 -51.24 169.38 0.05 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.05 0.452 . . . . 0.0 111.404 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 12.8 tt0 -143.77 135.34 26.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.457 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.513 ' CG2' HG22 ' A' ' 109' ' ' THR . 11.6 mt -114.44 128.1 71.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.863 0.363 . . . . 0.0 111.019 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.56 HG23 ' CG2' ' A' ' 140' ' ' ILE . 26.9 m -104.46 142.24 34.95 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.715 HG21 HD21 ' A' ' 84' ' ' LEU . 19.9 m -140.42 158.41 24.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -178.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.34 46.53 26.12 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.419 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.482 ' HA ' HG12 ' A' ' 140' ' ' ILE . 58.5 t -85.27 140.72 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-O 121.997 0.903 . . . . 0.0 112.983 -178.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.27 -46.64 0.78 Allowed Glycine 0 N--CA 1.434 -1.494 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.652 HG11 ' CB ' ' A' ' 139' ' ' ASP . 4.6 p -104.03 118.0 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 CA-C-N 113.902 -1.149 . . . . 0.0 109.388 177.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.478 ' HA ' HD12 ' A' ' 140' ' ' ILE . 1.2 pt-20 -57.53 -24.24 54.9 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.787 0.327 . . . . 0.0 111.3 -179.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.536 ' H ' HG22 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -92.92 -25.91 17.83 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -177.925 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.652 ' CB ' HG11 ' A' ' 136' ' ' VAL . 0.5 OUTLIER -105.53 25.43 10.75 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -177.642 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.56 ' CG2' HG23 ' A' ' 131' ' ' THR . 5.8 mt -88.8 139.81 16.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.064 177.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.777 HD23 ' N ' ' A' ' 142' ' ' SER . 3.0 tt -120.02 134.8 55.14 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.993 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.777 ' N ' HD23 ' A' ' 141' ' ' LEU . 43.4 t -115.65 150.26 37.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.521 0.677 . . . . 0.0 112.277 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.502 ' CD2' HD22 ' A' ' 141' ' ' LEU . 2.0 mm? -135.79 153.35 51.55 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.39 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 39.6 t -123.26 138.5 53.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.798 0.332 . . . . 0.0 110.695 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.5 HD11 HD11 ' A' ' 91' ' ' ILE . 1.3 mm -106.24 125.89 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-O 120.965 0.412 . . . . 0.0 111.064 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.33 111.72 23.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.68 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.759 HG12 HD12 ' A' ' 124' ' ' LEU . 3.6 mp -90.6 128.23 42.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.353 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -75.95 126.13 30.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.825 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -70.31 -30.86 67.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.994 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -60.05 -46.0 90.98 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.693 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -58.56 -44.12 89.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.954 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -65.08 -34.49 78.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.893 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -58.95 -47.0 86.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.047 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.488 ' SG ' HD13 ' A' ' 52' ' ' ILE . 10.9 t -65.86 -46.05 79.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.976 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.26 -35.97 80.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.835 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.97 -40.62 89.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.818 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.417 ' O ' ' N ' ' A' ' 159' ' ' LYS . 0.9 OUTLIER -86.78 -31.04 21.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.9 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 43.4 -91.01 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.638 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 157' ' ' GLN . 0.1 OUTLIER -107.65 152.44 24.3 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.827 0.346 . . . . 0.0 110.879 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.533 ' O ' HG13 ' A' ' 160' ' ' VAL . 13.3 p -100.65 117.26 45.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.126 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -61.59 -45.51 93.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.769 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.51 168.33 22.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.894 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.652 HD13 ' H ' ' A' ' 163' ' ' ILE . 0.2 OUTLIER -105.19 140.01 24.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.157 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.302 -0.856 . . . . 0.0 111.068 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.875 0.369 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -133.01 88.54 36.61 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.015 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -51.52 144.56 32.09 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.551 2.167 . . . . 0.0 112.25 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -177.75 79.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.873 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 169' ' ' TPO . . . . . 0.431 ' C ' HD23 ' B' ' 170' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.453 HD11 ' HB3' ' A' ' 82' ' ' SER . 0.1 OUTLIER -164.74 -179.44 5.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.814 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 171' ' ' GLU . . . . . 0.646 ' HG3' HG22 ' A' ' 106' ' ' THR . 0.0 OUTLIER -132.56 43.77 2.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.88 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 0.631 HG22 ' O ' ' B' ' 171' ' ' GLU . 8.5 tp 50.06 161.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.999 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 173' ' ' TYR . . . . . 0.404 ' N ' HG13 ' B' ' 172' ' ' ILE . 12.5 m-85 -47.76 96.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.144 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.922 -179.892 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.885 0.374 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.431 ' HB ' ' HB2' ' A' ' 18' ' ' PHE . 8.6 p -121.51 34.47 5.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.759 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -60.05 -47.21 86.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.828 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -71.24 -35.85 71.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.962 0.41 . . . . 0.0 110.541 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.431 ' HB2' ' HB ' ' A' ' 15' ' ' THR . 6.0 m-85 -58.05 -44.19 87.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.859 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 mp -60.99 -43.02 99.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.725 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.658 HG23 ' HE2' ' A' ' 23' ' ' PHE . 47.7 mm -64.57 -48.14 86.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.812 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -33.74 71.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.433 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.15 -47.14 87.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.985 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.658 ' HE2' HG23 ' A' ' 20' ' ' ILE . 3.5 p90 -71.76 -47.59 52.6 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.132 0.491 . . . . 0.0 111.031 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.533 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 0.9 OUTLIER -59.68 -44.79 93.48 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.987 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -104.03 102.46 12.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.855 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.35 141.11 41.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.819 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.12 115.66 27.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.4 mm -81.98 138.29 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 CA-C-O 121.683 0.754 . . . . 0.0 111.67 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.32 109.15 0.46 Allowed Glycine 0 C--N 1.314 -0.672 0 CA-C-N 114.475 -1.239 . . . . 0.0 112.55 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.02 -28.54 20.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.741 0.305 . . . . 0.0 111.091 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.441 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.2 m-20 176.65 39.41 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.717 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.1 mm -71.99 135.28 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 113.538 -1.664 . . . . 0.0 112.634 -177.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.01 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.3 t -91.38 -59.55 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.633 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.692 ' SG ' HD12 ' A' ' 48' ' ' LEU . 3.4 p -148.94 150.48 32.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.992 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.429 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -114.67 138.02 51.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.826 0.346 . . . . 0.0 111.639 -179.129 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.584 HG11 ' CE2' ' A' ' 68' ' ' PHE . 3.6 m -102.83 122.63 55.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.572 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.827 HG23 HG12 ' A' ' 45' ' ' ILE . 20.9 mt -127.54 124.9 64.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.605 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.696 ' HA ' HD13 ' A' ' 143' ' ' LEU . 51.9 t -83.17 121.16 26.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.531 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.66 -24.55 21.59 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.515 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.514 HG21 ' H ' ' A' ' 142' ' ' SER . 43.8 p -79.95 -2.06 42.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.461 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.6 75.97 0.31 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.787 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -147.2 -43.83 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.795 0.331 . . . . 0.0 110.886 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.812 HD13 HD22 ' A' ' 78' ' ' LEU . 3.0 mt -116.35 140.98 27.21 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.756 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.544 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.4 Cg_endo -72.93 145.49 40.31 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.138 1.892 . . . . 0.0 112.202 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.827 HG12 HG23 ' A' ' 37' ' ' ILE . 35.8 mt -56.03 141.51 12.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.669 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.461 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -127.25 164.05 22.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.17 179.551 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.429 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.7 OUTLIER -121.7 119.66 32.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.069 0.461 . . . . 0.0 111.68 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.692 HD12 ' SG ' ' A' ' 34' ' ' CYS . 3.1 mt -98.66 133.0 43.62 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . 1.01 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.98 157.97 43.87 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -178.584 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.485 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -142.12 147.79 37.28 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 113.577 -1.647 . . . . 0.0 110.748 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.664 ' O ' HG23 ' A' ' 55' ' ' VAL . 1.6 m-20 -74.96 136.26 41.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.167 0.508 . . . . 0.0 111.33 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.713 HD13 ' SG ' ' A' ' 154' ' ' CYS . 93.1 mt -64.32 -44.41 97.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.086 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.4 p -56.72 -38.15 71.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.191 0.519 . . . . 0.0 110.506 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.454 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 4.4 mm-40 -68.55 -36.86 79.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.421 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 51' ' ' ASP . 48.9 t -69.62 -45.22 78.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.097 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.0 mt -66.08 -42.09 89.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -67.28 -31.91 72.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.31 116.37 5.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.863 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.83 83.13 3.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.886 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 58.04 70.56 0.64 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.995 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.93 176.32 5.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.897 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.465 HD12 ' O ' ' A' ' 93' ' ' LEU . 9.8 tp -79.79 148.57 5.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.052 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.643 ' HE3' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -129.71 -38.79 1.48 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.723 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.433 ' CE ' ' O ' ' A' ' 49' ' ' SER . 1.9 ttpt -155.23 139.89 17.02 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.605 HG13 ' O ' ' A' ' 91' ' ' ILE . 21.3 t -136.05 139.33 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.581 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.521 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 18.2 m-90 -102.56 139.3 38.33 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.453 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.687 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.17 130.25 56.61 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 177.282 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.584 ' CE2' HG11 ' A' ' 36' ' ' VAL . 1.1 m-85 -117.97 145.25 44.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.926 0.394 . . . . 0.0 111.642 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.579 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.9 -170.22 39.87 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.751 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.435 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 20.6 mtm180 -82.01 1.42 35.75 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.448 HD22 ' HB3' ' A' ' 73' ' ' ALA . 2.0 t30 -84.87 135.0 40.52 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.685 0.278 . . . . 0.0 111.319 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -66.43 -12.53 36.09 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.635 2.223 . . . . 0.0 111.742 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.448 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.64 -43.94 16.35 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-O 121.965 0.888 . . . . 0.0 108.738 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.82 140.44 1.35 Allowed 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 113.707 -1.588 . . . . 0.0 110.635 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' A' ' 67' ' ' THR . 23.3 m-20 -56.14 -18.93 11.35 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.172 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.487 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 7.0 t80 -129.66 130.28 45.36 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-O 120.882 0.373 . . . . 0.0 111.017 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -105.99 113.97 27.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.784 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.812 HD22 HD13 ' A' ' 43' ' ' ILE . 1.4 mt -93.71 -67.02 0.88 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.875 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 179.15 -90.84 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.164 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.401 ' HA ' ' HD2' ' A' ' 70' ' ' ARG . 1.6 p-10 175.97 54.25 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.839 0.352 . . . . 0.0 111.01 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.745 ' HB ' HD13 ' A' ' 84' ' ' LEU . 29.5 mm -83.32 134.76 26.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.872 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.713 ' HB3' HD21 ' B' ' 170' ' ' LEU . 0.9 OUTLIER -64.53 -32.66 74.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.411 -179.645 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.549 ' H ' HG22 ' A' ' 81' ' ' ILE . 2.2 mpt_? -68.38 -23.77 64.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.502 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.745 HD13 ' HB ' ' A' ' 81' ' ' ILE . 5.7 mp -103.38 153.38 20.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.932 0.396 . . . . 0.0 111.114 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.4 m -95.94 168.58 10.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.034 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.579 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -43.45 -54.46 4.78 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.38 0.61 . . . . 0.0 109.698 179.176 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.573 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.1 OUTLIER -119.7 84.22 2.17 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 177.247 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.671 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 60.1 t-80 -57.95 -45.39 86.7 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.705 -176.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.457 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 32.1 p90 -148.24 159.4 44.01 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.079 -0.648 . . . . 0.0 111.922 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.687 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.1 tt0 -135.79 139.95 43.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.376 -178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.605 ' O ' HG13 ' A' ' 65' ' ' VAL . 44.0 mt -114.94 128.15 72.2 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.772 179.077 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.768 HD21 ' OD1' ' A' ' 121' ' ' ASN . 1.1 pt? -114.11 143.08 45.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.059 0.457 . . . . 0.0 111.61 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.87 HD22 HG11 ' A' ' 33' ' ' VAL . 28.5 tp -125.04 122.9 38.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.295 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.4 ' HA3' ' HD3' ' A' ' 63' ' ' LYS . . . 133.95 102.14 0.75 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.439 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -159.33 -45.74 0.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.819 0.342 . . . . 0.0 111.007 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -165.18 -43.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.978 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 174.2 43.03 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.475 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 39.3 p30 -165.92 -176.76 3.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.825 0.345 . . . . 0.0 110.983 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.787 ' HG ' HD13 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -106.99 159.79 16.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.839 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.724 HD23 ' OD1' ' A' ' 121' ' ' ASN . 1.8 mp -131.35 147.33 52.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.447 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.801 HD11 ' HA ' ' A' ' 124' ' ' LEU . 2.7 mp -112.86 124.92 53.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.304 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.446 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 61.4 t30 -120.57 115.76 24.04 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.794 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.3 p30 -78.13 138.93 38.97 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.523 HD12 ' CB ' ' A' ' 87' ' ' LYS . 7.2 pt -140.02 22.09 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.621 ' HB2' ' CG ' ' A' ' 88' ' ' HIS . 11.0 t -91.79 153.46 19.57 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 121.487 0.66 . . . . 0.0 112.641 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.1 m -69.99 -52.12 26.88 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.399 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -72.83 -5.07 35.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.139 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.53 156.04 30.88 Favored Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.73 -0.747 . . . . 0.0 113.459 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.501 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 5.6 m -117.33 137.74 52.23 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.846 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -113.39 148.44 35.8 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -177.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.428 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.25 113.42 18.25 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.252 177.382 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 44.51 43.22 6.2 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.98 -6.85 80.0 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.528 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -103.98 118.5 36.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.982 0.42 . . . . 0.0 110.578 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.846 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 20.9 tptt -74.54 118.32 17.36 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.343 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.794 HG23 ' OD2' ' A' ' 103' ' ' ASP . 7.0 m -95.88 159.45 2.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.864 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.677 ' O ' ' HB3' ' A' ' 120' ' ' SER . 5.5 mm-40 -69.97 133.97 47.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.109 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.686 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 27.1 tttt -55.48 165.78 0.75 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.131 0.491 . . . . 0.0 110.83 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.46 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.6 OUTLIER 36.46 34.43 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.687 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.677 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 1.4 t -112.21 145.12 40.45 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.76 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.768 ' OD1' HD21 ' A' ' 92' ' ' LEU . 11.4 m-80 -86.7 136.1 33.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.93 0.395 . . . . 0.0 111.086 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.501 ' O ' HD12 ' A' ' 101' ' ' LEU . 3.8 mm100 -128.68 144.2 51.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.204 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.621 HD23 ' O ' ' A' ' 124' ' ' LEU . 3.2 tt -72.67 131.41 42.37 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.221 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.913 HD21 HG12 ' A' ' 147' ' ' ILE . 54.0 tp -58.5 151.8 19.5 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.73 0.776 . . . . 0.0 111.751 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.429 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -125.37 152.83 44.26 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.587 179.57 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -72.11 117.93 14.35 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.73 25.78 66.04 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.839 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.429 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 30.9 t70 -51.1 167.85 0.07 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.946 0.403 . . . . 0.0 111.505 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.8 tt0 -145.21 135.4 23.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.902 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.545 HD11 HD23 ' A' ' 101' ' ' LEU . 15.3 mt -117.68 128.33 74.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.626 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.567 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.9 m -104.11 140.07 38.3 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.671 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 33.7 m -140.13 158.39 25.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.43 ' HA2' ' HB3' ' A' ' 83' ' ' ARG . . . 86.84 29.61 23.02 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.994 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.453 ' HB ' ' CZ3' ' A' ' 110' ' ' TRP . 72.2 t -75.8 140.44 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-O 121.602 0.715 . . . . 0.0 111.942 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.717 ' O ' HD12 ' B' ' 172' ' ' ILE . . . 145.25 -38.93 1.21 Allowed Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -178.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.425 HG11 ' OD2' ' A' ' 139' ' ' ASP . 3.3 t -120.2 118.72 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -50.6 -30.9 14.44 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.0 m -93.59 6.82 46.97 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.44 ' HB3' ' HD3' ' A' ' 83' ' ' ARG . 16.3 m-20 -130.33 35.17 4.1 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -178.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.567 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.5 mt -106.79 138.29 33.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-O 121.357 0.599 . . . . 0.0 110.562 177.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.1 134.47 52.47 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.902 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.626 ' C ' HD22 ' A' ' 143' ' ' LEU . 46.6 t -109.37 150.24 28.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.578 0.704 . . . . 0.0 112.051 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.696 HD13 ' HA ' ' A' ' 38' ' ' CYS . 3.2 mm? -136.12 147.53 47.81 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.615 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 23.6 t -118.1 140.21 42.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.809 0.337 . . . . 0.0 111.187 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.401 HG21 HD11 ' A' ' 124' ' ' LEU . 17.1 mt -106.26 125.84 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.099 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -111.8 117.64 33.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.563 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.913 HG12 HD21 ' A' ' 124' ' ' LEU . 4.6 mt -84.83 134.05 27.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.34 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.4 ' ND2' ' HB ' ' A' ' 32' ' ' ILE . 10.4 t30 -81.36 109.63 16.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.812 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -61.17 -33.09 72.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.083 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.27 -46.01 91.31 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.987 0.422 . . . . 0.0 110.773 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -60.06 -44.15 94.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.98 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 15.9 tttm -65.01 -39.41 93.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.94 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -61.45 -40.69 95.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.713 ' SG ' HD13 ' A' ' 52' ' ' ILE . 12.1 t -60.94 -46.11 92.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.965 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 155' ' ' LEU . 3.1 mm? -62.76 -46.38 88.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.83 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.98 -37.28 75.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.769 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -69.38 -15.0 63.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.157 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -128.57 178.78 6.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.845 0.355 . . . . 0.0 111.028 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -124.38 141.65 51.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.865 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.4 m -77.29 138.87 19.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.116 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.1 t0 60.78 160.18 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.34 139.33 22.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.834 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.5 pt -98.46 112.09 29.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.12 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.943 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.879 0.371 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -122.97 76.43 49.85 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.949 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.25 176.33 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.618 2.212 . . . . 0.0 112.24 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -124.72 137.58 54.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.796 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 169' ' ' TPO . . . . . 0.471 HG23 ' N ' ' B' ' 170' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.713 HD21 ' HB3' ' A' ' 82' ' ' SER . 0.4 OUTLIER -179.52 -179.23 0.52 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.023 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 171' ' ' GLU . . . . . 0.535 ' O ' HG22 ' B' ' 172' ' ' ILE . 10.3 mt-10 -140.96 72.76 1.4 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.735 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 0.717 HD12 ' O ' ' A' ' 135' ' ' GLY . 18.2 tt 49.88 158.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.151 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 173' ' ' TYR . . . . . 0.421 ' N ' HG12 ' B' ' 172' ' ' ILE . 18.3 m-85 -56.21 90.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.91 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.894 -179.979 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.827 0.346 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.7 m -135.52 -45.97 0.68 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.948 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -59.95 -44.89 94.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.941 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.8 mtm-85 -59.57 -42.46 92.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.905 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -60.19 -38.52 83.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.968 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.71 -42.12 96.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.93 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.529 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 9.6 mm -71.19 -35.07 56.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.22 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -57.17 -35.49 69.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.956 0.408 . . . . 0.0 110.45 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.2 -23.92 65.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.839 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.529 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.59 -47.68 79.04 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.059 0.457 . . . . 0.0 111.227 -179.808 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 m -67.28 -37.47 83.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.844 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 65.01 -78.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.033 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -64.92 139.22 58.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.026 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -69.35 142.19 54.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.884 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.2 mm -81.88 138.36 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 CA-C-O 121.706 0.765 . . . . 0.0 111.688 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.402 ' HA2' HG12 ' A' ' 32' ' ' ILE . . . 156.31 65.81 0.01 OUTLIER Glycine 0 C--N 1.314 -0.644 0 CA-C-N 114.403 -1.271 . . . . 0.0 112.311 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -89.0 -36.34 15.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.721 0.296 . . . . 0.0 111.302 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -176.54 37.97 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.746 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -78.41 134.34 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.57 0 CA-C-N 113.88 -1.509 . . . . 0.0 112.523 -177.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.023 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.7 t -89.15 -62.01 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.301 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.8 p -149.24 153.44 37.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.458 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 24.1 ttm180 -118.11 138.15 52.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.804 0.335 . . . . 0.0 111.592 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.758 HG11 ' CE2' ' A' ' 68' ' ' PHE . 34.4 m -103.48 122.91 56.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.983 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.85 HG23 HG12 ' A' ' 45' ' ' ILE . 21.0 mt -126.8 116.37 44.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.563 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.668 ' SG ' HD12 ' A' ' 43' ' ' ILE . 0.9 OUTLIER -81.02 112.52 18.49 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.115 179.374 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.52 -20.18 40.6 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.527 HG21 ' H ' ' A' ' 142' ' ' SER . 66.5 p -79.71 -2.5 43.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.703 0.287 . . . . 0.0 111.538 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.68 72.18 0.75 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.764 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -142.25 -41.48 0.34 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.902 0.382 . . . . 0.0 110.705 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.668 HD12 ' SG ' ' A' ' 38' ' ' CYS . 3.5 mt -119.49 142.15 32.14 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.06 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.602 ' HD2' HG23 ' A' ' 43' ' ' ILE . 57.7 Cg_endo -73.65 139.92 28.77 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.208 1.938 . . . . 0.0 112.026 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.85 HG12 HG23 ' A' ' 37' ' ' ILE . 34.3 mt -55.62 149.2 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.759 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -144.41 164.0 32.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.033 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -121.75 119.99 33.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.114 0.483 . . . . 0.0 112.049 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.557 HD22 ' CD1' ' A' ' 66' ' ' TRP . 7.3 mt -92.62 137.5 32.31 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . 1.023 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -144.6 158.31 43.83 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -178.961 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.482 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -144.73 145.8 31.87 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.661 -1.609 . . . . 0.0 110.947 178.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.746 ' O ' HG23 ' A' ' 55' ' ' VAL . 4.3 m-20 -75.19 108.22 7.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.061 0.458 . . . . 0.0 111.027 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 38.0 mt -64.53 -42.02 93.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.287 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.9 t -58.21 -41.65 84.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.313 0.577 . . . . 0.0 110.935 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.458 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 24.3 mt-30 -68.44 -36.87 79.65 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.941 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 51' ' ' ASP . 49.6 t -68.63 -38.04 78.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.882 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.98 -42.02 85.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.94 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -69.31 -34.37 74.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -83.75 122.07 28.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.892 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.3 33.11 2.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.937 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.14 -176.92 3.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.63 179.21 4.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.877 HD11 HG21 ' A' ' 65' ' ' VAL . 2.4 tp 35.9 95.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.221 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.735 ' HG2' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -90.26 -72.14 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.016 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.426 ' HE2' ' O ' ' A' ' 49' ' ' SER . 2.7 ttpt -131.24 138.61 49.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.025 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.877 HG21 HD11 ' A' ' 62' ' ' ILE . 22.0 t -134.02 139.62 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 121.384 0.611 . . . . 0.0 112.388 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.591 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 15.6 m-90 -105.09 138.95 40.51 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.948 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.689 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -115.94 125.89 53.16 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.298 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.79 ' CE1' HD12 ' A' ' 91' ' ' ILE . 2.1 m-85 -107.05 145.84 31.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.832 -178.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.669 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.63 179.84 38.94 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.578 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 18.4 mtm180 -78.66 -1.65 35.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.605 0.241 . . . . 0.0 111.382 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.481 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 7.8 t-20 -84.83 136.88 38.45 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 120.756 0.312 . . . . 0.0 111.037 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.1 Cg_exo -69.3 -5.88 16.99 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.879 2.386 . . . . 0.0 111.948 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.89 -45.66 13.94 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-O 122.04 0.924 . . . . 0.0 108.681 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -45.41 137.74 4.67 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 113.639 -1.619 . . . . 0.0 110.533 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.17 -18.89 11.4 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.061 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.662 ' CE1' HG21 ' A' ' 36' ' ' VAL . 50.7 t80 -129.59 125.0 35.19 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.652 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -98.48 112.67 24.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.034 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.642 HD23 ' HE2' ' A' ' 76' ' ' TYR . 19.5 mt -82.14 -69.27 0.63 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 174.93 -91.15 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.28 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.2 p30 -178.85 54.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.828 0.347 . . . . 0.0 111.098 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 30.1 mm -88.91 124.76 41.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.154 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.775 ' HB3' HD13 ' B' ' 170' ' ' LEU . 0.3 OUTLIER -55.69 -42.32 75.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.062 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.727 ' NH1' HD21 ' B' ' 170' ' ' LEU . 0.4 OUTLIER -60.96 -18.73 58.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.43 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.661 HD21 HG23 ' A' ' 132' ' ' VAL . 26.5 mt -104.0 152.14 22.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.763 0.316 . . . . 0.0 111.228 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 p -96.66 170.21 9.35 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.562 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.669 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 6.1 m-20 -43.81 -56.74 3.65 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.276 0.56 . . . . 0.0 109.693 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.446 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -117.85 84.84 2.23 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 177.177 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.658 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 61.7 t-80 -59.34 -46.26 89.12 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.907 -1.042 . . . . 0.0 113.11 -176.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.507 ' CZ ' ' CD2' ' A' ' 68' ' ' PHE . 22.4 p90 -149.3 158.53 44.25 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.919 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.689 ' HG3' HG23 ' A' ' 67' ' ' THR . 25.5 tt0 -136.18 138.55 42.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.834 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.79 HD12 ' CE1' ' A' ' 68' ' ' PHE . 4.4 mt -114.15 129.29 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 C-N-CA 121.122 -0.231 . . . . 0.0 110.649 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.663 ' CB ' HG22 ' A' ' 65' ' ' VAL . 2.2 pp -123.23 144.93 49.07 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 121.058 0.456 . . . . 0.0 111.864 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.644 HD13 ' CG1' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -125.22 122.95 38.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.253 179.198 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -123.93 -168.4 12.94 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.729 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -76.41 110.82 11.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.838 0.352 . . . . 0.0 110.902 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -178.5 -39.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.841 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 123.4 -24.73 6.46 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.471 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -114.02 -178.1 3.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.804 0.335 . . . . 0.0 111.01 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.813 HD21 HG12 ' A' ' 33' ' ' VAL . 1.4 mp -107.95 160.26 15.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.751 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.451 HD12 ' O ' ' A' ' 99' ' ' LEU . 4.1 mp -124.14 142.57 51.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.436 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.738 HD11 ' HA ' ' A' ' 124' ' ' LEU . 0.5 OUTLIER -112.88 123.98 51.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.135 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -118.99 115.67 24.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.963 0.411 . . . . 0.0 111.69 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.788 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.3 p30 -78.95 139.57 38.22 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.488 HG12 ' HA ' ' A' ' 89' ' ' PHE . 11.5 pt -143.16 26.49 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.909 -0.317 . . . . 0.0 111.824 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.554 ' HB2' ' CG ' ' A' ' 88' ' ' HIS . 10.6 t -92.11 155.62 17.93 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 121.534 0.683 . . . . 0.0 112.63 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.786 ' CB ' HG21 ' B' ' 169' ' ' TPO . 42.3 m -69.95 -52.1 27.3 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.583 178.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -77.59 -1.7 32.04 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.292 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.92 156.31 31.99 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.615 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.513 HG22 ' CG2' ' A' ' 130' ' ' ILE . 4.3 m -117.41 137.73 52.29 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.87 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -113.89 148.58 36.51 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -177.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.465 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.06 113.45 18.4 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.594 -1.185 . . . . 0.0 108.442 177.546 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.401 ' N ' HD12 ' A' ' 111' ' ' LEU . 57.1 m-20 44.47 43.37 6.23 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.1 -11.14 65.96 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.508 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -103.15 118.57 37.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.03 0.443 . . . . 0.0 110.508 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.87 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 2.5 tptm -72.6 112.72 8.9 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.373 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.788 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.0 m -84.44 162.69 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.775 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.3 OUTLIER -69.78 128.8 37.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.497 179.745 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.687 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 26.6 tttm -54.83 161.51 1.55 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.934 0.397 . . . . 0.0 110.316 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.503 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 36.24 32.97 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.334 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.5 144.94 41.12 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.771 179.188 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.645 ' OD1' HD21 ' A' ' 92' ' ' LEU . 13.5 m-80 -92.49 132.23 36.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.006 0.431 . . . . 0.0 111.147 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.735 ' O ' HD12 ' A' ' 101' ' ' LEU . 42.9 mm-40 -129.38 150.71 50.63 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.581 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.648 HD23 ' O ' ' A' ' 124' ' ' LEU . 3.1 tt -72.67 135.99 45.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.269 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.811 HD21 HG12 ' A' ' 147' ' ' ILE . 64.6 tp -63.54 154.5 32.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.613 0.72 . . . . 0.0 111.698 -179.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.413 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -124.97 153.06 43.35 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.373 179.606 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.81 122.8 21.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.909 0.385 . . . . 0.0 110.236 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.87 23.41 50.93 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.961 -0.637 . . . . 0.0 112.236 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -51.64 170.38 0.05 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.836 0.351 . . . . 0.0 110.983 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.902 ' CG ' HG22 ' A' ' 144' ' ' VAL . 4.7 mt-10 -145.14 135.61 24.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.184 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.756 HD11 HD11 ' A' ' 145' ' ' ILE . 14.8 mt -113.09 126.32 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.578 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.587 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.3 m -104.59 140.26 38.26 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.661 HG23 HD21 ' A' ' 84' ' ' LEU . 35.4 m -140.36 158.58 25.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.28 28.82 29.44 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.073 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.475 ' HA ' HG12 ' A' ' 140' ' ' ILE . 70.2 t -74.07 140.33 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-O 121.583 0.706 . . . . 0.0 111.945 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.644 ' HA3' HG21 ' B' ' 172' ' ' ILE . . . 140.92 -42.05 1.22 Allowed Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -178.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.938 HG22 HD13 ' B' ' 172' ' ' ILE . 2.2 t -117.32 123.41 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.3 -35.04 25.67 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 84.0 p -93.59 6.62 47.64 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -121.65 28.61 7.58 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.587 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.1 mt -107.36 137.88 36.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.49 0.662 . . . . 0.0 111.348 178.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.474 HD21 ' SG ' ' A' ' 38' ' ' CYS . 9.5 tt -125.37 134.61 52.11 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.079 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.527 ' H ' HG21 ' A' ' 40' ' ' THR . 46.3 t -108.47 150.06 27.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.702 0.763 . . . . 0.0 112.181 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.477 HD12 ' O ' ' A' ' 130' ' ' ILE . 4.0 mp -135.15 150.48 50.17 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.74 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.902 HG22 ' CG ' ' A' ' 129' ' ' GLU . 21.3 t -121.79 134.83 63.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.741 0.305 . . . . 0.0 111.025 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.756 HD11 HD11 ' A' ' 130' ' ' ILE . 16.9 mt -106.35 123.07 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-O 120.89 0.376 . . . . 0.0 111.039 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.73 119.26 38.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.777 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.811 HG12 HD21 ' A' ' 124' ' ' LEU . 2.5 mt -84.98 134.11 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.352 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -79.77 116.34 19.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.765 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -58.39 -31.95 68.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.075 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 17.0 mmmt -60.32 -46.07 91.18 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.773 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -60.69 -44.19 96.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.018 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -65.14 -49.52 69.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.89 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -38.85 79.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.996 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.8 t -60.04 -46.04 90.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.979 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.0 -43.94 73.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.946 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.68 -35.34 74.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.97 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -81.62 -30.75 32.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.897 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -121.89 82.09 1.91 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.948 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.7 tttt -65.78 155.0 37.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.928 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 17.6 m -75.94 124.59 34.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.123 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -129.29 -177.12 4.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.912 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 62.3 mtt85 -98.79 34.32 2.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.872 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 10.2 mt -96.7 111.04 25.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.13 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 48.3 mmm-85 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.915 179.964 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 2.9 m120 . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.766 0.317 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -173.74 134.29 0.61 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.012 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -73.17 140.19 30.57 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.514 2.142 . . . . 0.0 112.207 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -104.18 63.52 0.75 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.03 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 169' ' ' TPO . . . . . 0.786 HG21 ' CB ' ' A' ' 106' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.775 HD13 ' HB3' ' A' ' 82' ' ' SER . 1.6 tt -90.48 151.39 21.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.013 0.435 . . . . 0.0 111.108 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -147.21 139.37 24.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.594 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 0.938 HD13 HG22 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -50.15 128.97 7.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.079 0.466 . . . . 0.0 111.363 -179.746 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 173' ' ' TYR . . . . . 0.882 ' N ' HD12 ' B' ' 172' ' ' ILE . 2.0 p90 -66.59 -178.19 0.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.869 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 2.4 m . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.89 179.887 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.812 0.339 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.8 m -137.84 -54.11 0.65 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.848 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.27 -34.52 76.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.897 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -36.09 79.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.831 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.89 -39.67 94.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.899 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 19' ' ' LEU . 12.3 mt -58.49 -40.34 82.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.808 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.534 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.4 mm -70.14 -34.93 61.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.133 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.26 -33.66 67.84 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.481 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -67.24 -23.92 65.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.866 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.534 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.91 -47.56 80.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.187 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -61.1 -33.61 73.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.358 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -51.5 -47.93 63.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.86 0.362 . . . . 0.0 111.11 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.02 120.96 32.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.721 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -98.82 128.02 44.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.944 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.2 mm -81.94 138.31 19.72 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 CA-C-O 121.6 0.714 . . . . 0.0 111.613 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -139.01 89.9 0.2 Allowed Glycine 0 C--N 1.314 -0.674 0 CA-C-N 114.586 -1.188 . . . . 0.0 112.745 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -83.02 -37.35 24.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.958 0.409 . . . . 0.0 110.553 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.468 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.2 m-20 -179.27 37.17 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.709 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.7 mm -75.57 135.55 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 CA-C-N 113.686 -1.597 . . . . 0.0 112.655 -177.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.037 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -93.19 -60.75 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.062 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.63 ' SG ' HD12 ' A' ' 48' ' ' LEU . 1.9 p -145.44 145.42 31.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.301 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.426 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.92 138.07 50.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.797 0.332 . . . . 0.0 111.485 -179.237 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.662 HG21 ' CE2' ' A' ' 68' ' ' PHE . 44.6 t -107.17 122.75 61.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.95 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.817 HG23 HG12 ' A' ' 45' ' ' ILE . 17.8 mt -124.07 120.27 59.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.591 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.737 ' HA ' HD23 ' A' ' 143' ' ' LEU . 46.8 t -79.88 119.61 22.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.357 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.59 -23.2 22.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.648 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.534 HG21 ' H ' ' A' ' 142' ' ' SER . 63.5 p -79.8 -2.33 42.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.782 0.325 . . . . 0.0 111.459 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.35 73.58 0.52 Allowed Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.814 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -145.92 -37.76 0.25 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.777 0.322 . . . . 0.0 111.117 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.589 HD13 ' HB3' ' A' ' 78' ' ' LEU . 2.6 mt -121.54 140.96 32.52 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.928 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.547 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.2 Cg_endo -73.22 140.36 30.68 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.191 1.927 . . . . 0.0 112.087 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.817 HG12 HG23 ' A' ' 37' ' ' ILE . 34.6 mt -56.62 134.16 20.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.706 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.463 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -122.57 163.03 20.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.256 179.367 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.426 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.7 OUTLIER -118.89 120.63 37.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.083 0.468 . . . . 0.0 112.162 -179.326 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.63 HD12 ' SG ' ' A' ' 34' ' ' CYS . 1.6 mt -96.86 133.71 41.12 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . 1.037 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.24 158.91 43.91 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -178.526 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.501 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -144.38 141.89 29.98 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 113.586 -1.643 . . . . 0.0 110.731 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.542 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -78.11 141.84 38.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.068 0.461 . . . . 0.0 111.093 -179.859 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.622 HD13 ' SG ' ' A' ' 154' ' ' CYS . 89.2 mt -64.05 -42.49 95.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.557 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.4 p -56.63 -38.22 71.81 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.588 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.491 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 1.6 mt-30 -68.32 -36.88 79.97 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.306 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 51' ' ' ASP . 44.6 t -73.04 -41.48 59.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.948 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 tp -71.08 -32.26 68.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.807 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.45 -43.58 80.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.815 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -63.29 117.41 6.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.871 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -82.65 80.32 8.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.893 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.27 82.19 0.16 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.874 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.16 -170.14 0.28 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.824 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.59 HD11 HG22 ' A' ' 65' ' ' VAL . 9.1 tp -68.75 148.17 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.953 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.531 ' HE3' HG13 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -116.75 -61.0 1.78 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.013 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.415 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.1 ttpt -155.06 133.28 11.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.319 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.59 HG22 HD11 ' A' ' 62' ' ' ILE . 5.8 t -123.24 138.08 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-O 121.234 0.54 . . . . 0.0 111.768 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.554 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.3 m-90 -102.31 139.71 37.56 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.302 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.979 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -111.83 128.42 56.11 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 176.971 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.677 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.4 OUTLIER -118.66 145.28 45.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.264 -178.153 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.629 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.06 -172.4 38.19 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.748 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 27.2 mtm180 -78.69 3.2 17.12 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.516 HD22 ' HB3' ' A' ' 73' ' ' ALA . 1.9 t30 -84.69 132.46 46.47 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.687 0.279 . . . . 0.0 111.005 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.2 Cg_exo -65.98 -13.67 40.95 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.585 2.19 . . . . 0.0 111.68 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.516 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.74 -43.05 17.26 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.967 0.889 . . . . 0.0 108.953 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.23 138.7 1.6 Allowed 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 113.792 -1.549 . . . . 0.0 110.828 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.1 m-20 -56.42 -18.93 12.73 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.968 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.506 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 25.6 t80 -129.83 123.27 30.49 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.141 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -100.14 118.69 37.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.555 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.626 HD13 HD23 ' A' ' 84' ' ' LEU . 0.8 OUTLIER -125.39 72.36 1.25 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.247 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 48.97 -135.49 21.34 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.959 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -158.96 81.09 0.78 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.797 0.332 . . . . 0.0 110.92 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.639 HD13 HD22 ' A' ' 84' ' ' LEU . 4.9 mp -95.52 140.43 16.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.033 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.76 ' HB3' HD13 ' B' ' 170' ' ' LEU . 3.2 m -55.61 -45.0 77.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.132 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.531 ' N ' HD22 ' B' ' 170' ' ' LEU . 0.0 OUTLIER -60.74 -49.07 78.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.753 -179.357 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.639 HD22 HD13 ' A' ' 81' ' ' ILE . 4.3 mp -72.56 152.88 41.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.209 0.528 . . . . 0.0 111.215 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.6 p -102.48 168.27 9.41 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.758 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.629 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 9.0 m-20 -42.47 -60.02 1.66 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.389 0.614 . . . . 0.0 109.527 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.598 ' HB3' HG22 ' A' ' 67' ' ' THR . 3.0 mtmp? -115.63 84.58 2.12 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 176.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.627 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 10.2 t60 -61.45 -44.58 96.87 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.242 -0.89 . . . . 0.0 113.02 -176.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.533 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 12.1 p90 -146.16 162.87 37.04 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.07 -0.652 . . . . 0.0 112.254 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.979 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.54 138.03 42.63 Favored 'General case' 0 C--O 1.227 -0.111 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.006 -179.099 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.677 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 62.2 mt -114.86 129.23 71.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.656 178.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.859 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -108.0 148.07 30.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.994 0.426 . . . . 0.0 111.294 -179.623 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.828 HD22 HG11 ' A' ' 33' ' ' VAL . 49.7 tp -125.13 123.41 39.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.543 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 155.1 -149.86 21.21 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.529 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.91 83.57 0.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.945 0.403 . . . . 0.0 110.817 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.04 29.95 18.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.981 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 72.81 33.33 60.28 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.543 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.2 m-20 -108.66 178.62 4.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.864 0.364 . . . . 0.0 110.91 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.699 ' C ' HD12 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -116.74 138.84 51.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.81 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.877 HD23 ' HB3' ' A' ' 121' ' ' ASN . 11.1 mp -131.2 143.96 50.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.671 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.524 HD11 ' CD1' ' A' ' 130' ' ' ILE . 0.9 OUTLIER -112.61 125.26 54.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.128 179.715 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.859 ' HB2' HD11 ' A' ' 92' ' ' LEU . 49.0 t30 -115.72 115.71 26.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.901 0.382 . . . . 0.0 111.584 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.778 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.0 p30 -78.87 136.23 37.24 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.034 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.476 HD12 ' HB2' ' A' ' 87' ' ' LYS . 12.9 pt -144.28 39.7 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.58 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -97.42 157.01 16.21 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.191 0.52 . . . . 0.0 111.92 -178.872 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 92.4 m -69.11 -36.27 77.33 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.433 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 19.8 p30 -98.51 -19.86 17.4 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.58 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 122.66 156.07 9.52 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.277 -0.963 . . . . 0.0 113.515 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.523 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 4.8 m -117.68 137.78 52.43 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 122.818 0.447 . . . . 0.0 109.832 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.858 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -119.32 148.1 43.55 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -178.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.74 HD23 ' O ' ' A' ' 114' ' ' GLN . 0.7 OUTLIER -124.75 113.56 18.12 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.544 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 45.1 m-20 49.45 42.02 21.85 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 83.98 -6.05 76.68 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.924 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.74 ' O ' HD23 ' A' ' 111' ' ' LEU . 4.4 mt-30 -103.97 118.92 37.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.189 0.495 . . . . 0.0 110.589 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.858 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 7.3 tptt -74.92 127.14 32.5 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.339 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.778 HG23 ' OD2' ' A' ' 103' ' ' ASP . 13.2 m -103.0 164.09 3.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.883 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 120' ' ' SER . 9.9 tp10 -69.76 128.04 35.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.422 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.693 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 56.4 tttt -53.8 161.78 1.06 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.719 0.295 . . . . 0.0 110.414 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.9 p-10 35.23 34.77 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.141 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.22 145.11 40.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.363 179.61 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.877 ' HB3' HD23 ' A' ' 100' ' ' LEU . 6.5 m120 -89.14 125.48 35.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.589 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -129.5 148.73 51.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.201 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.617 HD23 ' O ' ' A' ' 124' ' ' LEU . 5.3 tt -72.83 114.53 11.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.015 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.733 HD21 HD13 ' A' ' 145' ' ' ILE . 5.2 mt -55.11 166.26 0.57 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.654 0.74 . . . . 0.0 112.063 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.428 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.6 OUTLIER -125.4 152.71 44.46 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.488 179.334 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.44 ' HA ' HD12 ' A' ' 147' ' ' ILE . 15.2 tp60 -71.95 124.48 24.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.87 0.366 . . . . 0.0 110.352 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 145' ' ' ILE . . . 58.35 20.92 46.44 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.227 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.428 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 8.3 t70 -56.85 178.67 0.05 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.656 0.265 . . . . 0.0 110.809 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.899 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.2 mt-10 -145.19 135.73 24.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.124 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.751 HD11 HD11 ' A' ' 145' ' ' ILE . 8.1 mt -108.9 124.62 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 121.005 0.431 . . . . 0.0 110.831 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.534 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.7 m -104.37 143.19 33.32 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.627 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 27.0 m -140.22 158.37 25.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.498 ' HA2' ' HG3' ' A' ' 83' ' ' ARG . . . 74.29 45.17 25.76 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.312 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.548 ' HA ' HG12 ' A' ' 140' ' ' ILE . 95.3 t -85.41 140.62 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 121.675 0.75 . . . . 0.0 112.379 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 140.29 -38.08 1.63 Allowed Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -178.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 1.161 HG23 HD11 ' B' ' 172' ' ' ILE . 1.1 t -126.49 118.68 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.463 ' HA ' HD12 ' A' ' 140' ' ' ILE . 3.2 mp0 -50.36 -24.75 3.21 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 17.0 m -93.18 4.49 53.9 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.475 ' N ' HG12 ' A' ' 136' ' ' VAL . 1.5 m-20 -128.96 26.73 5.49 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.548 HG12 ' HA ' ' A' ' 134' ' ' VAL . 6.3 mt -107.15 138.24 34.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-O 121.464 0.649 . . . . 0.0 111.487 178.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.4 tt -125.47 134.68 51.98 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.207 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.534 ' H ' HG21 ' A' ' 40' ' ' THR . 42.2 t -113.03 147.53 37.02 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.797 0.808 . . . . 0.0 112.355 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.737 HD23 ' HA ' ' A' ' 38' ' ' CYS . 77.8 mt -136.55 157.27 47.16 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.855 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.899 HG22 ' CG ' ' A' ' 129' ' ' GLU . 26.2 t -120.64 139.14 48.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.824 0.345 . . . . 0.0 110.995 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.751 HD11 HD11 ' A' ' 130' ' ' ILE . 70.0 mt -106.33 120.93 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.16 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.74 109.49 19.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.536 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' A' ' 126' ' ' GLN . 6.2 mt -84.64 132.11 32.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.476 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -78.5 113.39 16.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.815 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -64.57 -30.53 71.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.064 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.82 -46.13 91.73 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.763 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -61.7 -44.16 97.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.095 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -64.19 -37.7 88.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.074 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.98 -40.04 83.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.173 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.622 ' SG ' HD13 ' A' ' 52' ' ' ILE . 9.0 t -67.95 -44.56 76.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.121 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -69.06 -41.74 77.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.009 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -42.82 93.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.003 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -84.56 -37.04 21.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.951 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 44.13 -171.31 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.565 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.55 117.38 21.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.892 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.36 133.63 33.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.154 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -79.45 -42.1 26.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.84 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 -159.45 134.58 8.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.926 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 32.6 mt -100.56 125.99 54.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.142 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.899 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.773 0.32 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -79.03 149.55 73.57 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.999 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.16 161.83 44.53 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.583 2.189 . . . . 0.0 112.276 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -142.42 167.62 21.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.969 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.76 HD13 ' HB3' ' A' ' 82' ' ' SER . 0.9 OUTLIER -53.71 148.93 9.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.075 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 171' ' ' GLU . . . . . 0.6 ' O ' HG22 ' B' ' 172' ' ' ILE . 13.4 mt-10 -140.03 45.85 1.87 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.171 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 1.161 HD11 HG23 ' A' ' 136' ' ' VAL . 10.4 tt 50.27 156.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.035 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 173' ' ' TYR . . . . . 0.498 ' N ' HG12 ' B' ' 172' ' ' ILE . 13.3 m-85 -56.52 -171.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.04 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 32.9 t . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.892 -179.991 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.81 0.338 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.456 HG23 ' H ' ' A' ' 16' ' ' GLN . 1.1 t -140.42 -55.33 0.52 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.924 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.456 ' H ' HG23 ' A' ' 15' ' ' THR . 7.1 mt-30 -72.21 -32.62 66.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.878 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 -65.45 -37.55 87.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.005 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -57.07 -41.22 78.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.639 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.08 -31.78 71.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.5 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.6 mt -70.41 -43.76 77.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.864 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -57.8 -34.04 69.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.02 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -35.54 80.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.005 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -58.11 -47.32 83.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.012 0.434 . . . . 0.0 111.167 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.88 -30.85 71.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.963 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -59.1 -29.61 67.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.889 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.05 120.97 12.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.861 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -102.07 102.03 12.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.937 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.5 mm -81.92 138.36 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-O 121.629 0.728 . . . . 0.0 111.674 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.9 120.52 4.5 Favored Glycine 0 C--N 1.314 -0.659 0 CA-C-N 114.487 -1.233 . . . . 0.0 112.554 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -84.79 -27.82 26.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.831 0.348 . . . . 0.0 110.964 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.5 m-20 -179.27 37.82 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.675 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.0 mm -75.23 137.13 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 CA-C-N 113.632 -1.622 . . . . 0.0 112.778 -177.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.02 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.1 t -91.86 -58.89 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.497 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.72 ' SG ' HD22 ' A' ' 48' ' ' LEU . 4.6 p -147.88 165.41 30.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.444 179.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -133.28 138.31 46.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.854 0.359 . . . . 0.0 111.323 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.708 HG21 ' CE2' ' A' ' 68' ' ' PHE . 42.8 t -107.23 122.82 61.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.955 0.407 . . . . 0.0 110.916 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.816 HG23 HG12 ' A' ' 45' ' ' ILE . 13.2 mt -122.23 121.9 65.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.508 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.74 ' HA ' HD13 ' A' ' 143' ' ' LEU . 42.4 t -79.86 117.02 20.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.684 0.278 . . . . 0.0 110.663 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.555 HG23 HG21 ' A' ' 144' ' ' VAL . 0.6 OUTLIER -86.08 -23.36 26.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.37 -179.706 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.513 HG21 ' H ' ' A' ' 142' ' ' SER . 72.4 p -79.81 -2.33 42.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.838 0.351 . . . . 0.0 111.342 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.3 73.58 0.48 Allowed Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.203 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.436 ' HG3' HD21 ' A' ' 141' ' ' LEU . 6.0 mt-30 -146.79 -39.17 0.21 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.683 0.278 . . . . 0.0 111.181 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.557 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.8 mt -118.9 141.02 29.4 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.783 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.557 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 54.2 Cg_endo -72.28 144.54 41.65 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.157 1.905 . . . . 0.0 112.209 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.816 HG12 HG23 ' A' ' 37' ' ' ILE . 43.9 mt -56.45 144.6 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.66 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.497 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.2 OUTLIER -128.24 161.98 28.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.02 179.338 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -123.31 119.56 30.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.971 0.415 . . . . 0.0 111.465 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.85 HD23 ' CD2' ' A' ' 66' ' ' TRP . 6.9 mp -92.29 130.41 37.99 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . 1.02 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -142.03 155.37 45.41 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 122.257 1.027 . . . . 0.0 113.524 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.46 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -141.38 141.74 33.77 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 113.387 -1.733 . . . . 0.0 110.712 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.759 ' O ' HG23 ' A' ' 55' ' ' VAL . 2.3 m-20 -78.09 129.22 34.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.168 0.509 . . . . 0.0 111.089 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.4 mm -64.36 -41.65 93.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.383 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.3 m -57.29 -41.85 80.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.205 0.526 . . . . 0.0 110.898 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.491 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 11.5 mt-30 -68.44 -37.0 79.83 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.825 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.777 HG13 ' HD3' ' A' ' 63' ' ' LYS . 42.5 t -66.25 -39.89 85.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.947 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 tp -71.27 -42.02 69.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.319 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.69 -30.84 56.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.333 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -82.36 127.81 33.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.809 0.338 . . . . 0.0 110.871 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -130.49 15.95 5.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.247 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.5 ttt85 -142.15 149.57 39.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.694 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 m 60.04 162.7 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.679 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.67 HD13 HD12 ' A' ' 92' ' ' LEU . 4.7 tp -61.25 141.41 17.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.096 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.777 ' HD3' HG13 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -57.99 -69.75 0.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.991 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.438 ' CE ' ' O ' ' A' ' 49' ' ' SER . 4.7 ttpt -152.62 136.88 16.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.131 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.583 HG12 ' HG2' ' A' ' 90' ' ' GLN . 10.8 t -126.48 139.07 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-O 121.31 0.576 . . . . 0.0 112.016 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.85 ' CD2' HD23 ' A' ' 48' ' ' LEU . 17.7 m-90 -104.36 139.31 39.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.373 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.706 HG22 ' HB3' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -112.69 132.28 55.27 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 177.531 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.757 ' HZ ' HD21 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -118.67 145.55 45.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.899 0.38 . . . . 0.0 111.665 -178.728 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.65 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.49 -170.14 37.98 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.902 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.43 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 4.5 mtm105 -80.21 1.63 27.57 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.502 HD22 ' HB3' ' A' ' 73' ' ' ALA . 2.1 t30 -84.81 132.96 44.6 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.624 0.25 . . . . 0.0 111.16 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.28 -13.07 38.26 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.661 2.241 . . . . 0.0 111.796 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.502 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.62 -43.47 16.95 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-O 121.801 0.81 . . . . 0.0 108.856 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.22 140.4 1.16 Allowed 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 113.887 -1.506 . . . . 0.0 110.633 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.9 m-20 -56.29 -18.96 12.19 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.972 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.497 ' CE1' ' HB2' ' A' ' 46' ' ' ARG . 10.9 t80 -129.62 124.3 33.4 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 120.784 0.326 . . . . 0.0 110.98 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -95.56 107.85 20.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.522 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.438 HD13 ' N ' ' A' ' 69' ' ' GLY . 11.1 mp -82.75 -78.58 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.914 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -173.38 -88.53 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.02 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.0 p30 174.7 49.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.886 0.374 . . . . 0.0 111.117 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 1.11 HD13 HD12 ' A' ' 84' ' ' LEU . 4.1 mp -78.59 126.79 38.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.865 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.465 ' HB2' HD11 ' B' ' 170' ' ' LEU . 0.6 OUTLIER -54.87 -40.65 69.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.909 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.646 ' HA ' HD12 ' B' ' 170' ' ' LEU . 2.0 mmp_? -62.81 -49.13 76.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.267 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.11 HD12 HD13 ' A' ' 81' ' ' ILE . 23.2 mt -72.69 150.44 42.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.223 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.8 p -94.55 167.05 11.73 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.668 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.65 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.5 m-20 -43.73 -53.75 5.62 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.292 0.568 . . . . 0.0 109.744 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.706 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.1 OUTLIER -120.25 83.2 2.02 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 177.184 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.557 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.7 t60 -58.97 -45.88 89.47 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.221 -0.899 . . . . 0.0 112.634 -176.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.513 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 20.3 p90 -144.5 159.91 41.98 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.972 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.697 ' HG3' HG23 ' A' ' 67' ' ' THR . 3.6 tt0 -136.31 140.68 43.53 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.246 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.63 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 72.8 mt -115.78 130.19 70.86 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.706 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.67 HD12 HD13 ' A' ' 62' ' ' ILE . 0.6 OUTLIER -114.96 148.84 38.23 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.115 0.483 . . . . 0.0 111.776 -179.587 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.712 HD22 HG11 ' A' ' 33' ' ' VAL . 17.8 tp -125.16 122.79 38.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.308 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -84.42 178.88 51.65 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.672 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -57.57 -60.58 3.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.802 0.334 . . . . 0.0 110.86 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -68.92 175.64 3.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.659 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.99 -169.52 0.25 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.477 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 66.02 136.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.839 0.352 . . . . 0.0 111.137 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 1.005 HD21 HG12 ' A' ' 33' ' ' VAL . 5.2 mp -106.96 160.26 15.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.879 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.585 HD23 ' HB3' ' A' ' 121' ' ' ASN . 3.3 mp -121.52 147.1 46.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.224 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.635 HD11 HG12 ' A' ' 130' ' ' ILE . 1.1 tt -112.84 123.6 50.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.467 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.441 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 49.1 t30 -116.0 115.49 26.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.983 0.42 . . . . 0.0 111.256 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.776 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.1 p30 -79.97 134.0 36.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.951 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.494 HD12 ' HB2' ' A' ' 87' ' ' LYS . 10.6 pt -141.61 40.88 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -178.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.59 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -100.87 152.32 20.68 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 120.914 0.388 . . . . 0.0 111.254 -179.245 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.428 ' OG1' HG21 ' B' ' 169' ' ' TPO . 53.5 m -68.94 -32.1 71.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.316 178.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.441 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 27.9 p30 -98.62 -19.72 17.4 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.59 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.92 155.45 9.55 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.314 -0.946 . . . . 0.0 113.731 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.547 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.9 m -117.43 137.95 52.16 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.848 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -115.34 148.41 39.3 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -177.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.479 HD13 ' OD2' ' A' ' 128' ' ' ASP . 0.2 OUTLIER -124.18 113.37 18.23 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.238 177.371 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.406 ' N ' HD12 ' A' ' 111' ' ' LEU . 48.4 m-20 45.61 42.94 8.79 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.2 -6.27 80.14 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.549 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.55 118.61 37.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 117.018 0.409 . . . . 0.0 110.787 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.848 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 17.7 tptt -73.72 126.97 31.55 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.181 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.776 HG23 ' OD2' ' A' ' 103' ' ' ASP . 9.7 m -102.56 165.34 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.285 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.401 ' O ' ' HB3' ' A' ' 120' ' ' SER . 2.5 tt0 -69.89 128.86 37.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.423 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.691 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 76.7 tttt -54.1 164.23 0.67 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.3 m-80 33.6 37.0 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.803 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.9 p -111.77 145.11 39.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.005 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.585 ' HB3' HD23 ' A' ' 100' ' ' LEU . 75.9 m-20 -92.41 127.07 37.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.806 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.415 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 57.6 mm-40 -129.31 149.13 51.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.743 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.1 tp -72.86 128.83 36.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.386 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.584 HD23 HG12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -59.75 160.92 6.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.649 0.738 . . . . 0.0 112.173 -179.23 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.713 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.4 OUTLIER -124.99 153.3 42.99 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.636 -1.166 . . . . 0.0 110.034 179.308 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.605 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.44 119.2 15.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.882 0.373 . . . . 0.0 110.375 -179.71 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.52 26.42 56.91 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.036 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.496 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 7.6 t70 -57.24 175.24 0.15 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 120.914 0.388 . . . . 0.0 111.052 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.859 ' CG ' HG22 ' A' ' 144' ' ' VAL . 4.6 mt-10 -145.36 135.63 24.0 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.059 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 1.058 HD11 HD11 ' A' ' 145' ' ' ILE . 3.3 mt -110.07 127.93 66.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.832 0.348 . . . . 0.0 110.497 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.594 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.36 138.89 40.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.851 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.515 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 30.8 m -140.17 158.41 25.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.12 27.65 30.39 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.955 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.466 ' HA ' HG12 ' A' ' 140' ' ' ILE . 72.9 t -72.01 140.44 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-O 121.724 0.773 . . . . 0.0 112.197 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.656 ' C ' HD12 ' B' ' 172' ' ' ILE . . . 147.7 -49.75 0.6 Allowed Glycine 0 N--CA 1.434 -1.452 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -178.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.671 HG22 HG13 ' B' ' 172' ' ' ILE . 2.5 t -109.97 125.55 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -50.18 -35.7 27.38 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.2 t -93.57 6.67 47.47 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.422 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . 0.9 OUTLIER -122.3 31.61 6.09 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -178.473 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.594 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.4 mt -106.49 138.94 29.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-O 121.399 0.619 . . . . 0.0 110.898 178.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.459 ' HA ' HD22 ' A' ' 141' ' ' LEU . 0.4 OUTLIER -124.51 134.64 52.95 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.557 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.659 ' C ' HD22 ' A' ' 143' ' ' LEU . 39.4 t -111.15 150.16 29.87 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.653 0.74 . . . . 0.0 112.429 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.74 HD13 ' HA ' ' A' ' 38' ' ' CYS . 3.5 mm? -136.35 153.43 51.13 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.503 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.859 HG22 ' CG ' ' A' ' 129' ' ' GLU . 15.4 t -118.16 140.33 41.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.817 0.341 . . . . 0.0 111.067 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 1.058 HD11 HD11 ' A' ' 130' ' ' ILE . 41.6 mt -106.05 120.96 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.032 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.19 111.31 22.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.834 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.713 HD11 ' O ' ' A' ' 125' ' ' SER . 4.2 mp -85.55 129.45 37.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.342 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -81.08 128.64 33.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.01 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -74.06 -29.62 61.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.189 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.3 tttt -59.0 -43.69 91.54 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.851 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -63.47 -43.01 98.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.039 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -60.71 -50.1 74.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.214 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -60.28 -36.91 78.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.168 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 10.5 t -65.21 -45.89 82.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.956 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -67.51 -36.0 80.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.821 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -64.88 -33.99 77.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.956 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.82 -36.62 13.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.892 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.4 p30 42.68 87.5 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.481 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 11.0 mmmt -123.83 138.12 54.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.909 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.7 t -77.44 126.98 38.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.057 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -162.31 146.48 12.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.912 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -93.45 149.02 21.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.919 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 19.4 pt -91.82 130.83 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.071 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.902 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.809 0.338 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -113.25 90.49 16.78 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.86 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_exo -51.66 114.88 1.78 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.554 2.169 . . . . 0.0 112.333 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -111.05 134.63 52.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 169' ' ' TPO . . . . . 0.444 HG23 ' N ' ' B' ' 170' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.646 HD12 ' HA ' ' A' ' 83' ' ' ARG . 0.4 OUTLIER -175.2 177.6 1.86 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.006 -179.916 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 171' ' ' GLU . . . . . 0.606 ' O ' HG22 ' B' ' 172' ' ' ILE . 29.7 mt-10 -141.33 72.64 1.39 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.902 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 0.671 HG13 HG22 ' A' ' 136' ' ' VAL . 19.6 tt 50.37 159.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.173 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 173' ' ' TYR . . . . . 0.46 ' N ' HG12 ' B' ' 172' ' ' ILE . 3.5 m-85 -64.97 76.82 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.816 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.866 -179.915 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.605 ' HB1' ' HD3' ' A' ' 17' ' ' ARG . . . . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.836 0.35 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.37 -31.6 29.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.87 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -69.78 -46.91 64.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.605 ' HD3' ' HB1' ' A' ' 14' ' ' ALA . 0.7 OUTLIER -68.91 -37.95 79.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.891 180.0 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -63.93 -35.87 82.07 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.36 -41.81 97.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.921 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.505 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 9.4 mm -69.6 -35.07 64.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.151 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -57.19 -36.4 70.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.877 0.37 . . . . 0.0 110.368 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.7 ttpp -67.3 -23.83 65.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.755 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.505 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.7 -47.47 79.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.239 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.0 t -78.43 -44.16 25.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.828 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -99.29 104.44 16.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.19 139.28 48.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.1 102.03 6.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.917 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.9 mm -84.03 138.22 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-O 121.695 0.759 . . . . 0.0 111.768 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -169.32 39.25 0.2 Allowed Glycine 0 C--N 1.314 -0.681 0 CA-C-N 114.458 -1.246 . . . . 0.0 112.455 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -76.99 -42.47 38.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.819 0.343 . . . . 0.0 111.0 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.438 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER -170.99 34.77 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.71 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 2.9 mm -77.1 131.55 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-N 113.887 -1.506 . . . . 0.0 112.388 -177.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.034 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -90.42 -62.0 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 114.623 -1.172 . . . . 0.0 110.442 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.506 ' SG ' HD12 ' A' ' 48' ' ' LEU . 4.0 p -147.89 142.53 26.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.441 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -113.83 134.1 55.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.976 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.69 HG21 ' HE2' ' A' ' 68' ' ' PHE . 38.5 t -97.45 122.88 49.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.97 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.795 HG23 HG12 ' A' ' 45' ' ' ILE . 15.5 mt -119.8 110.93 30.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.653 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 1.1 m -84.53 111.48 19.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.003 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.2 p -100.27 -9.68 22.12 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.784 HG21 ' OG ' ' A' ' 142' ' ' SER . 10.0 p -88.04 -2.86 58.86 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.183 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.55 90.32 0.45 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.488 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.76 ' OE1' HD23 ' A' ' 141' ' ' LEU . 10.7 pt20 -165.64 -47.28 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.791 0.329 . . . . 0.0 111.435 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.61 HG23 ' HD2' ' A' ' 44' ' ' PRO . 6.8 mt -130.32 142.4 45.33 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.85 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.61 ' HD2' HG23 ' A' ' 43' ' ' ILE . 67.4 Cg_endo -76.04 141.33 23.63 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.151 1.901 . . . . 0.0 111.509 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.795 HG12 HG23 ' A' ' 37' ' ' ILE . 47.6 mt -50.14 139.65 4.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.116 0.484 . . . . 0.0 112.054 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.41 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -135.86 163.0 31.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.014 179.105 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -120.22 119.86 34.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.142 0.496 . . . . 0.0 112.334 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.527 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 4.7 mt -94.04 137.55 33.12 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 178.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . 1.034 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.2 158.09 43.86 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -178.272 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.482 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.33 141.89 28.92 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 113.094 -1.866 . . . . 0.0 110.166 178.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.684 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -78.88 142.46 36.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.209 0.528 . . . . 0.0 111.529 -179.171 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.572 ' H ' HD12 ' A' ' 52' ' ' ILE . 4.9 mp -64.1 -43.46 97.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.002 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.7 t -56.55 -38.34 71.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.433 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.523 ' CG ' ' HB2' ' A' ' 51' ' ' ASP . 0.4 OUTLIER -68.43 -36.7 79.44 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.281 179.304 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 51' ' ' ASP . 36.6 t -70.44 -41.71 78.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.26 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 68.3 mt -71.06 -28.96 64.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.166 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.36 -45.98 14.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.001 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -62.94 115.97 4.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.035 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.9 ptpt -103.95 -24.67 13.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.857 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.7 mmm180 -55.95 -171.22 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.893 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.8 p -95.64 31.64 2.0 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.988 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.942 HD11 ' CG2' ' A' ' 65' ' ' VAL . 10.0 tp -168.69 150.28 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.083 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.428 ' HE2' HG13 ' A' ' 55' ' ' VAL . 10.1 mttp -138.57 -67.22 0.47 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.861 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.43 ' NZ ' ' HA ' ' A' ' 50' ' ' ALA . 4.5 ttpt -141.03 129.76 22.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.779 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.942 ' CG2' HD11 ' A' ' 62' ' ' ILE . 16.4 t -128.93 139.18 52.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.409 0.623 . . . . 0.0 112.399 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.527 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.3 m-90 -101.27 138.66 38.0 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.846 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.694 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.91 126.28 54.99 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 176.857 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.69 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -108.8 145.36 35.33 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.407 -178.225 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.71 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.79 172.61 31.48 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.981 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.541 ' HG3' HD11 ' A' ' 78' ' ' LEU . 1.8 mtm105 -67.13 -4.77 10.99 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.456 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.8 t30 -84.48 135.32 41.17 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.744 0.307 . . . . 0.0 111.175 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.2 Cg_exo -69.63 -6.14 17.83 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.868 2.379 . . . . 0.0 112.058 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.92 -43.59 16.32 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 122.029 0.919 . . . . 0.0 108.846 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.18 138.31 2.25 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.986 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -56.53 -18.36 11.42 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.236 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.56 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 19.7 t80 -129.0 114.36 16.32 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.785 0.326 . . . . 0.0 110.646 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -88.26 130.61 35.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.271 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.576 HD21 ' CA ' ' A' ' 69' ' ' GLY . 1.4 pp -133.16 -177.67 4.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.593 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.556 ' O ' HD12 ' A' ' 78' ' ' LEU . . . -57.3 -168.34 0.11 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.266 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -123.92 82.93 2.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.858 0.361 . . . . 0.0 110.734 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.575 HG22 ' H ' ' A' ' 83' ' ' ARG . 3.5 mp -109.64 130.3 62.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.205 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.782 ' CB ' HD11 ' B' ' 170' ' ' LEU . 0.0 OUTLIER -56.8 -31.23 64.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.168 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.575 ' H ' HG22 ' A' ' 81' ' ' ILE . 1.4 mmp_? -60.75 -36.03 77.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.459 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.911 HD21 HG21 ' A' ' 132' ' ' VAL . 5.5 mp -93.28 152.98 18.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.201 0.524 . . . . 0.0 111.666 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.91 168.88 10.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.703 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.71 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.4 m-20 -44.03 -53.22 6.48 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.336 0.589 . . . . 0.0 109.722 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.53 ' NZ ' HG21 ' A' ' 67' ' ' THR . 0.1 OUTLIER -119.45 83.56 2.06 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.375 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.523 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 15.9 t60 -60.98 -47.42 86.55 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.685 -176.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.526 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 20.0 p90 -147.17 160.44 42.45 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.254 -0.578 . . . . 0.0 111.612 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.694 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.7 tt0 -136.1 141.49 44.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.639 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.613 ' O ' HG13 ' A' ' 65' ' ' VAL . 63.2 mt -116.9 127.66 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 121.219 -0.193 . . . . 0.0 110.531 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.504 ' CB ' HG22 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -112.33 150.17 31.4 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.158 0.504 . . . . 0.0 112.255 -179.14 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 1.036 HD12 HD11 ' A' ' 99' ' ' LEU . 6.9 tt -121.84 122.8 40.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.125 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -172.0 -158.78 16.89 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.561 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 59.44 -177.55 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.822 0.344 . . . . 0.0 110.82 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -74.53 64.43 1.18 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.789 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.82 -173.03 34.59 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.417 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.692 ' C ' HD22 ' A' ' 99' ' ' LEU . 25.3 m120 62.14 172.01 0.13 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.866 0.365 . . . . 0.0 110.86 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 1.036 HD11 HD12 ' A' ' 93' ' ' LEU . 3.9 mm? -130.81 160.22 35.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.122 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.725 HD23 ' O ' ' A' ' 122' ' ' GLN . 9.1 mt -126.04 147.38 49.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.19 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.11 122.17 47.02 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -112.93 115.37 28.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.614 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.862 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.7 p-10 -77.49 143.15 38.7 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.796 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.438 HG12 ' HA ' ' A' ' 89' ' ' PHE . 10.7 pt -151.41 36.79 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -178.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.562 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.34 148.43 24.19 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 120.924 0.392 . . . . 0.0 111.604 -179.183 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.6 m -68.7 -31.39 70.44 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 177.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -92.0 -19.82 21.99 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.484 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.562 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 113.29 152.46 11.06 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.293 -0.956 . . . . 0.0 113.937 179.009 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.537 HG22 ' CG2' ' A' ' 130' ' ' ILE . 4.9 m -117.35 137.72 52.26 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.837 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -117.56 148.18 42.13 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -178.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.474 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.27 113.56 18.42 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.468 177.597 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.417 ' N ' HD12 ' A' ' 111' ' ' LEU . 92.8 m-20 45.31 42.69 7.55 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.25 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 84.99 -4.05 86.13 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.53 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -104.78 118.74 37.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.034 0.445 . . . . 0.0 110.655 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.837 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 6.7 tptt -74.98 117.76 17.19 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.141 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.862 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.2 m -96.6 159.77 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.201 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.493 ' O ' ' HB3' ' A' ' 120' ' ' SER . 0.0 OUTLIER -69.81 130.11 41.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.536 179.861 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.698 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 9.2 ptmt -55.13 167.73 0.4 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.08 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.5 m-80 36.93 33.44 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.983 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.493 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 22.8 t -112.44 141.38 46.25 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.849 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.583 ' HB3' HD22 ' A' ' 100' ' ' LEU . 4.8 m-80 -92.08 129.55 38.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.85 0.357 . . . . 0.0 111.092 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.725 ' O ' HD23 ' A' ' 100' ' ' LEU . 13.3 mm100 -129.48 150.4 50.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.689 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.5 tp -72.5 133.3 44.73 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.273 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.901 HD13 ' HB2' ' A' ' 99' ' ' LEU . 1.3 pt? -63.48 160.85 15.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.81 0.814 . . . . 0.0 112.148 -179.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.719 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.3 OUTLIER -125.63 153.31 43.97 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.07 179.275 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.591 ' HA ' HD13 ' A' ' 147' ' ' ILE . 8.1 mm100 -71.41 115.7 10.89 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.81 28.49 68.39 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.585 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.419 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 24.9 t0 -53.44 173.84 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.945 0.402 . . . . 0.0 111.19 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 15.1 tt0 -145.15 135.24 23.86 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.898 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.537 ' CG2' HG22 ' A' ' 109' ' ' THR . 15.2 mt -115.49 126.58 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.342 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.539 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.37 141.51 36.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.275 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.911 HG21 HD21 ' A' ' 84' ' ' LEU . 34.2 m -140.06 158.42 26.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.021 0.439 . . . . 0.0 111.996 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.18 30.25 23.13 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.932 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.476 ' HA ' HG12 ' A' ' 140' ' ' ILE . 73.9 t -77.01 140.48 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 CA-C-O 121.647 0.737 . . . . 0.0 112.101 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.654 ' O ' HD12 ' B' ' 172' ' ' ILE . . . 144.17 -39.85 1.22 Allowed Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -178.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.672 HG22 HG13 ' B' ' 172' ' ' ILE . 2.8 t -118.01 119.12 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -50.42 -32.1 16.82 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 76.7 p -93.69 6.79 47.15 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.509 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.5 OUTLIER -129.49 34.44 4.35 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -178.463 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.539 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.1 mt -107.17 139.32 29.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.766 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.76 HD23 ' OE1' ' A' ' 42' ' ' GLN . 2.1 mp -124.15 134.78 53.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.879 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.784 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.3 OUTLIER -106.59 135.49 48.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.172 0.51 . . . . 0.0 111.804 -179.327 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.754 HD12 ' C ' ' A' ' 142' ' ' SER . 5.3 mp -123.69 141.4 52.05 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.4 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 20.8 t -110.9 132.99 57.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.906 0.384 . . . . 0.0 111.196 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.547 HD13 HG22 ' A' ' 36' ' ' VAL . 2.2 mm -106.3 121.64 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.935 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.21 138.58 44.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.662 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.719 HD11 ' O ' ' A' ' 125' ' ' SER . 4.2 mp -106.63 133.03 52.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.386 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -83.91 122.74 29.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.89 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -73.74 -27.46 61.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.978 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.05 -42.54 80.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.006 0.432 . . . . 0.0 110.455 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -58.95 -43.64 91.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.814 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -36.3 82.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.892 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -61.62 -47.1 86.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.043 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 7.6 t -68.01 -41.53 82.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.97 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.15 -35.93 82.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.99 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -43.62 98.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.8 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.411 ' O ' ' N ' ' A' ' 159' ' ' LYS . 2.8 mm100 -84.71 -30.97 24.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.864 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.35 -90.68 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.595 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 157' ' ' GLN . 3.2 ttpp -83.34 129.33 34.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.86 0.362 . . . . 0.0 110.936 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.4 t -95.54 131.68 41.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.145 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -98.8 142.97 29.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.827 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.78 -32.49 25.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.003 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 32.7 mt -92.82 117.42 36.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.135 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 9.6 mtm-85 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.888 179.932 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.8 0.333 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -126.96 98.77 29.97 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.993 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.64 -173.95 0.64 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.46 2.107 . . . . 0.0 112.283 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -168.71 155.87 7.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.848 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 169' ' ' TPO . . . . . 0.785 ' C ' HD13 ' B' ' 170' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.785 HD13 ' C ' ' B' ' 169' ' ' TPO . 0.0 OUTLIER -161.3 179.53 8.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.003 0.43 . . . . 0.0 111.231 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 171' ' ' GLU . . . . . 0.574 ' O ' HG22 ' B' ' 172' ' ' ILE . 2.0 mt-10 -141.43 69.39 1.33 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.475 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 0.672 HG13 HG22 ' A' ' 136' ' ' VAL . 13.9 tt 50.64 156.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.005 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 173' ' ' TYR . . . . . 0.477 ' N ' HG12 ' B' ' 172' ' ' ILE . 2.2 p90 -100.02 56.0 0.94 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.893 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.852 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.524 ' O ' HG23 ' A' ' 15' ' ' THR . . . . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.847 0.356 . . . . 0.0 111.081 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.524 HG23 ' O ' ' A' ' 14' ' ' ALA . 0.8 OUTLIER -162.73 -45.76 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.973 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -67.1 -39.82 86.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.4 ttm180 -59.97 -42.42 94.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.863 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -58.36 -38.69 77.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.798 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.0 mp -60.1 -31.76 70.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.746 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.436 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.2 mt -71.98 -35.59 54.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.788 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.55 -41.81 81.73 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.952 0.406 . . . . 0.0 110.371 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.11 -23.79 65.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.689 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.436 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.49 -47.35 79.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.246 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.4 m -64.09 -39.9 95.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.799 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 63.41 -80.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.973 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -70.49 159.01 35.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.891 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -64.83 142.1 58.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.813 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.4 mm -81.78 138.31 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 CA-C-O 121.673 0.749 . . . . 0.0 111.639 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.412 ' HA2' HG12 ' A' ' 32' ' ' ILE . . . -145.81 80.47 0.22 Allowed Glycine 0 C--N 1.314 -0.647 0 CA-C-N 114.457 -1.247 . . . . 0.0 112.542 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.42 -36.85 79.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.759 0.314 . . . . 0.0 110.85 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.408 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER 177.01 39.66 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.682 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.6 mm -75.74 135.43 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-N 113.529 -1.669 . . . . 0.0 112.574 -177.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.023 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.7 t -92.83 -61.43 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.845 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.501 ' SG ' HD22 ' A' ' 48' ' ' LEU . 1.7 p -138.58 158.3 44.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.029 178.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.43 119.11 26.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.829 0.347 . . . . 0.0 111.392 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.784 HG21 ' CE2' ' A' ' 68' ' ' PHE . 23.2 t -89.18 122.67 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.912 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.876 HG23 HG12 ' A' ' 45' ' ' ILE . 18.9 mt -131.74 117.47 34.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.488 -179.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 6.4 t -83.8 116.11 22.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.771 0.32 . . . . 0.0 110.149 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.3 t -92.49 -24.71 18.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.974 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.575 ' CG2' ' HB2' ' A' ' 142' ' ' SER . 49.4 p -79.78 -2.86 45.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.876 0.37 . . . . 0.0 111.484 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.405 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 72.15 76.58 0.6 Allowed Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 121.098 -0.572 . . . . 0.0 113.284 178.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.437 ' CB ' HD11 ' A' ' 141' ' ' LEU . 4.5 mt-30 -143.45 -40.41 0.3 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.815 0.34 . . . . 0.0 110.94 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.681 HG23 ' HD2' ' A' ' 44' ' ' PRO . 16.9 mt -132.48 143.24 47.96 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.212 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.681 ' HD2' HG23 ' A' ' 43' ' ' ILE . 51.5 Cg_endo -71.05 146.12 51.44 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.298 1.999 . . . . 0.0 111.967 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.876 HG12 HG23 ' A' ' 37' ' ' ILE . 37.4 mt -51.74 152.77 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.087 0.47 . . . . 0.0 111.998 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -147.2 164.21 33.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.041 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.53 120.01 27.31 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.766 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.7 mp -92.7 127.31 38.15 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . 1.023 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -137.95 157.06 47.17 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -179.111 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.488 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -141.84 142.16 33.14 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 113.608 -1.633 . . . . 0.0 110.899 179.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.619 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.9 OUTLIER -74.93 136.73 41.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.054 0.454 . . . . 0.0 111.117 -179.713 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.4 mm -64.21 -43.25 97.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.955 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.5 p -56.82 -37.9 71.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.168 0.508 . . . . 0.0 110.508 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.449 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 43.8 mm-40 -68.59 -36.8 79.19 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.352 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.723 HG13 ' HD3' ' A' ' 63' ' ' LYS . 61.3 t -67.74 -40.7 84.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.054 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.1 mt -70.98 -37.99 72.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.024 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -73.39 -38.6 65.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.877 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -69.16 106.58 2.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.951 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.69 30.51 4.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.831 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.67 -166.82 1.11 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.785 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 m -97.89 33.23 2.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.754 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.847 HD11 HG22 ' A' ' 65' ' ' VAL . 7.7 tp -173.78 151.69 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.025 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.723 ' HD3' HG13 ' A' ' 55' ' ' VAL . 23.4 mttt -135.54 -58.74 0.78 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.976 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.41 ' CE ' ' O ' ' A' ' 49' ' ' SER . 6.4 ttpt -145.53 131.0 18.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.981 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.847 HG22 HD11 ' A' ' 62' ' ' ILE . 3.5 t -124.31 138.83 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 121.259 0.552 . . . . 0.0 112.192 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.766 ' CD2' HD23 ' A' ' 48' ' ' LEU . 17.3 m-90 -102.25 139.54 37.73 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.241 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.726 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.45 126.97 55.92 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.612 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.836 ' CE1' HD13 ' A' ' 91' ' ' ILE . 1.1 m-85 -108.55 145.48 34.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.318 -178.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.694 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.97 178.43 37.52 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.26 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.476 ' HG3' HD11 ' A' ' 78' ' ' LEU . 11.8 mtp180 -70.49 -4.85 24.83 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.447 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 4.8 t30 -84.55 134.06 43.15 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.711 0.291 . . . . 0.0 111.27 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.0 Cg_exo -69.49 -6.52 18.65 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.727 2.284 . . . . 0.0 111.719 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.85 -43.79 16.21 Favored 'General case' 0 CA--C 1.497 -1.077 0 CA-C-O 121.993 0.902 . . . . 0.0 108.706 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -41.95 138.38 1.55 Allowed 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 113.698 -1.592 . . . . 0.0 110.445 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.49 -18.87 12.86 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.097 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.618 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 58.9 t80 -129.5 125.62 36.77 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 120.73 0.3 . . . . 0.0 110.667 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -98.55 131.83 44.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.907 0.384 . . . . 0.0 110.925 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.656 HD12 ' O ' ' A' ' 79' ' ' GLY . 0.9 OUTLIER -131.18 179.9 5.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.729 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.656 ' O ' HD12 ' A' ' 78' ' ' LEU . . . -61.77 177.58 4.97 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.258 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -97.42 70.73 2.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.954 0.407 . . . . 0.0 110.84 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.606 HD11 HD12 ' A' ' 141' ' ' LEU . 40.0 mt -94.24 116.22 34.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.042 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.804 ' HB3' HD13 ' B' ' 170' ' ' LEU . 0.1 OUTLIER -54.8 -34.38 62.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.313 -179.806 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.518 ' HG3' ' HB3' ' A' ' 139' ' ' ASP . 1.5 mmt180 -60.84 -25.39 66.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.989 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.696 HD21 HG23 ' A' ' 132' ' ' VAL . 28.2 mt -96.03 149.92 21.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.302 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 57.9 p -93.6 169.69 10.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.604 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.694 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.3 m-20 -43.21 -53.62 4.99 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.449 0.642 . . . . 0.0 109.912 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.47 ' HB2' HD12 ' A' ' 104' ' ' ILE . 6.4 ptmt -121.3 84.08 2.18 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 177.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.532 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 15.4 t60 -60.81 -47.26 87.15 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.978 -176.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.552 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 12.8 p90 -147.43 162.12 39.67 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 119.872 -0.731 . . . . 0.0 112.065 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.726 ' HG3' HG23 ' A' ' 67' ' ' THR . 3.4 tt0 -135.67 146.26 47.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.532 -178.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.836 HD13 ' CE1' ' A' ' 68' ' ' PHE . 4.3 mp -124.03 132.08 71.92 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.337 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.452 178.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.841 HD21 ' HB2' ' A' ' 102' ' ' ASN . 0.2 OUTLIER -120.66 148.57 43.75 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.262 0.553 . . . . 0.0 112.214 -179.145 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.709 HD13 ' CG1' ' A' ' 33' ' ' VAL . 5.5 tp -125.42 122.87 37.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.822 178.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.56 -42.1 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.747 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -51.62 170.6 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.738 0.304 . . . . 0.0 111.137 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -79.82 72.89 6.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.98 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.567 ' H ' HD22 ' A' ' 155' ' ' LEU . . . 103.62 -32.71 7.26 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.651 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -77.36 156.92 30.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.818 0.342 . . . . 0.0 110.863 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.587 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -114.8 160.09 19.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.955 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.587 HD12 ' O ' ' A' ' 99' ' ' LEU . 4.4 mp -129.14 136.61 50.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.661 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.891 HD11 HD11 ' A' ' 130' ' ' ILE . 0.3 OUTLIER -112.96 120.23 40.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.338 179.913 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.841 ' HB2' HD21 ' A' ' 92' ' ' LEU . 60.9 t30 -112.12 119.1 37.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.879 0.371 . . . . 0.0 111.806 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.785 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.8 p30 -79.99 139.36 37.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.668 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.488 HG12 ' HA ' ' A' ' 89' ' ' PHE . 17.3 pt -146.48 36.16 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -178.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.628 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -97.68 150.72 20.87 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-O 121.014 0.435 . . . . 0.0 112.14 -178.936 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.704 HG21 ' HB ' ' B' ' 169' ' ' TPO . 20.6 m -68.67 -31.61 70.85 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.683 177.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -96.13 -19.82 19.09 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -178.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.628 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.14 155.25 10.5 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.998 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.1 m -117.37 137.84 52.19 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.827 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -116.12 148.37 40.36 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 -177.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.472 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.1 113.6 18.58 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.487 177.536 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.416 ' N ' HD12 ' A' ' 111' ' ' LEU . 2.6 m120 44.85 42.95 6.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.399 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.62 -12.2 64.0 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.585 178.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -104.64 118.57 36.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.08 0.44 . . . . 0.0 110.627 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.827 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -71.91 125.41 27.12 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.37 -179.718 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.785 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.7 m -94.7 165.46 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.852 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 120' ' ' SER . 8.5 tp10 -69.88 126.33 29.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.586 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.691 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 64.8 tttt -53.41 161.55 0.95 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.887 0.375 . . . . 0.0 110.386 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.46 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.7 p-10 36.25 33.8 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.239 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.43 145.08 40.8 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.034 179.296 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.621 ' OD1' HD11 ' A' ' 92' ' ' LEU . 34.7 m-80 -91.62 127.63 37.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.688 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -129.21 147.13 51.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.941 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.699 HD23 ' O ' ' A' ' 124' ' ' LEU . 7.9 tt -72.88 111.94 8.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.018 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.699 ' O ' HD23 ' A' ' 123' ' ' LEU . 0.3 OUTLIER -56.41 167.8 0.64 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.654 0.74 . . . . 0.0 112.0 -178.979 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.18 153.36 43.19 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.489 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.74 116.56 12.25 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.17 24.47 73.36 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.923 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -60.09 179.74 0.13 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 120.799 0.333 . . . . 0.0 110.837 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.759 ' CG ' HG22 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -145.05 135.38 24.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.254 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.891 HD11 HD11 ' A' ' 101' ' ' LEU . 8.5 mt -116.82 127.72 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.098 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.582 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.0 m -104.43 140.1 38.41 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.696 HG23 HD21 ' A' ' 84' ' ' LEU . 35.6 m -140.16 158.35 25.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.139 0.495 . . . . 0.0 112.198 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.23 28.69 29.91 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.649 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.471 ' HA ' HG12 ' A' ' 140' ' ' ILE . 68.8 t -74.52 140.55 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-O 121.64 0.733 . . . . 0.0 112.186 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.711 ' HA3' HG21 ' B' ' 172' ' ' ILE . . . 147.78 -43.5 0.83 Allowed Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.941 ' CG2' HD13 ' B' ' 172' ' ' ILE . 1.9 t -111.97 128.9 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -50.58 -43.43 56.54 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.7 p -93.56 6.74 47.23 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -178.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.518 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . 5.7 m-20 -119.61 34.42 5.22 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -178.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.582 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.2 mt -107.29 139.79 27.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.822 178.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.606 HD12 HD11 ' A' ' 81' ' ' ILE . 8.6 tt -120.97 134.69 55.3 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.949 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.575 ' HB2' ' CG2' ' A' ' 40' ' ' THR . 1.0 OUTLIER -109.99 139.48 45.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.058 0.456 . . . . 0.0 111.904 -179.375 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 40.7 mt -131.7 143.6 50.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.917 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.759 HG22 ' CG ' ' A' ' 129' ' ' GLU . 22.3 t -114.25 131.77 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 120.704 0.288 . . . . 0.0 111.132 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.558 HG21 ' CD2' ' A' ' 124' ' ' LEU . 1.5 mm -106.21 130.92 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-O 120.864 0.364 . . . . 0.0 110.755 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.75 112.01 21.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.954 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.488 HG21 ' HE3' ' A' ' 152' ' ' LYS . 7.0 mt -84.86 129.57 37.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.292 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -75.95 126.68 31.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.972 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -73.92 -35.95 64.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.97 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.1 -45.08 91.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.616 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.45 ' CE2' ' CD1' ' A' ' 155' ' ' LEU . 37.4 t80 -58.15 -44.12 87.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.881 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.488 ' HE3' HG21 ' A' ' 147' ' ' ILE . 45.7 mttt -59.67 -40.88 89.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.998 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -59.1 -40.32 84.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.006 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 10.5 t -65.4 -45.96 81.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.017 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.567 HD22 ' H ' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -69.28 -44.57 71.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.933 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.89 -35.41 70.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.983 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -90.84 -34.23 15.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.893 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.6 p30 42.26 32.27 0.31 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.503 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 19.7 mtmt -124.97 142.79 51.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.891 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 5.7 m -98.48 125.11 51.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.077 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.26 80.93 2.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.843 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -121.76 31.42 6.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.928 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 14.1 pt -104.91 121.58 57.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.167 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.897 179.975 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 1.5 t30 . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.788 0.328 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -92.78 156.2 41.05 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.18 107.52 1.37 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.571 2.181 . . . . 0.0 112.228 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -110.7 162.34 14.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.989 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 169' ' ' TPO . . . . . 0.704 ' HB ' HG21 ' A' ' 106' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.804 HD13 ' HB3' ' A' ' 82' ' ' SER . 1.3 tt -75.9 150.81 37.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.229 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 171' ' ' GLU . . . . . 0.41 ' N ' ' HG ' ' B' ' 170' ' ' LEU . 41.4 mt-10 -147.0 131.84 18.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.465 179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 0.941 HD13 ' CG2' ' A' ' 136' ' ' VAL . 3.0 tp -51.28 139.42 6.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.079 0.466 . . . . 0.0 111.55 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 173' ' ' TYR . . . . . 0.694 ' H ' HD12 ' B' ' 172' ' ' ILE . 2.6 p90 -71.78 139.48 49.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.667 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.34 -0.838 . . . . 0.0 110.878 -179.956 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.876 0.37 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.64 -68.56 0.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.838 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -71.53 -30.61 66.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -36.78 77.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -60.54 -42.41 96.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 tp -59.85 -42.78 94.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.888 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.523 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.3 mm -71.23 -35.12 56.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.16 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -57.14 -35.98 70.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.915 0.388 . . . . 0.0 110.409 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -67.24 -23.92 65.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.787 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.523 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.67 -47.54 79.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.148 -179.814 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.23 -43.04 71.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.895 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -131.62 134.02 45.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.916 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.23 130.2 40.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.914 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -77.28 137.93 39.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.923 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.3 mm -81.98 138.35 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-O 121.685 0.755 . . . . 0.0 111.704 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.65 47.48 76.57 Favored Glycine 0 C--N 1.314 -0.684 0 CA-C-N 114.546 -1.206 . . . . 0.0 112.33 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.78 -40.19 96.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.754 0.311 . . . . 0.0 111.052 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.1 t-20 175.05 39.86 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.2 mm -72.81 134.95 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 CA-C-N 113.621 -1.627 . . . . 0.0 112.407 -177.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.0 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.2 t -92.56 -60.55 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.099 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.474 ' SG ' HD22 ' A' ' 48' ' ' LEU . 21.8 p -142.97 164.66 29.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.381 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.6 138.22 51.14 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.849 0.357 . . . . 0.0 111.326 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.741 HG11 ' CE2' ' A' ' 68' ' ' PHE . 3.2 m -107.45 122.64 61.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.841 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.804 HG23 HG12 ' A' ' 45' ' ' ILE . 18.4 mt -126.66 119.53 53.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.478 -179.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.759 ' HA ' HD13 ' A' ' 143' ' ' LEU . 23.1 t -79.78 111.38 16.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.808 0.337 . . . . 0.0 110.467 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.437 HG23 HG21 ' A' ' 144' ' ' VAL . 0.1 OUTLIER -82.15 -23.73 35.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.825 -179.163 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.518 HG23 ' HB3' ' A' ' 142' ' ' SER . 74.5 p -79.91 -2.25 42.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.788 0.327 . . . . 0.0 111.48 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.8 75.77 0.36 Allowed Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.821 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.554 ' CD ' HD11 ' A' ' 141' ' ' LEU . 9.7 mt-30 -146.6 -40.95 0.2 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.878 0.37 . . . . 0.0 111.053 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.559 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.7 mt -123.28 141.54 36.31 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.053 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.559 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.4 Cg_endo -72.63 146.01 42.82 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.33 2.02 . . . . 0.0 112.239 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.804 HG12 HG23 ' A' ' 37' ' ' ILE . 35.8 mt -55.51 148.98 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.677 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.43 164.15 28.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.152 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.33 119.74 31.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.993 0.425 . . . . 0.0 111.982 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.734 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.7 mp -95.81 125.48 40.41 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . 1.0 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -135.51 157.39 47.0 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -178.8 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.502 ' HB3' ' CD2' ' A' ' 93' ' ' LEU . . . -148.82 148.91 30.47 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.638 -1.619 . . . . 0.0 110.81 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.645 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -74.98 134.88 41.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.062 0.458 . . . . 0.0 111.185 -179.827 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.621 HD13 ' SG ' ' A' ' 154' ' ' CYS . 79.2 mt -64.31 -43.87 97.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.696 -0.683 . . . . 0.0 112.061 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.86 -38.56 72.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.346 0.593 . . . . 0.0 110.678 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.449 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 4.0 mm-40 -68.5 -36.92 79.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.607 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 51' ' ' ASP . 45.8 t -72.36 -43.54 64.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.127 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.7 tp -70.94 -32.18 69.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.998 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.15 -42.7 36.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.965 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -82.9 120.69 26.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.972 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.22 30.38 1.78 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.908 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -119.07 -51.04 2.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.865 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.94 -168.87 2.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.915 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.603 HG21 ' CG2' ' A' ' 65' ' ' VAL . 20.3 mm -66.3 158.51 5.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.032 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.461 ' N ' HG22 ' A' ' 62' ' ' ILE . 1.8 ptpt -126.07 -41.05 1.96 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.296 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.432 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.7 ttpt -142.9 123.87 14.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.974 0.416 . . . . 0.0 111.962 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.603 ' CG2' HG21 ' A' ' 62' ' ' ILE . 13.0 t -129.99 139.43 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.218 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.734 ' CD2' HD23 ' A' ' 48' ' ' LEU . 17.8 m-90 -100.92 139.63 36.35 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.983 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.656 HG23 ' CD ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -109.58 133.04 53.57 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 177.968 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.741 ' CE2' HG11 ' A' ' 36' ' ' VAL . 1.1 m-85 -120.19 145.52 46.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.055 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.763 ' CA ' HD21 ' A' ' 78' ' ' LEU . . . 159.56 -172.38 36.16 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.874 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.453 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 9.5 mtp-105 -80.31 3.7 20.16 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.469 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 5.1 t-20 -84.88 133.46 43.41 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 120.659 0.266 . . . . 0.0 110.988 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 13.2 Cg_exo -68.28 -10.28 28.47 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.646 2.231 . . . . 0.0 111.88 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.408 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -83.29 -43.44 16.02 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-O 122.001 0.905 . . . . 0.0 108.952 179.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.19 136.41 2.24 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 113.658 -1.61 . . . . 0.0 111.278 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -56.71 -18.38 12.22 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.153 179.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.531 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 66.7 t80 -129.32 112.1 13.52 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-O 120.812 0.339 . . . . 0.0 111.071 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -94.99 114.39 26.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.835 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.763 HD21 ' CA ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -97.2 -80.25 0.44 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.988 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.95 -131.17 1.19 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.576 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -141.6 60.77 1.48 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.887 0.375 . . . . 0.0 110.821 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.866 HD13 HD12 ' A' ' 84' ' ' LEU . 3.9 mp -88.61 120.21 37.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.012 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.753 ' C ' HD22 ' B' ' 170' ' ' LEU . 1.8 m -54.77 -42.94 72.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.878 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.565 ' CZ ' HG21 ' A' ' 136' ' ' VAL . 0.7 OUTLIER -60.88 -18.68 57.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.113 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.866 HD12 HD13 ' A' ' 81' ' ' ILE . 38.7 mt -107.0 152.17 24.34 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.661 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 95.3 p -96.83 163.98 12.75 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.768 0.318 . . . . 0.0 111.709 -179.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.631 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.6 m-20 -41.27 -52.48 3.41 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.532 0.682 . . . . 0.0 109.845 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.468 ' HB3' HD11 ' A' ' 104' ' ' ILE . 5.2 mttt -120.57 84.75 2.27 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 177.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.557 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.5 t60 -64.12 -45.76 87.13 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.023 -0.989 . . . . 0.0 113.252 -176.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.454 ' HA ' HG12 ' A' ' 104' ' ' ILE . 37.2 p90 -151.93 162.23 41.39 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.887 -0.725 . . . . 0.0 112.414 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.656 ' CD ' HG23 ' A' ' 67' ' ' THR . 11.0 mt-30 -135.55 154.3 51.42 Favored 'General case' 0 CA--C 1.522 -0.1 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.743 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.66 HG23 HD22 ' A' ' 101' ' ' LEU . 25.7 mt -119.91 132.19 70.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 177.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.58 HD12 HD12 ' A' ' 62' ' ' ILE . 0.6 OUTLIER -118.71 140.18 50.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.111 0.481 . . . . 0.0 112.254 -178.547 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.801 HD13 ' CG1' ' A' ' 33' ' ' VAL . 11.0 tp -125.36 128.83 48.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.088 178.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 160.88 -138.49 5.51 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.595 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 64.51 -78.88 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.751 0.31 . . . . 0.0 110.793 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -130.15 -42.07 1.24 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.995 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 167.27 -28.94 0.17 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.512 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -60.46 -174.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.842 0.353 . . . . 0.0 110.859 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.499 ' HB3' HD12 ' A' ' 124' ' ' LEU . 3.2 mm? -113.17 145.89 40.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.848 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.844 HD22 ' HB3' ' A' ' 121' ' ' ASN . 6.5 mt -133.08 140.95 47.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.096 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.66 HD22 HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -112.6 126.05 54.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.473 -179.782 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.403 ' HB2' HD23 ' A' ' 92' ' ' LEU . 48.8 t30 -114.07 115.51 27.67 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.491 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.851 ' OD2' HG23 ' A' ' 116' ' ' VAL . 9.5 p30 -79.21 143.24 35.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.942 178.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.516 HG21 ' OE1' ' A' ' 90' ' ' GLN . 9.7 pt -150.02 35.27 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -178.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.654 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -95.78 150.97 19.81 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 121.118 0.485 . . . . 0.0 112.09 -178.78 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.706 ' CB ' HG21 ' B' ' 169' ' ' TPO . 22.9 m -68.72 -31.39 70.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.791 177.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -97.76 -19.72 18.02 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.654 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 118.14 155.88 10.13 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.334 -0.936 . . . . 0.0 114.062 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 11.5 m -117.26 137.83 52.13 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.851 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -116.24 148.29 40.61 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.761 1.022 . . . . 0.0 113.761 -178.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.2 113.52 18.41 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.612 -1.177 . . . . 0.0 108.444 177.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.7 m120 43.62 43.72 4.89 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.375 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.32 -12.3 65.15 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.382 178.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 9.4 mp0 -103.74 118.59 37.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.053 0.454 . . . . 0.0 110.601 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.851 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.0 tptt -73.16 124.7 26.11 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.215 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.851 HG23 ' OD2' ' A' ' 103' ' ' ASP . 13.0 m -94.92 162.37 2.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.154 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 120' ' ' SER . 4.3 pm0 -69.94 126.37 29.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.47 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.687 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 18.6 tttm -51.42 160.52 0.57 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.015 0.435 . . . . 0.0 111.046 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.7 p-10 34.96 33.67 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.432 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.55 145.14 40.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.164 179.262 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.844 ' HB3' HD22 ' A' ' 100' ' ' LEU . 1.3 m-80 -87.42 127.51 35.22 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.048 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.697 ' O ' HD23 ' A' ' 100' ' ' LEU . 34.6 mm-40 -129.35 146.3 51.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.743 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.4 tp -72.9 112.43 8.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.173 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.566 HD22 HG21 ' A' ' 145' ' ' ILE . 3.2 mt -59.97 167.32 2.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.676 0.75 . . . . 0.0 111.886 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.408 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.0 OUTLIER -125.36 153.42 43.39 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.319 179.425 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -71.41 120.92 17.68 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.58 19.2 66.72 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.055 -178.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.408 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 14.3 t70 -58.06 177.44 0.12 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 120.794 0.33 . . . . 0.0 110.791 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.887 ' CG ' HG22 ' A' ' 144' ' ' VAL . 10.7 mt-10 -145.11 135.54 24.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.247 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.443 HG23 ' O ' ' A' ' 110' ' ' TRP . 6.0 mt -114.0 128.47 70.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.075 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.63 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.7 m -103.89 140.11 38.14 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.535 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 31.0 m -140.18 158.32 25.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.135 0.493 . . . . 0.0 112.279 -178.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.75 27.61 28.8 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.01 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.445 ' HB ' ' CZ3' ' A' ' 110' ' ' TRP . 77.3 t -73.4 140.46 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-O 121.616 0.722 . . . . 0.0 112.063 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.554 ' C ' HD12 ' B' ' 172' ' ' ILE . . . 147.43 -40.33 0.99 Allowed Glycine 0 N--CA 1.434 -1.455 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.565 HG21 ' CZ ' ' A' ' 83' ' ' ARG . 2.1 t -117.38 126.82 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -50.47 -40.1 49.96 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.2 m -93.44 6.66 47.41 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -178.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.482 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.7 OUTLIER -120.17 33.34 5.64 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -178.444 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.63 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.6 mt -107.09 138.83 31.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.384 0.611 . . . . 0.0 110.824 178.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.554 HD11 ' CD ' ' A' ' 42' ' ' GLN . 0.3 OUTLIER -124.46 134.64 52.99 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.533 -179.871 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.587 ' C ' HD22 ' A' ' 143' ' ' LEU . 42.2 t -110.29 150.44 28.73 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.615 0.721 . . . . 0.0 112.422 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.759 HD13 ' HA ' ' A' ' 38' ' ' CYS . 3.0 mm? -135.84 148.5 48.69 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.319 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.887 HG22 ' CG ' ' A' ' 129' ' ' GLU . 20.1 t -114.2 134.86 55.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.892 0.377 . . . . 0.0 111.281 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.566 HG21 HD22 ' A' ' 124' ' ' LEU . 2.3 mm -106.37 122.89 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.624 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.06 114.33 26.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.894 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 7.9 mm -84.95 129.35 37.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.06 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -75.88 107.92 8.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.845 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.3 -31.86 69.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.87 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -45.52 91.66 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.592 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -58.73 -44.22 90.4 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.88 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -65.17 -39.63 93.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.995 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -59.05 -46.39 88.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.971 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.621 ' SG ' HD13 ' A' ' 52' ' ' ILE . 9.1 t -65.97 -44.07 86.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.948 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.47 -36.0 82.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.13 -45.72 93.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.969 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -82.1 -36.52 27.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.887 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 42.43 76.36 0.08 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.476 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.2 ttmm -69.96 122.94 20.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.875 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.608 HG11 ' HD2' ' A' ' 164' ' ' ARG . 30.5 m -88.57 136.46 23.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.119 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -68.7 -74.18 0.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.856 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.7 mtm180 -149.94 -48.13 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.862 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.3 mt -100.76 136.69 31.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.111 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.608 ' HD2' HG11 ' A' ' 160' ' ' VAL . 8.4 ptt85 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.977 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.905 0.383 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 166' ' ' ASP . . . . . 0.403 ' HA ' ' HD2' ' B' ' 167' ' ' PRO . 7.1 m-20 -97.08 100.67 7.99 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.803 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 167' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' B' ' 166' ' ' ASP . 39.4 Cg_endo -67.1 176.29 4.76 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.329 2.019 . . . . 0.0 112.303 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.09 65.43 0.37 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.022 0.439 . . . . 0.0 110.843 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 169' ' ' TPO . . . . . 0.706 HG21 ' CB ' ' A' ' 106' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.753 HD22 ' C ' ' A' ' 82' ' ' SER . 0.6 OUTLIER -90.12 148.41 23.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.002 -179.756 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 171' ' ' GLU . . . . . 0.599 ' O ' HG22 ' B' ' 172' ' ' ILE . 3.4 mt-10 -143.84 49.72 1.37 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.876 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 0.599 HG22 ' O ' ' B' ' 171' ' ' GLU . 9.5 tt 50.72 152.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.206 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 173' ' ' TYR . . . . . 0.462 ' N ' HG12 ' B' ' 172' ' ' ILE . 3.0 p90 -86.21 -178.28 6.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.76 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 10.7 t . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.264 -0.875 . . . . 0.0 110.918 179.98 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.824 0.345 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -108.38 -64.32 1.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.837 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -68.81 -40.44 79.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.883 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -37.04 86.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.816 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -57.95 -39.85 79.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.784 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.7 -31.98 73.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.679 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.434 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.4 mt -73.23 -35.41 46.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.826 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.48 -43.11 83.83 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.968 0.413 . . . . 0.0 110.385 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.02 -23.81 65.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.607 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.434 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.74 -47.51 79.87 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.25 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 m -76.7 -47.09 23.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.913 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -105.51 51.75 0.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.673 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.62 121.18 22.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.004 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -64.96 101.96 0.56 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.319 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.6 mm -81.92 138.15 19.99 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.461 0 CA-C-O 121.794 0.807 . . . . 0.0 111.855 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.441 ' HA2' ' CG1' ' A' ' 32' ' ' ILE . . . 62.76 109.94 0.01 OUTLIER Glycine 0 C--N 1.314 -0.676 0 CA-C-N 114.305 -1.316 . . . . 0.0 112.712 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -86.85 -29.28 22.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.739 0.304 . . . . 0.0 110.94 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.435 ' O ' ' HB3' ' A' ' 49' ' ' SER . 2.0 m-20 -177.41 36.86 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.734 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.5 mm -75.77 135.65 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 CA-C-N 113.754 -1.566 . . . . 0.0 112.639 -177.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.038 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.0 t -90.81 -60.24 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.953 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.0 p -148.19 150.12 33.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.137 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.98 138.14 50.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.889 0.376 . . . . 0.0 111.622 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.521 HG21 ' HE2' ' A' ' 68' ' ' PHE . 12.9 p -104.64 122.75 58.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.642 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.808 HG23 HG12 ' A' ' 45' ' ' ILE . 20.3 mt -127.73 125.56 65.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.706 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.602 ' SG ' HD21 ' A' ' 141' ' ' LEU . 3.5 t -89.75 104.64 17.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.195 179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.9 p -81.55 -22.56 37.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.962 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.736 HG23 ' HB2' ' A' ' 142' ' ' SER . 67.8 p -79.81 -2.64 44.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.809 0.337 . . . . 0.0 111.496 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.29 74.93 0.48 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.833 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.506 ' HB2' HD21 ' A' ' 141' ' ' LEU . 0.5 OUTLIER -146.26 -36.19 0.26 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.808 0.337 . . . . 0.0 111.13 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.821 HD13 HD22 ' A' ' 78' ' ' LEU . 15.8 mt -131.72 141.9 43.29 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.947 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.578 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 48.7 Cg_endo -71.01 146.0 51.35 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.19 1.927 . . . . 0.0 112.357 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.808 HG12 HG23 ' A' ' 37' ' ' ILE . 36.4 mt -61.35 148.61 9.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.769 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.94 164.3 30.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.162 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -120.98 119.86 33.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.1 0.476 . . . . 0.0 111.847 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.611 HD22 ' CD1' ' A' ' 66' ' ' TRP . 10.4 mt -96.05 136.09 36.97 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . 1.038 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.97 158.7 44.0 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 -178.669 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.485 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -139.79 141.81 36.73 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 113.542 -1.663 . . . . 0.0 110.559 178.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.819 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.4 OUTLIER -79.31 141.1 37.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.222 0.534 . . . . 0.0 111.281 -179.526 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.52 HD13 ' SG ' ' A' ' 154' ' ' CYS . 64.5 mt -65.11 -45.35 94.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.254 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.3 p -60.13 -43.05 95.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.869 -178.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.525 ' HG3' ' O ' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -68.77 -36.87 78.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.924 0.392 . . . . 0.0 110.515 179.747 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.819 HG23 ' O ' ' A' ' 51' ' ' ASP . 64.5 t -71.05 -37.99 69.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.917 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.4 tp -70.13 -30.79 68.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.923 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.4 mttt -80.49 -47.06 14.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.941 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.95 116.94 5.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.904 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.88 29.86 3.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.769 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.71 -55.15 3.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.9 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.7 t -177.94 -39.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.954 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.443 ' CD1' ' HB2' ' A' ' 92' ' ' LEU . 8.8 tp -129.17 153.37 38.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.232 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.765 ' HG2' HG13 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -111.09 -67.69 0.98 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.855 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.422 ' HE2' ' O ' ' A' ' 49' ' ' SER . 4.0 ttpt -141.15 138.19 33.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.985 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 91' ' ' ILE . 14.2 t -132.16 139.4 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 121.255 0.55 . . . . 0.0 112.374 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.611 ' CD1' HD22 ' A' ' 48' ' ' LEU . 16.6 m-90 -104.58 139.51 39.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.943 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.625 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.57 125.82 54.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.123 0.487 . . . . 0.0 110.078 177.694 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.533 ' CD2' ' CD2' ' A' ' 76' ' ' TYR . 2.2 m-85 -109.73 145.48 36.53 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.061 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 157.73 -172.1 34.94 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.41 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.501 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 9.3 mtp-105 -76.92 2.45 14.69 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 0.2 OUTLIER -84.54 130.93 51.57 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.517 0.199 . . . . 0.0 110.976 -179.628 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 18.9 Cg_exo -65.54 -13.99 42.6 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.387 2.058 . . . . 0.0 111.501 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.02 -42.37 17.58 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-O 121.849 0.833 . . . . 0.0 108.839 178.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -42.05 138.32 1.62 Allowed 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.8 179.685 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.9 OUTLIER -56.33 -18.6 11.3 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.164 179.1 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.533 ' CD2' ' CD2' ' A' ' 68' ' ' PHE . 13.2 t80 -129.28 119.46 24.0 Favored 'General case' 0 CA--C 1.527 0.09 0 CA-C-O 120.758 0.313 . . . . 0.0 111.196 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -99.98 117.68 34.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.677 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.821 HD22 HD13 ' A' ' 43' ' ' ILE . 1.4 mt -88.85 -69.09 0.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.017 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 171.92 -85.67 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.519 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -174.46 49.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.901 0.382 . . . . 0.0 111.084 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.501 ' N ' ' HD2' ' A' ' 70' ' ' ARG . 30.1 mm -79.99 123.86 37.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.198 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.785 ' HB2' HD13 ' B' ' 170' ' ' LEU . 90.2 p -54.72 -41.16 69.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.254 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.521 ' N ' HD22 ' B' ' 170' ' ' LEU . 8.5 tpt85 -63.71 -49.16 74.19 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.437 ' CD1' HD13 ' A' ' 78' ' ' LEU . 16.7 mt -73.88 148.26 42.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.06 0.457 . . . . 0.0 111.856 -179.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.7 p -95.11 165.27 12.5 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.855 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.575 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.0 m-20 -41.5 -53.16 3.51 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.434 0.635 . . . . 0.0 110.21 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.443 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 8.5 ptpp? -123.8 81.96 1.97 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 177.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.558 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.9 t60 -59.73 -46.69 88.36 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.981 -1.009 . . . . 0.0 112.988 -176.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.514 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 23.6 p90 -147.65 160.55 42.55 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.116 -0.634 . . . . 0.0 111.621 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.625 ' HG3' HG23 ' A' ' 67' ' ' THR . 29.6 tt0 -135.94 139.75 43.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.555 -178.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.629 ' O ' HG13 ' A' ' 65' ' ' VAL . 17.5 mt -112.37 131.51 63.65 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.233 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.673 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.677 HD23 ' H ' ' A' ' 92' ' ' LEU . 1.8 pt? -118.93 146.83 44.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.044 0.45 . . . . 0.0 111.605 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.524 HD13 ' HG ' ' A' ' 99' ' ' LEU . 14.3 tp -125.11 122.9 38.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.396 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.407 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . -167.28 -156.46 9.86 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.628 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 60.14 -169.85 0.15 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.793 0.33 . . . . 0.0 110.869 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -82.09 59.66 4.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.824 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 101.13 -168.3 19.99 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.43 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 30.3 m120 60.92 178.57 0.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.868 0.366 . . . . 0.0 110.985 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.955 HD11 HG12 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -131.44 160.1 36.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.713 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.49 ' HB3' HD21 ' A' ' 92' ' ' LEU . 1.2 mp -127.33 144.58 51.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.327 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.761 HD11 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -112.77 124.72 53.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.283 -179.921 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.646 ' HB2' HD22 ' A' ' 92' ' ' LEU . 53.7 t30 -118.19 115.53 24.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.978 0.418 . . . . 0.0 111.45 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.825 ' OD2' HG23 ' A' ' 116' ' ' VAL . 8.8 p30 -79.07 142.44 36.48 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.095 178.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.499 HD11 HG22 ' A' ' 67' ' ' THR . 16.7 pt -151.09 37.59 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.602 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -95.18 155.38 16.76 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 121.0 0.429 . . . . 0.0 111.55 -179.304 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 82.8 m -68.82 -34.37 75.39 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.331 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 19.9 p30 -98.65 -19.87 17.29 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.602 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 122.6 156.67 9.7 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.279 -0.963 . . . . 0.0 113.749 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.507 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.4 m -117.35 137.9 52.14 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.855 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -116.26 148.34 40.59 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -178.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.468 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.15 113.39 18.27 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.284 177.441 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.41 ' N ' HD12 ' A' ' 111' ' ' LEU . 3.2 m120 44.41 42.92 5.8 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.385 -179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.27 -7.97 78.64 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.841 -0.695 . . . . 0.0 113.484 178.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.19 118.67 37.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.035 0.445 . . . . 0.0 110.688 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.855 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 9.6 tptp -74.16 118.28 16.93 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.236 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.825 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.4 m -90.73 164.23 2.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.14 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 120' ' ' SER . 33.8 tt0 -69.83 127.71 33.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.436 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.687 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 25.3 tttt -53.58 160.92 1.15 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.975 0.417 . . . . 0.0 110.599 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 34.18 35.32 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.351 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.24 145.06 40.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.222 179.435 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.457 ' HB3' HD23 ' A' ' 100' ' ' LEU . 14.2 m120 -83.73 128.75 34.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.748 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.409 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 4.2 mm100 -129.31 145.76 51.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.594 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.449 HD22 ' HA ' ' A' ' 123' ' ' LEU . 1.5 tm? -72.99 118.09 15.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.254 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.599 HD21 HG12 ' A' ' 147' ' ' ILE . 65.0 tp -56.41 157.25 5.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.359 0.6 . . . . 0.0 111.549 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.451 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.8 OUTLIER -124.53 153.14 42.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.592 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.436 ' HA ' HD12 ' A' ' 147' ' ' ILE . 8.6 tp60 -71.71 124.32 24.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.015 0.436 . . . . 0.0 110.61 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.37 20.65 45.43 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.344 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.451 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 9.8 t70 -58.71 173.22 0.43 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.942 0.401 . . . . 0.0 110.835 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 18.8 tt0 -145.17 135.6 24.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.106 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.897 HD11 HD11 ' A' ' 145' ' ' ILE . 5.5 mt -108.8 128.64 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.313 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.641 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.1 m -103.75 136.64 43.06 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.54 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 29.8 m -138.08 158.38 32.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.183 0.516 . . . . 0.0 112.381 -178.204 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.483 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 82.96 38.62 11.13 Favored Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.954 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.441 ' HA ' HG12 ' A' ' 140' ' ' ILE . 56.5 t -79.84 140.47 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-O 121.676 0.75 . . . . 0.0 112.203 -179.076 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.48 -46.16 0.64 Allowed Glycine 0 N--CA 1.435 -1.371 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.712 ' CG2' HD11 ' B' ' 172' ' ' ILE . 0.9 OUTLIER -127.19 125.49 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 CA-C-N 114.259 -0.97 . . . . 0.0 108.827 177.975 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.417 ' HA ' HD12 ' A' ' 140' ' ' ILE . 0.1 OUTLIER -49.92 -24.79 2.72 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -177.87 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.0 t -93.05 -0.36 57.13 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.434 ' N ' HG12 ' A' ' 136' ' ' VAL . 79.1 m-20 -120.05 25.61 9.8 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -178.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.641 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.4 mt -106.88 138.72 31.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-O 121.405 0.621 . . . . 0.0 111.559 178.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.602 HD21 ' SG ' ' A' ' 38' ' ' CYS . 1.6 tt -124.5 134.49 53.0 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.392 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.736 ' HB2' HG23 ' A' ' 40' ' ' THR . 2.1 m -107.02 142.17 37.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.158 0.504 . . . . 0.0 111.976 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.595 ' CD2' HD22 ' A' ' 141' ' ' LEU . 2.1 mm? -135.34 137.74 42.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.448 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 21.1 t -110.79 137.79 41.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.88 0.371 . . . . 0.0 111.236 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.897 HD11 HD11 ' A' ' 130' ' ' ILE . 52.6 mt -106.22 128.32 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.399 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.94 114.96 27.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.364 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.599 HG12 HD21 ' A' ' 124' ' ' LEU . 6.5 mt -84.73 130.93 35.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.951 0.405 . . . . 0.0 111.618 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -78.97 111.95 15.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.752 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -61.38 -33.13 73.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.139 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -45.99 91.2 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.034 0.445 . . . . 0.0 110.843 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -60.5 -44.13 96.3 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.05 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.51 -34.43 69.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.097 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -62.42 -46.59 87.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.862 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.52 ' SG ' HD13 ' A' ' 52' ' ' ILE . 10.4 t -66.28 -45.18 81.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.92 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.5 -44.01 84.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.793 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -70.33 -33.46 71.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.039 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.455 ' O ' ' C ' ' A' ' 158' ' ' ASN . 2.1 tt0 -73.06 -15.55 61.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.114 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 157' ' ' GLN . 12.3 p-10 -24.85 -46.87 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 157' ' ' GLN . 4.2 tttt -125.06 133.32 52.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.778 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.4 t -78.61 134.35 28.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.11 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -152.91 109.55 3.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.02 98.32 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.835 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 21.7 mt -84.93 138.38 19.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.154 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.898 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.782 0.325 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.47 163.92 47.34 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.951 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.39 144.87 63.27 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.588 2.192 . . . . 0.0 112.214 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -99.97 80.78 2.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.049 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 169' ' ' TPO . . . . . 0.478 HG23 ' N ' ' B' ' 170' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.785 HD13 ' HB2' ' A' ' 82' ' ' SER . 0.1 OUTLIER -117.89 144.11 45.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.993 -179.234 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 171' ' ' GLU . . . . . 0.668 ' O ' HG22 ' B' ' 172' ' ' ILE . 3.3 mm-40 -119.67 47.15 1.77 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.505 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 0.712 HD11 ' CG2' ' A' ' 136' ' ' VAL . 4.5 tp 51.77 162.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.873 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 173' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -99.78 121.94 42.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.815 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.898 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.849 0.357 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.1 p -150.82 -58.32 0.17 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -61.13 -41.25 96.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.957 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -38.34 82.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.911 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -64.69 -35.05 79.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.889 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.37 -41.59 96.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.935 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.431 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 7.2 mm -68.45 -35.27 69.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.194 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -57.19 -45.82 83.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.895 0.378 . . . . 0.0 110.341 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -67.0 -23.76 65.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.381 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.5 -47.42 79.32 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.293 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.6 m -67.34 -31.33 71.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.867 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -156.51 112.25 2.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.791 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -77.63 133.28 38.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -88.44 107.51 18.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.932 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.2 mm -82.04 138.33 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 CA-C-O 121.595 0.712 . . . . 0.0 111.81 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 137.34 65.43 0.05 OUTLIER Glycine 0 C--N 1.313 -0.699 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.428 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -82.25 -37.65 25.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.732 0.301 . . . . 0.0 110.94 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.41 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER 176.42 39.6 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.668 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -74.79 135.62 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 CA-C-N 113.63 -1.623 . . . . 0.0 112.404 -177.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.978 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.3 t -91.93 -59.46 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.923 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.47 ' SG ' HD22 ' A' ' 48' ' ' LEU . 4.8 p -148.31 165.17 31.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.482 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.99 138.29 51.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.831 0.348 . . . . 0.0 111.399 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.696 HG21 ' CE2' ' A' ' 68' ' ' PHE . 47.6 t -111.18 122.81 66.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.563 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.828 HG23 HG12 ' A' ' 45' ' ' ILE . 19.0 mt -122.25 120.06 60.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.857 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.548 ' SG ' HD13 ' A' ' 43' ' ' ILE . 0.9 OUTLIER -83.96 104.07 13.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.039 179.14 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.96 -20.88 48.09 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.585 HG21 ' H ' ' A' ' 142' ' ' SER . 72.8 p -79.85 -2.41 43.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.803 0.335 . . . . 0.0 111.547 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.72 75.12 0.44 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.819 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.642 ' HB2' HD12 ' A' ' 43' ' ' ILE . 9.5 mt-30 -145.84 -40.01 0.23 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.893 0.378 . . . . 0.0 110.88 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.642 HD12 ' HB2' ' A' ' 42' ' ' GLN . 4.4 mp -125.4 142.69 42.38 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.038 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.622 ' HD2' HG23 ' A' ' 43' ' ' ILE . 50.7 Cg_endo -70.75 145.86 52.58 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.207 1.938 . . . . 0.0 112.131 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.828 HG12 HG23 ' A' ' 37' ' ' ILE . 35.2 mt -62.93 138.95 22.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.77 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.43 163.98 25.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.951 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -124.38 119.88 30.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.082 0.468 . . . . 0.0 111.854 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.823 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.6 mp -85.88 132.08 34.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.558 178.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.978 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -140.31 155.81 46.68 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 122.281 1.038 . . . . 0.0 113.423 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.477 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.08 141.84 29.18 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 113.533 -1.667 . . . . 0.0 110.798 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.722 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -76.07 135.89 39.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.256 0.551 . . . . 0.0 111.198 -179.625 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.714 HD13 ' SG ' ' A' ' 154' ' ' CYS . 68.3 mt -64.83 -38.9 83.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.048 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.1 p -60.92 -42.72 98.67 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.721 -178.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' A' ' 51' ' ' ASP . 5.6 pt20 -68.56 -36.94 79.46 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.465 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.786 HG13 ' HG3' ' A' ' 63' ' ' LYS . 59.2 t -65.08 -44.04 95.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.966 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.5 tp -71.03 -30.97 67.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.887 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.88 -48.27 18.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.968 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.84 136.86 56.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.914 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.3 30.73 1.95 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.03 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.3 -58.14 2.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.857 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.09 -63.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.91 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.496 HG21 ' CG2' ' A' ' 65' ' ' VAL . 20.3 mm -110.51 145.22 17.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.094 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.786 ' HG3' HG13 ' A' ' 55' ' ' VAL . 1.6 mmtp -96.88 -46.95 6.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.006 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.416 ' CE ' ' O ' ' A' ' 49' ' ' SER . 4.1 ttpt -155.01 140.34 17.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.192 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.598 HG13 ' O ' ' A' ' 91' ' ' ILE . 17.4 t -130.67 139.21 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 121.34 0.59 . . . . 0.0 112.084 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.823 ' CD2' HD23 ' A' ' 48' ' ' LEU . 16.2 m-90 -105.44 138.71 41.19 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.952 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.456 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -112.01 131.95 55.1 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.493 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.696 ' HZ ' HD21 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -117.11 145.61 43.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.679 -178.316 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.673 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.92 -171.97 37.96 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.596 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 4.6 mtm105 -83.14 3.36 31.08 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.48 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.0 t30 -85.07 135.06 39.94 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.627 0.251 . . . . 0.0 110.95 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.8 Cg_exo -65.95 -11.83 32.67 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.613 2.209 . . . . 0.0 111.728 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.429 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.86 -45.31 14.4 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 121.952 0.882 . . . . 0.0 108.827 178.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.59 137.55 5.07 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 113.892 -1.504 . . . . 0.0 110.692 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.6 OUTLIER -56.66 -18.14 11.22 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.232 179.028 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.456 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 9.9 t80 -125.23 118.51 26.19 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-O 120.782 0.325 . . . . 0.0 110.928 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -99.77 115.73 30.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.543 HD11 ' HA2' ' A' ' 69' ' ' GLY . 2.6 mt -90.2 -168.28 2.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.093 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -91.68 19.36 48.6 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.828 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 63.88 84.31 0.15 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.865 0.365 . . . . 0.0 111.538 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.92 HD13 HD12 ' A' ' 84' ' ' LEU . 3.4 mp -108.3 131.4 58.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.714 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.459 ' C ' HD22 ' B' ' 170' ' ' LEU . 2.4 m -54.88 -39.55 68.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.03 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.511 ' NH1' HG23 ' A' ' 136' ' ' VAL . 1.9 tpt180 -66.37 -45.49 79.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.907 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.92 HD12 HD13 ' A' ' 81' ' ' ILE . 42.6 mt -72.81 151.54 42.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.892 0.377 . . . . 0.0 111.641 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.0 p -95.83 166.98 11.54 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.733 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.673 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.7 m-20 -43.85 -54.18 5.45 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.282 0.563 . . . . 0.0 109.842 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.455 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.6 OUTLIER -120.04 83.06 1.99 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.163 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.576 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 9.4 t60 -62.12 -46.32 89.54 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.791 -176.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.517 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 18.4 p90 -146.5 157.93 43.82 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.672 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.568 ' HG2' HG12 ' A' ' 65' ' ' VAL . 29.4 tt0 -135.94 140.66 44.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.332 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.755 HG12 HD13 ' A' ' 101' ' ' LEU . 39.3 mt -114.76 132.11 64.92 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.912 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.675 HD12 ' HB2' ' A' ' 100' ' ' LEU . 0.4 OUTLIER -123.59 146.28 48.28 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.141 0.496 . . . . 0.0 111.704 -179.805 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.761 HD13 ' HG ' ' A' ' 99' ' ' LEU . 14.5 tp -125.02 122.87 38.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.219 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 62' ' ' ILE . . . -164.68 84.78 0.1 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.529 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 176.95 -167.81 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 0.0 110.752 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.63 ' HA ' HD12 ' A' ' 155' ' ' LEU . 42.2 m-20 -83.98 57.77 4.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.886 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 100.02 -19.54 52.68 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.603 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.636 ' C ' HD12 ' A' ' 99' ' ' LEU . 47.6 m-20 -71.74 147.41 47.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.947 0.403 . . . . 0.0 110.996 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.761 ' HG ' HD13 ' A' ' 93' ' ' LEU . 7.6 mp -118.27 159.99 22.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.722 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.675 ' HB2' HD12 ' A' ' 92' ' ' LEU . 16.1 mt -133.1 146.58 51.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.879 0.371 . . . . 0.0 110.808 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.755 HD13 HG12 ' A' ' 91' ' ' ILE . 2.3 mm? -112.72 123.57 50.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.854 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -112.95 115.51 28.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.04 0.448 . . . . 0.0 111.229 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.823 ' OD2' HG23 ' A' ' 116' ' ' VAL . 15.1 p30 -81.34 133.19 35.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.874 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.461 HG12 ' HA ' ' A' ' 89' ' ' PHE . 19.2 pt -140.9 38.66 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.543 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -100.76 154.03 18.96 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 120.918 0.39 . . . . 0.0 111.577 -179.387 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.439 HG21 ' CG2' ' B' ' 169' ' ' TPO . 86.6 m -68.89 -31.77 70.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.43 178.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -97.74 -19.88 17.93 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.523 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.84 158.0 10.83 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.889 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.1 m -117.71 137.87 52.39 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.87 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -117.95 148.32 42.3 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.768 HD23 ' O ' ' A' ' 114' ' ' GLN . 0.4 OUTLIER -124.58 113.67 18.37 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 176.611 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 37.3 m-20 48.19 42.05 16.78 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.63 -8.38 75.51 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.77 -0.729 . . . . 0.0 113.925 178.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.768 ' O ' HD23 ' A' ' 111' ' ' LEU . 6.9 mt-30 -105.69 118.83 37.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.13 0.465 . . . . 0.0 110.786 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.87 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -73.14 135.08 44.66 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.404 -179.719 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.823 HG23 ' OD2' ' A' ' 103' ' ' ASP . 16.7 m -107.44 163.98 5.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.763 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 120' ' ' SER . 44.2 tt0 -69.87 127.32 32.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.384 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.69 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 76.7 tttt -52.16 161.57 0.6 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.896 0.379 . . . . 0.0 110.525 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.9 p-10 34.37 34.73 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.305 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.492 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.34 145.11 40.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.453 179.618 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.665 ' HB3' HD22 ' A' ' 100' ' ' LEU . 48.4 m-80 -87.43 123.99 32.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.615 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.472 ' O ' HD23 ' A' ' 100' ' ' LEU . 30.0 mm-40 -129.24 146.69 51.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.858 0.361 . . . . 0.0 111.102 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 32.6 tp -75.07 118.04 17.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.101 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.509 HD13 ' HB2' ' A' ' 99' ' ' LEU . 2.0 pt? -58.12 168.66 0.96 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.586 0.708 . . . . 0.0 112.039 -178.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.524 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.4 OUTLIER -124.38 154.13 40.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.81 -1.087 . . . . 0.0 109.905 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.751 ' HA ' HD13 ' A' ' 147' ' ' ILE . 17.1 tp60 -70.14 119.38 14.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.085 0.469 . . . . 0.0 110.27 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.06 23.38 59.41 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.905 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.468 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 25.6 t0 -57.81 179.2 0.07 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 120.716 0.293 . . . . 0.0 110.676 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.841 ' CG ' HG22 ' A' ' 144' ' ' VAL . 7.2 mt-10 -145.05 135.64 24.37 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.091 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.595 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 10.2 mt -107.3 123.67 62.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.924 0.392 . . . . 0.0 110.622 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.48 ' HB ' ' HB2' ' A' ' 110' ' ' TRP . 96.9 m -104.59 140.69 37.64 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.576 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 17.7 m -140.25 158.51 25.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.32 29.8 35.8 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.114 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.493 ' HB ' ' CH2' ' A' ' 110' ' ' TRP . 86.8 t -76.36 140.51 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-O 121.604 0.716 . . . . 0.0 111.986 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 139.04 -37.75 1.74 Allowed Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -178.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.945 HG22 ' CD1' ' B' ' 172' ' ' ILE . 2.5 t -123.01 118.35 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.85 -26.43 5.77 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -178.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 20.7 t -93.74 6.75 47.31 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -132.62 33.82 3.74 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -178.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.449 HG12 ' HA ' ' A' ' 134' ' ' VAL . 7.2 mt -107.21 138.02 35.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-O 121.619 0.723 . . . . 0.0 111.338 178.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.443 HD23 ' N ' ' A' ' 142' ' ' SER . 1.4 tt -125.65 135.02 51.7 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.374 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.585 ' H ' HG21 ' A' ' 40' ' ' THR . 46.8 t -112.38 147.42 36.44 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.87 0.843 . . . . 0.0 112.44 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.486 HD12 ' O ' ' A' ' 130' ' ' ILE . 3.7 mp -135.85 153.08 51.6 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.153 -1.385 . . . . 0.0 110.854 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.841 HG22 ' CG ' ' A' ' 129' ' ' GLU . 21.9 t -118.17 140.03 43.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.631 0.253 . . . . 0.0 110.544 179.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.5 mm -106.2 120.85 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-O 120.957 0.408 . . . . 0.0 110.989 -179.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.69 111.06 22.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.677 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.751 HD13 ' HA ' ' A' ' 126' ' ' GLN . 4.1 mp -89.93 134.23 29.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.853 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -85.52 108.2 17.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.5 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.79 -31.68 68.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.202 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -60.32 -45.95 91.6 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.967 0.413 . . . . 0.0 110.779 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -59.38 -44.1 92.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.049 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 34.4 mttt -64.34 -34.48 78.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.148 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -61.59 -43.32 99.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.154 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.714 ' SG ' HD13 ' A' ' 52' ' ' ILE . 8.5 t -68.05 -42.93 79.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.131 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.63 HD12 ' HA ' ' A' ' 96' ' ' ASP . 1.1 mm? -68.99 -45.59 70.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.095 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -62.86 -48.07 80.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.052 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -77.33 -36.94 53.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.068 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 42.61 55.23 4.28 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.409 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -67.06 121.46 15.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.921 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.621 HG21 HD13 ' A' ' 163' ' ' ILE . 10.7 m -76.0 137.9 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.116 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -73.18 109.16 6.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.879 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.64 95.17 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.916 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.621 HD13 HG21 ' A' ' 160' ' ' VAL . 6.2 tp -104.63 130.16 55.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.095 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.266 -0.874 . . . . 0.0 110.872 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 30.3 m120 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.9 0.381 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -101.15 101.81 17.98 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.819 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.07 92.93 0.39 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.433 2.088 . . . . 0.0 112.363 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -125.38 124.97 42.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.841 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 169' ' ' TPO . . . . . 0.452 ' O ' HD12 ' B' ' 170' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.466 ' HB2' ' HA ' ' A' ' 83' ' ' ARG . 1.1 tp -150.49 -170.0 3.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.984 0.421 . . . . 0.0 111.454 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 179.93 112.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.256 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 0.945 ' CD1' HG22 ' A' ' 136' ' ' VAL . 3.9 tp -46.36 144.32 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.011 0.434 . . . . 0.0 111.576 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 173' ' ' TYR . . . . . 0.615 ' H ' HD12 ' B' ' 172' ' ' ILE . 2.6 p90 -90.53 120.64 31.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.891 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.95 -179.985 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.851 0.358 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.6 m -126.08 -53.33 1.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.868 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -64.36 -42.96 95.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.952 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 22.9 mtt180 -59.89 -36.04 76.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.894 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -62.88 -40.25 96.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.2 -45.63 92.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.496 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.4 mm -65.99 -35.14 74.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.155 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -57.13 -37.75 72.47 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.939 0.399 . . . . 0.0 110.437 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -67.28 -23.84 65.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.659 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.496 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.74 -47.51 79.88 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.09 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.2 m -80.13 -26.38 39.45 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.917 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 64.7 145.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.879 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -63.03 152.53 36.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -75.14 106.65 6.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.961 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.4 mm -81.96 138.22 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-O 121.658 0.742 . . . . 0.0 111.75 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.42 81.98 0.86 Allowed Glycine 0 C--N 1.314 -0.682 0 CA-C-N 114.531 -1.213 . . . . 0.0 112.385 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -58.88 -43.37 90.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.759 0.314 . . . . 0.0 110.98 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.9 OUTLIER 175.2 39.66 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.852 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.683 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -72.29 135.45 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 CA-C-N 113.613 -1.63 . . . . 0.0 112.558 -177.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.985 HG12 HD11 ' A' ' 99' ' ' LEU . 3.5 t -91.56 -58.85 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.912 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 24.8 p -152.56 154.78 36.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.644 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.87 ' NE ' HG21 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -119.09 138.22 53.03 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.799 0.333 . . . . 0.0 110.971 -179.85 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.515 HG21 ' CE2' ' A' ' 68' ' ' PHE . 57.3 t -107.7 122.67 62.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.895 0.379 . . . . 0.0 110.906 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.691 HG23 HG12 ' A' ' 45' ' ' ILE . 14.4 mt -118.69 127.97 75.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.502 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.83 ' HA ' HD13 ' A' ' 143' ' ' LEU . 52.6 t -81.36 100.68 9.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.518 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.583 ' OG1' HG23 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -67.98 -24.19 65.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.816 -179.249 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.525 HG23 ' HB3' ' A' ' 142' ' ' SER . 72.9 p -79.82 -2.36 43.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.831 0.348 . . . . 0.0 111.376 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 59.99 76.28 0.23 Allowed Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 121.018 -0.611 . . . . 0.0 113.09 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -146.57 -43.14 0.19 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.92 0.39 . . . . 0.0 110.78 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.647 HG23 ' HD2' ' A' ' 44' ' ' PRO . 3.4 mp -119.55 142.55 32.95 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.035 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.647 ' HD2' HG23 ' A' ' 43' ' ' ILE . 50.7 Cg_endo -71.2 146.18 50.8 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.216 1.944 . . . . 0.0 112.203 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.87 HG21 ' NE ' ' A' ' 35' ' ' ARG . 51.7 mt -55.04 144.68 5.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.944 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.481 ' HB2' ' CE2' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -128.28 134.24 48.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.837 178.828 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -98.72 119.71 37.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.046 0.451 . . . . 0.0 112.199 -178.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.762 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.1 mp -93.68 128.12 39.71 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.984 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -133.71 156.84 47.23 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 122.067 0.937 . . . . 0.0 113.526 -179.602 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.483 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -153.02 142.02 21.28 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 113.817 -1.538 . . . . 0.0 111.136 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.892 ' O ' HG23 ' A' ' 55' ' ' VAL . 24.7 m-20 -77.59 122.82 25.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.104 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 61.4 mt -64.51 -43.78 96.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.128 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.2 t -59.02 -40.71 85.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.337 0.589 . . . . 0.0 110.719 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.466 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 4.5 mm-40 -68.55 -36.86 79.38 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.742 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.892 HG23 ' O ' ' A' ' 51' ' ' ASP . 49.1 t -65.94 -39.49 84.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.936 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.1 mt -70.98 -31.36 67.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.823 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.02 -50.8 37.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.9 130.37 35.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.77 33.39 2.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.799 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.14 -66.18 0.86 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.4 m -164.05 -64.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.918 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.48 HD11 HG22 ' A' ' 65' ' ' VAL . 8.3 tp -113.79 152.48 15.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.165 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.535 ' HG2' HG13 ' A' ' 55' ' ' VAL . 12.3 mptt -112.15 -73.91 0.65 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.959 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.462 ' HE2' ' O ' ' A' ' 49' ' ' SER . 4.0 ttpt -136.62 131.51 33.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.327 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.71 HG12 ' HG2' ' A' ' 90' ' ' GLN . 16.0 t -131.27 139.27 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-O 121.155 0.503 . . . . 0.0 111.733 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.762 ' CD2' HD23 ' A' ' 48' ' ' LEU . 20.2 m-90 -101.02 139.24 36.98 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.002 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.683 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.76 126.93 55.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.038 0.447 . . . . 0.0 109.904 177.911 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.635 ' HZ ' HD21 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -111.43 145.83 38.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.453 -178.965 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.682 ' HA2' HD12 ' A' ' 78' ' ' LEU . . . 161.42 -171.86 37.51 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.602 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.454 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 8.3 mtp-105 -82.15 1.48 36.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.624 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 8.9 t-20 -84.92 134.37 41.56 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.716 0.293 . . . . 0.0 111.035 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.5 Cg_exo -68.48 -8.97 24.64 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.625 2.217 . . . . 0.0 111.787 179.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.624 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -83.16 -43.9 15.67 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 122.031 0.92 . . . . 0.0 108.79 178.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.45 136.64 2.33 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 113.656 -1.611 . . . . 0.0 110.832 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -56.6 -19.08 14.26 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.831 179.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.644 ' HE1' HD23 ' A' ' 78' ' ' LEU . 9.8 t80 -129.95 119.3 23.0 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.723 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -93.94 111.03 22.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.907 0.384 . . . . 0.0 110.95 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.682 HD12 ' HA2' ' A' ' 69' ' ' GLY . 44.9 mt -76.07 -78.55 0.11 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.997 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.62 -87.16 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.506 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -177.5 47.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.853 0.359 . . . . 0.0 111.003 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.454 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 30.7 mm -83.35 117.39 29.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.108 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.841 ' HB3' HD21 ' B' ' 170' ' ' LEU . 0.7 OUTLIER -54.7 -31.99 58.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.042 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.415 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.4 OUTLIER -70.96 -17.39 62.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.274 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.709 HD21 HG23 ' A' ' 132' ' ' VAL . 41.2 mt -106.95 152.16 24.32 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.762 0.315 . . . . 0.0 111.436 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 87.2 p -96.39 166.0 11.92 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.663 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.664 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.1 m-20 -43.11 -52.35 5.48 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.425 0.631 . . . . 0.0 109.774 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.445 ' HB2' HD12 ' A' ' 104' ' ' ILE . 14.5 ptmt -119.77 82.86 1.95 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 177.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.671 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 61.1 t-80 -61.17 -46.66 89.61 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.875 -176.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.539 ' HA ' HG12 ' A' ' 104' ' ' ILE . 32.0 p90 -148.99 161.42 41.94 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.767 -179.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.71 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.4 tt0 -135.92 142.28 44.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.42 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.622 ' C ' HG13 ' A' ' 65' ' ' VAL . 46.2 mt -117.55 127.64 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.004 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.476 ' O ' HD23 ' A' ' 99' ' ' LEU . 0.7 OUTLIER -110.72 143.49 41.14 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.058 0.456 . . . . 0.0 111.752 -179.606 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.76 HD23 ' HG ' ' A' ' 99' ' ' LEU . 2.0 tm? -125.15 122.89 38.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.394 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.505 ' N ' HD22 ' A' ' 93' ' ' LEU . . . -163.59 -161.75 13.35 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.585 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 60.41 -173.92 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.794 0.331 . . . . 0.0 110.766 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -82.56 58.89 4.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.019 0.438 . . . . 0.0 110.807 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 108.69 -171.94 16.13 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.516 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.4 m120 61.54 170.2 0.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.901 0.382 . . . . 0.0 111.043 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.985 HD11 HG12 ' A' ' 33' ' ' VAL . 0.5 OUTLIER -135.05 160.12 39.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.689 179.946 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.624 HD23 ' HB3' ' A' ' 121' ' ' ASN . 2.3 mp -125.33 145.81 49.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.455 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.521 HD23 HG23 ' A' ' 91' ' ' ILE . 55.9 mt -112.99 123.29 49.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.33 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.436 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 59.5 t30 -118.2 115.77 25.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.829 0.347 . . . . 0.0 111.86 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.797 ' OD2' HG23 ' A' ' 116' ' ' VAL . 9.2 p30 -79.14 143.14 35.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.943 178.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.539 HG12 ' HA ' ' A' ' 89' ' ' PHE . 14.3 pt -146.88 26.73 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.585 ' HB2' ' CG ' ' A' ' 88' ' ' HIS . 11.0 t -93.98 154.97 17.39 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.517 ' OG1' HG21 ' B' ' 169' ' ' TPO . 5.7 m -70.12 -52.16 25.79 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.453 178.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -74.64 -4.06 34.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.247 -179.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.92 155.97 31.22 Favored Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.439 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.502 HG22 ' CG2' ' A' ' 130' ' ' ILE . 5.4 m -117.36 137.78 52.23 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.843 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -114.02 148.49 36.9 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -177.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.0 113.6 18.65 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.467 177.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 45.09 42.88 7.06 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.04 -13.44 61.38 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.726 -0.749 . . . . 0.0 113.486 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -104.49 118.49 36.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 117.104 0.452 . . . . 0.0 110.498 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.843 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -70.11 123.61 22.02 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.403 -179.793 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.797 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.7 m -95.08 164.64 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.01 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -69.94 127.88 34.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.587 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.682 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 17.6 tttm -53.66 162.47 0.85 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.754 0.312 . . . . 0.0 110.23 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.7 p-10 34.52 36.32 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.004 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.7 p -111.92 145.09 40.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.706 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.624 ' HB3' HD23 ' A' ' 100' ' ' LEU . 28.2 m-80 -92.71 130.67 38.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.872 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 58.3 mm-40 -129.28 150.93 50.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.558 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.7 tp -72.81 130.03 39.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.815 0.341 . . . . 0.0 110.226 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.754 HD22 ' HB2' ' A' ' 99' ' ' LEU . 30.0 tp -58.1 153.71 14.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.594 0.711 . . . . 0.0 111.737 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.452 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.6 OUTLIER -125.12 152.92 43.76 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.691 -1.14 . . . . 0.0 110.451 179.647 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -72.1 124.86 25.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.828 0.346 . . . . 0.0 110.09 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.84 22.82 48.92 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.758 -0.735 . . . . 0.0 111.981 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -50.4 165.71 0.09 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.896 0.379 . . . . 0.0 111.345 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.46 ' HG3' HG22 ' A' ' 144' ' ' VAL . 25.8 tt0 -145.05 135.48 24.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.99 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.502 ' CG2' HG22 ' A' ' 109' ' ' THR . 14.7 mt -114.73 128.24 71.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.798 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.639 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.08 139.84 38.61 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.709 HG23 HD21 ' A' ' 84' ' ' LEU . 35.8 m -140.42 158.67 25.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -178.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.85 29.27 29.43 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.236 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.426 ' HA ' HG12 ' A' ' 140' ' ' ILE . 74.6 t -73.38 140.51 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-O 121.622 0.725 . . . . 0.0 112.077 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.625 ' O ' HD12 ' B' ' 172' ' ' ILE . . . 144.23 -37.09 1.43 Allowed Glycine 0 N--CA 1.436 -1.36 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 -178.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.565 HG22 ' CD1' ' B' ' 172' ' ' ILE . 3.7 t -124.84 125.29 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.4 -35.92 30.51 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -178.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.0 p -93.59 6.57 47.8 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.461 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 30.4 m-20 -121.02 28.91 7.62 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -178.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.639 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.2 mt -107.04 138.52 32.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-O 121.5 0.667 . . . . 0.0 111.143 178.301 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.694 HD23 ' N ' ' A' ' 142' ' ' SER . 3.0 tt -124.85 134.42 52.73 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.149 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.694 ' N ' HD23 ' A' ' 141' ' ' LEU . 38.3 t -112.81 150.24 31.95 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.761 0.791 . . . . 0.0 112.642 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.83 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.9 mm? -136.02 143.67 44.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.525 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.583 HG23 ' OG1' ' A' ' 39' ' ' THR . 24.0 t -115.86 140.27 38.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.792 0.329 . . . . 0.0 111.008 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.55 HG21 HD11 ' A' ' 124' ' ' LEU . 33.2 mt -106.0 123.39 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-O 120.951 0.405 . . . . 0.0 111.278 -179.069 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.2 118.35 36.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.532 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.597 HG12 HD21 ' A' ' 124' ' ' LEU . 3.6 mt -88.07 133.96 29.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.649 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -82.72 113.53 20.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.738 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.57 -29.45 66.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.074 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.65 -45.77 91.02 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 120.976 0.417 . . . . 0.0 110.672 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -58.64 -44.12 89.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.951 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.0 -41.08 95.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.992 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -59.18 -40.1 84.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.103 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.3 t -60.7 -46.13 91.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.016 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.04 -38.39 79.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.016 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.76 -46.42 85.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.966 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.45 -37.07 32.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.946 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 42.22 82.98 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.532 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.79 141.23 55.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.963 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 10.6 m -96.73 136.22 28.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.099 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.54 107.49 1.72 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.821 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 59.95 171.16 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.965 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.1 tp -76.98 138.49 20.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.054 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.874 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 1.2 m120 . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.781 0.324 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.58 150.37 91.22 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.57 131.52 21.68 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.582 2.188 . . . . 0.0 112.254 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -121.78 47.32 1.9 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.008 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 169' ' ' TPO . . . . . 0.54 ' C ' HD23 ' B' ' 170' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.841 HD21 ' HB3' ' A' ' 82' ' ' SER . 0.2 OUTLIER -160.27 -177.88 6.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.9 0.381 . . . . 0.0 111.298 -179.649 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 171' ' ' GLU . . . . . 0.519 ' O ' HG22 ' B' ' 172' ' ' ILE . 21.5 mt-10 -143.66 75.08 1.46 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.654 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 0.625 HD12 ' O ' ' A' ' 135' ' ' GLY . 16.1 tt 50.28 156.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 121.395 0.617 . . . . 0.0 111.996 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 173' ' ' TYR . . . . . 0.411 ' N ' HG12 ' B' ' 172' ' ' ILE . 5.1 p90 -109.75 137.83 47.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.852 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 34.9 t . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.906 179.959 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.85 0.357 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.68 HG22 ' CD2' ' A' ' 18' ' ' PHE . 1.0 OUTLIER -111.86 41.5 1.92 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.844 179.951 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -59.95 -46.92 87.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.768 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.74 -35.86 72.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.8 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.68 ' CD2' HG22 ' A' ' 15' ' ' THR . 1.1 m-85 -56.99 -43.49 81.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.535 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.72 -31.86 68.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.251 179.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.558 HG23 ' HE2' ' A' ' 23' ' ' PHE . 11.5 mt -69.45 -47.99 69.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.57 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -63.33 -33.78 76.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.366 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.19 -47.04 86.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.936 -178.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.558 ' HE2' HG23 ' A' ' 20' ' ' ILE . 4.0 p90 -71.83 -47.43 53.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.022 0.439 . . . . 0.0 111.101 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.525 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 12.3 m -58.49 -47.04 85.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.928 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -115.37 86.23 2.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.89 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -92.44 131.19 37.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.845 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -80.61 124.47 29.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.859 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.0 mm -82.61 138.35 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-O 121.728 0.775 . . . . 0.0 111.809 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 56.2 77.47 0.16 Allowed Glycine 0 C--N 1.315 -0.59 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.603 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.38 -42.52 98.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.828 0.346 . . . . 0.0 110.816 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.7 OUTLIER 179.0 38.08 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.717 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -75.99 135.07 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-N 113.785 -1.552 . . . . 0.0 112.506 -177.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.037 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -91.88 -61.68 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.24 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.465 ' SG ' HD12 ' A' ' 48' ' ' LEU . 7.5 p -149.34 149.02 30.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.302 179.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -116.7 138.3 51.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.874 0.368 . . . . 0.0 111.417 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.635 HG21 ' HE2' ' A' ' 68' ' ' PHE . 24.0 t -103.89 122.89 57.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.998 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.823 HG23 HG12 ' A' ' 45' ' ' ILE . 21.4 mt -123.09 117.72 52.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.609 -179.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.582 ' HA ' HD23 ' A' ' 143' ' ' LEU . 49.1 t -80.74 112.75 18.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.185 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.05 -21.62 29.32 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.559 HG21 ' H ' ' A' ' 142' ' ' SER . 75.1 p -79.79 -2.47 43.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.788 0.328 . . . . 0.0 111.592 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.46 72.37 0.74 Allowed Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.977 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -142.45 -42.13 0.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.876 0.369 . . . . 0.0 110.919 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.561 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.3 mt -121.02 141.66 33.18 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.035 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.561 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.9 Cg_endo -72.83 140.36 31.92 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.167 1.912 . . . . 0.0 112.167 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.823 HG12 HG23 ' A' ' 37' ' ' ILE . 36.1 mt -55.95 145.63 6.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.766 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.09 163.72 31.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.153 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -120.5 119.88 34.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.08 0.467 . . . . 0.0 112.013 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.633 HD22 ' CD1' ' A' ' 66' ' ' TRP . 5.1 mt -93.93 137.55 33.02 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . 1.037 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.73 159.01 43.79 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -178.662 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.487 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -138.53 141.87 39.31 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 113.744 -1.571 . . . . 0.0 110.618 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.649 ' O ' HG23 ' A' ' 55' ' ' VAL . 3.6 m-20 -84.19 129.89 34.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.221 0.534 . . . . 0.0 111.578 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.628 HD13 ' SG ' ' A' ' 154' ' ' CYS . 10.2 mt -64.5 -45.39 95.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.435 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.9 t -56.67 -38.85 72.78 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.611 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.465 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 4.8 mm100 -68.55 -36.65 79.1 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.316 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 51' ' ' ASP . 97.5 t -59.77 -49.23 84.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.0 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.1 tt -68.77 -30.69 69.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.102 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -77.61 -46.54 21.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.037 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -83.63 129.98 34.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.935 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.03 31.12 3.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.908 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.1 mtm-85 -69.35 -69.24 0.35 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.827 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.7 m -164.82 -42.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.032 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.423 HD11 ' N ' ' A' ' 93' ' ' LEU . 3.6 tp -135.54 147.28 28.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.994 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.436 ' HE2' HG11 ' A' ' 55' ' ' VAL . 19.9 mttt -71.71 -68.89 0.42 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.859 0.362 . . . . 0.0 110.728 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.429 ' CE ' ' O ' ' A' ' 49' ' ' SER . 31.1 ttpt -150.69 140.09 21.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.667 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.597 HG13 ' O ' ' A' ' 91' ' ' ILE . 12.4 t -121.53 139.12 49.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.272 0.558 . . . . 0.0 111.906 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.633 ' CD1' HD22 ' A' ' 48' ' ' LEU . 18.2 m-90 -104.07 138.61 40.33 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.069 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.676 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.94 128.28 56.33 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 177.049 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.677 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -115.19 145.46 42.38 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.497 -177.963 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.584 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.35 -172.23 38.4 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.702 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.458 ' HD3' ' O ' ' A' ' 81' ' ' ILE . 9.4 mtm105 -80.46 2.29 25.79 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.476 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 3.0 t-20 -84.87 134.2 42.02 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.575 0.226 . . . . 0.0 111.125 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 15.8 Cg_exo -67.06 -11.9 34.01 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.531 2.154 . . . . 0.0 111.75 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.9 -43.33 16.65 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 122.017 0.913 . . . . 0.0 108.93 178.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.51 137.82 2.01 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.086 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.8 m-20 -56.58 -18.44 11.89 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.985 178.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.471 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 19.5 t80 -129.27 119.65 24.33 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.869 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -98.77 110.06 22.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.927 0.394 . . . . 0.0 111.031 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.456 HD11 ' HG3' ' A' ' 70' ' ' ARG . 1.9 pp -113.04 172.98 6.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.666 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.23 136.91 50.55 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.506 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -68.27 89.75 0.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.789 0.328 . . . . 0.0 110.777 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.458 ' O ' ' HD3' ' A' ' 70' ' ' ARG . 44.6 mt -107.86 135.55 46.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.024 0.44 . . . . 0.0 111.478 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.779 ' HB2' HD13 ' B' ' 170' ' ' LEU . 89.9 p -54.88 -43.94 73.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.274 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.505 ' HG3' ' HB3' ' A' ' 139' ' ' ASP . 1.6 mmt180 -60.85 -27.81 68.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.568 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.616 HD21 HG23 ' A' ' 132' ' ' VAL . 29.7 mt -96.23 150.95 19.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.9 0.381 . . . . 0.0 111.633 -179.268 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 75.4 p -98.62 169.05 9.78 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.416 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.584 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.0 m-20 -44.11 -55.3 4.85 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.318 0.58 . . . . 0.0 109.761 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.457 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 3.1 ptpp? -118.8 84.73 2.24 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 177.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.562 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 12.7 t60 -60.55 -47.02 88.0 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.874 -176.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.511 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 23.9 p90 -146.69 160.53 42.09 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.991 -179.161 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.676 ' HG3' HG23 ' A' ' 67' ' ' THR . 20.7 tt0 -135.95 139.15 43.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.395 -179.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.677 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 61.6 mt -114.61 132.14 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 121.104 -0.238 . . . . 0.0 110.965 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.507 HD21 ' HB2' ' A' ' 102' ' ' ASN . 0.2 OUTLIER -123.97 136.41 54.29 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.047 0.451 . . . . 0.0 111.966 -179.604 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.804 HD22 ' CG1' ' A' ' 33' ' ' VAL . 2.4 tp -125.41 122.98 38.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.43 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.25 41.65 0.06 OUTLIER Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.854 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.52 76.07 1.16 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.878 0.371 . . . . 0.0 110.733 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.68 29.88 18.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.825 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 103.09 175.68 26.53 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.351 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.481 ' O ' HD12 ' A' ' 93' ' ' LEU . 0.3 OUTLIER 62.05 -170.75 0.16 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.839 0.352 . . . . 0.0 110.83 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.748 ' HB3' HD22 ' A' ' 124' ' ' LEU . 0.3 OUTLIER -124.22 159.82 29.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.764 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.737 HD13 ' HB3' ' A' ' 121' ' ' ASN . 12.7 mt -133.34 140.7 47.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.704 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.491 ' O ' HD12 ' A' ' 101' ' ' LEU . 3.1 pp -112.66 124.61 52.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.929 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.507 ' HB2' HD21 ' A' ' 92' ' ' LEU . 47.3 t30 -114.62 115.92 27.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.9 0.381 . . . . 0.0 111.705 -179.123 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.767 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.2 p30 -78.57 136.67 37.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.885 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.484 HD11 HG22 ' A' ' 67' ' ' THR . 18.8 pt -147.41 38.92 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.645 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.0 151.77 20.56 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 121.098 0.475 . . . . 0.0 112.207 -178.717 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.804 HG21 ' CG2' ' B' ' 169' ' ' TPO . 16.7 m -68.92 -31.63 70.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.705 177.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -97.07 -19.79 18.47 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.482 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.645 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.08 156.79 10.95 Favored Glycine 0 N--CA 1.439 -1.115 0 C-N-CA 120.4 -0.905 . . . . 0.0 114.014 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.477 HG22 ' CG2' ' A' ' 130' ' ' ILE . 6.3 m -117.32 137.71 52.25 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.761 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -118.94 148.66 42.72 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -177.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.472 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -123.91 113.57 18.66 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.559 177.676 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.415 ' N ' HD12 ' A' ' 111' ' ' LEU . 87.5 m-20 44.36 43.23 5.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.547 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.07 -14.21 59.53 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.435 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -104.24 118.51 36.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.09 0.445 . . . . 0.0 110.626 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.761 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -71.68 129.75 39.46 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.473 -179.65 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.767 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.0 m -96.41 166.11 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.956 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 120' ' ' SER . 23.1 mm-40 -69.92 127.2 32.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.591 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.663 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -53.98 158.51 2.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.172 0.51 . . . . 0.0 110.702 -179.962 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.49 ' H ' ' HG3' ' A' ' 118' ' ' LYS . 0.5 OUTLIER 35.73 35.45 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.798 -179.74 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -111.96 145.03 40.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.134 179.606 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.737 ' HB3' HD13 ' A' ' 100' ' ' LEU . 65.6 m-20 -89.76 123.15 33.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.622 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.559 ' O ' HD23 ' A' ' 100' ' ' LEU . 6.3 mm100 -126.62 145.76 50.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.969 0.414 . . . . 0.0 110.858 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.0 tp -72.97 118.41 15.89 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.951 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.748 HD22 ' HB3' ' A' ' 99' ' ' LEU . 2.4 pt? -57.44 167.66 0.95 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.589 0.709 . . . . 0.0 111.865 -178.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.414 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.2 OUTLIER -124.89 153.75 42.14 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.228 179.769 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.04 118.92 14.42 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.8 22.03 67.94 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.458 -178.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.414 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 24.3 t70 -54.33 174.11 0.06 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.895 0.379 . . . . 0.0 111.046 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 9.6 tt0 -145.35 135.27 23.66 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.041 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.796 HD11 HD11 ' A' ' 145' ' ' ILE . 18.9 mt -114.71 126.49 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.214 178.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.543 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.6 m -104.14 139.86 38.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.264 -0.425 . . . . 0.0 109.928 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.616 HG23 HD21 ' A' ' 84' ' ' LEU . 33.9 m -140.18 158.26 25.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.114 0.483 . . . . 0.0 112.194 -178.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.97 27.2 29.33 Favored Glycine 0 N--CA 1.44 -1.085 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.926 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.444 ' HB ' ' CZ3' ' A' ' 110' ' ' TRP . 68.9 t -74.04 140.49 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-O 121.611 0.72 . . . . 0.0 112.069 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.604 ' O ' HD12 ' B' ' 172' ' ' ILE . . . 148.92 -39.76 0.93 Allowed Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.622 HG22 HG13 ' B' ' 172' ' ' ILE . 2.5 t -118.16 129.17 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -50.58 -42.35 55.58 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -178.062 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.6 m -93.47 6.76 47.1 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -178.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.505 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . 0.5 OUTLIER -120.14 34.54 5.18 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -178.539 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.543 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.1 mt -107.23 139.46 28.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.942 178.197 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 8.9 tt -124.03 134.64 53.39 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.647 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.559 ' H ' HG21 ' A' ' 40' ' ' THR . 44.3 t -111.82 150.54 30.2 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.748 0.785 . . . . 0.0 112.715 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.582 HD23 ' HA ' ' A' ' 38' ' ' CYS . 71.5 mt -135.71 149.34 49.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.779 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 24.2 t -117.01 139.07 45.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.829 0.347 . . . . 0.0 111.075 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.796 HD11 HD11 ' A' ' 130' ' ' ILE . 17.6 mt -106.36 124.54 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.045 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.38 114.01 26.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.607 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.491 HG12 HD12 ' A' ' 124' ' ' LEU . 5.0 mt -84.95 134.12 27.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.546 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -86.09 105.0 16.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.737 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -57.66 -28.19 63.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.115 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -43.7 88.89 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.607 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -59.5 -44.01 93.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.889 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -62.69 -33.94 76.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.912 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.62 -36.92 84.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.031 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.628 ' SG ' HD13 ' A' ' 52' ' ' ILE . 7.8 t -68.0 -40.82 82.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.108 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.15 -50.0 57.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.126 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -58.54 -42.39 87.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.001 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.11 -36.11 35.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.835 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 42.39 79.31 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.487 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.2 pttp -120.04 136.93 54.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.86 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 6.7 m -72.6 128.62 35.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.176 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -107.3 -45.78 4.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.865 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 8.9 ttm-85 -139.04 29.9 2.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.882 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.4 mt -105.04 137.93 32.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.044 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.859 -179.997 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.886 0.374 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.91 165.77 19.23 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.75 171.4 9.77 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.553 2.168 . . . . 0.0 112.228 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 178.41 85.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.005 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 169' ' ' TPO . . . . . 0.804 ' CG2' HG21 ' A' ' 106' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.779 HD13 ' HB2' ' A' ' 82' ' ' SER . 0.3 OUTLIER -163.53 153.0 14.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.92 -179.411 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 171' ' ' GLU . . . . . 0.569 ' O ' HG22 ' B' ' 172' ' ' ILE . 9.0 mt-10 -138.87 61.34 1.57 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.139 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 0.622 HG13 HG22 ' A' ' 136' ' ' VAL . 14.0 tt 49.44 158.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.276 0.56 . . . . 0.0 112.145 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 173' ' ' TYR . . . . . 0.48 ' N ' HG12 ' B' ' 172' ' ' ILE . 4.3 m-85 -51.64 94.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.005 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.293 -0.861 . . . . 0.0 110.863 -179.94 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.859 0.361 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.466 ' O ' HD23 ' A' ' 19' ' ' LEU . 1.9 t -160.28 -45.74 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.888 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -71.95 -44.45 63.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.922 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.94 -45.74 89.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.957 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -59.56 -35.81 74.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.851 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 15' ' ' THR . 2.2 mm? -65.22 -41.85 94.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.798 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.641 HG23 ' CE2' ' A' ' 23' ' ' PHE . 43.9 mm -68.19 -48.08 75.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.002 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.02 -33.67 72.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.329 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.3 tptp -58.6 -47.25 84.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.932 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.641 ' CE2' HG23 ' A' ' 20' ' ' ILE . 4.4 p90 -71.85 -47.38 53.44 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.982 0.42 . . . . 0.0 111.023 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.546 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 0.1 OUTLIER -61.74 -37.05 82.8 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.915 -179.936 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.03 169.1 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -81.02 131.35 35.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.843 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -87.59 131.41 34.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.888 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.5 mm -81.93 138.13 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 CA-C-O 121.65 0.738 . . . . 0.0 111.536 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.91 106.19 0.31 Allowed Glycine 0 C--N 1.313 -0.747 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.179 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 -80.82 -29.46 35.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.686 0.279 . . . . 0.0 111.156 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.516 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.9 m-20 176.41 41.19 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.654 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.3 mm -71.03 142.76 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-N 113.711 -1.586 . . . . 0.0 112.377 -176.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.722 ' CG2' HD22 ' A' ' 93' ' ' LEU . 0.9 OUTLIER -106.01 -48.99 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-N 114.275 -1.329 . . . . 0.0 109.91 -178.575 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.812 ' SG ' HD12 ' A' ' 48' ' ' LEU . 32.1 p -161.13 147.96 14.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.534 179.087 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -114.13 138.24 50.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.893 0.378 . . . . 0.0 111.317 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.748 HG21 ' CE2' ' A' ' 68' ' ' PHE . 21.3 t -101.81 122.73 54.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.062 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.559 HG23 HG12 ' A' ' 45' ' ' ILE . 20.1 mt -128.62 116.41 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.234 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.578 ' HA ' HD13 ' A' ' 143' ' ' LEU . 47.1 t -80.03 123.42 27.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.496 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.4 t -91.53 -27.33 18.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.546 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.578 HG21 ' H ' ' A' ' 142' ' ' SER . 7.0 p -79.81 -2.6 44.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.748 0.309 . . . . 0.0 111.408 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.7 77.99 0.24 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.752 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -146.4 -45.44 0.19 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.942 0.401 . . . . 0.0 110.788 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.56 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.0 mt -116.33 141.25 27.58 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.847 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.56 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.4 Cg_endo -72.73 146.01 42.31 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.271 1.981 . . . . 0.0 112.161 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.559 HG12 HG23 ' A' ' 37' ' ' ILE . 36.5 mt -55.9 151.83 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.683 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -149.8 162.3 40.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.19 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -122.65 119.81 31.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.049 0.452 . . . . 0.0 111.945 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.812 HD12 ' SG ' ' A' ' 34' ' ' CYS . 23.3 mt -93.28 138.04 32.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.231 178.577 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.654 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -141.18 156.95 45.86 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 122.14 0.971 . . . . 0.0 113.5 -178.932 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.621 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . -141.19 146.68 37.26 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 113.565 -1.652 . . . . 0.0 110.822 178.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.885 ' O ' HG23 ' A' ' 55' ' ' VAL . 4.3 m-20 -74.94 125.74 29.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.131 0.491 . . . . 0.0 111.187 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.531 HD13 ' SG ' ' A' ' 154' ' ' CYS . 91.3 mt -64.37 -44.46 97.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.641 -0.708 . . . . 0.0 112.099 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.498 ' HA ' HD21 ' A' ' 56' ' ' LEU . 2.9 m -57.06 -41.16 78.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.369 0.604 . . . . 0.0 110.673 -179.153 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.454 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 5.0 mm100 -68.62 -36.78 79.1 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.922 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.885 HG23 ' O ' ' A' ' 51' ' ' ASP . 40.4 t -69.13 -50.11 55.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.245 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.672 HD12 ' N ' ' A' ' 57' ' ' LYS . 4.3 pp -62.46 -25.36 67.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.093 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.672 ' N ' HD12 ' A' ' 56' ' ' LEU . 1.1 mttm -79.65 -55.04 5.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.936 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.11 108.75 4.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.97 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.52 -31.44 18.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.8 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.05 -179.09 3.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.687 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 58.84 -173.28 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.745 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.618 HD13 HD13 ' A' ' 92' ' ' LEU . 9.4 tp -91.39 156.53 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.104 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.675 ' HG2' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -94.43 -67.32 0.86 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.143 -179.867 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.46 ' CE ' ' O ' ' A' ' 49' ' ' SER . 15.5 ttpt -155.03 115.4 3.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.89 0.376 . . . . 0.0 111.864 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 91' ' ' ILE . 9.5 p -108.64 139.63 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.791 ' CD1' HD22 ' A' ' 48' ' ' LEU . 14.8 m-90 -100.71 139.9 35.74 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.151 -1.386 . . . . 0.0 112.064 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.597 HG23 ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -107.93 131.53 54.44 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 177.408 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.768 ' HZ ' HD11 ' A' ' 48' ' ' LEU . 3.0 m-85 -117.0 145.91 43.37 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.036 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.704 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.82 -171.34 37.74 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.293 -0.956 . . . . 0.0 113.011 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -82.67 2.97 30.91 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -84.81 142.84 39.65 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.695 0.283 . . . . 0.0 110.836 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.44 -11.79 22.65 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.341 2.027 . . . . 0.0 111.441 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.77 -43.73 16.39 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 121.931 0.872 . . . . 0.0 108.928 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.91 138.3 5.05 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 113.87 -1.514 . . . . 0.0 110.751 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.8 OUTLIER -56.37 -18.55 11.29 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.971 178.903 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.569 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 3.9 t80 -129.1 117.59 21.08 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-O 120.775 0.321 . . . . 0.0 110.96 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -92.78 107.87 19.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.655 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.957 HD23 HD13 ' A' ' 84' ' ' LEU . 8.9 mp -73.49 -175.04 1.84 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.107 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.16 17.71 49.76 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.804 -0.713 . . . . 0.0 113.037 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 65.43 74.71 0.37 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.022 0.439 . . . . 0.0 111.493 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.43 ' HB ' HD12 ' A' ' 84' ' ' LEU . 25.5 mm -112.0 126.87 69.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.643 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.831 ' HB2' HD11 ' B' ' 170' ' ' LEU . 0.9 OUTLIER -55.02 -41.35 71.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.312 -179.552 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.631 ' NH1' HD12 ' B' ' 170' ' ' LEU . 0.3 OUTLIER -60.81 -24.02 65.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.997 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.957 HD13 HD23 ' A' ' 78' ' ' LEU . 17.9 mt -98.16 152.11 19.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.879 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.5 p -96.29 164.53 12.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.759 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.704 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -40.06 -57.0 1.75 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.416 0.627 . . . . 0.0 109.584 178.976 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.462 ' HB3' HD11 ' A' ' 104' ' ' ILE . 6.4 mttp -116.59 85.69 2.36 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.68 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 63.5 t-80 -64.59 -44.94 89.02 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.074 -0.967 . . . . 0.0 113.428 -176.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.515 ' HA ' HG12 ' A' ' 104' ' ' ILE . 34.5 p90 -154.1 162.58 41.1 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.139 -0.625 . . . . 0.0 112.053 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.631 ' OE1' HG21 ' A' ' 104' ' ' ILE . 14.3 mt-30 -135.7 155.46 50.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.419 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.567 ' O ' HG23 ' A' ' 65' ' ' VAL . 65.0 mt -122.97 128.81 75.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.716 HD23 ' HB2' ' A' ' 102' ' ' ASN . 1.8 pp -118.97 130.97 55.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.008 0.432 . . . . 0.0 111.831 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.722 HD22 ' CG2' ' A' ' 33' ' ' VAL . 3.2 tp -108.12 139.82 42.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.21 179.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -178.45 -141.36 4.27 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.412 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 58.26 -176.58 0.08 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.798 0.332 . . . . 0.0 110.885 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -63.04 -30.89 71.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.901 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 174.56 66.65 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.493 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -155.62 169.95 23.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.861 0.363 . . . . 0.0 110.935 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.683 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -117.06 149.28 40.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.842 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.765 HD23 ' HB3' ' A' ' 121' ' ' ASN . 10.8 mp -129.3 146.54 51.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.414 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.503 HD11 HD11 ' A' ' 130' ' ' ILE . 0.2 OUTLIER -112.89 126.88 55.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.38 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.716 ' HB2' HD23 ' A' ' 92' ' ' LEU . 53.4 t30 -116.8 115.85 26.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.863 0.363 . . . . 0.0 111.857 -179.322 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.827 ' OD2' HG23 ' A' ' 116' ' ' VAL . 7.5 p30 -79.76 143.28 34.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.049 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.631 HG21 ' OE1' ' A' ' 90' ' ' GLN . 12.5 pt -146.19 22.89 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.588 ' HB2' ' CG ' ' A' ' 88' ' ' HIS . 9.2 t -91.43 154.86 18.87 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.6 m -70.22 -52.11 25.7 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.447 178.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.42 -2.75 26.81 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.375 -179.072 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.87 156.08 31.88 Favored Glycine 0 N--CA 1.438 -1.203 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.468 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.463 HG22 ' CG2' ' A' ' 130' ' ' ILE . 5.0 m -117.44 137.68 52.35 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.829 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -115.52 148.59 39.33 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -177.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.473 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.09 113.5 18.45 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.44 177.529 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.419 ' N ' HD12 ' A' ' 111' ' ' LEU . 46.0 m-20 44.79 43.09 6.58 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.93 -11.87 65.63 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.455 178.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -104.99 118.49 36.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.037 0.446 . . . . 0.0 110.682 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.829 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -70.99 124.54 24.61 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.484 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.827 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.2 m -96.39 162.87 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.818 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.48 ' O ' ' HB2' ' A' ' 120' ' ' SER . 2.1 tt0 -69.82 129.59 39.96 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.439 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.672 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 15.4 tttt -53.94 160.62 1.41 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.876 0.37 . . . . 0.0 110.572 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.7 p-10 34.58 34.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.303 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.48 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.35 145.31 40.29 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.117 179.477 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.765 ' HB3' HD23 ' A' ' 100' ' ' LEU . 1.7 m-80 -86.04 130.42 34.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.086 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.421 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 6.7 mm100 -129.37 146.3 51.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.377 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.432 HD13 ' C ' ' A' ' 123' ' ' LEU . 1.2 tm? -72.72 115.01 11.49 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.793 0.33 . . . . 0.0 110.314 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.496 HD21 HG12 ' A' ' 147' ' ' ILE . 65.6 tp -54.75 157.71 2.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.382 0.611 . . . . 0.0 111.7 -179.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.43 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.0 OUTLIER -124.28 153.53 41.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.374 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.463 ' HA ' HD12 ' A' ' 147' ' ' ILE . 6.4 mm-40 -71.06 119.63 15.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.969 0.414 . . . . 0.0 110.291 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.55 21.49 64.84 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.235 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.43 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 26.0 t70 -56.94 172.01 0.3 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.997 0.427 . . . . 0.0 111.069 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 4.5 tt0 -145.22 135.58 24.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.165 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.503 HD11 HD11 ' A' ' 101' ' ' LEU . 1.3 mp -110.5 128.73 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.443 179.322 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.605 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.1 m -103.64 140.02 38.13 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.68 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 28.2 m -140.41 158.45 25.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -178.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 87.32 24.68 35.95 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.332 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.427 ' HB ' ' CZ3' ' A' ' 110' ' ' TRP . 70.2 t -69.56 140.38 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-O 121.632 0.729 . . . . 0.0 111.907 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 143.04 -41.84 1.14 Allowed Glycine 0 N--CA 1.435 -1.385 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 1.054 HG22 HD12 ' B' ' 172' ' ' ILE . 6.2 t -119.15 126.05 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.28 -35.84 28.91 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 47.3 m -93.49 6.63 47.54 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.442 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 30.6 m-20 -120.81 29.65 7.29 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -178.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.605 ' CG2' HG22 ' A' ' 131' ' ' THR . 7.3 mt -106.89 138.91 30.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 121.478 0.656 . . . . 0.0 110.904 178.197 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.671 HD22 ' CD2' ' A' ' 143' ' ' LEU . 1.3 tt -124.65 134.64 52.82 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.729 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.6 ' N ' HD23 ' A' ' 141' ' ' LEU . 0.9 OUTLIER -109.57 133.39 53.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.001 0.429 . . . . 0.0 111.717 -179.819 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.671 ' CD2' HD22 ' A' ' 141' ' ' LEU . 1.4 mm? -128.84 135.73 49.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.554 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.422 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 24.0 t -110.93 134.45 53.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.829 0.347 . . . . 0.0 111.271 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.435 HD13 HG22 ' A' ' 36' ' ' VAL . 5.2 mm -106.11 139.0 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.975 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.34 122.35 41.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.798 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.496 HG12 HD21 ' A' ' 124' ' ' LEU . 6.7 mt -85.01 134.11 27.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.324 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -83.35 103.57 12.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.853 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -64.14 -28.08 69.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.063 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.15 -43.67 87.47 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.062 0.458 . . . . 0.0 110.618 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.433 ' CZ ' HG12 ' A' ' 52' ' ' ILE . 33.5 t80 -58.53 -44.01 89.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.901 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -60.94 -40.45 93.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.955 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -60.61 -37.09 80.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.073 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.531 ' SG ' HD13 ' A' ' 52' ' ' ILE . 10.2 t -64.71 -45.34 86.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.085 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -62.35 -36.01 80.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.919 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -62.19 -34.71 76.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.993 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -92.07 -37.0 13.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.928 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 44.36 -171.49 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.598 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -95.92 134.47 38.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.883 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.7 t -80.55 126.62 39.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.14 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -98.85 166.84 11.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.946 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -107.0 114.54 28.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.874 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.8 mt -85.4 134.56 26.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.075 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.87 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 165' ' ' ASN . . . . . 0.564 ' N ' HD21 ' B' ' 165' ' ' ASN . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.852 0.358 . . . . 0.0 111.22 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -62.66 119.65 52.74 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.826 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.89 126.56 11.41 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.359 2.039 . . . . 0.0 112.427 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -107.69 78.51 1.2 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.709 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 169' ' ' TPO . . . . . 0.479 HG23 ' N ' ' B' ' 170' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.831 HD11 ' HB2' ' A' ' 82' ' ' SER . 0.4 OUTLIER -100.6 173.06 6.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.904 0.383 . . . . 0.0 111.555 -179.48 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 171' ' ' GLU . . . . . 0.515 ' O ' ' O ' ' B' ' 172' ' ' ILE . 31.0 mt-10 -161.47 92.71 0.9 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.723 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 1.054 HD12 HG22 ' A' ' 136' ' ' VAL . 0.9 OUTLIER 44.85 114.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 121.349 0.595 . . . . 0.0 112.047 -179.73 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 173' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -80.99 60.53 4.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.055 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 83.4 p . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.854 179.951 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.453 ' HB1' ' HB2' ' A' ' 17' ' ' ARG . . . . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.772 0.32 . . . . 0.0 111.045 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.7 m 70.37 -64.17 0.37 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.903 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -41.11 88.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.921 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.453 ' HB2' ' HB1' ' A' ' 14' ' ' ALA . 5.8 ttt180 -62.13 -35.98 80.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.844 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -56.86 -39.26 73.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.741 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.8 mp -61.37 -31.91 71.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.422 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.42 ' O ' ' CD1' ' A' ' 23' ' ' PHE . 8.2 mt -69.21 -44.4 80.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.771 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -57.56 -32.71 67.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.418 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.5 -22.28 7.82 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.01 -179.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.42 ' CD1' ' O ' ' A' ' 20' ' ' ILE . 1.9 p90 -55.66 -44.3 77.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.925 0.393 . . . . 0.0 111.474 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.419 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 51.8 p -80.38 -25.13 39.28 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.935 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 65.11 141.24 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.866 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -63.04 140.91 58.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.826 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -82.82 109.02 16.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.923 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.4 mm -81.92 138.39 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 CA-C-O 121.615 0.721 . . . . 0.0 111.694 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.79 52.41 3.15 Favored Glycine 0 C--N 1.313 -0.705 0 CA-C-N 114.593 -1.185 . . . . 0.0 112.359 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -73.89 -44.6 54.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.853 0.359 . . . . 0.0 111.112 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.441 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER -170.38 33.31 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -179.767 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.702 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -73.2 133.84 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-N 113.839 -1.528 . . . . 0.0 112.407 -177.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.998 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -92.54 -61.37 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.09 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.691 ' SG ' HD12 ' A' ' 48' ' ' LEU . 1.6 p -143.38 163.44 33.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.272 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 146' ' ' PHE . 0.0 OUTLIER -127.05 138.3 53.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.962 0.411 . . . . 0.0 111.782 -179.131 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.668 HG11 ' CE2' ' A' ' 68' ' ' PHE . 2.0 m -108.63 122.9 63.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.579 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.897 HG23 HG12 ' A' ' 45' ' ' ILE . 21.5 mt -128.42 122.11 56.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.991 -178.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.845 ' HA ' HD23 ' A' ' 143' ' ' LEU . 42.0 t -81.81 102.63 10.93 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 178.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.488 ' OG1' HG23 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -74.32 -23.82 59.12 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.68 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.554 HG21 ' H ' ' A' ' 142' ' ' SER . 72.2 p -79.78 -2.29 42.55 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.683 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.23 77.19 0.37 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.87 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.714 ' OE1' HD12 ' A' ' 141' ' ' LEU . 15.9 mt-30 -146.62 -41.0 0.2 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.935 0.398 . . . . 0.0 110.696 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.583 HG21 ' CE1' ' A' ' 76' ' ' TYR . 1.3 mp -125.77 141.34 38.98 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.8 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.556 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 46.8 Cg_endo -71.68 146.1 48.07 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.102 1.868 . . . . 0.0 112.137 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.897 HG12 HG23 ' A' ' 37' ' ' ILE . 39.2 mt -51.44 148.33 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.898 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.84 150.3 49.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.083 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -112.87 119.63 38.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.049 0.452 . . . . 0.0 111.368 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.691 HD12 ' SG ' ' A' ' 34' ' ' CYS . 3.1 mt -95.98 135.26 37.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.227 178.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.998 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.04 158.01 43.87 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -178.834 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.488 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -140.91 143.26 34.53 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 113.528 -1.669 . . . . 0.0 110.861 178.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.789 ' O ' HG23 ' A' ' 55' ' ' VAL . 23.3 m-20 -74.92 122.31 23.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.223 0.535 . . . . 0.0 111.093 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.455 HD13 ' SG ' ' A' ' 154' ' ' CYS . 44.4 mt -64.34 -40.96 90.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.4 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 p -57.05 -42.17 80.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.229 0.538 . . . . 0.0 110.825 -178.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.483 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 13.4 mt-30 -68.7 -37.13 79.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.891 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.82 HG22 ' HG2' ' A' ' 63' ' ' LYS . 30.1 t -65.59 -45.51 92.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.283 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.13 -28.9 64.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.12 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.1 tmtm? -81.0 -46.78 14.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.048 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -77.08 135.0 38.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.905 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.98 29.39 4.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.9 mtm105 -150.21 151.81 33.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.865 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 59.42 -174.64 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.822 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.41 HG12 ' CG2' ' A' ' 65' ' ' VAL . 9.5 tp -81.96 144.46 10.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.1 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.82 ' HG2' HG22 ' A' ' 55' ' ' VAL . 1.6 tpmp? -69.38 -72.57 0.18 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.965 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.433 ' CE ' ' O ' ' A' ' 49' ' ' SER . 6.0 ttpt -149.38 137.37 20.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.952 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.617 HG12 ' HG2' ' A' ' 90' ' ' GLN . 13.9 t -128.79 139.09 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-O 121.375 0.607 . . . . 0.0 112.299 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.532 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.9 m-90 -103.03 139.24 38.84 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.887 179.142 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.62 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -114.21 129.05 56.63 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.338 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.668 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -118.3 145.45 45.07 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.6 -178.305 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.597 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.43 -166.6 35.38 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.393 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.412 ' HD3' ' O ' ' A' ' 81' ' ' ILE . 12.9 mtm180 -86.73 6.98 28.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.504 0.192 . . . . 0.0 111.512 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.671 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 9.7 t-20 -84.95 134.01 42.19 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.547 0.213 . . . . 0.0 111.036 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.9 Cg_exo -65.43 -15.07 48.13 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.53 2.153 . . . . 0.0 111.598 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.671 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -83.15 -43.26 16.38 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 121.962 0.887 . . . . 0.0 108.887 178.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.47 136.03 3.38 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 113.862 -1.517 . . . . 0.0 111.045 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.9 OUTLIER -56.87 -18.62 13.79 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.952 178.611 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.583 ' CE1' HG21 ' A' ' 43' ' ' ILE . 30.5 t80 -129.57 112.1 13.38 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.783 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -89.75 111.63 22.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.22 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.769 HD13 HD13 ' A' ' 84' ' ' LEU . 88.4 mt -78.52 -172.81 3.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.839 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -90.66 21.12 34.51 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.891 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 61.04 74.68 0.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.944 0.402 . . . . 0.0 111.601 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 1.042 HD13 HD12 ' A' ' 84' ' ' LEU . 4.3 mp -106.62 129.18 60.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.723 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.788 ' HB3' HD13 ' B' ' 170' ' ' LEU . 2.7 m -54.91 -37.21 66.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.293 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.794 ' NE ' HD21 ' B' ' 170' ' ' LEU . 0.0 OUTLIER -69.32 -15.94 63.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.452 -179.814 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.042 HD12 HD13 ' A' ' 81' ' ' ILE . 28.4 mt -107.06 152.01 24.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.719 0.295 . . . . 0.0 110.833 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.4 m -95.79 166.63 11.72 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.496 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.597 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 1.4 m-80 -42.46 -57.55 2.59 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.439 0.638 . . . . 0.0 109.545 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.486 ' HB3' HG22 ' A' ' 67' ' ' THR . 10.3 mtpt -116.79 84.39 2.13 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 176.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.549 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 12.4 t60 -60.89 -46.73 89.46 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.596 -176.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.492 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 25.6 p90 -145.08 158.07 43.93 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.116 -0.634 . . . . 0.0 112.157 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.62 ' HG3' HG23 ' A' ' 67' ' ' THR . 26.1 tt0 -135.9 139.91 43.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.164 -179.148 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.598 ' O ' HG13 ' A' ' 65' ' ' VAL . 72.6 mt -115.97 130.23 71.02 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 C-N-CA 121.134 -0.227 . . . . 0.0 111.002 179.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.51 HD21 ' HB2' ' A' ' 102' ' ' ASN . 0.2 OUTLIER -115.53 150.83 35.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.12 0.486 . . . . 0.0 111.851 -179.888 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.422 HD13 ' HG ' ' A' ' 99' ' ' LEU . 14.6 tp -124.99 122.87 38.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.223 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -82.67 -178.26 52.29 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.82 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -96.38 110.17 22.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.819 0.343 . . . . 0.0 110.864 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.1 t0 57.94 98.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.948 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 162.75 -94.32 0.12 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.515 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -154.18 -171.13 3.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.843 0.354 . . . . 0.0 110.864 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.983 HD21 HG12 ' A' ' 33' ' ' VAL . 4.2 mp -106.95 157.16 18.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.762 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.735 HD22 ' HB3' ' A' ' 121' ' ' ASN . 13.8 mt -133.2 144.38 49.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.893 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.649 HD11 ' HA ' ' A' ' 124' ' ' LEU . 2.2 mt -112.73 123.21 49.78 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.745 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.51 ' HB2' HD21 ' A' ' 92' ' ' LEU . 52.0 t30 -114.68 115.55 27.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.062 0.458 . . . . 0.0 111.664 -179.069 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.82 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.1 p30 -77.71 134.61 38.07 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.733 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.459 HD12 ' HB2' ' A' ' 87' ' ' LYS . 13.7 pt -141.71 39.48 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.623 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -101.93 151.63 21.88 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.005 0.431 . . . . 0.0 112.021 -178.892 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.742 HG21 ' HB ' ' B' ' 169' ' ' TPO . 19.6 m -68.89 -31.59 70.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.688 177.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -95.11 -19.55 20.02 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.328 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.623 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 112.78 158.96 13.82 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.781 179.265 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 11.4 m -117.1 137.69 52.12 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.871 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -115.89 148.32 40.12 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -177.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.485 HD13 ' OD2' ' A' ' 128' ' ' ASP . 0.2 OUTLIER -124.31 113.52 18.35 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.66 -1.155 . . . . 0.0 108.419 177.545 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 43.74 43.77 5.15 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.51 -11.14 66.87 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.58 178.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -103.57 118.59 37.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.027 0.441 . . . . 0.0 110.583 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.871 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 12.2 tptm -74.53 122.3 22.88 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.382 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.82 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.9 m -91.59 164.17 2.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.971 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 120' ' ' SER . 15.9 tt0 -69.89 126.26 29.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.468 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.702 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 28.2 tttt -53.2 162.69 0.66 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.944 0.402 . . . . 0.0 110.441 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.1 m-80 34.67 35.0 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.03 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.4 OUTLIER -112.27 145.01 40.72 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.293 179.578 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.735 ' HB3' HD22 ' A' ' 100' ' ' LEU . 50.3 m-80 -89.11 125.56 35.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.727 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.508 ' O ' HD23 ' A' ' 100' ' ' LEU . 38.5 mm-40 -129.31 147.65 51.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.089 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 tt -76.34 115.3 15.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.104 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.649 ' HA ' HD11 ' A' ' 101' ' ' LEU . 1.6 pt? -56.99 165.84 1.17 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.604 0.716 . . . . 0.0 112.043 -178.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.449 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.64 153.65 41.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.073 179.657 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.522 ' HA ' HD12 ' A' ' 147' ' ' ILE . 1.6 tp-100 -71.17 123.22 21.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.013 0.435 . . . . 0.0 110.287 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.06 20.19 53.16 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.107 -179.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.485 ' OD2' HD13 ' A' ' 111' ' ' LEU . 7.7 t70 -58.58 178.8 0.09 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.745 0.307 . . . . 0.0 110.673 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.885 ' CG ' HG22 ' A' ' 144' ' ' VAL . 5.4 mt-10 -145.11 135.61 24.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.415 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 1.038 HD11 HD11 ' A' ' 145' ' ' ILE . 15.3 mt -112.04 126.91 69.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.215 178.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.51 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.2 m -104.33 138.66 40.44 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.563 HG23 HD21 ' A' ' 84' ' ' LEU . 35.8 m -140.01 158.12 26.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.138 0.494 . . . . 0.0 112.268 -178.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 89.47 24.02 32.23 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.951 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.461 ' HB ' ' CZ3' ' A' ' 110' ' ' TRP . 73.5 t -71.12 140.52 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-O 121.654 0.74 . . . . 0.0 112.021 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.05 -45.74 0.66 Allowed Glycine 0 N--CA 1.433 -1.525 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.918 HG22 HG12 ' B' ' 172' ' ' ILE . 1.7 t -110.51 131.41 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -50.56 -44.22 56.53 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.8 m -93.37 6.92 46.48 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -178.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.47 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 16.5 m-20 -117.01 34.4 5.13 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -178.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.51 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.4 mt -107.01 139.09 29.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.973 178.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.714 HD12 ' OE1' ' A' ' 42' ' ' GLN . 10.2 tt -124.33 134.71 53.1 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.862 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.554 ' H ' HG21 ' A' ' 40' ' ' THR . 47.1 t -110.33 150.34 28.9 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.658 0.742 . . . . 0.0 112.195 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.845 HD23 ' HA ' ' A' ' 38' ' ' CYS . 75.0 mt -135.87 158.1 45.21 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.881 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.885 HG22 ' CG ' ' A' ' 129' ' ' GLU . 22.4 t -122.54 139.92 47.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.852 0.358 . . . . 0.0 111.026 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 1.038 HD11 HD11 ' A' ' 130' ' ' ILE . 30.7 mt -106.3 120.96 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.833 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.406 ' O ' ' N ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -109.99 108.62 18.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.841 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.522 HD12 ' HA ' ' A' ' 126' ' ' GLN . 6.1 mt -84.6 128.98 38.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.245 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -77.82 114.16 16.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -69.02 -31.59 70.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -57.39 -43.38 83.61 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.066 0.46 . . . . 0.0 110.411 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -58.18 -44.08 87.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.624 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -65.12 -34.43 78.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.957 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -64.13 -43.45 95.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.068 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.455 ' SG ' HD13 ' A' ' 52' ' ' ILE . 13.2 t -58.9 -46.21 88.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.939 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.1 -35.93 76.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.83 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -37.68 80.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -88.32 -37.12 16.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.94 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 44.24 -171.33 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.6 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.87 120.54 25.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.819 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 26.3 t -103.06 129.5 54.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.077 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -119.64 -68.38 0.92 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.958 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? 61.16 31.35 19.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.864 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 20.4 mt -102.79 117.18 47.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.178 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.176 -0.916 . . . . 0.0 110.945 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.888 0.375 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.1 146.81 33.27 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.832 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.29 155.01 56.47 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.474 2.116 . . . . 0.0 112.376 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -112.39 97.47 6.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.799 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 169' ' ' TPO . . . . . 0.742 ' HB ' HG21 ' A' ' 106' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.794 HD21 ' NE ' ' A' ' 83' ' ' ARG . 2.3 tt -53.36 152.18 4.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.437 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 171' ' ' GLU . . . . . 0.691 ' O ' HG22 ' B' ' 172' ' ' ILE . 53.6 mt-10 -153.83 79.76 1.14 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.869 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 0.918 HG12 HG22 ' A' ' 136' ' ' VAL . 0.1 OUTLIER 53.37 134.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 121.182 0.515 . . . . 0.0 111.587 -179.862 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 173' ' ' TYR . . . . . 0.909 ' N ' HD13 ' B' ' 172' ' ' ILE . 20.9 m-85 -56.17 105.67 0.21 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.939 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 1.3 p . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.899 -179.973 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.429 ' O ' ' HB ' ' A' ' 15' ' ' THR . . . . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.646 0.26 . . . . 0.0 111.031 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.429 ' HB ' ' O ' ' A' ' 14' ' ' ALA . 14.0 m 74.99 -52.91 0.67 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.413 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -59.66 -34.27 72.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.712 0.292 . . . . 0.0 110.962 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.81 -38.27 90.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.76 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -61.42 -40.77 95.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.716 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.6 mt -58.93 -31.83 69.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.726 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.427 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.8 mt -72.55 -35.31 50.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.921 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -57.32 -42.88 82.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.478 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.21 -24.17 65.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.537 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.427 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.91 -47.57 80.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.204 179.859 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.1 t -70.89 -31.12 67.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.001 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -63.08 82.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.858 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -65.22 155.34 35.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.767 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -85.56 101.86 13.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.931 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.3 mm -84.45 138.18 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 CA-C-O 121.611 0.72 . . . . 0.0 111.656 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 139.07 43.61 0.08 OUTLIER Glycine 0 C--N 1.313 -0.701 0 CA-C-N 114.546 -1.206 . . . . 0.0 112.549 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.473 ' HG2' HD11 ' A' ' 32' ' ' ILE . 2.5 pt-20 -59.89 -41.39 91.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.912 0.387 . . . . 0.0 110.792 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.461 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.0 OUTLIER -179.88 37.22 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.92 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.722 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.4 mm -73.48 135.67 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 CA-C-N 113.664 -1.607 . . . . 0.0 112.45 -177.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.014 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.4 t -91.81 -59.77 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.916 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.718 ' SG ' HD12 ' A' ' 48' ' ' LEU . 7.0 p -150.59 152.03 33.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.26 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.425 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.99 138.21 50.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.817 0.341 . . . . 0.0 111.352 -179.396 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.629 HG23 HD11 ' A' ' 48' ' ' LEU . 24.3 t -100.73 122.77 53.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.829 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.699 HG23 HG12 ' A' ' 45' ' ' ILE . 17.0 mt -132.93 122.08 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.581 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.621 ' HA ' HD23 ' A' ' 143' ' ' LEU . 51.4 t -80.68 136.55 36.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.405 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 t -97.38 -29.23 13.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.625 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.534 HG23 ' HB3' ' A' ' 142' ' ' SER . 70.4 p -79.79 -2.32 42.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.771 0.319 . . . . 0.0 111.472 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.51 78.27 0.25 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.909 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -146.58 -41.19 0.2 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.736 0.303 . . . . 0.0 111.122 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.729 HD12 HD21 ' A' ' 143' ' ' LEU . 1.5 mt -114.8 140.6 25.63 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.065 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.538 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.1 Cg_endo -74.35 145.93 34.86 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.24 1.96 . . . . 0.0 112.042 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.699 HG12 HG23 ' A' ' 37' ' ' ILE . 35.0 mt -61.92 136.69 24.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.805 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.06 164.17 26.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.08 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.425 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 1.3 p30 -117.77 123.21 45.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.128 0.49 . . . . 0.0 112.115 -179.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.718 HD12 ' SG ' ' A' ' 34' ' ' CYS . 0.8 OUTLIER -101.21 135.65 42.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.507 -0.77 . . . . 0.0 108.923 178.472 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . 1.014 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.21 159.1 43.53 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -178.764 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.491 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -146.71 149.89 34.31 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 113.766 -1.561 . . . . 0.0 111.146 178.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.679 ' O ' HG23 ' A' ' 55' ' ' VAL . 11.5 m-20 -79.18 123.95 27.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.088 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 49.3 mt -64.46 -42.58 95.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.176 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.3 p -56.97 -40.0 75.68 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.307 0.575 . . . . 0.0 110.704 -179.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.443 ' CG ' ' HB2' ' A' ' 51' ' ' ASP . 4.6 mm100 -68.58 -36.89 79.33 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.756 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.723 HG22 ' HG2' ' A' ' 63' ' ' LYS . 39.4 t -73.04 -49.1 41.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.126 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.22 -29.6 68.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.928 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.2 tptt -77.31 -59.07 2.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.785 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -76.69 133.91 39.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.886 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.77 49.56 2.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.984 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.74 -65.63 0.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.924 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 31.3 t -178.99 -38.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.754 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.748 HD13 ' N ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -132.62 151.22 34.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.949 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.748 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -117.58 -64.62 1.28 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.133 -179.859 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.403 ' CE ' ' O ' ' A' ' 49' ' ' SER . 6.4 ttpt -137.17 130.83 31.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.003 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.63 HG23 HD11 ' A' ' 62' ' ' ILE . 4.4 t -118.69 136.33 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 121.36 0.6 . . . . 0.0 111.94 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.633 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 15.4 m-90 -100.68 140.37 35.05 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.516 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.757 HG23 ' CG ' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -111.35 129.22 56.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.201 177.978 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.678 ' CD1' ' HB2' ' A' ' 76' ' ' TYR . 5.8 m-85 -120.39 145.42 47.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.472 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.651 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.49 -168.64 36.76 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.025 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.452 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 6.4 mtm105 -79.03 3.09 18.31 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.456 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 23.7 t-20 -84.7 131.74 48.62 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.612 0.244 . . . . 0.0 111.101 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.0 Cg_exo -66.14 -14.01 42.45 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.584 2.189 . . . . 0.0 111.59 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.87 -44.05 15.87 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 121.841 0.829 . . . . 0.0 108.803 178.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -40.19 138.91 0.79 Allowed 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 113.78 -1.554 . . . . 0.0 110.951 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 67' ' ' THR . 10.9 m-20 -56.73 -19.22 15.6 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.355 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.678 ' HB2' ' CD1' ' A' ' 68' ' ' PHE . 12.6 t80 -130.36 113.66 14.63 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.672 0.273 . . . . 0.0 111.027 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -85.87 107.83 17.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.672 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.557 HD22 ' HA2' ' A' ' 69' ' ' GLY . 8.0 mp -81.77 -78.76 0.18 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.007 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -173.25 -94.24 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.084 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.41 ' HA ' ' HD2' ' A' ' 70' ' ' ARG . 8.5 p30 -179.81 50.29 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.825 0.345 . . . . 0.0 111.143 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.407 HG22 ' H ' ' A' ' 83' ' ' ARG . 26.0 mm -79.05 125.49 38.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.848 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.751 ' HB3' HD21 ' B' ' 170' ' ' LEU . 0.3 OUTLIER -54.93 -37.21 66.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.913 -179.875 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.741 ' NH1' HG23 ' A' ' 136' ' ' VAL . 6.2 mtp180 -69.53 -37.14 76.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.108 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.558 HD21 HG23 ' A' ' 132' ' ' VAL . 44.6 mt -83.74 151.58 25.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.837 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 95.3 p -97.79 164.8 12.24 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.656 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.651 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.5 m-20 -42.55 -52.4 4.77 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.497 0.665 . . . . 0.0 109.61 179.076 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.732 ' HB3' HG22 ' A' ' 67' ' ' THR . 3.8 mttt -118.9 84.14 2.14 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 177.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.554 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.4 t60 -62.88 -44.7 95.4 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.103 -0.953 . . . . 0.0 113.137 -176.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.544 ' HZ ' HD13 ' A' ' 143' ' ' LEU . 0.1 OUTLIER -148.7 161.8 41.02 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.985 -0.686 . . . . 0.0 112.234 -179.564 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.757 ' CG ' HG23 ' A' ' 67' ' ' THR . 28.3 mt-30 -135.08 155.53 50.58 Favored 'General case' 0 C--N 1.334 -0.065 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.389 -178.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.709 HD11 HD11 ' A' ' 145' ' ' ILE . 32.5 mt -130.48 132.49 64.61 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.343 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 177.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.622 HD23 ' HB2' ' A' ' 102' ' ' ASN . 0.9 OUTLIER -122.73 145.78 48.09 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.069 0.461 . . . . 0.0 111.877 -179.392 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.807 HD22 ' CG1' ' A' ' 33' ' ' VAL . 8.2 tp -125.1 144.28 50.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.185 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.37 165.38 31.85 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.488 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -63.76 118.48 8.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.808 0.337 . . . . 0.0 110.956 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 176.96 -36.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.844 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 115.57 22.01 4.89 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.568 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -159.68 -177.59 6.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.766 0.317 . . . . 0.0 110.792 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.704 HD11 HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -118.74 158.75 24.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.851 179.994 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.751 HD13 ' O ' ' A' ' 122' ' ' GLN . 3.4 mm? -124.06 138.83 54.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.469 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.808 HD11 HD13 ' A' ' 124' ' ' LEU . 9.2 mp -112.6 125.06 53.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.048 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.622 ' HB2' HD23 ' A' ' 92' ' ' LEU . 50.4 t30 -115.8 115.75 26.82 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.12 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.785 ' OD2' HG23 ' A' ' 116' ' ' VAL . 8.8 p30 -78.08 142.9 37.83 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.524 HG21 ' OE1' ' A' ' 90' ' ' GLN . 8.1 pt -150.35 37.56 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -178.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.587 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.43 148.52 24.13 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 120.948 0.404 . . . . 0.0 111.712 -179.045 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.487 HG21 ' CG2' ' B' ' 169' ' ' TPO . 18.2 m -68.63 -31.37 70.47 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.64 177.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -94.56 -19.54 20.41 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.587 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.8 152.0 9.6 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.227 -0.987 . . . . 0.0 113.888 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.472 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.7 m -117.57 137.86 52.31 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.869 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -118.39 148.3 42.67 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.514 HD13 ' OD2' ' A' ' 128' ' ' ASP . 0.2 OUTLIER -124.16 113.65 18.61 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.484 177.541 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.409 ' N ' HD12 ' A' ' 111' ' ' LEU . 2.5 m120 45.3 43.01 7.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.273 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.5 -7.65 75.35 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.512 178.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -104.42 118.63 37.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.018 0.437 . . . . 0.0 110.671 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.869 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.0 tptm -74.12 121.5 21.25 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.187 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.785 HG23 ' OD2' ' A' ' 103' ' ' ASP . 8.2 m -96.22 163.57 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.133 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -69.77 128.83 37.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.493 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.686 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 12.4 tttt -53.72 162.77 0.8 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.764 0.316 . . . . 0.0 110.29 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.8 m-80 33.5 37.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.846 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.9 p -111.78 145.16 39.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.893 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.456 ' HB3' HD12 ' A' ' 100' ' ' LEU . 8.2 m-80 -88.83 124.44 34.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.864 0.364 . . . . 0.0 110.713 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.751 ' O ' HD13 ' A' ' 100' ' ' LEU . 50.6 mm-40 -128.98 149.45 50.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.598 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.5 tp -72.63 132.85 44.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.889 0.376 . . . . 0.0 110.441 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.834 HD11 HG21 ' A' ' 145' ' ' ILE . 64.0 tp -69.47 157.85 36.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.428 0.633 . . . . 0.0 111.519 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.427 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.6 OUTLIER -124.33 153.17 42.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.926 179.59 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.705 ' HA ' HD13 ' A' ' 147' ' ' ILE . 1.2 mm-40 -71.25 122.9 21.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.979 0.419 . . . . 0.0 110.659 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 56.98 22.93 44.05 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.267 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.514 ' OD2' HD13 ' A' ' 111' ' ' LEU . 15.5 t70 -56.17 175.06 0.11 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.852 0.358 . . . . 0.0 110.828 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.923 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.0 mt-10 -143.8 135.63 26.36 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.081 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.667 HD11 HG13 ' A' ' 145' ' ' ILE . 2.2 mp -112.5 128.14 69.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.574 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.567 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.0 m -104.32 145.12 30.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.443 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.558 HG23 HD21 ' A' ' 84' ' ' LEU . 29.9 m -140.37 158.46 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.052 0.453 . . . . 0.0 112.156 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.51 42.01 12.32 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.268 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.472 ' HB ' ' CH2' ' A' ' 110' ' ' TRP . 74.8 t -86.67 140.4 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-O 121.544 0.688 . . . . 0.0 112.124 -179.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 139.22 -34.1 2.1 Favored Glycine 0 N--CA 1.435 -1.371 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.838 HG22 HD12 ' B' ' 172' ' ' ILE . 9.0 t -124.56 118.34 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.125 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -50.77 -29.6 11.94 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -178.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 31.9 m -93.61 6.7 47.38 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -178.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.418 ' CB ' ' HD3' ' A' ' 83' ' ' ARG . 0.8 OUTLIER -130.07 31.28 4.69 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -178.583 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.567 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.1 mt -107.11 138.46 32.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-O 121.351 0.595 . . . . 0.0 110.866 178.052 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.407 HD23 ' C ' ' A' ' 141' ' ' LEU . 9.3 tt -125.09 134.72 52.38 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.692 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.534 ' HB3' HG23 ' A' ' 40' ' ' THR . 44.4 t -106.84 149.62 27.22 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.544 0.688 . . . . 0.0 112.066 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.729 HD21 HD12 ' A' ' 43' ' ' ILE . 75.6 mt -136.39 158.04 45.36 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.695 -1.138 . . . . 0.0 111.219 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.923 HG22 ' CG ' ' A' ' 129' ' ' GLU . 21.7 t -129.18 140.16 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.851 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.834 HG21 HD11 ' A' ' 124' ' ' LEU . 1.1 mm -106.36 129.55 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 CA-C-O 120.944 0.402 . . . . 0.0 110.911 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.02 110.67 21.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.858 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.705 HD13 ' HA ' ' A' ' 126' ' ' GLN . 4.3 mp -85.83 134.14 27.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.483 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -84.94 123.69 30.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.819 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -72.01 -27.78 62.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.069 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -58.74 -44.43 90.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.035 0.445 . . . . 0.0 110.756 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -59.36 -44.09 92.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.898 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.06 -40.66 95.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.905 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -59.16 -47.03 86.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.086 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 11.8 t -60.91 -45.99 92.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.968 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.65 -43.46 98.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.911 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -61.47 -39.6 91.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.814 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -68.17 -26.02 65.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.926 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -123.54 96.73 5.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.006 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 6.9 mttm -107.72 136.24 47.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.825 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.2 m -65.01 126.52 24.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.107 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -152.35 -46.05 0.1 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.952 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 63.15 -79.58 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.01 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.3 pp -89.19 135.01 26.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.178 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.955 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 5.6 p30 . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.784 0.326 . . . . 0.0 111.256 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.96 100.82 53.17 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.908 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -49.36 167.39 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.483 2.122 . . . . 0.0 112.381 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -108.52 117.47 34.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.915 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 169' ' ' TPO . . . . . 0.487 ' CG2' HG21 ' A' ' 106' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.751 HD21 ' HB3' ' A' ' 82' ' ' SER . 1.0 OUTLIER -156.4 -176.56 6.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.068 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 171' ' ' GLU . . . . . 0.509 ' O ' ' O ' ' B' ' 172' ' ' ILE . 31.0 mt-10 -145.24 68.6 1.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.94 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 0.838 HD12 HG22 ' A' ' 136' ' ' VAL . 15.0 tt 49.22 157.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.161 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 173' ' ' TYR . . . . . 0.423 ' N ' HG12 ' B' ' 172' ' ' ILE . 11.8 m-85 -53.85 92.1 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.078 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.951 -179.988 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.847 0.356 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.8 p -125.05 -44.28 1.92 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.954 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -46.98 64.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.95 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.3 ttm-85 -69.9 -43.25 72.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.9 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.66 -35.01 73.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.842 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.64 -40.81 96.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.94 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.503 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 10.2 mm -72.45 -35.29 51.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.231 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -57.41 -40.37 78.15 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.923 0.392 . . . . 0.0 110.301 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.24 -23.89 65.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.749 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.503 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.64 -47.63 79.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.364 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.62 -47.04 14.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.093 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -129.93 114.07 15.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.105 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -70.88 158.76 35.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -87.61 101.86 14.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.923 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.2 mm -86.9 138.48 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 CA-C-O 121.719 0.771 . . . . 0.0 111.903 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.7 62.79 4.29 Favored Glycine 0 C--N 1.316 -0.572 0 CA-C-N 114.443 -1.253 . . . . 0.0 112.581 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -83.81 -43.01 15.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.873 0.368 . . . . 0.0 110.986 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.436 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER -169.99 34.68 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 -179.9 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.682 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 2.9 mm -77.77 134.02 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 CA-C-N 113.878 -1.51 . . . . 0.0 112.58 -177.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.997 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -90.25 -60.89 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.677 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.6 p -146.14 150.8 36.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.169 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.97 138.12 50.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.743 0.306 . . . . 0.0 111.214 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.605 HG21 ' HE2' ' A' ' 68' ' ' PHE . 26.6 t -101.7 122.66 54.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.874 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.577 HG23 HG12 ' A' ' 45' ' ' ILE . 18.9 mt -129.43 125.78 62.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.405 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.475 ' SG ' HD21 ' A' ' 141' ' ' LEU . 7.4 t -95.36 107.37 19.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.904 0.383 . . . . 0.0 110.485 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 79.3 p -82.02 -20.6 38.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.516 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.7 HG21 ' OG ' ' A' ' 142' ' ' SER . 12.3 p -80.04 -3.1 47.11 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.736 0.303 . . . . 0.0 111.333 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.39 70.93 0.97 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 121.087 -0.578 . . . . 0.0 113.775 178.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.524 ' HB2' HD21 ' A' ' 141' ' ' LEU . 0.8 OUTLIER -145.08 -37.36 0.28 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.623 0.249 . . . . 0.0 111.469 179.411 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.835 HD13 ' HB3' ' A' ' 78' ' ' LEU . 52.2 mt -123.55 142.83 39.99 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.097 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.66 ' HD2' HG23 ' A' ' 43' ' ' ILE . 53.0 Cg_endo -71.97 146.04 46.37 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.206 1.937 . . . . 0.0 112.25 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.577 HG12 HG23 ' A' ' 37' ' ' ILE . 35.2 mt -59.58 144.22 12.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.773 -179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.34 164.02 31.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.013 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -131.64 119.85 21.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.993 0.425 . . . . 0.0 112.114 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.816 HD23 ' CD2' ' A' ' 66' ' ' TRP . 8.2 mp -87.25 133.83 33.62 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 178.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.997 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -138.69 156.18 47.62 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 -179.444 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.462 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -143.87 141.75 30.47 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 113.455 -1.702 . . . . 0.0 110.706 178.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.857 ' O ' HG23 ' A' ' 55' ' ' VAL . 39.9 m-20 -89.17 128.1 35.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.077 0.465 . . . . 0.0 111.232 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.589 ' H ' HD12 ' A' ' 52' ' ' ILE . 5.1 mp -64.26 -45.18 96.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.81 -179.223 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 73.2 m -56.66 -41.22 76.87 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.343 0.592 . . . . 0.0 110.603 -178.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.492 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 19.6 mt-30 -68.49 -36.58 79.13 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.228 -0.897 . . . . 0.0 110.546 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 51' ' ' ASP . 61.3 t -58.68 -49.26 83.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.066 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.6 -37.28 80.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.956 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -67.35 -36.22 80.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.918 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.78 114.83 23.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.69 88.4 4.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.805 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.68 156.42 9.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m -57.84 -26.84 62.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.031 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.866 HD11 ' CG2' ' A' ' 65' ' ' VAL . 8.5 tp -114.99 146.95 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.111 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.633 ' HD3' HG13 ' A' ' 55' ' ' VAL . 1.8 pttt -131.98 -43.95 0.97 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.252 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.417 ' HE2' ' O ' ' A' ' 49' ' ' SER . 2.6 ttpt -154.77 134.03 12.5 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.933 0.397 . . . . 0.0 111.648 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.866 ' CG2' HD11 ' A' ' 62' ' ' ILE . 21.8 t -135.34 139.43 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.776 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.816 ' CD2' HD23 ' A' ' 48' ' ' LEU . 19.7 m-90 -102.21 138.7 38.81 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.086 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.655 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -115.52 125.15 52.66 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.275 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.662 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.8 OUTLIER -108.09 145.58 33.85 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.305 -178.668 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.736 ' CA ' HD21 ' A' ' 78' ' ' LEU . . . 166.64 178.52 39.27 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.831 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.463 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 9.3 mtp-105 -73.46 -5.29 39.01 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.441 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.0 t-20 -84.89 134.96 40.53 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.699 0.285 . . . . 0.0 111.038 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 10.0 Cg_exo -69.76 -5.22 15.68 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.815 2.343 . . . . 0.0 111.831 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.54 -43.38 17.19 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 122.022 0.915 . . . . 0.0 108.558 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -44.04 139.34 2.51 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 113.641 -1.618 . . . . 0.0 110.469 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -56.12 -18.93 11.26 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.066 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.548 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 7.0 t80 -129.73 133.25 46.92 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.866 0.365 . . . . 0.0 110.94 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -109.77 120.42 42.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.643 179.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.835 ' HB3' HD13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -101.36 -81.63 0.48 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.124 -179.879 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.09 -133.07 1.41 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.512 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -138.73 66.7 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.879 0.371 . . . . 0.0 111.439 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.465 HG22 ' H ' ' A' ' 83' ' ' ARG . 31.6 mm -97.11 117.8 42.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.253 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.932 ' HB2' HD13 ' B' ' 170' ' ' LEU . 92.5 p -54.77 -30.98 58.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.19 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.517 ' CZ ' HD21 ' B' ' 170' ' ' LEU . 1.6 mmp_? -71.51 -23.65 61.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.386 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.524 HD21 HG23 ' A' ' 132' ' ' VAL . 29.5 mt -94.23 152.08 18.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.503 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 85.7 p -96.57 166.6 11.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.851 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.672 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 1.5 m-80 -42.81 -52.88 4.86 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.437 0.637 . . . . 0.0 109.675 179.078 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.554 ' HB2' HD12 ' A' ' 104' ' ' ILE . 3.7 ptmm? -120.51 84.78 2.28 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 177.306 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.665 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 61.0 t-80 -60.3 -46.99 87.94 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.952 -1.022 . . . . 0.0 113.042 -176.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.518 ' HA ' HG12 ' A' ' 104' ' ' ILE . 29.3 p90 -151.61 159.54 44.02 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.874 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.655 ' HG3' HG23 ' A' ' 67' ' ' THR . 28.5 tt0 -136.11 139.56 43.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.55 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.662 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 29.4 mt -116.17 129.58 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.915 179.096 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.588 ' CB ' HG22 ' A' ' 65' ' ' VAL . 0.4 OUTLIER -114.58 149.33 36.7 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.234 0.54 . . . . 0.0 112.029 -179.541 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.859 HD22 HG11 ' A' ' 33' ' ' VAL . 57.9 tp -125.19 125.88 44.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.033 179.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -123.01 149.37 16.82 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.584 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.45 107.41 0.66 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.791 0.329 . . . . 0.0 110.899 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -177.8 -39.62 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.896 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 130.8 -21.44 4.7 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.654 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -109.23 172.33 6.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.76 0.314 . . . . 0.0 111.076 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.63 ' HB2' HD13 ' A' ' 124' ' ' LEU . 1.7 mt -116.07 160.06 20.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.665 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.687 HD23 ' HB3' ' A' ' 121' ' ' ASN . 6.3 mp -125.51 139.15 53.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.55 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.593 HD11 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -112.87 123.4 50.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.084 179.665 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.452 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 61.1 t30 -117.74 115.85 25.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.889 0.376 . . . . 0.0 111.967 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.843 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.3 p30 -78.49 142.99 37.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.924 178.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.554 HD12 ' HB2' ' A' ' 87' ' ' LYS . 11.5 pt -147.76 28.0 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.651 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.534 ' HB2' ' CG ' ' A' ' 88' ' ' HIS . 11.3 t -93.56 155.09 17.5 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 121.584 0.707 . . . . 0.0 112.598 -178.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.573 HG21 ' HB ' ' B' ' 169' ' ' TPO . 65.9 m -70.1 -52.17 25.83 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.731 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -78.54 0.57 25.63 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.44 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.07 154.28 30.77 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 120.75 -0.738 . . . . 0.0 114.041 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.546 HG22 ' CG2' ' A' ' 130' ' ' ILE . 3.7 m -117.5 137.86 52.26 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.811 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -116.1 148.54 40.16 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -177.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.892 HD12 HG11 ' A' ' 116' ' ' VAL . 1.0 OUTLIER -124.44 113.64 18.41 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.956 177.363 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 48.3 35.53 5.73 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.072 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.17 -4.8 83.05 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.853 -0.689 . . . . 0.0 113.515 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.37 118.57 36.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.934 0.397 . . . . 0.0 110.498 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.811 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 9.1 tptm -71.04 111.64 6.56 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.128 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.892 HG11 HD12 ' A' ' 111' ' ' LEU . 17.1 m -87.89 162.95 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.106 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.8 OUTLIER -69.91 127.88 34.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.497 179.725 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.681 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 53.9 tttm -54.47 161.68 1.35 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.865 0.364 . . . . 0.0 110.517 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.506 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 35.45 33.89 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.371 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.38 145.09 40.71 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.991 179.279 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.687 ' HB3' HD23 ' A' ' 100' ' ' LEU . 17.3 m-80 -90.14 131.42 36.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.904 0.383 . . . . 0.0 110.976 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.442 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 43.9 mm-40 -129.28 148.77 51.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.43 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.61 123.96 24.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.374 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.63 HD13 ' HB2' ' A' ' 99' ' ' LEU . 7.8 tt -55.21 154.34 5.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.484 0.659 . . . . 0.0 111.723 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.419 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.73 153.24 42.68 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.303 179.73 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.56 ' HA ' HD13 ' A' ' 147' ' ' ILE . 1.9 tp-100 -71.66 126.35 29.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.828 0.347 . . . . 0.0 110.182 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.44 20.3 50.69 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.224 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.419 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 11.0 t70 -53.48 164.36 0.51 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.892 0.377 . . . . 0.0 111.074 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.7 tt0 -144.26 135.39 25.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.928 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.593 HD11 HD11 ' A' ' 101' ' ' LEU . 1.4 mp -109.1 127.02 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.598 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.592 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.7 m -104.17 140.48 37.76 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.665 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.0 m -140.18 158.42 25.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.87 23.6 41.28 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.283 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.437 ' HB ' ' CH2' ' A' ' 110' ' ' TRP . 82.2 t -68.34 140.47 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-O 121.515 0.674 . . . . 0.0 111.915 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.755 ' HA3' HG21 ' B' ' 172' ' ' ILE . . . 141.79 -41.23 1.24 Allowed Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -178.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.94 ' CG2' HD13 ' B' ' 172' ' ' ILE . 2.2 t -120.32 123.31 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.16 -31.05 12.63 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.118 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.68 6.75 47.29 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -178.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.506 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . 16.7 m-20 -125.34 31.0 5.67 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -178.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.592 ' CG2' HG22 ' A' ' 131' ' ' THR . 10.0 mt -106.42 138.71 30.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-O 121.456 0.646 . . . . 0.0 110.985 178.216 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' A' ' 143' ' ' LEU . 1.1 tt -124.76 134.53 52.76 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.517 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.7 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.7 OUTLIER -111.43 131.47 55.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.072 0.463 . . . . 0.0 111.698 -179.699 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.735 ' CD2' HD22 ' A' ' 141' ' ' LEU . 2.8 mm? -127.56 134.41 49.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.555 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 18.8 t -110.68 133.96 54.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.854 0.359 . . . . 0.0 111.18 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.569 ' CD1' HG22 ' A' ' 36' ' ' VAL . 1.2 mm -106.2 121.22 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.08 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -99.88 129.39 45.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.663 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.645 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.3 mp -92.54 129.21 43.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.867 0.365 . . . . 0.0 111.209 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -82.81 113.26 20.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.983 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 28.4 p-10 -61.17 -26.69 67.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.976 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.65 -43.44 84.92 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.007 0.432 . . . . 0.0 110.556 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -58.73 -43.7 90.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.746 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.0 mtmp? -63.77 -34.64 78.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.89 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.84 -36.89 78.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.065 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.0 t -66.1 -41.94 89.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.925 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.58 -37.86 82.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.942 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.28 -46.17 90.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.933 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -80.37 -34.05 36.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.1 p30 42.31 85.06 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.534 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -74.94 128.44 35.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.925 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 28.5 t -93.92 127.05 46.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.058 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 60.99 -178.34 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -106.14 172.47 6.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.0 pt -100.83 116.87 45.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.212 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.855 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.854 0.359 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -113.21 113.24 49.04 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.914 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.57 -177.39 0.9 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.313 2.009 . . . . 0.0 112.137 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -143.74 48.61 1.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.045 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 169' ' ' TPO . . . . . 0.573 ' HB ' HG21 ' A' ' 106' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.932 HD13 ' HB2' ' A' ' 82' ' ' SER . 1.5 tt -57.64 152.8 14.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.5 -179.459 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -151.73 143.97 24.0 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.62 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 0.94 HD13 ' CG2' ' A' ' 136' ' ' VAL . 1.1 tp -52.83 140.77 7.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.967 0.413 . . . . 0.0 111.236 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 173' ' ' TYR . . . . . 0.813 ' H ' HD12 ' B' ' 172' ' ' ILE . 1.7 m-85 -42.73 162.69 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.257 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 74.4 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.911 -179.995 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.808 0.337 . . . . 0.0 110.753 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER -179.73 37.74 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.658 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.1 mm -76.75 137.52 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 CA-C-N 113.812 -1.54 . . . . 0.0 112.574 -177.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.98 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.1 t -92.98 -59.85 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.826 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.401 ' SG ' HD22 ' A' ' 48' ' ' LEU . 21.4 p -148.19 162.52 39.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.218 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.406 ' HB3' ' HB2' ' A' ' 146' ' ' PHE . 2.8 ttm180 -119.98 138.31 53.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.896 0.379 . . . . 0.0 111.221 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.657 HG11 ' CE2' ' A' ' 68' ' ' PHE . 2.1 m -106.62 122.7 60.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.728 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.867 HG23 HG12 ' A' ' 45' ' ' ILE . 20.5 mt -127.03 130.13 71.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.525 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.713 ' HA ' HD13 ' A' ' 143' ' ' LEU . 41.9 t -86.99 119.37 27.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.559 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.43 ' OG1' HG23 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -86.06 -26.48 25.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.578 -179.244 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.511 HG21 ' H ' ' A' ' 142' ' ' SER . 68.9 p -79.83 -2.36 43.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.717 0.294 . . . . 0.0 111.464 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.19 77.22 0.22 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.903 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.506 ' OE1' HD11 ' A' ' 141' ' ' LEU . 12.8 mt-30 -146.92 -43.32 0.18 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.871 0.367 . . . . 0.0 110.955 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.573 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.0 mt -116.32 141.7 28.28 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.038 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.573 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 45.2 Cg_endo -70.88 145.76 51.53 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.182 1.921 . . . . 0.0 112.148 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.867 HG12 HG23 ' A' ' 37' ' ' ILE . 38.9 mt -56.56 139.85 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.852 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -132.57 157.13 45.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.966 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -120.68 121.93 39.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.069 0.461 . . . . 0.0 111.959 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.844 HD23 ' CD2' ' A' ' 66' ' ' TRP . 8.7 mp -87.8 133.63 33.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.469 178.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.98 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -138.71 156.46 47.37 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 122.219 1.009 . . . . 0.0 113.411 -179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.486 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.31 149.51 34.96 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 113.553 -1.658 . . . . 0.0 110.977 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 121.05 0.453 . . . . 0.0 110.993 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.406 ' HE2' ' O ' ' A' ' 49' ' ' SER . 7.5 ttpt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.751 0.31 . . . . 0.0 111.492 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 91' ' ' ILE . 16.3 t -130.88 138.91 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 121.227 0.537 . . . . 0.0 111.736 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.844 ' CD2' HD23 ' A' ' 48' ' ' LEU . 19.2 m-90 -102.03 139.39 37.72 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.428 -0.806 . . . . 0.0 112.086 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.984 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -110.98 126.68 55.03 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.421 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.657 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -110.9 145.43 38.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.12 -178.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.653 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 165.93 -179.85 39.89 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.646 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.9 mtm180 -77.58 -1.71 32.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.529 0.204 . . . . 0.0 111.505 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.456 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.5 t-20 -84.87 136.42 38.86 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 120.745 0.307 . . . . 0.0 110.996 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.5 Cg_exo -69.13 -6.45 18.32 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.704 2.269 . . . . 0.0 111.868 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.89 -45.35 14.32 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.96 0.886 . . . . 0.0 108.756 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -44.43 137.87 3.46 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 113.642 -1.617 . . . . 0.0 110.632 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -56.27 -19.33 13.66 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.927 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.525 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 46.6 t80 -130.13 130.25 44.55 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.586 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -111.04 122.3 47.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.785 0.326 . . . . 0.0 111.277 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.554 HD11 ' CA ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -120.44 179.66 4.24 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.877 179.251 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.26 133.54 52.67 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.665 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -64.78 92.3 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.849 0.357 . . . . 0.0 110.792 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.659 ' HB ' HD13 ' A' ' 84' ' ' LEU . 4.3 mt -111.99 141.07 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.235 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.9 p -65.12 -40.27 94.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.167 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.491 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -62.03 -21.31 64.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.519 -179.674 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.659 HD13 ' HB ' ' A' ' 81' ' ' ILE . 3.9 mp -99.95 153.4 19.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.057 0.456 . . . . 0.0 111.365 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.2 p -99.76 169.31 9.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.808 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.653 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 1.1 m-20 -44.87 -53.89 7.03 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.367 0.603 . . . . 0.0 109.562 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.607 ' CB ' HD12 ' A' ' 104' ' ' ILE . 71.7 mttt -118.13 85.47 2.35 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 177.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.576 ' CD2' ' HB2' ' A' ' 105' ' ' SER . 13.8 t60 -60.03 -45.86 91.4 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.691 -176.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.516 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 30.3 p90 -150.39 164.3 36.19 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.126 -0.629 . . . . 0.0 112.034 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.984 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.58 134.17 39.08 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.367 -178.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.646 HG23 HD12 ' A' ' 101' ' ' LEU . 47.5 mt -110.92 131.79 61.15 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.649 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.519 HD21 HD22 ' A' ' 121' ' ' ASN . 0.6 OUTLIER -123.29 140.75 52.7 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.981 0.419 . . . . 0.0 111.759 -179.29 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.554 ' C ' HD13 ' A' ' 93' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.441 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.676 HD11 HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.708 0.29 . . . . 0.0 110.779 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.502 HD23 ' HB3' ' A' ' 121' ' ' ASN . 5.2 mp -124.23 141.0 52.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.936 0.398 . . . . 0.0 110.36 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.646 HD12 HG23 ' A' ' 91' ' ' ILE . 2.8 mp -112.68 126.37 55.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.087 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.46 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 67.2 t30 -119.18 136.29 54.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.11 0.481 . . . . 0.0 111.8 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.807 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.7 p30 -98.42 142.54 29.91 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.996 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.607 HD12 ' CB ' ' A' ' 87' ' ' LYS . 8.7 pt -145.58 24.5 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.621 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.576 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 11.2 t -92.09 154.14 18.93 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 121.594 0.711 . . . . 0.0 112.51 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.9 m -70.11 -51.94 27.63 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.607 178.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -75.33 -2.59 29.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.301 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.58 154.68 30.79 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.749 -0.739 . . . . 0.0 113.671 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 4.2 m -117.47 137.81 52.28 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.845 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -114.72 148.48 38.23 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -178.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.461 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.16 113.52 18.44 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.457 177.622 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 44.59 43.25 6.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.373 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.89 -7.9 75.33 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.44 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -104.81 118.61 36.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.996 0.427 . . . . 0.0 110.593 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.845 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.4 tptm -72.91 114.48 11.1 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.266 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.807 HG23 ' OD2' ' A' ' 103' ' ' ASP . 6.2 m -88.81 161.61 2.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.984 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 120' ' ' SER . 23.5 tt0 -69.75 130.79 43.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.347 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.686 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 24.2 tttt -54.49 161.61 1.38 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.899 0.381 . . . . 0.0 110.408 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.495 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.0 m-80 35.1 33.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.135 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.481 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.51 145.11 40.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.145 179.524 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.519 HD22 HD21 ' A' ' 92' ' ' LEU . 21.8 m120 -90.33 133.82 34.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.895 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.452 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 49.8 mm-40 -129.57 152.11 49.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.56 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 25.4 tp -72.64 120.16 17.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.777 0.322 . . . . 0.0 110.507 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.664 HD13 ' CB ' ' A' ' 99' ' ' LEU . 6.4 tt -56.64 155.71 7.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.454 0.645 . . . . 0.0 111.441 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.401 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.52 153.15 42.51 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.342 179.686 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.8 114.94 10.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.92 0.391 . . . . 0.0 110.132 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.54 23.17 73.64 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.044 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.401 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 23.1 t70 -53.81 171.27 0.1 Allowed 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 120.933 0.397 . . . . 0.0 111.162 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.635 ' HG3' HG22 ' A' ' 144' ' ' VAL . 21.2 tt0 -145.13 135.53 24.16 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.089 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.516 ' CG2' HG22 ' A' ' 109' ' ' THR . 5.8 mt -111.39 127.73 68.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.422 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.677 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.7 m -104.41 140.74 37.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.852 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.559 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 33.9 m -140.24 158.49 25.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.14 28.38 31.07 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.192 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.433 ' HA ' HG12 ' A' ' 140' ' ' ILE . 70.6 t -72.63 140.42 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-O 121.598 0.713 . . . . 0.0 111.982 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 142.39 -39.82 1.33 Allowed Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.421 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 2.8 t -120.67 124.31 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -50.31 -35.0 25.6 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.6 p -93.77 6.7 47.51 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -178.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.421 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.6 OUTLIER -121.09 28.72 7.71 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -178.632 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.677 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.5 mt -107.27 138.11 34.92 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-O 121.544 0.688 . . . . 0.0 111.261 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.506 HD11 ' OE1' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -125.43 134.66 52.03 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.265 179.67 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.565 ' C ' HD22 ' A' ' 143' ' ' LEU . 38.5 t -111.3 148.44 32.91 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.739 0.781 . . . . 0.0 112.431 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.713 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.6 mm? -136.45 136.7 39.71 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.704 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.635 HG22 ' HG3' ' A' ' 129' ' ' GLU . 21.1 t -110.88 137.44 43.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.82 0.343 . . . . 0.0 111.073 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.516 HD12 HD21 ' A' ' 101' ' ' LEU . 4.9 mt -106.52 121.62 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.29 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.818 ' CE1' HD12 ' A' ' 37' ' ' ILE . 5.8 m-85 -105.37 115.3 30.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.485 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.606 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.1 mp -96.94 122.62 48.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.481 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -78.59 137.95 38.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.939 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.07 -18.69 60.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.366 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.52 -46.04 89.98 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.972 0.415 . . . . 0.0 110.814 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 36.5 t80 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.02 -179.934 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.568 0.223 . . . . 0.0 111.327 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER 176.77 38.99 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.722 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -73.78 134.26 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.55 0 CA-C-N 113.735 -1.575 . . . . 0.0 112.509 -177.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.034 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -93.55 -61.68 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.286 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.669 ' SG ' HD12 ' A' ' 48' ' ' LEU . 3.7 p -145.44 141.49 28.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.599 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.407 ' HD3' ' CG2' ' A' ' 45' ' ' ILE . 24.1 ttm180 -114.01 129.73 56.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.146 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.597 HG21 ' HE2' ' A' ' 68' ' ' PHE . 20.9 t -91.69 122.74 43.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.005 0.431 . . . . 0.0 111.099 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.812 HG23 HG12 ' A' ' 45' ' ' ILE . 21.8 mt -126.6 111.95 27.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.18 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 43.4 t -79.82 137.58 36.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.757 0.313 . . . . 0.0 110.499 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.2 t -116.36 -10.68 11.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.762 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.755 HG21 ' OG ' ' A' ' 142' ' ' SER . 5.0 p -96.38 -3.07 44.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.686 0.279 . . . . 0.0 111.262 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.48 93.11 0.25 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.042 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.569 ' HG3' ' N ' ' A' ' 43' ' ' ILE . 2.5 pt20 -171.51 -40.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.093 0.473 . . . . 0.0 111.464 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.663 HD12 HD21 ' A' ' 143' ' ' LEU . 65.0 mt -124.4 140.32 34.92 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.649 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.565 ' HD2' HG23 ' A' ' 43' ' ' ILE . 94.8 Cg_endo -80.31 144.37 16.24 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.576 2.184 . . . . 0.0 111.643 179.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.812 HG12 HG23 ' A' ' 37' ' ' ILE . 32.2 mt -58.59 123.87 11.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.944 0.402 . . . . 0.0 111.831 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.48 ' HB2' ' CZ ' ' A' ' 76' ' ' TYR . 2.3 ttt-85 -122.42 164.13 18.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.985 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.93 119.84 35.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.095 0.474 . . . . 0.0 111.949 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.669 HD12 ' SG ' ' A' ' 34' ' ' CYS . 3.1 mt -96.55 137.46 35.6 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 1.034 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.25 158.5 43.89 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -178.612 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.489 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -139.62 141.83 37.09 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.448 -1.705 . . . . 0.0 110.671 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 121.127 0.489 . . . . 0.0 111.606 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.433 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.0 ttpt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.753 0.311 . . . . 0.0 111.273 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.589 HG13 ' C ' ' A' ' 91' ' ' ILE . 14.8 t -129.49 139.22 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-O 121.343 0.592 . . . . 0.0 112.082 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.544 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.3 m-90 -100.93 139.64 36.33 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.125 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 1.038 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -113.38 126.84 55.81 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 176.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.68 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.5 OUTLIER -114.52 145.55 41.78 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.294 -178.517 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.702 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 165.88 -177.56 40.96 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.792 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.47 ' HG3' HD11 ' A' ' 78' ' ' LEU . 5.3 mtm105 -76.26 -2.0 29.29 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.408 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.6 t-20 -84.72 133.67 43.45 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.58 0.229 . . . . 0.0 110.91 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.0 Cg_exo -68.89 -7.52 20.95 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.607 2.205 . . . . 0.0 111.786 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.68 -43.16 17.22 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 121.916 0.865 . . . . 0.0 108.806 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.44 138.26 1.84 Allowed 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 113.764 -1.562 . . . . 0.0 110.652 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -56.16 -19.34 13.11 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.695 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.493 ' CD2' ' CE2' ' A' ' 68' ' ' PHE . 1.5 t80 -130.12 130.38 44.73 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.745 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -104.42 117.48 34.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.937 0.398 . . . . 0.0 110.933 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.48 ' HB3' HD13 ' A' ' 43' ' ' ILE . 2.7 pp -114.87 -178.03 3.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.887 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.75 144.02 48.49 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.528 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -76.8 91.67 3.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.791 0.329 . . . . 0.0 111.245 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.518 HD12 HD11 ' A' ' 84' ' ' LEU . 30.1 mt -112.09 139.99 33.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.084 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.05 -36.41 84.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.12 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.511 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -69.03 -15.69 63.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.799 -179.609 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.684 HD21 HG23 ' A' ' 132' ' ' VAL . 51.1 mt -103.38 152.42 21.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.701 0.286 . . . . 0.0 111.174 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.8 m -99.13 167.48 10.67 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.268 -0.423 . . . . 0.0 112.007 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.702 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.1 m-20 -43.72 -53.28 5.96 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.301 0.572 . . . . 0.0 109.658 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.546 ' HB3' HG22 ' A' ' 67' ' ' THR . 17.7 mtmt -118.3 83.76 2.06 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.568 ' CD2' ' HB2' ' A' ' 105' ' ' SER . 14.5 t60 -60.17 -46.03 91.08 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.698 -176.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.51 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 27.5 p90 -147.82 164.01 34.97 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.019 -0.672 . . . . 0.0 112.202 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 1.038 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.56 137.12 41.7 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.276 -178.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.68 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 63.8 mt -116.04 127.17 73.72 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.55 178.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.515 ' CB ' HG22 ' A' ' 65' ' ' VAL . 0.8 OUTLIER -111.42 140.64 45.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.089 0.471 . . . . 0.0 111.469 -179.649 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.621 HD23 ' HG ' ' A' ' 99' ' ' LEU . 2.5 tm? . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.539 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.621 ' HG ' HD23 ' A' ' 93' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.458 -0.075 0 CA-C-O 120.813 0.339 . . . . 0.0 110.831 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.628 HD23 ' HB3' ' A' ' 121' ' ' ASN . 2.2 mp -133.05 147.17 52.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.4 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.581 HD22 ' C ' ' A' ' 100' ' ' LEU . 3.0 mm? -112.77 123.95 51.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.273 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.456 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 58.1 t30 -118.5 115.79 25.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.895 0.379 . . . . 0.0 111.777 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.801 ' OD2' HG23 ' A' ' 116' ' ' VAL . 10.9 p30 -79.67 141.93 36.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.956 178.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.494 HG12 ' HA ' ' A' ' 89' ' ' PHE . 12.9 pt -144.69 24.22 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.767 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.568 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 10.3 t -91.4 154.44 19.18 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.54 0.686 . . . . 0.0 112.528 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.5 m -70.13 -52.02 26.86 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.553 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -75.64 -0.56 21.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.395 -0.821 . . . . 0.0 112.258 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.04 155.15 31.78 Favored Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.702 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.553 HG22 ' CG2' ' A' ' 130' ' ' ILE . 3.7 m -117.36 137.63 52.33 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.835 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -115.31 148.59 39.05 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -177.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.458 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.13 113.45 18.37 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.646 -1.161 . . . . 0.0 108.466 177.589 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 44.77 43.28 6.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.315 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.02 -6.3 79.65 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.525 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -104.16 118.59 37.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.995 0.426 . . . . 0.0 110.562 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.835 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.7 tptm -72.83 111.25 7.79 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.279 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.801 HG23 ' OD2' ' A' ' 103' ' ' ASP . 15.7 m -86.09 161.82 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.847 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 120' ' ' SER . 64.0 mt-10 -69.84 129.64 40.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.504 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.683 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 22.0 tttt -54.9 161.16 1.69 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.902 0.382 . . . . 0.0 110.343 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.8 p30 34.93 34.6 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.322 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.42 145.2 40.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.277 179.452 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.628 ' HB3' HD23 ' A' ' 100' ' ' LEU . 21.6 m120 -87.94 131.92 34.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.848 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.447 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 37.7 mm-40 -129.57 148.99 51.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.63 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.0 tp -72.61 126.37 29.71 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.569 HD22 ' C ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -56.71 157.76 5.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.846 0.832 . . . . 0.0 112.185 -178.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.27 152.91 44.01 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.094 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -71.81 117.13 13.01 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.83 26.87 67.61 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.858 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -50.83 170.7 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.953 0.406 . . . . 0.0 111.325 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.428 ' CG ' ' O ' ' A' ' 143' ' ' LEU . 18.1 tt0 -145.09 135.39 24.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.71 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.553 ' CG2' HG22 ' A' ' 109' ' ' THR . 14.5 mt -113.07 126.35 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.474 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.59 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.0 m -104.23 140.11 38.3 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.684 HG23 HD21 ' A' ' 84' ' ' LEU . 33.9 m -140.05 158.52 26.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -178.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.26 25.08 32.14 Favored Glycine 0 N--CA 1.439 -1.106 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.276 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.475 ' HA ' HG12 ' A' ' 140' ' ' ILE . 77.6 t -71.21 140.38 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-O 121.522 0.677 . . . . 0.0 111.893 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 139.83 -40.98 1.35 Allowed Glycine 0 N--CA 1.435 -1.384 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -178.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.442 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 2.5 t -116.28 123.55 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.32 -36.09 30.49 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.8 p -93.55 6.69 47.4 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.442 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.7 OUTLIER -121.77 30.5 6.65 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -178.409 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.59 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.1 mt -107.3 138.27 34.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.913 177.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.497 HD13 ' HA ' ' A' ' 141' ' ' LEU . 0.8 OUTLIER -125.25 134.95 52.12 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.101 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.755 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.4 OUTLIER -106.09 133.14 51.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.066 0.46 . . . . 0.0 111.727 -179.675 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.663 HD21 HD12 ' A' ' 43' ' ' ILE . 42.7 mt -127.53 140.85 51.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.665 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 23.0 t -116.06 132.58 65.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.878 0.37 . . . . 0.0 111.451 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 30.4 mt -106.26 139.02 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.949 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.48 132.69 56.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.847 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.545 ' CD1' HD23 ' A' ' 124' ' ' LEU . 3.1 mt -93.41 134.1 32.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.462 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -81.56 110.8 17.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.693 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -59.27 -29.5 67.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.268 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.9 tttm -59.58 -45.41 91.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.919 0.39 . . . . 0.0 110.743 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.0 t80 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.949 -179.911 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.788 0.328 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.429 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER 176.0 39.41 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.725 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.3 mm -72.78 134.09 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-N 113.577 -1.647 . . . . 0.0 112.554 -177.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.056 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -92.62 -60.84 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.954 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.633 ' SG ' HD12 ' A' ' 48' ' ' LEU . 1.8 p -145.6 149.5 34.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.22 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.96 138.2 50.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.857 0.36 . . . . 0.0 111.406 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.566 ' CG2' HD11 ' A' ' 48' ' ' LEU . 24.1 t -101.54 122.77 54.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.872 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.613 HG23 HG12 ' A' ' 45' ' ' ILE . 18.4 mt -129.33 121.37 53.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.41 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.679 ' HA ' HD13 ' A' ' 143' ' ' LEU . 34.3 t -85.1 118.07 24.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.376 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.93 -29.26 27.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.74 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.558 HG21 ' H ' ' A' ' 142' ' ' SER . 30.2 p -79.93 -2.22 42.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.652 0.263 . . . . 0.0 111.447 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.83 77.74 0.26 Allowed Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.965 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -144.09 -45.44 0.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.851 0.358 . . . . 0.0 110.834 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.634 HG12 HD23 ' A' ' 78' ' ' LEU . 3.0 mp -114.38 140.91 25.71 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.065 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.552 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.3 Cg_endo -73.41 136.55 24.15 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.239 1.96 . . . . 0.0 112.075 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.613 HG12 HG23 ' A' ' 37' ' ' ILE . 33.9 mt -54.41 129.76 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.736 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -122.99 164.28 18.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.284 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.89 119.76 37.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.985 0.421 . . . . 0.0 111.958 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.633 HD12 ' SG ' ' A' ' 34' ' ' CYS . 1.3 mt -96.65 134.48 39.84 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 1.056 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -147.82 158.93 44.28 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -178.426 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.483 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -139.66 141.65 37.01 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 113.337 -1.756 . . . . 0.0 110.185 178.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 121.35 0.595 . . . . 0.0 111.428 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.406 ' CE ' ' O ' ' A' ' 49' ' ' SER . 6.7 ttpt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.605 0.241 . . . . 0.0 110.999 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.706 HG22 ' HB3' ' A' ' 92' ' ' LEU . 6.6 t -122.7 138.4 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 121.292 0.568 . . . . 0.0 112.102 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.616 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 15.7 m-90 -100.8 140.12 35.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.548 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.727 HG23 ' CG ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -110.12 128.67 55.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.839 177.526 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.707 ' CD1' ' HB2' ' A' ' 76' ' ' TYR . 9.8 m-85 -120.59 145.46 47.34 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.501 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.629 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.24 -166.58 36.49 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.064 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.462 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 12.0 mtp-105 -84.42 5.36 27.54 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.431 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 19.4 t-20 -84.99 133.74 42.59 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.622 0.249 . . . . 0.0 110.74 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 18.0 Cg_exo -65.33 -14.96 47.73 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.493 2.129 . . . . 0.0 111.559 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.68 -45.84 13.98 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.971 0.891 . . . . 0.0 108.846 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.3 139.89 1.32 Allowed 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.794 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.9 OUTLIER -56.45 -19.19 14.01 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.087 179.049 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.707 ' HB2' ' CD1' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -130.1 127.97 40.92 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.554 179.421 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -100.99 107.91 19.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.871 0.367 . . . . 0.0 110.828 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.895 HD13 HD13 ' A' ' 84' ' ' LEU . 39.8 mt -71.5 -176.33 1.53 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.921 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -92.72 42.18 2.69 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.613 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.8 p30 42.83 61.0 2.25 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.891 0.377 . . . . 0.0 111.66 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.722 HD13 HD12 ' A' ' 84' ' ' LEU . 5.4 mp -96.61 126.23 49.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.788 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 m -54.77 -38.15 66.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.338 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.434 ' H ' HG22 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -65.86 -22.37 66.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.159 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.895 HD13 HD13 ' A' ' 78' ' ' LEU . 25.0 mt -102.56 152.28 21.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.082 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.5 p -98.11 166.17 11.55 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.629 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.3 m-20 -43.41 -53.4 5.41 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.438 0.637 . . . . 0.0 109.853 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.588 ' HB2' HD12 ' A' ' 104' ' ' ILE . 16.1 mttt -118.16 82.65 1.87 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 177.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.591 ' CD2' ' HB2' ' A' ' 105' ' ' SER . 14.8 t60 -62.93 -43.83 97.72 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.157 -0.929 . . . . 0.0 113.158 -176.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.49 ' CD1' ' HB2' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -151.24 161.63 42.37 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.05 -0.66 . . . . 0.0 112.37 -179.57 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.727 ' CG ' HG23 ' A' ' 67' ' ' THR . 7.8 mt-30 -135.2 151.81 50.98 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.415 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.525 ' C ' HG13 ' A' ' 65' ' ' VAL . 12.1 mt -124.12 127.49 73.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.206 178.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.768 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -111.31 149.33 31.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.013 0.435 . . . . 0.0 111.671 -179.307 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.537 HD13 ' HG ' ' A' ' 99' ' ' LEU . 24.4 tp . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.164 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 1.012 HD11 HG12 ' A' ' 33' ' ' VAL . 0.5 OUTLIER . . . . . 0 CA--C 1.527 0.073 0 CA-C-O 120.875 0.369 . . . . 0.0 110.92 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.638 HD13 ' O ' ' A' ' 122' ' ' GLN . 2.6 mm? -123.88 147.07 47.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.546 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.612 HD11 ' HA ' ' A' ' 124' ' ' LEU . 2.3 mt -113.39 122.39 47.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.013 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.768 ' HB2' HD11 ' A' ' 92' ' ' LEU . 58.8 t30 -116.98 124.71 50.04 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.811 ' OD2' HG23 ' A' ' 116' ' ' VAL . 10.9 p30 -88.16 140.24 29.69 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.588 HD12 ' HB2' ' A' ' 87' ' ' LYS . 9.5 pt -143.62 24.03 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 -179.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.591 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 10.5 t -91.13 154.45 19.34 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.709 0.766 . . . . 0.0 113.011 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.5 m -70.18 -52.08 26.14 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.469 -1.242 . . . . 0.0 110.495 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -77.92 0.67 23.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.322 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.32 155.69 31.83 Favored Glycine 0 N--CA 1.438 -1.207 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.724 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 4.0 m -117.46 137.78 52.29 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.82 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -116.58 148.54 40.81 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -177.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.735 HD12 HG11 ' A' ' 116' ' ' VAL . 0.6 OUTLIER -124.32 113.54 18.37 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.812 177.421 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 47.31 36.21 4.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.071 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.07 -3.82 80.8 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.482 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.73 118.59 37.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.046 0.423 . . . . 0.0 110.805 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.82 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.4 tptm -72.74 120.98 19.12 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.069 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.811 HG23 ' OD2' ' A' ' 103' ' ' ASP . 9.1 m -98.24 163.81 2.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.394 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 120' ' ' SER . 44.1 tt0 -69.93 128.96 38.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.555 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.676 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 14.4 tttm -54.28 163.36 0.85 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.83 0.348 . . . . 0.0 110.183 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.6 OUTLIER 35.94 33.89 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.854 -179.251 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.5 OUTLIER -112.23 145.14 40.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.057 179.491 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.56 ' OD1' HD13 ' A' ' 92' ' ' LEU . 1.4 m-80 -87.93 132.62 34.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.877 0.37 . . . . 0.0 111.111 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.638 ' O ' HD13 ' A' ' 100' ' ' LEU . 30.1 mm-40 -129.12 145.32 51.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.45 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 26.4 tp -72.71 126.07 29.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.325 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.614 HD23 HG12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -58.52 158.96 6.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.852 0.834 . . . . 0.0 112.316 -179.011 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.769 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.3 OUTLIER -125.04 153.41 42.9 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.759 179.214 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.546 ' HA ' HD13 ' A' ' 147' ' ' ILE . 1.2 mm-40 -70.93 115.49 10.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.96 0.41 . . . . 0.0 109.921 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.25 28.18 68.77 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.552 -178.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.584 ' OD2' HD23 ' A' ' 111' ' ' LEU . 12.1 t70 -54.5 172.0 0.11 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.128 0.489 . . . . 0.0 111.421 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 2.4 tt0 -145.2 135.33 23.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.675 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.759 HG13 HD11 ' A' ' 145' ' ' ILE . 4.1 mt -112.75 129.22 68.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.378 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.583 HG22 ' CG2' ' A' ' 140' ' ' ILE . 5.5 m -102.98 139.81 38.07 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.578 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.8 m -140.28 158.73 25.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -177.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.04 30.01 29.79 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.209 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.443 ' HB ' ' CH2' ' A' ' 110' ' ' TRP . 77.6 t -74.19 140.34 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-O 121.551 0.691 . . . . 0.0 112.013 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.9 -38.09 1.29 Allowed Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.477 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 2.7 t -121.33 128.39 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -50.56 -40.83 53.24 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.5 p -93.49 6.5 47.99 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.477 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 22.0 m-20 -117.7 30.13 7.45 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.583 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.3 mt -107.05 138.79 31.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.905 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.797 HD23 ' N ' ' A' ' 142' ' ' SER . 3.7 tt -124.67 134.62 52.82 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.448 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.797 ' N ' HD23 ' A' ' 141' ' ' LEU . 47.2 t -108.68 150.23 27.85 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.71 0.766 . . . . 0.0 112.576 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.679 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.1 mm? -136.1 151.03 49.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.472 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 40.5 t -125.18 133.45 69.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.803 0.335 . . . . 0.0 110.908 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.759 HD11 HG13 ' A' ' 130' ' ' ILE . 0.9 OUTLIER -105.62 124.59 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.438 -178.85 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -105.97 114.91 29.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.755 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.769 HD11 ' O ' ' A' ' 125' ' ' SER . 3.4 mp -85.05 133.31 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.571 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -82.34 118.78 23.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.916 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -69.94 -32.9 71.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.021 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.42 -45.55 91.23 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.959 0.409 . . . . 0.0 110.704 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 24.7 t80 . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.931 -179.934 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.88 0.371 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER 179.09 38.19 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.679 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.6 mm -74.93 136.05 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.558 0 CA-C-N 113.697 -1.592 . . . . 0.0 112.525 -177.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.016 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.0 t -91.92 -60.31 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 114.75 -1.113 . . . . 0.0 109.969 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.1 p -145.28 157.88 43.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.368 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.66 138.35 53.99 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.843 0.354 . . . . 0.0 111.474 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.788 HG11 ' CE2' ' A' ' 68' ' ' PHE . 1.1 m -108.06 122.66 62.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.724 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.807 HG23 HG12 ' A' ' 45' ' ' ILE . 19.2 mt -128.33 121.66 56.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.694 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.718 ' HA ' HD23 ' A' ' 143' ' ' LEU . 42.4 t -79.85 111.52 16.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.747 0.308 . . . . 0.0 110.257 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.5 t -78.81 -24.33 44.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.423 . . . . 0.0 112.088 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.522 HG23 ' HB3' ' A' ' 142' ' ' SER . 66.1 p -79.94 -2.14 42.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.73 0.3 . . . . 0.0 111.489 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.51 76.54 0.25 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.812 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -146.08 -43.96 0.2 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.887 0.375 . . . . 0.0 110.715 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.588 HG23 ' HD2' ' A' ' 44' ' ' PRO . 2.4 mp -117.54 142.1 29.93 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.062 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.588 ' HD2' HG23 ' A' ' 43' ' ' ILE . 48.2 Cg_endo -71.24 145.93 49.98 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.167 1.911 . . . . 0.0 112.27 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.807 HG12 HG23 ' A' ' 37' ' ' ILE . 42.5 mt -57.91 149.71 4.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.746 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.97 164.04 28.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.993 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.65 119.82 30.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.086 0.47 . . . . 0.0 111.948 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.731 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.3 mp -94.54 124.23 38.44 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 1.016 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -134.58 157.79 45.66 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -178.809 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.49 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -147.99 142.63 26.59 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.653 -1.612 . . . . 0.0 110.737 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 121.199 0.524 . . . . 0.0 111.003 -179.716 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.416 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.5 ttpt . . . . . 0 CA--C 1.523 -0.075 0 CA-C-O 120.706 0.289 . . . . 0.0 111.125 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.526 HG22 ' CB ' ' A' ' 92' ' ' LEU . 11.5 t -123.92 139.12 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 121.273 0.559 . . . . 0.0 111.951 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.731 ' CD2' HD23 ' A' ' 48' ' ' LEU . 16.4 m-90 -102.01 139.6 37.42 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.067 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.611 HG23 ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -108.8 132.27 54.16 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.425 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.788 ' CE2' HG11 ' A' ' 36' ' ' VAL . 2.7 m-85 -115.22 145.85 42.02 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.566 -178.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.786 ' HA2' HD12 ' A' ' 78' ' ' LEU . . . 161.91 -177.67 38.05 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.709 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.6 mtm180 -80.46 1.09 30.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.609 0.242 . . . . 0.0 111.373 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.46 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.9 t-20 -84.86 135.79 39.62 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.677 0.275 . . . . 0.0 110.872 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.1 Cg_exo -68.74 -6.96 19.22 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.672 2.248 . . . . 0.0 111.91 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.03 -45.09 14.47 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-O 122.093 0.949 . . . . 0.0 108.859 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -45.8 136.51 6.16 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 113.674 -1.603 . . . . 0.0 110.75 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.62 -19.02 14.04 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.0 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.61 ' HE1' HD23 ' A' ' 78' ' ' LEU . 33.3 t80 -129.76 118.7 22.25 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.678 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -93.87 107.9 19.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.865 0.364 . . . . 0.0 110.911 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.786 HD12 ' HA2' ' A' ' 69' ' ' GLY . 22.4 mt -73.19 -70.19 0.38 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.712 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 174.36 -86.72 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.235 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.7 p30 179.81 55.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.947 0.403 . . . . 0.0 110.866 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 1.109 HD13 HD12 ' A' ' 84' ' ' LEU . 4.1 mp -87.4 120.42 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.136 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 18.0 m -55.08 -41.49 71.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.919 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.404 ' HD3' ' CB ' ' A' ' 139' ' ' ASP . 0.0 OUTLIER -64.34 -22.43 66.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.228 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.109 HD12 HD13 ' A' ' 81' ' ' ILE . 49.5 mt -98.73 152.29 19.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.847 0.356 . . . . 0.0 111.118 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.7 p -95.76 165.84 12.1 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.649 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.717 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -42.76 -52.81 4.84 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.384 0.611 . . . . 0.0 109.686 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.484 ' HB3' HD11 ' A' ' 104' ' ' ILE . 19.1 mttt -119.3 84.92 2.28 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 177.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.548 ' NE2' ' HB ' ' A' ' 132' ' ' VAL . 14.7 t60 -64.19 -45.83 86.62 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.995 -1.002 . . . . 0.0 113.244 -176.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.499 ' HA ' HG12 ' A' ' 104' ' ' ILE . 36.7 p90 -153.72 162.39 41.28 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.068 -0.653 . . . . 0.0 112.27 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.611 ' HG2' HG23 ' A' ' 67' ' ' THR . 9.8 mt-30 -135.64 154.88 51.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.779 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.521 ' O ' HG13 ' A' ' 65' ' ' VAL . 59.5 mt -123.54 132.35 71.53 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.269 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.536 HD11 HD13 ' A' ' 100' ' ' LEU . 0.6 OUTLIER -117.3 149.91 39.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.032 0.444 . . . . 0.0 111.866 -179.243 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.68 HD22 ' CG1' ' A' ' 33' ' ' VAL . 18.9 tp . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.355 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.501 HD23 ' O ' ' A' ' 92' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.837 0.351 . . . . 0.0 110.796 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.859 HD22 ' HB3' ' A' ' 121' ' ' ASN . 6.5 mt -133.12 141.0 47.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.533 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.82 128.21 56.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.13 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.416 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 50.2 t30 -116.6 115.63 26.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.887 0.375 . . . . 0.0 111.972 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.808 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.5 p30 -78.29 143.19 37.22 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.855 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.565 HG21 ' OE1' ' A' ' 90' ' ' GLN . 9.7 pt -149.67 35.86 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.591 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.05 150.98 21.45 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.651 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.2 m -68.71 -31.66 70.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.457 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -93.11 -19.57 21.37 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.172 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.591 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 110.73 158.12 15.7 Favored Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.738 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.501 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.7 m -117.18 137.65 52.2 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.865 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -115.83 148.35 40.01 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -178.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.555 HD13 ' OD2' ' A' ' 128' ' ' ASP . 0.2 OUTLIER -124.22 113.4 18.24 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.535 177.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.404 ' N ' HD12 ' A' ' 111' ' ' LEU . 71.6 m-20 43.61 43.62 4.83 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.16 -11.39 67.56 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.789 -0.719 . . . . 0.0 113.449 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -103.85 118.58 37.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.997 0.427 . . . . 0.0 110.625 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.865 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 2.8 tptp -74.04 121.39 21.0 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.41 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.808 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.8 m -91.54 163.44 2.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.958 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.5 OUTLIER -69.84 128.07 35.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.448 179.694 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.703 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 18.2 tttt -54.87 161.78 1.48 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.976 0.417 . . . . 0.0 110.631 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.6 OUTLIER 35.65 33.42 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.045 -179.263 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.47 145.16 40.69 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.234 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.859 ' HB3' HD22 ' A' ' 100' ' ' LEU . 5.5 m120 -89.32 128.78 35.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.763 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.708 ' O ' HD23 ' A' ' 100' ' ' LEU . 40.1 mm-40 -129.25 148.67 51.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.513 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.5 tp -72.71 111.91 8.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.885 0.374 . . . . 0.0 110.364 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.423 ' HG ' ' N ' ' A' ' 125' ' ' SER . 66.3 tp -53.68 158.88 1.75 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.247 0.546 . . . . 0.0 111.509 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.45 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.8 OUTLIER -124.01 153.25 41.58 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.331 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.434 ' HA ' HD12 ' A' ' 147' ' ' ILE . 12.2 tp60 -71.68 122.53 20.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.03 0.443 . . . . 0.0 110.79 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.18 21.9 48.2 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.429 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.555 ' OD2' HD13 ' A' ' 111' ' ' LEU . 5.3 t70 -59.87 -177.96 0.07 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 120.571 0.224 . . . . 0.0 110.449 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.888 ' CG ' HG22 ' A' ' 144' ' ' VAL . 6.1 mt-10 -145.07 135.55 24.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.743 0.306 . . . . 0.0 111.444 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.822 HG13 HD11 ' A' ' 145' ' ' ILE . 3.3 mt -114.52 126.66 72.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.218 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.574 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.4 m -104.28 140.04 38.43 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.041 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.548 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 26.4 m -140.33 158.37 25.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.131 0.491 . . . . 0.0 112.23 -178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.67 24.32 33.44 Favored Glycine 0 N--CA 1.439 -1.139 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.081 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.445 ' HB ' ' CZ3' ' A' ' 110' ' ' TRP . 77.9 t -70.93 140.32 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-O 121.544 0.688 . . . . 0.0 111.994 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.71 -38.13 1.08 Allowed Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.458 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 3.3 t -121.27 129.26 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.45 -40.65 51.18 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.55 6.69 47.39 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -178.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.458 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.7 OUTLIER -119.62 32.4 6.09 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -178.514 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.574 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.0 mt -107.25 138.65 32.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.411 0.624 . . . . 0.0 111.064 178.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.4 tt -124.88 134.61 52.63 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.718 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.522 ' HB3' HG23 ' A' ' 40' ' ' THR . 47.0 t -109.67 150.17 28.66 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.571 0.7 . . . . 0.0 112.25 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.718 HD23 ' HA ' ' A' ' 38' ' ' CYS . 69.7 mt -135.95 152.78 51.33 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.976 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.888 HG22 ' CG ' ' A' ' 129' ' ' GLU . 21.6 t -121.31 132.78 69.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.115 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.822 HD11 HG13 ' A' ' 130' ' ' ILE . 1.0 OUTLIER -105.74 121.73 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-O 120.881 0.372 . . . . 0.0 111.205 -179.345 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.99 115.01 29.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.95 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.434 HD12 ' HA ' ' A' ' 126' ' ' GLN . 6.5 mt -85.02 134.06 27.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.445 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -78.83 105.09 9.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.669 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.29 -35.24 73.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.08 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.97 -44.66 91.56 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.986 0.422 . . . . 0.0 110.669 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 29.6 t80 . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.898 179.997 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.749 0.309 . . . . 0.0 111.029 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.408 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.8 OUTLIER 177.42 38.91 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.682 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.7 mm -72.56 137.08 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 113.652 -1.613 . . . . 0.0 112.492 -177.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.002 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.3 t -91.6 -58.78 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.777 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.414 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 3.0 p -147.76 165.33 30.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.404 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -127.12 138.27 53.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.913 0.387 . . . . 0.0 111.43 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.455 ' O ' HG13 ' A' ' 36' ' ' VAL . 12.1 p -106.94 122.62 61.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.783 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.769 HG23 HG12 ' A' ' 45' ' ' ILE . 20.8 mt -127.53 127.92 69.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.618 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.47 ' HA ' HD13 ' A' ' 143' ' ' LEU . 35.2 t -88.5 114.23 24.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.76 0.314 . . . . 0.0 110.487 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.97 -23.68 33.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.701 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.502 HG21 ' H ' ' A' ' 142' ' ' SER . 58.3 p -79.96 -2.43 43.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.69 0.281 . . . . 0.0 111.465 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.6 69.86 1.21 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.185 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -141.01 -42.28 0.39 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.9 0.381 . . . . 0.0 110.974 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.543 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.7 mt -118.89 140.85 29.16 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.752 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.543 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.2 Cg_endo -73.39 146.02 39.15 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.139 1.893 . . . . 0.0 112.28 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.769 HG12 HG23 ' A' ' 37' ' ' ILE . 41.3 mt -57.31 148.38 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.08 0.467 . . . . 0.0 111.686 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -134.25 164.09 28.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.167 179.464 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -120.69 119.56 33.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.047 0.451 . . . . 0.0 111.63 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.797 HD23 ' CD2' ' A' ' 66' ' ' TRP . 6.8 mp -95.72 123.33 39.24 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 1.002 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -135.15 156.96 48.11 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 122.163 0.983 . . . . 0.0 113.407 -179.541 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.478 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -153.62 141.92 20.56 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 113.662 -1.608 . . . . 0.0 111.132 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 121.124 0.487 . . . . 0.0 111.104 -179.78 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.457 ' HE2' ' O ' ' A' ' 49' ' ' SER . 3.6 ttpt . . . . . 0 CA--C 1.523 -0.088 0 CA-C-O 120.77 0.319 . . . . 0.0 111.412 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.655 HG12 ' HG2' ' A' ' 90' ' ' GLN . 19.3 t -132.13 139.2 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.274 0.559 . . . . 0.0 111.741 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.797 ' CD2' HD23 ' A' ' 48' ' ' LEU . 19.7 m-90 -102.42 139.37 38.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.309 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.644 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -114.18 131.1 56.57 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.779 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.686 ' HZ ' HD21 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -117.13 145.49 43.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.963 -179.125 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.616 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.99 -166.41 36.9 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.759 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -90.99 36.87 0.92 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.684 0.278 . . . . 0.0 111.41 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.464 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 3.9 t-20 -119.94 135.44 24.29 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.093 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 20.2 Cg_exo -64.63 -15.54 50.56 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.491 2.127 . . . . 0.0 111.5 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.72 -45.45 14.42 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 121.95 0.881 . . . . 0.0 109.089 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.36 139.54 2.65 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 113.885 -1.507 . . . . 0.0 110.845 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 67' ' ' THR . 9.3 m-20 -56.22 -18.57 10.71 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.844 178.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.537 ' CE2' HG21 ' A' ' 43' ' ' ILE . 2.8 t80 -129.18 116.71 19.6 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.737 0.303 . . . . 0.0 111.007 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -88.58 107.94 19.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.779 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.639 HD23 HD13 ' A' ' 84' ' ' LEU . 6.9 mp -77.91 -176.33 4.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.059 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.63 11.85 68.88 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.633 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 64.76 75.63 0.36 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.956 0.408 . . . . 0.0 111.473 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.933 ' HB ' HD12 ' A' ' 84' ' ' LEU . 3.7 mp -111.51 141.42 26.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.654 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.95 -41.73 71.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.047 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.526 ' H ' HG22 ' A' ' 81' ' ' ILE . 9.9 mmp_? -61.02 -49.07 78.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.261 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.933 HD12 ' HB ' ' A' ' 81' ' ' ILE . 1.4 mt -76.39 151.79 36.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.099 0.476 . . . . 0.0 111.664 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.3 p -100.89 167.55 10.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.401 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.616 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -44.56 -53.0 7.53 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.436 0.636 . . . . 0.0 109.816 179.123 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.654 ' HB2' HD12 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -121.83 82.8 2.0 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 177.456 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.586 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 9.2 t60 -62.73 -46.12 89.58 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.094 -0.957 . . . . 0.0 113.036 -176.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.504 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 20.4 p90 -147.98 160.1 43.18 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.592 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.655 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.2 tt0 -136.19 141.28 44.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.485 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.607 ' O ' HG13 ' A' ' 65' ' ' VAL . 44.1 mt -116.12 127.43 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.892 179.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.577 HD21 HD22 ' A' ' 121' ' ' ASN . 0.6 OUTLIER -110.99 144.64 39.77 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.069 0.461 . . . . 0.0 111.888 -179.383 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.768 HD22 HG11 ' A' ' 33' ' ' VAL . 16.1 tp . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.485 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.92 ' HB2' HD13 ' A' ' 124' ' ' LEU . 1.7 mt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.844 0.354 . . . . 0.0 111.004 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.601 HD12 ' O ' ' A' ' 99' ' ' LEU . 3.2 mp -131.49 145.22 51.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.872 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.448 HD21 ' HB2' ' A' ' 122' ' ' GLN . 0.6 OUTLIER -112.71 124.27 52.19 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.36 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.414 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 51.5 t30 -115.74 115.58 26.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.905 0.383 . . . . 0.0 111.386 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.76 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.1 p30 -79.11 138.76 38.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.167 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.654 HD12 ' HB2' ' A' ' 87' ' ' LYS . 12.3 pt -146.96 39.35 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.728 -0.214 . . . . 0.0 111.574 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.574 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -96.13 158.51 15.41 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 121.055 0.455 . . . . 0.0 111.709 -179.06 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 86.4 m -69.07 -37.83 78.72 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.862 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.61 -19.91 17.3 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.553 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 123.8 158.35 10.1 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.074 -1.06 . . . . 0.0 113.799 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.8 m -117.78 137.99 52.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.924 -0.638 . . . . 0.0 109.731 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.891 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -114.58 148.42 38.05 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -178.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.472 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.2 113.54 18.44 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.384 177.393 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.417 ' N ' HD12 ' A' ' 111' ' ' LEU . 87.3 m-20 44.0 43.99 5.77 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.39 -11.05 66.87 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.711 -0.756 . . . . 0.0 113.486 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -103.4 118.58 37.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.01 0.433 . . . . 0.0 110.544 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.891 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 3.8 tptm -74.37 113.86 12.08 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.473 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.76 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.5 m -84.5 162.64 2.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.876 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.416 ' O ' ' CB ' ' A' ' 120' ' ' SER . 13.2 tp10 -69.85 131.14 44.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.464 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.674 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 32.3 tttm -53.1 162.97 0.58 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.7 p30 34.07 39.1 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.099 0.476 . . . . 0.0 111.83 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 25.0 p -111.54 145.07 39.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.734 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.577 HD22 HD21 ' A' ' 92' ' ' LEU . 22.1 m120 -94.64 123.82 38.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.71 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.448 ' HB2' HD21 ' A' ' 101' ' ' LEU . 24.7 mm-40 -127.96 148.45 50.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.558 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.8 tp -72.68 136.25 45.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.486 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.92 HD13 ' HB2' ' A' ' 99' ' ' LEU . 1.5 pt? -61.81 160.48 11.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.847 0.832 . . . . 0.0 112.088 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.406 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.0 OUTLIER -125.66 153.17 44.22 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.912 178.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.56 117.55 13.26 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.36 27.27 65.3 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.917 -0.659 . . . . 0.0 111.789 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.406 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 25.0 t0 -51.24 169.38 0.05 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.05 0.452 . . . . 0.0 111.404 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 12.8 tt0 -143.77 135.34 26.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.457 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.513 ' CG2' HG22 ' A' ' 109' ' ' THR . 11.6 mt -114.44 128.1 71.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.863 0.363 . . . . 0.0 111.019 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.56 HG23 ' CG2' ' A' ' 140' ' ' ILE . 26.9 m -104.46 142.24 34.95 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.715 HG21 HD21 ' A' ' 84' ' ' LEU . 19.9 m -140.42 158.41 24.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -178.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.34 46.53 26.12 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.419 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.482 ' HA ' HG12 ' A' ' 140' ' ' ILE . 58.5 t -85.27 140.72 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-O 121.997 0.903 . . . . 0.0 112.983 -178.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.27 -46.64 0.78 Allowed Glycine 0 N--CA 1.434 -1.494 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.652 HG11 ' CB ' ' A' ' 139' ' ' ASP . 4.6 p -104.03 118.0 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 CA-C-N 113.902 -1.149 . . . . 0.0 109.388 177.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.478 ' HA ' HD12 ' A' ' 140' ' ' ILE . 1.2 pt-20 -57.53 -24.24 54.9 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.787 0.327 . . . . 0.0 111.3 -179.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.536 ' H ' HG22 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -92.92 -25.91 17.83 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -177.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.652 ' CB ' HG11 ' A' ' 136' ' ' VAL . 0.5 OUTLIER -105.53 25.43 10.75 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -177.642 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.56 ' CG2' HG23 ' A' ' 131' ' ' THR . 5.8 mt -88.8 139.81 16.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.064 177.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.777 HD23 ' N ' ' A' ' 142' ' ' SER . 3.0 tt -120.02 134.8 55.14 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.993 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.777 ' N ' HD23 ' A' ' 141' ' ' LEU . 43.4 t -115.65 150.26 37.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.521 0.677 . . . . 0.0 112.277 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.502 ' CD2' HD22 ' A' ' 141' ' ' LEU . 2.0 mm? -135.79 153.35 51.55 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.39 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 39.6 t -123.26 138.5 53.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.798 0.332 . . . . 0.0 110.695 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.5 HD11 HD11 ' A' ' 91' ' ' ILE . 1.3 mm -106.24 125.89 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-O 120.965 0.412 . . . . 0.0 111.064 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.33 111.72 23.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.68 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.759 HG12 HD12 ' A' ' 124' ' ' LEU . 3.6 mp -90.6 128.23 42.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.353 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -75.95 126.13 30.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.825 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -70.31 -30.86 67.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.994 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -60.05 -46.0 90.98 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.693 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 29.1 t80 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.954 179.963 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.741 0.305 . . . . 0.0 111.091 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.441 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.2 m-20 176.65 39.41 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.717 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.1 mm -71.99 135.28 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 113.538 -1.664 . . . . 0.0 112.634 -177.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.01 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.3 t -91.38 -59.55 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.633 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.692 ' SG ' HD12 ' A' ' 48' ' ' LEU . 3.4 p -148.94 150.48 32.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.992 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.429 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -114.67 138.02 51.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.826 0.346 . . . . 0.0 111.639 -179.129 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.584 HG11 ' CE2' ' A' ' 68' ' ' PHE . 3.6 m -102.83 122.63 55.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.572 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.827 HG23 HG12 ' A' ' 45' ' ' ILE . 20.9 mt -127.54 124.9 64.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.605 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.696 ' HA ' HD13 ' A' ' 143' ' ' LEU . 51.9 t -83.17 121.16 26.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.531 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.66 -24.55 21.59 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.515 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.514 HG21 ' H ' ' A' ' 142' ' ' SER . 43.8 p -79.95 -2.06 42.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.461 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.6 75.97 0.31 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.787 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -147.2 -43.83 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.795 0.331 . . . . 0.0 110.886 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.812 HD13 HD22 ' A' ' 78' ' ' LEU . 3.0 mt -116.35 140.98 27.21 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.756 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.544 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.4 Cg_endo -72.93 145.49 40.31 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.138 1.892 . . . . 0.0 112.202 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.827 HG12 HG23 ' A' ' 37' ' ' ILE . 35.8 mt -56.03 141.51 12.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.669 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.461 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -127.25 164.05 22.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.17 179.551 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.429 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.7 OUTLIER -121.7 119.66 32.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.069 0.461 . . . . 0.0 111.68 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.692 HD12 ' SG ' ' A' ' 34' ' ' CYS . 3.1 mt -98.66 133.0 43.62 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 1.01 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.98 157.97 43.87 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -178.584 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.485 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -142.12 147.79 37.28 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 113.577 -1.647 . . . . 0.0 110.748 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--N 1.33 -0.273 0 CA-C-O 121.167 0.508 . . . . 0.0 111.33 -179.376 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.433 ' CE ' ' O ' ' A' ' 49' ' ' SER . 1.9 ttpt . . . . . 0 C--O 1.232 0.149 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.605 HG13 ' O ' ' A' ' 91' ' ' ILE . 21.3 t -136.05 139.33 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.581 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.521 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 18.2 m-90 -102.56 139.3 38.33 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.453 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.687 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.17 130.25 56.61 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 177.282 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.584 ' CE2' HG11 ' A' ' 36' ' ' VAL . 1.1 m-85 -117.97 145.25 44.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.926 0.394 . . . . 0.0 111.642 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.579 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.9 -170.22 39.87 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.751 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.435 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 20.6 mtm180 -82.01 1.42 35.75 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.448 HD22 ' HB3' ' A' ' 73' ' ' ALA . 2.0 t30 -84.87 135.0 40.52 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.685 0.278 . . . . 0.0 111.319 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -66.43 -12.53 36.09 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.635 2.223 . . . . 0.0 111.742 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.448 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.64 -43.94 16.35 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-O 121.965 0.888 . . . . 0.0 108.738 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.82 140.44 1.35 Allowed 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 113.707 -1.588 . . . . 0.0 110.635 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' A' ' 67' ' ' THR . 23.3 m-20 -56.14 -18.93 11.35 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.172 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.487 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 7.0 t80 -129.66 130.28 45.36 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-O 120.882 0.373 . . . . 0.0 111.017 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -105.99 113.97 27.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.784 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.812 HD22 HD13 ' A' ' 43' ' ' ILE . 1.4 mt -93.71 -67.02 0.88 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.875 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 179.15 -90.84 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.164 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.401 ' HA ' ' HD2' ' A' ' 70' ' ' ARG . 3.9 p30 175.97 54.25 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.839 0.352 . . . . 0.0 111.01 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.745 ' HB ' HD13 ' A' ' 84' ' ' LEU . 29.5 mm -83.32 134.76 26.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.872 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.53 -32.66 74.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.411 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.549 ' H ' HG22 ' A' ' 81' ' ' ILE . 2.2 mpt_? -68.38 -23.77 64.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.502 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.745 HD13 ' HB ' ' A' ' 81' ' ' ILE . 5.7 mp -103.38 153.38 20.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.932 0.396 . . . . 0.0 111.114 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.4 m -95.94 168.58 10.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.034 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.579 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -43.45 -54.46 4.78 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.38 0.61 . . . . 0.0 109.698 179.176 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.573 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.1 OUTLIER -119.7 84.22 2.17 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 177.247 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.621 ' CG ' ' HB2' ' A' ' 105' ' ' SER . 12.7 t60 -57.95 -45.39 86.7 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.705 -176.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.457 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 32.1 p90 -148.24 159.4 44.01 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.079 -0.648 . . . . 0.0 111.922 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.687 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.1 tt0 -135.79 139.95 43.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.376 -178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.605 ' O ' HG13 ' A' ' 65' ' ' VAL . 44.0 mt -114.94 128.15 72.2 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.772 179.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.768 HD21 ' OD1' ' A' ' 121' ' ' ASN . 1.1 pt? -114.11 143.08 45.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.059 0.457 . . . . 0.0 111.61 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.87 HD22 HG11 ' A' ' 33' ' ' VAL . 28.5 tp . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.295 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.787 ' HG ' HD13 ' A' ' 93' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.78 0.324 . . . . 0.0 110.839 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.724 HD23 ' OD1' ' A' ' 121' ' ' ASN . 1.8 mp -131.35 147.33 52.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.447 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.801 HD11 ' HA ' ' A' ' 124' ' ' LEU . 2.7 mp -112.86 124.92 53.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.304 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.446 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 61.4 t30 -120.57 115.76 24.04 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.794 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.3 p30 -78.13 138.93 38.97 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.523 HD12 ' CB ' ' A' ' 87' ' ' LYS . 7.2 pt -140.02 22.09 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.621 ' HB2' ' CG ' ' A' ' 88' ' ' HIS . 11.0 t -91.79 153.46 19.57 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 121.487 0.66 . . . . 0.0 112.641 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.1 m -69.99 -52.12 26.88 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.399 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -72.83 -5.07 35.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.139 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.53 156.04 30.88 Favored Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.73 -0.747 . . . . 0.0 113.459 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.501 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 5.6 m -117.33 137.74 52.23 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.846 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -113.39 148.44 35.8 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -177.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.428 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.25 113.42 18.25 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.252 177.382 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 44.51 43.22 6.2 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.98 -6.85 80.0 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.528 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -103.98 118.5 36.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.982 0.42 . . . . 0.0 110.578 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.846 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 20.9 tptt -74.54 118.32 17.36 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.343 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.794 HG23 ' OD2' ' A' ' 103' ' ' ASP . 7.0 m -95.88 159.45 2.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.864 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.677 ' O ' ' HB3' ' A' ' 120' ' ' SER . 5.5 mm-40 -69.97 133.97 47.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.109 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.686 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 27.1 tttt -55.48 165.78 0.75 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.131 0.491 . . . . 0.0 110.83 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.46 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.6 OUTLIER 36.46 34.43 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.687 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.677 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 1.4 t -112.21 145.12 40.45 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.76 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.768 ' OD1' HD21 ' A' ' 92' ' ' LEU . 11.4 m-80 -86.7 136.1 33.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.93 0.395 . . . . 0.0 111.086 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.501 ' O ' HD12 ' A' ' 101' ' ' LEU . 19.0 mm-40 -128.68 144.2 51.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.204 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.621 HD23 ' O ' ' A' ' 124' ' ' LEU . 3.2 tt -72.67 131.41 42.37 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.221 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.913 HD21 HG12 ' A' ' 147' ' ' ILE . 54.0 tp -58.5 151.8 19.5 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.73 0.776 . . . . 0.0 111.751 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.429 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -125.37 152.83 44.26 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.587 179.57 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.11 117.93 14.35 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.73 25.78 66.04 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.839 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.429 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 30.9 t70 -51.1 167.85 0.07 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.946 0.403 . . . . 0.0 111.505 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.8 tt0 -145.21 135.4 23.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.902 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.545 HD11 HD23 ' A' ' 101' ' ' LEU . 15.3 mt -117.68 128.33 74.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.626 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.567 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.9 m -104.11 140.07 38.3 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.597 ' CG2' HD21 ' A' ' 84' ' ' LEU . 33.7 m -140.13 158.39 25.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.43 ' HA2' ' HB3' ' A' ' 83' ' ' ARG . . . 86.84 29.61 23.02 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.994 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.453 ' HB ' ' CZ3' ' A' ' 110' ' ' TRP . 72.2 t -75.8 140.44 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-O 121.602 0.715 . . . . 0.0 111.942 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.25 -38.93 1.21 Allowed Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.425 HG11 ' OD2' ' A' ' 139' ' ' ASP . 3.3 t -120.2 118.72 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -50.6 -30.9 14.44 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.0 m -93.59 6.82 46.97 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.44 ' HB3' ' HD3' ' A' ' 83' ' ' ARG . 16.3 m-20 -130.33 35.17 4.1 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -178.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.567 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.5 mt -106.79 138.29 33.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-O 121.357 0.599 . . . . 0.0 110.562 177.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.1 134.47 52.47 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.902 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.626 ' C ' HD22 ' A' ' 143' ' ' LEU . 46.6 t -109.37 150.24 28.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.578 0.704 . . . . 0.0 112.051 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.696 HD13 ' HA ' ' A' ' 38' ' ' CYS . 3.2 mm? -136.12 147.53 47.81 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.615 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 23.6 t -118.1 140.21 42.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.809 0.337 . . . . 0.0 111.187 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.401 HG21 HD11 ' A' ' 124' ' ' LEU . 17.1 mt -106.26 125.84 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.099 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -111.8 117.64 33.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.563 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.913 HG12 HD21 ' A' ' 124' ' ' LEU . 4.6 mt -84.83 134.05 27.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.34 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.4 ' ND2' ' HB ' ' A' ' 32' ' ' ILE . 10.4 t30 -81.36 109.63 16.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.812 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -61.17 -33.09 72.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.083 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.27 -46.01 91.31 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.987 0.422 . . . . 0.0 110.773 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 18.8 t80 . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.98 -179.826 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.721 0.296 . . . . 0.0 111.302 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -176.54 37.97 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.746 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -78.41 134.34 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.57 0 CA-C-N 113.88 -1.509 . . . . 0.0 112.523 -177.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.023 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.7 t -89.15 -62.01 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.301 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.8 p -149.24 153.44 37.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.458 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 24.1 ttm180 -118.11 138.15 52.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.804 0.335 . . . . 0.0 111.592 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.758 HG11 ' CE2' ' A' ' 68' ' ' PHE . 34.4 m -103.48 122.91 56.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.983 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.85 HG23 HG12 ' A' ' 45' ' ' ILE . 21.0 mt -126.8 116.37 44.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.563 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.668 ' SG ' HD12 ' A' ' 43' ' ' ILE . 0.9 OUTLIER -81.02 112.52 18.49 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.115 179.374 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.52 -20.18 40.6 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.527 HG21 ' H ' ' A' ' 142' ' ' SER . 66.5 p -79.71 -2.5 43.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.703 0.287 . . . . 0.0 111.538 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.68 72.18 0.75 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.764 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -142.25 -41.48 0.34 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.902 0.382 . . . . 0.0 110.705 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.668 HD12 ' SG ' ' A' ' 38' ' ' CYS . 3.5 mt -119.49 142.15 32.14 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.06 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.602 ' HD2' HG23 ' A' ' 43' ' ' ILE . 57.7 Cg_endo -73.65 139.92 28.77 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.208 1.938 . . . . 0.0 112.026 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.85 HG12 HG23 ' A' ' 37' ' ' ILE . 34.3 mt -55.62 149.2 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.759 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -144.41 164.0 32.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.033 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -121.75 119.99 33.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.114 0.483 . . . . 0.0 112.049 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.557 HD22 ' CD1' ' A' ' 66' ' ' TRP . 7.3 mt -92.62 137.5 32.31 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 1.023 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -144.6 158.31 43.83 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -178.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.482 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -144.73 145.8 31.87 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.661 -1.609 . . . . 0.0 110.947 178.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 121.061 0.458 . . . . 0.0 111.027 -179.725 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.426 ' HE2' ' O ' ' A' ' 49' ' ' SER . 2.7 ttpt . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.72 0.295 . . . . 0.0 111.025 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.663 HG22 ' CB ' ' A' ' 92' ' ' LEU . 22.0 t -134.02 139.62 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 121.384 0.611 . . . . 0.0 112.388 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.591 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 15.6 m-90 -105.09 138.95 40.51 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.948 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.689 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -115.94 125.89 53.16 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.298 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.79 ' CE1' HD12 ' A' ' 91' ' ' ILE . 2.1 m-85 -107.05 145.84 31.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.832 -178.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.669 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.63 179.84 38.94 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.578 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 18.4 mtm180 -78.66 -1.65 35.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.605 0.241 . . . . 0.0 111.382 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.481 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 7.8 t-20 -84.83 136.88 38.45 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 120.756 0.312 . . . . 0.0 111.037 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.1 Cg_exo -69.3 -5.88 16.99 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.879 2.386 . . . . 0.0 111.948 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.89 -45.66 13.94 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-O 122.04 0.924 . . . . 0.0 108.681 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -45.41 137.74 4.67 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 113.639 -1.619 . . . . 0.0 110.533 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.17 -18.89 11.4 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.061 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.662 ' CE1' HG21 ' A' ' 36' ' ' VAL . 50.7 t80 -129.59 125.0 35.19 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.652 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -98.48 112.67 24.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.034 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.642 HD23 ' HE2' ' A' ' 76' ' ' TYR . 19.5 mt -82.14 -69.27 0.63 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 174.93 -91.15 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.28 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.2 p30 -178.85 54.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.828 0.347 . . . . 0.0 111.098 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 30.1 mm -88.91 124.76 41.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.154 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.69 -42.32 75.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.062 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.96 -18.73 58.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.43 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.661 HD21 HG23 ' A' ' 132' ' ' VAL . 26.5 mt -104.0 152.14 22.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.763 0.316 . . . . 0.0 111.228 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 p -96.66 170.21 9.35 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.562 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.669 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 6.1 m-20 -43.81 -56.74 3.65 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.276 0.56 . . . . 0.0 109.693 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.446 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -117.85 84.84 2.23 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 177.177 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.587 ' CD2' ' HB2' ' A' ' 105' ' ' SER . 14.9 t60 -59.34 -46.26 89.12 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.907 -1.042 . . . . 0.0 113.11 -176.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.507 ' CZ ' ' CD2' ' A' ' 68' ' ' PHE . 22.4 p90 -149.3 158.53 44.25 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.919 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.689 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.5 tt0 -136.18 138.55 42.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.834 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.79 HD12 ' CE1' ' A' ' 68' ' ' PHE . 4.4 mt -114.15 129.29 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 C-N-CA 121.122 -0.231 . . . . 0.0 110.649 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.663 ' CB ' HG22 ' A' ' 65' ' ' VAL . 2.2 pp -123.23 144.93 49.07 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 121.058 0.456 . . . . 0.0 111.864 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.644 HD13 ' CG1' ' A' ' 33' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.253 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.813 HD21 HG12 ' A' ' 33' ' ' VAL . 1.4 mp . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.733 0.301 . . . . 0.0 110.751 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.451 HD12 ' O ' ' A' ' 99' ' ' LEU . 4.1 mp -124.14 142.57 51.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.436 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.738 HD11 ' HA ' ' A' ' 124' ' ' LEU . 0.5 OUTLIER -112.88 123.98 51.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.135 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -118.99 115.67 24.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.963 0.411 . . . . 0.0 111.69 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.788 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.3 p30 -78.95 139.57 38.22 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.488 HG12 ' HA ' ' A' ' 89' ' ' PHE . 11.5 pt -143.16 26.49 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.909 -0.317 . . . . 0.0 111.824 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.587 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 10.6 t -92.11 155.62 17.93 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 121.534 0.683 . . . . 0.0 112.63 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 42.3 m -69.95 -52.1 27.3 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.583 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -77.59 -1.7 32.04 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.292 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.92 156.31 31.99 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.615 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.513 HG22 ' CG2' ' A' ' 130' ' ' ILE . 4.3 m -117.41 137.73 52.29 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.87 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -113.89 148.58 36.51 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -177.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.465 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.06 113.45 18.4 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.594 -1.185 . . . . 0.0 108.442 177.546 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.401 ' N ' HD12 ' A' ' 111' ' ' LEU . 57.1 m-20 44.47 43.37 6.23 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.1 -11.14 65.96 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.508 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -103.15 118.57 37.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.03 0.443 . . . . 0.0 110.508 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.87 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 2.5 tptm -72.6 112.72 8.9 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.373 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.788 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.0 m -84.44 162.69 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.775 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.3 OUTLIER -69.78 128.8 37.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.497 179.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.687 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 26.6 tttm -54.83 161.51 1.55 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.934 0.397 . . . . 0.0 110.316 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.503 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.1 p30 36.24 32.97 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.334 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.5 144.94 41.12 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.771 179.188 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.645 ' OD1' HD21 ' A' ' 92' ' ' LEU . 13.5 m-80 -92.49 132.23 36.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.006 0.431 . . . . 0.0 111.147 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.735 ' O ' HD12 ' A' ' 101' ' ' LEU . 42.9 mm-40 -129.38 150.71 50.63 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.581 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.648 HD23 ' O ' ' A' ' 124' ' ' LEU . 3.1 tt -72.67 135.99 45.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.269 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.811 HD21 HG12 ' A' ' 147' ' ' ILE . 64.6 tp -63.54 154.5 32.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.613 0.72 . . . . 0.0 111.698 -179.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.413 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -124.97 153.06 43.35 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.373 179.606 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.81 122.8 21.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.909 0.385 . . . . 0.0 110.236 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.87 23.41 50.93 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.961 -0.637 . . . . 0.0 112.236 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -51.64 170.38 0.05 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.836 0.351 . . . . 0.0 110.983 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.902 ' CG ' HG22 ' A' ' 144' ' ' VAL . 4.7 mt-10 -145.14 135.61 24.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.184 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.756 HD11 HD11 ' A' ' 145' ' ' ILE . 14.8 mt -113.09 126.32 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.578 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.587 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.3 m -104.59 140.26 38.26 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.661 HG23 HD21 ' A' ' 84' ' ' LEU . 35.4 m -140.36 158.58 25.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.28 28.82 29.44 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.073 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.475 ' HA ' HG12 ' A' ' 140' ' ' ILE . 70.2 t -74.07 140.33 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-O 121.583 0.706 . . . . 0.0 111.945 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 140.92 -42.05 1.22 Allowed Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -178.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.2 t -117.32 123.41 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.3 -35.04 25.67 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 84.0 p -93.59 6.62 47.64 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -121.65 28.61 7.58 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.587 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.1 mt -107.36 137.88 36.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.49 0.662 . . . . 0.0 111.348 178.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.474 HD21 ' SG ' ' A' ' 38' ' ' CYS . 9.5 tt -125.37 134.61 52.11 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.079 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.527 ' H ' HG21 ' A' ' 40' ' ' THR . 46.3 t -108.47 150.06 27.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.702 0.763 . . . . 0.0 112.181 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.477 HD12 ' O ' ' A' ' 130' ' ' ILE . 4.0 mp -135.15 150.48 50.17 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.74 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.902 HG22 ' CG ' ' A' ' 129' ' ' GLU . 21.3 t -121.79 134.83 63.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.741 0.305 . . . . 0.0 111.025 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.756 HD11 HD11 ' A' ' 130' ' ' ILE . 16.9 mt -106.35 123.07 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-O 120.89 0.376 . . . . 0.0 111.039 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.73 119.26 38.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.777 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.811 HG12 HD21 ' A' ' 124' ' ' LEU . 2.5 mt -84.98 134.11 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.352 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -79.77 116.34 19.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.765 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -58.39 -31.95 68.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.075 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 17.0 mmmt -60.32 -46.07 91.18 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.773 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 5.1 t80 . . . . . 0 C--N 1.327 -0.406 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.018 -179.92 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.958 0.409 . . . . 0.0 110.553 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.468 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER -179.27 37.17 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 179.83 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.709 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.7 mm -75.57 135.55 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 CA-C-N 113.686 -1.597 . . . . 0.0 112.655 -177.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.037 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -93.19 -60.75 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.062 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.63 ' SG ' HD12 ' A' ' 48' ' ' LEU . 1.9 p -145.44 145.42 31.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.301 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.426 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.92 138.07 50.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.797 0.332 . . . . 0.0 111.485 -179.237 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.662 HG21 ' CE2' ' A' ' 68' ' ' PHE . 44.6 t -107.17 122.75 61.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.95 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.817 HG23 HG12 ' A' ' 45' ' ' ILE . 17.8 mt -124.07 120.27 59.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.591 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.737 ' HA ' HD23 ' A' ' 143' ' ' LEU . 46.8 t -79.88 119.61 22.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.357 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.59 -23.2 22.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.648 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.534 HG21 ' H ' ' A' ' 142' ' ' SER . 63.5 p -79.8 -2.33 42.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.782 0.325 . . . . 0.0 111.459 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.35 73.58 0.52 Allowed Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.814 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -145.92 -37.76 0.25 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.777 0.322 . . . . 0.0 111.117 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.589 HD13 ' HB3' ' A' ' 78' ' ' LEU . 2.6 mt -121.54 140.96 32.52 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.928 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.547 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.2 Cg_endo -73.22 140.36 30.68 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.191 1.927 . . . . 0.0 112.087 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.817 HG12 HG23 ' A' ' 37' ' ' ILE . 34.6 mt -56.62 134.16 20.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.706 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.463 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -122.57 163.03 20.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.256 179.367 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.426 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.7 OUTLIER -118.89 120.63 37.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.083 0.468 . . . . 0.0 112.162 -179.326 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.63 HD12 ' SG ' ' A' ' 34' ' ' CYS . 1.6 mt -96.86 133.71 41.12 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 1.037 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.24 158.91 43.91 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -178.526 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.501 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -144.38 141.89 29.98 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 113.586 -1.643 . . . . 0.0 110.731 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 121.068 0.461 . . . . 0.0 111.093 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.415 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.1 ttpt . . . . . 0 CA--C 1.523 -0.079 0 CA-C-O 120.698 0.285 . . . . 0.0 111.319 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.517 HG13 ' O ' ' A' ' 91' ' ' ILE . 5.8 t -123.24 138.08 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-O 121.234 0.54 . . . . 0.0 111.768 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.554 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.3 m-90 -102.31 139.71 37.56 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.302 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.979 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -111.83 128.42 56.11 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 176.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.677 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.4 OUTLIER -118.66 145.28 45.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.264 -178.153 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.629 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.06 -172.4 38.19 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.748 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 27.2 mtm180 -78.69 3.2 17.12 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.516 HD22 ' HB3' ' A' ' 73' ' ' ALA . 1.9 t30 -84.69 132.46 46.47 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.687 0.279 . . . . 0.0 111.005 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.2 Cg_exo -65.98 -13.67 40.95 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.585 2.19 . . . . 0.0 111.68 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.516 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.74 -43.05 17.26 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.967 0.889 . . . . 0.0 108.953 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.23 138.7 1.6 Allowed 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 113.792 -1.549 . . . . 0.0 110.828 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.1 m-20 -56.42 -18.93 12.73 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.968 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.506 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 25.6 t80 -129.83 123.27 30.49 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.141 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -100.14 118.69 37.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.555 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.626 HD13 HD23 ' A' ' 84' ' ' LEU . 0.8 OUTLIER -125.39 72.36 1.25 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.247 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 48.97 -135.49 21.34 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.959 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -158.96 81.09 0.78 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.797 0.332 . . . . 0.0 110.92 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.639 HD13 HD22 ' A' ' 84' ' ' LEU . 4.9 mp -95.52 140.43 16.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.033 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 m -55.61 -45.0 77.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.132 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.498 ' HG3' ' HA2' ' A' ' 133' ' ' GLY . 0.0 OUTLIER -60.74 -49.07 78.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.753 -179.357 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.639 HD22 HD13 ' A' ' 81' ' ' ILE . 4.3 mp -72.56 152.88 41.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.209 0.528 . . . . 0.0 111.215 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.6 p -102.48 168.27 9.41 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.758 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.629 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 9.0 m-20 -42.47 -60.02 1.66 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.389 0.614 . . . . 0.0 109.527 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.598 ' HB3' HG22 ' A' ' 67' ' ' THR . 3.0 mtmp? -115.63 84.58 2.12 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 176.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.627 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 10.2 t60 -61.45 -44.58 96.87 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.242 -0.89 . . . . 0.0 113.02 -176.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.533 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 12.1 p90 -146.16 162.87 37.04 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.07 -0.652 . . . . 0.0 112.254 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.979 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.54 138.03 42.63 Favored 'General case' 0 C--O 1.227 -0.111 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.006 -179.099 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.677 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 62.2 mt -114.86 129.23 71.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.656 178.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.859 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -108.0 148.07 30.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.994 0.426 . . . . 0.0 111.294 -179.623 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.828 HD22 HG11 ' A' ' 33' ' ' VAL . 49.7 tp . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.543 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.699 ' C ' HD12 ' A' ' 100' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.786 0.327 . . . . 0.0 110.81 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.877 HD23 ' HB3' ' A' ' 121' ' ' ASN . 11.1 mp -131.2 143.96 50.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.671 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.524 HD11 ' CD1' ' A' ' 130' ' ' ILE . 0.9 OUTLIER -112.61 125.26 54.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.128 179.715 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.859 ' HB2' HD11 ' A' ' 92' ' ' LEU . 49.0 t30 -115.72 115.71 26.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.901 0.382 . . . . 0.0 111.584 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.778 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.0 p30 -78.87 136.23 37.24 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.034 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.476 HD12 ' HB2' ' A' ' 87' ' ' LYS . 12.9 pt -144.28 39.7 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.58 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -97.42 157.01 16.21 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.191 0.52 . . . . 0.0 111.92 -178.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 92.4 m -69.11 -36.27 77.33 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.433 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 19.8 p30 -98.51 -19.86 17.4 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.58 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 122.66 156.07 9.52 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.277 -0.963 . . . . 0.0 113.515 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.523 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 4.8 m -117.68 137.78 52.43 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 122.818 0.447 . . . . 0.0 109.832 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.858 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -119.32 148.1 43.55 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -178.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.74 HD23 ' O ' ' A' ' 114' ' ' GLN . 0.7 OUTLIER -124.75 113.56 18.12 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.544 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 45.1 m-20 49.45 42.02 21.85 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 83.98 -6.05 76.68 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.924 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.74 ' O ' HD23 ' A' ' 111' ' ' LEU . 4.4 mt-30 -103.97 118.92 37.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.189 0.495 . . . . 0.0 110.589 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.858 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 7.3 tptt -74.92 127.14 32.5 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.339 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.778 HG23 ' OD2' ' A' ' 103' ' ' ASP . 13.2 m -103.0 164.09 3.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.883 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 120' ' ' SER . 9.9 tp10 -69.76 128.04 35.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.422 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.693 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 56.4 tttt -53.8 161.78 1.06 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.719 0.295 . . . . 0.0 110.414 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.9 p30 35.23 34.77 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.141 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.22 145.11 40.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.363 179.61 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.877 ' HB3' HD23 ' A' ' 100' ' ' LEU . 6.5 m120 -89.14 125.48 35.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.589 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -129.5 148.73 51.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.201 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.617 HD23 ' O ' ' A' ' 124' ' ' LEU . 5.3 tt -72.83 114.53 11.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.015 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.733 HD21 HD13 ' A' ' 145' ' ' ILE . 5.2 mt -55.11 166.26 0.57 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.654 0.74 . . . . 0.0 112.063 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.428 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.6 OUTLIER -125.4 152.71 44.46 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.488 179.334 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.44 ' HA ' HD12 ' A' ' 147' ' ' ILE . 15.2 tp60 -71.95 124.48 24.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.87 0.366 . . . . 0.0 110.352 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 145' ' ' ILE . . . 58.35 20.92 46.44 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.227 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.428 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 8.3 t70 -56.85 178.67 0.05 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.656 0.265 . . . . 0.0 110.809 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.899 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.2 mt-10 -145.19 135.73 24.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.124 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.751 HD11 HD11 ' A' ' 145' ' ' ILE . 8.1 mt -108.9 124.62 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 121.005 0.431 . . . . 0.0 110.831 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.534 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.7 m -104.37 143.19 33.32 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.627 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 27.0 m -140.22 158.37 25.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.498 ' HA2' ' HG3' ' A' ' 83' ' ' ARG . . . 74.29 45.17 25.76 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.312 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.548 ' HA ' HG12 ' A' ' 140' ' ' ILE . 95.3 t -85.41 140.62 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 121.675 0.75 . . . . 0.0 112.379 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 140.29 -38.08 1.63 Allowed Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -178.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 139' ' ' ASP . 1.1 t -126.49 118.68 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.463 ' HA ' HD12 ' A' ' 140' ' ' ILE . 3.2 mp0 -50.36 -24.75 3.21 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 17.0 m -93.18 4.49 53.9 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.475 ' N ' HG12 ' A' ' 136' ' ' VAL . 1.5 m-20 -128.96 26.73 5.49 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.548 HG12 ' HA ' ' A' ' 134' ' ' VAL . 6.3 mt -107.15 138.24 34.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-O 121.464 0.649 . . . . 0.0 111.487 178.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.4 tt -125.47 134.68 51.98 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.207 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.534 ' H ' HG21 ' A' ' 40' ' ' THR . 42.2 t -113.03 147.53 37.02 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.797 0.808 . . . . 0.0 112.355 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.737 HD23 ' HA ' ' A' ' 38' ' ' CYS . 77.8 mt -136.55 157.27 47.16 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.855 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.899 HG22 ' CG ' ' A' ' 129' ' ' GLU . 26.2 t -120.64 139.14 48.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.824 0.345 . . . . 0.0 110.995 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.751 HD11 HD11 ' A' ' 130' ' ' ILE . 70.0 mt -106.33 120.93 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.16 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.74 109.49 19.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.536 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' A' ' 126' ' ' GLN . 6.2 mt -84.64 132.11 32.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.476 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -78.5 113.39 16.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.815 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -64.57 -30.53 71.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.064 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.82 -46.13 91.73 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.763 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 30.8 t80 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.095 -179.886 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.831 0.348 . . . . 0.0 110.964 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER -179.27 37.82 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.675 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.0 mm -75.23 137.13 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 CA-C-N 113.632 -1.622 . . . . 0.0 112.778 -177.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.02 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.1 t -91.86 -58.89 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.497 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.72 ' SG ' HD22 ' A' ' 48' ' ' LEU . 4.6 p -147.88 165.41 30.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.444 179.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -133.28 138.31 46.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.854 0.359 . . . . 0.0 111.323 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.708 HG21 ' CE2' ' A' ' 68' ' ' PHE . 42.8 t -107.23 122.82 61.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.955 0.407 . . . . 0.0 110.916 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.816 HG23 HG12 ' A' ' 45' ' ' ILE . 13.2 mt -122.23 121.9 65.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.508 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.74 ' HA ' HD13 ' A' ' 143' ' ' LEU . 42.4 t -79.86 117.02 20.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.684 0.278 . . . . 0.0 110.663 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.555 HG23 HG21 ' A' ' 144' ' ' VAL . 0.6 OUTLIER -86.08 -23.36 26.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.37 -179.706 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.513 HG21 ' H ' ' A' ' 142' ' ' SER . 72.4 p -79.81 -2.33 42.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.838 0.351 . . . . 0.0 111.342 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.3 73.58 0.48 Allowed Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.203 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.436 ' HG3' HD21 ' A' ' 141' ' ' LEU . 1.8 mt-30 -146.79 -39.17 0.21 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.683 0.278 . . . . 0.0 111.181 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.557 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.8 mt -118.9 141.02 29.4 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.783 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.557 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 54.2 Cg_endo -72.28 144.54 41.65 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.157 1.905 . . . . 0.0 112.209 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.816 HG12 HG23 ' A' ' 37' ' ' ILE . 43.9 mt -56.45 144.6 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.66 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.497 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.2 OUTLIER -128.24 161.98 28.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.02 179.338 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -123.31 119.56 30.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.971 0.415 . . . . 0.0 111.465 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.85 HD23 ' CD2' ' A' ' 66' ' ' TRP . 6.9 mp -92.29 130.41 37.99 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 1.02 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -142.03 155.37 45.41 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 122.257 1.027 . . . . 0.0 113.524 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.46 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -141.38 141.74 33.77 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 113.387 -1.733 . . . . 0.0 110.712 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 121.168 0.509 . . . . 0.0 111.089 -179.71 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.438 ' CE ' ' O ' ' A' ' 49' ' ' SER . 4.7 ttpt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.69 0.281 . . . . 0.0 111.131 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.583 HG12 ' HG2' ' A' ' 90' ' ' GLN . 10.8 t -126.48 139.07 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-O 121.31 0.576 . . . . 0.0 112.016 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.85 ' CD2' HD23 ' A' ' 48' ' ' LEU . 17.7 m-90 -104.36 139.31 39.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.373 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.706 HG22 ' HB3' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -112.69 132.28 55.27 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 177.531 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.757 ' HZ ' HD21 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -118.67 145.55 45.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.899 0.38 . . . . 0.0 111.665 -178.728 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.65 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.49 -170.14 37.98 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.902 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.43 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 4.5 mtm105 -80.21 1.63 27.57 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.502 HD22 ' HB3' ' A' ' 73' ' ' ALA . 2.1 t30 -84.81 132.96 44.6 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.624 0.25 . . . . 0.0 111.16 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.28 -13.07 38.26 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.661 2.241 . . . . 0.0 111.796 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.502 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.62 -43.47 16.95 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-O 121.801 0.81 . . . . 0.0 108.856 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.22 140.4 1.16 Allowed 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 113.887 -1.506 . . . . 0.0 110.633 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.9 m-20 -56.29 -18.96 12.19 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.972 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.497 ' CE1' ' HB2' ' A' ' 46' ' ' ARG . 10.9 t80 -129.62 124.3 33.4 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 120.784 0.326 . . . . 0.0 110.98 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -95.56 107.85 20.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.522 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.438 HD13 ' N ' ' A' ' 69' ' ' GLY . 11.1 mp -82.75 -78.58 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.914 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -173.38 -88.53 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.02 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.0 p30 174.7 49.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.886 0.374 . . . . 0.0 111.117 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 1.11 HD13 HD12 ' A' ' 84' ' ' LEU . 4.1 mp -78.59 126.79 38.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.865 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.87 -40.65 69.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.909 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.441 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 2.0 mmp_? -62.81 -49.13 76.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.267 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.11 HD12 HD13 ' A' ' 81' ' ' ILE . 23.2 mt -72.69 150.44 42.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.223 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.8 p -94.55 167.05 11.73 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.668 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.65 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.5 m-20 -43.73 -53.75 5.62 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.292 0.568 . . . . 0.0 109.744 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.706 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.1 OUTLIER -120.25 83.2 2.02 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 177.184 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.557 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.7 t60 -58.97 -45.88 89.47 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.221 -0.899 . . . . 0.0 112.634 -176.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.513 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 20.3 p90 -144.5 159.91 41.98 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.972 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.697 ' HG3' HG23 ' A' ' 67' ' ' THR . 3.6 tt0 -136.31 140.68 43.53 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.246 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.63 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 72.8 mt -115.78 130.19 70.86 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.706 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.54 HD21 HD22 ' A' ' 121' ' ' ASN . 0.6 OUTLIER -114.96 148.84 38.23 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.115 0.483 . . . . 0.0 111.776 -179.587 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.712 HD22 HG11 ' A' ' 33' ' ' VAL . 17.8 tp . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.308 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 1.005 HD21 HG12 ' A' ' 33' ' ' VAL . 5.2 mp . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.817 0.341 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.585 HD23 ' HB3' ' A' ' 121' ' ' ASN . 3.3 mp -121.52 147.1 46.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.224 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.635 HD11 HG12 ' A' ' 130' ' ' ILE . 1.1 tt -112.84 123.6 50.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.467 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.441 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 49.1 t30 -116.0 115.49 26.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.983 0.42 . . . . 0.0 111.256 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.776 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.1 p30 -79.97 134.0 36.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.951 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.494 HD12 ' HB2' ' A' ' 87' ' ' LYS . 10.6 pt -141.61 40.88 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -178.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.59 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -100.87 152.32 20.68 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 120.914 0.388 . . . . 0.0 111.254 -179.245 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.5 m -68.94 -32.1 71.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.316 178.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.441 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 27.9 p30 -98.62 -19.72 17.4 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.59 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.92 155.45 9.55 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.314 -0.946 . . . . 0.0 113.731 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.547 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.9 m -117.43 137.95 52.16 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.848 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -115.34 148.41 39.3 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -177.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.479 HD13 ' OD2' ' A' ' 128' ' ' ASP . 0.2 OUTLIER -124.18 113.37 18.23 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.238 177.371 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.406 ' N ' HD12 ' A' ' 111' ' ' LEU . 48.4 m-20 45.61 42.94 8.79 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.2 -6.27 80.14 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.549 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.55 118.61 37.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 117.018 0.409 . . . . 0.0 110.787 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.848 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 17.7 tptt -73.72 126.97 31.55 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.181 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.776 HG23 ' OD2' ' A' ' 103' ' ' ASP . 9.7 m -102.56 165.34 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.285 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.401 ' O ' ' HB3' ' A' ' 120' ' ' SER . 2.5 tt0 -69.89 128.86 37.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.423 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.691 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 76.7 tttt -54.1 164.23 0.67 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.3 m-80 33.6 37.0 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.803 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.9 p -111.77 145.11 39.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.005 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.585 ' HB3' HD23 ' A' ' 100' ' ' LEU . 22.4 m120 -92.41 127.07 37.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.806 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.415 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 57.6 mm-40 -129.31 149.13 51.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.743 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.1 tp -72.86 128.83 36.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.386 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.584 HD23 HG12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -59.75 160.92 6.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.649 0.738 . . . . 0.0 112.173 -179.23 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.713 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.4 OUTLIER -124.99 153.3 42.99 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.636 -1.166 . . . . 0.0 110.034 179.308 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.605 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.44 119.2 15.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.882 0.373 . . . . 0.0 110.375 -179.71 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.52 26.42 56.91 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.036 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.496 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 7.6 t70 -57.24 175.24 0.15 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 120.914 0.388 . . . . 0.0 111.052 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.859 ' CG ' HG22 ' A' ' 144' ' ' VAL . 4.6 mt-10 -145.36 135.63 24.0 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.059 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 1.058 HD11 HD11 ' A' ' 145' ' ' ILE . 3.3 mt -110.07 127.93 66.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.832 0.348 . . . . 0.0 110.497 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.594 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.36 138.89 40.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.851 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.515 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 30.8 m -140.17 158.41 25.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.12 27.65 30.39 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.955 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.466 ' HA ' HG12 ' A' ' 140' ' ' ILE . 72.9 t -72.01 140.44 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-O 121.724 0.773 . . . . 0.0 112.197 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.7 -49.75 0.6 Allowed Glycine 0 N--CA 1.434 -1.452 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.406 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 2.5 t -109.97 125.55 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -50.18 -35.7 27.38 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.2 t -93.57 6.67 47.47 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.422 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . 0.9 OUTLIER -122.3 31.61 6.09 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -178.473 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.594 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.4 mt -106.49 138.94 29.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-O 121.399 0.619 . . . . 0.0 110.898 178.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.459 ' HA ' HD22 ' A' ' 141' ' ' LEU . 0.4 OUTLIER -124.51 134.64 52.95 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.557 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.659 ' C ' HD22 ' A' ' 143' ' ' LEU . 39.4 t -111.15 150.16 29.87 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.653 0.74 . . . . 0.0 112.429 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.74 HD13 ' HA ' ' A' ' 38' ' ' CYS . 3.5 mm? -136.35 153.43 51.13 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.503 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.859 HG22 ' CG ' ' A' ' 129' ' ' GLU . 15.4 t -118.16 140.33 41.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.817 0.341 . . . . 0.0 111.067 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 1.058 HD11 HD11 ' A' ' 130' ' ' ILE . 41.6 mt -106.05 120.96 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.032 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.19 111.31 22.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.834 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.713 HD11 ' O ' ' A' ' 125' ' ' SER . 4.2 mp -85.55 129.45 37.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.342 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -81.08 128.64 33.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.01 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -74.06 -29.62 61.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.189 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.3 tttt -59.0 -43.69 91.54 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.851 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 30.1 t80 . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.039 -179.855 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.819 0.343 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.438 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER -170.99 34.77 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.71 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 2.9 mm -77.1 131.55 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-N 113.887 -1.506 . . . . 0.0 112.388 -177.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.034 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -90.42 -62.0 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 114.623 -1.172 . . . . 0.0 110.442 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.506 ' SG ' HD12 ' A' ' 48' ' ' LEU . 4.0 p -147.89 142.53 26.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.441 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -113.83 134.1 55.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.976 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.69 HG21 ' HE2' ' A' ' 68' ' ' PHE . 38.5 t -97.45 122.88 49.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.97 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.795 HG23 HG12 ' A' ' 45' ' ' ILE . 15.5 mt -119.8 110.93 30.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.653 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 1.1 m -84.53 111.48 19.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.003 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.2 p -100.27 -9.68 22.12 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.784 HG21 ' OG ' ' A' ' 142' ' ' SER . 10.0 p -88.04 -2.86 58.86 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.183 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.55 90.32 0.45 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.488 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.76 ' OE1' HD23 ' A' ' 141' ' ' LEU . 10.7 pt20 -165.64 -47.28 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.791 0.329 . . . . 0.0 111.435 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.61 HG23 ' HD2' ' A' ' 44' ' ' PRO . 6.8 mt -130.32 142.4 45.33 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.85 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.61 ' HD2' HG23 ' A' ' 43' ' ' ILE . 67.4 Cg_endo -76.04 141.33 23.63 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.151 1.901 . . . . 0.0 111.509 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.795 HG12 HG23 ' A' ' 37' ' ' ILE . 47.6 mt -50.14 139.65 4.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.116 0.484 . . . . 0.0 112.054 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.41 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -135.86 163.0 31.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.014 179.105 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -120.22 119.86 34.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.142 0.496 . . . . 0.0 112.334 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.527 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 4.7 mt -94.04 137.55 33.12 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 178.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 1.034 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.2 158.09 43.86 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -178.272 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.482 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.33 141.89 28.92 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 113.094 -1.866 . . . . 0.0 110.166 178.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 121.209 0.528 . . . . 0.0 111.529 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.43 ' NZ ' ' HA ' ' A' ' 50' ' ' ALA . 4.5 ttpt . . . . . 0 CA--C 1.522 -0.116 0 CA-C-O 120.644 0.259 . . . . 0.0 110.779 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.685 HG12 ' HG2' ' A' ' 90' ' ' GLN . 16.4 t -128.93 139.18 52.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.409 0.623 . . . . 0.0 112.399 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.527 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.3 m-90 -101.27 138.66 38.0 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.846 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.694 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.91 126.28 54.99 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 176.857 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.69 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -108.8 145.36 35.33 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.407 -178.225 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.71 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.79 172.61 31.48 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.981 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.541 ' HG3' HD11 ' A' ' 78' ' ' LEU . 1.8 mtm105 -67.13 -4.77 10.99 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.456 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.8 t30 -84.48 135.32 41.17 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.744 0.307 . . . . 0.0 111.175 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.2 Cg_exo -69.63 -6.14 17.83 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.868 2.379 . . . . 0.0 112.058 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.92 -43.59 16.32 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 122.029 0.919 . . . . 0.0 108.846 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.18 138.31 2.25 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.986 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -56.53 -18.36 11.42 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.236 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.56 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 19.7 t80 -129.0 114.36 16.32 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.785 0.326 . . . . 0.0 110.646 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.414 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.7 t-160 -88.26 130.61 35.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.271 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.576 HD21 ' CA ' ' A' ' 69' ' ' GLY . 1.4 pp -133.16 -177.67 4.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.593 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.556 ' O ' HD12 ' A' ' 78' ' ' LEU . . . -57.3 -168.34 0.11 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.266 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -123.92 82.93 2.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.858 0.361 . . . . 0.0 110.734 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.575 HG22 ' H ' ' A' ' 83' ' ' ARG . 3.5 mp -109.64 130.3 62.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.205 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.8 -31.23 64.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.168 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.575 ' H ' HG22 ' A' ' 81' ' ' ILE . 1.4 mmp_? -60.75 -36.03 77.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.459 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.911 HD21 HG21 ' A' ' 132' ' ' VAL . 5.5 mp -93.28 152.98 18.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.201 0.524 . . . . 0.0 111.666 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.91 168.88 10.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.703 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.71 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.4 m-20 -44.03 -53.22 6.48 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.336 0.589 . . . . 0.0 109.722 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.53 ' NZ ' HG21 ' A' ' 67' ' ' THR . 0.1 OUTLIER -119.45 83.56 2.06 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.375 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.523 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 15.9 t60 -60.98 -47.42 86.55 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.685 -176.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.526 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 20.0 p90 -147.17 160.44 42.45 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.254 -0.578 . . . . 0.0 111.612 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.694 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.7 tt0 -136.1 141.49 44.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.639 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.613 ' O ' HG13 ' A' ' 65' ' ' VAL . 63.2 mt -116.9 127.66 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 121.219 -0.193 . . . . 0.0 110.531 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.504 ' CB ' HG22 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -112.33 150.17 31.4 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.158 0.504 . . . . 0.0 112.255 -179.14 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 1.036 HD12 HD11 ' A' ' 99' ' ' LEU . 6.9 tt . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.125 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 1.036 HD11 HD12 ' A' ' 93' ' ' LEU . 3.9 mm? . . . . . 0 N--CA 1.458 -0.057 0 CA-C-O 120.891 0.377 . . . . 0.0 111.122 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.725 HD23 ' O ' ' A' ' 122' ' ' GLN . 9.1 mt -126.04 147.38 49.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.19 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.11 122.17 47.02 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -112.93 115.37 28.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.614 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.862 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.7 p-10 -77.49 143.15 38.7 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.796 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.438 HG12 ' HA ' ' A' ' 89' ' ' PHE . 10.7 pt -151.41 36.79 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -178.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.562 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.34 148.43 24.19 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 120.924 0.392 . . . . 0.0 111.604 -179.183 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.6 m -68.7 -31.39 70.44 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 177.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -92.0 -19.82 21.99 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.484 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.562 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 113.29 152.46 11.06 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.293 -0.956 . . . . 0.0 113.937 179.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.537 HG22 ' CG2' ' A' ' 130' ' ' ILE . 4.9 m -117.35 137.72 52.26 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.837 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -117.56 148.18 42.13 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -178.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.474 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.27 113.56 18.42 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.468 177.597 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.417 ' N ' HD12 ' A' ' 111' ' ' LEU . 92.8 m-20 45.31 42.69 7.55 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.25 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 84.99 -4.05 86.13 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.53 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -104.78 118.74 37.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.034 0.445 . . . . 0.0 110.655 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.837 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 6.7 tptt -74.98 117.76 17.19 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.141 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.862 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.2 m -96.6 159.77 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.201 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.493 ' O ' ' HB3' ' A' ' 120' ' ' SER . 0.0 OUTLIER -69.81 130.11 41.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.536 179.861 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.698 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 9.2 ptmt -55.13 167.73 0.4 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.08 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.5 m-80 36.93 33.44 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.983 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.493 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 22.8 t -112.44 141.38 46.25 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.849 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.583 ' HB3' HD22 ' A' ' 100' ' ' LEU . 7.1 m120 -92.08 129.55 38.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.85 0.357 . . . . 0.0 111.092 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.725 ' O ' HD23 ' A' ' 100' ' ' LEU . 54.3 mm-40 -129.48 150.4 50.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.689 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.5 tp -72.5 133.3 44.73 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.273 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.901 HD13 ' HB2' ' A' ' 99' ' ' LEU . 1.3 pt? -63.48 160.85 15.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.81 0.814 . . . . 0.0 112.148 -179.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.719 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.3 OUTLIER -125.63 153.31 43.97 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.07 179.275 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.591 ' HA ' HD13 ' A' ' 147' ' ' ILE . 8.1 mm100 -71.41 115.7 10.89 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.81 28.49 68.39 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.585 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.419 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 24.9 t0 -53.44 173.84 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.945 0.402 . . . . 0.0 111.19 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 15.1 tt0 -145.15 135.24 23.86 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.898 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.537 ' CG2' HG22 ' A' ' 109' ' ' THR . 15.2 mt -115.49 126.58 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.342 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.539 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.37 141.51 36.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.275 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.911 HG21 HD21 ' A' ' 84' ' ' LEU . 34.2 m -140.06 158.42 26.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.021 0.439 . . . . 0.0 111.996 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.18 30.25 23.13 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.932 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.476 ' HA ' HG12 ' A' ' 140' ' ' ILE . 73.9 t -77.01 140.48 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 CA-C-O 121.647 0.737 . . . . 0.0 112.101 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.17 -39.85 1.22 Allowed Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.509 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 2.8 t -118.01 119.12 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -50.42 -32.1 16.82 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 76.7 p -93.69 6.79 47.15 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.509 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.5 OUTLIER -129.49 34.44 4.35 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -178.463 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.539 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.1 mt -107.17 139.32 29.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.766 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.76 HD23 ' OE1' ' A' ' 42' ' ' GLN . 2.1 mp -124.15 134.78 53.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.879 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.784 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.3 OUTLIER -106.59 135.49 48.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.172 0.51 . . . . 0.0 111.804 -179.327 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.754 HD12 ' C ' ' A' ' 142' ' ' SER . 5.3 mp -123.69 141.4 52.05 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.4 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 20.8 t -110.9 132.99 57.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.906 0.384 . . . . 0.0 111.196 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.547 HD13 HG22 ' A' ' 36' ' ' VAL . 2.2 mm -106.3 121.64 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.935 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.21 138.58 44.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.662 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.719 HD11 ' O ' ' A' ' 125' ' ' SER . 4.2 mp -106.63 133.03 52.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.386 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -83.91 122.74 29.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.89 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -73.74 -27.46 61.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.978 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.05 -42.54 80.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.006 0.432 . . . . 0.0 110.455 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 27.4 t80 . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.814 179.788 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.759 0.314 . . . . 0.0 110.85 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.408 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER 177.01 39.66 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.682 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.6 mm -75.74 135.43 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-N 113.529 -1.669 . . . . 0.0 112.574 -177.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.023 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.7 t -92.83 -61.43 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.845 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.501 ' SG ' HD22 ' A' ' 48' ' ' LEU . 1.7 p -138.58 158.3 44.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.029 178.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.43 119.11 26.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.829 0.347 . . . . 0.0 111.392 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.784 HG21 ' CE2' ' A' ' 68' ' ' PHE . 23.2 t -89.18 122.67 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.912 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.876 HG23 HG12 ' A' ' 45' ' ' ILE . 18.9 mt -131.74 117.47 34.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.488 -179.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 6.4 t -83.8 116.11 22.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.771 0.32 . . . . 0.0 110.149 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.3 t -92.49 -24.71 18.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.974 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.575 ' CG2' ' HB2' ' A' ' 142' ' ' SER . 49.4 p -79.78 -2.86 45.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.876 0.37 . . . . 0.0 111.484 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.405 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 72.15 76.58 0.6 Allowed Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 121.098 -0.572 . . . . 0.0 113.284 178.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.437 ' CB ' HD11 ' A' ' 141' ' ' LEU . 4.5 mt-30 -143.45 -40.41 0.3 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.815 0.34 . . . . 0.0 110.94 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.681 HG23 ' HD2' ' A' ' 44' ' ' PRO . 16.9 mt -132.48 143.24 47.96 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.212 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.681 ' HD2' HG23 ' A' ' 43' ' ' ILE . 51.5 Cg_endo -71.05 146.12 51.44 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.298 1.999 . . . . 0.0 111.967 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.876 HG12 HG23 ' A' ' 37' ' ' ILE . 37.4 mt -51.74 152.77 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.087 0.47 . . . . 0.0 111.998 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -147.2 164.21 33.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.041 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.53 120.01 27.31 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.766 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.7 mp -92.7 127.31 38.15 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 1.023 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -137.95 157.06 47.17 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -179.111 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.488 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -141.84 142.16 33.14 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 113.608 -1.633 . . . . 0.0 110.899 179.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 121.054 0.454 . . . . 0.0 111.117 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.41 ' CE ' ' O ' ' A' ' 49' ' ' SER . 6.4 ttpt . . . . . 0 CA--C 1.523 -0.085 0 CA-C-O 120.68 0.276 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.562 HG22 ' HB3' ' A' ' 92' ' ' LEU . 3.5 t -124.31 138.83 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 121.259 0.552 . . . . 0.0 112.192 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.766 ' CD2' HD23 ' A' ' 48' ' ' LEU . 17.3 m-90 -102.25 139.54 37.73 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.241 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.726 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.45 126.97 55.92 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.612 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.836 ' CE1' HD13 ' A' ' 91' ' ' ILE . 1.1 m-85 -108.55 145.48 34.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.318 -178.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.694 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.97 178.43 37.52 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.26 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.476 ' HG3' HD11 ' A' ' 78' ' ' LEU . 11.8 mtp180 -70.49 -4.85 24.83 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.447 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.0 OUTLIER -84.55 134.06 43.15 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.711 0.291 . . . . 0.0 111.27 -179.329 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.0 Cg_exo -69.49 -6.52 18.65 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.727 2.284 . . . . 0.0 111.719 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.85 -43.79 16.21 Favored 'General case' 0 CA--C 1.497 -1.077 0 CA-C-O 121.993 0.902 . . . . 0.0 108.706 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -41.95 138.38 1.55 Allowed 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 113.698 -1.592 . . . . 0.0 110.445 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.49 -18.87 12.86 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.097 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.618 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 58.9 t80 -129.5 125.62 36.77 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 120.73 0.3 . . . . 0.0 110.667 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -98.55 131.83 44.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.907 0.384 . . . . 0.0 110.925 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.656 HD12 ' O ' ' A' ' 79' ' ' GLY . 0.9 OUTLIER -131.18 179.9 5.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.729 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.656 ' O ' HD12 ' A' ' 78' ' ' LEU . . . -61.77 177.58 4.97 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.258 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -97.42 70.73 2.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.954 0.407 . . . . 0.0 110.84 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.606 HD11 HD12 ' A' ' 141' ' ' LEU . 40.0 mt -94.24 116.22 34.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.042 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.8 -34.38 62.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.313 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.518 ' HG3' ' HB3' ' A' ' 139' ' ' ASP . 1.5 mmt180 -60.84 -25.39 66.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.989 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.696 HD21 HG23 ' A' ' 132' ' ' VAL . 28.2 mt -96.03 149.92 21.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.302 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 57.9 p -93.6 169.69 10.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.604 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.694 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -43.21 -53.62 4.99 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.449 0.642 . . . . 0.0 109.912 179.251 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.47 ' HB2' HD12 ' A' ' 104' ' ' ILE . 6.4 ptmt -121.3 84.08 2.18 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 177.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.532 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 15.4 t60 -60.81 -47.26 87.15 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.978 -176.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.552 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 12.8 p90 -147.43 162.12 39.67 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 119.872 -0.731 . . . . 0.0 112.065 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.726 ' HG3' HG23 ' A' ' 67' ' ' THR . 3.4 tt0 -135.67 146.26 47.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.532 -178.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.836 HD13 ' CE1' ' A' ' 68' ' ' PHE . 4.3 mp -124.03 132.08 71.92 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.337 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.452 178.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.841 HD21 ' HB2' ' A' ' 102' ' ' ASN . 0.2 OUTLIER -120.66 148.57 43.75 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.262 0.553 . . . . 0.0 112.214 -179.145 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.709 HD13 ' CG1' ' A' ' 33' ' ' VAL . 5.5 tp . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.822 178.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.587 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.866 0.365 . . . . 0.0 110.955 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.587 HD12 ' O ' ' A' ' 99' ' ' LEU . 4.4 mp -129.14 136.61 50.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.661 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.891 HD11 HD11 ' A' ' 130' ' ' ILE . 0.3 OUTLIER -112.96 120.23 40.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.338 179.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.841 ' HB2' HD21 ' A' ' 92' ' ' LEU . 60.9 t30 -112.12 119.1 37.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.879 0.371 . . . . 0.0 111.806 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.785 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.8 p30 -79.99 139.36 37.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.668 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.488 HG12 ' HA ' ' A' ' 89' ' ' PHE . 17.3 pt -146.48 36.16 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -178.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.628 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -97.68 150.72 20.87 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-O 121.014 0.435 . . . . 0.0 112.14 -178.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.6 m -68.67 -31.61 70.85 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.683 177.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -96.13 -19.82 19.09 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -178.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.628 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.14 155.25 10.5 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.998 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.1 m -117.37 137.84 52.19 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.827 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -116.12 148.37 40.36 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 -177.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.472 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.1 113.6 18.58 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.487 177.536 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.416 ' N ' HD12 ' A' ' 111' ' ' LEU . 8.9 m-80 44.85 42.95 6.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.399 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.62 -12.2 64.0 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.585 178.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -104.64 118.57 36.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.08 0.44 . . . . 0.0 110.627 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.827 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -71.91 125.41 27.12 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.37 -179.718 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.785 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.7 m -94.7 165.46 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.852 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 120' ' ' SER . 8.5 tp10 -69.88 126.33 29.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.586 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.691 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 64.8 tttt -53.41 161.55 0.95 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.887 0.375 . . . . 0.0 110.386 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.46 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.2 p30 36.25 33.8 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.239 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.43 145.08 40.8 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.034 179.296 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.771 ' ND2' HD11 ' A' ' 92' ' ' LEU . 22.2 m120 -91.62 127.63 37.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.688 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -129.21 147.13 51.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.941 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.699 HD23 ' O ' ' A' ' 124' ' ' LEU . 7.9 tt -72.88 111.94 8.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.018 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.699 ' O ' HD23 ' A' ' 123' ' ' LEU . 0.3 OUTLIER -56.41 167.8 0.64 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.654 0.74 . . . . 0.0 112.0 -178.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.18 153.36 43.19 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.489 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.74 116.56 12.25 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.17 24.47 73.36 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.923 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -60.09 179.74 0.13 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 120.799 0.333 . . . . 0.0 110.837 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.759 ' CG ' HG22 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -145.05 135.38 24.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.254 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.891 HD11 HD11 ' A' ' 101' ' ' LEU . 8.5 mt -116.82 127.72 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.098 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.582 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.0 m -104.43 140.1 38.41 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.696 HG23 HD21 ' A' ' 84' ' ' LEU . 35.6 m -140.16 158.35 25.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.139 0.495 . . . . 0.0 112.198 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.23 28.69 29.91 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.649 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.471 ' HA ' HG12 ' A' ' 140' ' ' ILE . 68.8 t -74.52 140.55 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-O 121.64 0.733 . . . . 0.0 112.186 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.78 -43.5 0.83 Allowed Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -178.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.438 HG11 ' OD2' ' A' ' 139' ' ' ASP . 1.9 t -111.97 128.9 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -50.58 -43.43 56.54 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.7 p -93.56 6.74 47.23 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -178.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.518 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . 5.7 m-20 -119.61 34.42 5.22 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -178.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.582 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.2 mt -107.29 139.79 27.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.822 178.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.606 HD12 HD11 ' A' ' 81' ' ' ILE . 8.6 tt -120.97 134.69 55.3 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.949 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.575 ' HB2' ' CG2' ' A' ' 40' ' ' THR . 1.0 OUTLIER -109.99 139.48 45.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.058 0.456 . . . . 0.0 111.904 -179.375 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 40.7 mt -131.7 143.6 50.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.917 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.759 HG22 ' CG ' ' A' ' 129' ' ' GLU . 22.3 t -114.25 131.77 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 120.704 0.288 . . . . 0.0 111.132 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.558 HG21 ' CD2' ' A' ' 124' ' ' LEU . 1.5 mm -106.21 130.92 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-O 120.864 0.364 . . . . 0.0 110.755 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.75 112.01 21.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.954 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.428 HG23 HD13 ' A' ' 99' ' ' LEU . 7.0 mt -84.86 129.57 37.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.292 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -75.95 126.68 31.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.972 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -73.92 -35.95 64.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.97 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.1 -45.08 91.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.616 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.421 ' HE2' HD21 ' A' ' 93' ' ' LEU . 37.4 t80 . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.881 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.754 0.311 . . . . 0.0 111.052 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.1 t-20 175.05 39.86 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.2 mm -72.81 134.95 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 CA-C-N 113.621 -1.627 . . . . 0.0 112.407 -177.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.0 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.2 t -92.56 -60.55 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.099 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.474 ' SG ' HD22 ' A' ' 48' ' ' LEU . 21.8 p -142.97 164.66 29.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.381 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.6 138.22 51.14 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.849 0.357 . . . . 0.0 111.326 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.741 HG11 ' CE2' ' A' ' 68' ' ' PHE . 3.2 m -107.45 122.64 61.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.841 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.804 HG23 HG12 ' A' ' 45' ' ' ILE . 18.4 mt -126.66 119.53 53.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.478 -179.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.759 ' HA ' HD13 ' A' ' 143' ' ' LEU . 23.1 t -79.78 111.38 16.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.808 0.337 . . . . 0.0 110.467 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.437 HG23 HG21 ' A' ' 144' ' ' VAL . 0.1 OUTLIER -82.15 -23.73 35.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.825 -179.163 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.518 HG23 ' HB3' ' A' ' 142' ' ' SER . 74.5 p -79.91 -2.25 42.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.788 0.327 . . . . 0.0 111.48 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.8 75.77 0.36 Allowed Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.821 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.554 ' CD ' HD11 ' A' ' 141' ' ' LEU . 9.7 mt-30 -146.6 -40.95 0.2 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.878 0.37 . . . . 0.0 111.053 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.559 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.7 mt -123.28 141.54 36.31 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.053 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.559 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.4 Cg_endo -72.63 146.01 42.82 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.33 2.02 . . . . 0.0 112.239 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.804 HG12 HG23 ' A' ' 37' ' ' ILE . 35.8 mt -55.51 148.98 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.677 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.43 164.15 28.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.152 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.33 119.74 31.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.993 0.425 . . . . 0.0 111.982 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.734 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.7 mp -95.81 125.48 40.41 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 1.0 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -135.51 157.39 47.0 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -178.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.502 ' HB3' ' CD2' ' A' ' 93' ' ' LEU . . . -148.82 148.91 30.47 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.638 -1.619 . . . . 0.0 110.81 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 121.062 0.458 . . . . 0.0 111.185 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.432 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.7 ttpt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.974 0.416 . . . . 0.0 111.962 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 91' ' ' ILE . 13.0 t -129.99 139.43 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.218 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.734 ' CD2' HD23 ' A' ' 48' ' ' LEU . 17.8 m-90 -100.92 139.63 36.35 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.983 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.656 HG23 ' CD ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -109.58 133.04 53.57 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 177.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.741 ' CE2' HG11 ' A' ' 36' ' ' VAL . 1.1 m-85 -120.19 145.52 46.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.055 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.763 ' CA ' HD21 ' A' ' 78' ' ' LEU . . . 159.56 -172.38 36.16 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.874 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.453 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 9.5 mtp-105 -80.31 3.7 20.16 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.469 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 5.1 t-20 -84.88 133.46 43.41 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 120.659 0.266 . . . . 0.0 110.988 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 13.2 Cg_exo -68.28 -10.28 28.47 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.646 2.231 . . . . 0.0 111.88 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.408 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -83.29 -43.44 16.02 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-O 122.001 0.905 . . . . 0.0 108.952 179.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.19 136.41 2.24 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 113.658 -1.61 . . . . 0.0 111.278 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -56.71 -18.38 12.22 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.153 179.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.531 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 66.7 t80 -129.32 112.1 13.52 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-O 120.812 0.339 . . . . 0.0 111.071 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -94.99 114.39 26.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.835 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.763 HD21 ' CA ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -97.2 -80.25 0.44 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.988 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.95 -131.17 1.19 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.576 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -141.6 60.77 1.48 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.887 0.375 . . . . 0.0 110.821 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.866 HD13 HD12 ' A' ' 84' ' ' LEU . 3.9 mp -88.61 120.21 37.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.012 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 m -54.77 -42.94 72.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.878 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.565 ' CZ ' HG21 ' A' ' 136' ' ' VAL . 0.7 OUTLIER -60.88 -18.68 57.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.113 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.866 HD12 HD13 ' A' ' 81' ' ' ILE . 38.7 mt -107.0 152.17 24.34 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.661 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 95.3 p -96.83 163.98 12.75 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.768 0.318 . . . . 0.0 111.709 -179.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.631 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.6 m-20 -41.27 -52.48 3.41 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.532 0.682 . . . . 0.0 109.845 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.468 ' HB3' HD11 ' A' ' 104' ' ' ILE . 5.2 mttt -120.57 84.75 2.27 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 177.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.557 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.5 t60 -64.12 -45.76 87.13 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.023 -0.989 . . . . 0.0 113.252 -176.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.454 ' HA ' HG12 ' A' ' 104' ' ' ILE . 37.2 p90 -151.93 162.23 41.39 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.887 -0.725 . . . . 0.0 112.414 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.656 ' CD ' HG23 ' A' ' 67' ' ' THR . 11.0 mt-30 -135.55 154.3 51.42 Favored 'General case' 0 CA--C 1.522 -0.1 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.743 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.66 HG23 HD22 ' A' ' 101' ' ' LEU . 25.7 mt -119.91 132.19 70.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 177.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.565 HD11 HD13 ' A' ' 100' ' ' LEU . 0.6 OUTLIER -118.71 140.18 50.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.111 0.481 . . . . 0.0 112.254 -178.547 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.801 HD13 ' CG1' ' A' ' 33' ' ' VAL . 11.0 tp . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.088 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.499 ' HB3' HD12 ' A' ' 124' ' ' LEU . 3.2 mm? . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.802 0.334 . . . . 0.0 110.848 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.844 HD22 ' HB3' ' A' ' 121' ' ' ASN . 6.5 mt -133.08 140.95 47.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.096 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.66 HD22 HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -112.6 126.05 54.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.473 -179.782 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.403 ' HB2' HD23 ' A' ' 92' ' ' LEU . 48.8 t30 -114.07 115.51 27.67 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.491 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.851 ' OD2' HG23 ' A' ' 116' ' ' VAL . 9.5 p30 -79.21 143.24 35.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.942 178.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.516 HG21 ' OE1' ' A' ' 90' ' ' GLN . 9.7 pt -150.02 35.27 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -178.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.654 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -95.78 150.97 19.81 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 121.118 0.485 . . . . 0.0 112.09 -178.78 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.9 m -68.72 -31.39 70.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.791 177.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -97.76 -19.72 18.02 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.654 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 118.14 155.88 10.13 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.334 -0.936 . . . . 0.0 114.062 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 11.5 m -117.26 137.83 52.13 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.851 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -116.24 148.29 40.61 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.761 1.022 . . . . 0.0 113.761 -178.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.2 113.52 18.41 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.612 -1.177 . . . . 0.0 108.444 177.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 43.62 43.72 4.89 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.375 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.32 -12.3 65.15 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.382 178.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 9.4 mp0 -103.74 118.59 37.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.053 0.454 . . . . 0.0 110.601 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.851 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.0 tptt -73.16 124.7 26.11 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.215 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.851 HG23 ' OD2' ' A' ' 103' ' ' ASP . 13.0 m -94.92 162.37 2.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.154 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 120' ' ' SER . 4.3 pm0 -69.94 126.37 29.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.47 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.687 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 18.6 tttm -51.42 160.52 0.57 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.015 0.435 . . . . 0.0 111.046 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.8 p30 34.96 33.67 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.432 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.55 145.14 40.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.164 179.262 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.844 ' HB3' HD22 ' A' ' 100' ' ' LEU . 4.4 m120 -87.42 127.51 35.22 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.048 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.697 ' O ' HD23 ' A' ' 100' ' ' LEU . 34.6 mm-40 -129.35 146.3 51.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.743 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.4 tp -72.9 112.43 8.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.173 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.566 HD22 HG21 ' A' ' 145' ' ' ILE . 3.2 mt -59.97 167.32 2.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.676 0.75 . . . . 0.0 111.886 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.408 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.0 OUTLIER -125.36 153.42 43.39 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.319 179.425 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.41 120.92 17.68 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.58 19.2 66.72 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.055 -178.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.408 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 14.3 t70 -58.06 177.44 0.12 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 120.794 0.33 . . . . 0.0 110.791 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.887 ' CG ' HG22 ' A' ' 144' ' ' VAL . 10.7 mt-10 -145.11 135.54 24.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.247 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.443 HG23 ' O ' ' A' ' 110' ' ' TRP . 6.0 mt -114.0 128.47 70.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.075 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.63 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.7 m -103.89 140.11 38.14 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.535 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 31.0 m -140.18 158.32 25.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.135 0.493 . . . . 0.0 112.279 -178.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.75 27.61 28.8 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.01 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.445 ' HB ' ' CZ3' ' A' ' 110' ' ' TRP . 77.3 t -73.4 140.46 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-O 121.616 0.722 . . . . 0.0 112.063 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.43 -40.33 0.99 Allowed Glycine 0 N--CA 1.434 -1.455 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.565 HG21 ' CZ ' ' A' ' 83' ' ' ARG . 2.1 t -117.38 126.82 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -50.47 -40.1 49.96 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.2 m -93.44 6.66 47.41 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -178.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.482 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.7 OUTLIER -120.17 33.34 5.64 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -178.444 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.63 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.6 mt -107.09 138.83 31.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.384 0.611 . . . . 0.0 110.824 178.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.554 HD11 ' CD ' ' A' ' 42' ' ' GLN . 0.3 OUTLIER -124.46 134.64 52.99 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.533 -179.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.587 ' C ' HD22 ' A' ' 143' ' ' LEU . 42.2 t -110.29 150.44 28.73 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.615 0.721 . . . . 0.0 112.422 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.759 HD13 ' HA ' ' A' ' 38' ' ' CYS . 3.0 mm? -135.84 148.5 48.69 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.319 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.887 HG22 ' CG ' ' A' ' 129' ' ' GLU . 20.1 t -114.2 134.86 55.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.892 0.377 . . . . 0.0 111.281 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.566 HG21 HD22 ' A' ' 124' ' ' LEU . 2.3 mm -106.37 122.89 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.624 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.06 114.33 26.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.894 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 7.9 mm -84.95 129.35 37.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.06 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -75.88 107.92 8.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.845 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.3 -31.86 69.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.87 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -45.52 91.66 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.592 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 36.1 t80 . . . . . 0 N--CA 1.452 -0.344 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.88 179.918 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.739 0.304 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.435 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER -177.41 36.86 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.734 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.5 mm -75.77 135.65 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 CA-C-N 113.754 -1.566 . . . . 0.0 112.639 -177.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.038 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.0 t -90.81 -60.24 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.953 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.0 p -148.19 150.12 33.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.137 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.98 138.14 50.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.889 0.376 . . . . 0.0 111.622 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.521 HG21 ' HE2' ' A' ' 68' ' ' PHE . 12.9 p -104.64 122.75 58.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.642 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.808 HG23 HG12 ' A' ' 45' ' ' ILE . 20.3 mt -127.73 125.56 65.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.706 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.602 ' SG ' HD21 ' A' ' 141' ' ' LEU . 3.5 t -89.75 104.64 17.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.195 179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.9 p -81.55 -22.56 37.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.962 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.736 HG23 ' HB2' ' A' ' 142' ' ' SER . 67.8 p -79.81 -2.64 44.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.809 0.337 . . . . 0.0 111.496 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.29 74.93 0.48 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.833 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.506 ' HB2' HD21 ' A' ' 141' ' ' LEU . 0.5 OUTLIER -146.26 -36.19 0.26 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.808 0.337 . . . . 0.0 111.13 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.821 HD13 HD22 ' A' ' 78' ' ' LEU . 15.8 mt -131.72 141.9 43.29 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.947 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.578 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 48.7 Cg_endo -71.01 146.0 51.35 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.19 1.927 . . . . 0.0 112.357 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.808 HG12 HG23 ' A' ' 37' ' ' ILE . 36.4 mt -61.35 148.61 9.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.769 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.94 164.3 30.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.162 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -120.98 119.86 33.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.1 0.476 . . . . 0.0 111.847 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.611 HD22 ' CD1' ' A' ' 66' ' ' TRP . 10.4 mt -96.05 136.09 36.97 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 1.038 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.97 158.7 44.0 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 -178.669 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.485 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -139.79 141.81 36.73 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 113.542 -1.663 . . . . 0.0 110.559 178.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 121.222 0.534 . . . . 0.0 111.281 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.422 ' HE2' ' O ' ' A' ' 49' ' ' SER . 4.0 ttpt . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.726 0.298 . . . . 0.0 110.985 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 91' ' ' ILE . 14.2 t -132.16 139.4 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 121.255 0.55 . . . . 0.0 112.374 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.611 ' CD1' HD22 ' A' ' 48' ' ' LEU . 16.6 m-90 -104.58 139.51 39.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.943 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.625 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.57 125.82 54.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.123 0.487 . . . . 0.0 110.078 177.694 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.533 ' CD2' ' CD2' ' A' ' 76' ' ' TYR . 2.2 m-85 -109.73 145.48 36.53 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.061 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 157.73 -172.1 34.94 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.41 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.501 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 9.3 mtp-105 -76.92 2.45 14.69 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 0.2 OUTLIER -84.54 130.93 51.57 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.517 0.199 . . . . 0.0 110.976 -179.628 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 18.9 Cg_exo -65.54 -13.99 42.6 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.387 2.058 . . . . 0.0 111.501 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.02 -42.37 17.58 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-O 121.849 0.833 . . . . 0.0 108.839 178.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -42.05 138.32 1.62 Allowed 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.8 179.685 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.9 OUTLIER -56.33 -18.6 11.3 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.164 179.1 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.533 ' CD2' ' CD2' ' A' ' 68' ' ' PHE . 13.2 t80 -129.28 119.46 24.0 Favored 'General case' 0 CA--C 1.527 0.09 0 CA-C-O 120.758 0.313 . . . . 0.0 111.196 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -99.98 117.68 34.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.677 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.821 HD22 HD13 ' A' ' 43' ' ' ILE . 1.4 mt -88.85 -69.09 0.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.017 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 171.92 -85.67 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.519 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -174.46 49.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.901 0.382 . . . . 0.0 111.084 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.501 ' N ' ' HD2' ' A' ' 70' ' ' ARG . 30.1 mm -79.99 123.86 37.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.198 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 90.2 p -54.72 -41.16 69.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.254 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.483 ' HG2' ' CA ' ' A' ' 133' ' ' GLY . 8.5 tpt85 -63.71 -49.16 74.19 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.437 ' CD1' HD13 ' A' ' 78' ' ' LEU . 16.7 mt -73.88 148.26 42.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.06 0.457 . . . . 0.0 111.856 -179.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.7 p -95.11 165.27 12.5 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.855 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.575 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.0 m-20 -41.5 -53.16 3.51 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.434 0.635 . . . . 0.0 110.21 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.443 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 8.5 ptpp? -123.8 81.96 1.97 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 177.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.558 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.9 t60 -59.73 -46.69 88.36 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.981 -1.009 . . . . 0.0 112.988 -176.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.514 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 23.6 p90 -147.65 160.55 42.55 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.116 -0.634 . . . . 0.0 111.621 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.625 ' HG3' HG23 ' A' ' 67' ' ' THR . 5.4 tt0 -135.94 139.75 43.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.555 -178.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.629 ' O ' HG13 ' A' ' 65' ' ' VAL . 17.5 mt -112.37 131.51 63.65 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.233 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.673 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.677 ' H ' HD23 ' A' ' 92' ' ' LEU . 1.8 pt? -118.93 146.83 44.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.044 0.45 . . . . 0.0 111.605 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.524 HD13 ' HG ' ' A' ' 99' ' ' LEU . 14.3 tp . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.396 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.955 HD11 HG12 ' A' ' 33' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.707 0.289 . . . . 0.0 110.713 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.49 ' HB3' HD21 ' A' ' 92' ' ' LEU . 1.2 mp -127.33 144.58 51.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.327 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.761 HD11 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -112.77 124.72 53.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.283 -179.921 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.646 ' HB2' HD22 ' A' ' 92' ' ' LEU . 53.7 t30 -118.19 115.53 24.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.978 0.418 . . . . 0.0 111.45 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.825 ' OD2' HG23 ' A' ' 116' ' ' VAL . 8.8 p30 -79.07 142.44 36.48 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.095 178.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.499 HD11 HG22 ' A' ' 67' ' ' THR . 16.7 pt -151.09 37.59 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.602 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -95.18 155.38 16.76 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 121.0 0.429 . . . . 0.0 111.55 -179.304 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 82.8 m -68.82 -34.37 75.39 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.331 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 19.9 p30 -98.65 -19.87 17.29 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.602 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 122.6 156.67 9.7 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.279 -0.963 . . . . 0.0 113.749 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.507 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.4 m -117.35 137.9 52.14 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.855 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -116.26 148.34 40.59 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -178.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.468 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.15 113.39 18.27 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.284 177.441 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.41 ' N ' HD12 ' A' ' 111' ' ' LEU . 7.5 m-80 44.41 42.92 5.8 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.385 -179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.27 -7.97 78.64 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.841 -0.695 . . . . 0.0 113.484 178.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.19 118.67 37.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.035 0.445 . . . . 0.0 110.688 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.855 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 9.6 tptp -74.16 118.28 16.93 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.236 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.825 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.4 m -90.73 164.23 2.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.14 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 120' ' ' SER . 33.8 tt0 -69.83 127.71 33.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.436 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.687 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 25.3 tttt -53.58 160.92 1.15 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.975 0.417 . . . . 0.0 110.599 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.5 p30 34.18 35.32 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.351 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.24 145.06 40.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.222 179.435 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.457 ' HB3' HD23 ' A' ' 100' ' ' LEU . 14.2 m120 -83.73 128.75 34.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.748 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.409 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 21.3 mm-40 -129.31 145.76 51.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.594 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.449 HD22 ' HA ' ' A' ' 123' ' ' LEU . 1.5 tm? -72.99 118.09 15.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.254 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.599 HD21 HG12 ' A' ' 147' ' ' ILE . 65.0 tp -56.41 157.25 5.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.359 0.6 . . . . 0.0 111.549 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.451 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.8 OUTLIER -124.53 153.14 42.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.592 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.436 ' HA ' HD12 ' A' ' 147' ' ' ILE . 8.6 tp60 -71.71 124.32 24.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.015 0.436 . . . . 0.0 110.61 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.37 20.65 45.43 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.344 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.451 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 9.8 t70 -58.71 173.22 0.43 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.942 0.401 . . . . 0.0 110.835 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 18.8 tt0 -145.17 135.6 24.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.106 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.897 HD11 HD11 ' A' ' 145' ' ' ILE . 5.5 mt -108.8 128.64 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.313 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.641 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.1 m -103.75 136.64 43.06 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.54 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 29.8 m -138.08 158.38 32.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.183 0.516 . . . . 0.0 112.381 -178.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.483 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 82.96 38.62 11.13 Favored Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.954 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.441 ' HA ' HG12 ' A' ' 140' ' ' ILE . 56.5 t -79.84 140.47 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-O 121.676 0.75 . . . . 0.0 112.203 -179.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.48 -46.16 0.64 Allowed Glycine 0 N--CA 1.435 -1.371 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.434 HG12 ' N ' ' A' ' 139' ' ' ASP . 0.9 OUTLIER -127.19 125.49 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 CA-C-N 114.259 -0.97 . . . . 0.0 108.827 177.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.417 ' HA ' HD12 ' A' ' 140' ' ' ILE . 0.1 OUTLIER -49.92 -24.79 2.72 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -177.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.0 t -93.05 -0.36 57.13 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.434 ' N ' HG12 ' A' ' 136' ' ' VAL . 79.1 m-20 -120.05 25.61 9.8 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -178.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.641 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.4 mt -106.88 138.72 31.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-O 121.405 0.621 . . . . 0.0 111.559 178.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.602 HD21 ' SG ' ' A' ' 38' ' ' CYS . 1.6 tt -124.5 134.49 53.0 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.392 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.736 ' HB2' HG23 ' A' ' 40' ' ' THR . 2.1 m -107.02 142.17 37.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.158 0.504 . . . . 0.0 111.976 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.595 ' CD2' HD22 ' A' ' 141' ' ' LEU . 2.1 mm? -135.34 137.74 42.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.448 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 21.1 t -110.79 137.79 41.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.88 0.371 . . . . 0.0 111.236 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.897 HD11 HD11 ' A' ' 130' ' ' ILE . 52.6 mt -106.22 128.32 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.399 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.94 114.96 27.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.364 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.599 HG12 HD21 ' A' ' 124' ' ' LEU . 6.5 mt -84.73 130.93 35.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.951 0.405 . . . . 0.0 111.618 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -78.97 111.95 15.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.752 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -61.38 -33.13 73.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.139 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -45.99 91.2 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.034 0.445 . . . . 0.0 110.843 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 26.8 t80 . . . . . 0 N--CA 1.451 -0.382 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.05 -179.893 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.732 0.301 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.41 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER 176.42 39.6 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.668 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -74.79 135.62 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 CA-C-N 113.63 -1.623 . . . . 0.0 112.404 -177.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.978 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.3 t -91.93 -59.46 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.923 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.47 ' SG ' HD22 ' A' ' 48' ' ' LEU . 4.8 p -148.31 165.17 31.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.482 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.99 138.29 51.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.831 0.348 . . . . 0.0 111.399 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.696 HG21 ' CE2' ' A' ' 68' ' ' PHE . 47.6 t -111.18 122.81 66.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.563 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.828 HG23 HG12 ' A' ' 45' ' ' ILE . 19.0 mt -122.25 120.06 60.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.857 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.548 ' SG ' HD13 ' A' ' 43' ' ' ILE . 0.9 OUTLIER -83.96 104.07 13.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.039 179.14 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.96 -20.88 48.09 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.585 HG21 ' H ' ' A' ' 142' ' ' SER . 72.8 p -79.85 -2.41 43.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.803 0.335 . . . . 0.0 111.547 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.72 75.12 0.44 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.819 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.642 ' HB2' HD12 ' A' ' 43' ' ' ILE . 9.5 mt-30 -145.84 -40.01 0.23 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.893 0.378 . . . . 0.0 110.88 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.642 HD12 ' HB2' ' A' ' 42' ' ' GLN . 4.4 mp -125.4 142.69 42.38 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.038 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.622 ' HD2' HG23 ' A' ' 43' ' ' ILE . 50.7 Cg_endo -70.75 145.86 52.58 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.207 1.938 . . . . 0.0 112.131 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.828 HG12 HG23 ' A' ' 37' ' ' ILE . 35.2 mt -62.93 138.95 22.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.77 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.43 163.98 25.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.951 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -124.38 119.88 30.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.082 0.468 . . . . 0.0 111.854 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.823 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.6 mp -85.88 132.08 34.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.558 178.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.978 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -140.31 155.81 46.68 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 122.281 1.038 . . . . 0.0 113.423 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.477 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.08 141.84 29.18 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 113.533 -1.667 . . . . 0.0 110.798 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 121.256 0.551 . . . . 0.0 111.198 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.416 ' CE ' ' O ' ' A' ' 49' ' ' SER . 4.1 ttpt . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.782 0.325 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.598 HG13 ' O ' ' A' ' 91' ' ' ILE . 17.4 t -130.67 139.21 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 121.34 0.59 . . . . 0.0 112.084 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.823 ' CD2' HD23 ' A' ' 48' ' ' LEU . 16.2 m-90 -105.44 138.71 41.19 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.952 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.456 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -112.01 131.95 55.1 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.493 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.696 ' CE2' HG21 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -117.11 145.61 43.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.679 -178.316 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.673 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.92 -171.97 37.96 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.596 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 4.6 mtm105 -83.14 3.36 31.08 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.48 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.0 t30 -85.07 135.06 39.94 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.627 0.251 . . . . 0.0 110.95 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.8 Cg_exo -65.95 -11.83 32.67 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.613 2.209 . . . . 0.0 111.728 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.429 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.86 -45.31 14.4 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 121.952 0.882 . . . . 0.0 108.827 178.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.59 137.55 5.07 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 113.892 -1.504 . . . . 0.0 110.692 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.6 OUTLIER -56.66 -18.14 11.22 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.232 179.028 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.456 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 9.9 t80 -125.23 118.51 26.19 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-O 120.782 0.325 . . . . 0.0 110.928 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -99.77 115.73 30.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.543 HD11 ' HA2' ' A' ' 69' ' ' GLY . 2.6 mt -90.2 -168.28 2.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.093 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -91.68 19.36 48.6 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.828 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 63.88 84.31 0.15 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.865 0.365 . . . . 0.0 111.538 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.92 HD13 HD12 ' A' ' 84' ' ' LEU . 3.4 mp -108.3 131.4 58.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.714 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.4 m -54.88 -39.55 68.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.03 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.511 ' NH1' HG23 ' A' ' 136' ' ' VAL . 1.9 tpt180 -66.37 -45.49 79.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.907 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.92 HD12 HD13 ' A' ' 81' ' ' ILE . 42.6 mt -72.81 151.54 42.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.892 0.377 . . . . 0.0 111.641 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.0 p -95.83 166.98 11.54 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.733 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.673 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.7 m-20 -43.85 -54.18 5.45 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.282 0.563 . . . . 0.0 109.842 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.455 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.6 OUTLIER -120.04 83.06 1.99 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.163 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.576 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 9.4 t60 -62.12 -46.32 89.54 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.791 -176.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.517 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 18.4 p90 -146.5 157.93 43.82 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.672 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.568 ' HG2' HG12 ' A' ' 65' ' ' VAL . 5.5 tt0 -135.94 140.66 44.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.332 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.755 HG12 HD13 ' A' ' 101' ' ' LEU . 39.3 mt -114.76 132.11 64.92 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.912 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.675 HD12 ' HB2' ' A' ' 100' ' ' LEU . 0.4 OUTLIER -123.59 146.28 48.28 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.141 0.496 . . . . 0.0 111.704 -179.805 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.761 HD13 ' HG ' ' A' ' 99' ' ' LEU . 14.5 tp . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.219 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.761 ' HG ' HD13 ' A' ' 93' ' ' LEU . 7.6 mp . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.729 0.299 . . . . 0.0 110.722 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.675 ' HB2' HD12 ' A' ' 92' ' ' LEU . 16.1 mt -133.1 146.58 51.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.879 0.371 . . . . 0.0 110.808 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.755 HD13 HG12 ' A' ' 91' ' ' ILE . 2.3 mm? -112.72 123.57 50.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.854 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -112.95 115.51 28.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.04 0.448 . . . . 0.0 111.229 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.823 ' OD2' HG23 ' A' ' 116' ' ' VAL . 15.1 p30 -81.34 133.19 35.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.874 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.461 HG12 ' HA ' ' A' ' 89' ' ' PHE . 19.2 pt -140.9 38.66 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.543 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -100.76 154.03 18.96 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 120.918 0.39 . . . . 0.0 111.577 -179.387 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 86.6 m -68.89 -31.77 70.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.43 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -97.74 -19.88 17.93 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.523 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.84 158.0 10.83 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.889 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.1 m -117.71 137.87 52.39 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.87 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -117.95 148.32 42.3 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.768 HD23 ' O ' ' A' ' 114' ' ' GLN . 0.4 OUTLIER -124.58 113.67 18.37 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 176.611 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 37.3 m-20 48.19 42.05 16.78 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.63 -8.38 75.51 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.77 -0.729 . . . . 0.0 113.925 178.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.768 ' O ' HD23 ' A' ' 111' ' ' LEU . 6.9 mt-30 -105.69 118.83 37.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.13 0.465 . . . . 0.0 110.786 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.87 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -73.14 135.08 44.66 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.404 -179.719 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.823 HG23 ' OD2' ' A' ' 103' ' ' ASP . 16.7 m -107.44 163.98 5.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.763 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 120' ' ' SER . 44.2 tt0 -69.87 127.32 32.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.384 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.69 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 76.7 tttt -52.16 161.57 0.6 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.896 0.379 . . . . 0.0 110.525 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.7 p30 34.37 34.73 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.305 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.492 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.34 145.11 40.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.453 179.618 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.665 ' HB3' HD22 ' A' ' 100' ' ' LEU . 26.0 m120 -87.43 123.99 32.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.615 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.472 ' O ' HD23 ' A' ' 100' ' ' LEU . 30.0 mm-40 -129.24 146.69 51.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.858 0.361 . . . . 0.0 111.102 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 32.6 tp -75.07 118.04 17.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.101 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.509 HD13 ' HB2' ' A' ' 99' ' ' LEU . 2.0 pt? -58.12 168.66 0.96 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.586 0.708 . . . . 0.0 112.039 -178.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.524 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.4 OUTLIER -124.38 154.13 40.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.81 -1.087 . . . . 0.0 109.905 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.751 ' HA ' HD13 ' A' ' 147' ' ' ILE . 17.1 tp60 -70.14 119.38 14.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.085 0.469 . . . . 0.0 110.27 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.06 23.38 59.41 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.905 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.468 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 25.6 t0 -57.81 179.2 0.07 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 120.716 0.293 . . . . 0.0 110.676 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.841 ' CG ' HG22 ' A' ' 144' ' ' VAL . 7.2 mt-10 -145.05 135.64 24.37 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.091 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.595 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 10.2 mt -107.3 123.67 62.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.924 0.392 . . . . 0.0 110.622 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.48 ' HB ' ' HB2' ' A' ' 110' ' ' TRP . 96.9 m -104.59 140.69 37.64 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.576 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 17.7 m -140.25 158.51 25.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.32 29.8 35.8 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.114 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.493 ' HB ' ' CH2' ' A' ' 110' ' ' TRP . 86.8 t -76.36 140.51 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-O 121.604 0.716 . . . . 0.0 111.986 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 139.04 -37.75 1.74 Allowed Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -178.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.511 HG23 ' NH1' ' A' ' 83' ' ' ARG . 2.5 t -123.01 118.35 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.85 -26.43 5.77 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -178.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 20.7 t -93.74 6.75 47.31 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -132.62 33.82 3.74 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -178.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.449 HG12 ' HA ' ' A' ' 134' ' ' VAL . 7.2 mt -107.21 138.02 35.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-O 121.619 0.723 . . . . 0.0 111.338 178.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.443 HD23 ' N ' ' A' ' 142' ' ' SER . 1.4 tt -125.65 135.02 51.7 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.374 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.585 ' H ' HG21 ' A' ' 40' ' ' THR . 46.8 t -112.38 147.42 36.44 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.87 0.843 . . . . 0.0 112.44 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.486 HD12 ' O ' ' A' ' 130' ' ' ILE . 3.7 mp -135.85 153.08 51.6 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.153 -1.385 . . . . 0.0 110.854 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.841 HG22 ' CG ' ' A' ' 129' ' ' GLU . 21.9 t -118.17 140.03 43.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.631 0.253 . . . . 0.0 110.544 179.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.5 mm -106.2 120.85 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-O 120.957 0.408 . . . . 0.0 110.989 -179.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.69 111.06 22.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.677 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.751 HD13 ' HA ' ' A' ' 126' ' ' GLN . 4.1 mp -89.93 134.23 29.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.853 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -85.52 108.2 17.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.5 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.79 -31.68 68.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.202 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -60.32 -45.95 91.6 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.967 0.413 . . . . 0.0 110.779 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 36.5 t80 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.049 -179.869 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 . . . . . 0 C--O 1.23 0.032 0 CA-C-O 120.759 0.314 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.9 OUTLIER 175.2 39.66 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.852 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.683 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -72.29 135.45 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 CA-C-N 113.613 -1.63 . . . . 0.0 112.558 -177.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.985 HG12 HD11 ' A' ' 99' ' ' LEU . 3.5 t -91.56 -58.85 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.912 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 24.8 p -152.56 154.78 36.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.644 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.87 ' NE ' HG21 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -119.09 138.22 53.03 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.799 0.333 . . . . 0.0 110.971 -179.85 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.515 HG21 ' CE2' ' A' ' 68' ' ' PHE . 57.3 t -107.7 122.67 62.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.895 0.379 . . . . 0.0 110.906 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.691 HG23 HG12 ' A' ' 45' ' ' ILE . 14.4 mt -118.69 127.97 75.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.502 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.83 ' HA ' HD13 ' A' ' 143' ' ' LEU . 52.6 t -81.36 100.68 9.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.518 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.583 ' OG1' HG23 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -67.98 -24.19 65.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.816 -179.249 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.525 HG23 ' HB3' ' A' ' 142' ' ' SER . 72.9 p -79.82 -2.36 43.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.831 0.348 . . . . 0.0 111.376 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 59.99 76.28 0.23 Allowed Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 121.018 -0.611 . . . . 0.0 113.09 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -146.57 -43.14 0.19 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.92 0.39 . . . . 0.0 110.78 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.647 HG23 ' HD2' ' A' ' 44' ' ' PRO . 3.4 mp -119.55 142.55 32.95 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.035 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.647 ' HD2' HG23 ' A' ' 43' ' ' ILE . 50.7 Cg_endo -71.2 146.18 50.8 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.216 1.944 . . . . 0.0 112.203 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.87 HG21 ' NE ' ' A' ' 35' ' ' ARG . 51.7 mt -55.04 144.68 5.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.944 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.481 ' HB2' ' CE2' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -128.28 134.24 48.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.837 178.828 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -98.72 119.71 37.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.046 0.451 . . . . 0.0 112.199 -178.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.762 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.1 mp -93.68 128.12 39.71 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.984 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -133.71 156.84 47.23 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 122.067 0.937 . . . . 0.0 113.526 -179.602 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.483 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -153.02 142.02 21.28 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 113.817 -1.538 . . . . 0.0 111.136 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.104 -179.701 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.462 ' HE2' ' O ' ' A' ' 49' ' ' SER . 4.0 ttpt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.757 0.313 . . . . 0.0 111.327 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.71 HG12 ' HG2' ' A' ' 90' ' ' GLN . 16.0 t -131.27 139.27 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-O 121.155 0.503 . . . . 0.0 111.733 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.762 ' CD2' HD23 ' A' ' 48' ' ' LEU . 20.2 m-90 -101.02 139.24 36.98 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.002 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.683 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.76 126.93 55.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.038 0.447 . . . . 0.0 109.904 177.911 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.635 ' HZ ' HD21 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -111.43 145.83 38.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.453 -178.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.682 ' HA2' HD12 ' A' ' 78' ' ' LEU . . . 161.42 -171.86 37.51 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.602 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.454 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 8.3 mtp-105 -82.15 1.48 36.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.624 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 8.9 t-20 -84.92 134.37 41.56 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.716 0.293 . . . . 0.0 111.035 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.5 Cg_exo -68.48 -8.97 24.64 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.625 2.217 . . . . 0.0 111.787 179.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.624 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -83.16 -43.9 15.67 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 122.031 0.92 . . . . 0.0 108.79 178.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.45 136.64 2.33 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 113.656 -1.611 . . . . 0.0 110.832 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -56.6 -19.08 14.26 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.831 179.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.644 ' HE1' HD23 ' A' ' 78' ' ' LEU . 9.8 t80 -129.95 119.3 23.0 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.723 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -93.94 111.03 22.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.907 0.384 . . . . 0.0 110.95 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.682 HD12 ' HA2' ' A' ' 69' ' ' GLY . 44.9 mt -76.07 -78.55 0.11 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.997 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.62 -87.16 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.506 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -177.5 47.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.853 0.359 . . . . 0.0 111.003 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.454 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 30.7 mm -83.35 117.39 29.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.108 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.7 -31.99 58.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.042 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.415 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.4 OUTLIER -70.96 -17.39 62.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.274 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.709 HD21 HG23 ' A' ' 132' ' ' VAL . 41.2 mt -106.95 152.16 24.32 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.762 0.315 . . . . 0.0 111.436 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 87.2 p -96.39 166.0 11.92 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.663 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.664 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.1 m-20 -43.11 -52.35 5.48 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.425 0.631 . . . . 0.0 109.774 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.445 ' HB2' HD12 ' A' ' 104' ' ' ILE . 14.5 ptmt -119.77 82.86 1.95 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 177.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.589 ' CE1' ' OG ' ' A' ' 105' ' ' SER . 14.2 t60 -61.17 -46.66 89.61 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.875 -176.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.539 ' HA ' HG12 ' A' ' 104' ' ' ILE . 32.0 p90 -148.99 161.42 41.94 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.767 -179.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.71 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.4 tt0 -135.92 142.28 44.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.42 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.622 ' C ' HG13 ' A' ' 65' ' ' VAL . 46.2 mt -117.55 127.64 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.004 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.504 HD21 HD22 ' A' ' 121' ' ' ASN . 0.7 OUTLIER -110.72 143.49 41.14 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.058 0.456 . . . . 0.0 111.752 -179.606 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.76 HD23 ' HG ' ' A' ' 99' ' ' LEU . 2.0 tm? . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.394 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.985 HD11 HG12 ' A' ' 33' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.728 0.299 . . . . 0.0 110.689 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.624 HD23 ' HB3' ' A' ' 121' ' ' ASN . 2.3 mp -125.33 145.81 49.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.455 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.521 HD23 HG23 ' A' ' 91' ' ' ILE . 55.9 mt -112.99 123.29 49.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.33 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.436 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 59.5 t30 -118.2 115.77 25.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.829 0.347 . . . . 0.0 111.86 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.797 ' OD2' HG23 ' A' ' 116' ' ' VAL . 9.2 p30 -79.14 143.14 35.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.943 178.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.539 HG12 ' HA ' ' A' ' 89' ' ' PHE . 14.3 pt -146.88 26.73 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.589 ' OG ' ' CE1' ' A' ' 88' ' ' HIS . 11.0 t -93.98 154.97 17.39 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.7 m -70.12 -52.16 25.79 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.453 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -74.64 -4.06 34.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.247 -179.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.92 155.97 31.22 Favored Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.439 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.502 HG22 ' CG2' ' A' ' 130' ' ' ILE . 5.4 m -117.36 137.78 52.23 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.843 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -114.02 148.49 36.9 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -177.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.0 113.6 18.65 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.467 177.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 45.09 42.88 7.06 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.04 -13.44 61.38 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.726 -0.749 . . . . 0.0 113.486 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -104.49 118.49 36.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 117.104 0.452 . . . . 0.0 110.498 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.843 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -70.11 123.61 22.02 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.403 -179.793 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.797 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.7 m -95.08 164.64 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.01 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -69.94 127.88 34.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.587 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.682 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 17.6 tttm -53.66 162.47 0.85 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.754 0.312 . . . . 0.0 110.23 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.6 p30 34.52 36.32 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.004 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.7 p -111.92 145.09 40.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.706 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.624 ' HB3' HD23 ' A' ' 100' ' ' LEU . 18.6 m120 -92.71 130.67 38.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.872 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 58.3 mm-40 -129.28 150.93 50.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.558 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.7 tp -72.81 130.03 39.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.815 0.341 . . . . 0.0 110.226 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.754 HD22 ' HB2' ' A' ' 99' ' ' LEU . 30.0 tp -58.1 153.71 14.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.594 0.711 . . . . 0.0 111.737 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.452 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.6 OUTLIER -125.12 152.92 43.76 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.691 -1.14 . . . . 0.0 110.451 179.647 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -72.1 124.86 25.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.828 0.346 . . . . 0.0 110.09 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.84 22.82 48.92 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.758 -0.735 . . . . 0.0 111.981 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -50.4 165.71 0.09 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.896 0.379 . . . . 0.0 111.345 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.46 ' HG3' HG22 ' A' ' 144' ' ' VAL . 25.8 tt0 -145.05 135.48 24.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.99 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.502 ' CG2' HG22 ' A' ' 109' ' ' THR . 14.7 mt -114.73 128.24 71.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.798 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.639 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.08 139.84 38.61 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.709 HG23 HD21 ' A' ' 84' ' ' LEU . 35.8 m -140.42 158.67 25.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -178.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.85 29.27 29.43 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.236 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.426 ' HA ' HG12 ' A' ' 140' ' ' ILE . 74.6 t -73.38 140.51 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-O 121.622 0.725 . . . . 0.0 112.077 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.23 -37.09 1.43 Allowed Glycine 0 N--CA 1.436 -1.36 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 -178.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.461 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 3.7 t -124.84 125.29 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.4 -35.92 30.51 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -178.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.0 p -93.59 6.57 47.8 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.461 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 30.4 m-20 -121.02 28.91 7.62 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -178.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.639 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.2 mt -107.04 138.52 32.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-O 121.5 0.667 . . . . 0.0 111.143 178.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.694 HD23 ' N ' ' A' ' 142' ' ' SER . 3.0 tt -124.85 134.42 52.73 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.149 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.694 ' N ' HD23 ' A' ' 141' ' ' LEU . 38.3 t -112.81 150.24 31.95 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.761 0.791 . . . . 0.0 112.642 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.83 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.9 mm? -136.02 143.67 44.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.525 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.583 HG23 ' OG1' ' A' ' 39' ' ' THR . 24.0 t -115.86 140.27 38.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.792 0.329 . . . . 0.0 111.008 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.55 HG21 HD11 ' A' ' 124' ' ' LEU . 33.2 mt -106.0 123.39 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-O 120.951 0.405 . . . . 0.0 111.278 -179.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.2 118.35 36.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.532 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.597 HG12 HD21 ' A' ' 124' ' ' LEU . 3.6 mt -88.07 133.96 29.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.649 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -82.72 113.53 20.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.738 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.57 -29.45 66.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.074 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.65 -45.77 91.02 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 120.976 0.417 . . . . 0.0 110.672 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.1 t80 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.951 -179.933 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.828 0.346 . . . . 0.0 110.816 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.7 OUTLIER 179.0 38.08 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.717 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -75.99 135.07 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-N 113.785 -1.552 . . . . 0.0 112.506 -177.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.037 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -91.88 -61.68 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.24 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.465 ' SG ' HD12 ' A' ' 48' ' ' LEU . 7.5 p -149.34 149.02 30.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.302 179.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -116.7 138.3 51.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.874 0.368 . . . . 0.0 111.417 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.635 HG21 ' HE2' ' A' ' 68' ' ' PHE . 24.0 t -103.89 122.89 57.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.998 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.823 HG23 HG12 ' A' ' 45' ' ' ILE . 21.4 mt -123.09 117.72 52.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.609 -179.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.582 ' HA ' HD23 ' A' ' 143' ' ' LEU . 49.1 t -80.74 112.75 18.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.185 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.05 -21.62 29.32 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.559 HG21 ' H ' ' A' ' 142' ' ' SER . 75.1 p -79.79 -2.47 43.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.788 0.328 . . . . 0.0 111.592 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.46 72.37 0.74 Allowed Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.977 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -142.45 -42.13 0.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.876 0.369 . . . . 0.0 110.919 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.561 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.3 mt -121.02 141.66 33.18 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.035 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.561 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.9 Cg_endo -72.83 140.36 31.92 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.167 1.912 . . . . 0.0 112.167 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.823 HG12 HG23 ' A' ' 37' ' ' ILE . 36.1 mt -55.95 145.63 6.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.766 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.09 163.72 31.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.153 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -120.5 119.88 34.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.08 0.467 . . . . 0.0 112.013 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.633 HD22 ' CD1' ' A' ' 66' ' ' TRP . 5.1 mt -93.93 137.55 33.02 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 1.037 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.73 159.01 43.79 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -178.662 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.487 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -138.53 141.87 39.31 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 113.744 -1.571 . . . . 0.0 110.618 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 121.221 0.534 . . . . 0.0 111.578 -179.291 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.429 ' CE ' ' O ' ' A' ' 49' ' ' SER . 31.1 ttpt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.793 0.33 . . . . 0.0 110.667 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.597 HG13 ' O ' ' A' ' 91' ' ' ILE . 12.4 t -121.53 139.12 49.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.272 0.558 . . . . 0.0 111.906 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.633 ' CD1' HD22 ' A' ' 48' ' ' LEU . 18.2 m-90 -104.07 138.61 40.33 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.069 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.676 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.94 128.28 56.33 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 177.049 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.677 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -115.19 145.46 42.38 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.497 -177.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.584 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.35 -172.23 38.4 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.702 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.458 ' HD3' ' O ' ' A' ' 81' ' ' ILE . 9.4 mtm105 -80.46 2.29 25.79 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.476 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 3.0 t-20 -84.87 134.2 42.02 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.575 0.226 . . . . 0.0 111.125 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 15.8 Cg_exo -67.06 -11.9 34.01 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.531 2.154 . . . . 0.0 111.75 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.9 -43.33 16.65 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 122.017 0.913 . . . . 0.0 108.93 178.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.51 137.82 2.01 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.086 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.8 m-20 -56.58 -18.44 11.89 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.985 178.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.471 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 19.5 t80 -129.27 119.65 24.33 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.869 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -98.77 110.06 22.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.927 0.394 . . . . 0.0 111.031 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.456 HD11 ' HG3' ' A' ' 70' ' ' ARG . 1.9 pp -113.04 172.98 6.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.666 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.23 136.91 50.55 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.506 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -68.27 89.75 0.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.789 0.328 . . . . 0.0 110.777 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.458 ' O ' ' HD3' ' A' ' 70' ' ' ARG . 44.6 mt -107.86 135.55 46.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.024 0.44 . . . . 0.0 111.478 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 89.9 p -54.88 -43.94 73.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.274 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.505 ' HG3' ' HB3' ' A' ' 139' ' ' ASP . 1.6 mmt180 -60.85 -27.81 68.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.568 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.616 HD21 HG23 ' A' ' 132' ' ' VAL . 29.7 mt -96.23 150.95 19.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.9 0.381 . . . . 0.0 111.633 -179.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 75.4 p -98.62 169.05 9.78 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.416 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.584 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.0 m-20 -44.11 -55.3 4.85 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.318 0.58 . . . . 0.0 109.761 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.457 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 3.1 ptpp? -118.8 84.73 2.24 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 177.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.562 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 12.7 t60 -60.55 -47.02 88.0 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.874 -176.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.511 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 23.9 p90 -146.69 160.53 42.09 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.991 -179.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.676 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.3 tt0 -135.95 139.15 43.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.395 -179.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.677 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 61.6 mt -114.61 132.14 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 121.104 -0.238 . . . . 0.0 110.965 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.586 HD11 ' ND2' ' A' ' 121' ' ' ASN . 0.2 OUTLIER -123.97 136.41 54.29 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.047 0.451 . . . . 0.0 111.966 -179.604 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.804 HD22 ' CG1' ' A' ' 33' ' ' VAL . 2.4 tp . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.43 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.748 ' HB3' HD22 ' A' ' 124' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.826 0.346 . . . . 0.0 110.764 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.737 HD13 ' HB3' ' A' ' 121' ' ' ASN . 12.7 mt -133.34 140.7 47.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.704 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.491 ' O ' HD12 ' A' ' 101' ' ' LEU . 3.1 pp -112.66 124.61 52.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.929 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.507 ' HB2' HD21 ' A' ' 92' ' ' LEU . 47.3 t30 -114.62 115.92 27.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.9 0.381 . . . . 0.0 111.705 -179.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.767 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.2 p30 -78.57 136.67 37.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.885 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.484 HD11 HG22 ' A' ' 67' ' ' THR . 18.8 pt -147.41 38.92 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.645 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.0 151.77 20.56 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 121.098 0.475 . . . . 0.0 112.207 -178.717 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 16.7 m -68.92 -31.63 70.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.705 177.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -97.07 -19.79 18.47 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.482 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.645 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.08 156.79 10.95 Favored Glycine 0 N--CA 1.439 -1.115 0 C-N-CA 120.4 -0.905 . . . . 0.0 114.014 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.477 HG22 ' CG2' ' A' ' 130' ' ' ILE . 6.3 m -117.32 137.71 52.25 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.761 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -118.94 148.66 42.72 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -177.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.472 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -123.91 113.57 18.66 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.559 177.676 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.415 ' N ' HD12 ' A' ' 111' ' ' LEU . 87.5 m-20 44.36 43.23 5.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.547 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.07 -14.21 59.53 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.435 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -104.24 118.51 36.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.09 0.445 . . . . 0.0 110.626 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.761 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -71.68 129.75 39.46 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.473 -179.65 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.767 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.0 m -96.41 166.11 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.956 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 120' ' ' SER . 23.1 mm-40 -69.92 127.2 32.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.591 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.663 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -53.98 158.51 2.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.172 0.51 . . . . 0.0 110.702 -179.962 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.49 ' H ' ' HG3' ' A' ' 118' ' ' LYS . 0.5 OUTLIER 35.73 35.45 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.798 -179.74 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -111.96 145.03 40.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.134 179.606 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.737 ' HB3' HD13 ' A' ' 100' ' ' LEU . 26.6 m120 -89.76 123.15 33.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.622 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.559 ' O ' HD23 ' A' ' 100' ' ' LEU . 30.1 mm-40 -126.62 145.76 50.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.969 0.414 . . . . 0.0 110.858 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.0 tp -72.97 118.41 15.89 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.951 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.748 HD22 ' HB3' ' A' ' 99' ' ' LEU . 2.4 pt? -57.44 167.66 0.95 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.589 0.709 . . . . 0.0 111.865 -178.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.414 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.2 OUTLIER -124.89 153.75 42.14 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.228 179.769 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.04 118.92 14.42 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.8 22.03 67.94 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.458 -178.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.414 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 24.3 t70 -54.33 174.11 0.06 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.895 0.379 . . . . 0.0 111.046 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 9.6 tt0 -145.35 135.27 23.66 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.041 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.796 HD11 HD11 ' A' ' 145' ' ' ILE . 18.9 mt -114.71 126.49 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.214 178.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.543 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.6 m -104.14 139.86 38.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.264 -0.425 . . . . 0.0 109.928 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.616 HG23 HD21 ' A' ' 84' ' ' LEU . 33.9 m -140.18 158.26 25.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.114 0.483 . . . . 0.0 112.194 -178.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.97 27.2 29.33 Favored Glycine 0 N--CA 1.44 -1.085 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.926 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.444 ' HB ' ' CZ3' ' A' ' 110' ' ' TRP . 68.9 t -74.04 140.49 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-O 121.611 0.72 . . . . 0.0 112.069 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.92 -39.76 0.93 Allowed Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.496 HG21 ' NH1' ' A' ' 83' ' ' ARG . 2.5 t -118.16 129.17 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -50.58 -42.35 55.58 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -178.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.6 m -93.47 6.76 47.1 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -178.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.505 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . 0.5 OUTLIER -120.14 34.54 5.18 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -178.539 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.543 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.1 mt -107.23 139.46 28.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.942 178.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 8.9 tt -124.03 134.64 53.39 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.647 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.559 ' H ' HG21 ' A' ' 40' ' ' THR . 44.3 t -111.82 150.54 30.2 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.748 0.785 . . . . 0.0 112.715 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.582 HD23 ' HA ' ' A' ' 38' ' ' CYS . 71.5 mt -135.71 149.34 49.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.779 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 24.2 t -117.01 139.07 45.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.829 0.347 . . . . 0.0 111.075 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.796 HD11 HD11 ' A' ' 130' ' ' ILE . 17.6 mt -106.36 124.54 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.045 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.38 114.01 26.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.607 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.491 HG12 HD12 ' A' ' 124' ' ' LEU . 5.0 mt -84.95 134.12 27.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.546 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -86.09 105.0 16.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.737 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -57.66 -28.19 63.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.115 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -43.7 88.89 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.607 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 33.7 t80 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.889 -179.97 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.686 0.279 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.516 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.9 m-20 176.41 41.19 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.654 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.3 mm -71.03 142.76 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-N 113.711 -1.586 . . . . 0.0 112.377 -176.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.722 ' CG2' HD22 ' A' ' 93' ' ' LEU . 0.9 OUTLIER -106.01 -48.99 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-N 114.275 -1.329 . . . . 0.0 109.91 -178.575 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.812 ' SG ' HD12 ' A' ' 48' ' ' LEU . 32.1 p -161.13 147.96 14.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.534 179.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -114.13 138.24 50.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.893 0.378 . . . . 0.0 111.317 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.748 HG21 ' CE2' ' A' ' 68' ' ' PHE . 21.3 t -101.81 122.73 54.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.062 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.559 HG23 HG12 ' A' ' 45' ' ' ILE . 20.1 mt -128.62 116.41 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.234 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.578 ' HA ' HD13 ' A' ' 143' ' ' LEU . 47.1 t -80.03 123.42 27.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.496 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.4 t -91.53 -27.33 18.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.546 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.578 HG21 ' H ' ' A' ' 142' ' ' SER . 7.0 p -79.81 -2.6 44.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.748 0.309 . . . . 0.0 111.408 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.7 77.99 0.24 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.752 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -146.4 -45.44 0.19 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.942 0.401 . . . . 0.0 110.788 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.56 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.0 mt -116.33 141.25 27.58 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.847 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.56 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.4 Cg_endo -72.73 146.01 42.31 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.271 1.981 . . . . 0.0 112.161 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.559 HG12 HG23 ' A' ' 37' ' ' ILE . 36.5 mt -55.9 151.83 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.683 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -149.8 162.3 40.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.19 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -122.65 119.81 31.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.049 0.452 . . . . 0.0 111.945 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.812 HD12 ' SG ' ' A' ' 34' ' ' CYS . 23.3 mt -93.28 138.04 32.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.231 178.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.654 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -141.18 156.95 45.86 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 122.14 0.971 . . . . 0.0 113.5 -178.932 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.621 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . -141.19 146.68 37.26 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 113.565 -1.652 . . . . 0.0 110.822 178.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 121.131 0.491 . . . . 0.0 111.187 -179.509 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.46 ' CE ' ' O ' ' A' ' 49' ' ' SER . 15.5 ttpt . . . . . 0 N--CA 1.462 0.147 0 CA-C-O 120.89 0.376 . . . . 0.0 111.864 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 91' ' ' ILE . 9.5 p -108.64 139.63 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.791 ' CD1' HD22 ' A' ' 48' ' ' LEU . 14.8 m-90 -100.71 139.9 35.74 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.151 -1.386 . . . . 0.0 112.064 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.597 HG23 ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -107.93 131.53 54.44 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 177.408 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.768 ' HZ ' HD11 ' A' ' 48' ' ' LEU . 3.0 m-85 -117.0 145.91 43.37 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.036 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.704 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.82 -171.34 37.74 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.293 -0.956 . . . . 0.0 113.011 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -82.67 2.97 30.91 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -84.81 142.84 39.65 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.695 0.283 . . . . 0.0 110.836 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.44 -11.79 22.65 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.341 2.027 . . . . 0.0 111.441 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.77 -43.73 16.39 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 121.931 0.872 . . . . 0.0 108.928 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.91 138.3 5.05 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 113.87 -1.514 . . . . 0.0 110.751 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.8 OUTLIER -56.37 -18.55 11.29 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.971 178.903 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.569 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 3.9 t80 -129.1 117.59 21.08 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-O 120.775 0.321 . . . . 0.0 110.96 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -92.78 107.87 19.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.655 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.957 HD23 HD13 ' A' ' 84' ' ' LEU . 8.9 mp -73.49 -175.04 1.84 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.107 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.16 17.71 49.76 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.804 -0.713 . . . . 0.0 113.037 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 65.43 74.71 0.37 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.022 0.439 . . . . 0.0 111.493 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.43 ' HB ' HD12 ' A' ' 84' ' ' LEU . 25.5 mm -112.0 126.87 69.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.643 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.02 -41.35 71.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.312 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.81 -24.02 65.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.997 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.957 HD13 HD23 ' A' ' 78' ' ' LEU . 17.9 mt -98.16 152.11 19.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.879 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.5 p -96.29 164.53 12.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.759 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.704 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 4.8 m-20 -40.06 -57.0 1.75 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.416 0.627 . . . . 0.0 109.584 178.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.462 ' HB3' HD11 ' A' ' 104' ' ' ILE . 6.4 mttp -116.59 85.69 2.36 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.588 ' CD2' ' HB2' ' A' ' 105' ' ' SER . 15.5 t60 -64.59 -44.94 89.02 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.074 -0.967 . . . . 0.0 113.428 -176.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.515 ' HA ' HG12 ' A' ' 104' ' ' ILE . 34.5 p90 -154.1 162.58 41.1 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.139 -0.625 . . . . 0.0 112.053 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.631 ' OE1' HG21 ' A' ' 104' ' ' ILE . 14.3 mt-30 -135.7 155.46 50.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.419 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.567 ' O ' HG23 ' A' ' 65' ' ' VAL . 65.0 mt -122.97 128.81 75.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.716 HD23 ' HB2' ' A' ' 102' ' ' ASN . 1.8 pp -118.97 130.97 55.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.008 0.432 . . . . 0.0 111.831 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.722 HD22 ' CG2' ' A' ' 33' ' ' VAL . 3.2 tp . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.21 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.683 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.832 0.349 . . . . 0.0 110.842 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.765 HD23 ' HB3' ' A' ' 121' ' ' ASN . 10.8 mp -129.3 146.54 51.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.414 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.503 HD11 HD11 ' A' ' 130' ' ' ILE . 0.2 OUTLIER -112.89 126.88 55.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.38 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.716 ' HB2' HD23 ' A' ' 92' ' ' LEU . 53.4 t30 -116.8 115.85 26.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.863 0.363 . . . . 0.0 111.857 -179.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.827 ' OD2' HG23 ' A' ' 116' ' ' VAL . 7.5 p30 -79.76 143.28 34.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.049 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.631 HG21 ' OE1' ' A' ' 90' ' ' GLN . 12.5 pt -146.19 22.89 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.588 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 9.2 t -91.43 154.86 18.87 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.6 m -70.22 -52.11 25.7 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.447 178.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -74.42 -2.75 26.81 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.375 -179.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.87 156.08 31.88 Favored Glycine 0 N--CA 1.438 -1.203 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.468 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.463 HG22 ' CG2' ' A' ' 130' ' ' ILE . 5.0 m -117.44 137.68 52.35 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.829 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -115.52 148.59 39.33 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -177.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.473 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.09 113.5 18.45 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.44 177.529 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.419 ' N ' HD12 ' A' ' 111' ' ' LEU . 46.0 m-20 44.79 43.09 6.58 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.93 -11.87 65.63 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.455 178.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -104.99 118.49 36.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.037 0.446 . . . . 0.0 110.682 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.829 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -70.99 124.54 24.61 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.484 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.827 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.2 m -96.39 162.87 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.818 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.48 ' O ' ' HB2' ' A' ' 120' ' ' SER . 2.1 tt0 -69.82 129.59 39.96 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.439 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.672 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 15.4 tttt -53.94 160.62 1.41 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.876 0.37 . . . . 0.0 110.572 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.7 p30 34.58 34.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.303 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.48 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.35 145.31 40.29 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.117 179.477 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.765 ' HB3' HD23 ' A' ' 100' ' ' LEU . 5.1 m120 -86.04 130.42 34.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.086 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.421 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 30.4 mm-40 -129.37 146.3 51.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.377 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.432 HD13 ' C ' ' A' ' 123' ' ' LEU . 1.2 tm? -72.72 115.01 11.49 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.793 0.33 . . . . 0.0 110.314 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.496 HD21 HG12 ' A' ' 147' ' ' ILE . 65.6 tp -54.75 157.71 2.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.382 0.611 . . . . 0.0 111.7 -179.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.43 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.0 OUTLIER -124.28 153.53 41.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.374 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.463 ' HA ' HD12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.06 119.63 15.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.969 0.414 . . . . 0.0 110.291 -179.65 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.55 21.49 64.84 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.235 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.43 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 26.0 t70 -56.94 172.01 0.3 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.997 0.427 . . . . 0.0 111.069 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 4.5 tt0 -145.22 135.58 24.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.165 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.503 HD11 HD11 ' A' ' 101' ' ' LEU . 1.3 mp -110.5 128.73 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.443 179.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.605 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.1 m -103.64 140.02 38.13 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.645 HG23 HD21 ' A' ' 84' ' ' LEU . 28.2 m -140.41 158.45 25.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -178.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 87.32 24.68 35.95 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.332 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.427 ' HB ' ' CZ3' ' A' ' 110' ' ' TRP . 70.2 t -69.56 140.38 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-O 121.632 0.729 . . . . 0.0 111.907 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 143.04 -41.84 1.14 Allowed Glycine 0 N--CA 1.435 -1.385 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.442 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 6.2 t -119.15 126.05 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.28 -35.84 28.91 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 47.3 m -93.49 6.63 47.54 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.442 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 30.6 m-20 -120.81 29.65 7.29 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -178.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.605 ' CG2' HG22 ' A' ' 131' ' ' THR . 7.3 mt -106.89 138.91 30.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 121.478 0.656 . . . . 0.0 110.904 178.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.671 HD22 ' CD2' ' A' ' 143' ' ' LEU . 1.3 tt -124.65 134.64 52.82 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.729 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.6 ' N ' HD23 ' A' ' 141' ' ' LEU . 0.9 OUTLIER -109.57 133.39 53.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.001 0.429 . . . . 0.0 111.717 -179.819 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.671 ' CD2' HD22 ' A' ' 141' ' ' LEU . 1.4 mm? -128.84 135.73 49.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.554 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.422 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 24.0 t -110.93 134.45 53.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.829 0.347 . . . . 0.0 111.271 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.435 HD13 HG22 ' A' ' 36' ' ' VAL . 5.2 mm -106.11 139.0 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.975 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.34 122.35 41.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.798 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.496 HG12 HD21 ' A' ' 124' ' ' LEU . 6.7 mt -85.01 134.11 27.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.324 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -83.35 103.57 12.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.853 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -64.14 -28.08 69.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.063 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.15 -43.67 87.47 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.062 0.458 . . . . 0.0 110.618 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 33.5 t80 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.901 179.847 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.853 0.359 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.441 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER -170.38 33.31 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -179.767 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.702 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -73.2 133.84 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-N 113.839 -1.528 . . . . 0.0 112.407 -177.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.998 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -92.54 -61.37 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.09 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.691 ' SG ' HD12 ' A' ' 48' ' ' LEU . 1.6 p -143.38 163.44 33.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.272 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 146' ' ' PHE . 0.0 OUTLIER -127.05 138.3 53.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.962 0.411 . . . . 0.0 111.782 -179.131 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.668 HG11 ' CE2' ' A' ' 68' ' ' PHE . 2.0 m -108.63 122.9 63.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.579 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.897 HG23 HG12 ' A' ' 45' ' ' ILE . 21.5 mt -128.42 122.11 56.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.991 -178.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.845 ' HA ' HD23 ' A' ' 143' ' ' LEU . 42.0 t -81.81 102.63 10.93 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 178.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.488 ' OG1' HG23 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -74.32 -23.82 59.12 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.68 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.554 HG21 ' H ' ' A' ' 142' ' ' SER . 72.2 p -79.78 -2.29 42.55 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.683 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.23 77.19 0.37 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.87 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.714 ' OE1' HD12 ' A' ' 141' ' ' LEU . 15.9 mt-30 -146.62 -41.0 0.2 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.935 0.398 . . . . 0.0 110.696 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.583 HG21 ' CE1' ' A' ' 76' ' ' TYR . 1.3 mp -125.77 141.34 38.98 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.8 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.556 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 46.8 Cg_endo -71.68 146.1 48.07 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.102 1.868 . . . . 0.0 112.137 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.897 HG12 HG23 ' A' ' 37' ' ' ILE . 39.2 mt -51.44 148.33 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.898 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.84 150.3 49.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.083 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -112.87 119.63 38.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.049 0.452 . . . . 0.0 111.368 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.691 HD12 ' SG ' ' A' ' 34' ' ' CYS . 3.1 mt -95.98 135.26 37.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.227 178.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.998 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.04 158.01 43.87 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -178.834 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.488 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -140.91 143.26 34.53 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 113.528 -1.669 . . . . 0.0 110.861 178.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 121.223 0.535 . . . . 0.0 111.093 -179.621 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.433 ' CE ' ' O ' ' A' ' 49' ' ' SER . 6.0 ttpt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.71 0.29 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.617 HG12 ' HG2' ' A' ' 90' ' ' GLN . 13.9 t -128.79 139.09 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-O 121.375 0.607 . . . . 0.0 112.299 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.532 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.9 m-90 -103.03 139.24 38.84 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.887 179.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.62 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -114.21 129.05 56.63 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.338 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.668 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -118.3 145.45 45.07 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.6 -178.305 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.597 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.43 -166.6 35.38 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.393 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.412 ' HD3' ' O ' ' A' ' 81' ' ' ILE . 12.9 mtm180 -86.73 6.98 28.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.504 0.192 . . . . 0.0 111.512 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.671 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 9.7 t-20 -84.95 134.01 42.19 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.547 0.213 . . . . 0.0 111.036 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.9 Cg_exo -65.43 -15.07 48.13 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.53 2.153 . . . . 0.0 111.598 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.671 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -83.15 -43.26 16.38 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 121.962 0.887 . . . . 0.0 108.887 178.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.47 136.03 3.38 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 113.862 -1.517 . . . . 0.0 111.045 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.9 OUTLIER -56.87 -18.62 13.79 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.952 178.611 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.583 ' CE1' HG21 ' A' ' 43' ' ' ILE . 30.5 t80 -129.57 112.1 13.38 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.783 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -89.75 111.63 22.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.22 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.769 HD13 HD13 ' A' ' 84' ' ' LEU . 88.4 mt -78.52 -172.81 3.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.839 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -90.66 21.12 34.51 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.891 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.04 74.68 0.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.944 0.402 . . . . 0.0 111.601 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 1.042 HD13 HD12 ' A' ' 84' ' ' LEU . 4.3 mp -106.62 129.18 60.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.723 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.7 m -54.91 -37.21 66.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.293 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.455 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -69.32 -15.94 63.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.452 -179.814 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.042 HD12 HD13 ' A' ' 81' ' ' ILE . 28.4 mt -107.06 152.01 24.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.719 0.295 . . . . 0.0 110.833 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.4 m -95.79 166.63 11.72 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.496 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.597 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 1.4 m-80 -42.46 -57.55 2.59 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.439 0.638 . . . . 0.0 109.545 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.486 ' HB3' HG22 ' A' ' 67' ' ' THR . 10.3 mtpt -116.79 84.39 2.13 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 176.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.549 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 12.4 t60 -60.89 -46.73 89.46 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.596 -176.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.492 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 25.6 p90 -145.08 158.07 43.93 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.116 -0.634 . . . . 0.0 112.157 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.62 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.9 tt0 -135.9 139.91 43.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.164 -179.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.598 ' O ' HG13 ' A' ' 65' ' ' VAL . 72.6 mt -115.97 130.23 71.02 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 C-N-CA 121.134 -0.227 . . . . 0.0 111.002 179.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.51 HD21 ' HB2' ' A' ' 102' ' ' ASN . 0.2 OUTLIER -115.53 150.83 35.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.12 0.486 . . . . 0.0 111.851 -179.888 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.422 HD13 ' HG ' ' A' ' 99' ' ' LEU . 14.6 tp . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.223 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.983 HD21 HG12 ' A' ' 33' ' ' VAL . 4.2 mp . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.884 0.373 . . . . 0.0 110.762 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.735 HD22 ' HB3' ' A' ' 121' ' ' ASN . 13.8 mt -133.2 144.38 49.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.893 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.649 HD11 ' HA ' ' A' ' 124' ' ' LEU . 2.2 mt -112.73 123.21 49.78 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.745 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.51 ' HB2' HD21 ' A' ' 92' ' ' LEU . 52.0 t30 -114.68 115.55 27.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.062 0.458 . . . . 0.0 111.664 -179.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.82 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.1 p30 -77.71 134.61 38.07 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.733 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.459 HD12 ' HB2' ' A' ' 87' ' ' LYS . 13.7 pt -141.71 39.48 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.623 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -101.93 151.63 21.88 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.005 0.431 . . . . 0.0 112.021 -178.892 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.6 m -68.89 -31.59 70.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.688 177.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -95.11 -19.55 20.02 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.328 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.623 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 112.78 158.96 13.82 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.781 179.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 11.4 m -117.1 137.69 52.12 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.871 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -115.89 148.32 40.12 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -177.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.485 HD13 ' OD2' ' A' ' 128' ' ' ASP . 0.2 OUTLIER -124.31 113.52 18.35 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.66 -1.155 . . . . 0.0 108.419 177.545 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 43.74 43.77 5.15 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.51 -11.14 66.87 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.58 178.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -103.57 118.59 37.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.027 0.441 . . . . 0.0 110.583 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.871 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 12.2 tptm -74.53 122.3 22.88 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.382 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.82 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.9 m -91.59 164.17 2.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.971 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 120' ' ' SER . 15.9 tt0 -69.89 126.26 29.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.468 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.702 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 28.2 tttt -53.2 162.69 0.66 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.944 0.402 . . . . 0.0 110.441 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.1 m-80 34.67 35.0 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.03 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.4 OUTLIER -112.27 145.01 40.72 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.293 179.578 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.735 ' HB3' HD22 ' A' ' 100' ' ' LEU . 28.2 m120 -89.11 125.56 35.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.727 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.508 ' O ' HD23 ' A' ' 100' ' ' LEU . 38.5 mm-40 -129.31 147.65 51.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.089 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 tt -76.34 115.3 15.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.104 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.649 ' HA ' HD11 ' A' ' 101' ' ' LEU . 1.6 pt? -56.99 165.84 1.17 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.604 0.716 . . . . 0.0 112.043 -178.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.449 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.64 153.65 41.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.073 179.657 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.522 ' HA ' HD12 ' A' ' 147' ' ' ILE . 3.4 tp60 -71.17 123.22 21.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.013 0.435 . . . . 0.0 110.287 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.06 20.19 53.16 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.107 -179.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.485 ' OD2' HD13 ' A' ' 111' ' ' LEU . 7.7 t70 -58.58 178.8 0.09 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.745 0.307 . . . . 0.0 110.673 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.885 ' CG ' HG22 ' A' ' 144' ' ' VAL . 5.4 mt-10 -145.11 135.61 24.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.415 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 1.038 HD11 HD11 ' A' ' 145' ' ' ILE . 15.3 mt -112.04 126.91 69.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.215 178.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.51 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.2 m -104.33 138.66 40.44 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.563 HG23 HD21 ' A' ' 84' ' ' LEU . 35.8 m -140.01 158.12 26.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.138 0.494 . . . . 0.0 112.268 -178.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 89.47 24.02 32.23 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.951 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.461 ' HB ' ' CZ3' ' A' ' 110' ' ' TRP . 73.5 t -71.12 140.52 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-O 121.654 0.74 . . . . 0.0 112.021 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.05 -45.74 0.66 Allowed Glycine 0 N--CA 1.433 -1.525 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.47 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 1.7 t -110.51 131.41 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -50.56 -44.22 56.53 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.8 m -93.37 6.92 46.48 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -178.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.47 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 16.5 m-20 -117.01 34.4 5.13 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -178.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.51 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.4 mt -107.01 139.09 29.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.973 178.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.714 HD12 ' OE1' ' A' ' 42' ' ' GLN . 10.2 tt -124.33 134.71 53.1 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.862 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.554 ' H ' HG21 ' A' ' 40' ' ' THR . 47.1 t -110.33 150.34 28.9 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.658 0.742 . . . . 0.0 112.195 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.845 HD23 ' HA ' ' A' ' 38' ' ' CYS . 75.0 mt -135.87 158.1 45.21 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.881 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.885 HG22 ' CG ' ' A' ' 129' ' ' GLU . 22.4 t -122.54 139.92 47.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.852 0.358 . . . . 0.0 111.026 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 1.038 HD11 HD11 ' A' ' 130' ' ' ILE . 30.7 mt -106.3 120.96 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.833 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.406 ' O ' ' N ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -109.99 108.62 18.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.841 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.522 HD12 ' HA ' ' A' ' 126' ' ' GLN . 6.1 mt -84.6 128.98 38.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.245 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -77.82 114.16 16.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -69.02 -31.59 70.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -57.39 -43.38 83.61 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.066 0.46 . . . . 0.0 110.411 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 15.5 t80 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.624 179.771 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.473 ' HG2' HD11 ' A' ' 32' ' ' ILE . 2.5 pt-20 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.912 0.387 . . . . 0.0 110.792 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.461 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.0 OUTLIER -179.88 37.22 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.92 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.722 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.4 mm -73.48 135.67 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 CA-C-N 113.664 -1.607 . . . . 0.0 112.45 -177.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.014 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.4 t -91.81 -59.77 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.916 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.718 ' SG ' HD12 ' A' ' 48' ' ' LEU . 7.0 p -150.59 152.03 33.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.26 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.425 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.99 138.21 50.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.817 0.341 . . . . 0.0 111.352 -179.396 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.629 HG23 HD11 ' A' ' 48' ' ' LEU . 24.3 t -100.73 122.77 53.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.829 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.699 HG23 HG12 ' A' ' 45' ' ' ILE . 17.0 mt -132.93 122.08 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.581 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.621 ' HA ' HD23 ' A' ' 143' ' ' LEU . 51.4 t -80.68 136.55 36.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.405 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 t -97.38 -29.23 13.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.625 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.534 HG23 ' HB3' ' A' ' 142' ' ' SER . 70.4 p -79.79 -2.32 42.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.771 0.319 . . . . 0.0 111.472 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.51 78.27 0.25 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.909 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -146.58 -41.19 0.2 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.736 0.303 . . . . 0.0 111.122 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.729 HD12 HD21 ' A' ' 143' ' ' LEU . 1.5 mt -114.8 140.6 25.63 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.065 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.538 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.1 Cg_endo -74.35 145.93 34.86 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.24 1.96 . . . . 0.0 112.042 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.699 HG12 HG23 ' A' ' 37' ' ' ILE . 35.0 mt -61.92 136.69 24.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.805 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.06 164.17 26.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.08 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.425 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 1.3 p30 -117.77 123.21 45.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.128 0.49 . . . . 0.0 112.115 -179.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.718 HD12 ' SG ' ' A' ' 34' ' ' CYS . 0.8 OUTLIER -101.21 135.65 42.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.507 -0.77 . . . . 0.0 108.923 178.472 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 1.014 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.21 159.1 43.53 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -178.764 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.491 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -146.71 149.89 34.31 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 113.766 -1.561 . . . . 0.0 111.146 178.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.088 -179.742 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.403 ' CE ' ' O ' ' A' ' 49' ' ' SER . 6.4 ttpt . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.693 0.282 . . . . 0.0 111.003 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.521 HG22 ' CB ' ' A' ' 92' ' ' LEU . 4.4 t -118.69 136.33 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 121.36 0.6 . . . . 0.0 111.94 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.633 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 15.4 m-90 -100.68 140.37 35.05 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.516 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.757 HG23 ' CG ' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -111.35 129.22 56.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.201 177.978 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.678 ' CD1' ' HB2' ' A' ' 76' ' ' TYR . 5.8 m-85 -120.39 145.42 47.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.472 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.651 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.49 -168.64 36.76 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.025 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.452 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 6.4 mtm105 -79.03 3.09 18.31 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.456 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 23.7 t-20 -84.7 131.74 48.62 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.612 0.244 . . . . 0.0 111.101 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.0 Cg_exo -66.14 -14.01 42.45 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.584 2.189 . . . . 0.0 111.59 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.87 -44.05 15.87 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 121.841 0.829 . . . . 0.0 108.803 178.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -40.19 138.91 0.79 Allowed 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 113.78 -1.554 . . . . 0.0 110.951 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 67' ' ' THR . 10.9 m-20 -56.73 -19.22 15.6 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.355 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.678 ' HB2' ' CD1' ' A' ' 68' ' ' PHE . 12.6 t80 -130.36 113.66 14.63 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.672 0.273 . . . . 0.0 111.027 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.403 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.6 t-160 -85.87 107.83 17.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.672 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.557 HD22 ' HA2' ' A' ' 69' ' ' GLY . 8.0 mp -81.77 -78.76 0.18 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.007 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -173.25 -94.24 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.084 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.41 ' HA ' ' HD2' ' A' ' 70' ' ' ARG . 8.5 p30 -179.81 50.29 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.825 0.345 . . . . 0.0 111.143 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.407 HG22 ' H ' ' A' ' 83' ' ' ARG . 26.0 mm -79.05 125.49 38.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.848 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.93 -37.21 66.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.913 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.741 ' NH1' HG23 ' A' ' 136' ' ' VAL . 6.2 mtp180 -69.53 -37.14 76.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.108 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.558 HD21 HG23 ' A' ' 132' ' ' VAL . 44.6 mt -83.74 151.58 25.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.837 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 95.3 p -97.79 164.8 12.24 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.656 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.651 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.5 m-20 -42.55 -52.4 4.77 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.497 0.665 . . . . 0.0 109.61 179.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.732 ' HB3' HG22 ' A' ' 67' ' ' THR . 3.8 mttt -118.9 84.14 2.14 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 177.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.554 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.4 t60 -62.88 -44.7 95.4 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.103 -0.953 . . . . 0.0 113.137 -176.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.544 ' HZ ' HD13 ' A' ' 143' ' ' LEU . 0.1 OUTLIER -148.7 161.8 41.02 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.985 -0.686 . . . . 0.0 112.234 -179.564 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.757 ' CG ' HG23 ' A' ' 67' ' ' THR . 28.3 mt-30 -135.08 155.53 50.58 Favored 'General case' 0 C--N 1.334 -0.065 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.389 -178.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.709 HD11 HD11 ' A' ' 145' ' ' ILE . 32.5 mt -130.48 132.49 64.61 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.343 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 177.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.633 HD21 HD22 ' A' ' 121' ' ' ASN . 0.9 OUTLIER -122.73 145.78 48.09 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.069 0.461 . . . . 0.0 111.877 -179.392 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.807 HD22 ' CG1' ' A' ' 33' ' ' VAL . 8.2 tp . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.185 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.704 HD11 HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.847 0.356 . . . . 0.0 110.851 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.751 HD13 ' O ' ' A' ' 122' ' ' GLN . 3.4 mm? -124.06 138.83 54.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.469 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.808 HD11 HD13 ' A' ' 124' ' ' LEU . 9.2 mp -112.6 125.06 53.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.048 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.622 ' HB2' HD23 ' A' ' 92' ' ' LEU . 50.4 t30 -115.8 115.75 26.82 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.785 ' OD2' HG23 ' A' ' 116' ' ' VAL . 8.8 p30 -78.08 142.9 37.83 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.524 HG21 ' OE1' ' A' ' 90' ' ' GLN . 8.1 pt -150.35 37.56 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -178.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.587 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.43 148.52 24.13 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 120.948 0.404 . . . . 0.0 111.712 -179.045 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.2 m -68.63 -31.37 70.47 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.64 177.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -94.56 -19.54 20.41 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.587 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.8 152.0 9.6 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.227 -0.987 . . . . 0.0 113.888 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.472 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.7 m -117.57 137.86 52.31 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.869 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -118.39 148.3 42.67 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.514 HD13 ' OD2' ' A' ' 128' ' ' ASP . 0.2 OUTLIER -124.16 113.65 18.61 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.484 177.541 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.409 ' N ' HD12 ' A' ' 111' ' ' LEU . 8.7 m-80 45.3 43.01 7.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.273 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.5 -7.65 75.35 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.512 178.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -104.42 118.63 37.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.018 0.437 . . . . 0.0 110.671 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.869 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.0 tptm -74.12 121.5 21.25 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.187 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.785 HG23 ' OD2' ' A' ' 103' ' ' ASP . 8.2 m -96.22 163.57 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.133 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -69.77 128.83 37.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.493 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.686 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 12.4 tttt -53.72 162.77 0.8 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.764 0.316 . . . . 0.0 110.29 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.8 m-80 33.5 37.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.846 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.9 p -111.78 145.16 39.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.893 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.633 HD22 HD21 ' A' ' 92' ' ' LEU . 6.4 m120 -88.83 124.44 34.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.864 0.364 . . . . 0.0 110.713 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.751 ' O ' HD13 ' A' ' 100' ' ' LEU . 50.6 mm-40 -128.98 149.45 50.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.598 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.5 tp -72.63 132.85 44.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.889 0.376 . . . . 0.0 110.441 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.834 HD11 HG21 ' A' ' 145' ' ' ILE . 64.0 tp -69.47 157.85 36.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.428 0.633 . . . . 0.0 111.519 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.427 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.6 OUTLIER -124.33 153.17 42.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.926 179.59 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.705 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.25 122.9 21.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.979 0.419 . . . . 0.0 110.659 -179.314 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 56.98 22.93 44.05 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.267 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.514 ' OD2' HD13 ' A' ' 111' ' ' LEU . 15.5 t70 -56.17 175.06 0.11 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.852 0.358 . . . . 0.0 110.828 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.923 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.0 mt-10 -143.8 135.63 26.36 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.081 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.667 HD11 HG13 ' A' ' 145' ' ' ILE . 2.2 mp -112.5 128.14 69.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.574 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.567 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.0 m -104.32 145.12 30.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.443 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.558 HG23 HD21 ' A' ' 84' ' ' LEU . 29.9 m -140.37 158.46 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.052 0.453 . . . . 0.0 112.156 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.51 42.01 12.32 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.268 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.472 ' HB ' ' CH2' ' A' ' 110' ' ' TRP . 74.8 t -86.67 140.4 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-O 121.544 0.688 . . . . 0.0 112.124 -179.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 139.22 -34.1 2.1 Favored Glycine 0 N--CA 1.435 -1.371 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.741 HG23 ' NH1' ' A' ' 83' ' ' ARG . 9.0 t -124.56 118.34 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -50.77 -29.6 11.94 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -178.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 31.9 m -93.61 6.7 47.38 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -178.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.418 ' CB ' ' HD3' ' A' ' 83' ' ' ARG . 0.8 OUTLIER -130.07 31.28 4.69 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -178.583 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.567 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.1 mt -107.11 138.46 32.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-O 121.351 0.595 . . . . 0.0 110.866 178.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.407 HD23 ' C ' ' A' ' 141' ' ' LEU . 9.3 tt -125.09 134.72 52.38 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.692 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.534 ' HB3' HG23 ' A' ' 40' ' ' THR . 44.4 t -106.84 149.62 27.22 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.544 0.688 . . . . 0.0 112.066 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.729 HD21 HD12 ' A' ' 43' ' ' ILE . 75.6 mt -136.39 158.04 45.36 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.695 -1.138 . . . . 0.0 111.219 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.923 HG22 ' CG ' ' A' ' 129' ' ' GLU . 21.7 t -129.18 140.16 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.851 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.834 HG21 HD11 ' A' ' 124' ' ' LEU . 1.1 mm -106.36 129.55 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 CA-C-O 120.944 0.402 . . . . 0.0 110.911 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.02 110.67 21.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.858 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.705 HD13 ' HA ' ' A' ' 126' ' ' GLN . 4.3 mp -85.83 134.14 27.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.483 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -84.94 123.69 30.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.819 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -72.01 -27.78 62.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.069 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -58.74 -44.43 90.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.035 0.445 . . . . 0.0 110.756 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.4 t80 . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.898 179.963 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.873 0.368 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.436 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER -169.99 34.68 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 -179.9 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.682 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 2.9 mm -77.77 134.02 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 CA-C-N 113.878 -1.51 . . . . 0.0 112.58 -177.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.997 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -90.25 -60.89 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.677 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.6 p -146.14 150.8 36.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.169 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.97 138.12 50.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.743 0.306 . . . . 0.0 111.214 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.605 HG21 ' HE2' ' A' ' 68' ' ' PHE . 26.6 t -101.7 122.66 54.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.874 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.577 HG23 HG12 ' A' ' 45' ' ' ILE . 18.9 mt -129.43 125.78 62.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.405 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.475 ' SG ' HD21 ' A' ' 141' ' ' LEU . 7.4 t -95.36 107.37 19.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.904 0.383 . . . . 0.0 110.485 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 79.3 p -82.02 -20.6 38.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.516 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.7 HG21 ' OG ' ' A' ' 142' ' ' SER . 12.3 p -80.04 -3.1 47.11 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.736 0.303 . . . . 0.0 111.333 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.39 70.93 0.97 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 121.087 -0.578 . . . . 0.0 113.775 178.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.524 ' HB2' HD21 ' A' ' 141' ' ' LEU . 7.4 mt-30 -145.08 -37.36 0.28 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.623 0.249 . . . . 0.0 111.469 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.835 HD13 ' HB3' ' A' ' 78' ' ' LEU . 52.2 mt -123.55 142.83 39.99 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.097 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.66 ' HD2' HG23 ' A' ' 43' ' ' ILE . 53.0 Cg_endo -71.97 146.04 46.37 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.206 1.937 . . . . 0.0 112.25 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.577 HG12 HG23 ' A' ' 37' ' ' ILE . 35.2 mt -59.58 144.22 12.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.773 -179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.34 164.02 31.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.013 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -131.64 119.85 21.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.993 0.425 . . . . 0.0 112.114 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.816 HD23 ' CD2' ' A' ' 66' ' ' TRP . 8.2 mp -87.25 133.83 33.62 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 178.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.997 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -138.69 156.18 47.62 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 -179.444 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.462 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -143.87 141.75 30.47 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 113.455 -1.702 . . . . 0.0 110.706 178.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 121.077 0.465 . . . . 0.0 111.232 -179.473 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.417 ' HE2' ' O ' ' A' ' 49' ' ' SER . 2.6 ttpt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.933 0.397 . . . . 0.0 111.648 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.645 HG12 ' HG2' ' A' ' 90' ' ' GLN . 21.8 t -135.34 139.43 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.776 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.816 ' CD2' HD23 ' A' ' 48' ' ' LEU . 19.7 m-90 -102.21 138.7 38.81 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.086 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.655 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -115.52 125.15 52.66 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.275 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.662 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.8 OUTLIER -108.09 145.58 33.85 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.305 -178.668 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.736 ' CA ' HD21 ' A' ' 78' ' ' LEU . . . 166.64 178.52 39.27 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.831 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.463 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 9.3 mtp-105 -73.46 -5.29 39.01 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.441 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.0 t-20 -84.89 134.96 40.53 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.699 0.285 . . . . 0.0 111.038 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 10.0 Cg_exo -69.76 -5.22 15.68 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.815 2.343 . . . . 0.0 111.831 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.54 -43.38 17.19 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 122.022 0.915 . . . . 0.0 108.558 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -44.04 139.34 2.51 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 113.641 -1.618 . . . . 0.0 110.469 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -56.12 -18.93 11.26 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.066 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.548 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 7.0 t80 -129.73 133.25 46.92 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.866 0.365 . . . . 0.0 110.94 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -109.77 120.42 42.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.643 179.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.835 ' HB3' HD13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -101.36 -81.63 0.48 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.124 -179.879 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.09 -133.07 1.41 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.512 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -138.73 66.7 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.879 0.371 . . . . 0.0 111.439 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.465 HG22 ' H ' ' A' ' 83' ' ' ARG . 31.6 mm -97.11 117.8 42.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.253 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 92.5 p -54.77 -30.98 58.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.19 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.506 ' HG3' ' HB3' ' A' ' 139' ' ' ASP . 1.6 mmp_? -71.51 -23.65 61.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.386 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.524 HD21 HG23 ' A' ' 132' ' ' VAL . 29.5 mt -94.23 152.08 18.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.503 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 85.7 p -96.57 166.6 11.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.851 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.672 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 1.5 m-80 -42.81 -52.88 4.86 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.437 0.637 . . . . 0.0 109.675 179.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.554 ' HB2' HD12 ' A' ' 104' ' ' ILE . 3.7 ptmm? -120.51 84.78 2.28 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 177.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.59 ' CD2' ' HB2' ' A' ' 105' ' ' SER . 14.1 t60 -60.3 -46.99 87.94 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.952 -1.022 . . . . 0.0 113.042 -176.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.518 ' HA ' HG12 ' A' ' 104' ' ' ILE . 29.3 p90 -151.61 159.54 44.02 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.874 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.655 ' HG3' HG23 ' A' ' 67' ' ' THR . 5.2 tt0 -136.11 139.56 43.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.55 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.662 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 29.4 mt -116.17 129.58 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.915 179.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.613 HD21 HD22 ' A' ' 121' ' ' ASN . 0.4 OUTLIER -114.58 149.33 36.7 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.234 0.54 . . . . 0.0 112.029 -179.541 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.859 HD22 HG11 ' A' ' 33' ' ' VAL . 57.9 tp . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.033 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.63 ' HB2' HD13 ' A' ' 124' ' ' LEU . 1.7 mt . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.78 0.324 . . . . 0.0 110.665 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.687 HD23 ' HB3' ' A' ' 121' ' ' ASN . 6.3 mp -125.51 139.15 53.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.55 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.593 HD11 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -112.87 123.4 50.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.084 179.665 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.452 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 61.1 t30 -117.74 115.85 25.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.889 0.376 . . . . 0.0 111.967 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.843 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.3 p30 -78.49 142.99 37.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.924 178.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.554 HD12 ' HB2' ' A' ' 87' ' ' LYS . 11.5 pt -147.76 28.0 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.651 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.59 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 11.3 t -93.56 155.09 17.5 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 121.584 0.707 . . . . 0.0 112.598 -178.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 65.9 m -70.1 -52.17 25.83 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.731 178.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -78.54 0.57 25.63 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.44 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.07 154.28 30.77 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 120.75 -0.738 . . . . 0.0 114.041 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.546 HG22 ' CG2' ' A' ' 130' ' ' ILE . 3.7 m -117.5 137.86 52.26 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.811 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -116.1 148.54 40.16 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -177.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.892 HD12 HG11 ' A' ' 116' ' ' VAL . 1.0 OUTLIER -124.44 113.64 18.41 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.956 177.363 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 48.3 35.53 5.73 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.072 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.17 -4.8 83.05 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.853 -0.689 . . . . 0.0 113.515 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.37 118.57 36.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.934 0.397 . . . . 0.0 110.498 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.811 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 9.1 tptm -71.04 111.64 6.56 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.128 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.892 HG11 HD12 ' A' ' 111' ' ' LEU . 17.1 m -87.89 162.95 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.106 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.8 OUTLIER -69.91 127.88 34.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.497 179.725 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.681 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 53.9 tttm -54.47 161.68 1.35 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.865 0.364 . . . . 0.0 110.517 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.506 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.9 p30 35.45 33.89 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.371 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.38 145.09 40.71 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.991 179.279 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.687 ' HB3' HD23 ' A' ' 100' ' ' LEU . 11.0 m120 -90.14 131.42 36.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.904 0.383 . . . . 0.0 110.976 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.442 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 43.9 mm-40 -129.28 148.77 51.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.43 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.61 123.96 24.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.374 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.63 HD13 ' HB2' ' A' ' 99' ' ' LEU . 7.8 tt -55.21 154.34 5.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.484 0.659 . . . . 0.0 111.723 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.419 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.73 153.24 42.68 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.303 179.73 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.56 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.66 126.35 29.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.828 0.347 . . . . 0.0 110.182 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.44 20.3 50.69 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.224 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.419 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 11.0 t70 -53.48 164.36 0.51 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.892 0.377 . . . . 0.0 111.074 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.7 tt0 -144.26 135.39 25.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.928 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.593 HD11 HD11 ' A' ' 101' ' ' LEU . 1.4 mp -109.1 127.02 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.598 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.592 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.7 m -104.17 140.48 37.76 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.527 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.0 m -140.18 158.42 25.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.87 23.6 41.28 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.283 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.437 ' HB ' ' CH2' ' A' ' 110' ' ' TRP . 82.2 t -68.34 140.47 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-O 121.515 0.674 . . . . 0.0 111.915 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 141.79 -41.23 1.24 Allowed Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -178.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 2.2 t -120.32 123.31 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.16 -31.05 12.63 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.68 6.75 47.29 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -178.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.506 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . 16.7 m-20 -125.34 31.0 5.67 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -178.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.592 ' CG2' HG22 ' A' ' 131' ' ' THR . 10.0 mt -106.42 138.71 30.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-O 121.456 0.646 . . . . 0.0 110.985 178.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' A' ' 143' ' ' LEU . 1.1 tt -124.76 134.53 52.76 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.517 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.7 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.7 OUTLIER -111.43 131.47 55.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.072 0.463 . . . . 0.0 111.698 -179.699 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.735 ' CD2' HD22 ' A' ' 141' ' ' LEU . 2.8 mm? -127.56 134.41 49.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.555 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 18.8 t -110.68 133.96 54.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.854 0.359 . . . . 0.0 111.18 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.569 ' CD1' HG22 ' A' ' 36' ' ' VAL . 1.2 mm -106.2 121.22 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.08 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -99.88 129.39 45.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.663 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.645 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.3 mp -92.54 129.21 43.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.867 0.365 . . . . 0.0 111.209 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -82.81 113.26 20.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.983 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 28.4 p-10 -61.17 -26.69 67.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.976 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.65 -43.44 84.92 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.007 0.432 . . . . 0.0 110.556 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.1 t80 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.746 179.847 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 120.837 0.351 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.9 p -145.25 -70.83 0.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.881 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.0 -37.49 87.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.861 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -60.41 -37.22 80.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.882 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -58.46 -41.96 86.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.2 tp -60.47 -32.59 71.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.72 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.455 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.8 mt -73.15 -35.34 47.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.913 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -57.46 -40.03 77.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.509 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -23.86 65.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.654 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.78 -47.55 79.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.228 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.2 m -81.2 -45.87 15.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.805 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -99.45 94.28 6.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.917 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -92.09 135.44 33.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.839 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.86 101.82 11.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.963 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.5 mm -89.03 138.46 19.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 CA-C-O 121.614 0.721 . . . . 0.0 111.864 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.36 50.01 1.08 Allowed Glycine 0 C--N 1.314 -0.679 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.574 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -70.44 -43.16 70.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.808 0.337 . . . . 0.0 110.753 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER -179.73 37.74 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.658 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.1 mm -76.75 137.52 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 CA-C-N 113.812 -1.54 . . . . 0.0 112.574 -177.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.98 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.1 t -92.98 -59.85 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.826 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.401 ' SG ' HD22 ' A' ' 48' ' ' LEU . 21.4 p -148.19 162.52 39.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.218 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.406 ' HB3' ' HB2' ' A' ' 146' ' ' PHE . 2.8 ttm180 -119.98 138.31 53.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.896 0.379 . . . . 0.0 111.221 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.657 HG11 ' CE2' ' A' ' 68' ' ' PHE . 2.1 m -106.62 122.7 60.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.728 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.867 HG23 HG12 ' A' ' 45' ' ' ILE . 20.5 mt -127.03 130.13 71.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.525 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.713 ' HA ' HD13 ' A' ' 143' ' ' LEU . 41.9 t -86.99 119.37 27.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.559 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.43 ' OG1' HG23 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -86.06 -26.48 25.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.578 -179.244 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.511 HG21 ' H ' ' A' ' 142' ' ' SER . 68.9 p -79.83 -2.36 43.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.717 0.294 . . . . 0.0 111.464 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.19 77.22 0.22 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.903 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.506 ' OE1' HD11 ' A' ' 141' ' ' LEU . 12.8 mt-30 -146.92 -43.32 0.18 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.871 0.367 . . . . 0.0 110.955 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.573 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.0 mt -116.32 141.7 28.28 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.038 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.573 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 45.2 Cg_endo -70.88 145.76 51.53 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.182 1.921 . . . . 0.0 112.148 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.867 HG12 HG23 ' A' ' 37' ' ' ILE . 38.9 mt -56.56 139.85 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.852 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -132.57 157.13 45.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.966 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -120.68 121.93 39.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.069 0.461 . . . . 0.0 111.959 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.844 HD23 ' CD2' ' A' ' 66' ' ' TRP . 8.7 mp -87.8 133.63 33.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.469 178.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.98 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -138.71 156.46 47.37 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 122.219 1.009 . . . . 0.0 113.411 -179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.486 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.31 149.51 34.96 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 113.553 -1.658 . . . . 0.0 110.977 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.622 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -76.28 128.35 34.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.05 0.453 . . . . 0.0 110.993 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.808 HD13 ' SG ' ' A' ' 154' ' ' CYS . 34.3 mt -64.1 -39.61 86.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.602 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.4 m -59.29 -39.64 83.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.198 0.523 . . . . 0.0 110.505 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.546 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 3.7 mm100 -68.55 -45.17 72.88 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.564 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.769 HG13 ' HG3' ' A' ' 63' ' ' LYS . 46.4 t -62.15 -39.21 83.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.354 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.532 HD21 ' HA ' ' A' ' 158' ' ' ASN . 0.2 OUTLIER -71.04 -37.86 72.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.08 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.1 tptt -74.64 -45.55 44.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.146 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.84 120.58 14.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.02 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -106.61 -25.09 11.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.888 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -115.81 162.7 16.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.925 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 74.5 m 60.32 -175.55 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.88 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.89 HG21 ' HB2' ' A' ' 92' ' ' LEU . 19.4 mm -92.29 141.9 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.197 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.769 ' HG3' HG13 ' A' ' 55' ' ' VAL . 27.8 mmtm -64.1 -59.32 4.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.984 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.406 ' HE2' ' O ' ' A' ' 49' ' ' SER . 7.5 ttpt -150.39 143.07 24.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.492 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 91' ' ' ILE . 16.3 t -130.88 138.91 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 121.227 0.537 . . . . 0.0 111.736 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.844 ' CD2' HD23 ' A' ' 48' ' ' LEU . 19.2 m-90 -102.03 139.39 37.72 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.428 -0.806 . . . . 0.0 112.086 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.984 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -110.98 126.68 55.03 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.421 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.657 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -110.9 145.43 38.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.12 -178.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.653 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 165.93 -179.85 39.89 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.646 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.9 mtm180 -77.58 -1.71 32.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.529 0.204 . . . . 0.0 111.505 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.456 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.5 t-20 -84.87 136.42 38.86 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 120.745 0.307 . . . . 0.0 110.996 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.5 Cg_exo -69.13 -6.45 18.32 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.704 2.269 . . . . 0.0 111.868 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.89 -45.35 14.32 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.96 0.886 . . . . 0.0 108.756 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -44.43 137.87 3.46 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 113.642 -1.617 . . . . 0.0 110.632 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -56.27 -19.33 13.66 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.927 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.525 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 46.6 t80 -130.13 130.25 44.55 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.586 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -111.04 122.3 47.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.785 0.326 . . . . 0.0 111.277 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.554 HD11 ' CA ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -120.44 179.66 4.24 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.877 179.251 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.26 133.54 52.67 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.665 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -64.78 92.3 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.849 0.357 . . . . 0.0 110.792 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.659 ' HB ' HD13 ' A' ' 84' ' ' LEU . 4.3 mt -111.99 141.07 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.235 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.738 ' HB2' HD11 ' B' ' 170' ' ' LEU . 2.9 p -65.12 -40.27 94.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.167 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.491 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -62.03 -21.31 64.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.519 -179.674 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.659 HD13 ' HB ' ' A' ' 81' ' ' ILE . 3.9 mp -99.95 153.4 19.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.057 0.456 . . . . 0.0 111.365 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.2 p -99.76 169.31 9.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.808 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.653 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 1.1 m-20 -44.87 -53.89 7.03 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.367 0.603 . . . . 0.0 109.562 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.607 ' CB ' HD12 ' A' ' 104' ' ' ILE . 71.7 mttt -118.13 85.47 2.35 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 177.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.576 ' CD2' ' HB2' ' A' ' 105' ' ' SER . 13.8 t60 -60.03 -45.86 91.4 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.691 -176.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.516 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 30.3 p90 -150.39 164.3 36.19 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.126 -0.629 . . . . 0.0 112.034 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.984 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.58 134.17 39.08 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.367 -178.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.646 HG23 HD12 ' A' ' 101' ' ' LEU . 47.5 mt -110.92 131.79 61.15 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.649 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.89 ' HB2' HG21 ' A' ' 62' ' ' ILE . 0.6 OUTLIER -123.29 140.75 52.7 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.981 0.419 . . . . 0.0 111.759 -179.29 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.71 HD22 ' N ' ' A' ' 94' ' ' GLY . 1.0 OUTLIER -125.25 122.95 38.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.441 179.166 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.71 ' N ' HD22 ' A' ' 93' ' ' LEU . . . -178.68 -144.19 5.56 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.327 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 58.41 -166.95 0.15 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.759 0.314 . . . . 0.0 110.879 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -81.18 59.88 4.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.973 0.416 . . . . 0.0 110.867 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.29 -178.97 36.01 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.578 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 33.5 m120 61.86 174.76 0.12 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.909 0.385 . . . . 0.0 110.917 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.676 HD11 HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -124.29 160.31 28.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.779 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.502 HD23 ' HB3' ' A' ' 121' ' ' ASN . 5.2 mp -124.23 141.0 52.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.936 0.398 . . . . 0.0 110.36 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.646 HD12 HG23 ' A' ' 91' ' ' ILE . 2.8 mp -112.68 126.37 55.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.087 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.46 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 67.2 t30 -119.18 136.29 54.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.11 0.481 . . . . 0.0 111.8 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.807 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.7 p30 -98.42 142.54 29.91 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.996 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.607 HD12 ' CB ' ' A' ' 87' ' ' LYS . 8.7 pt -145.58 24.5 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.621 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.576 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 11.2 t -92.09 154.14 18.93 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 121.594 0.711 . . . . 0.0 112.51 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.707 HG21 HG23 ' B' ' 169' ' ' TPO . 22.9 m -70.11 -51.94 27.63 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.607 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -75.33 -2.59 29.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.301 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.58 154.68 30.79 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.749 -0.739 . . . . 0.0 113.671 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 4.2 m -117.47 137.81 52.28 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.845 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -114.72 148.48 38.23 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -178.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.461 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.16 113.52 18.44 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.457 177.622 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 44.59 43.25 6.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.373 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.89 -7.9 75.33 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.44 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -104.81 118.61 36.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.996 0.427 . . . . 0.0 110.593 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.845 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.4 tptm -72.91 114.48 11.1 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.266 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.807 HG23 ' OD2' ' A' ' 103' ' ' ASP . 6.2 m -88.81 161.61 2.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.984 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 120' ' ' SER . 23.5 tt0 -69.75 130.79 43.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.347 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.686 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 24.2 tttt -54.49 161.61 1.38 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.899 0.381 . . . . 0.0 110.408 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.495 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.0 m-80 35.1 33.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.135 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.481 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.51 145.11 40.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.145 179.524 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.519 HD22 HD21 ' A' ' 92' ' ' LEU . 21.8 m120 -90.33 133.82 34.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.895 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.452 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 49.8 mm-40 -129.57 152.11 49.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.56 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 25.4 tp -72.64 120.16 17.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.777 0.322 . . . . 0.0 110.507 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.664 HD13 ' CB ' ' A' ' 99' ' ' LEU . 6.4 tt -56.64 155.71 7.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.454 0.645 . . . . 0.0 111.441 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.401 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.52 153.15 42.51 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.342 179.686 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.8 114.94 10.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.92 0.391 . . . . 0.0 110.132 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.54 23.17 73.64 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.044 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.401 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 23.1 t70 -53.81 171.27 0.1 Allowed 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 120.933 0.397 . . . . 0.0 111.162 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.635 ' HG3' HG22 ' A' ' 144' ' ' VAL . 21.2 tt0 -145.13 135.53 24.16 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.089 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.516 ' CG2' HG22 ' A' ' 109' ' ' THR . 5.8 mt -111.39 127.73 68.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.422 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.677 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.7 m -104.41 140.74 37.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.852 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.559 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 33.9 m -140.24 158.49 25.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.14 28.38 31.07 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.192 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.433 ' HA ' HG12 ' A' ' 140' ' ' ILE . 70.6 t -72.63 140.42 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-O 121.598 0.713 . . . . 0.0 111.982 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.649 ' O ' HD12 ' B' ' 172' ' ' ILE . . . 142.39 -39.82 1.33 Allowed Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -178.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.625 HG22 HG13 ' B' ' 172' ' ' ILE . 2.8 t -120.67 124.31 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -50.31 -35.0 25.6 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.6 p -93.77 6.7 47.51 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -178.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.421 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.6 OUTLIER -121.09 28.72 7.71 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -178.632 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.677 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.5 mt -107.27 138.11 34.92 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-O 121.544 0.688 . . . . 0.0 111.261 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.506 HD11 ' OE1' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -125.43 134.66 52.03 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.265 179.67 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.565 ' C ' HD22 ' A' ' 143' ' ' LEU . 38.5 t -111.3 148.44 32.91 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.739 0.781 . . . . 0.0 112.431 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.713 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.6 mm? -136.45 136.7 39.71 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.704 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.635 HG22 ' HG3' ' A' ' 129' ' ' GLU . 21.1 t -110.88 137.44 43.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.82 0.343 . . . . 0.0 111.073 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.516 HD12 HD21 ' A' ' 101' ' ' LEU . 4.9 mt -106.52 121.62 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.29 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.818 ' CE1' HD12 ' A' ' 37' ' ' ILE . 5.8 m-85 -105.37 115.3 30.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.485 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.606 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.1 mp -96.94 122.62 48.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.481 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -78.59 137.95 38.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.939 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.07 -18.69 60.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.366 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.52 -46.04 89.98 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.972 0.415 . . . . 0.0 110.814 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -59.97 -44.2 94.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.02 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt -65.33 -34.91 79.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.989 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.99 -47.01 86.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.056 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.808 ' SG ' HD13 ' A' ' 52' ' ' ILE . 8.8 t -67.56 -43.26 81.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.906 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.88 -35.95 71.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.86 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.14 -41.78 97.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.756 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.59 -36.17 33.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.825 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.532 ' HA ' HD21 ' A' ' 56' ' ' LEU . 2.8 p30 42.45 36.42 0.77 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.524 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.03 135.43 52.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.81 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.9 p -97.82 132.1 43.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.103 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -162.47 31.12 0.11 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.983 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.87 155.46 23.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.864 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.8 pt -100.96 117.8 46.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.105 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.222 -0.895 . . . . 0.0 110.976 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.853 0.358 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -150.3 143.02 16.12 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.755 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -74.65 -168.47 0.5 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.542 2.161 . . . . 0.0 112.303 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -169.73 105.82 0.35 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.996 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 169' ' ' TPO . . . . . 0.707 HG23 HG21 ' A' ' 106' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.738 HD11 ' HB2' ' A' ' 82' ' ' SER . 0.0 OUTLIER -154.01 -178.36 7.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.333 -179.776 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . 0.517 ' O ' ' O ' ' B' ' 172' ' ' ILE . 51.6 mt-10 -140.49 73.04 1.41 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.818 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 0.649 HD12 ' O ' ' A' ' 135' ' ' GLY . 13.4 tt 49.88 156.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.038 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 173' ' ' TYR . . . . . 0.461 ' N ' HG12 ' B' ' 172' ' ' ILE . 3.1 p90 -105.45 141.18 37.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.833 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.169 -0.919 . . . . 0.0 110.987 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.836 0.35 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.405 HG23 ' N ' ' A' ' 16' ' ' GLN . 9.5 t -165.44 -44.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.405 ' N ' HG23 ' A' ' 15' ' ' THR . 58.9 tt0 -60.84 -41.49 95.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.935 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -40.28 88.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.894 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -56.92 -42.29 79.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.487 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.7 tp -59.02 -31.86 69.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.186 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.525 HG23 ' HE2' ' A' ' 23' ' ' PHE . 8.7 mt -69.84 -48.05 66.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.545 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.75 -33.81 76.48 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.22 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -58.01 -46.92 84.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.312 -0.403 . . . . 0.0 112.01 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.546 ' CD1' ' N ' ' A' ' 24' ' ' SER . 4.3 p90 -71.83 -47.42 53.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.012 0.434 . . . . 0.0 111.031 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.546 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 0.7 OUTLIER -60.76 -37.65 82.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.925 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -134.87 82.12 1.94 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.884 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.53 136.33 40.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.791 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -68.61 102.22 1.44 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.968 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.1 mm -83.47 138.31 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 CA-C-O 121.675 0.75 . . . . 0.0 111.632 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.52 41.77 5.34 Favored Glycine 0 C--N 1.313 -0.697 0 CA-C-N 114.509 -1.223 . . . . 0.0 112.309 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -89.0 -30.14 18.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.568 0.223 . . . . 0.0 111.327 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER 176.77 38.99 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.722 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -73.78 134.26 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.55 0 CA-C-N 113.735 -1.575 . . . . 0.0 112.509 -177.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.034 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -93.55 -61.68 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.286 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.669 ' SG ' HD12 ' A' ' 48' ' ' LEU . 3.7 p -145.44 141.49 28.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.599 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.407 ' HD3' ' CG2' ' A' ' 45' ' ' ILE . 24.1 ttm180 -114.01 129.73 56.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.146 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.597 HG21 ' HE2' ' A' ' 68' ' ' PHE . 20.9 t -91.69 122.74 43.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.005 0.431 . . . . 0.0 111.099 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.812 HG23 HG12 ' A' ' 45' ' ' ILE . 21.8 mt -126.6 111.95 27.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.18 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 43.4 t -79.82 137.58 36.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.757 0.313 . . . . 0.0 110.499 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.2 t -116.36 -10.68 11.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.762 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.755 HG21 ' OG ' ' A' ' 142' ' ' SER . 5.0 p -96.38 -3.07 44.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.686 0.279 . . . . 0.0 111.262 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.48 93.11 0.25 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.042 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.569 ' HG3' ' N ' ' A' ' 43' ' ' ILE . 2.5 pt20 -171.51 -40.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.093 0.473 . . . . 0.0 111.464 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.663 HD12 HD21 ' A' ' 143' ' ' LEU . 65.0 mt -124.4 140.32 34.92 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.649 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.565 ' HD2' HG23 ' A' ' 43' ' ' ILE . 94.8 Cg_endo -80.31 144.37 16.24 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.576 2.184 . . . . 0.0 111.643 179.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.812 HG12 HG23 ' A' ' 37' ' ' ILE . 32.2 mt -58.59 123.87 11.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.944 0.402 . . . . 0.0 111.831 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.48 ' HB2' ' CZ ' ' A' ' 76' ' ' TYR . 2.3 ttt-85 -122.42 164.13 18.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.985 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.93 119.84 35.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.095 0.474 . . . . 0.0 111.949 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.669 HD12 ' SG ' ' A' ' 34' ' ' CYS . 3.1 mt -96.55 137.46 35.6 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 1.034 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.25 158.5 43.89 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -178.612 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.489 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -139.62 141.83 37.09 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.448 -1.705 . . . . 0.0 110.671 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.845 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -79.99 125.94 30.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.127 0.489 . . . . 0.0 111.606 -179.416 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.796 HD13 ' SG ' ' A' ' 154' ' ' CYS . 41.3 mt -64.49 -45.12 96.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.547 -0.752 . . . . 0.0 112.184 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.1 -39.82 79.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.363 0.602 . . . . 0.0 110.572 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.496 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 9.2 mm-40 -68.58 -36.89 79.35 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.674 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 51' ' ' ASP . 46.7 t -70.37 -41.58 78.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.983 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.04 -35.27 71.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.6 mmtt -73.65 -47.33 40.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.962 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.89 112.91 12.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.905 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.0 ptpt -103.7 28.82 6.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.866 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -101.07 -178.19 3.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.895 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.789 ' O ' HG22 ' A' ' 62' ' ' ILE . 9.3 t -70.84 139.47 50.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.911 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.945 HD11 ' HB2' ' A' ' 92' ' ' LEU . 7.8 tp 56.45 155.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.703 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.773 ' HG2' HG13 ' A' ' 55' ' ' VAL . 1.2 mptt -120.67 -64.19 1.27 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.154 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.433 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.0 ttpt -147.54 134.04 19.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.273 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.589 HG13 ' C ' ' A' ' 91' ' ' ILE . 14.8 t -129.49 139.22 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-O 121.343 0.592 . . . . 0.0 112.082 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.544 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.3 m-90 -100.93 139.64 36.33 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.125 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 1.038 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -113.38 126.84 55.81 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 176.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.68 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.5 OUTLIER -114.52 145.55 41.78 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.294 -178.517 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.702 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 165.88 -177.56 40.96 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.792 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.47 ' HG3' HD11 ' A' ' 78' ' ' LEU . 5.3 mtm105 -76.26 -2.0 29.29 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.408 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.6 t-20 -84.72 133.67 43.45 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.58 0.229 . . . . 0.0 110.91 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.0 Cg_exo -68.89 -7.52 20.95 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.607 2.205 . . . . 0.0 111.786 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.68 -43.16 17.22 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 121.916 0.865 . . . . 0.0 108.806 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.44 138.26 1.84 Allowed 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 113.764 -1.562 . . . . 0.0 110.652 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -56.16 -19.34 13.11 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.695 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.493 ' CD2' ' CE2' ' A' ' 68' ' ' PHE . 1.5 t80 -130.12 130.38 44.73 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.745 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -104.42 117.48 34.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.937 0.398 . . . . 0.0 110.933 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.48 ' HB3' HD13 ' A' ' 43' ' ' ILE . 2.7 pp -114.87 -178.03 3.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.887 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.75 144.02 48.49 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.528 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -76.8 91.67 3.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.791 0.329 . . . . 0.0 111.245 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.518 HD12 HD11 ' A' ' 84' ' ' LEU . 30.1 mt -112.09 139.99 33.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.084 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.771 ' HB3' HD21 ' B' ' 170' ' ' LEU . 0.4 OUTLIER -65.05 -36.41 84.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.12 -179.87 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.511 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -69.03 -15.69 63.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.799 -179.609 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.684 HD21 HG23 ' A' ' 132' ' ' VAL . 51.1 mt -103.38 152.42 21.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.701 0.286 . . . . 0.0 111.174 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.8 m -99.13 167.48 10.67 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.268 -0.423 . . . . 0.0 112.007 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.702 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.1 m-20 -43.72 -53.28 5.96 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.301 0.572 . . . . 0.0 109.658 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.546 ' HB3' HG22 ' A' ' 67' ' ' THR . 17.7 mtmt -118.3 83.76 2.06 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.568 ' CD2' ' HB2' ' A' ' 105' ' ' SER . 14.5 t60 -60.17 -46.03 91.08 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.698 -176.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.51 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 27.5 p90 -147.82 164.01 34.97 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.019 -0.672 . . . . 0.0 112.202 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 1.038 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.56 137.12 41.7 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.276 -178.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.68 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 63.8 mt -116.04 127.17 73.72 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.55 178.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.945 ' HB2' HD11 ' A' ' 62' ' ' ILE . 0.8 OUTLIER -111.42 140.64 45.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.089 0.471 . . . . 0.0 111.469 -179.649 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.621 HD23 ' HG ' ' A' ' 99' ' ' LEU . 2.5 tm? -114.05 123.48 49.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.539 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.443 ' N ' HD22 ' A' ' 93' ' ' LEU . . . -178.37 -128.03 1.13 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.289 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 51.36 30.12 5.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.774 0.321 . . . . 0.0 111.05 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 43.5 t0 69.17 28.85 4.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.072 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 129.67 -43.48 1.3 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.744 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -57.75 158.91 5.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.801 0.334 . . . . 0.0 111.142 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.621 ' HG ' HD23 ' A' ' 93' ' ' LEU . 0.8 OUTLIER -109.54 152.56 25.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.831 179.952 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.628 HD23 ' HB3' ' A' ' 121' ' ' ASN . 2.2 mp -133.05 147.17 52.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.4 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.581 HD22 ' C ' ' A' ' 100' ' ' LEU . 3.0 mm? -112.77 123.95 51.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.273 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.456 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 58.1 t30 -118.5 115.79 25.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.895 0.379 . . . . 0.0 111.777 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.801 ' OD2' HG23 ' A' ' 116' ' ' VAL . 10.9 p30 -79.67 141.93 36.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.956 178.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.494 HG12 ' HA ' ' A' ' 89' ' ' PHE . 12.9 pt -144.69 24.22 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.767 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.568 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 10.3 t -91.4 154.44 19.18 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.54 0.686 . . . . 0.0 112.528 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.479 ' CB ' HG21 ' B' ' 169' ' ' TPO . 8.5 m -70.13 -52.02 26.86 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.553 178.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -75.64 -0.56 21.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.395 -0.821 . . . . 0.0 112.258 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.04 155.15 31.78 Favored Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.702 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.553 HG22 ' CG2' ' A' ' 130' ' ' ILE . 3.7 m -117.36 137.63 52.33 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.835 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -115.31 148.59 39.05 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -177.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.458 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.13 113.45 18.37 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.646 -1.161 . . . . 0.0 108.466 177.589 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 44.77 43.28 6.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.315 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.02 -6.3 79.65 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.525 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -104.16 118.59 37.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.995 0.426 . . . . 0.0 110.562 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.835 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.7 tptm -72.83 111.25 7.79 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.279 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.801 HG23 ' OD2' ' A' ' 103' ' ' ASP . 15.7 m -86.09 161.82 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.847 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 120' ' ' SER . 64.0 mt-10 -69.84 129.64 40.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.504 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.683 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 22.0 tttt -54.9 161.16 1.69 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.902 0.382 . . . . 0.0 110.343 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.8 p30 34.93 34.6 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.322 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.42 145.2 40.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.277 179.452 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.628 ' HB3' HD23 ' A' ' 100' ' ' LEU . 21.6 m120 -87.94 131.92 34.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.848 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.447 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 37.7 mm-40 -129.57 148.99 51.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.63 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.0 tp -72.61 126.37 29.71 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.569 HD22 ' C ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -56.71 157.76 5.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.846 0.832 . . . . 0.0 112.185 -178.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.27 152.91 44.01 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.094 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -71.81 117.13 13.01 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.83 26.87 67.61 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.858 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -50.83 170.7 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.953 0.406 . . . . 0.0 111.325 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.428 ' CG ' ' O ' ' A' ' 143' ' ' LEU . 18.1 tt0 -145.09 135.39 24.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.71 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.553 ' CG2' HG22 ' A' ' 109' ' ' THR . 14.5 mt -113.07 126.35 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.474 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.59 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.0 m -104.23 140.11 38.3 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.684 HG23 HD21 ' A' ' 84' ' ' LEU . 33.9 m -140.05 158.52 26.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -178.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.26 25.08 32.14 Favored Glycine 0 N--CA 1.439 -1.106 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.276 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.475 ' HA ' HG12 ' A' ' 140' ' ' ILE . 77.6 t -71.21 140.38 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-O 121.522 0.677 . . . . 0.0 111.893 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 139.83 -40.98 1.35 Allowed Glycine 0 N--CA 1.435 -1.384 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -178.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.964 HG22 HD13 ' B' ' 172' ' ' ILE . 2.5 t -116.28 123.55 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.32 -36.09 30.49 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.8 p -93.55 6.69 47.4 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.442 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.7 OUTLIER -121.77 30.5 6.65 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -178.409 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.59 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.1 mt -107.3 138.27 34.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.913 177.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.497 HD13 ' HA ' ' A' ' 141' ' ' LEU . 0.8 OUTLIER -125.25 134.95 52.12 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.101 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.755 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.4 OUTLIER -106.09 133.14 51.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.066 0.46 . . . . 0.0 111.727 -179.675 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.663 HD21 HD12 ' A' ' 43' ' ' ILE . 42.7 mt -127.53 140.85 51.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.665 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 23.0 t -116.06 132.58 65.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.878 0.37 . . . . 0.0 111.451 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 30.4 mt -106.26 139.02 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.949 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.48 132.69 56.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.847 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.545 ' CD1' HD23 ' A' ' 124' ' ' LEU . 3.1 mt -93.41 134.1 32.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.462 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -81.56 110.8 17.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.693 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -59.27 -29.5 67.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.268 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.9 tttm -59.58 -45.41 91.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.919 0.39 . . . . 0.0 110.743 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -59.4 -44.1 92.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.949 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 13.7 tttp -65.03 -36.61 84.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.035 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -65.29 -47.1 77.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.02 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.796 ' SG ' HD13 ' A' ' 52' ' ' ILE . 9.2 t -65.97 -45.98 79.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.031 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.94 -43.48 91.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.883 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.57 -40.84 96.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.782 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.17 -27.09 63.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.99 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -122.96 102.4 7.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.944 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 17.4 pttt -89.31 161.97 16.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.919 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.4 m -78.19 133.65 29.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.158 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 59.69 94.8 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.953 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.13 -38.4 3.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 11.0 mt -76.94 117.65 22.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.065 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.27 -0.872 . . . . 0.0 110.942 179.947 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 2.5 t30 . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.8 0.333 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.73 166.5 31.86 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.899 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.25 -175.56 0.68 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.537 2.158 . . . . 0.0 112.254 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -172.44 138.76 0.94 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.162 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 169' ' ' TPO . . . . . 0.493 HG23 ' N ' ' B' ' 170' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.771 HD21 ' HB3' ' A' ' 82' ' ' SER . 1.9 pp -161.36 -178.15 6.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.058 0.456 . . . . 0.0 111.684 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -142.89 160.45 40.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.343 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 0.964 HD13 HG22 ' A' ' 136' ' ' VAL . 3.2 tp -51.32 142.0 4.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.892 0.377 . . . . 0.0 111.094 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 173' ' ' TYR . . . . . 0.618 ' H ' HD12 ' B' ' 172' ' ' ILE . 4.8 p90 -98.41 133.68 42.46 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.95 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 3.9 m . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.232 -0.889 . . . . 0.0 111.011 179.954 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.723 0.297 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.45 -50.86 2.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.982 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.9 -44.15 64.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.872 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.07 -36.0 74.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.966 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -58.23 -48.13 81.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.946 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 mp -58.85 -41.73 87.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.826 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.587 HG23 ' HE2' ' A' ' 23' ' ' PHE . 33.6 mm -66.52 -47.98 81.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.025 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -60.85 -33.67 73.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.364 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -56.4 -47.19 79.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.339 -0.391 . . . . 0.0 112.033 -178.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.587 ' HE2' HG23 ' A' ' 20' ' ' ILE . 5.7 p90 -71.89 -47.29 53.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.972 0.415 . . . . 0.0 110.964 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.56 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 0.4 OUTLIER -59.63 -46.96 87.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.843 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -73.82 81.38 1.61 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.869 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -90.16 143.82 26.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -83.67 123.44 29.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.1 mm -82.1 138.27 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-O 121.684 0.754 . . . . 0.0 111.859 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -143.48 56.71 0.55 Allowed Glycine 0 C--N 1.315 -0.631 0 CA-C-N 114.467 -1.242 . . . . 0.0 112.389 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -68.85 -39.77 79.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.788 0.328 . . . . 0.0 111.088 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.429 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER 176.0 39.41 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.725 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.3 mm -72.78 134.09 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-N 113.577 -1.647 . . . . 0.0 112.554 -177.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.056 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -92.62 -60.84 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.954 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.633 ' SG ' HD12 ' A' ' 48' ' ' LEU . 1.8 p -145.6 149.5 34.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.22 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.96 138.2 50.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.857 0.36 . . . . 0.0 111.406 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.566 ' CG2' HD11 ' A' ' 48' ' ' LEU . 24.1 t -101.54 122.77 54.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.872 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.613 HG23 HG12 ' A' ' 45' ' ' ILE . 18.4 mt -129.33 121.37 53.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.41 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.679 ' HA ' HD13 ' A' ' 143' ' ' LEU . 34.3 t -85.1 118.07 24.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.376 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.93 -29.26 27.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.74 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.558 HG21 ' H ' ' A' ' 142' ' ' SER . 30.2 p -79.93 -2.22 42.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.652 0.263 . . . . 0.0 111.447 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.83 77.74 0.26 Allowed Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.965 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -144.09 -45.44 0.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.851 0.358 . . . . 0.0 110.834 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.634 HG12 HD23 ' A' ' 78' ' ' LEU . 3.0 mp -114.38 140.91 25.71 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.065 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.552 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.3 Cg_endo -73.41 136.55 24.15 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.239 1.96 . . . . 0.0 112.075 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.613 HG12 HG23 ' A' ' 37' ' ' ILE . 33.9 mt -54.41 129.76 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.736 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -122.99 164.28 18.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.284 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.89 119.76 37.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.985 0.421 . . . . 0.0 111.958 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.633 HD12 ' SG ' ' A' ' 34' ' ' CYS . 1.3 mt -96.65 134.48 39.84 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 1.056 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -147.82 158.93 44.28 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -178.426 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.483 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -139.66 141.65 37.01 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 113.337 -1.756 . . . . 0.0 110.185 178.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.754 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -81.67 134.15 35.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.35 0.595 . . . . 0.0 111.428 -179.327 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.688 HD13 ' SG ' ' A' ' 154' ' ' CYS . 54.8 mt -64.22 -42.69 96.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.186 -0.916 . . . . 0.0 112.246 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.9 t -56.96 -41.96 79.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.051 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.546 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -68.64 -38.62 80.65 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.676 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 51' ' ' ASP . 41.0 t -67.04 -43.19 89.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.902 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.472 HD12 HG22 ' A' ' 52' ' ' ILE . 30.9 mt -71.12 -31.61 67.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.5 tpmp? -81.02 -48.25 12.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.085 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -72.17 106.75 4.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.874 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -93.03 87.35 5.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.916 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -158.55 178.44 10.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.4 p -73.36 -56.48 5.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.934 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.763 HD11 ' CG2' ' A' ' 65' ' ' VAL . 9.2 tp -86.56 148.54 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.122 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.733 ' HD3' HG13 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -124.72 -62.96 1.21 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.912 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.406 ' CE ' ' O ' ' A' ' 49' ' ' SER . 6.7 ttpt -149.82 129.64 13.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.999 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.763 ' CG2' HD11 ' A' ' 62' ' ' ILE . 6.6 t -122.7 138.4 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 121.292 0.568 . . . . 0.0 112.102 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.616 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 15.7 m-90 -100.8 140.12 35.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.548 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.727 HG23 ' CG ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -110.12 128.67 55.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.839 177.526 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.707 ' CD1' ' HB2' ' A' ' 76' ' ' TYR . 9.8 m-85 -120.59 145.46 47.34 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.501 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.629 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.24 -166.58 36.49 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.064 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.462 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 12.0 mtp-105 -84.42 5.36 27.54 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.431 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 19.4 t-20 -84.99 133.74 42.59 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.622 0.249 . . . . 0.0 110.74 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 18.0 Cg_exo -65.33 -14.96 47.73 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.493 2.129 . . . . 0.0 111.559 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.68 -45.84 13.98 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.971 0.891 . . . . 0.0 108.846 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.3 139.89 1.32 Allowed 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.794 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.9 OUTLIER -56.45 -19.19 14.01 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.087 179.049 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.707 ' HB2' ' CD1' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -130.1 127.97 40.92 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.554 179.421 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -100.99 107.91 19.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.871 0.367 . . . . 0.0 110.828 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.895 HD13 HD13 ' A' ' 84' ' ' LEU . 39.8 mt -71.5 -176.33 1.53 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.921 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -92.72 42.18 2.69 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.613 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.8 p30 42.83 61.0 2.25 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.891 0.377 . . . . 0.0 111.66 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.722 HD13 HD12 ' A' ' 84' ' ' LEU . 5.4 mp -96.61 126.23 49.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.788 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.748 ' CB ' HD21 ' B' ' 170' ' ' LEU . 1.5 m -54.77 -38.15 66.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.338 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.434 ' H ' HG22 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -65.86 -22.37 66.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.159 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.895 HD13 HD13 ' A' ' 78' ' ' LEU . 25.0 mt -102.56 152.28 21.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.082 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.414 ' HA ' ' O3P' ' B' ' 169' ' ' TPO . 23.5 p -98.11 166.17 11.55 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.629 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.3 m-20 -43.41 -53.4 5.41 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.438 0.637 . . . . 0.0 109.853 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.588 ' HB2' HD12 ' A' ' 104' ' ' ILE . 16.1 mttt -118.16 82.65 1.87 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 177.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.591 ' CD2' ' HB2' ' A' ' 105' ' ' SER . 14.8 t60 -62.93 -43.83 97.72 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.157 -0.929 . . . . 0.0 113.158 -176.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.49 ' CD1' ' HB2' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -151.24 161.63 42.37 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.05 -0.66 . . . . 0.0 112.37 -179.57 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.727 ' CG ' HG23 ' A' ' 67' ' ' THR . 7.8 mt-30 -135.2 151.81 50.98 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.415 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.525 ' C ' HG13 ' A' ' 65' ' ' VAL . 12.1 mt -124.12 127.49 73.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.206 178.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.768 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -111.31 149.33 31.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.013 0.435 . . . . 0.0 111.671 -179.307 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.537 HD13 ' HG ' ' A' ' 99' ' ' LEU . 24.4 tp -125.08 122.79 38.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.164 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.53 -171.92 41.1 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.792 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.6 -36.43 82.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.799 0.333 . . . . 0.0 110.966 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.86 152.45 43.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.792 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.598 ' HA2' HD22 ' A' ' 155' ' ' LEU . . . -56.77 -21.11 35.2 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.646 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -65.3 176.53 1.34 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.919 0.39 . . . . 0.0 110.881 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 1.012 HD11 HG12 ' A' ' 33' ' ' VAL . 0.5 OUTLIER -135.01 160.13 39.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.92 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.638 HD13 ' O ' ' A' ' 122' ' ' GLN . 2.6 mm? -123.88 147.07 47.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.546 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.612 HD11 ' HA ' ' A' ' 124' ' ' LEU . 2.3 mt -113.39 122.39 47.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.013 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.768 ' HB2' HD11 ' A' ' 92' ' ' LEU . 58.8 t30 -116.98 124.71 50.04 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.811 ' OD2' HG23 ' A' ' 116' ' ' VAL . 10.9 p30 -88.16 140.24 29.69 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.588 HD12 ' HB2' ' A' ' 87' ' ' LYS . 9.5 pt -143.62 24.03 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 -179.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.591 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 10.5 t -91.13 154.45 19.34 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.709 0.766 . . . . 0.0 113.011 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.474 HG21 ' CG2' ' B' ' 169' ' ' TPO . 17.5 m -70.18 -52.08 26.14 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.469 -1.242 . . . . 0.0 110.495 178.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -77.92 0.67 23.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.322 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.32 155.69 31.83 Favored Glycine 0 N--CA 1.438 -1.207 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.724 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 4.0 m -117.46 137.78 52.29 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.82 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -116.58 148.54 40.81 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -177.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.735 HD12 HG11 ' A' ' 116' ' ' VAL . 0.6 OUTLIER -124.32 113.54 18.37 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.812 177.421 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 47.31 36.21 4.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.071 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.07 -3.82 80.8 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.482 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.73 118.59 37.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.046 0.423 . . . . 0.0 110.805 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.82 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.4 tptm -72.74 120.98 19.12 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.069 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.811 HG23 ' OD2' ' A' ' 103' ' ' ASP . 9.1 m -98.24 163.81 2.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.394 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 120' ' ' SER . 44.1 tt0 -69.93 128.96 38.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.555 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.676 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 14.4 tttm -54.28 163.36 0.85 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.83 0.348 . . . . 0.0 110.183 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.6 OUTLIER 35.94 33.89 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.854 -179.251 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.5 OUTLIER -112.23 145.14 40.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.057 179.491 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.56 ' OD1' HD13 ' A' ' 92' ' ' LEU . 1.4 m-80 -87.93 132.62 34.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.877 0.37 . . . . 0.0 111.111 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.638 ' O ' HD13 ' A' ' 100' ' ' LEU . 30.1 mm-40 -129.12 145.32 51.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.45 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 26.4 tp -72.71 126.07 29.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.325 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.614 HD23 HG12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -58.52 158.96 6.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.852 0.834 . . . . 0.0 112.316 -179.011 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.769 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.3 OUTLIER -125.04 153.41 42.9 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.759 179.214 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.546 ' HA ' HD13 ' A' ' 147' ' ' ILE . 1.2 mm-40 -70.93 115.49 10.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.96 0.41 . . . . 0.0 109.921 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.25 28.18 68.77 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.552 -178.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.584 ' OD2' HD23 ' A' ' 111' ' ' LEU . 12.1 t70 -54.5 172.0 0.11 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.128 0.489 . . . . 0.0 111.421 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 2.4 tt0 -145.2 135.33 23.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.675 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.759 HG13 HD11 ' A' ' 145' ' ' ILE . 4.1 mt -112.75 129.22 68.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.378 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.583 HG22 ' CG2' ' A' ' 140' ' ' ILE . 5.5 m -102.98 139.81 38.07 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.578 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.8 m -140.28 158.73 25.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -177.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.04 30.01 29.79 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.209 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.443 ' HB ' ' CH2' ' A' ' 110' ' ' TRP . 77.6 t -74.19 140.34 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-O 121.551 0.691 . . . . 0.0 112.013 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.574 ' O ' HD12 ' B' ' 172' ' ' ILE . . . 144.9 -38.09 1.29 Allowed Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -178.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.589 HG22 HG13 ' B' ' 172' ' ' ILE . 2.7 t -121.33 128.39 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -50.56 -40.83 53.24 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.5 p -93.49 6.5 47.99 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.477 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 22.0 m-20 -117.7 30.13 7.45 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.583 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.3 mt -107.05 138.79 31.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.905 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.797 HD23 ' N ' ' A' ' 142' ' ' SER . 3.7 tt -124.67 134.62 52.82 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.448 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.797 ' N ' HD23 ' A' ' 141' ' ' LEU . 47.2 t -108.68 150.23 27.85 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.71 0.766 . . . . 0.0 112.576 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.679 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.1 mm? -136.1 151.03 49.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.472 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 40.5 t -125.18 133.45 69.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.803 0.335 . . . . 0.0 110.908 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.759 HD11 HG13 ' A' ' 130' ' ' ILE . 0.9 OUTLIER -105.62 124.59 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.438 -178.85 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -105.97 114.91 29.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.755 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.769 HD11 ' O ' ' A' ' 125' ' ' SER . 3.4 mp -85.05 133.31 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.571 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -82.34 118.78 23.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.916 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -69.94 -32.9 71.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.021 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.42 -45.55 91.23 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.959 0.409 . . . . 0.0 110.704 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -58.7 -44.16 90.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.931 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -63.46 -33.93 76.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.84 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.33 -43.85 97.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.027 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.688 ' SG ' HD13 ' A' ' 52' ' ' ILE . 10.0 t -66.52 -46.01 77.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.055 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.598 HD22 ' HA2' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -63.77 -37.25 86.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.007 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -60.69 -36.04 77.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.79 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -92.05 -30.99 15.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.928 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.8 p30 42.61 34.45 0.56 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.532 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.38 159.56 20.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.875 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 12.3 p -83.55 136.33 23.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.105 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -86.75 134.12 33.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.933 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -89.43 156.67 18.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 16.8 tt -91.07 129.36 41.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.025 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.904 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.807 0.337 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.97 166.43 12.45 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.897 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.2 139.46 42.19 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.529 2.153 . . . . 0.0 112.208 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -92.35 58.2 3.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 169' ' ' TPO . . . . . 0.633 ' O3P' HG22 ' B' ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.748 HD21 ' CB ' ' A' ' 82' ' ' SER . 0.5 OUTLIER -157.45 -176.37 5.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.052 0.453 . . . . 0.0 111.412 -179.669 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . 0.543 ' O ' HG22 ' B' ' 172' ' ' ILE . 51.1 mt-10 -156.51 79.28 0.95 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.603 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 0.589 HG13 HG22 ' A' ' 136' ' ' VAL . 15.8 tt 50.15 156.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 121.228 0.537 . . . . 0.0 112.048 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 173' ' ' TYR . . . . . 0.428 ' N ' HG12 ' B' ' 172' ' ' ILE . 4.5 p90 -112.69 87.89 2.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.946 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 4.8 p . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.893 179.975 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.8 0.334 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.98 -38.64 3.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.058 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -72.06 -41.96 66.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.94 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.48 -45.52 92.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.867 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -58.94 -35.02 72.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.996 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.04 -39.96 94.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.962 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.532 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 10.1 mm -70.38 -35.25 61.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.187 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -57.29 -37.6 72.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.952 0.406 . . . . 0.0 110.43 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -67.35 -23.68 65.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.79 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.532 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.57 -47.64 79.08 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.257 -179.72 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.3 m -66.08 -34.77 78.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.823 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -132.43 69.56 1.48 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.732 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -75.66 146.72 40.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.009 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -79.19 142.11 36.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.816 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.2 mm -81.83 138.12 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-O 121.7 0.762 . . . . 0.0 111.769 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 173.75 106.59 0.19 Allowed Glycine 0 C--N 1.313 -0.709 0 CA-C-N 114.419 -1.264 . . . . 0.0 112.437 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -86.63 -30.0 22.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.88 0.371 . . . . 0.0 111.008 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER 179.09 38.19 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.679 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.6 mm -74.93 136.05 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.558 0 CA-C-N 113.697 -1.592 . . . . 0.0 112.525 -177.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.016 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.0 t -91.92 -60.31 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 114.75 -1.113 . . . . 0.0 109.969 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.1 p -145.28 157.88 43.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.368 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.66 138.35 53.99 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.843 0.354 . . . . 0.0 111.474 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.788 HG11 ' CE2' ' A' ' 68' ' ' PHE . 1.1 m -108.06 122.66 62.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.724 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.807 HG23 HG12 ' A' ' 45' ' ' ILE . 19.2 mt -128.33 121.66 56.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.694 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.718 ' HA ' HD23 ' A' ' 143' ' ' LEU . 42.4 t -79.85 111.52 16.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.747 0.308 . . . . 0.0 110.257 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.5 t -78.81 -24.33 44.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.423 . . . . 0.0 112.088 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.522 HG23 ' HB3' ' A' ' 142' ' ' SER . 66.1 p -79.94 -2.14 42.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.73 0.3 . . . . 0.0 111.489 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.51 76.54 0.25 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.812 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -146.08 -43.96 0.2 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.887 0.375 . . . . 0.0 110.715 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.588 HG23 ' HD2' ' A' ' 44' ' ' PRO . 2.4 mp -117.54 142.1 29.93 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.062 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.588 ' HD2' HG23 ' A' ' 43' ' ' ILE . 48.2 Cg_endo -71.24 145.93 49.98 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.167 1.911 . . . . 0.0 112.27 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.807 HG12 HG23 ' A' ' 37' ' ' ILE . 42.5 mt -57.91 149.71 4.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.746 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.97 164.04 28.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.993 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.65 119.82 30.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.086 0.47 . . . . 0.0 111.948 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.731 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.3 mp -94.54 124.23 38.44 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 1.016 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -134.58 157.79 45.66 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -178.809 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.49 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -147.99 142.63 26.59 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.653 -1.612 . . . . 0.0 110.737 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.516 ' HB2' ' HG3' ' A' ' 54' ' ' GLN . 1.2 m-20 -74.85 126.82 31.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.199 0.524 . . . . 0.0 111.003 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.584 HD13 ' SG ' ' A' ' 154' ' ' CYS . 63.8 mt -64.11 -38.75 83.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.98 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 m -56.62 -40.44 75.37 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.885 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.516 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -68.49 -43.82 76.08 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.574 179.822 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.827 HG13 ' HD3' ' A' ' 63' ' ' LYS . 46.3 t -63.62 -37.93 80.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.38 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.63 -42.03 74.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.348 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? -74.49 -38.2 62.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.306 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -82.94 125.15 31.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.945 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.16 84.33 1.91 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.871 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.6 mtp85 -151.27 -177.29 5.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.822 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 78.3 p -98.16 30.42 3.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.794 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.882 HD11 ' CG2' ' A' ' 65' ' ' VAL . 8.9 tp -171.25 140.12 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.999 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.827 ' HD3' HG13 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -132.61 -53.22 0.94 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.416 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.5 ttpt -151.59 131.42 13.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.125 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.882 ' CG2' HD11 ' A' ' 62' ' ' ILE . 11.5 t -123.92 139.12 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 121.273 0.559 . . . . 0.0 111.951 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.731 ' CD2' HD23 ' A' ' 48' ' ' LEU . 16.4 m-90 -102.01 139.6 37.42 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.067 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.611 HG23 ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -108.8 132.27 54.16 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.425 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.788 ' CE2' HG11 ' A' ' 36' ' ' VAL . 2.7 m-85 -115.22 145.85 42.02 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.566 -178.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.786 ' HA2' HD12 ' A' ' 78' ' ' LEU . . . 161.91 -177.67 38.05 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.709 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.6 mtm180 -80.46 1.09 30.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.609 0.242 . . . . 0.0 111.373 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.46 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.9 t-20 -84.86 135.79 39.62 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.677 0.275 . . . . 0.0 110.872 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.1 Cg_exo -68.74 -6.96 19.22 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.672 2.248 . . . . 0.0 111.91 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.03 -45.09 14.47 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-O 122.093 0.949 . . . . 0.0 108.859 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -45.8 136.51 6.16 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 113.674 -1.603 . . . . 0.0 110.75 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.62 -19.02 14.04 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.0 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.61 ' HE1' HD23 ' A' ' 78' ' ' LEU . 33.3 t80 -129.76 118.7 22.25 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.678 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -93.87 107.9 19.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.865 0.364 . . . . 0.0 110.911 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.786 HD12 ' HA2' ' A' ' 69' ' ' GLY . 22.4 mt -73.19 -70.19 0.38 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.712 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 174.36 -86.72 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.235 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.7 p30 179.81 55.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.947 0.403 . . . . 0.0 110.866 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 1.109 HD13 HD12 ' A' ' 84' ' ' LEU . 4.1 mp -87.4 120.42 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.136 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.706 ' HB3' HD11 ' B' ' 170' ' ' LEU . 18.0 m -55.08 -41.49 71.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.919 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.604 ' CZ ' HD12 ' B' ' 170' ' ' LEU . 0.0 OUTLIER -64.34 -22.43 66.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.228 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.109 HD12 HD13 ' A' ' 81' ' ' ILE . 49.5 mt -98.73 152.29 19.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.847 0.356 . . . . 0.0 111.118 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.7 p -95.76 165.84 12.1 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.649 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.717 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -42.76 -52.81 4.84 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.384 0.611 . . . . 0.0 109.686 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.484 ' HB3' HD11 ' A' ' 104' ' ' ILE . 19.1 mttt -119.3 84.92 2.28 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 177.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.548 ' NE2' ' HB ' ' A' ' 132' ' ' VAL . 14.7 t60 -64.19 -45.83 86.62 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.995 -1.002 . . . . 0.0 113.244 -176.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.499 ' HA ' HG12 ' A' ' 104' ' ' ILE . 36.7 p90 -153.72 162.39 41.28 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.068 -0.653 . . . . 0.0 112.27 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.611 ' HG2' HG23 ' A' ' 67' ' ' THR . 9.8 mt-30 -135.64 154.88 51.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.779 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.521 ' O ' HG13 ' A' ' 65' ' ' VAL . 59.5 mt -123.54 132.35 71.53 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.269 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.536 HD11 HD13 ' A' ' 100' ' ' LEU . 0.6 OUTLIER -117.3 149.91 39.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.032 0.444 . . . . 0.0 111.866 -179.243 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.68 HD22 ' CG1' ' A' ' 33' ' ' VAL . 18.9 tp -125.21 122.93 38.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.355 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.83 -152.27 20.23 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.633 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.91 173.2 10.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.824 0.345 . . . . 0.0 110.924 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 59.8 -167.5 0.17 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.835 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -95.57 27.85 14.31 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.51 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -98.58 160.32 14.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.838 0.351 . . . . 0.0 110.967 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.501 HD23 ' O ' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -134.47 155.2 50.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.796 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.859 HD22 ' HB3' ' A' ' 121' ' ' ASN . 6.5 mt -133.12 141.0 47.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.533 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.82 128.21 56.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.13 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.416 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 50.2 t30 -116.6 115.63 26.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.887 0.375 . . . . 0.0 111.972 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.808 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.5 p30 -78.29 143.19 37.22 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.855 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.565 HG21 ' OE1' ' A' ' 90' ' ' GLN . 9.7 pt -149.67 35.86 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.591 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.05 150.98 21.45 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.651 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.546 HG21 ' CG2' ' B' ' 169' ' ' TPO . 3.2 m -68.71 -31.66 70.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.457 177.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -93.11 -19.57 21.37 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.172 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.591 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 110.73 158.12 15.7 Favored Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.738 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.501 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.7 m -117.18 137.65 52.2 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.865 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -115.83 148.35 40.01 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -178.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.555 HD13 ' OD2' ' A' ' 128' ' ' ASP . 0.2 OUTLIER -124.22 113.4 18.24 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.535 177.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.404 ' N ' HD12 ' A' ' 111' ' ' LEU . 71.6 m-20 43.61 43.62 4.83 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.16 -11.39 67.56 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.789 -0.719 . . . . 0.0 113.449 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -103.85 118.58 37.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.997 0.427 . . . . 0.0 110.625 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.865 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 2.8 tptp -74.04 121.39 21.0 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.41 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.808 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.8 m -91.54 163.44 2.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.958 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.5 OUTLIER -69.84 128.07 35.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.448 179.694 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.703 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 18.2 tttt -54.87 161.78 1.48 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.976 0.417 . . . . 0.0 110.631 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.6 OUTLIER 35.65 33.42 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.045 -179.263 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.47 145.16 40.69 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.234 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.859 ' HB3' HD22 ' A' ' 100' ' ' LEU . 5.5 m120 -89.32 128.78 35.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.763 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.708 ' O ' HD23 ' A' ' 100' ' ' LEU . 40.1 mm-40 -129.25 148.67 51.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.513 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.5 tp -72.71 111.91 8.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.885 0.374 . . . . 0.0 110.364 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.423 ' HG ' ' N ' ' A' ' 125' ' ' SER . 66.3 tp -53.68 158.88 1.75 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.247 0.546 . . . . 0.0 111.509 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.45 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.8 OUTLIER -124.01 153.25 41.58 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.331 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.434 ' HA ' HD12 ' A' ' 147' ' ' ILE . 12.2 tp60 -71.68 122.53 20.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.03 0.443 . . . . 0.0 110.79 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.18 21.9 48.2 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.429 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.555 ' OD2' HD13 ' A' ' 111' ' ' LEU . 5.3 t70 -59.87 -177.96 0.07 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 120.571 0.224 . . . . 0.0 110.449 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.888 ' CG ' HG22 ' A' ' 144' ' ' VAL . 6.1 mt-10 -145.07 135.55 24.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.743 0.306 . . . . 0.0 111.444 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.822 HG13 HD11 ' A' ' 145' ' ' ILE . 3.3 mt -114.52 126.66 72.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.218 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.574 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.4 m -104.28 140.04 38.43 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.041 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.548 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 26.4 m -140.33 158.37 25.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.131 0.491 . . . . 0.0 112.23 -178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.67 24.32 33.44 Favored Glycine 0 N--CA 1.439 -1.139 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.081 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.445 ' HB ' ' CZ3' ' A' ' 110' ' ' TRP . 77.9 t -70.93 140.32 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-O 121.544 0.688 . . . . 0.0 111.994 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.71 -38.13 1.08 Allowed Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 1.014 HG22 HD13 ' B' ' 172' ' ' ILE . 3.3 t -121.27 129.26 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.45 -40.65 51.18 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.55 6.69 47.39 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -178.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.458 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.7 OUTLIER -119.62 32.4 6.09 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -178.514 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.574 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.0 mt -107.25 138.65 32.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.411 0.624 . . . . 0.0 111.064 178.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.4 tt -124.88 134.61 52.63 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.718 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.522 ' HB3' HG23 ' A' ' 40' ' ' THR . 47.0 t -109.67 150.17 28.66 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.571 0.7 . . . . 0.0 112.25 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.718 HD23 ' HA ' ' A' ' 38' ' ' CYS . 69.7 mt -135.95 152.78 51.33 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.976 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.888 HG22 ' CG ' ' A' ' 129' ' ' GLU . 21.6 t -121.31 132.78 69.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.115 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.822 HD11 HG13 ' A' ' 130' ' ' ILE . 1.0 OUTLIER -105.74 121.73 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-O 120.881 0.372 . . . . 0.0 111.205 -179.345 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.99 115.01 29.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.95 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.434 HD12 ' HA ' ' A' ' 126' ' ' GLN . 6.5 mt -85.02 134.06 27.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.445 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -78.83 105.09 9.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.669 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.29 -35.24 73.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.08 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.97 -44.66 91.56 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.986 0.422 . . . . 0.0 110.669 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -58.77 -44.03 90.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.898 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.431 ' HE3' HG22 ' A' ' 147' ' ' ILE . 0.1 OUTLIER -61.55 -42.24 98.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.031 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -36.96 78.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.017 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.584 ' SG ' HD13 ' A' ' 52' ' ' ILE . 8.7 t -68.17 -42.14 80.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.197 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -66.49 -49.58 66.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.303 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -56.28 -35.67 67.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.276 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? -88.8 -37.13 15.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.052 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.4 p30 44.81 -173.41 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.549 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -117.11 128.32 55.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.913 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 10.3 m -87.46 130.61 36.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.096 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.58 62.01 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.931 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 60.48 96.74 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.871 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.3 pt -79.37 111.61 16.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.114 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.958 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.731 0.3 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -64.94 115.7 23.22 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.891 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.63 143.85 58.11 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.395 2.063 . . . . 0.0 112.389 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -173.19 115.84 0.27 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.753 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 169' ' ' TPO . . . . . 0.728 ' C ' HD23 ' B' ' 170' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.728 HD23 ' C ' ' B' ' 169' ' ' TPO . 0.1 OUTLIER -163.44 174.6 11.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.07 -179.619 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . 0.416 ' O ' ' O ' ' B' ' 172' ' ' ILE . 5.4 mt-10 -142.66 78.13 1.6 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.858 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 1.014 HD13 HG22 ' A' ' 136' ' ' VAL . 3.2 tp 43.01 102.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.9 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 173' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -55.68 -177.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.013 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 26.9 t . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.188 -0.91 . . . . 0.0 110.901 179.982 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.847 0.356 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 81.8 p -144.87 -61.58 0.36 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.837 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -67.32 -34.71 77.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.927 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.51 -35.99 81.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.83 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -57.98 -42.77 85.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.828 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.57 -31.98 71.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.67 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.447 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.5 mt -72.98 -35.43 48.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.939 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -57.5 -41.47 80.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.939 0.399 . . . . 0.0 110.498 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.17 -23.76 65.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.667 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.65 -47.53 79.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.217 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.8 p -79.32 -36.7 39.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.831 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 64.73 -79.18 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.978 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -77.18 145.78 37.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.941 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.61 122.95 26.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.836 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.9 mm -83.04 138.2 19.72 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 CA-C-O 121.678 0.751 . . . . 0.0 111.832 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.33 62.4 4.06 Favored Glycine 0 C--N 1.314 -0.641 0 CA-C-N 114.47 -1.241 . . . . 0.0 112.446 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.37 -42.19 95.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.749 0.309 . . . . 0.0 111.029 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.408 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.8 OUTLIER 177.42 38.91 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.682 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.7 mm -72.56 137.08 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 113.652 -1.613 . . . . 0.0 112.492 -177.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.002 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.3 t -91.6 -58.78 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.777 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.414 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 3.0 p -147.76 165.33 30.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.404 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -127.12 138.27 53.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.913 0.387 . . . . 0.0 111.43 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.455 ' O ' HG13 ' A' ' 36' ' ' VAL . 12.1 p -106.94 122.62 61.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.783 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.769 HG23 HG12 ' A' ' 45' ' ' ILE . 20.8 mt -127.53 127.92 69.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.618 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.47 ' HA ' HD13 ' A' ' 143' ' ' LEU . 35.2 t -88.5 114.23 24.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.76 0.314 . . . . 0.0 110.487 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.97 -23.68 33.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.701 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.502 HG21 ' H ' ' A' ' 142' ' ' SER . 58.3 p -79.96 -2.43 43.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.69 0.281 . . . . 0.0 111.465 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.6 69.86 1.21 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.185 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -141.01 -42.28 0.39 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.9 0.381 . . . . 0.0 110.974 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.543 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.7 mt -118.89 140.85 29.16 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.752 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.543 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.2 Cg_endo -73.39 146.02 39.15 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.139 1.893 . . . . 0.0 112.28 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.769 HG12 HG23 ' A' ' 37' ' ' ILE . 41.3 mt -57.31 148.38 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.08 0.467 . . . . 0.0 111.686 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -134.25 164.09 28.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.167 179.464 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -120.69 119.56 33.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.047 0.451 . . . . 0.0 111.63 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.797 HD23 ' CD2' ' A' ' 66' ' ' TRP . 6.8 mp -95.72 123.33 39.24 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 1.002 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -135.15 156.96 48.11 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 122.163 0.983 . . . . 0.0 113.407 -179.541 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.478 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -153.62 141.92 20.56 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 113.662 -1.608 . . . . 0.0 111.132 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.692 ' O ' HG23 ' A' ' 55' ' ' VAL . 2.4 m-20 -76.89 127.83 33.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.124 0.487 . . . . 0.0 111.104 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.488 HD13 ' SG ' ' A' ' 154' ' ' CYS . 55.1 mt -64.45 -43.11 96.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.093 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 71.8 m -58.28 -40.4 81.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.315 0.578 . . . . 0.0 110.808 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.44 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 4.4 mm-40 -68.43 -37.16 80.01 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.769 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.873 HG13 ' HG3' ' A' ' 63' ' ' LYS . 48.2 t -73.22 -44.29 55.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.036 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.5 mp -70.48 -31.48 68.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.922 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -77.13 -45.78 25.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.908 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -79.08 122.37 26.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.918 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -104.1 31.31 4.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.867 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.5 mmm180 -80.04 -179.05 6.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.92 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.73 -39.35 84.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.977 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.427 HD13 HD12 ' A' ' 92' ' ' LEU . 9.6 tp -140.52 155.08 22.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.054 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.873 ' HG3' HG13 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -108.47 -66.55 1.04 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.111 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.457 ' HE2' ' O ' ' A' ' 49' ' ' SER . 3.6 ttpt -138.09 136.0 36.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.412 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.655 HG12 ' HG2' ' A' ' 90' ' ' GLN . 19.3 t -132.13 139.2 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.274 0.559 . . . . 0.0 111.741 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.797 ' CD2' HD23 ' A' ' 48' ' ' LEU . 19.7 m-90 -102.42 139.37 38.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.309 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.644 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -114.18 131.1 56.57 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.779 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.686 ' HZ ' HD21 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -117.13 145.49 43.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.963 -179.125 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.616 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.99 -166.41 36.9 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.759 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -90.99 36.87 0.92 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.684 0.278 . . . . 0.0 111.41 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.464 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 3.9 t-20 -119.94 135.44 24.29 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.093 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 20.2 Cg_exo -64.63 -15.54 50.56 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.491 2.127 . . . . 0.0 111.5 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.72 -45.45 14.42 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 121.95 0.881 . . . . 0.0 109.089 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.36 139.54 2.65 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 113.885 -1.507 . . . . 0.0 110.845 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 67' ' ' THR . 9.3 m-20 -56.22 -18.57 10.71 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.844 178.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.537 ' CE2' HG21 ' A' ' 43' ' ' ILE . 2.8 t80 -129.18 116.71 19.6 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.737 0.303 . . . . 0.0 111.007 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -88.58 107.94 19.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.779 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.639 HD23 HD13 ' A' ' 84' ' ' LEU . 6.9 mp -77.91 -176.33 4.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.059 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.63 11.85 68.88 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.633 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 64.76 75.63 0.36 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.956 0.408 . . . . 0.0 111.473 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.933 ' HB ' HD12 ' A' ' 84' ' ' LEU . 3.7 mp -111.51 141.42 26.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.654 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.453 ' HB3' HD11 ' B' ' 170' ' ' LEU . 0.5 OUTLIER -54.95 -41.73 71.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.047 -179.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.526 ' H ' HG22 ' A' ' 81' ' ' ILE . 9.9 mmp_? -61.02 -49.07 78.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.261 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.933 HD12 ' HB ' ' A' ' 81' ' ' ILE . 1.4 mt -76.39 151.79 36.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.099 0.476 . . . . 0.0 111.664 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.3 p -100.89 167.55 10.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.401 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.616 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -44.56 -53.0 7.53 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.436 0.636 . . . . 0.0 109.816 179.123 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.654 ' HB2' HD12 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -121.83 82.8 2.0 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 177.456 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.586 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 9.2 t60 -62.73 -46.12 89.58 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.094 -0.957 . . . . 0.0 113.036 -176.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.504 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 20.4 p90 -147.98 160.1 43.18 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.592 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.655 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.2 tt0 -136.19 141.28 44.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.485 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.607 ' O ' HG13 ' A' ' 65' ' ' VAL . 44.1 mt -116.12 127.43 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.892 179.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.577 HD21 HD22 ' A' ' 121' ' ' ASN . 0.6 OUTLIER -110.99 144.64 39.77 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.069 0.461 . . . . 0.0 111.888 -179.383 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.768 HD22 HG11 ' A' ' 33' ' ' VAL . 16.1 tp -125.28 129.3 49.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.485 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.83 -153.31 24.71 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.755 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 63.12 -80.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.735 0.303 . . . . 0.0 111.077 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -117.31 -164.74 1.01 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.757 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -86.48 51.68 4.39 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.522 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -153.49 -170.48 3.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.901 0.381 . . . . 0.0 110.693 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.92 ' HB2' HD13 ' A' ' 124' ' ' LEU . 1.7 mt -119.65 160.16 23.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.004 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.601 HD12 ' O ' ' A' ' 99' ' ' LEU . 3.2 mp -131.49 145.22 51.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.872 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.448 HD21 ' HB2' ' A' ' 122' ' ' GLN . 0.6 OUTLIER -112.71 124.27 52.19 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.36 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.414 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 51.5 t30 -115.74 115.58 26.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.905 0.383 . . . . 0.0 111.386 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.76 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.1 p30 -79.11 138.76 38.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.167 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.654 HD12 ' HB2' ' A' ' 87' ' ' LYS . 12.3 pt -146.96 39.35 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.728 -0.214 . . . . 0.0 111.574 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.574 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -96.13 158.51 15.41 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 121.055 0.455 . . . . 0.0 111.709 -179.06 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.646 HG22 ' HG3' ' B' ' 171' ' ' GLU . 86.4 m -69.07 -37.83 78.72 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.862 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.61 -19.91 17.3 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.553 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 123.8 158.35 10.1 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.074 -1.06 . . . . 0.0 113.799 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.8 m -117.78 137.99 52.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.924 -0.638 . . . . 0.0 109.731 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.891 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -114.58 148.42 38.05 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -178.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.472 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.2 113.54 18.44 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.384 177.393 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.417 ' N ' HD12 ' A' ' 111' ' ' LEU . 87.3 m-20 44.0 43.99 5.77 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.39 -11.05 66.87 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.711 -0.756 . . . . 0.0 113.486 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -103.4 118.58 37.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.01 0.433 . . . . 0.0 110.544 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.891 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 3.8 tptm -74.37 113.86 12.08 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.473 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.76 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.5 m -84.5 162.64 2.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.876 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.416 ' O ' ' CB ' ' A' ' 120' ' ' SER . 13.2 tp10 -69.85 131.14 44.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.464 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.674 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 32.3 tttm -53.1 162.97 0.58 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.7 p30 34.07 39.1 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.099 0.476 . . . . 0.0 111.83 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 25.0 p -111.54 145.07 39.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.734 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.577 HD22 HD21 ' A' ' 92' ' ' LEU . 22.1 m120 -94.64 123.82 38.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.71 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.448 ' HB2' HD21 ' A' ' 101' ' ' LEU . 24.7 mm-40 -127.96 148.45 50.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.558 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.8 tp -72.68 136.25 45.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.486 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.92 HD13 ' HB2' ' A' ' 99' ' ' LEU . 1.5 pt? -61.81 160.48 11.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.847 0.832 . . . . 0.0 112.088 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.406 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.0 OUTLIER -125.66 153.17 44.22 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.912 178.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.56 117.55 13.26 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.36 27.27 65.3 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.917 -0.659 . . . . 0.0 111.789 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.406 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 25.0 t0 -51.24 169.38 0.05 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.05 0.452 . . . . 0.0 111.404 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 12.8 tt0 -143.77 135.34 26.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.457 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.513 ' CG2' HG22 ' A' ' 109' ' ' THR . 11.6 mt -114.44 128.1 71.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.863 0.363 . . . . 0.0 111.019 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.56 HG23 ' CG2' ' A' ' 140' ' ' ILE . 26.9 m -104.46 142.24 34.95 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.715 HG21 HD21 ' A' ' 84' ' ' LEU . 19.9 m -140.42 158.41 24.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -178.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.34 46.53 26.12 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.419 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.482 ' HA ' HG12 ' A' ' 140' ' ' ILE . 58.5 t -85.27 140.72 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-O 121.997 0.903 . . . . 0.0 112.983 -178.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.27 -46.64 0.78 Allowed Glycine 0 N--CA 1.434 -1.494 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.652 HG11 ' CB ' ' A' ' 139' ' ' ASP . 4.6 p -104.03 118.0 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 CA-C-N 113.902 -1.149 . . . . 0.0 109.388 177.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.478 ' HA ' HD12 ' A' ' 140' ' ' ILE . 1.2 pt-20 -57.53 -24.24 54.9 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.787 0.327 . . . . 0.0 111.3 -179.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.536 ' H ' HG22 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -92.92 -25.91 17.83 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -177.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.652 ' CB ' HG11 ' A' ' 136' ' ' VAL . 0.5 OUTLIER -105.53 25.43 10.75 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -177.642 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.56 ' CG2' HG23 ' A' ' 131' ' ' THR . 5.8 mt -88.8 139.81 16.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.064 177.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.777 HD23 ' N ' ' A' ' 142' ' ' SER . 3.0 tt -120.02 134.8 55.14 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.993 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.777 ' N ' HD23 ' A' ' 141' ' ' LEU . 43.4 t -115.65 150.26 37.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.521 0.677 . . . . 0.0 112.277 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.502 ' CD2' HD22 ' A' ' 141' ' ' LEU . 2.0 mm? -135.79 153.35 51.55 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.39 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 39.6 t -123.26 138.5 53.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.798 0.332 . . . . 0.0 110.695 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.5 HD11 HD11 ' A' ' 91' ' ' ILE . 1.3 mm -106.24 125.89 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-O 120.965 0.412 . . . . 0.0 111.064 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.33 111.72 23.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.68 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.759 HG12 HD12 ' A' ' 124' ' ' LEU . 3.6 mp -90.6 128.23 42.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.353 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -75.95 126.13 30.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.825 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -70.31 -30.86 67.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.994 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -60.05 -46.0 90.98 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.693 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -58.56 -44.12 89.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.954 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -65.08 -34.49 78.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.893 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -58.95 -47.0 86.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.047 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.488 ' SG ' HD13 ' A' ' 52' ' ' ILE . 10.9 t -65.86 -46.05 79.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.976 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.26 -35.97 80.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.835 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.97 -40.62 89.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.818 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.417 ' O ' ' N ' ' A' ' 159' ' ' LYS . 0.9 OUTLIER -86.78 -31.04 21.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.9 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 43.4 -91.01 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.638 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 157' ' ' GLN . 0.1 OUTLIER -107.65 152.44 24.3 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.827 0.346 . . . . 0.0 110.879 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.533 ' O ' HG13 ' A' ' 160' ' ' VAL . 13.3 p -100.65 117.26 45.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.126 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -61.59 -45.51 93.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.769 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.51 168.33 22.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.894 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.652 HD13 ' H ' ' A' ' 163' ' ' ILE . 0.2 OUTLIER -105.19 140.01 24.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.157 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.302 -0.856 . . . . 0.0 111.068 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.875 0.369 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -133.01 88.54 36.61 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.015 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -51.52 144.56 32.09 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.551 2.167 . . . . 0.0 112.25 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -177.75 79.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.873 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 169' ' ' TPO . . . . . 0.431 ' C ' HD23 ' B' ' 170' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.453 HD11 ' HB3' ' A' ' 82' ' ' SER . 0.1 OUTLIER -164.74 -179.44 5.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.814 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . 0.646 ' HG3' HG22 ' A' ' 106' ' ' THR . 0.0 OUTLIER -132.56 43.77 2.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.88 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 0.631 HG22 ' O ' ' B' ' 171' ' ' GLU . 8.5 tp 50.06 161.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.999 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 173' ' ' TYR . . . . . 0.404 ' N ' HG13 ' B' ' 172' ' ' ILE . 12.5 m-85 -47.76 96.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.144 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.922 -179.892 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.885 0.374 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.431 ' HB ' ' HB2' ' A' ' 18' ' ' PHE . 8.6 p -121.51 34.47 5.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.759 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -60.05 -47.21 86.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.828 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -71.24 -35.85 71.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.962 0.41 . . . . 0.0 110.541 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.431 ' HB2' ' HB ' ' A' ' 15' ' ' THR . 6.0 m-85 -58.05 -44.19 87.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.859 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 mp -60.99 -43.02 99.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.725 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.658 HG23 ' HE2' ' A' ' 23' ' ' PHE . 47.7 mm -64.57 -48.14 86.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.812 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -33.74 71.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.433 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.15 -47.14 87.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.985 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.658 ' HE2' HG23 ' A' ' 20' ' ' ILE . 3.5 p90 -71.76 -47.59 52.6 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.132 0.491 . . . . 0.0 111.031 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.533 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 0.9 OUTLIER -59.68 -44.79 93.48 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.987 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -104.03 102.46 12.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.855 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.35 141.11 41.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.819 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.12 115.66 27.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.4 mm -81.98 138.29 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 CA-C-O 121.683 0.754 . . . . 0.0 111.67 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.32 109.15 0.46 Allowed Glycine 0 C--N 1.314 -0.672 0 CA-C-N 114.475 -1.239 . . . . 0.0 112.55 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.02 -28.54 20.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.741 0.305 . . . . 0.0 111.091 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.441 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.2 m-20 176.65 39.41 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.717 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.1 mm -71.99 135.28 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 113.538 -1.664 . . . . 0.0 112.634 -177.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.01 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.3 t -91.38 -59.55 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.633 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.692 ' SG ' HD12 ' A' ' 48' ' ' LEU . 3.4 p -148.94 150.48 32.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.992 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.429 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -114.67 138.02 51.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.826 0.346 . . . . 0.0 111.639 -179.129 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.584 HG11 ' CE2' ' A' ' 68' ' ' PHE . 3.6 m -102.83 122.63 55.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.572 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.827 HG23 HG12 ' A' ' 45' ' ' ILE . 20.9 mt -127.54 124.9 64.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.605 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.696 ' HA ' HD13 ' A' ' 143' ' ' LEU . 51.9 t -83.17 121.16 26.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.531 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.66 -24.55 21.59 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.515 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.514 HG21 ' H ' ' A' ' 142' ' ' SER . 43.8 p -79.95 -2.06 42.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.461 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.6 75.97 0.31 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.787 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -147.2 -43.83 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.795 0.331 . . . . 0.0 110.886 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.812 HD13 HD22 ' A' ' 78' ' ' LEU . 3.0 mt -116.35 140.98 27.21 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.756 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.544 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.4 Cg_endo -72.93 145.49 40.31 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.138 1.892 . . . . 0.0 112.202 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.827 HG12 HG23 ' A' ' 37' ' ' ILE . 35.8 mt -56.03 141.51 12.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.669 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.461 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -127.25 164.05 22.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.17 179.551 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.429 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.7 OUTLIER -121.7 119.66 32.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.069 0.461 . . . . 0.0 111.68 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.692 HD12 ' SG ' ' A' ' 34' ' ' CYS . 3.1 mt -98.66 133.0 43.62 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 1.01 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.98 157.97 43.87 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -178.584 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.485 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -142.12 147.79 37.28 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 113.577 -1.647 . . . . 0.0 110.748 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.664 ' O ' HG23 ' A' ' 55' ' ' VAL . 1.6 m-20 -74.96 136.26 41.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.167 0.508 . . . . 0.0 111.33 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.713 HD13 ' SG ' ' A' ' 154' ' ' CYS . 93.1 mt -64.32 -44.41 97.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.086 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.4 p -56.72 -38.15 71.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.191 0.519 . . . . 0.0 110.506 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.454 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 4.4 mm-40 -68.55 -36.86 79.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.421 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 51' ' ' ASP . 48.9 t -69.62 -45.22 78.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.097 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.0 mt -66.08 -42.09 89.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -67.28 -31.91 72.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.31 116.37 5.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.863 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.83 83.13 3.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.886 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 58.04 70.56 0.64 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.995 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.93 176.32 5.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.897 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.465 HD12 ' O ' ' A' ' 93' ' ' LEU . 9.8 tp -79.79 148.57 5.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.052 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.643 ' HE3' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -129.71 -38.79 1.48 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.723 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.433 ' CE ' ' O ' ' A' ' 49' ' ' SER . 1.9 ttpt -155.23 139.89 17.02 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.605 HG13 ' O ' ' A' ' 91' ' ' ILE . 21.3 t -136.05 139.33 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.581 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.521 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 18.2 m-90 -102.56 139.3 38.33 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.453 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.687 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.17 130.25 56.61 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 177.282 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.584 ' CE2' HG11 ' A' ' 36' ' ' VAL . 1.1 m-85 -117.97 145.25 44.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.926 0.394 . . . . 0.0 111.642 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.579 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.9 -170.22 39.87 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.751 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.435 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 20.6 mtm180 -82.01 1.42 35.75 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.448 HD22 ' HB3' ' A' ' 73' ' ' ALA . 2.0 t30 -84.87 135.0 40.52 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.685 0.278 . . . . 0.0 111.319 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -66.43 -12.53 36.09 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.635 2.223 . . . . 0.0 111.742 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.448 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.64 -43.94 16.35 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-O 121.965 0.888 . . . . 0.0 108.738 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.82 140.44 1.35 Allowed 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 113.707 -1.588 . . . . 0.0 110.635 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' A' ' 67' ' ' THR . 23.3 m-20 -56.14 -18.93 11.35 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.172 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.487 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 7.0 t80 -129.66 130.28 45.36 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-O 120.882 0.373 . . . . 0.0 111.017 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -105.99 113.97 27.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.784 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.812 HD22 HD13 ' A' ' 43' ' ' ILE . 1.4 mt -93.71 -67.02 0.88 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.875 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 179.15 -90.84 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.164 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.401 ' HA ' ' HD2' ' A' ' 70' ' ' ARG . 3.9 p30 175.97 54.25 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.839 0.352 . . . . 0.0 111.01 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.745 ' HB ' HD13 ' A' ' 84' ' ' LEU . 29.5 mm -83.32 134.76 26.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.872 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.713 ' HB3' HD21 ' B' ' 170' ' ' LEU . 0.9 OUTLIER -64.53 -32.66 74.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.411 -179.645 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.549 ' H ' HG22 ' A' ' 81' ' ' ILE . 2.2 mpt_? -68.38 -23.77 64.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.502 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.745 HD13 ' HB ' ' A' ' 81' ' ' ILE . 5.7 mp -103.38 153.38 20.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.932 0.396 . . . . 0.0 111.114 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.4 m -95.94 168.58 10.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.034 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.579 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -43.45 -54.46 4.78 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.38 0.61 . . . . 0.0 109.698 179.176 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.573 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.1 OUTLIER -119.7 84.22 2.17 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 177.247 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.621 ' CG ' ' HB2' ' A' ' 105' ' ' SER . 12.7 t60 -57.95 -45.39 86.7 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.705 -176.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.457 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 32.1 p90 -148.24 159.4 44.01 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.079 -0.648 . . . . 0.0 111.922 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.687 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.1 tt0 -135.79 139.95 43.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.376 -178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.605 ' O ' HG13 ' A' ' 65' ' ' VAL . 44.0 mt -114.94 128.15 72.2 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.772 179.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.768 HD21 ' OD1' ' A' ' 121' ' ' ASN . 1.1 pt? -114.11 143.08 45.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.059 0.457 . . . . 0.0 111.61 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.87 HD22 HG11 ' A' ' 33' ' ' VAL . 28.5 tp -125.04 122.9 38.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.295 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.4 ' HA3' ' HD3' ' A' ' 63' ' ' LYS . . . 133.95 102.14 0.75 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.439 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -159.33 -45.74 0.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.819 0.342 . . . . 0.0 111.007 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -165.18 -43.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.978 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 174.2 43.03 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.475 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 39.3 p30 -165.92 -176.76 3.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.825 0.345 . . . . 0.0 110.983 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.787 ' HG ' HD13 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -106.99 159.79 16.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.839 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.724 HD23 ' OD1' ' A' ' 121' ' ' ASN . 1.8 mp -131.35 147.33 52.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.447 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.801 HD11 ' HA ' ' A' ' 124' ' ' LEU . 2.7 mp -112.86 124.92 53.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.304 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.446 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 61.4 t30 -120.57 115.76 24.04 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.794 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.3 p30 -78.13 138.93 38.97 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.523 HD12 ' CB ' ' A' ' 87' ' ' LYS . 7.2 pt -140.02 22.09 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.621 ' HB2' ' CG ' ' A' ' 88' ' ' HIS . 11.0 t -91.79 153.46 19.57 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 121.487 0.66 . . . . 0.0 112.641 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.1 m -69.99 -52.12 26.88 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.399 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -72.83 -5.07 35.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.139 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.53 156.04 30.88 Favored Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.73 -0.747 . . . . 0.0 113.459 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.501 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 5.6 m -117.33 137.74 52.23 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.846 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -113.39 148.44 35.8 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -177.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.428 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.25 113.42 18.25 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.252 177.382 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 44.51 43.22 6.2 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.98 -6.85 80.0 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.528 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -103.98 118.5 36.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.982 0.42 . . . . 0.0 110.578 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.846 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 20.9 tptt -74.54 118.32 17.36 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.343 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.794 HG23 ' OD2' ' A' ' 103' ' ' ASP . 7.0 m -95.88 159.45 2.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.864 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.677 ' O ' ' HB3' ' A' ' 120' ' ' SER . 5.5 mm-40 -69.97 133.97 47.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.109 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.686 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 27.1 tttt -55.48 165.78 0.75 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.131 0.491 . . . . 0.0 110.83 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.46 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.6 OUTLIER 36.46 34.43 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.687 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.677 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 1.4 t -112.21 145.12 40.45 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.76 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.768 ' OD1' HD21 ' A' ' 92' ' ' LEU . 11.4 m-80 -86.7 136.1 33.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.93 0.395 . . . . 0.0 111.086 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.501 ' O ' HD12 ' A' ' 101' ' ' LEU . 19.0 mm-40 -128.68 144.2 51.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.204 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.621 HD23 ' O ' ' A' ' 124' ' ' LEU . 3.2 tt -72.67 131.41 42.37 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.221 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.913 HD21 HG12 ' A' ' 147' ' ' ILE . 54.0 tp -58.5 151.8 19.5 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.73 0.776 . . . . 0.0 111.751 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.429 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -125.37 152.83 44.26 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.587 179.57 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.11 117.93 14.35 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.73 25.78 66.04 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.839 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.429 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 30.9 t70 -51.1 167.85 0.07 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.946 0.403 . . . . 0.0 111.505 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.8 tt0 -145.21 135.4 23.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.902 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.545 HD11 HD23 ' A' ' 101' ' ' LEU . 15.3 mt -117.68 128.33 74.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.626 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.567 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.9 m -104.11 140.07 38.3 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.597 ' CG2' HD21 ' A' ' 84' ' ' LEU . 33.7 m -140.13 158.39 25.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.43 ' HA2' ' HB3' ' A' ' 83' ' ' ARG . . . 86.84 29.61 23.02 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.994 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.453 ' HB ' ' CZ3' ' A' ' 110' ' ' TRP . 72.2 t -75.8 140.44 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-O 121.602 0.715 . . . . 0.0 111.942 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.717 ' O ' HD12 ' B' ' 172' ' ' ILE . . . 145.25 -38.93 1.21 Allowed Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -178.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.425 HG11 ' OD2' ' A' ' 139' ' ' ASP . 3.3 t -120.2 118.72 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -50.6 -30.9 14.44 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.0 m -93.59 6.82 46.97 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.44 ' HB3' ' HD3' ' A' ' 83' ' ' ARG . 16.3 m-20 -130.33 35.17 4.1 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -178.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.567 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.5 mt -106.79 138.29 33.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-O 121.357 0.599 . . . . 0.0 110.562 177.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.1 134.47 52.47 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.902 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.626 ' C ' HD22 ' A' ' 143' ' ' LEU . 46.6 t -109.37 150.24 28.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.578 0.704 . . . . 0.0 112.051 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.696 HD13 ' HA ' ' A' ' 38' ' ' CYS . 3.2 mm? -136.12 147.53 47.81 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.615 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 23.6 t -118.1 140.21 42.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.809 0.337 . . . . 0.0 111.187 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.401 HG21 HD11 ' A' ' 124' ' ' LEU . 17.1 mt -106.26 125.84 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.099 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -111.8 117.64 33.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.563 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.913 HG12 HD21 ' A' ' 124' ' ' LEU . 4.6 mt -84.83 134.05 27.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.34 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.4 ' ND2' ' HB ' ' A' ' 32' ' ' ILE . 10.4 t30 -81.36 109.63 16.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.812 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -61.17 -33.09 72.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.083 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.27 -46.01 91.31 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.987 0.422 . . . . 0.0 110.773 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -60.06 -44.15 94.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.98 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 15.9 tttm -65.01 -39.41 93.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.94 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -61.45 -40.69 95.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.713 ' SG ' HD13 ' A' ' 52' ' ' ILE . 12.1 t -60.94 -46.11 92.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.965 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 155' ' ' LEU . 3.1 mm? -62.76 -46.38 88.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.83 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.98 -37.28 75.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.769 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -69.38 -15.0 63.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.157 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -128.57 178.78 6.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.845 0.355 . . . . 0.0 111.028 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -124.38 141.65 51.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.865 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.4 m -77.29 138.87 19.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.116 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.1 t0 60.78 160.18 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.34 139.33 22.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.834 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.5 pt -98.46 112.09 29.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.12 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.943 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.879 0.371 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -122.97 76.43 49.85 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.949 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.25 176.33 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.618 2.212 . . . . 0.0 112.24 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -124.72 137.58 54.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.796 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 169' ' ' TPO . . . . . 0.471 HG23 ' N ' ' B' ' 170' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.713 HD21 ' HB3' ' A' ' 82' ' ' SER . 0.4 OUTLIER -179.52 -179.23 0.52 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.023 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . 0.535 ' O ' HG22 ' B' ' 172' ' ' ILE . 10.3 mt-10 -140.96 72.76 1.4 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.735 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 0.717 HD12 ' O ' ' A' ' 135' ' ' GLY . 18.2 tt 49.88 158.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.151 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 173' ' ' TYR . . . . . 0.421 ' N ' HG12 ' B' ' 172' ' ' ILE . 18.3 m-85 -56.21 90.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.91 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.894 -179.979 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.827 0.346 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.7 m -135.52 -45.97 0.68 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.948 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -59.95 -44.89 94.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.941 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.8 mtm-85 -59.57 -42.46 92.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.905 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -60.19 -38.52 83.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.968 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.71 -42.12 96.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.93 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.529 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 9.6 mm -71.19 -35.07 56.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.22 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -57.17 -35.49 69.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.956 0.408 . . . . 0.0 110.45 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.2 -23.92 65.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.839 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.529 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.59 -47.68 79.04 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.059 0.457 . . . . 0.0 111.227 -179.808 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 m -67.28 -37.47 83.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.844 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 65.01 -78.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.033 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -64.92 139.22 58.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.026 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -69.35 142.19 54.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.884 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.2 mm -81.88 138.36 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 CA-C-O 121.706 0.765 . . . . 0.0 111.688 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.402 ' HA2' HG12 ' A' ' 32' ' ' ILE . . . 156.31 65.81 0.01 OUTLIER Glycine 0 C--N 1.314 -0.644 0 CA-C-N 114.403 -1.271 . . . . 0.0 112.311 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -89.0 -36.34 15.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.721 0.296 . . . . 0.0 111.302 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -176.54 37.97 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.746 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -78.41 134.34 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.57 0 CA-C-N 113.88 -1.509 . . . . 0.0 112.523 -177.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.023 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.7 t -89.15 -62.01 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.301 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.8 p -149.24 153.44 37.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.458 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 24.1 ttm180 -118.11 138.15 52.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.804 0.335 . . . . 0.0 111.592 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.758 HG11 ' CE2' ' A' ' 68' ' ' PHE . 34.4 m -103.48 122.91 56.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.983 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.85 HG23 HG12 ' A' ' 45' ' ' ILE . 21.0 mt -126.8 116.37 44.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.563 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.668 ' SG ' HD12 ' A' ' 43' ' ' ILE . 0.9 OUTLIER -81.02 112.52 18.49 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.115 179.374 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.52 -20.18 40.6 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.527 HG21 ' H ' ' A' ' 142' ' ' SER . 66.5 p -79.71 -2.5 43.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.703 0.287 . . . . 0.0 111.538 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.68 72.18 0.75 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.764 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -142.25 -41.48 0.34 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.902 0.382 . . . . 0.0 110.705 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.668 HD12 ' SG ' ' A' ' 38' ' ' CYS . 3.5 mt -119.49 142.15 32.14 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.06 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.602 ' HD2' HG23 ' A' ' 43' ' ' ILE . 57.7 Cg_endo -73.65 139.92 28.77 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.208 1.938 . . . . 0.0 112.026 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.85 HG12 HG23 ' A' ' 37' ' ' ILE . 34.3 mt -55.62 149.2 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.759 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -144.41 164.0 32.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.033 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -121.75 119.99 33.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.114 0.483 . . . . 0.0 112.049 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.557 HD22 ' CD1' ' A' ' 66' ' ' TRP . 7.3 mt -92.62 137.5 32.31 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 1.023 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -144.6 158.31 43.83 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -178.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.482 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -144.73 145.8 31.87 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.661 -1.609 . . . . 0.0 110.947 178.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.746 ' O ' HG23 ' A' ' 55' ' ' VAL . 4.3 m-20 -75.19 108.22 7.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.061 0.458 . . . . 0.0 111.027 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 38.0 mt -64.53 -42.02 93.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.287 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.9 t -58.21 -41.65 84.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.313 0.577 . . . . 0.0 110.935 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.458 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 24.3 mt-30 -68.44 -36.87 79.65 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.941 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 51' ' ' ASP . 49.6 t -68.63 -38.04 78.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.882 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.98 -42.02 85.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.94 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -69.31 -34.37 74.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -83.75 122.07 28.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.892 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.3 33.11 2.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.937 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.14 -176.92 3.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.63 179.21 4.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.877 HD11 HG21 ' A' ' 65' ' ' VAL . 2.4 tp 35.9 95.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.221 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.735 ' HG2' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -90.26 -72.14 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.016 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.426 ' HE2' ' O ' ' A' ' 49' ' ' SER . 2.7 ttpt -131.24 138.61 49.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.025 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.877 HG21 HD11 ' A' ' 62' ' ' ILE . 22.0 t -134.02 139.62 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 121.384 0.611 . . . . 0.0 112.388 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.591 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 15.6 m-90 -105.09 138.95 40.51 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.948 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.689 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -115.94 125.89 53.16 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.298 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.79 ' CE1' HD12 ' A' ' 91' ' ' ILE . 2.1 m-85 -107.05 145.84 31.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.832 -178.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.669 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.63 179.84 38.94 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.578 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 18.4 mtm180 -78.66 -1.65 35.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.605 0.241 . . . . 0.0 111.382 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.481 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 7.8 t-20 -84.83 136.88 38.45 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 120.756 0.312 . . . . 0.0 111.037 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.1 Cg_exo -69.3 -5.88 16.99 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.879 2.386 . . . . 0.0 111.948 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.89 -45.66 13.94 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-O 122.04 0.924 . . . . 0.0 108.681 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -45.41 137.74 4.67 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 113.639 -1.619 . . . . 0.0 110.533 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.17 -18.89 11.4 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.061 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.662 ' CE1' HG21 ' A' ' 36' ' ' VAL . 50.7 t80 -129.59 125.0 35.19 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.652 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -98.48 112.67 24.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.034 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.642 HD23 ' HE2' ' A' ' 76' ' ' TYR . 19.5 mt -82.14 -69.27 0.63 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 174.93 -91.15 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.28 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.2 p30 -178.85 54.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.828 0.347 . . . . 0.0 111.098 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 30.1 mm -88.91 124.76 41.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.154 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.775 ' HB3' HD13 ' B' ' 170' ' ' LEU . 0.3 OUTLIER -55.69 -42.32 75.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.062 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.727 ' NH1' HD21 ' B' ' 170' ' ' LEU . 0.4 OUTLIER -60.96 -18.73 58.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.43 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.661 HD21 HG23 ' A' ' 132' ' ' VAL . 26.5 mt -104.0 152.14 22.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.763 0.316 . . . . 0.0 111.228 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 p -96.66 170.21 9.35 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.562 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.669 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 6.1 m-20 -43.81 -56.74 3.65 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.276 0.56 . . . . 0.0 109.693 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.446 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -117.85 84.84 2.23 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 177.177 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.587 ' CD2' ' HB2' ' A' ' 105' ' ' SER . 14.9 t60 -59.34 -46.26 89.12 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.907 -1.042 . . . . 0.0 113.11 -176.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.507 ' CZ ' ' CD2' ' A' ' 68' ' ' PHE . 22.4 p90 -149.3 158.53 44.25 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.919 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.689 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.5 tt0 -136.18 138.55 42.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.834 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.79 HD12 ' CE1' ' A' ' 68' ' ' PHE . 4.4 mt -114.15 129.29 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 C-N-CA 121.122 -0.231 . . . . 0.0 110.649 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.663 ' CB ' HG22 ' A' ' 65' ' ' VAL . 2.2 pp -123.23 144.93 49.07 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 121.058 0.456 . . . . 0.0 111.864 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.644 HD13 ' CG1' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -125.22 122.95 38.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.253 179.198 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -123.93 -168.4 12.94 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.729 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -76.41 110.82 11.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.838 0.352 . . . . 0.0 110.902 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -178.5 -39.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.841 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 123.4 -24.73 6.46 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.471 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -114.02 -178.1 3.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.804 0.335 . . . . 0.0 111.01 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.813 HD21 HG12 ' A' ' 33' ' ' VAL . 1.4 mp -107.95 160.26 15.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.751 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.451 HD12 ' O ' ' A' ' 99' ' ' LEU . 4.1 mp -124.14 142.57 51.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.436 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.738 HD11 ' HA ' ' A' ' 124' ' ' LEU . 0.5 OUTLIER -112.88 123.98 51.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.135 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -118.99 115.67 24.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.963 0.411 . . . . 0.0 111.69 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.788 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.3 p30 -78.95 139.57 38.22 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.488 HG12 ' HA ' ' A' ' 89' ' ' PHE . 11.5 pt -143.16 26.49 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.909 -0.317 . . . . 0.0 111.824 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.587 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 10.6 t -92.11 155.62 17.93 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 121.534 0.683 . . . . 0.0 112.63 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.786 ' CB ' HG21 ' B' ' 169' ' ' TPO . 42.3 m -69.95 -52.1 27.3 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.583 178.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -77.59 -1.7 32.04 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.292 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.92 156.31 31.99 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.615 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.513 HG22 ' CG2' ' A' ' 130' ' ' ILE . 4.3 m -117.41 137.73 52.29 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.87 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -113.89 148.58 36.51 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -177.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.465 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.06 113.45 18.4 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.594 -1.185 . . . . 0.0 108.442 177.546 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.401 ' N ' HD12 ' A' ' 111' ' ' LEU . 57.1 m-20 44.47 43.37 6.23 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.1 -11.14 65.96 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.508 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -103.15 118.57 37.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.03 0.443 . . . . 0.0 110.508 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.87 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 2.5 tptm -72.6 112.72 8.9 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.373 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.788 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.0 m -84.44 162.69 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.775 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.3 OUTLIER -69.78 128.8 37.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.497 179.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.687 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 26.6 tttm -54.83 161.51 1.55 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.934 0.397 . . . . 0.0 110.316 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.503 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.1 p30 36.24 32.97 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.334 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.5 144.94 41.12 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.771 179.188 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.645 ' OD1' HD21 ' A' ' 92' ' ' LEU . 13.5 m-80 -92.49 132.23 36.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.006 0.431 . . . . 0.0 111.147 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.735 ' O ' HD12 ' A' ' 101' ' ' LEU . 42.9 mm-40 -129.38 150.71 50.63 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.581 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.648 HD23 ' O ' ' A' ' 124' ' ' LEU . 3.1 tt -72.67 135.99 45.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.269 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.811 HD21 HG12 ' A' ' 147' ' ' ILE . 64.6 tp -63.54 154.5 32.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.613 0.72 . . . . 0.0 111.698 -179.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.413 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -124.97 153.06 43.35 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.373 179.606 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.81 122.8 21.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.909 0.385 . . . . 0.0 110.236 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.87 23.41 50.93 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.961 -0.637 . . . . 0.0 112.236 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -51.64 170.38 0.05 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.836 0.351 . . . . 0.0 110.983 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.902 ' CG ' HG22 ' A' ' 144' ' ' VAL . 4.7 mt-10 -145.14 135.61 24.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.184 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.756 HD11 HD11 ' A' ' 145' ' ' ILE . 14.8 mt -113.09 126.32 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.578 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.587 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.3 m -104.59 140.26 38.26 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.661 HG23 HD21 ' A' ' 84' ' ' LEU . 35.4 m -140.36 158.58 25.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.28 28.82 29.44 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.073 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.475 ' HA ' HG12 ' A' ' 140' ' ' ILE . 70.2 t -74.07 140.33 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-O 121.583 0.706 . . . . 0.0 111.945 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.644 ' HA3' HG21 ' B' ' 172' ' ' ILE . . . 140.92 -42.05 1.22 Allowed Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -178.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.938 HG22 HD13 ' B' ' 172' ' ' ILE . 2.2 t -117.32 123.41 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.3 -35.04 25.67 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 84.0 p -93.59 6.62 47.64 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -121.65 28.61 7.58 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.587 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.1 mt -107.36 137.88 36.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.49 0.662 . . . . 0.0 111.348 178.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.474 HD21 ' SG ' ' A' ' 38' ' ' CYS . 9.5 tt -125.37 134.61 52.11 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.079 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.527 ' H ' HG21 ' A' ' 40' ' ' THR . 46.3 t -108.47 150.06 27.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.702 0.763 . . . . 0.0 112.181 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.477 HD12 ' O ' ' A' ' 130' ' ' ILE . 4.0 mp -135.15 150.48 50.17 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.74 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.902 HG22 ' CG ' ' A' ' 129' ' ' GLU . 21.3 t -121.79 134.83 63.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.741 0.305 . . . . 0.0 111.025 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.756 HD11 HD11 ' A' ' 130' ' ' ILE . 16.9 mt -106.35 123.07 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-O 120.89 0.376 . . . . 0.0 111.039 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.73 119.26 38.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.777 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.811 HG12 HD21 ' A' ' 124' ' ' LEU . 2.5 mt -84.98 134.11 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.352 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -79.77 116.34 19.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.765 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -58.39 -31.95 68.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.075 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 17.0 mmmt -60.32 -46.07 91.18 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.773 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -60.69 -44.19 96.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.018 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -65.14 -49.52 69.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.89 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -38.85 79.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.996 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.8 t -60.04 -46.04 90.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.979 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.0 -43.94 73.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.946 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.68 -35.34 74.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.97 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -81.62 -30.75 32.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.897 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -121.89 82.09 1.91 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.948 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.7 tttt -65.78 155.0 37.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.928 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 17.6 m -75.94 124.59 34.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.123 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -129.29 -177.12 4.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.912 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 62.3 mtt85 -98.79 34.32 2.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.872 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 10.2 mt -96.7 111.04 25.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.13 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 48.3 mmm-85 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.915 179.964 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 2.9 m120 . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.766 0.317 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -173.74 134.29 0.61 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.012 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -73.17 140.19 30.57 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.514 2.142 . . . . 0.0 112.207 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -104.18 63.52 0.75 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.03 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 169' ' ' TPO . . . . . 0.786 HG21 ' CB ' ' A' ' 106' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.775 HD13 ' HB3' ' A' ' 82' ' ' SER . 1.6 tt -90.48 151.39 21.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.013 0.435 . . . . 0.0 111.108 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -147.21 139.37 24.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.594 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 0.938 HD13 HG22 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -50.15 128.97 7.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.079 0.466 . . . . 0.0 111.363 -179.746 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 173' ' ' TYR . . . . . 0.882 ' N ' HD12 ' B' ' 172' ' ' ILE . 2.0 p90 -66.59 -178.19 0.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.869 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 2.4 m . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.89 179.887 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.812 0.339 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.8 m -137.84 -54.11 0.65 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.848 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.27 -34.52 76.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.897 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -36.09 79.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.831 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.89 -39.67 94.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.899 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 19' ' ' LEU . 12.3 mt -58.49 -40.34 82.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.808 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.534 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.4 mm -70.14 -34.93 61.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.133 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.26 -33.66 67.84 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.481 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -67.24 -23.92 65.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.866 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.534 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.91 -47.56 80.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.187 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -61.1 -33.61 73.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.358 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -51.5 -47.93 63.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.86 0.362 . . . . 0.0 111.11 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.02 120.96 32.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.721 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -98.82 128.02 44.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.944 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.2 mm -81.94 138.31 19.72 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 CA-C-O 121.6 0.714 . . . . 0.0 111.613 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -139.01 89.9 0.2 Allowed Glycine 0 C--N 1.314 -0.674 0 CA-C-N 114.586 -1.188 . . . . 0.0 112.745 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -83.02 -37.35 24.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.958 0.409 . . . . 0.0 110.553 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.468 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER -179.27 37.17 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 179.83 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.709 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.7 mm -75.57 135.55 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 CA-C-N 113.686 -1.597 . . . . 0.0 112.655 -177.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.037 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -93.19 -60.75 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.062 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.63 ' SG ' HD12 ' A' ' 48' ' ' LEU . 1.9 p -145.44 145.42 31.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.301 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.426 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.92 138.07 50.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.797 0.332 . . . . 0.0 111.485 -179.237 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.662 HG21 ' CE2' ' A' ' 68' ' ' PHE . 44.6 t -107.17 122.75 61.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.95 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.817 HG23 HG12 ' A' ' 45' ' ' ILE . 17.8 mt -124.07 120.27 59.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.591 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.737 ' HA ' HD23 ' A' ' 143' ' ' LEU . 46.8 t -79.88 119.61 22.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.357 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.59 -23.2 22.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.648 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.534 HG21 ' H ' ' A' ' 142' ' ' SER . 63.5 p -79.8 -2.33 42.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.782 0.325 . . . . 0.0 111.459 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.35 73.58 0.52 Allowed Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.814 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -145.92 -37.76 0.25 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.777 0.322 . . . . 0.0 111.117 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.589 HD13 ' HB3' ' A' ' 78' ' ' LEU . 2.6 mt -121.54 140.96 32.52 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.928 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.547 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.2 Cg_endo -73.22 140.36 30.68 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.191 1.927 . . . . 0.0 112.087 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.817 HG12 HG23 ' A' ' 37' ' ' ILE . 34.6 mt -56.62 134.16 20.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.706 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.463 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -122.57 163.03 20.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.256 179.367 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.426 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.7 OUTLIER -118.89 120.63 37.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.083 0.468 . . . . 0.0 112.162 -179.326 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.63 HD12 ' SG ' ' A' ' 34' ' ' CYS . 1.6 mt -96.86 133.71 41.12 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 1.037 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.24 158.91 43.91 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -178.526 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.501 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -144.38 141.89 29.98 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 113.586 -1.643 . . . . 0.0 110.731 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.542 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -78.11 141.84 38.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.068 0.461 . . . . 0.0 111.093 -179.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.622 HD13 ' SG ' ' A' ' 154' ' ' CYS . 89.2 mt -64.05 -42.49 95.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.557 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.4 p -56.63 -38.22 71.81 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.588 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.491 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 1.6 mt-30 -68.32 -36.88 79.97 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.306 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 51' ' ' ASP . 44.6 t -73.04 -41.48 59.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.948 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 tp -71.08 -32.26 68.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.807 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.45 -43.58 80.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.815 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -63.29 117.41 6.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.871 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -82.65 80.32 8.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.893 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.27 82.19 0.16 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.874 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.16 -170.14 0.28 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.824 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.59 HD11 HG22 ' A' ' 65' ' ' VAL . 9.1 tp -68.75 148.17 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.953 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.531 ' HE3' HG13 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -116.75 -61.0 1.78 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.013 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.415 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.1 ttpt -155.06 133.28 11.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.319 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.59 HG22 HD11 ' A' ' 62' ' ' ILE . 5.8 t -123.24 138.08 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-O 121.234 0.54 . . . . 0.0 111.768 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.554 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.3 m-90 -102.31 139.71 37.56 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.302 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.979 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -111.83 128.42 56.11 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 176.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.677 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.4 OUTLIER -118.66 145.28 45.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.264 -178.153 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.629 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.06 -172.4 38.19 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.748 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 27.2 mtm180 -78.69 3.2 17.12 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.516 HD22 ' HB3' ' A' ' 73' ' ' ALA . 1.9 t30 -84.69 132.46 46.47 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.687 0.279 . . . . 0.0 111.005 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.2 Cg_exo -65.98 -13.67 40.95 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.585 2.19 . . . . 0.0 111.68 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.516 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.74 -43.05 17.26 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.967 0.889 . . . . 0.0 108.953 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.23 138.7 1.6 Allowed 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 113.792 -1.549 . . . . 0.0 110.828 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.1 m-20 -56.42 -18.93 12.73 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.968 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.506 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 25.6 t80 -129.83 123.27 30.49 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.141 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -100.14 118.69 37.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.555 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.626 HD13 HD23 ' A' ' 84' ' ' LEU . 0.8 OUTLIER -125.39 72.36 1.25 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.247 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 48.97 -135.49 21.34 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.959 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -158.96 81.09 0.78 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.797 0.332 . . . . 0.0 110.92 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.639 HD13 HD22 ' A' ' 84' ' ' LEU . 4.9 mp -95.52 140.43 16.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.033 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.76 ' HB3' HD13 ' B' ' 170' ' ' LEU . 3.2 m -55.61 -45.0 77.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.132 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.531 ' N ' HD22 ' B' ' 170' ' ' LEU . 0.0 OUTLIER -60.74 -49.07 78.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.753 -179.357 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.639 HD22 HD13 ' A' ' 81' ' ' ILE . 4.3 mp -72.56 152.88 41.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.209 0.528 . . . . 0.0 111.215 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.6 p -102.48 168.27 9.41 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.758 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.629 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 9.0 m-20 -42.47 -60.02 1.66 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.389 0.614 . . . . 0.0 109.527 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.598 ' HB3' HG22 ' A' ' 67' ' ' THR . 3.0 mtmp? -115.63 84.58 2.12 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 176.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.627 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 10.2 t60 -61.45 -44.58 96.87 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.242 -0.89 . . . . 0.0 113.02 -176.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.533 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 12.1 p90 -146.16 162.87 37.04 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.07 -0.652 . . . . 0.0 112.254 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.979 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.54 138.03 42.63 Favored 'General case' 0 C--O 1.227 -0.111 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.006 -179.099 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.677 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 62.2 mt -114.86 129.23 71.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.656 178.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.859 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -108.0 148.07 30.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.994 0.426 . . . . 0.0 111.294 -179.623 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.828 HD22 HG11 ' A' ' 33' ' ' VAL . 49.7 tp -125.13 123.41 39.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.543 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 155.1 -149.86 21.21 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.529 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.91 83.57 0.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.945 0.403 . . . . 0.0 110.817 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.04 29.95 18.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.981 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 72.81 33.33 60.28 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.543 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.2 m-20 -108.66 178.62 4.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.864 0.364 . . . . 0.0 110.91 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.699 ' C ' HD12 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -116.74 138.84 51.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.81 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.877 HD23 ' HB3' ' A' ' 121' ' ' ASN . 11.1 mp -131.2 143.96 50.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.671 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.524 HD11 ' CD1' ' A' ' 130' ' ' ILE . 0.9 OUTLIER -112.61 125.26 54.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.128 179.715 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.859 ' HB2' HD11 ' A' ' 92' ' ' LEU . 49.0 t30 -115.72 115.71 26.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.901 0.382 . . . . 0.0 111.584 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.778 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.0 p30 -78.87 136.23 37.24 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.034 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.476 HD12 ' HB2' ' A' ' 87' ' ' LYS . 12.9 pt -144.28 39.7 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.58 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -97.42 157.01 16.21 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.191 0.52 . . . . 0.0 111.92 -178.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 92.4 m -69.11 -36.27 77.33 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.433 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 19.8 p30 -98.51 -19.86 17.4 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.58 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 122.66 156.07 9.52 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.277 -0.963 . . . . 0.0 113.515 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.523 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 4.8 m -117.68 137.78 52.43 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 122.818 0.447 . . . . 0.0 109.832 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.858 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -119.32 148.1 43.55 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -178.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.74 HD23 ' O ' ' A' ' 114' ' ' GLN . 0.7 OUTLIER -124.75 113.56 18.12 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.544 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 45.1 m-20 49.45 42.02 21.85 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 83.98 -6.05 76.68 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.924 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.74 ' O ' HD23 ' A' ' 111' ' ' LEU . 4.4 mt-30 -103.97 118.92 37.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.189 0.495 . . . . 0.0 110.589 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.858 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 7.3 tptt -74.92 127.14 32.5 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.339 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.778 HG23 ' OD2' ' A' ' 103' ' ' ASP . 13.2 m -103.0 164.09 3.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.883 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 120' ' ' SER . 9.9 tp10 -69.76 128.04 35.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.422 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.693 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 56.4 tttt -53.8 161.78 1.06 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.719 0.295 . . . . 0.0 110.414 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.9 p30 35.23 34.77 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.141 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.22 145.11 40.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.363 179.61 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.877 ' HB3' HD23 ' A' ' 100' ' ' LEU . 6.5 m120 -89.14 125.48 35.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.589 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -129.5 148.73 51.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.201 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.617 HD23 ' O ' ' A' ' 124' ' ' LEU . 5.3 tt -72.83 114.53 11.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.015 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.733 HD21 HD13 ' A' ' 145' ' ' ILE . 5.2 mt -55.11 166.26 0.57 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.654 0.74 . . . . 0.0 112.063 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.428 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.6 OUTLIER -125.4 152.71 44.46 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.488 179.334 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.44 ' HA ' HD12 ' A' ' 147' ' ' ILE . 15.2 tp60 -71.95 124.48 24.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.87 0.366 . . . . 0.0 110.352 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 145' ' ' ILE . . . 58.35 20.92 46.44 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.227 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.428 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 8.3 t70 -56.85 178.67 0.05 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.656 0.265 . . . . 0.0 110.809 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.899 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.2 mt-10 -145.19 135.73 24.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.124 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.751 HD11 HD11 ' A' ' 145' ' ' ILE . 8.1 mt -108.9 124.62 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 121.005 0.431 . . . . 0.0 110.831 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.534 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.7 m -104.37 143.19 33.32 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.627 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 27.0 m -140.22 158.37 25.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.498 ' HA2' ' HG3' ' A' ' 83' ' ' ARG . . . 74.29 45.17 25.76 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.312 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.548 ' HA ' HG12 ' A' ' 140' ' ' ILE . 95.3 t -85.41 140.62 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 121.675 0.75 . . . . 0.0 112.379 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 140.29 -38.08 1.63 Allowed Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -178.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 1.161 HG23 HD11 ' B' ' 172' ' ' ILE . 1.1 t -126.49 118.68 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.463 ' HA ' HD12 ' A' ' 140' ' ' ILE . 3.2 mp0 -50.36 -24.75 3.21 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 17.0 m -93.18 4.49 53.9 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.475 ' N ' HG12 ' A' ' 136' ' ' VAL . 1.5 m-20 -128.96 26.73 5.49 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.548 HG12 ' HA ' ' A' ' 134' ' ' VAL . 6.3 mt -107.15 138.24 34.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-O 121.464 0.649 . . . . 0.0 111.487 178.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.4 tt -125.47 134.68 51.98 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.207 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.534 ' H ' HG21 ' A' ' 40' ' ' THR . 42.2 t -113.03 147.53 37.02 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.797 0.808 . . . . 0.0 112.355 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.737 HD23 ' HA ' ' A' ' 38' ' ' CYS . 77.8 mt -136.55 157.27 47.16 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.855 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.899 HG22 ' CG ' ' A' ' 129' ' ' GLU . 26.2 t -120.64 139.14 48.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.824 0.345 . . . . 0.0 110.995 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.751 HD11 HD11 ' A' ' 130' ' ' ILE . 70.0 mt -106.33 120.93 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.16 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.74 109.49 19.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.536 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' A' ' 126' ' ' GLN . 6.2 mt -84.64 132.11 32.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.476 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -78.5 113.39 16.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.815 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -64.57 -30.53 71.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.064 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.82 -46.13 91.73 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.763 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -61.7 -44.16 97.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.095 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -64.19 -37.7 88.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.074 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.98 -40.04 83.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.173 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.622 ' SG ' HD13 ' A' ' 52' ' ' ILE . 9.0 t -67.95 -44.56 76.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.121 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -69.06 -41.74 77.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.009 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -42.82 93.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.003 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -84.56 -37.04 21.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.951 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.7 p30 44.13 -171.31 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.565 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.55 117.38 21.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.892 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.36 133.63 33.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.154 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -79.45 -42.1 26.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.84 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 -159.45 134.58 8.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.926 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 32.6 mt -100.56 125.99 54.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.142 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.899 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.773 0.32 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -79.03 149.55 73.57 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.999 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.16 161.83 44.53 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.583 2.189 . . . . 0.0 112.276 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -142.42 167.62 21.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.969 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.76 HD13 ' HB3' ' A' ' 82' ' ' SER . 0.9 OUTLIER -53.71 148.93 9.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.075 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . 0.6 ' O ' HG22 ' B' ' 172' ' ' ILE . 13.4 mt-10 -140.03 45.85 1.87 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.171 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 1.161 HD11 HG23 ' A' ' 136' ' ' VAL . 10.4 tt 50.27 156.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.035 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 173' ' ' TYR . . . . . 0.498 ' N ' HG12 ' B' ' 172' ' ' ILE . 13.3 m-85 -56.52 -171.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.04 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 32.9 t . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.892 -179.991 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.81 0.338 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.456 HG23 ' H ' ' A' ' 16' ' ' GLN . 1.1 t -140.42 -55.33 0.52 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.924 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.456 ' H ' HG23 ' A' ' 15' ' ' THR . 7.1 mt-30 -72.21 -32.62 66.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.878 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 -65.45 -37.55 87.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.005 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -57.07 -41.22 78.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.639 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.08 -31.78 71.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.5 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.6 mt -70.41 -43.76 77.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.864 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -57.8 -34.04 69.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.02 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -35.54 80.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.005 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -58.11 -47.32 83.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.012 0.434 . . . . 0.0 111.167 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.88 -30.85 71.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.963 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -59.1 -29.61 67.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.889 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.05 120.97 12.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.861 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -102.07 102.03 12.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.937 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.5 mm -81.92 138.36 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-O 121.629 0.728 . . . . 0.0 111.674 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.9 120.52 4.5 Favored Glycine 0 C--N 1.314 -0.659 0 CA-C-N 114.487 -1.233 . . . . 0.0 112.554 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -84.79 -27.82 26.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.831 0.348 . . . . 0.0 110.964 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER -179.27 37.82 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.675 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.0 mm -75.23 137.13 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 CA-C-N 113.632 -1.622 . . . . 0.0 112.778 -177.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.02 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.1 t -91.86 -58.89 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.497 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.72 ' SG ' HD22 ' A' ' 48' ' ' LEU . 4.6 p -147.88 165.41 30.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.444 179.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -133.28 138.31 46.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.854 0.359 . . . . 0.0 111.323 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.708 HG21 ' CE2' ' A' ' 68' ' ' PHE . 42.8 t -107.23 122.82 61.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.955 0.407 . . . . 0.0 110.916 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.816 HG23 HG12 ' A' ' 45' ' ' ILE . 13.2 mt -122.23 121.9 65.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.508 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.74 ' HA ' HD13 ' A' ' 143' ' ' LEU . 42.4 t -79.86 117.02 20.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.684 0.278 . . . . 0.0 110.663 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.555 HG23 HG21 ' A' ' 144' ' ' VAL . 0.6 OUTLIER -86.08 -23.36 26.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.37 -179.706 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.513 HG21 ' H ' ' A' ' 142' ' ' SER . 72.4 p -79.81 -2.33 42.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.838 0.351 . . . . 0.0 111.342 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.3 73.58 0.48 Allowed Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.203 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.436 ' HG3' HD21 ' A' ' 141' ' ' LEU . 1.8 mt-30 -146.79 -39.17 0.21 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.683 0.278 . . . . 0.0 111.181 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.557 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.8 mt -118.9 141.02 29.4 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.783 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.557 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 54.2 Cg_endo -72.28 144.54 41.65 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.157 1.905 . . . . 0.0 112.209 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.816 HG12 HG23 ' A' ' 37' ' ' ILE . 43.9 mt -56.45 144.6 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.66 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.497 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.2 OUTLIER -128.24 161.98 28.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.02 179.338 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -123.31 119.56 30.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.971 0.415 . . . . 0.0 111.465 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.85 HD23 ' CD2' ' A' ' 66' ' ' TRP . 6.9 mp -92.29 130.41 37.99 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 1.02 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -142.03 155.37 45.41 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 122.257 1.027 . . . . 0.0 113.524 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.46 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -141.38 141.74 33.77 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 113.387 -1.733 . . . . 0.0 110.712 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.759 ' O ' HG23 ' A' ' 55' ' ' VAL . 2.3 m-20 -78.09 129.22 34.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.168 0.509 . . . . 0.0 111.089 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.4 mm -64.36 -41.65 93.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.383 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.3 m -57.29 -41.85 80.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.205 0.526 . . . . 0.0 110.898 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.491 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 11.5 mt-30 -68.44 -37.0 79.83 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.825 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.777 HG13 ' HD3' ' A' ' 63' ' ' LYS . 42.5 t -66.25 -39.89 85.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.947 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 tp -71.27 -42.02 69.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.319 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.69 -30.84 56.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.333 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -82.36 127.81 33.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.809 0.338 . . . . 0.0 110.871 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -130.49 15.95 5.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.247 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.5 ttt85 -142.15 149.57 39.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.694 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 m 60.04 162.7 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.679 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.67 HD13 HD12 ' A' ' 92' ' ' LEU . 4.7 tp -61.25 141.41 17.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.096 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.777 ' HD3' HG13 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -57.99 -69.75 0.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.991 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.438 ' CE ' ' O ' ' A' ' 49' ' ' SER . 4.7 ttpt -152.62 136.88 16.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.131 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.583 HG12 ' HG2' ' A' ' 90' ' ' GLN . 10.8 t -126.48 139.07 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-O 121.31 0.576 . . . . 0.0 112.016 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.85 ' CD2' HD23 ' A' ' 48' ' ' LEU . 17.7 m-90 -104.36 139.31 39.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.373 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.706 HG22 ' HB3' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -112.69 132.28 55.27 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 177.531 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.757 ' HZ ' HD21 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -118.67 145.55 45.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.899 0.38 . . . . 0.0 111.665 -178.728 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.65 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.49 -170.14 37.98 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.902 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.43 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 4.5 mtm105 -80.21 1.63 27.57 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.502 HD22 ' HB3' ' A' ' 73' ' ' ALA . 2.1 t30 -84.81 132.96 44.6 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.624 0.25 . . . . 0.0 111.16 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.28 -13.07 38.26 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.661 2.241 . . . . 0.0 111.796 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.502 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.62 -43.47 16.95 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-O 121.801 0.81 . . . . 0.0 108.856 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.22 140.4 1.16 Allowed 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 113.887 -1.506 . . . . 0.0 110.633 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.9 m-20 -56.29 -18.96 12.19 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.972 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.497 ' CE1' ' HB2' ' A' ' 46' ' ' ARG . 10.9 t80 -129.62 124.3 33.4 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 120.784 0.326 . . . . 0.0 110.98 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -95.56 107.85 20.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.522 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.438 HD13 ' N ' ' A' ' 69' ' ' GLY . 11.1 mp -82.75 -78.58 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.914 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -173.38 -88.53 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.02 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.0 p30 174.7 49.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.886 0.374 . . . . 0.0 111.117 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 1.11 HD13 HD12 ' A' ' 84' ' ' LEU . 4.1 mp -78.59 126.79 38.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.865 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.465 ' HB2' HD11 ' B' ' 170' ' ' LEU . 0.6 OUTLIER -54.87 -40.65 69.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.909 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.646 ' HA ' HD12 ' B' ' 170' ' ' LEU . 2.0 mmp_? -62.81 -49.13 76.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.267 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.11 HD12 HD13 ' A' ' 81' ' ' ILE . 23.2 mt -72.69 150.44 42.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.223 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.8 p -94.55 167.05 11.73 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.668 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.65 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.5 m-20 -43.73 -53.75 5.62 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.292 0.568 . . . . 0.0 109.744 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.706 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.1 OUTLIER -120.25 83.2 2.02 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 177.184 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.557 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.7 t60 -58.97 -45.88 89.47 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.221 -0.899 . . . . 0.0 112.634 -176.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.513 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 20.3 p90 -144.5 159.91 41.98 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.972 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.697 ' HG3' HG23 ' A' ' 67' ' ' THR . 3.6 tt0 -136.31 140.68 43.53 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.246 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.63 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 72.8 mt -115.78 130.19 70.86 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.706 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.67 HD12 HD13 ' A' ' 62' ' ' ILE . 0.6 OUTLIER -114.96 148.84 38.23 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.115 0.483 . . . . 0.0 111.776 -179.587 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.712 HD22 HG11 ' A' ' 33' ' ' VAL . 17.8 tp -125.16 122.79 38.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.308 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -84.42 178.88 51.65 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.672 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -57.57 -60.58 3.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.802 0.334 . . . . 0.0 110.86 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -68.92 175.64 3.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.659 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.99 -169.52 0.25 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.477 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 66.02 136.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.839 0.352 . . . . 0.0 111.137 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 1.005 HD21 HG12 ' A' ' 33' ' ' VAL . 5.2 mp -106.96 160.26 15.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.879 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.585 HD23 ' HB3' ' A' ' 121' ' ' ASN . 3.3 mp -121.52 147.1 46.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.224 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.635 HD11 HG12 ' A' ' 130' ' ' ILE . 1.1 tt -112.84 123.6 50.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.467 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.441 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 49.1 t30 -116.0 115.49 26.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.983 0.42 . . . . 0.0 111.256 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.776 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.1 p30 -79.97 134.0 36.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.951 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.494 HD12 ' HB2' ' A' ' 87' ' ' LYS . 10.6 pt -141.61 40.88 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -178.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.59 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -100.87 152.32 20.68 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 120.914 0.388 . . . . 0.0 111.254 -179.245 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.428 ' OG1' HG21 ' B' ' 169' ' ' TPO . 53.5 m -68.94 -32.1 71.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.316 178.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.441 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 27.9 p30 -98.62 -19.72 17.4 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.59 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.92 155.45 9.55 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.314 -0.946 . . . . 0.0 113.731 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.547 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.9 m -117.43 137.95 52.16 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.848 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -115.34 148.41 39.3 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -177.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.479 HD13 ' OD2' ' A' ' 128' ' ' ASP . 0.2 OUTLIER -124.18 113.37 18.23 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.238 177.371 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.406 ' N ' HD12 ' A' ' 111' ' ' LEU . 48.4 m-20 45.61 42.94 8.79 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.2 -6.27 80.14 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.549 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.55 118.61 37.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 117.018 0.409 . . . . 0.0 110.787 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.848 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 17.7 tptt -73.72 126.97 31.55 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.181 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.776 HG23 ' OD2' ' A' ' 103' ' ' ASP . 9.7 m -102.56 165.34 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.285 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.401 ' O ' ' HB3' ' A' ' 120' ' ' SER . 2.5 tt0 -69.89 128.86 37.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.423 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.691 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 76.7 tttt -54.1 164.23 0.67 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.3 m-80 33.6 37.0 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.803 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.9 p -111.77 145.11 39.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.005 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.585 ' HB3' HD23 ' A' ' 100' ' ' LEU . 22.4 m120 -92.41 127.07 37.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.806 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.415 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 57.6 mm-40 -129.31 149.13 51.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.743 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.1 tp -72.86 128.83 36.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.386 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.584 HD23 HG12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -59.75 160.92 6.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.649 0.738 . . . . 0.0 112.173 -179.23 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.713 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.4 OUTLIER -124.99 153.3 42.99 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.636 -1.166 . . . . 0.0 110.034 179.308 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.605 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.44 119.2 15.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.882 0.373 . . . . 0.0 110.375 -179.71 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.52 26.42 56.91 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.036 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.496 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 7.6 t70 -57.24 175.24 0.15 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 120.914 0.388 . . . . 0.0 111.052 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.859 ' CG ' HG22 ' A' ' 144' ' ' VAL . 4.6 mt-10 -145.36 135.63 24.0 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.059 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 1.058 HD11 HD11 ' A' ' 145' ' ' ILE . 3.3 mt -110.07 127.93 66.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.832 0.348 . . . . 0.0 110.497 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.594 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.36 138.89 40.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.851 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.515 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 30.8 m -140.17 158.41 25.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.12 27.65 30.39 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.955 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.466 ' HA ' HG12 ' A' ' 140' ' ' ILE . 72.9 t -72.01 140.44 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-O 121.724 0.773 . . . . 0.0 112.197 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.656 ' C ' HD12 ' B' ' 172' ' ' ILE . . . 147.7 -49.75 0.6 Allowed Glycine 0 N--CA 1.434 -1.452 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -178.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.671 HG22 HG13 ' B' ' 172' ' ' ILE . 2.5 t -109.97 125.55 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -50.18 -35.7 27.38 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.2 t -93.57 6.67 47.47 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.422 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . 0.9 OUTLIER -122.3 31.61 6.09 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -178.473 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.594 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.4 mt -106.49 138.94 29.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-O 121.399 0.619 . . . . 0.0 110.898 178.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.459 ' HA ' HD22 ' A' ' 141' ' ' LEU . 0.4 OUTLIER -124.51 134.64 52.95 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.557 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.659 ' C ' HD22 ' A' ' 143' ' ' LEU . 39.4 t -111.15 150.16 29.87 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.653 0.74 . . . . 0.0 112.429 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.74 HD13 ' HA ' ' A' ' 38' ' ' CYS . 3.5 mm? -136.35 153.43 51.13 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.503 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.859 HG22 ' CG ' ' A' ' 129' ' ' GLU . 15.4 t -118.16 140.33 41.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.817 0.341 . . . . 0.0 111.067 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 1.058 HD11 HD11 ' A' ' 130' ' ' ILE . 41.6 mt -106.05 120.96 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.032 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.19 111.31 22.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.834 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.713 HD11 ' O ' ' A' ' 125' ' ' SER . 4.2 mp -85.55 129.45 37.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.342 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -81.08 128.64 33.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.01 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -74.06 -29.62 61.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.189 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.3 tttt -59.0 -43.69 91.54 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.851 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -63.47 -43.01 98.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.039 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -60.71 -50.1 74.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.214 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -60.28 -36.91 78.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.168 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 10.5 t -65.21 -45.89 82.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.956 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -67.51 -36.0 80.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.821 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -64.88 -33.99 77.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.956 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.82 -36.62 13.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.892 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.4 p30 42.68 87.5 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.481 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 11.0 mmmt -123.83 138.12 54.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.909 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.7 t -77.44 126.98 38.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.057 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -162.31 146.48 12.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.912 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -93.45 149.02 21.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.919 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 19.4 pt -91.82 130.83 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.071 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.902 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.809 0.338 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -113.25 90.49 16.78 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.86 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_exo -51.66 114.88 1.78 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.554 2.169 . . . . 0.0 112.333 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -111.05 134.63 52.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 169' ' ' TPO . . . . . 0.444 HG23 ' N ' ' B' ' 170' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.646 HD12 ' HA ' ' A' ' 83' ' ' ARG . 0.4 OUTLIER -175.2 177.6 1.86 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.006 -179.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . 0.606 ' O ' HG22 ' B' ' 172' ' ' ILE . 29.7 mt-10 -141.33 72.64 1.39 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.902 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 0.671 HG13 HG22 ' A' ' 136' ' ' VAL . 19.6 tt 50.37 159.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.173 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 173' ' ' TYR . . . . . 0.46 ' N ' HG12 ' B' ' 172' ' ' ILE . 3.5 m-85 -64.97 76.82 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.816 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.866 -179.915 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.605 ' HB1' ' HD3' ' A' ' 17' ' ' ARG . . . . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.836 0.35 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.37 -31.6 29.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.87 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -69.78 -46.91 64.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.605 ' HD3' ' HB1' ' A' ' 14' ' ' ALA . 0.7 OUTLIER -68.91 -37.95 79.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.891 180.0 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -63.93 -35.87 82.07 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.36 -41.81 97.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.921 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.505 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 9.4 mm -69.6 -35.07 64.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.151 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -57.19 -36.4 70.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.877 0.37 . . . . 0.0 110.368 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.7 ttpp -67.3 -23.83 65.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.755 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.505 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.7 -47.47 79.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.239 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.0 t -78.43 -44.16 25.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.828 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -99.29 104.44 16.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.19 139.28 48.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.1 102.03 6.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.917 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.9 mm -84.03 138.22 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-O 121.695 0.759 . . . . 0.0 111.768 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -169.32 39.25 0.2 Allowed Glycine 0 C--N 1.314 -0.681 0 CA-C-N 114.458 -1.246 . . . . 0.0 112.455 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -76.99 -42.47 38.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.819 0.343 . . . . 0.0 111.0 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.438 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER -170.99 34.77 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.71 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 2.9 mm -77.1 131.55 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-N 113.887 -1.506 . . . . 0.0 112.388 -177.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.034 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -90.42 -62.0 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 114.623 -1.172 . . . . 0.0 110.442 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.506 ' SG ' HD12 ' A' ' 48' ' ' LEU . 4.0 p -147.89 142.53 26.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.441 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -113.83 134.1 55.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.976 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.69 HG21 ' HE2' ' A' ' 68' ' ' PHE . 38.5 t -97.45 122.88 49.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.97 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.795 HG23 HG12 ' A' ' 45' ' ' ILE . 15.5 mt -119.8 110.93 30.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.653 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 1.1 m -84.53 111.48 19.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.003 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.2 p -100.27 -9.68 22.12 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.784 HG21 ' OG ' ' A' ' 142' ' ' SER . 10.0 p -88.04 -2.86 58.86 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.183 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.55 90.32 0.45 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.488 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.76 ' OE1' HD23 ' A' ' 141' ' ' LEU . 10.7 pt20 -165.64 -47.28 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.791 0.329 . . . . 0.0 111.435 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.61 HG23 ' HD2' ' A' ' 44' ' ' PRO . 6.8 mt -130.32 142.4 45.33 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.85 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.61 ' HD2' HG23 ' A' ' 43' ' ' ILE . 67.4 Cg_endo -76.04 141.33 23.63 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.151 1.901 . . . . 0.0 111.509 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.795 HG12 HG23 ' A' ' 37' ' ' ILE . 47.6 mt -50.14 139.65 4.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.116 0.484 . . . . 0.0 112.054 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.41 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -135.86 163.0 31.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.014 179.105 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -120.22 119.86 34.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.142 0.496 . . . . 0.0 112.334 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.527 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 4.7 mt -94.04 137.55 33.12 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 178.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 1.034 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.2 158.09 43.86 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -178.272 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.482 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.33 141.89 28.92 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 113.094 -1.866 . . . . 0.0 110.166 178.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.684 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -78.88 142.46 36.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.209 0.528 . . . . 0.0 111.529 -179.171 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.572 ' H ' HD12 ' A' ' 52' ' ' ILE . 4.9 mp -64.1 -43.46 97.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.002 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.7 t -56.55 -38.34 71.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.433 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.523 ' CG ' ' HB2' ' A' ' 51' ' ' ASP . 0.4 OUTLIER -68.43 -36.7 79.44 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.281 179.304 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 51' ' ' ASP . 36.6 t -70.44 -41.71 78.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.26 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 68.3 mt -71.06 -28.96 64.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.166 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.36 -45.98 14.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.001 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -62.94 115.97 4.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.035 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.9 ptpt -103.95 -24.67 13.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.857 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.7 mmm180 -55.95 -171.22 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.893 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.8 p -95.64 31.64 2.0 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.988 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.942 HD11 ' CG2' ' A' ' 65' ' ' VAL . 10.0 tp -168.69 150.28 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.083 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.428 ' HE2' HG13 ' A' ' 55' ' ' VAL . 10.1 mttp -138.57 -67.22 0.47 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.861 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.43 ' NZ ' ' HA ' ' A' ' 50' ' ' ALA . 4.5 ttpt -141.03 129.76 22.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.779 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.942 ' CG2' HD11 ' A' ' 62' ' ' ILE . 16.4 t -128.93 139.18 52.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.409 0.623 . . . . 0.0 112.399 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.527 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.3 m-90 -101.27 138.66 38.0 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.846 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.694 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.91 126.28 54.99 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 176.857 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.69 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -108.8 145.36 35.33 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.407 -178.225 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.71 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.79 172.61 31.48 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.981 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.541 ' HG3' HD11 ' A' ' 78' ' ' LEU . 1.8 mtm105 -67.13 -4.77 10.99 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.456 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.8 t30 -84.48 135.32 41.17 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.744 0.307 . . . . 0.0 111.175 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.2 Cg_exo -69.63 -6.14 17.83 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.868 2.379 . . . . 0.0 112.058 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.92 -43.59 16.32 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 122.029 0.919 . . . . 0.0 108.846 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.18 138.31 2.25 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.986 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -56.53 -18.36 11.42 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.236 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.56 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 19.7 t80 -129.0 114.36 16.32 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.785 0.326 . . . . 0.0 110.646 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.414 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.7 t-160 -88.26 130.61 35.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.271 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.576 HD21 ' CA ' ' A' ' 69' ' ' GLY . 1.4 pp -133.16 -177.67 4.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.593 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.556 ' O ' HD12 ' A' ' 78' ' ' LEU . . . -57.3 -168.34 0.11 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.266 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -123.92 82.93 2.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.858 0.361 . . . . 0.0 110.734 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.575 HG22 ' H ' ' A' ' 83' ' ' ARG . 3.5 mp -109.64 130.3 62.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.205 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.782 ' CB ' HD11 ' B' ' 170' ' ' LEU . 0.0 OUTLIER -56.8 -31.23 64.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.168 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.575 ' H ' HG22 ' A' ' 81' ' ' ILE . 1.4 mmp_? -60.75 -36.03 77.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.459 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.911 HD21 HG21 ' A' ' 132' ' ' VAL . 5.5 mp -93.28 152.98 18.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.201 0.524 . . . . 0.0 111.666 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.91 168.88 10.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.703 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.71 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.4 m-20 -44.03 -53.22 6.48 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.336 0.589 . . . . 0.0 109.722 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.53 ' NZ ' HG21 ' A' ' 67' ' ' THR . 0.1 OUTLIER -119.45 83.56 2.06 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.375 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.523 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 15.9 t60 -60.98 -47.42 86.55 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.685 -176.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.526 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 20.0 p90 -147.17 160.44 42.45 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.254 -0.578 . . . . 0.0 111.612 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.694 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.7 tt0 -136.1 141.49 44.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.639 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.613 ' O ' HG13 ' A' ' 65' ' ' VAL . 63.2 mt -116.9 127.66 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 121.219 -0.193 . . . . 0.0 110.531 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.504 ' CB ' HG22 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -112.33 150.17 31.4 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.158 0.504 . . . . 0.0 112.255 -179.14 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 1.036 HD12 HD11 ' A' ' 99' ' ' LEU . 6.9 tt -121.84 122.8 40.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.125 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -172.0 -158.78 16.89 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.561 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 59.44 -177.55 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.822 0.344 . . . . 0.0 110.82 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -74.53 64.43 1.18 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.789 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.82 -173.03 34.59 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.417 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.692 ' C ' HD22 ' A' ' 99' ' ' LEU . 25.3 m120 62.14 172.01 0.13 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.866 0.365 . . . . 0.0 110.86 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 1.036 HD11 HD12 ' A' ' 93' ' ' LEU . 3.9 mm? -130.81 160.22 35.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.122 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.725 HD23 ' O ' ' A' ' 122' ' ' GLN . 9.1 mt -126.04 147.38 49.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.19 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.11 122.17 47.02 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -112.93 115.37 28.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.614 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.862 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.7 p-10 -77.49 143.15 38.7 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.796 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.438 HG12 ' HA ' ' A' ' 89' ' ' PHE . 10.7 pt -151.41 36.79 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -178.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.562 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.34 148.43 24.19 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 120.924 0.392 . . . . 0.0 111.604 -179.183 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.6 m -68.7 -31.39 70.44 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 177.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -92.0 -19.82 21.99 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.484 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.562 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 113.29 152.46 11.06 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.293 -0.956 . . . . 0.0 113.937 179.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.537 HG22 ' CG2' ' A' ' 130' ' ' ILE . 4.9 m -117.35 137.72 52.26 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.837 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -117.56 148.18 42.13 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -178.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.474 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.27 113.56 18.42 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.468 177.597 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.417 ' N ' HD12 ' A' ' 111' ' ' LEU . 92.8 m-20 45.31 42.69 7.55 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.25 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 84.99 -4.05 86.13 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.53 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -104.78 118.74 37.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.034 0.445 . . . . 0.0 110.655 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.837 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 6.7 tptt -74.98 117.76 17.19 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.141 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.862 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.2 m -96.6 159.77 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.201 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.493 ' O ' ' HB3' ' A' ' 120' ' ' SER . 0.0 OUTLIER -69.81 130.11 41.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.536 179.861 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.698 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 9.2 ptmt -55.13 167.73 0.4 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.08 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.5 m-80 36.93 33.44 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.983 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.493 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 22.8 t -112.44 141.38 46.25 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.849 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.583 ' HB3' HD22 ' A' ' 100' ' ' LEU . 7.1 m120 -92.08 129.55 38.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.85 0.357 . . . . 0.0 111.092 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.725 ' O ' HD23 ' A' ' 100' ' ' LEU . 54.3 mm-40 -129.48 150.4 50.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.689 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.5 tp -72.5 133.3 44.73 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.273 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.901 HD13 ' HB2' ' A' ' 99' ' ' LEU . 1.3 pt? -63.48 160.85 15.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.81 0.814 . . . . 0.0 112.148 -179.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.719 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.3 OUTLIER -125.63 153.31 43.97 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.07 179.275 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.591 ' HA ' HD13 ' A' ' 147' ' ' ILE . 8.1 mm100 -71.41 115.7 10.89 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.81 28.49 68.39 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.585 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.419 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 24.9 t0 -53.44 173.84 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.945 0.402 . . . . 0.0 111.19 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 15.1 tt0 -145.15 135.24 23.86 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.898 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.537 ' CG2' HG22 ' A' ' 109' ' ' THR . 15.2 mt -115.49 126.58 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.342 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.539 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.37 141.51 36.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.275 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.911 HG21 HD21 ' A' ' 84' ' ' LEU . 34.2 m -140.06 158.42 26.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.021 0.439 . . . . 0.0 111.996 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.18 30.25 23.13 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.932 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.476 ' HA ' HG12 ' A' ' 140' ' ' ILE . 73.9 t -77.01 140.48 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 CA-C-O 121.647 0.737 . . . . 0.0 112.101 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.654 ' O ' HD12 ' B' ' 172' ' ' ILE . . . 144.17 -39.85 1.22 Allowed Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -178.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.672 HG22 HG13 ' B' ' 172' ' ' ILE . 2.8 t -118.01 119.12 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -50.42 -32.1 16.82 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 76.7 p -93.69 6.79 47.15 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.509 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.5 OUTLIER -129.49 34.44 4.35 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -178.463 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.539 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.1 mt -107.17 139.32 29.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.766 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.76 HD23 ' OE1' ' A' ' 42' ' ' GLN . 2.1 mp -124.15 134.78 53.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.879 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.784 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.3 OUTLIER -106.59 135.49 48.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.172 0.51 . . . . 0.0 111.804 -179.327 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.754 HD12 ' C ' ' A' ' 142' ' ' SER . 5.3 mp -123.69 141.4 52.05 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.4 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 20.8 t -110.9 132.99 57.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.906 0.384 . . . . 0.0 111.196 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.547 HD13 HG22 ' A' ' 36' ' ' VAL . 2.2 mm -106.3 121.64 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.935 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.21 138.58 44.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.662 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.719 HD11 ' O ' ' A' ' 125' ' ' SER . 4.2 mp -106.63 133.03 52.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.386 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -83.91 122.74 29.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.89 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -73.74 -27.46 61.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.978 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.05 -42.54 80.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.006 0.432 . . . . 0.0 110.455 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -58.95 -43.64 91.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.814 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -36.3 82.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.892 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -61.62 -47.1 86.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.043 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 7.6 t -68.01 -41.53 82.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.97 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.15 -35.93 82.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.99 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -43.62 98.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.8 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.411 ' O ' ' N ' ' A' ' 159' ' ' LYS . 2.8 mm100 -84.71 -30.97 24.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.864 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.35 -90.68 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.595 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 157' ' ' GLN . 3.2 ttpp -83.34 129.33 34.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.86 0.362 . . . . 0.0 110.936 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.4 t -95.54 131.68 41.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.145 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -98.8 142.97 29.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.827 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.78 -32.49 25.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.003 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 32.7 mt -92.82 117.42 36.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.135 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 9.6 mtm-85 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.888 179.932 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.8 0.333 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -126.96 98.77 29.97 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.993 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.64 -173.95 0.64 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.46 2.107 . . . . 0.0 112.283 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -168.71 155.87 7.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.848 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 169' ' ' TPO . . . . . 0.785 ' C ' HD13 ' B' ' 170' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.785 HD13 ' C ' ' B' ' 169' ' ' TPO . 0.0 OUTLIER -161.3 179.53 8.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.003 0.43 . . . . 0.0 111.231 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . 0.574 ' O ' HG22 ' B' ' 172' ' ' ILE . 2.0 mt-10 -141.43 69.39 1.33 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.475 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 0.672 HG13 HG22 ' A' ' 136' ' ' VAL . 13.9 tt 50.64 156.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.005 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 173' ' ' TYR . . . . . 0.477 ' N ' HG12 ' B' ' 172' ' ' ILE . 2.2 p90 -100.02 56.0 0.94 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.893 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.852 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.524 ' O ' HG23 ' A' ' 15' ' ' THR . . . . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.847 0.356 . . . . 0.0 111.081 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.524 HG23 ' O ' ' A' ' 14' ' ' ALA . 0.8 OUTLIER -162.73 -45.76 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.973 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -67.1 -39.82 86.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.4 ttm180 -59.97 -42.42 94.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.863 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -58.36 -38.69 77.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.798 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.0 mp -60.1 -31.76 70.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.746 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.436 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.2 mt -71.98 -35.59 54.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.788 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.55 -41.81 81.73 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.952 0.406 . . . . 0.0 110.371 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.11 -23.79 65.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.689 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.436 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.49 -47.35 79.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.246 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.4 m -64.09 -39.9 95.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.799 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 63.41 -80.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.973 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -70.49 159.01 35.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.891 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -64.83 142.1 58.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.813 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.4 mm -81.78 138.31 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 CA-C-O 121.673 0.749 . . . . 0.0 111.639 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.412 ' HA2' HG12 ' A' ' 32' ' ' ILE . . . -145.81 80.47 0.22 Allowed Glycine 0 C--N 1.314 -0.647 0 CA-C-N 114.457 -1.247 . . . . 0.0 112.542 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.42 -36.85 79.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.759 0.314 . . . . 0.0 110.85 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.408 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER 177.01 39.66 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.682 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.6 mm -75.74 135.43 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-N 113.529 -1.669 . . . . 0.0 112.574 -177.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.023 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.7 t -92.83 -61.43 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.845 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.501 ' SG ' HD22 ' A' ' 48' ' ' LEU . 1.7 p -138.58 158.3 44.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.029 178.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.43 119.11 26.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.829 0.347 . . . . 0.0 111.392 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.784 HG21 ' CE2' ' A' ' 68' ' ' PHE . 23.2 t -89.18 122.67 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.912 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.876 HG23 HG12 ' A' ' 45' ' ' ILE . 18.9 mt -131.74 117.47 34.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.488 -179.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 6.4 t -83.8 116.11 22.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.771 0.32 . . . . 0.0 110.149 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.3 t -92.49 -24.71 18.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.974 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.575 ' CG2' ' HB2' ' A' ' 142' ' ' SER . 49.4 p -79.78 -2.86 45.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.876 0.37 . . . . 0.0 111.484 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.405 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 72.15 76.58 0.6 Allowed Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 121.098 -0.572 . . . . 0.0 113.284 178.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.437 ' CB ' HD11 ' A' ' 141' ' ' LEU . 4.5 mt-30 -143.45 -40.41 0.3 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.815 0.34 . . . . 0.0 110.94 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.681 HG23 ' HD2' ' A' ' 44' ' ' PRO . 16.9 mt -132.48 143.24 47.96 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.212 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.681 ' HD2' HG23 ' A' ' 43' ' ' ILE . 51.5 Cg_endo -71.05 146.12 51.44 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.298 1.999 . . . . 0.0 111.967 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.876 HG12 HG23 ' A' ' 37' ' ' ILE . 37.4 mt -51.74 152.77 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.087 0.47 . . . . 0.0 111.998 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -147.2 164.21 33.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.041 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.53 120.01 27.31 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.766 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.7 mp -92.7 127.31 38.15 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 1.023 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -137.95 157.06 47.17 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -179.111 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.488 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -141.84 142.16 33.14 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 113.608 -1.633 . . . . 0.0 110.899 179.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.619 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.9 OUTLIER -74.93 136.73 41.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.054 0.454 . . . . 0.0 111.117 -179.713 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.4 mm -64.21 -43.25 97.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.955 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.5 p -56.82 -37.9 71.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.168 0.508 . . . . 0.0 110.508 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.449 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 43.8 mm-40 -68.59 -36.8 79.19 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.352 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.723 HG13 ' HD3' ' A' ' 63' ' ' LYS . 61.3 t -67.74 -40.7 84.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.054 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.1 mt -70.98 -37.99 72.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.024 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -73.39 -38.6 65.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.877 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -69.16 106.58 2.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.951 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.69 30.51 4.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.831 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.67 -166.82 1.11 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.785 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 m -97.89 33.23 2.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.754 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.847 HD11 HG22 ' A' ' 65' ' ' VAL . 7.7 tp -173.78 151.69 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.025 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.723 ' HD3' HG13 ' A' ' 55' ' ' VAL . 23.4 mttt -135.54 -58.74 0.78 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.976 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.41 ' CE ' ' O ' ' A' ' 49' ' ' SER . 6.4 ttpt -145.53 131.0 18.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.981 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.847 HG22 HD11 ' A' ' 62' ' ' ILE . 3.5 t -124.31 138.83 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 121.259 0.552 . . . . 0.0 112.192 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.766 ' CD2' HD23 ' A' ' 48' ' ' LEU . 17.3 m-90 -102.25 139.54 37.73 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.241 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.726 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.45 126.97 55.92 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.612 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.836 ' CE1' HD13 ' A' ' 91' ' ' ILE . 1.1 m-85 -108.55 145.48 34.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.318 -178.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.694 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.97 178.43 37.52 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.26 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.476 ' HG3' HD11 ' A' ' 78' ' ' LEU . 11.8 mtp180 -70.49 -4.85 24.83 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.447 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.0 OUTLIER -84.55 134.06 43.15 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.711 0.291 . . . . 0.0 111.27 -179.329 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.0 Cg_exo -69.49 -6.52 18.65 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.727 2.284 . . . . 0.0 111.719 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.85 -43.79 16.21 Favored 'General case' 0 CA--C 1.497 -1.077 0 CA-C-O 121.993 0.902 . . . . 0.0 108.706 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -41.95 138.38 1.55 Allowed 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 113.698 -1.592 . . . . 0.0 110.445 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.49 -18.87 12.86 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.097 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.618 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 58.9 t80 -129.5 125.62 36.77 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 120.73 0.3 . . . . 0.0 110.667 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -98.55 131.83 44.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.907 0.384 . . . . 0.0 110.925 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.656 HD12 ' O ' ' A' ' 79' ' ' GLY . 0.9 OUTLIER -131.18 179.9 5.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.729 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.656 ' O ' HD12 ' A' ' 78' ' ' LEU . . . -61.77 177.58 4.97 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.258 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -97.42 70.73 2.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.954 0.407 . . . . 0.0 110.84 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.606 HD11 HD12 ' A' ' 141' ' ' LEU . 40.0 mt -94.24 116.22 34.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.042 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.804 ' HB3' HD13 ' B' ' 170' ' ' LEU . 0.1 OUTLIER -54.8 -34.38 62.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.313 -179.806 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.518 ' HG3' ' HB3' ' A' ' 139' ' ' ASP . 1.5 mmt180 -60.84 -25.39 66.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.989 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.696 HD21 HG23 ' A' ' 132' ' ' VAL . 28.2 mt -96.03 149.92 21.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.302 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 57.9 p -93.6 169.69 10.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.604 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.694 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -43.21 -53.62 4.99 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.449 0.642 . . . . 0.0 109.912 179.251 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.47 ' HB2' HD12 ' A' ' 104' ' ' ILE . 6.4 ptmt -121.3 84.08 2.18 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 177.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.532 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 15.4 t60 -60.81 -47.26 87.15 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.978 -176.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.552 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 12.8 p90 -147.43 162.12 39.67 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 119.872 -0.731 . . . . 0.0 112.065 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.726 ' HG3' HG23 ' A' ' 67' ' ' THR . 3.4 tt0 -135.67 146.26 47.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.532 -178.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.836 HD13 ' CE1' ' A' ' 68' ' ' PHE . 4.3 mp -124.03 132.08 71.92 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.337 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.452 178.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.841 HD21 ' HB2' ' A' ' 102' ' ' ASN . 0.2 OUTLIER -120.66 148.57 43.75 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.262 0.553 . . . . 0.0 112.214 -179.145 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.709 HD13 ' CG1' ' A' ' 33' ' ' VAL . 5.5 tp -125.42 122.87 37.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.822 178.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.56 -42.1 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.747 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -51.62 170.6 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.738 0.304 . . . . 0.0 111.137 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -79.82 72.89 6.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.98 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.567 ' H ' HD22 ' A' ' 155' ' ' LEU . . . 103.62 -32.71 7.26 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.651 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -77.36 156.92 30.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.818 0.342 . . . . 0.0 110.863 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.587 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -114.8 160.09 19.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.955 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.587 HD12 ' O ' ' A' ' 99' ' ' LEU . 4.4 mp -129.14 136.61 50.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.661 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.891 HD11 HD11 ' A' ' 130' ' ' ILE . 0.3 OUTLIER -112.96 120.23 40.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.338 179.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.841 ' HB2' HD21 ' A' ' 92' ' ' LEU . 60.9 t30 -112.12 119.1 37.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.879 0.371 . . . . 0.0 111.806 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.785 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.8 p30 -79.99 139.36 37.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.668 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.488 HG12 ' HA ' ' A' ' 89' ' ' PHE . 17.3 pt -146.48 36.16 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -178.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.628 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -97.68 150.72 20.87 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-O 121.014 0.435 . . . . 0.0 112.14 -178.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.704 HG21 ' HB ' ' B' ' 169' ' ' TPO . 20.6 m -68.67 -31.61 70.85 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.683 177.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -96.13 -19.82 19.09 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -178.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.628 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.14 155.25 10.5 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.998 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.1 m -117.37 137.84 52.19 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.827 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -116.12 148.37 40.36 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 -177.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.472 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.1 113.6 18.58 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.487 177.536 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.416 ' N ' HD12 ' A' ' 111' ' ' LEU . 8.9 m-80 44.85 42.95 6.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.399 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.62 -12.2 64.0 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.585 178.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -104.64 118.57 36.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.08 0.44 . . . . 0.0 110.627 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.827 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -71.91 125.41 27.12 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.37 -179.718 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.785 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.7 m -94.7 165.46 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.852 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 120' ' ' SER . 8.5 tp10 -69.88 126.33 29.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.586 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.691 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 64.8 tttt -53.41 161.55 0.95 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.887 0.375 . . . . 0.0 110.386 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.46 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.2 p30 36.25 33.8 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.239 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.43 145.08 40.8 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.034 179.296 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.771 ' ND2' HD11 ' A' ' 92' ' ' LEU . 22.2 m120 -91.62 127.63 37.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.688 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -129.21 147.13 51.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.941 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.699 HD23 ' O ' ' A' ' 124' ' ' LEU . 7.9 tt -72.88 111.94 8.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.018 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.699 ' O ' HD23 ' A' ' 123' ' ' LEU . 0.3 OUTLIER -56.41 167.8 0.64 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.654 0.74 . . . . 0.0 112.0 -178.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.18 153.36 43.19 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.489 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.74 116.56 12.25 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.17 24.47 73.36 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.923 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -60.09 179.74 0.13 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 120.799 0.333 . . . . 0.0 110.837 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.759 ' CG ' HG22 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -145.05 135.38 24.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.254 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.891 HD11 HD11 ' A' ' 101' ' ' LEU . 8.5 mt -116.82 127.72 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.098 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.582 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.0 m -104.43 140.1 38.41 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.696 HG23 HD21 ' A' ' 84' ' ' LEU . 35.6 m -140.16 158.35 25.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.139 0.495 . . . . 0.0 112.198 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.23 28.69 29.91 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.649 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.471 ' HA ' HG12 ' A' ' 140' ' ' ILE . 68.8 t -74.52 140.55 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-O 121.64 0.733 . . . . 0.0 112.186 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.711 ' HA3' HG21 ' B' ' 172' ' ' ILE . . . 147.78 -43.5 0.83 Allowed Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.941 ' CG2' HD13 ' B' ' 172' ' ' ILE . 1.9 t -111.97 128.9 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -50.58 -43.43 56.54 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.7 p -93.56 6.74 47.23 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -178.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.518 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . 5.7 m-20 -119.61 34.42 5.22 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -178.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.582 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.2 mt -107.29 139.79 27.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.822 178.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.606 HD12 HD11 ' A' ' 81' ' ' ILE . 8.6 tt -120.97 134.69 55.3 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.949 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.575 ' HB2' ' CG2' ' A' ' 40' ' ' THR . 1.0 OUTLIER -109.99 139.48 45.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.058 0.456 . . . . 0.0 111.904 -179.375 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 40.7 mt -131.7 143.6 50.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.917 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.759 HG22 ' CG ' ' A' ' 129' ' ' GLU . 22.3 t -114.25 131.77 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 120.704 0.288 . . . . 0.0 111.132 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.558 HG21 ' CD2' ' A' ' 124' ' ' LEU . 1.5 mm -106.21 130.92 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-O 120.864 0.364 . . . . 0.0 110.755 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.75 112.01 21.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.954 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.488 HG21 ' HE3' ' A' ' 152' ' ' LYS . 7.0 mt -84.86 129.57 37.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.292 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -75.95 126.68 31.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.972 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -73.92 -35.95 64.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.97 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.1 -45.08 91.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.616 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.45 ' CE2' ' CD1' ' A' ' 155' ' ' LEU . 37.4 t80 -58.15 -44.12 87.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.881 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.488 ' HE3' HG21 ' A' ' 147' ' ' ILE . 45.7 mttt -59.67 -40.88 89.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.998 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -59.1 -40.32 84.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.006 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 10.5 t -65.4 -45.96 81.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.017 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.567 HD22 ' H ' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -69.28 -44.57 71.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.933 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.89 -35.41 70.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.983 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -90.84 -34.23 15.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.893 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.6 p30 42.26 32.27 0.31 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.503 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 19.7 mtmt -124.97 142.79 51.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.891 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 5.7 m -98.48 125.11 51.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.077 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.26 80.93 2.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.843 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -121.76 31.42 6.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.928 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 14.1 pt -104.91 121.58 57.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.167 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.897 179.975 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 1.5 t30 . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.788 0.328 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -92.78 156.2 41.05 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.18 107.52 1.37 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.571 2.181 . . . . 0.0 112.228 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -110.7 162.34 14.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.989 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 169' ' ' TPO . . . . . 0.704 ' HB ' HG21 ' A' ' 106' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.804 HD13 ' HB3' ' A' ' 82' ' ' SER . 1.3 tt -75.9 150.81 37.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.229 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . 0.41 ' N ' ' HG ' ' B' ' 170' ' ' LEU . 41.4 mt-10 -147.0 131.84 18.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.465 179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 0.941 HD13 ' CG2' ' A' ' 136' ' ' VAL . 3.0 tp -51.28 139.42 6.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.079 0.466 . . . . 0.0 111.55 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 173' ' ' TYR . . . . . 0.694 ' H ' HD12 ' B' ' 172' ' ' ILE . 2.6 p90 -71.78 139.48 49.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.667 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.34 -0.838 . . . . 0.0 110.878 -179.956 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.876 0.37 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.64 -68.56 0.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.838 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -71.53 -30.61 66.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -36.78 77.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -60.54 -42.41 96.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 tp -59.85 -42.78 94.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.888 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.523 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.3 mm -71.23 -35.12 56.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.16 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -57.14 -35.98 70.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.915 0.388 . . . . 0.0 110.409 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -67.24 -23.92 65.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.787 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.523 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.67 -47.54 79.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.148 -179.814 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.23 -43.04 71.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.895 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -131.62 134.02 45.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.916 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.23 130.2 40.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.914 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -77.28 137.93 39.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.923 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.3 mm -81.98 138.35 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-O 121.685 0.755 . . . . 0.0 111.704 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.65 47.48 76.57 Favored Glycine 0 C--N 1.314 -0.684 0 CA-C-N 114.546 -1.206 . . . . 0.0 112.33 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.78 -40.19 96.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.754 0.311 . . . . 0.0 111.052 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.1 t-20 175.05 39.86 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.2 mm -72.81 134.95 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 CA-C-N 113.621 -1.627 . . . . 0.0 112.407 -177.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.0 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.2 t -92.56 -60.55 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.099 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.474 ' SG ' HD22 ' A' ' 48' ' ' LEU . 21.8 p -142.97 164.66 29.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.381 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.6 138.22 51.14 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.849 0.357 . . . . 0.0 111.326 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.741 HG11 ' CE2' ' A' ' 68' ' ' PHE . 3.2 m -107.45 122.64 61.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.841 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.804 HG23 HG12 ' A' ' 45' ' ' ILE . 18.4 mt -126.66 119.53 53.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.478 -179.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.759 ' HA ' HD13 ' A' ' 143' ' ' LEU . 23.1 t -79.78 111.38 16.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.808 0.337 . . . . 0.0 110.467 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.437 HG23 HG21 ' A' ' 144' ' ' VAL . 0.1 OUTLIER -82.15 -23.73 35.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.825 -179.163 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.518 HG23 ' HB3' ' A' ' 142' ' ' SER . 74.5 p -79.91 -2.25 42.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.788 0.327 . . . . 0.0 111.48 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.8 75.77 0.36 Allowed Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.821 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.554 ' CD ' HD11 ' A' ' 141' ' ' LEU . 9.7 mt-30 -146.6 -40.95 0.2 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.878 0.37 . . . . 0.0 111.053 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.559 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.7 mt -123.28 141.54 36.31 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.053 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.559 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.4 Cg_endo -72.63 146.01 42.82 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.33 2.02 . . . . 0.0 112.239 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.804 HG12 HG23 ' A' ' 37' ' ' ILE . 35.8 mt -55.51 148.98 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.677 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.43 164.15 28.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.152 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.33 119.74 31.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.993 0.425 . . . . 0.0 111.982 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.734 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.7 mp -95.81 125.48 40.41 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 1.0 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -135.51 157.39 47.0 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -178.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.502 ' HB3' ' CD2' ' A' ' 93' ' ' LEU . . . -148.82 148.91 30.47 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.638 -1.619 . . . . 0.0 110.81 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.645 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -74.98 134.88 41.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.062 0.458 . . . . 0.0 111.185 -179.827 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.621 HD13 ' SG ' ' A' ' 154' ' ' CYS . 79.2 mt -64.31 -43.87 97.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.696 -0.683 . . . . 0.0 112.061 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.86 -38.56 72.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.346 0.593 . . . . 0.0 110.678 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.449 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 4.0 mm-40 -68.5 -36.92 79.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.607 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 51' ' ' ASP . 45.8 t -72.36 -43.54 64.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.127 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.7 tp -70.94 -32.18 69.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.998 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.15 -42.7 36.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.965 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -82.9 120.69 26.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.972 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.22 30.38 1.78 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.908 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -119.07 -51.04 2.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.865 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.94 -168.87 2.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.915 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.603 HG21 ' CG2' ' A' ' 65' ' ' VAL . 20.3 mm -66.3 158.51 5.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.032 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.461 ' N ' HG22 ' A' ' 62' ' ' ILE . 1.8 ptpt -126.07 -41.05 1.96 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.296 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.432 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.7 ttpt -142.9 123.87 14.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.974 0.416 . . . . 0.0 111.962 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.603 ' CG2' HG21 ' A' ' 62' ' ' ILE . 13.0 t -129.99 139.43 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.218 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.734 ' CD2' HD23 ' A' ' 48' ' ' LEU . 17.8 m-90 -100.92 139.63 36.35 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.983 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.656 HG23 ' CD ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -109.58 133.04 53.57 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 177.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.741 ' CE2' HG11 ' A' ' 36' ' ' VAL . 1.1 m-85 -120.19 145.52 46.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.055 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.763 ' CA ' HD21 ' A' ' 78' ' ' LEU . . . 159.56 -172.38 36.16 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.874 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.453 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 9.5 mtp-105 -80.31 3.7 20.16 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.469 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 5.1 t-20 -84.88 133.46 43.41 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 120.659 0.266 . . . . 0.0 110.988 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 13.2 Cg_exo -68.28 -10.28 28.47 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.646 2.231 . . . . 0.0 111.88 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.408 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -83.29 -43.44 16.02 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-O 122.001 0.905 . . . . 0.0 108.952 179.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.19 136.41 2.24 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 113.658 -1.61 . . . . 0.0 111.278 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -56.71 -18.38 12.22 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.153 179.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.531 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 66.7 t80 -129.32 112.1 13.52 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-O 120.812 0.339 . . . . 0.0 111.071 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -94.99 114.39 26.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.835 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.763 HD21 ' CA ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -97.2 -80.25 0.44 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.988 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.95 -131.17 1.19 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.576 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -141.6 60.77 1.48 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.887 0.375 . . . . 0.0 110.821 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.866 HD13 HD12 ' A' ' 84' ' ' LEU . 3.9 mp -88.61 120.21 37.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.012 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.753 ' C ' HD22 ' B' ' 170' ' ' LEU . 1.8 m -54.77 -42.94 72.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.878 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.565 ' CZ ' HG21 ' A' ' 136' ' ' VAL . 0.7 OUTLIER -60.88 -18.68 57.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.113 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.866 HD12 HD13 ' A' ' 81' ' ' ILE . 38.7 mt -107.0 152.17 24.34 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.661 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 95.3 p -96.83 163.98 12.75 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.768 0.318 . . . . 0.0 111.709 -179.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.631 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.6 m-20 -41.27 -52.48 3.41 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.532 0.682 . . . . 0.0 109.845 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.468 ' HB3' HD11 ' A' ' 104' ' ' ILE . 5.2 mttt -120.57 84.75 2.27 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 177.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.557 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.5 t60 -64.12 -45.76 87.13 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.023 -0.989 . . . . 0.0 113.252 -176.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.454 ' HA ' HG12 ' A' ' 104' ' ' ILE . 37.2 p90 -151.93 162.23 41.39 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.887 -0.725 . . . . 0.0 112.414 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.656 ' CD ' HG23 ' A' ' 67' ' ' THR . 11.0 mt-30 -135.55 154.3 51.42 Favored 'General case' 0 CA--C 1.522 -0.1 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.743 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.66 HG23 HD22 ' A' ' 101' ' ' LEU . 25.7 mt -119.91 132.19 70.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 177.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.58 HD12 HD12 ' A' ' 62' ' ' ILE . 0.6 OUTLIER -118.71 140.18 50.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.111 0.481 . . . . 0.0 112.254 -178.547 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.801 HD13 ' CG1' ' A' ' 33' ' ' VAL . 11.0 tp -125.36 128.83 48.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.088 178.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 160.88 -138.49 5.51 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.595 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 64.51 -78.88 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.751 0.31 . . . . 0.0 110.793 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -130.15 -42.07 1.24 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.995 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 167.27 -28.94 0.17 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.512 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -60.46 -174.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.842 0.353 . . . . 0.0 110.859 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.499 ' HB3' HD12 ' A' ' 124' ' ' LEU . 3.2 mm? -113.17 145.89 40.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.848 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.844 HD22 ' HB3' ' A' ' 121' ' ' ASN . 6.5 mt -133.08 140.95 47.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.096 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.66 HD22 HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -112.6 126.05 54.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.473 -179.782 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.403 ' HB2' HD23 ' A' ' 92' ' ' LEU . 48.8 t30 -114.07 115.51 27.67 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.491 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.851 ' OD2' HG23 ' A' ' 116' ' ' VAL . 9.5 p30 -79.21 143.24 35.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.942 178.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.516 HG21 ' OE1' ' A' ' 90' ' ' GLN . 9.7 pt -150.02 35.27 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -178.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.654 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -95.78 150.97 19.81 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 121.118 0.485 . . . . 0.0 112.09 -178.78 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.706 ' CB ' HG21 ' B' ' 169' ' ' TPO . 22.9 m -68.72 -31.39 70.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.791 177.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -97.76 -19.72 18.02 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.654 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 118.14 155.88 10.13 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.334 -0.936 . . . . 0.0 114.062 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 11.5 m -117.26 137.83 52.13 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.851 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -116.24 148.29 40.61 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.761 1.022 . . . . 0.0 113.761 -178.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.2 113.52 18.41 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.612 -1.177 . . . . 0.0 108.444 177.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 43.62 43.72 4.89 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.375 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.32 -12.3 65.15 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.382 178.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 9.4 mp0 -103.74 118.59 37.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.053 0.454 . . . . 0.0 110.601 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.851 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.0 tptt -73.16 124.7 26.11 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.215 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.851 HG23 ' OD2' ' A' ' 103' ' ' ASP . 13.0 m -94.92 162.37 2.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.154 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 120' ' ' SER . 4.3 pm0 -69.94 126.37 29.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.47 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.687 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 18.6 tttm -51.42 160.52 0.57 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.015 0.435 . . . . 0.0 111.046 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.8 p30 34.96 33.67 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.432 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.55 145.14 40.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.164 179.262 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.844 ' HB3' HD22 ' A' ' 100' ' ' LEU . 4.4 m120 -87.42 127.51 35.22 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.048 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.697 ' O ' HD23 ' A' ' 100' ' ' LEU . 34.6 mm-40 -129.35 146.3 51.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.743 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.4 tp -72.9 112.43 8.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.173 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.566 HD22 HG21 ' A' ' 145' ' ' ILE . 3.2 mt -59.97 167.32 2.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.676 0.75 . . . . 0.0 111.886 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.408 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.0 OUTLIER -125.36 153.42 43.39 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.319 179.425 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.41 120.92 17.68 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.58 19.2 66.72 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.055 -178.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.408 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 14.3 t70 -58.06 177.44 0.12 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 120.794 0.33 . . . . 0.0 110.791 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.887 ' CG ' HG22 ' A' ' 144' ' ' VAL . 10.7 mt-10 -145.11 135.54 24.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.247 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.443 HG23 ' O ' ' A' ' 110' ' ' TRP . 6.0 mt -114.0 128.47 70.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.075 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.63 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.7 m -103.89 140.11 38.14 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.535 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 31.0 m -140.18 158.32 25.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.135 0.493 . . . . 0.0 112.279 -178.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.75 27.61 28.8 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.01 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.445 ' HB ' ' CZ3' ' A' ' 110' ' ' TRP . 77.3 t -73.4 140.46 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-O 121.616 0.722 . . . . 0.0 112.063 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.554 ' C ' HD12 ' B' ' 172' ' ' ILE . . . 147.43 -40.33 0.99 Allowed Glycine 0 N--CA 1.434 -1.455 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.565 HG21 ' CZ ' ' A' ' 83' ' ' ARG . 2.1 t -117.38 126.82 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -50.47 -40.1 49.96 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.2 m -93.44 6.66 47.41 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -178.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.482 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.7 OUTLIER -120.17 33.34 5.64 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -178.444 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.63 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.6 mt -107.09 138.83 31.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.384 0.611 . . . . 0.0 110.824 178.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.554 HD11 ' CD ' ' A' ' 42' ' ' GLN . 0.3 OUTLIER -124.46 134.64 52.99 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.533 -179.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.587 ' C ' HD22 ' A' ' 143' ' ' LEU . 42.2 t -110.29 150.44 28.73 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.615 0.721 . . . . 0.0 112.422 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.759 HD13 ' HA ' ' A' ' 38' ' ' CYS . 3.0 mm? -135.84 148.5 48.69 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.319 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.887 HG22 ' CG ' ' A' ' 129' ' ' GLU . 20.1 t -114.2 134.86 55.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.892 0.377 . . . . 0.0 111.281 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.566 HG21 HD22 ' A' ' 124' ' ' LEU . 2.3 mm -106.37 122.89 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.624 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.06 114.33 26.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.894 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 7.9 mm -84.95 129.35 37.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.06 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -75.88 107.92 8.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.845 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.3 -31.86 69.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.87 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -45.52 91.66 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.592 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -58.73 -44.22 90.4 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.88 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -65.17 -39.63 93.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.995 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -59.05 -46.39 88.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.971 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.621 ' SG ' HD13 ' A' ' 52' ' ' ILE . 9.1 t -65.97 -44.07 86.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.948 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.47 -36.0 82.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.13 -45.72 93.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.969 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -82.1 -36.52 27.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.887 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.3 p30 42.43 76.36 0.08 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.476 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.2 ttmm -69.96 122.94 20.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.875 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.608 HG11 ' HD2' ' A' ' 164' ' ' ARG . 30.5 m -88.57 136.46 23.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.119 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -68.7 -74.18 0.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.856 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.7 mtm180 -149.94 -48.13 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.862 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.3 mt -100.76 136.69 31.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.111 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.608 ' HD2' HG11 ' A' ' 160' ' ' VAL . 8.4 ptt85 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.977 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.905 0.383 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . 0.403 ' HA ' ' HD2' ' B' ' 167' ' ' PRO . 7.1 m-20 -97.08 100.67 7.99 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.803 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' B' ' 166' ' ' ASP . 39.4 Cg_endo -67.1 176.29 4.76 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.329 2.019 . . . . 0.0 112.303 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.09 65.43 0.37 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.022 0.439 . . . . 0.0 110.843 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 169' ' ' TPO . . . . . 0.706 HG21 ' CB ' ' A' ' 106' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.753 HD22 ' C ' ' A' ' 82' ' ' SER . 0.6 OUTLIER -90.12 148.41 23.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.002 -179.756 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . 0.599 ' O ' HG22 ' B' ' 172' ' ' ILE . 3.4 mt-10 -143.84 49.72 1.37 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.876 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 0.599 HG22 ' O ' ' B' ' 171' ' ' GLU . 9.5 tt 50.72 152.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.206 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 173' ' ' TYR . . . . . 0.462 ' N ' HG12 ' B' ' 172' ' ' ILE . 3.0 p90 -86.21 -178.28 6.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.76 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 10.7 t . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.264 -0.875 . . . . 0.0 110.918 179.98 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.824 0.345 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -108.38 -64.32 1.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.837 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -68.81 -40.44 79.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.883 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -37.04 86.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.816 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -57.95 -39.85 79.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.784 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.7 -31.98 73.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.679 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.434 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.4 mt -73.23 -35.41 46.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.826 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.48 -43.11 83.83 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.968 0.413 . . . . 0.0 110.385 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.02 -23.81 65.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.607 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.434 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.74 -47.51 79.87 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.25 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 m -76.7 -47.09 23.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.913 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -105.51 51.75 0.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.673 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.62 121.18 22.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.004 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -64.96 101.96 0.56 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.319 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.6 mm -81.92 138.15 19.99 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.461 0 CA-C-O 121.794 0.807 . . . . 0.0 111.855 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.441 ' HA2' ' CG1' ' A' ' 32' ' ' ILE . . . 62.76 109.94 0.01 OUTLIER Glycine 0 C--N 1.314 -0.676 0 CA-C-N 114.305 -1.316 . . . . 0.0 112.712 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -86.85 -29.28 22.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.739 0.304 . . . . 0.0 110.94 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.435 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER -177.41 36.86 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.734 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.5 mm -75.77 135.65 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 CA-C-N 113.754 -1.566 . . . . 0.0 112.639 -177.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.038 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.0 t -90.81 -60.24 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.953 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.0 p -148.19 150.12 33.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.137 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.98 138.14 50.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.889 0.376 . . . . 0.0 111.622 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.521 HG21 ' HE2' ' A' ' 68' ' ' PHE . 12.9 p -104.64 122.75 58.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.642 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.808 HG23 HG12 ' A' ' 45' ' ' ILE . 20.3 mt -127.73 125.56 65.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.706 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.602 ' SG ' HD21 ' A' ' 141' ' ' LEU . 3.5 t -89.75 104.64 17.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.195 179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.9 p -81.55 -22.56 37.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.962 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.736 HG23 ' HB2' ' A' ' 142' ' ' SER . 67.8 p -79.81 -2.64 44.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.809 0.337 . . . . 0.0 111.496 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.29 74.93 0.48 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.833 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.506 ' HB2' HD21 ' A' ' 141' ' ' LEU . 0.5 OUTLIER -146.26 -36.19 0.26 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.808 0.337 . . . . 0.0 111.13 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.821 HD13 HD22 ' A' ' 78' ' ' LEU . 15.8 mt -131.72 141.9 43.29 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.947 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.578 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 48.7 Cg_endo -71.01 146.0 51.35 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.19 1.927 . . . . 0.0 112.357 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.808 HG12 HG23 ' A' ' 37' ' ' ILE . 36.4 mt -61.35 148.61 9.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.769 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.94 164.3 30.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.162 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -120.98 119.86 33.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.1 0.476 . . . . 0.0 111.847 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.611 HD22 ' CD1' ' A' ' 66' ' ' TRP . 10.4 mt -96.05 136.09 36.97 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 1.038 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.97 158.7 44.0 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 -178.669 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.485 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -139.79 141.81 36.73 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 113.542 -1.663 . . . . 0.0 110.559 178.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.819 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.4 OUTLIER -79.31 141.1 37.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.222 0.534 . . . . 0.0 111.281 -179.526 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.52 HD13 ' SG ' ' A' ' 154' ' ' CYS . 64.5 mt -65.11 -45.35 94.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.254 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.3 p -60.13 -43.05 95.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.869 -178.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.525 ' HG3' ' O ' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -68.77 -36.87 78.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.924 0.392 . . . . 0.0 110.515 179.747 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.819 HG23 ' O ' ' A' ' 51' ' ' ASP . 64.5 t -71.05 -37.99 69.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.917 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.4 tp -70.13 -30.79 68.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.923 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.4 mttt -80.49 -47.06 14.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.941 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.95 116.94 5.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.904 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.88 29.86 3.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.769 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.71 -55.15 3.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.9 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.7 t -177.94 -39.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.954 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.443 ' CD1' ' HB2' ' A' ' 92' ' ' LEU . 8.8 tp -129.17 153.37 38.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.232 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.765 ' HG2' HG13 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -111.09 -67.69 0.98 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.855 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.422 ' HE2' ' O ' ' A' ' 49' ' ' SER . 4.0 ttpt -141.15 138.19 33.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.985 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 91' ' ' ILE . 14.2 t -132.16 139.4 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 121.255 0.55 . . . . 0.0 112.374 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.611 ' CD1' HD22 ' A' ' 48' ' ' LEU . 16.6 m-90 -104.58 139.51 39.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.943 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.625 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.57 125.82 54.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.123 0.487 . . . . 0.0 110.078 177.694 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.533 ' CD2' ' CD2' ' A' ' 76' ' ' TYR . 2.2 m-85 -109.73 145.48 36.53 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.061 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 157.73 -172.1 34.94 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.41 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.501 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 9.3 mtp-105 -76.92 2.45 14.69 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 0.2 OUTLIER -84.54 130.93 51.57 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.517 0.199 . . . . 0.0 110.976 -179.628 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 18.9 Cg_exo -65.54 -13.99 42.6 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.387 2.058 . . . . 0.0 111.501 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.02 -42.37 17.58 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-O 121.849 0.833 . . . . 0.0 108.839 178.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -42.05 138.32 1.62 Allowed 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.8 179.685 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.9 OUTLIER -56.33 -18.6 11.3 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.164 179.1 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.533 ' CD2' ' CD2' ' A' ' 68' ' ' PHE . 13.2 t80 -129.28 119.46 24.0 Favored 'General case' 0 CA--C 1.527 0.09 0 CA-C-O 120.758 0.313 . . . . 0.0 111.196 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -99.98 117.68 34.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.677 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.821 HD22 HD13 ' A' ' 43' ' ' ILE . 1.4 mt -88.85 -69.09 0.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.017 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 171.92 -85.67 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.519 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -174.46 49.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.901 0.382 . . . . 0.0 111.084 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.501 ' N ' ' HD2' ' A' ' 70' ' ' ARG . 30.1 mm -79.99 123.86 37.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.198 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.785 ' HB2' HD13 ' B' ' 170' ' ' LEU . 90.2 p -54.72 -41.16 69.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.254 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.521 ' N ' HD22 ' B' ' 170' ' ' LEU . 8.5 tpt85 -63.71 -49.16 74.19 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.437 ' CD1' HD13 ' A' ' 78' ' ' LEU . 16.7 mt -73.88 148.26 42.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.06 0.457 . . . . 0.0 111.856 -179.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.7 p -95.11 165.27 12.5 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.855 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.575 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.0 m-20 -41.5 -53.16 3.51 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.434 0.635 . . . . 0.0 110.21 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.443 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 8.5 ptpp? -123.8 81.96 1.97 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 177.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.558 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.9 t60 -59.73 -46.69 88.36 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.981 -1.009 . . . . 0.0 112.988 -176.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.514 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 23.6 p90 -147.65 160.55 42.55 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.116 -0.634 . . . . 0.0 111.621 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.625 ' HG3' HG23 ' A' ' 67' ' ' THR . 5.4 tt0 -135.94 139.75 43.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.555 -178.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.629 ' O ' HG13 ' A' ' 65' ' ' VAL . 17.5 mt -112.37 131.51 63.65 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.233 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.673 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.677 ' H ' HD23 ' A' ' 92' ' ' LEU . 1.8 pt? -118.93 146.83 44.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.044 0.45 . . . . 0.0 111.605 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.524 HD13 ' HG ' ' A' ' 99' ' ' LEU . 14.3 tp -125.11 122.9 38.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.396 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.407 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . -167.28 -156.46 9.86 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.628 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 60.14 -169.85 0.15 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.793 0.33 . . . . 0.0 110.869 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -82.09 59.66 4.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.824 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 101.13 -168.3 19.99 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.43 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 30.3 m120 60.92 178.57 0.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.868 0.366 . . . . 0.0 110.985 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.955 HD11 HG12 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -131.44 160.1 36.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.713 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.49 ' HB3' HD21 ' A' ' 92' ' ' LEU . 1.2 mp -127.33 144.58 51.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.327 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.761 HD11 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -112.77 124.72 53.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.283 -179.921 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.646 ' HB2' HD22 ' A' ' 92' ' ' LEU . 53.7 t30 -118.19 115.53 24.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.978 0.418 . . . . 0.0 111.45 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.825 ' OD2' HG23 ' A' ' 116' ' ' VAL . 8.8 p30 -79.07 142.44 36.48 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.095 178.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.499 HD11 HG22 ' A' ' 67' ' ' THR . 16.7 pt -151.09 37.59 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.602 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -95.18 155.38 16.76 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 121.0 0.429 . . . . 0.0 111.55 -179.304 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 82.8 m -68.82 -34.37 75.39 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.331 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 19.9 p30 -98.65 -19.87 17.29 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.602 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 122.6 156.67 9.7 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.279 -0.963 . . . . 0.0 113.749 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.507 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.4 m -117.35 137.9 52.14 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.855 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -116.26 148.34 40.59 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -178.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.468 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.15 113.39 18.27 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.284 177.441 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.41 ' N ' HD12 ' A' ' 111' ' ' LEU . 7.5 m-80 44.41 42.92 5.8 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.385 -179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.27 -7.97 78.64 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.841 -0.695 . . . . 0.0 113.484 178.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.19 118.67 37.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.035 0.445 . . . . 0.0 110.688 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.855 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 9.6 tptp -74.16 118.28 16.93 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.236 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.825 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.4 m -90.73 164.23 2.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.14 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 120' ' ' SER . 33.8 tt0 -69.83 127.71 33.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.436 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.687 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 25.3 tttt -53.58 160.92 1.15 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.975 0.417 . . . . 0.0 110.599 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.5 p30 34.18 35.32 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.351 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.24 145.06 40.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.222 179.435 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.457 ' HB3' HD23 ' A' ' 100' ' ' LEU . 14.2 m120 -83.73 128.75 34.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.748 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.409 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 21.3 mm-40 -129.31 145.76 51.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.594 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.449 HD22 ' HA ' ' A' ' 123' ' ' LEU . 1.5 tm? -72.99 118.09 15.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.254 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.599 HD21 HG12 ' A' ' 147' ' ' ILE . 65.0 tp -56.41 157.25 5.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.359 0.6 . . . . 0.0 111.549 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.451 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.8 OUTLIER -124.53 153.14 42.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.592 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.436 ' HA ' HD12 ' A' ' 147' ' ' ILE . 8.6 tp60 -71.71 124.32 24.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.015 0.436 . . . . 0.0 110.61 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.37 20.65 45.43 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.344 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.451 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 9.8 t70 -58.71 173.22 0.43 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.942 0.401 . . . . 0.0 110.835 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 18.8 tt0 -145.17 135.6 24.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.106 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.897 HD11 HD11 ' A' ' 145' ' ' ILE . 5.5 mt -108.8 128.64 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.313 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.641 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.1 m -103.75 136.64 43.06 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.54 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 29.8 m -138.08 158.38 32.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.183 0.516 . . . . 0.0 112.381 -178.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.483 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 82.96 38.62 11.13 Favored Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.954 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.441 ' HA ' HG12 ' A' ' 140' ' ' ILE . 56.5 t -79.84 140.47 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-O 121.676 0.75 . . . . 0.0 112.203 -179.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.48 -46.16 0.64 Allowed Glycine 0 N--CA 1.435 -1.371 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.712 ' CG2' HD11 ' B' ' 172' ' ' ILE . 0.9 OUTLIER -127.19 125.49 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 CA-C-N 114.259 -0.97 . . . . 0.0 108.827 177.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.417 ' HA ' HD12 ' A' ' 140' ' ' ILE . 0.1 OUTLIER -49.92 -24.79 2.72 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -177.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.0 t -93.05 -0.36 57.13 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.434 ' N ' HG12 ' A' ' 136' ' ' VAL . 79.1 m-20 -120.05 25.61 9.8 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -178.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.641 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.4 mt -106.88 138.72 31.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-O 121.405 0.621 . . . . 0.0 111.559 178.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.602 HD21 ' SG ' ' A' ' 38' ' ' CYS . 1.6 tt -124.5 134.49 53.0 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.392 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.736 ' HB2' HG23 ' A' ' 40' ' ' THR . 2.1 m -107.02 142.17 37.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.158 0.504 . . . . 0.0 111.976 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.595 ' CD2' HD22 ' A' ' 141' ' ' LEU . 2.1 mm? -135.34 137.74 42.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.448 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 21.1 t -110.79 137.79 41.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.88 0.371 . . . . 0.0 111.236 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.897 HD11 HD11 ' A' ' 130' ' ' ILE . 52.6 mt -106.22 128.32 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.399 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.94 114.96 27.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.364 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.599 HG12 HD21 ' A' ' 124' ' ' LEU . 6.5 mt -84.73 130.93 35.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.951 0.405 . . . . 0.0 111.618 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -78.97 111.95 15.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.752 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -61.38 -33.13 73.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.139 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -45.99 91.2 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.034 0.445 . . . . 0.0 110.843 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -60.5 -44.13 96.3 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.05 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.51 -34.43 69.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.097 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -62.42 -46.59 87.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.862 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.52 ' SG ' HD13 ' A' ' 52' ' ' ILE . 10.4 t -66.28 -45.18 81.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.92 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.457 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 0.2 OUTLIER -57.5 -44.01 84.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.793 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -70.33 -33.46 71.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.039 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.455 ' O ' ' C ' ' A' ' 158' ' ' ASN . 2.1 tt0 -73.06 -15.55 61.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.114 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.457 ' ND2' ' O ' ' A' ' 155' ' ' LEU . 1.6 p30 -24.85 -46.87 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 157' ' ' GLN . 4.2 tttt -125.06 133.32 52.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.778 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.4 t -78.61 134.35 28.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.11 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -152.91 109.55 3.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.02 98.32 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.835 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 21.7 mt -84.93 138.38 19.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.154 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.898 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.782 0.325 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.47 163.92 47.34 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.951 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.39 144.87 63.27 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.588 2.192 . . . . 0.0 112.214 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -99.97 80.78 2.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.049 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 169' ' ' TPO . . . . . 0.478 HG23 ' N ' ' B' ' 170' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.785 HD13 ' HB2' ' A' ' 82' ' ' SER . 0.1 OUTLIER -117.89 144.11 45.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.993 -179.234 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . 0.668 ' O ' HG22 ' B' ' 172' ' ' ILE . 3.3 mm-40 -119.67 47.15 1.77 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.505 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 0.712 HD11 ' CG2' ' A' ' 136' ' ' VAL . 4.5 tp 51.77 162.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.873 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 173' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -99.78 121.94 42.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.815 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.898 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.849 0.357 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.1 p -150.82 -58.32 0.17 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -61.13 -41.25 96.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.957 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -38.34 82.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.911 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -64.69 -35.05 79.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.889 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.37 -41.59 96.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.935 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.431 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 7.2 mm -68.45 -35.27 69.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.194 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -57.19 -45.82 83.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.895 0.378 . . . . 0.0 110.341 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -67.0 -23.76 65.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.381 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.5 -47.42 79.32 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.293 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.6 m -67.34 -31.33 71.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.867 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -156.51 112.25 2.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.791 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -77.63 133.28 38.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -88.44 107.51 18.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.932 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.2 mm -82.04 138.33 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 CA-C-O 121.595 0.712 . . . . 0.0 111.81 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 137.34 65.43 0.05 OUTLIER Glycine 0 C--N 1.313 -0.699 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.428 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -82.25 -37.65 25.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.732 0.301 . . . . 0.0 110.94 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.41 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER 176.42 39.6 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.668 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -74.79 135.62 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 CA-C-N 113.63 -1.623 . . . . 0.0 112.404 -177.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.978 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.3 t -91.93 -59.46 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.923 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.47 ' SG ' HD22 ' A' ' 48' ' ' LEU . 4.8 p -148.31 165.17 31.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.482 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.99 138.29 51.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.831 0.348 . . . . 0.0 111.399 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.696 HG21 ' CE2' ' A' ' 68' ' ' PHE . 47.6 t -111.18 122.81 66.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.563 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.828 HG23 HG12 ' A' ' 45' ' ' ILE . 19.0 mt -122.25 120.06 60.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.857 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.548 ' SG ' HD13 ' A' ' 43' ' ' ILE . 0.9 OUTLIER -83.96 104.07 13.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.039 179.14 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.96 -20.88 48.09 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.585 HG21 ' H ' ' A' ' 142' ' ' SER . 72.8 p -79.85 -2.41 43.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.803 0.335 . . . . 0.0 111.547 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.72 75.12 0.44 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.819 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.642 ' HB2' HD12 ' A' ' 43' ' ' ILE . 9.5 mt-30 -145.84 -40.01 0.23 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.893 0.378 . . . . 0.0 110.88 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.642 HD12 ' HB2' ' A' ' 42' ' ' GLN . 4.4 mp -125.4 142.69 42.38 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.038 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.622 ' HD2' HG23 ' A' ' 43' ' ' ILE . 50.7 Cg_endo -70.75 145.86 52.58 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.207 1.938 . . . . 0.0 112.131 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.828 HG12 HG23 ' A' ' 37' ' ' ILE . 35.2 mt -62.93 138.95 22.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.77 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.43 163.98 25.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.951 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -124.38 119.88 30.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.082 0.468 . . . . 0.0 111.854 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.823 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.6 mp -85.88 132.08 34.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.558 178.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.978 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -140.31 155.81 46.68 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 122.281 1.038 . . . . 0.0 113.423 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.477 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.08 141.84 29.18 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 113.533 -1.667 . . . . 0.0 110.798 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.722 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -76.07 135.89 39.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.256 0.551 . . . . 0.0 111.198 -179.625 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.714 HD13 ' SG ' ' A' ' 154' ' ' CYS . 68.3 mt -64.83 -38.9 83.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.048 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.1 p -60.92 -42.72 98.67 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.721 -178.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' A' ' 51' ' ' ASP . 5.6 pt20 -68.56 -36.94 79.46 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.465 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.786 HG13 ' HG3' ' A' ' 63' ' ' LYS . 59.2 t -65.08 -44.04 95.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.966 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.5 tp -71.03 -30.97 67.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.887 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.88 -48.27 18.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.968 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.84 136.86 56.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.914 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.3 30.73 1.95 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.03 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.3 -58.14 2.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.857 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.09 -63.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.91 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.496 HG21 ' CG2' ' A' ' 65' ' ' VAL . 20.3 mm -110.51 145.22 17.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.094 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.786 ' HG3' HG13 ' A' ' 55' ' ' VAL . 1.6 mmtp -96.88 -46.95 6.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.006 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.416 ' CE ' ' O ' ' A' ' 49' ' ' SER . 4.1 ttpt -155.01 140.34 17.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.192 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.598 HG13 ' O ' ' A' ' 91' ' ' ILE . 17.4 t -130.67 139.21 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 121.34 0.59 . . . . 0.0 112.084 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.823 ' CD2' HD23 ' A' ' 48' ' ' LEU . 16.2 m-90 -105.44 138.71 41.19 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.952 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.456 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -112.01 131.95 55.1 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.493 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.696 ' CE2' HG21 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -117.11 145.61 43.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.679 -178.316 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.673 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.92 -171.97 37.96 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.596 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 4.6 mtm105 -83.14 3.36 31.08 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.48 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.0 t30 -85.07 135.06 39.94 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.627 0.251 . . . . 0.0 110.95 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.8 Cg_exo -65.95 -11.83 32.67 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.613 2.209 . . . . 0.0 111.728 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.429 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.86 -45.31 14.4 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 121.952 0.882 . . . . 0.0 108.827 178.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.59 137.55 5.07 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 113.892 -1.504 . . . . 0.0 110.692 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.6 OUTLIER -56.66 -18.14 11.22 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.232 179.028 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.456 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 9.9 t80 -125.23 118.51 26.19 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-O 120.782 0.325 . . . . 0.0 110.928 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -99.77 115.73 30.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.543 HD11 ' HA2' ' A' ' 69' ' ' GLY . 2.6 mt -90.2 -168.28 2.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.093 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -91.68 19.36 48.6 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.828 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 63.88 84.31 0.15 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.865 0.365 . . . . 0.0 111.538 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.92 HD13 HD12 ' A' ' 84' ' ' LEU . 3.4 mp -108.3 131.4 58.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.714 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.459 ' C ' HD22 ' B' ' 170' ' ' LEU . 2.4 m -54.88 -39.55 68.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.03 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.511 ' NH1' HG23 ' A' ' 136' ' ' VAL . 1.9 tpt180 -66.37 -45.49 79.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.907 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.92 HD12 HD13 ' A' ' 81' ' ' ILE . 42.6 mt -72.81 151.54 42.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.892 0.377 . . . . 0.0 111.641 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.0 p -95.83 166.98 11.54 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.733 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.673 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.7 m-20 -43.85 -54.18 5.45 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.282 0.563 . . . . 0.0 109.842 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.455 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.6 OUTLIER -120.04 83.06 1.99 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.163 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.576 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 9.4 t60 -62.12 -46.32 89.54 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.791 -176.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.517 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 18.4 p90 -146.5 157.93 43.82 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.672 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.568 ' HG2' HG12 ' A' ' 65' ' ' VAL . 5.5 tt0 -135.94 140.66 44.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.332 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.755 HG12 HD13 ' A' ' 101' ' ' LEU . 39.3 mt -114.76 132.11 64.92 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.912 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.675 HD12 ' HB2' ' A' ' 100' ' ' LEU . 0.4 OUTLIER -123.59 146.28 48.28 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.141 0.496 . . . . 0.0 111.704 -179.805 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.761 HD13 ' HG ' ' A' ' 99' ' ' LEU . 14.5 tp -125.02 122.87 38.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.219 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 62' ' ' ILE . . . -164.68 84.78 0.1 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.529 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 176.95 -167.81 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 0.0 110.752 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.63 ' HA ' HD12 ' A' ' 155' ' ' LEU . 42.2 m-20 -83.98 57.77 4.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.886 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 100.02 -19.54 52.68 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.603 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.636 ' C ' HD12 ' A' ' 99' ' ' LEU . 47.6 m-20 -71.74 147.41 47.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.947 0.403 . . . . 0.0 110.996 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.761 ' HG ' HD13 ' A' ' 93' ' ' LEU . 7.6 mp -118.27 159.99 22.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.722 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.675 ' HB2' HD12 ' A' ' 92' ' ' LEU . 16.1 mt -133.1 146.58 51.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.879 0.371 . . . . 0.0 110.808 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.755 HD13 HG12 ' A' ' 91' ' ' ILE . 2.3 mm? -112.72 123.57 50.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.854 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -112.95 115.51 28.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.04 0.448 . . . . 0.0 111.229 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.823 ' OD2' HG23 ' A' ' 116' ' ' VAL . 15.1 p30 -81.34 133.19 35.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.874 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.461 HG12 ' HA ' ' A' ' 89' ' ' PHE . 19.2 pt -140.9 38.66 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.543 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -100.76 154.03 18.96 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 120.918 0.39 . . . . 0.0 111.577 -179.387 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.439 HG21 ' CG2' ' B' ' 169' ' ' TPO . 86.6 m -68.89 -31.77 70.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.43 178.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -97.74 -19.88 17.93 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.523 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.84 158.0 10.83 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.889 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.1 m -117.71 137.87 52.39 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.87 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -117.95 148.32 42.3 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.768 HD23 ' O ' ' A' ' 114' ' ' GLN . 0.4 OUTLIER -124.58 113.67 18.37 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 176.611 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 37.3 m-20 48.19 42.05 16.78 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.63 -8.38 75.51 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.77 -0.729 . . . . 0.0 113.925 178.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.768 ' O ' HD23 ' A' ' 111' ' ' LEU . 6.9 mt-30 -105.69 118.83 37.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.13 0.465 . . . . 0.0 110.786 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.87 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -73.14 135.08 44.66 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.404 -179.719 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.823 HG23 ' OD2' ' A' ' 103' ' ' ASP . 16.7 m -107.44 163.98 5.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.763 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 120' ' ' SER . 44.2 tt0 -69.87 127.32 32.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.384 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.69 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 76.7 tttt -52.16 161.57 0.6 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.896 0.379 . . . . 0.0 110.525 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.7 p30 34.37 34.73 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.305 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.492 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.34 145.11 40.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.453 179.618 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.665 ' HB3' HD22 ' A' ' 100' ' ' LEU . 26.0 m120 -87.43 123.99 32.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.615 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.472 ' O ' HD23 ' A' ' 100' ' ' LEU . 30.0 mm-40 -129.24 146.69 51.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.858 0.361 . . . . 0.0 111.102 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 32.6 tp -75.07 118.04 17.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.101 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.509 HD13 ' HB2' ' A' ' 99' ' ' LEU . 2.0 pt? -58.12 168.66 0.96 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.586 0.708 . . . . 0.0 112.039 -178.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.524 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.4 OUTLIER -124.38 154.13 40.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.81 -1.087 . . . . 0.0 109.905 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.751 ' HA ' HD13 ' A' ' 147' ' ' ILE . 17.1 tp60 -70.14 119.38 14.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.085 0.469 . . . . 0.0 110.27 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.06 23.38 59.41 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.905 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.468 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 25.6 t0 -57.81 179.2 0.07 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 120.716 0.293 . . . . 0.0 110.676 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.841 ' CG ' HG22 ' A' ' 144' ' ' VAL . 7.2 mt-10 -145.05 135.64 24.37 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.091 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.595 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 10.2 mt -107.3 123.67 62.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.924 0.392 . . . . 0.0 110.622 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.48 ' HB ' ' HB2' ' A' ' 110' ' ' TRP . 96.9 m -104.59 140.69 37.64 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.576 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 17.7 m -140.25 158.51 25.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.32 29.8 35.8 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.114 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.493 ' HB ' ' CH2' ' A' ' 110' ' ' TRP . 86.8 t -76.36 140.51 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-O 121.604 0.716 . . . . 0.0 111.986 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 139.04 -37.75 1.74 Allowed Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -178.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.945 HG22 ' CD1' ' B' ' 172' ' ' ILE . 2.5 t -123.01 118.35 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.85 -26.43 5.77 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -178.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 20.7 t -93.74 6.75 47.31 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -132.62 33.82 3.74 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -178.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.449 HG12 ' HA ' ' A' ' 134' ' ' VAL . 7.2 mt -107.21 138.02 35.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-O 121.619 0.723 . . . . 0.0 111.338 178.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.443 HD23 ' N ' ' A' ' 142' ' ' SER . 1.4 tt -125.65 135.02 51.7 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.374 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.585 ' H ' HG21 ' A' ' 40' ' ' THR . 46.8 t -112.38 147.42 36.44 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.87 0.843 . . . . 0.0 112.44 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.486 HD12 ' O ' ' A' ' 130' ' ' ILE . 3.7 mp -135.85 153.08 51.6 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.153 -1.385 . . . . 0.0 110.854 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.841 HG22 ' CG ' ' A' ' 129' ' ' GLU . 21.9 t -118.17 140.03 43.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.631 0.253 . . . . 0.0 110.544 179.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.5 mm -106.2 120.85 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-O 120.957 0.408 . . . . 0.0 110.989 -179.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.69 111.06 22.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.677 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.751 HD13 ' HA ' ' A' ' 126' ' ' GLN . 4.1 mp -89.93 134.23 29.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.853 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -85.52 108.2 17.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.5 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.79 -31.68 68.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.202 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -60.32 -45.95 91.6 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.967 0.413 . . . . 0.0 110.779 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -59.38 -44.1 92.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.049 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 34.4 mttt -64.34 -34.48 78.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.148 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -61.59 -43.32 99.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.154 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.714 ' SG ' HD13 ' A' ' 52' ' ' ILE . 8.5 t -68.05 -42.93 79.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.131 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.63 HD12 ' HA ' ' A' ' 96' ' ' ASP . 1.1 mm? -68.99 -45.59 70.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.095 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -62.86 -48.07 80.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.052 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -77.33 -36.94 53.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.068 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.3 p30 42.61 55.23 4.28 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.409 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -67.06 121.46 15.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.921 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.621 HG21 HD13 ' A' ' 163' ' ' ILE . 10.7 m -76.0 137.9 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.116 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -73.18 109.16 6.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.879 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.64 95.17 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.916 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.621 HD13 HG21 ' A' ' 160' ' ' VAL . 6.2 tp -104.63 130.16 55.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.095 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.266 -0.874 . . . . 0.0 110.872 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 30.3 m120 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.9 0.381 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -101.15 101.81 17.98 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.819 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.07 92.93 0.39 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.433 2.088 . . . . 0.0 112.363 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -125.38 124.97 42.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.841 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 169' ' ' TPO . . . . . 0.452 ' O ' HD12 ' B' ' 170' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.466 ' HB2' ' HA ' ' A' ' 83' ' ' ARG . 1.1 tp -150.49 -170.0 3.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.984 0.421 . . . . 0.0 111.454 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 179.93 112.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.256 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 0.945 ' CD1' HG22 ' A' ' 136' ' ' VAL . 3.9 tp -46.36 144.32 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.011 0.434 . . . . 0.0 111.576 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 173' ' ' TYR . . . . . 0.615 ' H ' HD12 ' B' ' 172' ' ' ILE . 2.6 p90 -90.53 120.64 31.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.891 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.95 -179.985 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.851 0.358 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.6 m -126.08 -53.33 1.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.868 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -64.36 -42.96 95.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.952 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 22.9 mtt180 -59.89 -36.04 76.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.894 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -62.88 -40.25 96.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.2 -45.63 92.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.496 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.4 mm -65.99 -35.14 74.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.155 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -57.13 -37.75 72.47 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.939 0.399 . . . . 0.0 110.437 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -67.28 -23.84 65.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.659 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.496 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.74 -47.51 79.88 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.09 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.2 m -80.13 -26.38 39.45 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.917 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 64.7 145.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.879 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -63.03 152.53 36.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -75.14 106.65 6.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.961 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.4 mm -81.96 138.22 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-O 121.658 0.742 . . . . 0.0 111.75 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.42 81.98 0.86 Allowed Glycine 0 C--N 1.314 -0.682 0 CA-C-N 114.531 -1.213 . . . . 0.0 112.385 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -58.88 -43.37 90.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.759 0.314 . . . . 0.0 110.98 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.9 OUTLIER 175.2 39.66 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.852 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.683 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -72.29 135.45 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 CA-C-N 113.613 -1.63 . . . . 0.0 112.558 -177.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.985 HG12 HD11 ' A' ' 99' ' ' LEU . 3.5 t -91.56 -58.85 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.912 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 24.8 p -152.56 154.78 36.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.644 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.87 ' NE ' HG21 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -119.09 138.22 53.03 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.799 0.333 . . . . 0.0 110.971 -179.85 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.515 HG21 ' CE2' ' A' ' 68' ' ' PHE . 57.3 t -107.7 122.67 62.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.895 0.379 . . . . 0.0 110.906 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.691 HG23 HG12 ' A' ' 45' ' ' ILE . 14.4 mt -118.69 127.97 75.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.502 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.83 ' HA ' HD13 ' A' ' 143' ' ' LEU . 52.6 t -81.36 100.68 9.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.518 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.583 ' OG1' HG23 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -67.98 -24.19 65.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.816 -179.249 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.525 HG23 ' HB3' ' A' ' 142' ' ' SER . 72.9 p -79.82 -2.36 43.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.831 0.348 . . . . 0.0 111.376 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 59.99 76.28 0.23 Allowed Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 121.018 -0.611 . . . . 0.0 113.09 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -146.57 -43.14 0.19 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.92 0.39 . . . . 0.0 110.78 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.647 HG23 ' HD2' ' A' ' 44' ' ' PRO . 3.4 mp -119.55 142.55 32.95 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.035 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.647 ' HD2' HG23 ' A' ' 43' ' ' ILE . 50.7 Cg_endo -71.2 146.18 50.8 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.216 1.944 . . . . 0.0 112.203 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.87 HG21 ' NE ' ' A' ' 35' ' ' ARG . 51.7 mt -55.04 144.68 5.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.944 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.481 ' HB2' ' CE2' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -128.28 134.24 48.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.837 178.828 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -98.72 119.71 37.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.046 0.451 . . . . 0.0 112.199 -178.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.762 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.1 mp -93.68 128.12 39.71 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.984 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -133.71 156.84 47.23 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 122.067 0.937 . . . . 0.0 113.526 -179.602 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.483 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -153.02 142.02 21.28 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 113.817 -1.538 . . . . 0.0 111.136 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.892 ' O ' HG23 ' A' ' 55' ' ' VAL . 24.7 m-20 -77.59 122.82 25.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.104 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 61.4 mt -64.51 -43.78 96.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.128 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.2 t -59.02 -40.71 85.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.337 0.589 . . . . 0.0 110.719 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.466 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 4.5 mm-40 -68.55 -36.86 79.38 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.742 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.892 HG23 ' O ' ' A' ' 51' ' ' ASP . 49.1 t -65.94 -39.49 84.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.936 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.1 mt -70.98 -31.36 67.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.823 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.02 -50.8 37.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.9 130.37 35.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.77 33.39 2.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.799 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.14 -66.18 0.86 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.4 m -164.05 -64.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.918 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.48 HD11 HG22 ' A' ' 65' ' ' VAL . 8.3 tp -113.79 152.48 15.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.165 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.535 ' HG2' HG13 ' A' ' 55' ' ' VAL . 12.3 mptt -112.15 -73.91 0.65 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.959 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.462 ' HE2' ' O ' ' A' ' 49' ' ' SER . 4.0 ttpt -136.62 131.51 33.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.327 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.71 HG12 ' HG2' ' A' ' 90' ' ' GLN . 16.0 t -131.27 139.27 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-O 121.155 0.503 . . . . 0.0 111.733 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.762 ' CD2' HD23 ' A' ' 48' ' ' LEU . 20.2 m-90 -101.02 139.24 36.98 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.002 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.683 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.76 126.93 55.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.038 0.447 . . . . 0.0 109.904 177.911 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.635 ' HZ ' HD21 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -111.43 145.83 38.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.453 -178.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.682 ' HA2' HD12 ' A' ' 78' ' ' LEU . . . 161.42 -171.86 37.51 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.602 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.454 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 8.3 mtp-105 -82.15 1.48 36.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.624 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 8.9 t-20 -84.92 134.37 41.56 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.716 0.293 . . . . 0.0 111.035 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.5 Cg_exo -68.48 -8.97 24.64 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.625 2.217 . . . . 0.0 111.787 179.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.624 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -83.16 -43.9 15.67 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 122.031 0.92 . . . . 0.0 108.79 178.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.45 136.64 2.33 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 113.656 -1.611 . . . . 0.0 110.832 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -56.6 -19.08 14.26 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.831 179.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.644 ' HE1' HD23 ' A' ' 78' ' ' LEU . 9.8 t80 -129.95 119.3 23.0 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.723 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -93.94 111.03 22.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.907 0.384 . . . . 0.0 110.95 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.682 HD12 ' HA2' ' A' ' 69' ' ' GLY . 44.9 mt -76.07 -78.55 0.11 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.997 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.62 -87.16 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.506 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -177.5 47.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.853 0.359 . . . . 0.0 111.003 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.454 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 30.7 mm -83.35 117.39 29.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.108 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.841 ' HB3' HD21 ' B' ' 170' ' ' LEU . 0.7 OUTLIER -54.7 -31.99 58.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.042 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.415 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.4 OUTLIER -70.96 -17.39 62.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.274 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.709 HD21 HG23 ' A' ' 132' ' ' VAL . 41.2 mt -106.95 152.16 24.32 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.762 0.315 . . . . 0.0 111.436 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 87.2 p -96.39 166.0 11.92 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.663 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.664 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.1 m-20 -43.11 -52.35 5.48 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.425 0.631 . . . . 0.0 109.774 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.445 ' HB2' HD12 ' A' ' 104' ' ' ILE . 14.5 ptmt -119.77 82.86 1.95 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 177.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.589 ' CE1' ' OG ' ' A' ' 105' ' ' SER . 14.2 t60 -61.17 -46.66 89.61 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.875 -176.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.539 ' HA ' HG12 ' A' ' 104' ' ' ILE . 32.0 p90 -148.99 161.42 41.94 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.767 -179.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.71 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.4 tt0 -135.92 142.28 44.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.42 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.622 ' C ' HG13 ' A' ' 65' ' ' VAL . 46.2 mt -117.55 127.64 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.004 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.504 HD21 HD22 ' A' ' 121' ' ' ASN . 0.7 OUTLIER -110.72 143.49 41.14 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.058 0.456 . . . . 0.0 111.752 -179.606 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.76 HD23 ' HG ' ' A' ' 99' ' ' LEU . 2.0 tm? -125.15 122.89 38.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.394 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.505 ' N ' HD22 ' A' ' 93' ' ' LEU . . . -163.59 -161.75 13.35 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.585 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 60.41 -173.92 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.794 0.331 . . . . 0.0 110.766 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -82.56 58.89 4.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.019 0.438 . . . . 0.0 110.807 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 108.69 -171.94 16.13 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.516 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.4 m120 61.54 170.2 0.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.901 0.382 . . . . 0.0 111.043 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.985 HD11 HG12 ' A' ' 33' ' ' VAL . 0.5 OUTLIER -135.05 160.12 39.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.689 179.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.624 HD23 ' HB3' ' A' ' 121' ' ' ASN . 2.3 mp -125.33 145.81 49.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.455 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.521 HD23 HG23 ' A' ' 91' ' ' ILE . 55.9 mt -112.99 123.29 49.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.33 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.436 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 59.5 t30 -118.2 115.77 25.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.829 0.347 . . . . 0.0 111.86 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.797 ' OD2' HG23 ' A' ' 116' ' ' VAL . 9.2 p30 -79.14 143.14 35.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.943 178.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.539 HG12 ' HA ' ' A' ' 89' ' ' PHE . 14.3 pt -146.88 26.73 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.589 ' OG ' ' CE1' ' A' ' 88' ' ' HIS . 11.0 t -93.98 154.97 17.39 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.517 ' OG1' HG21 ' B' ' 169' ' ' TPO . 5.7 m -70.12 -52.16 25.79 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.453 178.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -74.64 -4.06 34.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.247 -179.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.92 155.97 31.22 Favored Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.439 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.502 HG22 ' CG2' ' A' ' 130' ' ' ILE . 5.4 m -117.36 137.78 52.23 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.843 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -114.02 148.49 36.9 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -177.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.0 113.6 18.65 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.467 177.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 45.09 42.88 7.06 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.04 -13.44 61.38 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.726 -0.749 . . . . 0.0 113.486 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -104.49 118.49 36.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 117.104 0.452 . . . . 0.0 110.498 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.843 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -70.11 123.61 22.02 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.403 -179.793 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.797 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.7 m -95.08 164.64 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.01 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -69.94 127.88 34.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.587 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.682 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 17.6 tttm -53.66 162.47 0.85 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.754 0.312 . . . . 0.0 110.23 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.6 p30 34.52 36.32 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.004 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.7 p -111.92 145.09 40.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.706 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.624 ' HB3' HD23 ' A' ' 100' ' ' LEU . 18.6 m120 -92.71 130.67 38.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.872 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 58.3 mm-40 -129.28 150.93 50.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.558 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.7 tp -72.81 130.03 39.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.815 0.341 . . . . 0.0 110.226 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.754 HD22 ' HB2' ' A' ' 99' ' ' LEU . 30.0 tp -58.1 153.71 14.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.594 0.711 . . . . 0.0 111.737 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.452 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.6 OUTLIER -125.12 152.92 43.76 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.691 -1.14 . . . . 0.0 110.451 179.647 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -72.1 124.86 25.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.828 0.346 . . . . 0.0 110.09 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.84 22.82 48.92 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.758 -0.735 . . . . 0.0 111.981 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -50.4 165.71 0.09 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.896 0.379 . . . . 0.0 111.345 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.46 ' HG3' HG22 ' A' ' 144' ' ' VAL . 25.8 tt0 -145.05 135.48 24.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.99 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.502 ' CG2' HG22 ' A' ' 109' ' ' THR . 14.7 mt -114.73 128.24 71.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.798 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.639 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.08 139.84 38.61 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.709 HG23 HD21 ' A' ' 84' ' ' LEU . 35.8 m -140.42 158.67 25.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -178.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.85 29.27 29.43 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.236 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.426 ' HA ' HG12 ' A' ' 140' ' ' ILE . 74.6 t -73.38 140.51 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-O 121.622 0.725 . . . . 0.0 112.077 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.625 ' O ' HD12 ' B' ' 172' ' ' ILE . . . 144.23 -37.09 1.43 Allowed Glycine 0 N--CA 1.436 -1.36 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 -178.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.565 HG22 ' CD1' ' B' ' 172' ' ' ILE . 3.7 t -124.84 125.29 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.4 -35.92 30.51 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -178.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.0 p -93.59 6.57 47.8 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.461 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 30.4 m-20 -121.02 28.91 7.62 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -178.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.639 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.2 mt -107.04 138.52 32.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-O 121.5 0.667 . . . . 0.0 111.143 178.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.694 HD23 ' N ' ' A' ' 142' ' ' SER . 3.0 tt -124.85 134.42 52.73 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.149 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.694 ' N ' HD23 ' A' ' 141' ' ' LEU . 38.3 t -112.81 150.24 31.95 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.761 0.791 . . . . 0.0 112.642 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.83 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.9 mm? -136.02 143.67 44.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.525 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.583 HG23 ' OG1' ' A' ' 39' ' ' THR . 24.0 t -115.86 140.27 38.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.792 0.329 . . . . 0.0 111.008 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.55 HG21 HD11 ' A' ' 124' ' ' LEU . 33.2 mt -106.0 123.39 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-O 120.951 0.405 . . . . 0.0 111.278 -179.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.2 118.35 36.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.532 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.597 HG12 HD21 ' A' ' 124' ' ' LEU . 3.6 mt -88.07 133.96 29.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.649 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -82.72 113.53 20.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.738 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.57 -29.45 66.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.074 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.65 -45.77 91.02 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 120.976 0.417 . . . . 0.0 110.672 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -58.64 -44.12 89.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.951 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.0 -41.08 95.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.992 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -59.18 -40.1 84.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.103 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.3 t -60.7 -46.13 91.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.016 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.04 -38.39 79.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.016 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.76 -46.42 85.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.966 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.45 -37.07 32.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.946 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.1 p30 42.22 82.98 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.532 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.79 141.23 55.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.963 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 10.6 m -96.73 136.22 28.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.099 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.54 107.49 1.72 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.821 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 59.95 171.16 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.965 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.1 tp -76.98 138.49 20.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.054 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.874 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 1.2 m120 . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.781 0.324 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.58 150.37 91.22 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.57 131.52 21.68 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.582 2.188 . . . . 0.0 112.254 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -121.78 47.32 1.9 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.008 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 169' ' ' TPO . . . . . 0.54 ' C ' HD23 ' B' ' 170' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.841 HD21 ' HB3' ' A' ' 82' ' ' SER . 0.2 OUTLIER -160.27 -177.88 6.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.9 0.381 . . . . 0.0 111.298 -179.649 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . 0.519 ' O ' HG22 ' B' ' 172' ' ' ILE . 21.5 mt-10 -143.66 75.08 1.46 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.654 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 0.625 HD12 ' O ' ' A' ' 135' ' ' GLY . 16.1 tt 50.28 156.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 121.395 0.617 . . . . 0.0 111.996 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 173' ' ' TYR . . . . . 0.411 ' N ' HG12 ' B' ' 172' ' ' ILE . 5.1 p90 -109.75 137.83 47.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.852 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 34.9 t . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.906 179.959 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.85 0.357 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.68 HG22 ' CD2' ' A' ' 18' ' ' PHE . 1.0 OUTLIER -111.86 41.5 1.92 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.844 179.951 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -59.95 -46.92 87.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.768 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.74 -35.86 72.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.8 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.68 ' CD2' HG22 ' A' ' 15' ' ' THR . 1.1 m-85 -56.99 -43.49 81.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.535 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.72 -31.86 68.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.251 179.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.558 HG23 ' HE2' ' A' ' 23' ' ' PHE . 11.5 mt -69.45 -47.99 69.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.57 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -63.33 -33.78 76.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.366 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.19 -47.04 86.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.936 -178.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.558 ' HE2' HG23 ' A' ' 20' ' ' ILE . 4.0 p90 -71.83 -47.43 53.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.022 0.439 . . . . 0.0 111.101 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.525 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 12.3 m -58.49 -47.04 85.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.928 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -115.37 86.23 2.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.89 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -92.44 131.19 37.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.845 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -80.61 124.47 29.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.859 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.0 mm -82.61 138.35 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-O 121.728 0.775 . . . . 0.0 111.809 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 56.2 77.47 0.16 Allowed Glycine 0 C--N 1.315 -0.59 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.603 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.38 -42.52 98.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.828 0.346 . . . . 0.0 110.816 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.7 OUTLIER 179.0 38.08 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.717 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -75.99 135.07 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-N 113.785 -1.552 . . . . 0.0 112.506 -177.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.037 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -91.88 -61.68 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.24 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.465 ' SG ' HD12 ' A' ' 48' ' ' LEU . 7.5 p -149.34 149.02 30.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.302 179.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -116.7 138.3 51.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.874 0.368 . . . . 0.0 111.417 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.635 HG21 ' HE2' ' A' ' 68' ' ' PHE . 24.0 t -103.89 122.89 57.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.998 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.823 HG23 HG12 ' A' ' 45' ' ' ILE . 21.4 mt -123.09 117.72 52.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.609 -179.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.582 ' HA ' HD23 ' A' ' 143' ' ' LEU . 49.1 t -80.74 112.75 18.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.185 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.05 -21.62 29.32 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.559 HG21 ' H ' ' A' ' 142' ' ' SER . 75.1 p -79.79 -2.47 43.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.788 0.328 . . . . 0.0 111.592 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.46 72.37 0.74 Allowed Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.977 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -142.45 -42.13 0.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.876 0.369 . . . . 0.0 110.919 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.561 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.3 mt -121.02 141.66 33.18 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.035 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.561 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.9 Cg_endo -72.83 140.36 31.92 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.167 1.912 . . . . 0.0 112.167 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.823 HG12 HG23 ' A' ' 37' ' ' ILE . 36.1 mt -55.95 145.63 6.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.766 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.09 163.72 31.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.153 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -120.5 119.88 34.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.08 0.467 . . . . 0.0 112.013 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.633 HD22 ' CD1' ' A' ' 66' ' ' TRP . 5.1 mt -93.93 137.55 33.02 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 1.037 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.73 159.01 43.79 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -178.662 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.487 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -138.53 141.87 39.31 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 113.744 -1.571 . . . . 0.0 110.618 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.649 ' O ' HG23 ' A' ' 55' ' ' VAL . 3.6 m-20 -84.19 129.89 34.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.221 0.534 . . . . 0.0 111.578 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.628 HD13 ' SG ' ' A' ' 154' ' ' CYS . 10.2 mt -64.5 -45.39 95.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.435 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.9 t -56.67 -38.85 72.78 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.611 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.465 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 4.8 mm100 -68.55 -36.65 79.1 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.316 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 51' ' ' ASP . 97.5 t -59.77 -49.23 84.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.0 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.1 tt -68.77 -30.69 69.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.102 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -77.61 -46.54 21.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.037 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -83.63 129.98 34.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.935 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.03 31.12 3.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.908 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.1 mtm-85 -69.35 -69.24 0.35 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.827 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.7 m -164.82 -42.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.032 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.423 HD11 ' N ' ' A' ' 93' ' ' LEU . 3.6 tp -135.54 147.28 28.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.994 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.436 ' HE2' HG11 ' A' ' 55' ' ' VAL . 19.9 mttt -71.71 -68.89 0.42 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.859 0.362 . . . . 0.0 110.728 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.429 ' CE ' ' O ' ' A' ' 49' ' ' SER . 31.1 ttpt -150.69 140.09 21.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.667 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.597 HG13 ' O ' ' A' ' 91' ' ' ILE . 12.4 t -121.53 139.12 49.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.272 0.558 . . . . 0.0 111.906 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.633 ' CD1' HD22 ' A' ' 48' ' ' LEU . 18.2 m-90 -104.07 138.61 40.33 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.069 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.676 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.94 128.28 56.33 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 177.049 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.677 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -115.19 145.46 42.38 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.497 -177.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.584 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.35 -172.23 38.4 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.702 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.458 ' HD3' ' O ' ' A' ' 81' ' ' ILE . 9.4 mtm105 -80.46 2.29 25.79 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.476 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 3.0 t-20 -84.87 134.2 42.02 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.575 0.226 . . . . 0.0 111.125 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 15.8 Cg_exo -67.06 -11.9 34.01 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.531 2.154 . . . . 0.0 111.75 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.9 -43.33 16.65 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 122.017 0.913 . . . . 0.0 108.93 178.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.51 137.82 2.01 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.086 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.8 m-20 -56.58 -18.44 11.89 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.985 178.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.471 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 19.5 t80 -129.27 119.65 24.33 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.869 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -98.77 110.06 22.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.927 0.394 . . . . 0.0 111.031 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.456 HD11 ' HG3' ' A' ' 70' ' ' ARG . 1.9 pp -113.04 172.98 6.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.666 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.23 136.91 50.55 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.506 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -68.27 89.75 0.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.789 0.328 . . . . 0.0 110.777 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.458 ' O ' ' HD3' ' A' ' 70' ' ' ARG . 44.6 mt -107.86 135.55 46.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.024 0.44 . . . . 0.0 111.478 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.779 ' HB2' HD13 ' B' ' 170' ' ' LEU . 89.9 p -54.88 -43.94 73.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.274 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.505 ' HG3' ' HB3' ' A' ' 139' ' ' ASP . 1.6 mmt180 -60.85 -27.81 68.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.568 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.616 HD21 HG23 ' A' ' 132' ' ' VAL . 29.7 mt -96.23 150.95 19.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.9 0.381 . . . . 0.0 111.633 -179.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 75.4 p -98.62 169.05 9.78 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.416 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.584 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.0 m-20 -44.11 -55.3 4.85 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.318 0.58 . . . . 0.0 109.761 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.457 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 3.1 ptpp? -118.8 84.73 2.24 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 177.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.562 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 12.7 t60 -60.55 -47.02 88.0 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.874 -176.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.511 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 23.9 p90 -146.69 160.53 42.09 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.991 -179.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.676 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.3 tt0 -135.95 139.15 43.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.395 -179.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.677 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 61.6 mt -114.61 132.14 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 121.104 -0.238 . . . . 0.0 110.965 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.586 HD11 ' ND2' ' A' ' 121' ' ' ASN . 0.2 OUTLIER -123.97 136.41 54.29 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.047 0.451 . . . . 0.0 111.966 -179.604 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.804 HD22 ' CG1' ' A' ' 33' ' ' VAL . 2.4 tp -125.41 122.98 38.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.43 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.25 41.65 0.06 OUTLIER Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.854 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.52 76.07 1.16 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.878 0.371 . . . . 0.0 110.733 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.68 29.88 18.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.825 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 103.09 175.68 26.53 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.351 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.481 ' O ' HD12 ' A' ' 93' ' ' LEU . 0.3 OUTLIER 62.05 -170.75 0.16 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.839 0.352 . . . . 0.0 110.83 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.748 ' HB3' HD22 ' A' ' 124' ' ' LEU . 0.3 OUTLIER -124.22 159.82 29.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.764 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.737 HD13 ' HB3' ' A' ' 121' ' ' ASN . 12.7 mt -133.34 140.7 47.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.704 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.491 ' O ' HD12 ' A' ' 101' ' ' LEU . 3.1 pp -112.66 124.61 52.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.929 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.507 ' HB2' HD21 ' A' ' 92' ' ' LEU . 47.3 t30 -114.62 115.92 27.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.9 0.381 . . . . 0.0 111.705 -179.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.767 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.2 p30 -78.57 136.67 37.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.885 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.484 HD11 HG22 ' A' ' 67' ' ' THR . 18.8 pt -147.41 38.92 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.645 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.0 151.77 20.56 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 121.098 0.475 . . . . 0.0 112.207 -178.717 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.804 HG21 ' CG2' ' B' ' 169' ' ' TPO . 16.7 m -68.92 -31.63 70.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.705 177.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -97.07 -19.79 18.47 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.482 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.645 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.08 156.79 10.95 Favored Glycine 0 N--CA 1.439 -1.115 0 C-N-CA 120.4 -0.905 . . . . 0.0 114.014 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.477 HG22 ' CG2' ' A' ' 130' ' ' ILE . 6.3 m -117.32 137.71 52.25 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.761 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -118.94 148.66 42.72 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -177.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.472 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -123.91 113.57 18.66 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.559 177.676 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.415 ' N ' HD12 ' A' ' 111' ' ' LEU . 87.5 m-20 44.36 43.23 5.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.547 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.07 -14.21 59.53 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.435 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -104.24 118.51 36.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.09 0.445 . . . . 0.0 110.626 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.761 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -71.68 129.75 39.46 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.473 -179.65 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.767 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.0 m -96.41 166.11 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.956 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 120' ' ' SER . 23.1 mm-40 -69.92 127.2 32.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.591 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.663 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -53.98 158.51 2.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.172 0.51 . . . . 0.0 110.702 -179.962 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.49 ' H ' ' HG3' ' A' ' 118' ' ' LYS . 0.5 OUTLIER 35.73 35.45 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.798 -179.74 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -111.96 145.03 40.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.134 179.606 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.737 ' HB3' HD13 ' A' ' 100' ' ' LEU . 26.6 m120 -89.76 123.15 33.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.622 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.559 ' O ' HD23 ' A' ' 100' ' ' LEU . 30.1 mm-40 -126.62 145.76 50.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.969 0.414 . . . . 0.0 110.858 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.0 tp -72.97 118.41 15.89 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.951 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.748 HD22 ' HB3' ' A' ' 99' ' ' LEU . 2.4 pt? -57.44 167.66 0.95 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.589 0.709 . . . . 0.0 111.865 -178.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.414 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.2 OUTLIER -124.89 153.75 42.14 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.228 179.769 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.04 118.92 14.42 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.8 22.03 67.94 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.458 -178.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.414 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 24.3 t70 -54.33 174.11 0.06 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.895 0.379 . . . . 0.0 111.046 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 9.6 tt0 -145.35 135.27 23.66 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.041 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.796 HD11 HD11 ' A' ' 145' ' ' ILE . 18.9 mt -114.71 126.49 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.214 178.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.543 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.6 m -104.14 139.86 38.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.264 -0.425 . . . . 0.0 109.928 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.616 HG23 HD21 ' A' ' 84' ' ' LEU . 33.9 m -140.18 158.26 25.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.114 0.483 . . . . 0.0 112.194 -178.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.97 27.2 29.33 Favored Glycine 0 N--CA 1.44 -1.085 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.926 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.444 ' HB ' ' CZ3' ' A' ' 110' ' ' TRP . 68.9 t -74.04 140.49 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-O 121.611 0.72 . . . . 0.0 112.069 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.604 ' O ' HD12 ' B' ' 172' ' ' ILE . . . 148.92 -39.76 0.93 Allowed Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.622 HG22 HG13 ' B' ' 172' ' ' ILE . 2.5 t -118.16 129.17 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -50.58 -42.35 55.58 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -178.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.6 m -93.47 6.76 47.1 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -178.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.505 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . 0.5 OUTLIER -120.14 34.54 5.18 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -178.539 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.543 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.1 mt -107.23 139.46 28.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.942 178.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 8.9 tt -124.03 134.64 53.39 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.647 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.559 ' H ' HG21 ' A' ' 40' ' ' THR . 44.3 t -111.82 150.54 30.2 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.748 0.785 . . . . 0.0 112.715 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.582 HD23 ' HA ' ' A' ' 38' ' ' CYS . 71.5 mt -135.71 149.34 49.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.779 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 24.2 t -117.01 139.07 45.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.829 0.347 . . . . 0.0 111.075 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.796 HD11 HD11 ' A' ' 130' ' ' ILE . 17.6 mt -106.36 124.54 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.045 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.38 114.01 26.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.607 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.491 HG12 HD12 ' A' ' 124' ' ' LEU . 5.0 mt -84.95 134.12 27.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.546 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -86.09 105.0 16.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.737 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -57.66 -28.19 63.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.115 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -43.7 88.89 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.607 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -59.5 -44.01 93.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.889 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -62.69 -33.94 76.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.912 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.62 -36.92 84.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.031 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.628 ' SG ' HD13 ' A' ' 52' ' ' ILE . 7.8 t -68.0 -40.82 82.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.108 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.15 -50.0 57.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.126 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -58.54 -42.39 87.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.001 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.11 -36.11 35.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.835 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.3 p30 42.39 79.31 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.487 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.2 pttp -120.04 136.93 54.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.86 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 6.7 m -72.6 128.62 35.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.176 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -107.3 -45.78 4.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.865 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 8.9 ttm-85 -139.04 29.9 2.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.882 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.4 mt -105.04 137.93 32.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.044 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.859 -179.997 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.886 0.374 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.91 165.77 19.23 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.75 171.4 9.77 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.553 2.168 . . . . 0.0 112.228 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 178.41 85.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.005 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 169' ' ' TPO . . . . . 0.804 ' CG2' HG21 ' A' ' 106' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.779 HD13 ' HB2' ' A' ' 82' ' ' SER . 0.3 OUTLIER -163.53 153.0 14.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.92 -179.411 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . 0.569 ' O ' HG22 ' B' ' 172' ' ' ILE . 9.0 mt-10 -138.87 61.34 1.57 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.139 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 0.622 HG13 HG22 ' A' ' 136' ' ' VAL . 14.0 tt 49.44 158.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.276 0.56 . . . . 0.0 112.145 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 173' ' ' TYR . . . . . 0.48 ' N ' HG12 ' B' ' 172' ' ' ILE . 4.3 m-85 -51.64 94.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.005 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.293 -0.861 . . . . 0.0 110.863 -179.94 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.859 0.361 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.466 ' O ' HD23 ' A' ' 19' ' ' LEU . 1.9 t -160.28 -45.74 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.888 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -71.95 -44.45 63.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.922 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.94 -45.74 89.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.957 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -59.56 -35.81 74.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.851 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 15' ' ' THR . 2.2 mm? -65.22 -41.85 94.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.798 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.641 HG23 ' CE2' ' A' ' 23' ' ' PHE . 43.9 mm -68.19 -48.08 75.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.002 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.02 -33.67 72.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.329 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.3 tptp -58.6 -47.25 84.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.932 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.641 ' CE2' HG23 ' A' ' 20' ' ' ILE . 4.4 p90 -71.85 -47.38 53.44 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.982 0.42 . . . . 0.0 111.023 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.546 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 0.1 OUTLIER -61.74 -37.05 82.8 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.915 -179.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.03 169.1 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -81.02 131.35 35.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.843 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -87.59 131.41 34.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.888 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.5 mm -81.93 138.13 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 CA-C-O 121.65 0.738 . . . . 0.0 111.536 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.91 106.19 0.31 Allowed Glycine 0 C--N 1.313 -0.747 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.179 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 -80.82 -29.46 35.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.686 0.279 . . . . 0.0 111.156 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.516 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.9 m-20 176.41 41.19 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.654 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.3 mm -71.03 142.76 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-N 113.711 -1.586 . . . . 0.0 112.377 -176.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.722 ' CG2' HD22 ' A' ' 93' ' ' LEU . 0.9 OUTLIER -106.01 -48.99 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-N 114.275 -1.329 . . . . 0.0 109.91 -178.575 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.812 ' SG ' HD12 ' A' ' 48' ' ' LEU . 32.1 p -161.13 147.96 14.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.534 179.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -114.13 138.24 50.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.893 0.378 . . . . 0.0 111.317 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.748 HG21 ' CE2' ' A' ' 68' ' ' PHE . 21.3 t -101.81 122.73 54.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.062 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.559 HG23 HG12 ' A' ' 45' ' ' ILE . 20.1 mt -128.62 116.41 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.234 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.578 ' HA ' HD13 ' A' ' 143' ' ' LEU . 47.1 t -80.03 123.42 27.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.496 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.4 t -91.53 -27.33 18.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.546 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.578 HG21 ' H ' ' A' ' 142' ' ' SER . 7.0 p -79.81 -2.6 44.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.748 0.309 . . . . 0.0 111.408 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.7 77.99 0.24 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.752 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -146.4 -45.44 0.19 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.942 0.401 . . . . 0.0 110.788 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.56 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.0 mt -116.33 141.25 27.58 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.847 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.56 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.4 Cg_endo -72.73 146.01 42.31 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.271 1.981 . . . . 0.0 112.161 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.559 HG12 HG23 ' A' ' 37' ' ' ILE . 36.5 mt -55.9 151.83 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.683 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -149.8 162.3 40.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.19 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -122.65 119.81 31.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.049 0.452 . . . . 0.0 111.945 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.812 HD12 ' SG ' ' A' ' 34' ' ' CYS . 23.3 mt -93.28 138.04 32.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.231 178.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.654 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -141.18 156.95 45.86 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 122.14 0.971 . . . . 0.0 113.5 -178.932 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.621 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . -141.19 146.68 37.26 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 113.565 -1.652 . . . . 0.0 110.822 178.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.885 ' O ' HG23 ' A' ' 55' ' ' VAL . 4.3 m-20 -74.94 125.74 29.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.131 0.491 . . . . 0.0 111.187 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.531 HD13 ' SG ' ' A' ' 154' ' ' CYS . 91.3 mt -64.37 -44.46 97.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.641 -0.708 . . . . 0.0 112.099 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.498 ' HA ' HD21 ' A' ' 56' ' ' LEU . 2.9 m -57.06 -41.16 78.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.369 0.604 . . . . 0.0 110.673 -179.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.454 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 5.0 mm100 -68.62 -36.78 79.1 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.922 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.885 HG23 ' O ' ' A' ' 51' ' ' ASP . 40.4 t -69.13 -50.11 55.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.245 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.672 HD12 ' N ' ' A' ' 57' ' ' LYS . 4.3 pp -62.46 -25.36 67.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.093 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.672 ' N ' HD12 ' A' ' 56' ' ' LEU . 1.1 mttm -79.65 -55.04 5.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.936 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.11 108.75 4.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.97 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.52 -31.44 18.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.8 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.05 -179.09 3.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.687 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 58.84 -173.28 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.745 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.618 HD13 HD13 ' A' ' 92' ' ' LEU . 9.4 tp -91.39 156.53 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.104 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.675 ' HG2' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -94.43 -67.32 0.86 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.143 -179.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.46 ' CE ' ' O ' ' A' ' 49' ' ' SER . 15.5 ttpt -155.03 115.4 3.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.89 0.376 . . . . 0.0 111.864 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 91' ' ' ILE . 9.5 p -108.64 139.63 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.791 ' CD1' HD22 ' A' ' 48' ' ' LEU . 14.8 m-90 -100.71 139.9 35.74 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.151 -1.386 . . . . 0.0 112.064 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.597 HG23 ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -107.93 131.53 54.44 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 177.408 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.768 ' HZ ' HD11 ' A' ' 48' ' ' LEU . 3.0 m-85 -117.0 145.91 43.37 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.036 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.704 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.82 -171.34 37.74 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.293 -0.956 . . . . 0.0 113.011 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -82.67 2.97 30.91 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -84.81 142.84 39.65 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.695 0.283 . . . . 0.0 110.836 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.44 -11.79 22.65 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.341 2.027 . . . . 0.0 111.441 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.77 -43.73 16.39 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 121.931 0.872 . . . . 0.0 108.928 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.91 138.3 5.05 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 113.87 -1.514 . . . . 0.0 110.751 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.8 OUTLIER -56.37 -18.55 11.29 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.971 178.903 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.569 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 3.9 t80 -129.1 117.59 21.08 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-O 120.775 0.321 . . . . 0.0 110.96 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -92.78 107.87 19.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.655 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.957 HD23 HD13 ' A' ' 84' ' ' LEU . 8.9 mp -73.49 -175.04 1.84 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.107 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.16 17.71 49.76 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.804 -0.713 . . . . 0.0 113.037 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 65.43 74.71 0.37 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.022 0.439 . . . . 0.0 111.493 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.43 ' HB ' HD12 ' A' ' 84' ' ' LEU . 25.5 mm -112.0 126.87 69.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.643 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.831 ' HB2' HD11 ' B' ' 170' ' ' LEU . 0.9 OUTLIER -55.02 -41.35 71.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.312 -179.552 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.631 ' NH1' HD12 ' B' ' 170' ' ' LEU . 0.3 OUTLIER -60.81 -24.02 65.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.997 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.957 HD13 HD23 ' A' ' 78' ' ' LEU . 17.9 mt -98.16 152.11 19.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.879 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.5 p -96.29 164.53 12.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.759 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.704 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 4.8 m-20 -40.06 -57.0 1.75 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.416 0.627 . . . . 0.0 109.584 178.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.462 ' HB3' HD11 ' A' ' 104' ' ' ILE . 6.4 mttp -116.59 85.69 2.36 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.588 ' CD2' ' HB2' ' A' ' 105' ' ' SER . 15.5 t60 -64.59 -44.94 89.02 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.074 -0.967 . . . . 0.0 113.428 -176.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.515 ' HA ' HG12 ' A' ' 104' ' ' ILE . 34.5 p90 -154.1 162.58 41.1 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.139 -0.625 . . . . 0.0 112.053 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.631 ' OE1' HG21 ' A' ' 104' ' ' ILE . 14.3 mt-30 -135.7 155.46 50.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.419 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.567 ' O ' HG23 ' A' ' 65' ' ' VAL . 65.0 mt -122.97 128.81 75.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.716 HD23 ' HB2' ' A' ' 102' ' ' ASN . 1.8 pp -118.97 130.97 55.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.008 0.432 . . . . 0.0 111.831 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.722 HD22 ' CG2' ' A' ' 33' ' ' VAL . 3.2 tp -108.12 139.82 42.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.21 179.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -178.45 -141.36 4.27 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.412 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 58.26 -176.58 0.08 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.798 0.332 . . . . 0.0 110.885 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -63.04 -30.89 71.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.901 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 174.56 66.65 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.493 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -155.62 169.95 23.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.861 0.363 . . . . 0.0 110.935 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.683 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -117.06 149.28 40.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.842 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.765 HD23 ' HB3' ' A' ' 121' ' ' ASN . 10.8 mp -129.3 146.54 51.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.414 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.503 HD11 HD11 ' A' ' 130' ' ' ILE . 0.2 OUTLIER -112.89 126.88 55.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.38 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.716 ' HB2' HD23 ' A' ' 92' ' ' LEU . 53.4 t30 -116.8 115.85 26.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.863 0.363 . . . . 0.0 111.857 -179.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.827 ' OD2' HG23 ' A' ' 116' ' ' VAL . 7.5 p30 -79.76 143.28 34.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.049 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.631 HG21 ' OE1' ' A' ' 90' ' ' GLN . 12.5 pt -146.19 22.89 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.588 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 9.2 t -91.43 154.86 18.87 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.6 m -70.22 -52.11 25.7 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.447 178.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -74.42 -2.75 26.81 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.375 -179.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.87 156.08 31.88 Favored Glycine 0 N--CA 1.438 -1.203 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.468 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.463 HG22 ' CG2' ' A' ' 130' ' ' ILE . 5.0 m -117.44 137.68 52.35 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.829 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -115.52 148.59 39.33 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -177.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.473 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.09 113.5 18.45 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.44 177.529 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.419 ' N ' HD12 ' A' ' 111' ' ' LEU . 46.0 m-20 44.79 43.09 6.58 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.93 -11.87 65.63 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.455 178.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -104.99 118.49 36.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.037 0.446 . . . . 0.0 110.682 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.829 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -70.99 124.54 24.61 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.484 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.827 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.2 m -96.39 162.87 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.818 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.48 ' O ' ' HB2' ' A' ' 120' ' ' SER . 2.1 tt0 -69.82 129.59 39.96 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.439 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.672 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 15.4 tttt -53.94 160.62 1.41 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.876 0.37 . . . . 0.0 110.572 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.7 p30 34.58 34.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.303 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.48 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.35 145.31 40.29 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.117 179.477 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.765 ' HB3' HD23 ' A' ' 100' ' ' LEU . 5.1 m120 -86.04 130.42 34.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.086 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.421 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 30.4 mm-40 -129.37 146.3 51.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.377 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.432 HD13 ' C ' ' A' ' 123' ' ' LEU . 1.2 tm? -72.72 115.01 11.49 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.793 0.33 . . . . 0.0 110.314 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.496 HD21 HG12 ' A' ' 147' ' ' ILE . 65.6 tp -54.75 157.71 2.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.382 0.611 . . . . 0.0 111.7 -179.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.43 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.0 OUTLIER -124.28 153.53 41.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.374 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.463 ' HA ' HD12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.06 119.63 15.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.969 0.414 . . . . 0.0 110.291 -179.65 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.55 21.49 64.84 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.235 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.43 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 26.0 t70 -56.94 172.01 0.3 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.997 0.427 . . . . 0.0 111.069 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 4.5 tt0 -145.22 135.58 24.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.165 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.503 HD11 HD11 ' A' ' 101' ' ' LEU . 1.3 mp -110.5 128.73 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.443 179.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.605 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.1 m -103.64 140.02 38.13 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.645 HG23 HD21 ' A' ' 84' ' ' LEU . 28.2 m -140.41 158.45 25.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -178.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 87.32 24.68 35.95 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.332 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.427 ' HB ' ' CZ3' ' A' ' 110' ' ' TRP . 70.2 t -69.56 140.38 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-O 121.632 0.729 . . . . 0.0 111.907 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 143.04 -41.84 1.14 Allowed Glycine 0 N--CA 1.435 -1.385 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 1.054 HG22 HD12 ' B' ' 172' ' ' ILE . 6.2 t -119.15 126.05 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.28 -35.84 28.91 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 47.3 m -93.49 6.63 47.54 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.442 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 30.6 m-20 -120.81 29.65 7.29 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -178.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.605 ' CG2' HG22 ' A' ' 131' ' ' THR . 7.3 mt -106.89 138.91 30.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 121.478 0.656 . . . . 0.0 110.904 178.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.671 HD22 ' CD2' ' A' ' 143' ' ' LEU . 1.3 tt -124.65 134.64 52.82 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.729 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.6 ' N ' HD23 ' A' ' 141' ' ' LEU . 0.9 OUTLIER -109.57 133.39 53.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.001 0.429 . . . . 0.0 111.717 -179.819 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.671 ' CD2' HD22 ' A' ' 141' ' ' LEU . 1.4 mm? -128.84 135.73 49.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.554 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.422 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 24.0 t -110.93 134.45 53.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.829 0.347 . . . . 0.0 111.271 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.435 HD13 HG22 ' A' ' 36' ' ' VAL . 5.2 mm -106.11 139.0 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.975 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.34 122.35 41.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.798 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.496 HG12 HD21 ' A' ' 124' ' ' LEU . 6.7 mt -85.01 134.11 27.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.324 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -83.35 103.57 12.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.853 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -64.14 -28.08 69.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.063 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.15 -43.67 87.47 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.062 0.458 . . . . 0.0 110.618 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.433 ' CZ ' HG12 ' A' ' 52' ' ' ILE . 33.5 t80 -58.53 -44.01 89.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.901 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -60.94 -40.45 93.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.955 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -60.61 -37.09 80.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.073 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.531 ' SG ' HD13 ' A' ' 52' ' ' ILE . 10.2 t -64.71 -45.34 86.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.085 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -62.35 -36.01 80.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.919 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -62.19 -34.71 76.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.993 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -92.07 -37.0 13.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.928 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.9 p30 44.36 -171.49 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.598 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -95.92 134.47 38.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.883 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.7 t -80.55 126.62 39.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.14 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -98.85 166.84 11.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.946 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -107.0 114.54 28.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.874 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.8 mt -85.4 134.56 26.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.075 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.87 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.852 0.358 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -62.66 119.65 52.74 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.826 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.89 126.56 11.41 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.359 2.039 . . . . 0.0 112.427 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -107.69 78.51 1.2 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.709 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 169' ' ' TPO . . . . . 0.479 HG23 ' N ' ' B' ' 170' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.831 HD11 ' HB2' ' A' ' 82' ' ' SER . 0.4 OUTLIER -100.6 173.06 6.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.904 0.383 . . . . 0.0 111.555 -179.48 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . 0.515 ' O ' ' O ' ' B' ' 172' ' ' ILE . 31.0 mt-10 -161.47 92.71 0.9 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.723 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 1.054 HD12 HG22 ' A' ' 136' ' ' VAL . 0.9 OUTLIER 44.85 114.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 121.349 0.595 . . . . 0.0 112.047 -179.73 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 173' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -80.99 60.53 4.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.055 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 83.4 p . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.854 179.951 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.453 ' HB1' ' HB2' ' A' ' 17' ' ' ARG . . . . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.772 0.32 . . . . 0.0 111.045 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.7 m 70.37 -64.17 0.37 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.903 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -41.11 88.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.921 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.453 ' HB2' ' HB1' ' A' ' 14' ' ' ALA . 5.8 ttt180 -62.13 -35.98 80.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.844 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -56.86 -39.26 73.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.741 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.8 mp -61.37 -31.91 71.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.422 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.42 ' O ' ' CD1' ' A' ' 23' ' ' PHE . 8.2 mt -69.21 -44.4 80.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.771 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -57.56 -32.71 67.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.418 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.5 -22.28 7.82 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.01 -179.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.42 ' CD1' ' O ' ' A' ' 20' ' ' ILE . 1.9 p90 -55.66 -44.3 77.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.925 0.393 . . . . 0.0 111.474 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.419 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 51.8 p -80.38 -25.13 39.28 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.935 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 65.11 141.24 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.866 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -63.04 140.91 58.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.826 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -82.82 109.02 16.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.923 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.4 mm -81.92 138.39 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 CA-C-O 121.615 0.721 . . . . 0.0 111.694 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.79 52.41 3.15 Favored Glycine 0 C--N 1.313 -0.705 0 CA-C-N 114.593 -1.185 . . . . 0.0 112.359 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -73.89 -44.6 54.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.853 0.359 . . . . 0.0 111.112 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.441 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER -170.38 33.31 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -179.767 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.702 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -73.2 133.84 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-N 113.839 -1.528 . . . . 0.0 112.407 -177.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.998 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -92.54 -61.37 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.09 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.691 ' SG ' HD12 ' A' ' 48' ' ' LEU . 1.6 p -143.38 163.44 33.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.272 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 146' ' ' PHE . 0.0 OUTLIER -127.05 138.3 53.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.962 0.411 . . . . 0.0 111.782 -179.131 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.668 HG11 ' CE2' ' A' ' 68' ' ' PHE . 2.0 m -108.63 122.9 63.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.579 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.897 HG23 HG12 ' A' ' 45' ' ' ILE . 21.5 mt -128.42 122.11 56.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.991 -178.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.845 ' HA ' HD23 ' A' ' 143' ' ' LEU . 42.0 t -81.81 102.63 10.93 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 178.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.488 ' OG1' HG23 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -74.32 -23.82 59.12 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.68 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.554 HG21 ' H ' ' A' ' 142' ' ' SER . 72.2 p -79.78 -2.29 42.55 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.683 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.23 77.19 0.37 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.87 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.714 ' OE1' HD12 ' A' ' 141' ' ' LEU . 15.9 mt-30 -146.62 -41.0 0.2 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.935 0.398 . . . . 0.0 110.696 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.583 HG21 ' CE1' ' A' ' 76' ' ' TYR . 1.3 mp -125.77 141.34 38.98 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.8 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.556 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 46.8 Cg_endo -71.68 146.1 48.07 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.102 1.868 . . . . 0.0 112.137 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.897 HG12 HG23 ' A' ' 37' ' ' ILE . 39.2 mt -51.44 148.33 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.898 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.84 150.3 49.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.083 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -112.87 119.63 38.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.049 0.452 . . . . 0.0 111.368 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.691 HD12 ' SG ' ' A' ' 34' ' ' CYS . 3.1 mt -95.98 135.26 37.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.227 178.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.998 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.04 158.01 43.87 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -178.834 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.488 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -140.91 143.26 34.53 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 113.528 -1.669 . . . . 0.0 110.861 178.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.789 ' O ' HG23 ' A' ' 55' ' ' VAL . 23.3 m-20 -74.92 122.31 23.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.223 0.535 . . . . 0.0 111.093 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.455 HD13 ' SG ' ' A' ' 154' ' ' CYS . 44.4 mt -64.34 -40.96 90.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.4 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 p -57.05 -42.17 80.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.229 0.538 . . . . 0.0 110.825 -178.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.483 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 13.4 mt-30 -68.7 -37.13 79.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.891 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.82 HG22 ' HG2' ' A' ' 63' ' ' LYS . 30.1 t -65.59 -45.51 92.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.283 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.13 -28.9 64.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.12 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.1 tmtm? -81.0 -46.78 14.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.048 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -77.08 135.0 38.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.905 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.98 29.39 4.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.9 mtm105 -150.21 151.81 33.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.865 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 59.42 -174.64 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.822 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.41 HG12 ' CG2' ' A' ' 65' ' ' VAL . 9.5 tp -81.96 144.46 10.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.1 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.82 ' HG2' HG22 ' A' ' 55' ' ' VAL . 1.6 tpmp? -69.38 -72.57 0.18 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.965 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.433 ' CE ' ' O ' ' A' ' 49' ' ' SER . 6.0 ttpt -149.38 137.37 20.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.952 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.617 HG12 ' HG2' ' A' ' 90' ' ' GLN . 13.9 t -128.79 139.09 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-O 121.375 0.607 . . . . 0.0 112.299 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.532 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.9 m-90 -103.03 139.24 38.84 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.887 179.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.62 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -114.21 129.05 56.63 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.338 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.668 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -118.3 145.45 45.07 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.6 -178.305 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.597 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.43 -166.6 35.38 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.393 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.412 ' HD3' ' O ' ' A' ' 81' ' ' ILE . 12.9 mtm180 -86.73 6.98 28.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.504 0.192 . . . . 0.0 111.512 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.671 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 9.7 t-20 -84.95 134.01 42.19 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.547 0.213 . . . . 0.0 111.036 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.9 Cg_exo -65.43 -15.07 48.13 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.53 2.153 . . . . 0.0 111.598 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.671 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -83.15 -43.26 16.38 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 121.962 0.887 . . . . 0.0 108.887 178.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.47 136.03 3.38 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 113.862 -1.517 . . . . 0.0 111.045 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.9 OUTLIER -56.87 -18.62 13.79 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.952 178.611 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.583 ' CE1' HG21 ' A' ' 43' ' ' ILE . 30.5 t80 -129.57 112.1 13.38 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.783 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -89.75 111.63 22.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.22 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.769 HD13 HD13 ' A' ' 84' ' ' LEU . 88.4 mt -78.52 -172.81 3.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.839 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -90.66 21.12 34.51 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.891 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.04 74.68 0.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.944 0.402 . . . . 0.0 111.601 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 1.042 HD13 HD12 ' A' ' 84' ' ' LEU . 4.3 mp -106.62 129.18 60.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.723 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.788 ' HB3' HD13 ' B' ' 170' ' ' LEU . 2.7 m -54.91 -37.21 66.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.293 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.794 ' NE ' HD21 ' B' ' 170' ' ' LEU . 0.0 OUTLIER -69.32 -15.94 63.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.452 -179.814 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.042 HD12 HD13 ' A' ' 81' ' ' ILE . 28.4 mt -107.06 152.01 24.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.719 0.295 . . . . 0.0 110.833 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.4 m -95.79 166.63 11.72 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.496 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.597 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 1.4 m-80 -42.46 -57.55 2.59 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.439 0.638 . . . . 0.0 109.545 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.486 ' HB3' HG22 ' A' ' 67' ' ' THR . 10.3 mtpt -116.79 84.39 2.13 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 176.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.549 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 12.4 t60 -60.89 -46.73 89.46 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.596 -176.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.492 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 25.6 p90 -145.08 158.07 43.93 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.116 -0.634 . . . . 0.0 112.157 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.62 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.9 tt0 -135.9 139.91 43.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.164 -179.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.598 ' O ' HG13 ' A' ' 65' ' ' VAL . 72.6 mt -115.97 130.23 71.02 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 C-N-CA 121.134 -0.227 . . . . 0.0 111.002 179.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.51 HD21 ' HB2' ' A' ' 102' ' ' ASN . 0.2 OUTLIER -115.53 150.83 35.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.12 0.486 . . . . 0.0 111.851 -179.888 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.422 HD13 ' HG ' ' A' ' 99' ' ' LEU . 14.6 tp -124.99 122.87 38.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.223 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -82.67 -178.26 52.29 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.82 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -96.38 110.17 22.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.819 0.343 . . . . 0.0 110.864 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.1 t0 57.94 98.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.948 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 162.75 -94.32 0.12 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.515 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -154.18 -171.13 3.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.843 0.354 . . . . 0.0 110.864 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.983 HD21 HG12 ' A' ' 33' ' ' VAL . 4.2 mp -106.95 157.16 18.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.762 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.735 HD22 ' HB3' ' A' ' 121' ' ' ASN . 13.8 mt -133.2 144.38 49.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.893 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.649 HD11 ' HA ' ' A' ' 124' ' ' LEU . 2.2 mt -112.73 123.21 49.78 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.745 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.51 ' HB2' HD21 ' A' ' 92' ' ' LEU . 52.0 t30 -114.68 115.55 27.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.062 0.458 . . . . 0.0 111.664 -179.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.82 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.1 p30 -77.71 134.61 38.07 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.733 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.459 HD12 ' HB2' ' A' ' 87' ' ' LYS . 13.7 pt -141.71 39.48 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.623 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -101.93 151.63 21.88 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.005 0.431 . . . . 0.0 112.021 -178.892 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.742 HG21 ' HB ' ' B' ' 169' ' ' TPO . 19.6 m -68.89 -31.59 70.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.688 177.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -95.11 -19.55 20.02 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.328 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.623 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 112.78 158.96 13.82 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.781 179.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 11.4 m -117.1 137.69 52.12 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.871 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -115.89 148.32 40.12 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -177.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.485 HD13 ' OD2' ' A' ' 128' ' ' ASP . 0.2 OUTLIER -124.31 113.52 18.35 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.66 -1.155 . . . . 0.0 108.419 177.545 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 43.74 43.77 5.15 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.51 -11.14 66.87 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.58 178.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -103.57 118.59 37.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.027 0.441 . . . . 0.0 110.583 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.871 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 12.2 tptm -74.53 122.3 22.88 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.382 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.82 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.9 m -91.59 164.17 2.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.971 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 120' ' ' SER . 15.9 tt0 -69.89 126.26 29.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.468 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.702 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 28.2 tttt -53.2 162.69 0.66 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.944 0.402 . . . . 0.0 110.441 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.1 m-80 34.67 35.0 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.03 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.4 OUTLIER -112.27 145.01 40.72 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.293 179.578 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.735 ' HB3' HD22 ' A' ' 100' ' ' LEU . 28.2 m120 -89.11 125.56 35.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.727 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.508 ' O ' HD23 ' A' ' 100' ' ' LEU . 38.5 mm-40 -129.31 147.65 51.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.089 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 tt -76.34 115.3 15.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.104 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.649 ' HA ' HD11 ' A' ' 101' ' ' LEU . 1.6 pt? -56.99 165.84 1.17 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.604 0.716 . . . . 0.0 112.043 -178.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.449 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.64 153.65 41.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.073 179.657 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.522 ' HA ' HD12 ' A' ' 147' ' ' ILE . 3.4 tp60 -71.17 123.22 21.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.013 0.435 . . . . 0.0 110.287 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.06 20.19 53.16 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.107 -179.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.485 ' OD2' HD13 ' A' ' 111' ' ' LEU . 7.7 t70 -58.58 178.8 0.09 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.745 0.307 . . . . 0.0 110.673 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.885 ' CG ' HG22 ' A' ' 144' ' ' VAL . 5.4 mt-10 -145.11 135.61 24.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.415 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 1.038 HD11 HD11 ' A' ' 145' ' ' ILE . 15.3 mt -112.04 126.91 69.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.215 178.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.51 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.2 m -104.33 138.66 40.44 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.563 HG23 HD21 ' A' ' 84' ' ' LEU . 35.8 m -140.01 158.12 26.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.138 0.494 . . . . 0.0 112.268 -178.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 89.47 24.02 32.23 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.951 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.461 ' HB ' ' CZ3' ' A' ' 110' ' ' TRP . 73.5 t -71.12 140.52 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-O 121.654 0.74 . . . . 0.0 112.021 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.05 -45.74 0.66 Allowed Glycine 0 N--CA 1.433 -1.525 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.918 HG22 HG12 ' B' ' 172' ' ' ILE . 1.7 t -110.51 131.41 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -50.56 -44.22 56.53 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.8 m -93.37 6.92 46.48 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -178.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.47 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 16.5 m-20 -117.01 34.4 5.13 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -178.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.51 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.4 mt -107.01 139.09 29.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.973 178.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.714 HD12 ' OE1' ' A' ' 42' ' ' GLN . 10.2 tt -124.33 134.71 53.1 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.862 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.554 ' H ' HG21 ' A' ' 40' ' ' THR . 47.1 t -110.33 150.34 28.9 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.658 0.742 . . . . 0.0 112.195 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.845 HD23 ' HA ' ' A' ' 38' ' ' CYS . 75.0 mt -135.87 158.1 45.21 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.881 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.885 HG22 ' CG ' ' A' ' 129' ' ' GLU . 22.4 t -122.54 139.92 47.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.852 0.358 . . . . 0.0 111.026 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 1.038 HD11 HD11 ' A' ' 130' ' ' ILE . 30.7 mt -106.3 120.96 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.833 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.406 ' O ' ' N ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -109.99 108.62 18.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.841 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.522 HD12 ' HA ' ' A' ' 126' ' ' GLN . 6.1 mt -84.6 128.98 38.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.245 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -77.82 114.16 16.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -69.02 -31.59 70.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -57.39 -43.38 83.61 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.066 0.46 . . . . 0.0 110.411 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -58.18 -44.08 87.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.624 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -65.12 -34.43 78.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.957 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -64.13 -43.45 95.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.068 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.455 ' SG ' HD13 ' A' ' 52' ' ' ILE . 13.2 t -58.9 -46.21 88.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.939 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.1 -35.93 76.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.83 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -37.68 80.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -88.32 -37.12 16.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.94 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.5 p30 44.24 -171.33 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.6 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.87 120.54 25.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.819 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 26.3 t -103.06 129.5 54.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.077 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -119.64 -68.38 0.92 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.958 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? 61.16 31.35 19.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.864 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 20.4 mt -102.79 117.18 47.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.178 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.176 -0.916 . . . . 0.0 110.945 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.888 0.375 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.1 146.81 33.27 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.832 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.29 155.01 56.47 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.474 2.116 . . . . 0.0 112.376 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -112.39 97.47 6.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.799 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 169' ' ' TPO . . . . . 0.742 ' HB ' HG21 ' A' ' 106' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.794 HD21 ' NE ' ' A' ' 83' ' ' ARG . 2.3 tt -53.36 152.18 4.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.437 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . 0.691 ' O ' HG22 ' B' ' 172' ' ' ILE . 53.6 mt-10 -153.83 79.76 1.14 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.869 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 0.918 HG12 HG22 ' A' ' 136' ' ' VAL . 0.1 OUTLIER 53.37 134.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 121.182 0.515 . . . . 0.0 111.587 -179.862 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 173' ' ' TYR . . . . . 0.909 ' N ' HD13 ' B' ' 172' ' ' ILE . 20.9 m-85 -56.17 105.67 0.21 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.939 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 1.3 p . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.899 -179.973 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.429 ' O ' ' HB ' ' A' ' 15' ' ' THR . . . . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.646 0.26 . . . . 0.0 111.031 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.429 ' HB ' ' O ' ' A' ' 14' ' ' ALA . 14.0 m 74.99 -52.91 0.67 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.413 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -59.66 -34.27 72.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.712 0.292 . . . . 0.0 110.962 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.81 -38.27 90.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.76 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -61.42 -40.77 95.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.716 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.6 mt -58.93 -31.83 69.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.726 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.427 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.8 mt -72.55 -35.31 50.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.921 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -57.32 -42.88 82.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.478 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.21 -24.17 65.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.537 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.427 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.91 -47.57 80.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.204 179.859 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.1 t -70.89 -31.12 67.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.001 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -63.08 82.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.858 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -65.22 155.34 35.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.767 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -85.56 101.86 13.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.931 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.3 mm -84.45 138.18 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 CA-C-O 121.611 0.72 . . . . 0.0 111.656 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 139.07 43.61 0.08 OUTLIER Glycine 0 C--N 1.313 -0.701 0 CA-C-N 114.546 -1.206 . . . . 0.0 112.549 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.473 ' HG2' HD11 ' A' ' 32' ' ' ILE . 2.5 pt-20 -59.89 -41.39 91.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.912 0.387 . . . . 0.0 110.792 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.461 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.0 OUTLIER -179.88 37.22 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.92 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.722 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.4 mm -73.48 135.67 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 CA-C-N 113.664 -1.607 . . . . 0.0 112.45 -177.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.014 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.4 t -91.81 -59.77 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.916 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.718 ' SG ' HD12 ' A' ' 48' ' ' LEU . 7.0 p -150.59 152.03 33.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.26 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.425 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.99 138.21 50.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.817 0.341 . . . . 0.0 111.352 -179.396 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.629 HG23 HD11 ' A' ' 48' ' ' LEU . 24.3 t -100.73 122.77 53.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.829 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.699 HG23 HG12 ' A' ' 45' ' ' ILE . 17.0 mt -132.93 122.08 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.581 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.621 ' HA ' HD23 ' A' ' 143' ' ' LEU . 51.4 t -80.68 136.55 36.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.405 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 t -97.38 -29.23 13.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.625 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.534 HG23 ' HB3' ' A' ' 142' ' ' SER . 70.4 p -79.79 -2.32 42.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.771 0.319 . . . . 0.0 111.472 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.51 78.27 0.25 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.909 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -146.58 -41.19 0.2 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.736 0.303 . . . . 0.0 111.122 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.729 HD12 HD21 ' A' ' 143' ' ' LEU . 1.5 mt -114.8 140.6 25.63 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.065 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.538 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.1 Cg_endo -74.35 145.93 34.86 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.24 1.96 . . . . 0.0 112.042 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.699 HG12 HG23 ' A' ' 37' ' ' ILE . 35.0 mt -61.92 136.69 24.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.805 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.06 164.17 26.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.08 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.425 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 1.3 p30 -117.77 123.21 45.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.128 0.49 . . . . 0.0 112.115 -179.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.718 HD12 ' SG ' ' A' ' 34' ' ' CYS . 0.8 OUTLIER -101.21 135.65 42.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.507 -0.77 . . . . 0.0 108.923 178.472 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 1.014 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.21 159.1 43.53 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -178.764 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.491 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -146.71 149.89 34.31 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 113.766 -1.561 . . . . 0.0 111.146 178.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.679 ' O ' HG23 ' A' ' 55' ' ' VAL . 11.5 m-20 -79.18 123.95 27.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.088 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 49.3 mt -64.46 -42.58 95.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.176 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.3 p -56.97 -40.0 75.68 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.307 0.575 . . . . 0.0 110.704 -179.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.443 ' CG ' ' HB2' ' A' ' 51' ' ' ASP . 4.6 mm100 -68.58 -36.89 79.33 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.756 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.723 HG22 ' HG2' ' A' ' 63' ' ' LYS . 39.4 t -73.04 -49.1 41.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.126 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.22 -29.6 68.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.928 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.2 tptt -77.31 -59.07 2.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.785 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -76.69 133.91 39.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.886 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.77 49.56 2.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.984 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.74 -65.63 0.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.924 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 31.3 t -178.99 -38.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.754 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.748 HD13 ' N ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -132.62 151.22 34.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.949 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.748 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -117.58 -64.62 1.28 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.133 -179.859 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.403 ' CE ' ' O ' ' A' ' 49' ' ' SER . 6.4 ttpt -137.17 130.83 31.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.003 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.63 HG23 HD11 ' A' ' 62' ' ' ILE . 4.4 t -118.69 136.33 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 121.36 0.6 . . . . 0.0 111.94 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.633 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 15.4 m-90 -100.68 140.37 35.05 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.516 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.757 HG23 ' CG ' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -111.35 129.22 56.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.201 177.978 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.678 ' CD1' ' HB2' ' A' ' 76' ' ' TYR . 5.8 m-85 -120.39 145.42 47.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.472 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.651 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.49 -168.64 36.76 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.025 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.452 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 6.4 mtm105 -79.03 3.09 18.31 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.456 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 23.7 t-20 -84.7 131.74 48.62 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.612 0.244 . . . . 0.0 111.101 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.0 Cg_exo -66.14 -14.01 42.45 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.584 2.189 . . . . 0.0 111.59 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.87 -44.05 15.87 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 121.841 0.829 . . . . 0.0 108.803 178.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -40.19 138.91 0.79 Allowed 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 113.78 -1.554 . . . . 0.0 110.951 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 67' ' ' THR . 10.9 m-20 -56.73 -19.22 15.6 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.355 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.678 ' HB2' ' CD1' ' A' ' 68' ' ' PHE . 12.6 t80 -130.36 113.66 14.63 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.672 0.273 . . . . 0.0 111.027 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.403 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.6 t-160 -85.87 107.83 17.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.672 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.557 HD22 ' HA2' ' A' ' 69' ' ' GLY . 8.0 mp -81.77 -78.76 0.18 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.007 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -173.25 -94.24 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.084 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.41 ' HA ' ' HD2' ' A' ' 70' ' ' ARG . 8.5 p30 -179.81 50.29 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.825 0.345 . . . . 0.0 111.143 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.407 HG22 ' H ' ' A' ' 83' ' ' ARG . 26.0 mm -79.05 125.49 38.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.848 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.751 ' HB3' HD21 ' B' ' 170' ' ' LEU . 0.3 OUTLIER -54.93 -37.21 66.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.913 -179.875 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.741 ' NH1' HG23 ' A' ' 136' ' ' VAL . 6.2 mtp180 -69.53 -37.14 76.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.108 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.558 HD21 HG23 ' A' ' 132' ' ' VAL . 44.6 mt -83.74 151.58 25.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.837 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 95.3 p -97.79 164.8 12.24 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.656 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.651 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.5 m-20 -42.55 -52.4 4.77 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.497 0.665 . . . . 0.0 109.61 179.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.732 ' HB3' HG22 ' A' ' 67' ' ' THR . 3.8 mttt -118.9 84.14 2.14 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 177.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.554 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.4 t60 -62.88 -44.7 95.4 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.103 -0.953 . . . . 0.0 113.137 -176.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.544 ' HZ ' HD13 ' A' ' 143' ' ' LEU . 0.1 OUTLIER -148.7 161.8 41.02 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.985 -0.686 . . . . 0.0 112.234 -179.564 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.757 ' CG ' HG23 ' A' ' 67' ' ' THR . 28.3 mt-30 -135.08 155.53 50.58 Favored 'General case' 0 C--N 1.334 -0.065 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.389 -178.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.709 HD11 HD11 ' A' ' 145' ' ' ILE . 32.5 mt -130.48 132.49 64.61 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.343 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 177.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.633 HD21 HD22 ' A' ' 121' ' ' ASN . 0.9 OUTLIER -122.73 145.78 48.09 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.069 0.461 . . . . 0.0 111.877 -179.392 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.807 HD22 ' CG1' ' A' ' 33' ' ' VAL . 8.2 tp -125.1 144.28 50.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.185 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.37 165.38 31.85 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.488 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -63.76 118.48 8.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.808 0.337 . . . . 0.0 110.956 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 176.96 -36.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.844 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 115.57 22.01 4.89 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.568 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -159.68 -177.59 6.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.766 0.317 . . . . 0.0 110.792 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.704 HD11 HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -118.74 158.75 24.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.851 179.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.751 HD13 ' O ' ' A' ' 122' ' ' GLN . 3.4 mm? -124.06 138.83 54.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.469 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.808 HD11 HD13 ' A' ' 124' ' ' LEU . 9.2 mp -112.6 125.06 53.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.048 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.622 ' HB2' HD23 ' A' ' 92' ' ' LEU . 50.4 t30 -115.8 115.75 26.82 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.785 ' OD2' HG23 ' A' ' 116' ' ' VAL . 8.8 p30 -78.08 142.9 37.83 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.524 HG21 ' OE1' ' A' ' 90' ' ' GLN . 8.1 pt -150.35 37.56 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -178.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.587 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.43 148.52 24.13 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 120.948 0.404 . . . . 0.0 111.712 -179.045 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.487 HG21 ' CG2' ' B' ' 169' ' ' TPO . 18.2 m -68.63 -31.37 70.47 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.64 177.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -94.56 -19.54 20.41 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.587 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.8 152.0 9.6 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.227 -0.987 . . . . 0.0 113.888 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.472 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.7 m -117.57 137.86 52.31 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.869 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -118.39 148.3 42.67 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.514 HD13 ' OD2' ' A' ' 128' ' ' ASP . 0.2 OUTLIER -124.16 113.65 18.61 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.484 177.541 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.409 ' N ' HD12 ' A' ' 111' ' ' LEU . 8.7 m-80 45.3 43.01 7.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.273 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.5 -7.65 75.35 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.512 178.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -104.42 118.63 37.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.018 0.437 . . . . 0.0 110.671 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.869 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.0 tptm -74.12 121.5 21.25 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.187 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.785 HG23 ' OD2' ' A' ' 103' ' ' ASP . 8.2 m -96.22 163.57 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.133 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -69.77 128.83 37.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.493 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.686 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 12.4 tttt -53.72 162.77 0.8 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.764 0.316 . . . . 0.0 110.29 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.8 m-80 33.5 37.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.846 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.9 p -111.78 145.16 39.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.893 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.633 HD22 HD21 ' A' ' 92' ' ' LEU . 6.4 m120 -88.83 124.44 34.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.864 0.364 . . . . 0.0 110.713 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.751 ' O ' HD13 ' A' ' 100' ' ' LEU . 50.6 mm-40 -128.98 149.45 50.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.598 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.5 tp -72.63 132.85 44.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.889 0.376 . . . . 0.0 110.441 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.834 HD11 HG21 ' A' ' 145' ' ' ILE . 64.0 tp -69.47 157.85 36.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.428 0.633 . . . . 0.0 111.519 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.427 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.6 OUTLIER -124.33 153.17 42.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.926 179.59 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.705 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.25 122.9 21.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.979 0.419 . . . . 0.0 110.659 -179.314 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 56.98 22.93 44.05 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.267 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.514 ' OD2' HD13 ' A' ' 111' ' ' LEU . 15.5 t70 -56.17 175.06 0.11 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.852 0.358 . . . . 0.0 110.828 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.923 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.0 mt-10 -143.8 135.63 26.36 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.081 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.667 HD11 HG13 ' A' ' 145' ' ' ILE . 2.2 mp -112.5 128.14 69.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.574 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.567 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.0 m -104.32 145.12 30.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.443 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.558 HG23 HD21 ' A' ' 84' ' ' LEU . 29.9 m -140.37 158.46 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.052 0.453 . . . . 0.0 112.156 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.51 42.01 12.32 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.268 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.472 ' HB ' ' CH2' ' A' ' 110' ' ' TRP . 74.8 t -86.67 140.4 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-O 121.544 0.688 . . . . 0.0 112.124 -179.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 139.22 -34.1 2.1 Favored Glycine 0 N--CA 1.435 -1.371 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.838 HG22 HD12 ' B' ' 172' ' ' ILE . 9.0 t -124.56 118.34 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -50.77 -29.6 11.94 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -178.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 31.9 m -93.61 6.7 47.38 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -178.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.418 ' CB ' ' HD3' ' A' ' 83' ' ' ARG . 0.8 OUTLIER -130.07 31.28 4.69 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -178.583 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.567 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.1 mt -107.11 138.46 32.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-O 121.351 0.595 . . . . 0.0 110.866 178.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.407 HD23 ' C ' ' A' ' 141' ' ' LEU . 9.3 tt -125.09 134.72 52.38 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.692 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.534 ' HB3' HG23 ' A' ' 40' ' ' THR . 44.4 t -106.84 149.62 27.22 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.544 0.688 . . . . 0.0 112.066 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.729 HD21 HD12 ' A' ' 43' ' ' ILE . 75.6 mt -136.39 158.04 45.36 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.695 -1.138 . . . . 0.0 111.219 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.923 HG22 ' CG ' ' A' ' 129' ' ' GLU . 21.7 t -129.18 140.16 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.851 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.834 HG21 HD11 ' A' ' 124' ' ' LEU . 1.1 mm -106.36 129.55 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 CA-C-O 120.944 0.402 . . . . 0.0 110.911 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.02 110.67 21.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.858 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.705 HD13 ' HA ' ' A' ' 126' ' ' GLN . 4.3 mp -85.83 134.14 27.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.483 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -84.94 123.69 30.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.819 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -72.01 -27.78 62.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.069 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -58.74 -44.43 90.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.035 0.445 . . . . 0.0 110.756 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -59.36 -44.09 92.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.898 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.06 -40.66 95.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.905 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -59.16 -47.03 86.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.086 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 11.8 t -60.91 -45.99 92.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.968 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.65 -43.46 98.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.911 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -61.47 -39.6 91.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.814 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -68.17 -26.02 65.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.926 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -123.54 96.73 5.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.006 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 6.9 mttm -107.72 136.24 47.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.825 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.2 m -65.01 126.52 24.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.107 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -152.35 -46.05 0.1 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.952 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 63.15 -79.58 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.01 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.3 pp -89.19 135.01 26.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.178 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.955 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 5.6 p30 . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.784 0.326 . . . . 0.0 111.256 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.96 100.82 53.17 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.908 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -49.36 167.39 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.483 2.122 . . . . 0.0 112.381 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -108.52 117.47 34.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.915 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 169' ' ' TPO . . . . . 0.487 ' CG2' HG21 ' A' ' 106' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.751 HD21 ' HB3' ' A' ' 82' ' ' SER . 1.0 OUTLIER -156.4 -176.56 6.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.068 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . 0.509 ' O ' ' O ' ' B' ' 172' ' ' ILE . 31.0 mt-10 -145.24 68.6 1.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.94 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 0.838 HD12 HG22 ' A' ' 136' ' ' VAL . 15.0 tt 49.22 157.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.161 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 173' ' ' TYR . . . . . 0.423 ' N ' HG12 ' B' ' 172' ' ' ILE . 11.8 m-85 -53.85 92.1 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.078 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.951 -179.988 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.847 0.356 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.8 p -125.05 -44.28 1.92 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.954 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -46.98 64.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.95 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.3 ttm-85 -69.9 -43.25 72.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.9 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.66 -35.01 73.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.842 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.64 -40.81 96.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.94 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.503 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 10.2 mm -72.45 -35.29 51.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.231 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -57.41 -40.37 78.15 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.923 0.392 . . . . 0.0 110.301 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.24 -23.89 65.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.749 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.503 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.64 -47.63 79.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.364 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.62 -47.04 14.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.093 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -129.93 114.07 15.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.105 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -70.88 158.76 35.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -87.61 101.86 14.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.923 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.2 mm -86.9 138.48 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 CA-C-O 121.719 0.771 . . . . 0.0 111.903 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.7 62.79 4.29 Favored Glycine 0 C--N 1.316 -0.572 0 CA-C-N 114.443 -1.253 . . . . 0.0 112.581 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -83.81 -43.01 15.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.873 0.368 . . . . 0.0 110.986 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.436 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER -169.99 34.68 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 -179.9 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.682 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 2.9 mm -77.77 134.02 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 CA-C-N 113.878 -1.51 . . . . 0.0 112.58 -177.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.997 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -90.25 -60.89 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.677 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.6 p -146.14 150.8 36.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.169 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.97 138.12 50.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.743 0.306 . . . . 0.0 111.214 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.605 HG21 ' HE2' ' A' ' 68' ' ' PHE . 26.6 t -101.7 122.66 54.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.874 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.577 HG23 HG12 ' A' ' 45' ' ' ILE . 18.9 mt -129.43 125.78 62.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.405 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.475 ' SG ' HD21 ' A' ' 141' ' ' LEU . 7.4 t -95.36 107.37 19.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.904 0.383 . . . . 0.0 110.485 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 79.3 p -82.02 -20.6 38.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.516 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.7 HG21 ' OG ' ' A' ' 142' ' ' SER . 12.3 p -80.04 -3.1 47.11 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.736 0.303 . . . . 0.0 111.333 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.39 70.93 0.97 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 121.087 -0.578 . . . . 0.0 113.775 178.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.524 ' HB2' HD21 ' A' ' 141' ' ' LEU . 7.4 mt-30 -145.08 -37.36 0.28 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.623 0.249 . . . . 0.0 111.469 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.835 HD13 ' HB3' ' A' ' 78' ' ' LEU . 52.2 mt -123.55 142.83 39.99 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.097 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.66 ' HD2' HG23 ' A' ' 43' ' ' ILE . 53.0 Cg_endo -71.97 146.04 46.37 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.206 1.937 . . . . 0.0 112.25 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.577 HG12 HG23 ' A' ' 37' ' ' ILE . 35.2 mt -59.58 144.22 12.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.773 -179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.34 164.02 31.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.013 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -131.64 119.85 21.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.993 0.425 . . . . 0.0 112.114 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.816 HD23 ' CD2' ' A' ' 66' ' ' TRP . 8.2 mp -87.25 133.83 33.62 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 178.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.997 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -138.69 156.18 47.62 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 -179.444 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.462 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -143.87 141.75 30.47 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 113.455 -1.702 . . . . 0.0 110.706 178.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.857 ' O ' HG23 ' A' ' 55' ' ' VAL . 39.9 m-20 -89.17 128.1 35.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.077 0.465 . . . . 0.0 111.232 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.589 ' H ' HD12 ' A' ' 52' ' ' ILE . 5.1 mp -64.26 -45.18 96.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.81 -179.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 73.2 m -56.66 -41.22 76.87 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.343 0.592 . . . . 0.0 110.603 -178.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.492 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 19.6 mt-30 -68.49 -36.58 79.13 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.228 -0.897 . . . . 0.0 110.546 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 51' ' ' ASP . 61.3 t -58.68 -49.26 83.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.066 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.6 -37.28 80.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.956 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -67.35 -36.22 80.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.918 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.78 114.83 23.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.69 88.4 4.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.805 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.68 156.42 9.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m -57.84 -26.84 62.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.031 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.866 HD11 ' CG2' ' A' ' 65' ' ' VAL . 8.5 tp -114.99 146.95 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.111 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.633 ' HD3' HG13 ' A' ' 55' ' ' VAL . 1.8 pttt -131.98 -43.95 0.97 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.252 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.417 ' HE2' ' O ' ' A' ' 49' ' ' SER . 2.6 ttpt -154.77 134.03 12.5 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.933 0.397 . . . . 0.0 111.648 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.866 ' CG2' HD11 ' A' ' 62' ' ' ILE . 21.8 t -135.34 139.43 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.776 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.816 ' CD2' HD23 ' A' ' 48' ' ' LEU . 19.7 m-90 -102.21 138.7 38.81 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.086 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.655 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -115.52 125.15 52.66 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.275 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.662 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.8 OUTLIER -108.09 145.58 33.85 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.305 -178.668 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.736 ' CA ' HD21 ' A' ' 78' ' ' LEU . . . 166.64 178.52 39.27 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.831 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.463 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 9.3 mtp-105 -73.46 -5.29 39.01 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.441 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.0 t-20 -84.89 134.96 40.53 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.699 0.285 . . . . 0.0 111.038 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 10.0 Cg_exo -69.76 -5.22 15.68 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.815 2.343 . . . . 0.0 111.831 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.54 -43.38 17.19 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 122.022 0.915 . . . . 0.0 108.558 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -44.04 139.34 2.51 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 113.641 -1.618 . . . . 0.0 110.469 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -56.12 -18.93 11.26 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.066 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.548 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 7.0 t80 -129.73 133.25 46.92 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.866 0.365 . . . . 0.0 110.94 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -109.77 120.42 42.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.643 179.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.835 ' HB3' HD13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -101.36 -81.63 0.48 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.124 -179.879 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.09 -133.07 1.41 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.512 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -138.73 66.7 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.879 0.371 . . . . 0.0 111.439 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.465 HG22 ' H ' ' A' ' 83' ' ' ARG . 31.6 mm -97.11 117.8 42.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.253 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.932 ' HB2' HD13 ' B' ' 170' ' ' LEU . 92.5 p -54.77 -30.98 58.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.19 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.517 ' CZ ' HD21 ' B' ' 170' ' ' LEU . 1.6 mmp_? -71.51 -23.65 61.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.386 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.524 HD21 HG23 ' A' ' 132' ' ' VAL . 29.5 mt -94.23 152.08 18.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.503 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 85.7 p -96.57 166.6 11.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.851 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.672 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 1.5 m-80 -42.81 -52.88 4.86 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.437 0.637 . . . . 0.0 109.675 179.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.554 ' HB2' HD12 ' A' ' 104' ' ' ILE . 3.7 ptmm? -120.51 84.78 2.28 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 177.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.59 ' CD2' ' HB2' ' A' ' 105' ' ' SER . 14.1 t60 -60.3 -46.99 87.94 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.952 -1.022 . . . . 0.0 113.042 -176.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.518 ' HA ' HG12 ' A' ' 104' ' ' ILE . 29.3 p90 -151.61 159.54 44.02 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.874 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.655 ' HG3' HG23 ' A' ' 67' ' ' THR . 5.2 tt0 -136.11 139.56 43.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.55 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.662 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 29.4 mt -116.17 129.58 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.915 179.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.613 HD21 HD22 ' A' ' 121' ' ' ASN . 0.4 OUTLIER -114.58 149.33 36.7 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.234 0.54 . . . . 0.0 112.029 -179.541 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.859 HD22 HG11 ' A' ' 33' ' ' VAL . 57.9 tp -125.19 125.88 44.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.033 179.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -123.01 149.37 16.82 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.584 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.45 107.41 0.66 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.791 0.329 . . . . 0.0 110.899 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -177.8 -39.62 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.896 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 130.8 -21.44 4.7 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.654 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -109.23 172.33 6.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.76 0.314 . . . . 0.0 111.076 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.63 ' HB2' HD13 ' A' ' 124' ' ' LEU . 1.7 mt -116.07 160.06 20.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.665 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.687 HD23 ' HB3' ' A' ' 121' ' ' ASN . 6.3 mp -125.51 139.15 53.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.55 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.593 HD11 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -112.87 123.4 50.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.084 179.665 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.452 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 61.1 t30 -117.74 115.85 25.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.889 0.376 . . . . 0.0 111.967 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.843 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.3 p30 -78.49 142.99 37.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.924 178.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.554 HD12 ' HB2' ' A' ' 87' ' ' LYS . 11.5 pt -147.76 28.0 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.651 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.59 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 11.3 t -93.56 155.09 17.5 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 121.584 0.707 . . . . 0.0 112.598 -178.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.573 HG21 ' HB ' ' B' ' 169' ' ' TPO . 65.9 m -70.1 -52.17 25.83 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.731 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -78.54 0.57 25.63 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.44 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.07 154.28 30.77 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 120.75 -0.738 . . . . 0.0 114.041 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.546 HG22 ' CG2' ' A' ' 130' ' ' ILE . 3.7 m -117.5 137.86 52.26 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.811 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -116.1 148.54 40.16 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -177.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.892 HD12 HG11 ' A' ' 116' ' ' VAL . 1.0 OUTLIER -124.44 113.64 18.41 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.956 177.363 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 48.3 35.53 5.73 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.072 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.17 -4.8 83.05 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.853 -0.689 . . . . 0.0 113.515 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.37 118.57 36.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.934 0.397 . . . . 0.0 110.498 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.811 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 9.1 tptm -71.04 111.64 6.56 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.128 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.892 HG11 HD12 ' A' ' 111' ' ' LEU . 17.1 m -87.89 162.95 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.106 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.8 OUTLIER -69.91 127.88 34.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.497 179.725 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.681 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 53.9 tttm -54.47 161.68 1.35 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.865 0.364 . . . . 0.0 110.517 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.506 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.9 p30 35.45 33.89 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.371 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.38 145.09 40.71 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.991 179.279 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.687 ' HB3' HD23 ' A' ' 100' ' ' LEU . 11.0 m120 -90.14 131.42 36.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.904 0.383 . . . . 0.0 110.976 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.442 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 43.9 mm-40 -129.28 148.77 51.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.43 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.61 123.96 24.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.374 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.63 HD13 ' HB2' ' A' ' 99' ' ' LEU . 7.8 tt -55.21 154.34 5.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.484 0.659 . . . . 0.0 111.723 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.419 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.73 153.24 42.68 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.303 179.73 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.56 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.66 126.35 29.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.828 0.347 . . . . 0.0 110.182 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.44 20.3 50.69 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.224 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.419 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 11.0 t70 -53.48 164.36 0.51 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.892 0.377 . . . . 0.0 111.074 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.7 tt0 -144.26 135.39 25.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.928 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.593 HD11 HD11 ' A' ' 101' ' ' LEU . 1.4 mp -109.1 127.02 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.598 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.592 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.7 m -104.17 140.48 37.76 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.527 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.0 m -140.18 158.42 25.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.87 23.6 41.28 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.283 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.437 ' HB ' ' CH2' ' A' ' 110' ' ' TRP . 82.2 t -68.34 140.47 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-O 121.515 0.674 . . . . 0.0 111.915 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.755 ' HA3' HG21 ' B' ' 172' ' ' ILE . . . 141.79 -41.23 1.24 Allowed Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -178.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.94 ' CG2' HD13 ' B' ' 172' ' ' ILE . 2.2 t -120.32 123.31 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.16 -31.05 12.63 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.68 6.75 47.29 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -178.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.506 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . 16.7 m-20 -125.34 31.0 5.67 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -178.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.592 ' CG2' HG22 ' A' ' 131' ' ' THR . 10.0 mt -106.42 138.71 30.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-O 121.456 0.646 . . . . 0.0 110.985 178.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' A' ' 143' ' ' LEU . 1.1 tt -124.76 134.53 52.76 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.517 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.7 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.7 OUTLIER -111.43 131.47 55.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.072 0.463 . . . . 0.0 111.698 -179.699 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.735 ' CD2' HD22 ' A' ' 141' ' ' LEU . 2.8 mm? -127.56 134.41 49.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.555 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 18.8 t -110.68 133.96 54.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.854 0.359 . . . . 0.0 111.18 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.569 ' CD1' HG22 ' A' ' 36' ' ' VAL . 1.2 mm -106.2 121.22 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.08 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -99.88 129.39 45.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.663 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.645 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.3 mp -92.54 129.21 43.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.867 0.365 . . . . 0.0 111.209 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -82.81 113.26 20.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.983 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 28.4 p-10 -61.17 -26.69 67.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.976 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.65 -43.44 84.92 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.007 0.432 . . . . 0.0 110.556 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -58.73 -43.7 90.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.746 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.0 mtmp? -63.77 -34.64 78.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.89 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.84 -36.89 78.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.065 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.0 t -66.1 -41.94 89.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.925 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.58 -37.86 82.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.942 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.28 -46.17 90.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.933 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -80.37 -34.05 36.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.1 p30 42.31 85.06 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.534 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -74.94 128.44 35.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.925 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 28.5 t -93.92 127.05 46.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.058 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 60.99 -178.34 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -106.14 172.47 6.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.0 pt -100.83 116.87 45.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.212 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.855 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 165' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.854 0.359 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -113.21 113.24 49.04 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.914 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.57 -177.39 0.9 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.313 2.009 . . . . 0.0 112.137 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 168' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -143.74 48.61 1.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.045 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 169' ' ' TPO . . . . . 0.573 ' HB ' HG21 ' A' ' 106' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.932 HD13 ' HB2' ' A' ' 82' ' ' SER . 1.5 tt -57.64 152.8 14.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.5 -179.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -151.73 143.97 24.0 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.62 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 0.94 HD13 ' CG2' ' A' ' 136' ' ' VAL . 1.1 tp -52.83 140.77 7.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.967 0.413 . . . . 0.0 111.236 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 173' ' ' TYR . . . . . 0.813 ' H ' HD12 ' B' ' 172' ' ' ILE . 1.7 m-85 -42.73 162.69 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.257 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 74.4 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.911 -179.995 . . . . . . . . 0 0 . 1 stop_ save_